<SEC-DOCUMENT>0001628280-21-023213.txt : 20211112 <SEC-HEADER>0001628280-21-023213.hdr.sgml : 20211112 <ACCEPTANCE-DATETIME>20211112171626 ACCESSION NUMBER: 0001628280-21-023213 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 66 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211112 DATE AS OF CHANGE: 20211112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001087294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33637 FILM NUMBER: 211404867 BUSINESS ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE, STATE: TN ZIP: 37203 BUSINESS PHONE: 615-255-0068 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 </SEC-HEADER> <DOCUMENT> <TYPE>10-Q <SEQUENCE>1 <FILENAME>cpix-20210930.htm <DESCRIPTION>10-Q <TEXT> <XBRL> <?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:719f38f6-81ec-4e77-a876-c86386f0dd09,g:3c5f884f-ec0b-48db-97a2-96993ede30b3,d:8e8bdb91dc894234b9d87e17a18b54fd--><html xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:cpix="http://www.cumberlandpharma.com/20210930" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/> <title>cpix-20210930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80L2ZyYWc6ODk0NTg5NTU0MWNiNGQzYWFjY2U2ZDFkODcxNmI4ODYvdGFibGU6NTczZThlZjFjZTVkNGNkNzljZTcwYWE4ZDQ3OWMyNWMvdGFibGVyYW5nZTo1NzNlOGVmMWNlNWQ0Y2Q3OWNlNzBhYThkNDc5YzI1Y181LTEtMS0xLTk1NTg_cb626646-506a-4773-ac71-5f2cad713dc8">2021</ix:nonNumeric><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80L2ZyYWc6ODk0NTg5NTU0MWNiNGQzYWFjY2U2ZDFkODcxNmI4ODYvdGFibGU6NTczZThlZjFjZTVkNGNkNzljZTcwYWE4ZDQ3OWMyNWMvdGFibGVyYW5nZTo1NzNlOGVmMWNlNWQ0Y2Q3OWNlNzBhYThkNDc5YzI1Y182LTEtMS0xLTk1NTg_c6478a7c-da3a-4b2d-a18c-094fdad418d7">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" format="ixt:fixed-false" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80L2ZyYWc6ODk0NTg5NTU0MWNiNGQzYWFjY2U2ZDFkODcxNmI4ODYvdGFibGU6NTczZThlZjFjZTVkNGNkNzljZTcwYWE4ZDQ3OWMyNWMvdGFibGVyYW5nZTo1NzNlOGVmMWNlNWQ0Y2Q3OWNlNzBhYThkNDc5YzI1Y183LTEtMS0xLTk1NTg_28954d82-22f1-466a-afde-42cf97abdc80">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80L2ZyYWc6ODk0NTg5NTU0MWNiNGQzYWFjY2U2ZDFkODcxNmI4ODYvdGV4dHJlZ2lvbjo4OTQ1ODk1NTQxY2I0ZDNhYWNjZTZkMWQ4NzE2Yjg4Nl83OA_2bdee78c-154e-4d86-88a8-03ce3ee1095d">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80L2ZyYWc6ODk0NTg5NTU0MWNiNGQzYWFjY2U2ZDFkODcxNmI4ODYvdGV4dHJlZ2lvbjo4OTQ1ODk1NTQxY2I0ZDNhYWNjZTZkMWQ4NzE2Yjg4Nl83OQ_bfd22206-570a-4a0c-9502-ece83f38b7bb">0001087294</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cpix-20210930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i997bd44925334429a7698804c0800bcd_I20211108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-11-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i5fc3bb3df16548c98cacace445d903da_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb172cb6365440839665fd6ec022472c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb58760ea84940319b35492cd1910735_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cpix:ClinigenHealthcareLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifca7f9fa06d14f85a52cbd81ac170d2c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cpix:ClinigenHealthcareLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45bdfab35dd74d60ac86fc023b908b73_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cpix:ClinigenHealthcareLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8c8802e62b74a919450a1c6017bba7e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cpix:ClinigenHealthcareLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fa410e0219e41c3b8a23d8140a1ca8c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ae7216a773d47d889c5f34d67e867fe_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90ac8e9aca0748058577add35fc3a6f9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f67242cec184569be979f0eab3bb2dd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1925af7a08774bc4a2752a9cd6b75c35_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf2c0f582f1a48b1b7132666868a1789_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4167fc9dfbd441ed853e3173c4f077bf_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4f1350ea2fc4eb18dc553f1c359d775_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94a852cb675745e89723e30ec61bfcee_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98ca8db1bbc14991a38ad2f127cdc3f7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9ade7c2b96049c891663efff729f1ef_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia79d5a078419401d86bc7174c913bcf6_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8cac0f57d4c4aa1bf61accf6f74bfda_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62b7e40824ec46c1a5d32166d46d8910_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i374ad433cb0d4675ae41fef76147919d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7d9f053c7b34fd799481310c6ca1498_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06622f546c724e4289669409575c7f9d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5c699d5da91427e80a66ec6b1991b3a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70a1ecea99f7485195b3405682bd0c55_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fb60215b0504a758fcf2dfe00ea4b97_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00b5fc7364e347f39acdca8004cef0f9_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i786c6ae7dd8d4840bb2995fce1423b07_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c344dec4461400991796893b71c39f3_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1cdf0875abf4833a9b0038791a1ea6c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e43169536834b7daa78040307754845_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1adc976609fe48d4b014ec48f05e022c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i169b3e774913430bb6c450a8d1cd8300_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i659fa119f70c4793a43053cddb879d71_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50909170032a4c00a004f6dd1808751c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42e8ab4712444a43a1f231cb65ac3dcd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idecbe529c8e14131b56433eb5e130916_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c8473bff64c498ab624fafa4cca5132_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i781a96ef93c24d05bb7f12625a033ec0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38154999f15f41cca19a77a5f4d0ccac_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d845908b01747ac9d721fff45f53abf_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32deafcb20a948cf995118abdf3ce1a4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2593ac397b63496686231e5a4d277b3b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8320ae6bb40c49b4b91522210805d996_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief227cab10a245ff9baa903632237a80_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83fce5d3edda4b1cbab16d0e4a53c979_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe562d54463741e8949d25484a516053_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f91139b751f41ee943e86bdb734f2f4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ea7194dbc454dbdbc6632db38bf6066_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic49c90ad54954ba9a5f89e54eb1dfedb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1e3b4d188524c1791c80059e8f7515a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64b2d71ddb0c448d9959f1b9a74a7dad_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10df7b4f9a35418da7673ef6ae315d51_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae1347d2d1d84aa3a135e3245bdf0d90_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cc79eb883d54f61bdec225f436b82c9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56aafc7718c145c8b150a8e54f33a5d2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1da3f9dccc043f1b509c4e381803002_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied663adb59564577989ed6d27ea6493f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>cpix:Segment</xbrli:measure></xbrli:unit><xbrli:context id="i2b064560ae764b05aee16232fc2b982f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:AcetadoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9189ef3c405466780ff2b301ce69072_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:AcetadoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib543c8c5c4a0438eb3b83a9549c72767_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:KristaloseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i851181d1e03446adb4d2b6f666a489e7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:KristaloseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i343ad32279094a2585bfa47056ea0769_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:OmeclamoxPakMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf76fee1053a41f897bb2b308eda43b7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:OmeclamoxPakMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a175b2126f3439e978ef755a5187703_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:VIBATIVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1221e6e62b0d4437aa038a1593455cdb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:VIBATIVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide5a86375216464d9ebfdf112640aff3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:KristaloseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d2eab230e924fb094455dfdb93d19f6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:KristaloseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib32ee538452d4d108fd0d0249f232e4e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:CaldolorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie38185217cb649a98c782f849b956b81_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:CaldolorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb5e5973ac81495ca434caa4250ad1e6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:VIBATIVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f2cff2563f6434383fad1a3433a95bf_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:VIBATIVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87b67bdb94e6413eab1ada4bb36a71b7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:VaprisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70e186cdc2a444de9d34c6b0a9840fa3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:VaprisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0301ef84e6814fc1afd5bda0bb02be0c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:VaprisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10d6fa0a80234f6fbdf7f486df4beed1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:VaprisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba2b0e3ce8dc46a892511cbd1f0b38cf_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:AcetadoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2075e961d64a4c4184f2117135160c9e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:AcetadoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67bca755a168477fb7af6f54edd41311_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:CaldolorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i369b52ac1f754a4a9275b8917dc3bb9d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:CaldolorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2206c2c78e3347cf9fd2bb7625961847_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:OmeclamoxPakMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64299c3a88d84d888de7a4e8264da6a1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:OmeclamoxPakMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica59276837544b3e89921005c9db373f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:RediTrexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d8203f933864c8d869320c4b6ce16d2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:RediTrexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if79d16ca01cf493f84c3a1bcbcf07c1d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:RediTrexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3900d92fcea4358838f65d608ad8088_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:RediTrexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d6efd6bd2c041769f9fbf0d1a3e5685_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:OtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1571108ca25f4e179a9d14073629ae96_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:OtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cf12a139ea74881b685de000f63434e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:OtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbd3b5d4865547179a8bf7fbe50a430c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:OtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7beb09efdc954e3387adf27b4cc99538_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c591eb458184e3baae21c9c26245264_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32601382eaeb463ba862531b12def23c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76c8b1e743d441a3ad6f81bc894366dd_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i890f0fecec4a4eb899b3171ad304df32_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:VIBATIVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d7014c036534d1ab07ea1c7138ece74_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:VIBATIVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fb3c2ea35a146918884002eb0319cb9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">cpix:IfetrobanClinicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85407d87b0cc40608f88c792ee3187bc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">cpix:IfetrobanClinicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:context id="ifd0c03fd249e4e64a76675f06c950be1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67e0bde90efc45a7a814f5c68fb0096f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">srt:OfficeBuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i6b60adc716c54226bd1b0d9f82b62a4c_I20100513"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2010-05-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d045c0da7504a3081ac01dc90d95aed_I20160131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3eac19ab71204baa8b814cd80e8e55ab_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i545187d4937e41ec99d80966b809dd78_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b890701c9304f309d867768f2a90a7b_D20171101-20171130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-11-01</xbrli:startDate><xbrli:endDate>2017-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib59b0ab18a9847a48768cc76def0c5ce_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7109429b4bb94262ab81694be586f875_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i448fcba2bca740069897cf519754695f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie91a73f23b39413ca4897ecef5e9c6b9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cpix:IncentiveStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie35d5d79a31d4a97ada4dc5eb118435d_I20211028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cpix:FifthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cpix:PinnacleBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i433310853533429eb0bd0de42c8cb8c0_D20200814-20200814"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cpix:PinnacleBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-14</xbrli:startDate><xbrli:endDate>2020-08-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7857ace04dd14acd90de8bfdfc44e2ad_D20200814-20200814"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cpix:PinnacleBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-14</xbrli:startDate><xbrli:endDate>2020-08-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia066a8f68c2c4b2bb8d23f93616af446_D20200814-20200814"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-14</xbrli:startDate><xbrli:endDate>2020-08-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c79a3c371c84f16b64c6d20ef3f26bd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cpix:PinnacleBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29e07103e7b54d69af01f448919f0979_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cpix:PinnacleBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5729693e898c46118beacc910390b13c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f0ec15fc71f49aca22d17a26142e958_D20200420-20200420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cpix:PinnacleBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-20</xbrli:startDate><xbrli:endDate>2020-04-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f3eb3a61d724b16837687fe50bb6592_I20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cpix:WinHealthInvestmentSingaporeLtdDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10ede8aae6b6477eb6df1f13d1f8042a_I20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cpix:WinHealthInvestmentSingaporeLtdDomain</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic25c3441c5a0477ebd8c769c3ea98555_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57f795672a2a465e9209a65e0162f0b4_D20181101-20181130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:VIBATIVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-01</xbrli:startDate><xbrli:endDate>2018-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id08ba9ef8fce4ef0b1aebddae7a819be_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:VIBATIVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0463cd68913447b0aec736a9a21b1701_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:VIBATIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf562c30b2d9493a84db87baebada783_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:VIBATIVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7d1c3dbcd4b4c6eabe94af067f29d41_D20161101-20161130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:MethotrexateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-11-01</xbrli:startDate><xbrli:endDate>2016-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb1ab73ec0354946b843823c167cac73_D20161101-20161130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:MethotrexateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-11-01</xbrli:startDate><xbrli:endDate>2016-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fbce1ec780d49a78a390da0ae5f4c6c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:MethotrexateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a2ac195a36045adacdf507f9366ba39_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:MethotrexateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0899d206bf0144cb8f97b035bbc59bdc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:MethotrexateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab3199a2232b4c38950a9c717c8b9171_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:MethotrexateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c783d360e1948c18a55f375b9840bca_D20191001-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cpix:ClinigenHealthcareLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54eac56082574a4c986a915dc06c3af5_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_1"></div><div style="min-height:45pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGV4dHJlZ2lvbjozZGQ5ZTk2YjM3YTk0MWJiYmZkZDMxMDNmZmJiM2ZjNF8xOTc0_413f7ba7-e2d7-436a-8c53-feb9f8cd07ef">10-Q</ix:nonNumeric> </span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" format="ixt:fixed-true" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6ZmZkZGI4YTQ0NDg5NGE1NmJhY2FlNTk3YzhhNjRkYjYvdGFibGVyYW5nZTpmZmRkYjhhNDQ0ODk0YTU2YmFjYWU1OTdjOGE2NGRiNl8wLTAtMS0xLTk1NTg_0193c29b-07e6-4626-b4b6-5b4b054e6863">☒</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGV4dHJlZ2lvbjozZGQ5ZTk2YjM3YTk0MWJiYmZkZDMxMDNmZmJiM2ZjNF8xMzA_b4ca3137-0810-4842-98d1-620cf0993095">September 30, 2021</ix:nonNumeric> </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" format="ixt:fixed-false" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6YWM5M2U4YzMwNDdiNGJiMGE0MDNhYjdjMzdhZWY4YzAvdGFibGVyYW5nZTphYzkzZThjMzA0N2I0YmIwYTQwM2FiN2MzN2FlZjhjMF8wLTAtMS0xLTk1NTg_ce9f6d89-702f-45c0-8e61-a2522acd25a8">☐</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from             to             .</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number: <ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGV4dHJlZ2lvbjozZGQ5ZTk2YjM3YTk0MWJiYmZkZDMxMDNmZmJiM2ZjNF8xOTc4_36805ec4-cee7-4afa-801f-1742a659163e">001-33637</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGV4dHJlZ2lvbjozZGQ5ZTk2YjM3YTk0MWJiYmZkZDMxMDNmZmJiM2ZjNF8xOTY5_4cf731a1-abc1-422a-9c7b-5330e5e0ce7c">Cumberland Pharmaceuticals Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact Name of Registrant as Specified In Its Charter)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:48.532%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6YTM3MjY2MzViN2FiNGVjZmIzOGE5YzQzM2IwZDMyMjgvdGFibGVyYW5nZTphMzcyNjYzNWI3YWI0ZWNmYjM4YTljNDMzYjBkMzIyOF8wLTAtMS0xLTk1NTg_8583c7e4-a8b7-4425-9c38-63f67826b600">Tennessee</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6YTM3MjY2MzViN2FiNGVjZmIzOGE5YzQzM2IwZDMyMjgvdGFibGVyYW5nZTphMzcyNjYzNWI3YWI0ZWNmYjM4YTljNDMzYjBkMzIyOF8wLTItMS0xLTk1NTg_6f20bc22-eb7c-4658-b1b3-084391b2a373">62-1765329</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or Other Jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporation or Organization)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identification No.)</span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6YTM3MjY2MzViN2FiNGVjZmIzOGE5YzQzM2IwZDMyMjgvdGFibGVyYW5nZTphMzcyNjYzNWI3YWI0ZWNmYjM4YTljNDMzYjBkMzIyOF8zLTAtMS0xLTk1NTgvdGV4dHJlZ2lvbjo5ZTFmYTY1YWJjMTY0YmZlOTVlYWE5ZDY1N2EyMTdhNl81_b5979669-f620-46bc-9dbf-9c4cabcab966">2525 West End Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6YTM3MjY2MzViN2FiNGVjZmIzOGE5YzQzM2IwZDMyMjgvdGFibGVyYW5nZTphMzcyNjYzNWI3YWI0ZWNmYjM4YTljNDMzYjBkMzIyOF8zLTAtMS0xLTk1NTgvdGV4dHJlZ2lvbjo5ZTFmYTY1YWJjMTY0YmZlOTVlYWE5ZDY1N2EyMTdhNl85_e78457b9-2afe-4c2b-b82e-2f2567bd5d4c">Suite 950</ix:nonNumeric>,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6YTM3MjY2MzViN2FiNGVjZmIzOGE5YzQzM2IwZDMyMjgvdGFibGVyYW5nZTphMzcyNjYzNWI3YWI0ZWNmYjM4YTljNDMzYjBkMzIyOF8zLTAtMS0xLTk1NTgvdGV4dHJlZ2lvbjo5ZTFmYTY1YWJjMTY0YmZlOTVlYWE5ZDY1N2EyMTdhNl8xMw_75339330-5a44-452f-9806-700c80e6b3bf">Nashville</ix:nonNumeric>, <ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6YTM3MjY2MzViN2FiNGVjZmIzOGE5YzQzM2IwZDMyMjgvdGFibGVyYW5nZTphMzcyNjYzNWI3YWI0ZWNmYjM4YTljNDMzYjBkMzIyOF8zLTAtMS0xLTk1NTgvdGV4dHJlZ2lvbjo5ZTFmYTY1YWJjMTY0YmZlOTVlYWE5ZDY1N2EyMTdhNl8xNw_4323f3b1-7adb-4ac9-b793-7e689744eb90">Tennessee</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6YTM3MjY2MzViN2FiNGVjZmIzOGE5YzQzM2IwZDMyMjgvdGFibGVyYW5nZTphMzcyNjYzNWI3YWI0ZWNmYjM4YTljNDMzYjBkMzIyOF8zLTItMS0xLTk1NTg_de47de8e-7def-40af-a663-b858ad864ead">37203</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of Principal Executive Offices)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></div></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGV4dHJlZ2lvbjozZGQ5ZTk2YjM3YTk0MWJiYmZkZDMxMDNmZmJiM2ZjNF8xOTcw_431485a3-0c85-4366-8baf-d5389ef35036">615</ix:nonNumeric>) <ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGV4dHJlZ2lvbjozZGQ5ZTk2YjM3YTk0MWJiYmZkZDMxMDNmZmJiM2ZjNF8xOTc5_d4442311-1438-4c31-8204-2a61f56d85ca">255-0068</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant’s Telephone Number, Including Area Code)</span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.269%"><tr><td style="width:1.0%"></td><td style="width:31.774%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.585%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6OGVkMTI3NTMwNjQ2NDJhZjhkMDQ1M2M3Y2JlNDExMTQvdGFibGVyYW5nZTo4ZWQxMjc1MzA2NDY0MmFmOGQwNDUzYzdjYmU0MTExNF8yLTAtMS0xLTk1NTg_dbc6485a-9b04-48d9-ab1e-933fafa8d685">Common stock, no par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6OGVkMTI3NTMwNjQ2NDJhZjhkMDQ1M2M3Y2JlNDExMTQvdGFibGVyYW5nZTo4ZWQxMjc1MzA2NDY0MmFmOGQwNDUzYzdjYmU0MTExNF8yLTItMS0xLTk1NTg_ce24b53b-7247-410b-ad91-432b01c6b5ac">CPIX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6OGVkMTI3NTMwNjQ2NDJhZjhkMDQ1M2M3Y2JlNDExMTQvdGFibGVyYW5nZTo4ZWQxMjc1MzA2NDY0MmFmOGQwNDUzYzdjYmU0MTExNF8yLTQtMS0xLTk1NTg_a291ec19-e1df-41ae-9b90-3e40561e3ef8">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGV4dHJlZ2lvbjozZGQ5ZTk2YjM3YTk0MWJiYmZkZDMxMDNmZmJiM2ZjNF8xOTcx_a1197e3d-0243-4955-858b-e5861b80cc79">Yes</ix:nonNumeric>  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">☒</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">    No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">☐</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files.)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGV4dHJlZ2lvbjozZGQ5ZTk2YjM3YTk0MWJiYmZkZDMxMDNmZmJiM2ZjNF8xOTcz_0ecac0a7-c30d-45ed-afd0-a854de4113ed">Yes</ix:nonNumeric>  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">☒</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">    No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">☐</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.431%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.923%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.434%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Large accelerated filer</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">☐</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accelerated filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">☐</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6MTlkZWY3YjM0OGE0NGQxMTg0Y2I0MDVkNjk3MTJlOTEvdGFibGVyYW5nZToxOWRlZjdiMzQ4YTQ0ZDExODRjYjQwNWQ2OTcxMmU5MV8xLTAtMS0xLTk1NTg_a13d1c57-8798-413c-b5aa-c8cb048eeeff">Non-accelerated filer</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">☒</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Smaller reporting company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" format="ixt:fixed-true" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6MTlkZWY3YjM0OGE0NGQxMTg0Y2I0MDVkNjk3MTJlOTEvdGFibGVyYW5nZToxOWRlZjdiMzQ4YTQ0ZDExODRjYjQwNWQ2OTcxMmU5MV8xLTUtMS0xLTk1NTg_e9748f51-9a1a-4a17-b634-37be966893d1">☒</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Emerging growth company</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" format="ixt:fixed-false" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6MTlkZWY3YjM0OGE0NGQxMTg0Y2I0MDVkNjk3MTJlOTEvdGFibGVyYW5nZToxOWRlZjdiMzQ4YTQ0ZDExODRjYjQwNWQ2OTcxMmU5MV8yLTItMS0xLTk1NTg_821ed55f-0c00-421e-a584-5e383491ef49">☐</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">☐</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" format="ixt:fixed-false" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGV4dHJlZ2lvbjozZGQ5ZTk2YjM3YTk0MWJiYmZkZDMxMDNmZmJiM2ZjNF8xOTcy_0ec90156-7610-4193-b1bb-515ad245e4fb">☐</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">    No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">☒</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: <ix:nonFraction unitRef="shares" contextRef="i997bd44925334429a7698804c0800bcd_I20211108" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGV4dHJlZ2lvbjozZGQ5ZTk2YjM3YTk0MWJiYmZkZDMxMDNmZmJiM2ZjNF8xOTM0_ab701435-31e9-4fbd-bbbe-411e26afa1cb">14,809,628</ix:nonFraction> shares of common stock as of November 8, 2021.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="margin-top:9pt"><span><br/></span></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_7"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUMBERLAND PHARMACEUTICALS INC.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:82.331%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.469%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_10">PART I – FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_10">1</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;padding-right:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_13">Item 1. Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_13">1</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_16">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_16">1</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_19">Condensed Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_19">2</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_22">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_22">3</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_25">Condensed Consolidated Statements of Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_25">4</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_28">Notes to the Unaudited Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_28">5</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_58">Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_58">15</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_79">Item 3. Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_79">28</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_82">Item 4. Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_82">28</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_85">PART II – OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_85">29</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_88">Item 1. Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_88">29</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_91">Item 1A. Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_91">29</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_94">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_94">29</a></span></div></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_97">Item 6. Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_97">30</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_100">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8e8bdb91dc894234b9d87e17a18b54fd_100">31</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I – FINANCIAL INFORMATION</span></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_13"></div><div style="-sec-extract:summary;margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements (Unaudited)</span></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_16"></div><div style="-sec-extract:summary;margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:58.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMy0xLTEtMS05NTU4_787d08f4-2adf-45cf-8ada-8543d9c4b7c2">25,843,231</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMy0zLTEtMS05NTU4_20b75322-7cc4-45af-a7b9-5bad822d5257">24,753,796</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfNS0xLTEtMS05NTU4_6164065d-c25f-42e4-aed6-8dd4a5841b0f">9,850,530</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfNS0zLTEtMS05NTU4_e5d96494-3cdc-41c5-8e4a-906eb5f179a1">12,377,713</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfNi0xLTEtMS05NTU4_4091615e-1774-4c16-aa12-07e5ffc72fe1">10,262,769</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfNi0zLTEtMS05NTU4_13de659e-a85f-4081-b06d-3f0c52b59079">10,638,157</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfNy0xLTEtMS05NTU4_568cd97a-6a6c-4229-9766-4c44f00313a8">1,259,098</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfNy0zLTEtMS05NTU4_b5991ed0-da52-464e-8879-f96ae93c44a2">2,199,926</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfOC0xLTEtMS05NTU4_4f9a7cdd-26b3-4189-ab38-3d0c2752e571">47,215,628</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfOC0zLTEtMS05NTU4_65f340e6-74d7-4cfb-8680-658c8b0c7355">49,969,592</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfOS0xLTEtMS05NTU4_0a7c4539-54b6-4642-9ec1-09646f9defe7">9,476,737</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfOS0zLTEtMS05NTU4_a3509e15-8629-4f7b-bfda-f1d4dc62d644">11,656,742</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTAtMS0xLTEtOTU1OA_004f0d13-8464-41b7-9449-bf9485368979">493,488</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTAtMy0xLTEtOTU1OA_c827415f-8dde-4bd9-9046-8ad08abe9049">574,169</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTEtMS0xLTEtOTU1OA_920a2aaf-4d92-4bf8-a5dc-58ff9573a845">24,918,830</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTEtMy0xLTEtOTU1OA_1a9fc573-d3af-4646-aafd-ca0c7bba6963">28,118,316</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTItMS0xLTEtOTU1OA_7254f054-db53-436c-9ae6-407968371295">882,000</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTItMy0xLTEtOTU1OA_713236f1-498e-41a5-9fa9-38897a12caf9">882,000</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTMtMS0xLTEtOTU1OA_03898100-deee-4659-8993-7d7a00a7e0cb">1,282,275</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTMtMy0xLTEtOTU1OA_863fa60a-3bd3-4571-9ab0-fd2514ae1214">2,028,148</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTQtMS0xLTEtOTU1OA_801dd865-0a0e-49e3-bc13-7bd89a23b7d2">3,301,816</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTQtMy0xLTEtOTU1OA_3f1cd0a6-9066-4941-82a0-79fd010cd287">3,234,338</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTUtMS0xLTEtOTU1OA_6706308c-7f71-4f21-972f-a8ad2870ec2e">87,570,774</ix:nonFraction> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTUtMy0xLTEtOTU1OA_82aecfa9-2487-419d-a33e-917eac28150e">96,463,305</ix:nonFraction> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTgtMS0xLTEtOTU1OA_e8ba911c-7e76-467c-b067-eb434552668d">9,233,383</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTgtMy0xLTEtOTU1OA_be938f19-8780-42e5-8abd-ed1477094964">13,396,286</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTktMS0xLTEtOTU1OA_2e433f39-34c1-4921-a1eb-2c04de7596b4">1,094,187</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTktMy0xLTEtOTU1OA_bf87e2d5-b8e2-423f-a2f7-8d0c2eb7ad8b">1,016,779</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjAtMS0xLTEtOTU1OA_3a3e9276-4446-462c-a7f5-4e7eef72aa6d">7,617,913</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjAtMy0xLTEtOTU1OA_725654e5-26d7-4902-9849-bd17c75541fc">11,254,381</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjEtMS0xLTEtOTU1OA_d3d1b324-a332-4b6d-a876-cb7d8d486075">17,945,483</ix:nonFraction> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjEtMy0xLTEtOTU1OA_b49161b8-b618-488e-b4a6-773df0e33080">25,667,446</ix:nonFraction> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving line of credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LongTermLineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjItMS0xLTEtOTU1OA_af71ed23-ef84-4ab4-95f6-8d24a4bf3e9c">15,000,000</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LongTermLineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjItMy0xLTEtOTU1OA_7a2cac12-dbbc-42cb-9a68-445a8d1da521">15,000,000</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjMtMS0xLTEtOTU1OA_ac21f239-47a9-4048-b4e5-fb6a30904c23">229,605</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjMtMy0xLTEtOTU1OA_04dacca8-58ff-48be-bfca-d19061523658">1,059,693</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="cpix:OtherLongTermObligationsExcludingCurrentPortion" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjQtMS0xLTEtOTU1OA_c19e5623-3ca3-42df-8206-a6ce00f2578f">7,749,421</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="cpix:OtherLongTermObligationsExcludingCurrentPortion" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjQtMy0xLTEtOTU1OA_a62c5665-b11d-4da6-a66d-afb64849d36e">7,862,772</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjUtMS0xLTEtOTU1OA_73ff469a-33c7-4e34-b6de-c03e5cbf5c37">40,924,509</ix:nonFraction> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjUtMy0xLTEtOTU1OA_21c45af4-7bbb-4e9f-93c5-e8cc48452fdc">49,589,911</ix:nonFraction> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjYtMS0xLTEtOTU1OA_66f332c8-513c-4391-89f7-80f43f532cdc"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjYtMy0xLTEtOTU1OA_339a1c3d-e189-4d33-8982-7a811ac1d9a2"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders’ equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock—<ix:nonFraction unitRef="usdPerShare" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:CommonStockNoParValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjktMC0xLTEtOTU1OC90ZXh0cmVnaW9uOjVjNjY5YmEwMWIwNzRiZWE5ZWZmYWFhMWRlZDI3YmRhXzE3_9a3bc384-8dfc-4d87-8e86-c41e535e62b9"><ix:nonFraction unitRef="usdPerShare" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:CommonStockNoParValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjktMC0xLTEtOTU1OC90ZXh0cmVnaW9uOjVjNjY5YmEwMWIwNzRiZWE5ZWZmYWFhMWRlZDI3YmRhXzE3_d7c4882b-b860-43a2-8bfd-14b2f3796291">no</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjktMC0xLTEtOTU1OC90ZXh0cmVnaW9uOjVjNjY5YmEwMWIwNzRiZWE5ZWZmYWFhMWRlZDI3YmRhXzMx_1c740f40-7da7-456f-95fa-9268f3238850"><ix:nonFraction unitRef="shares" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjktMC0xLTEtOTU1OC90ZXh0cmVnaW9uOjVjNjY5YmEwMWIwNzRiZWE5ZWZmYWFhMWRlZDI3YmRhXzMx_53125269-be7e-42ef-9921-6f2a51910e59">100,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjktMC0xLTEtOTU1OC90ZXh0cmVnaW9uOjVjNjY5YmEwMWIwNzRiZWE5ZWZmYWFhMWRlZDI3YmRhXzUz_6b190ba3-e572-4622-ba7a-b37fdcadfb15"><ix:nonFraction unitRef="shares" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjktMC0xLTEtOTU1OC90ZXh0cmVnaW9uOjVjNjY5YmEwMWIwNzRiZWE5ZWZmYWFhMWRlZDI3YmRhXzUz_bb67aab8-19d8-476d-8916-e107f319fb15">14,850,526</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjktMC0xLTEtOTU1OC90ZXh0cmVnaW9uOjVjNjY5YmEwMWIwNzRiZWE5ZWZmYWFhMWRlZDI3YmRhXzYw_4c6882e3-b738-41e7-a85b-56aacaf9ed05"><ix:nonFraction unitRef="shares" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjktMC0xLTEtOTU1OC90ZXh0cmVnaW9uOjVjNjY5YmEwMWIwNzRiZWE5ZWZmYWFhMWRlZDI3YmRhXzYw_8d49a5ab-c46e-42ea-a4f8-80205bda09b4">14,988,429</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjktMS0xLTEtOTU1OA_9c6d8501-d714-4356-87c0-7924d6ddc4ef">48,612,935</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjktMy0xLTEtOTU1OA_769b8ef2-f306-486a-9e63-a06957175847">49,121,523</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings (deficit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMzAtMS0xLTEtOTU1OA_3b15b693-c359-4ce7-b87f-511e55fa1eef">1,790,903</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMzAtMy0xLTEtOTU1OA_5d68e1b4-1c75-4931-a323-8e5fc3315e24">2,131,013</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders’ equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMzEtMS0xLTEtOTU1OA_c5e3a62d-c398-4bf2-bdea-affe7c7df09f">46,822,032</ix:nonFraction> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMzEtMy0xLTEtOTU1OA_c9407c7c-e82b-42a2-ab9c-ea2529d40ef9">46,990,510</ix:nonFraction> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:MinorityInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMzItMS0xLTEtOTU1OA_cad970f6-47ee-4c47-b6c9-68e9a38d0b2f">175,767</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:MinorityInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMzItMy0xLTEtOTU1OA_1ea42f2e-d2d2-4282-b4f5-ac7cb8cbeda9">117,116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMzMtMS0xLTEtOTU1OA_423074bc-2abb-4837-80ba-f1b03dfed65d">46,646,265</ix:nonFraction> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMzMtMy0xLTEtOTU1OA_0ee8ed29-747b-41b1-85ea-72ef916138ac">46,873,394</ix:nonFraction> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMzQtMS0xLTEtOTU1OA_0ab55b8c-68bc-426b-8dd2-9ef966d2fbfe">87,570,774</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMzQtMy0xLTEtOTU1OA_72a379ed-af9c-48c1-b7a0-22bff9f116e2">96,463,305</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Unaudited Condensed Consolidated Financial Statements. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMi0xLTEtMS05NTU4_6f46574a-47f1-4e7e-83a2-11d516edf5df">8,072,540</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMi0zLTEtMS05NTU4_781307c7-4873-440a-a67f-16f5e8051428">9,250,689</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMi01LTEtMS05NTU4_8fe8b1e2-7d0e-48d4-832c-abcbb47375bc">27,665,182</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMi03LTEtMS05NTU4_b207bca1-855a-42c8-a38f-b516c62c0810">27,179,600</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNC0xLTEtMS05NTU4_30ab3989-a784-4170-8210-f4be533b3726">1,328,027</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNC0zLTEtMS05NTU4_1c21b574-e3de-4cec-ad57-4f7203ac943f">2,142,839</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNC01LTEtMS05NTU4_2b82165b-3391-40fe-a80f-40a5f1978c1e">5,486,005</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNC03LTEtMS05NTU4_e0b06033-3b40-42d4-9e09-9da2d367ea4e">6,387,002</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNS0xLTEtMS05NTU4_d52d2797-a9a4-423f-8498-e0bc613433b4">3,800,288</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNS0zLTEtMS05NTU4_f398d241-1297-4a49-8c83-c0fda68dc2e6">3,587,842</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNS01LTEtMS05NTU4_1e12fbb7-fcb2-46f9-a167-e40e704bcd35">11,709,445</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNS03LTEtMS05NTU4_5730eef7-534c-4101-962f-a45a5ba9752c">11,160,924</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNi0xLTEtMS05NTU4_05867931-330e-4627-af39-5446206d6911">1,453,873</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNi0zLTEtMS05NTU4_2e927709-7a9e-45c2-971b-eedb8d26f8cd">1,230,335</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNi01LTEtMS05NTU4_3c87e122-3c97-43b7-b1da-8b80290d7f0a">4,071,638</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNi03LTEtMS05NTU4_707984ff-0726-49c9-bee3-3fb751c02d13">4,374,392</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNy0xLTEtMS05NTU4_7ad913a9-6ea3-457d-a36c-183a1bc3f50e">2,039,799</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNy0zLTEtMS05NTU4_cd118aae-c492-4977-9b43-f06bef4041a6">2,381,273</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNy01LTEtMS05NTU4_51a66d19-bed2-4820-943b-44d902fd58d7">6,367,438</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNy03LTEtMS05NTU4_2dea87ad-3e9a-4662-a320-d4b528758da6">6,608,321</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfOC0xLTEtMS05NTU4_9eddcd2e-8186-4a8b-83dc-8a4d3cdabb2d">1,013,948</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfOC0zLTEtMS05NTU4_a8010101-60c6-47cc-bc0d-16bc9147d98f">1,117,086</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfOC01LTEtMS05NTU4_cefad2e7-9dff-44fd-bdce-dfe606df4451">3,354,080</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfOC03LTEtMS05NTU4_887a51b6-b6be-4f90-b32b-ea605eea9dec">3,284,610</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfOS0xLTEtMS05NTU4_9c2c75c1-9664-463c-b7ef-84f47727fa13">9,635,935</ix:nonFraction> </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfOS0zLTEtMS05NTU4_30f0355f-3abd-47b9-b804-f2432eeab0bc">10,459,375</ix:nonFraction> </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfOS01LTEtMS05NTU4_91cbb7d5-4f2f-4682-9016-39e0ee0e3387">30,988,606</ix:nonFraction> </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfOS03LTEtMS05NTU4_10c21e8b-bb5c-47c1-927b-370d46368b2a">31,815,249</ix:nonFraction> </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTAtMS0xLTEtOTU1OA_ae1a9867-e350-43ac-bfe5-1bea13f9f96e">1,563,395</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTAtMy0xLTEtOTU1OA_aed8b499-3963-46c0-8e86-e674dbcf5105">1,208,686</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTAtNS0xLTEtOTU1OA_7f0a5665-0b83-4f2a-bc2b-9d5a18a632c0">3,323,424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTAtNy0xLTEtOTU1OA_285e5679-4ce2-4028-bb45-76b0e4029e6f">4,635,649</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTEtMS0xLTEtOTU1OA_b79c0005-d793-42ad-8871-3e5affea3b4c">7,394</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTEtMy0xLTEtOTU1OA_33714327-17f9-432a-bbd7-05e7bdb63b6b">12,004</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTEtNS0xLTEtOTU1OA_e5c8d4b5-17d5-4c4a-8a7f-2f627a542e07">19,411</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTEtNy0xLTEtOTU1OA_41104900-f351-491a-bab1-b30b9fd15234">70,553</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" format="ixt:fixed-zero" name="us-gaap:OtherIncome" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTItMS0xLTEtOTU1OA_dd85f6d7-3a80-400d-b618-f051b8483b96">—</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" format="ixt:fixed-zero" name="us-gaap:OtherIncome" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTItMy0xLTEtOTU1OA_9d09f8e6-d7c4-4f40-a2a4-b171d5f6123e">—</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherIncome" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTItNS0xLTEtOTU1OA_0e4fd688-c910-4bc8-a68f-9b8c0c944e76">2,187,140</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:fixed-zero" name="us-gaap:OtherIncome" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTItNy0xLTEtOTU1OA_55a923b2-ca81-4b0e-a82e-ebace9edccc2">—</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTMtMS0xLTEtOTU1OA_67f8592b-00b5-4034-a33b-ecd29f48ef95">20,021</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTMtMy0xLTEtOTU1OA_1ddd391c-88a9-4c1f-bbe0-4f9e226a4b32">75,210</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTMtNS0xLTEtOTU1OA_65623fa4-671a-43c5-bde5-8562e9b49515">70,297</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTMtNy0xLTEtOTU1OA_bc5b3654-4886-420f-a374-45cc9684a22a">227,730</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTQtMS0xLTEtOTU1OA_0c797158-a708-4ac6-8d37-0262cd0dd6fa">1,576,022</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTQtMy0xLTEtOTU1OA_2569ea11-8714-4d6c-baf4-e91df255bc78">1,271,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTQtNS0xLTEtOTU1OA_5e69759b-231d-41c7-ba19-5564cd6e1ce0">1,187,170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTQtNy0xLTEtOTU1OA_8b452270-9963-4838-9755-92ce0bae4762">4,792,826</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense) benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTUtMS0xLTEtOTU1OA_b869375d-639f-4754-abf2-01920f3599d8">7,458</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTUtMy0xLTEtOTU1OA_aa81b9db-f796-42d9-83d8-c60ef02c0315">3,728</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTUtNS0xLTEtOTU1OA_30ff0664-3748-402f-8681-afd87fbec2c7">22,375</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTUtNy0xLTEtOTU1OA_335dcc55-efaa-477d-9b65-d9261b0045d2">45,423</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTYtMS0xLTEtOTU1OA_3656b68a-e37c-4633-8dd8-a003efd3e39e">1,583,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTYtMy0xLTEtOTU1OA_ec6850d2-e817-4b14-9487-ff3e910e4c91">1,275,620</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTYtNS0xLTEtOTU1OA_4c64bffd-ba77-41a6-8d18-51bfc653c845">1,209,545</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTYtNy0xLTEtOTU1OA_85fb5be7-0aae-4020-9da3-9e25c9015f6a">4,838,249</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb58760ea84940319b35492cd1910735_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTctMS0xLTEtOTU1OA_86849bd9-9c34-42dc-a4b6-2061e77af27b">496,787</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca7f9fa06d14f85a52cbd81ac170d2c_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTctMy0xLTEtOTU1OA_0fe8db84-b272-4c9f-a304-4c34cd7b14a3">777,916</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45bdfab35dd74d60ac86fc023b908b73_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTctNS0xLTEtOTU1OA_1acd7b61-10d3-4d57-a3bb-db27abac79f0">1,491,004</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c8802e62b74a919450a1c6017bba7e_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTctNy0xLTEtOTU1OA_841b8fa5-722e-49de-805f-6e1ba99049bf">2,334,811</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTgtMS0xLTEtOTU1OA_ff808f60-a689-42b1-b71a-d3683b123ee4">1,086,693</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTgtMy0xLTEtOTU1OA_4509f6be-b34d-4bbe-b84e-cdb293c90119">497,704</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTgtNS0xLTEtOTU1OA_ae2476e8-c4f3-48c3-8213-5c212995ddb4">281,459</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTgtNy0xLTEtOTU1OA_3a624214-4eec-4a5b-928a-eb7a9881e84b">2,503,438</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss at subsidiary attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTktMS0xLTEtOTU1OA_95b61dfc-d977-4115-94c6-54e0d0af5a99">31,415</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTktMy0xLTEtOTU1OA_2141b745-6e38-4f81-959c-3756a18c45c0">15,967</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTktNS0xLTEtOTU1OA_ce0a12c3-7567-454b-93ce-355822e98dea">58,651</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTktNy0xLTEtOTU1OA_f17bcff7-0f96-4279-931e-32336eb1034d">47,806</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjAtMS0xLTEtOTU1OA_8e25e5e8-98f3-44fe-bcfe-7cb6ae67a6e0">1,055,278</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjAtMy0xLTEtOTU1OA_4df57ef8-bc72-4d47-97d5-a0535ac6e0d4">481,737</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjAtNS0xLTEtOTU1OA_5cb25c6b-5d1e-43e1-a9db-72676163fbcd">340,110</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjAtNy0xLTEtOTU1OA_f7aef4bc-6f7d-491b-8a3f-1c613544acf4">2,455,632</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share attributable to common shareholders</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- Continuing operations - basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjItMS0xLTEtOTU1OA_c3ee7aaf-3a59-42cd-940a-86344d472155">0.10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjItMy0xLTEtOTU1OA_e9a75676-a793-4eb3-85fb-048dbf56209e">0.08</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjItNS0xLTEtOTU1OA_b0a294d3-17b1-4601-a366-4fe9f21c4be0">0.08</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjItNy0xLTEtOTU1OA_cda5bd02-15e1-473c-812c-74665fa1fe4d">0.31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- Discontinued operations - basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjMtMS0xLTEtOTU1OA_37f3b733-baaf-4885-bf03-c35f039ca671">0.03</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjMtMy0xLTEtOTU1OA_bab9de8c-5909-4833-b95a-6100886a552d">0.05</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjMtNS0xLTEtOTU1OA_928e6367-0e20-47fc-9aa7-165419cb71eb">0.10</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjMtNy0xLTEtOTU1OA_a5dbfd8d-da81-4d2e-99b3-639e22d701d2">0.15</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjQtMS0xLTEtOTU1OA_faad5f17-3f38-4945-98da-5539c2be542d">0.07</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjQtMy0xLTEtOTU1OA_86b37b93-22c3-4dfd-bfe1-cd362d65aa78">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjQtNS0xLTEtOTU1OA_a166b8d6-4829-434d-b0a4-41dcc0e1ab67">0.02</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjQtNy0xLTEtOTU1OA_989cb314-176e-4a6d-903b-7ce71e9e7714">0.16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- Continuing operations - diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjYtMS0xLTEtOTU1OA_2551170e-c478-440a-807a-3ecc39c0c8e9">0.10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjYtMy0xLTEtOTU1OA_e55be91d-017f-4f3b-8125-0783557edcc2">0.08</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjYtNS0xLTEtOTU1OA_ed699d40-1314-4c13-bdb5-9ff9f8c481c8">0.08</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjYtNy0xLTEtOTU1OA_65b47aa0-3662-4ea9-9da8-c2b69a32a832">0.31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- Discontinued operations - diluted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjctMS0xLTEtOTU1OA_9765f3af-225f-496c-97ee-9241f98051c2">0.03</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjctMy0xLTEtOTU1OA_15fc1ada-b89e-4061-a698-326ecf4cfdb3">0.05</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjctNS0xLTEtOTU1OA_b4bac775-1172-46db-b64d-6c3011ba516d">0.10</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjctNy0xLTEtOTU1OA_3624f2a6-007b-41dc-ac2a-0f85f44e9264">0.15</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjgtMS0xLTEtOTU1OA_07e652a8-0c5b-47b7-9c3a-111848dece26">0.07</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjgtMy0xLTEtOTU1OA_fe830645-ab82-48af-85e3-456b5dcbc53d">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjgtNS0xLTEtOTU1OA_51ea79d0-37ad-4ad4-8e73-5b994ed87c28">0.02</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjgtNy0xLTEtOTU1OA_0307a832-9abe-4cc4-8ea6-470da96f1710">0.16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMzAtMS0xLTEtOTU1OA_b5e1a767-1b86-4012-89bc-7628a19420c8">14,880,887</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMzAtMy0xLTEtOTU1OA_7ddc136a-92bb-439a-a38a-0bfad779387e">15,134,583</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMzAtNS0xLTEtOTU1OA_8cdb33ce-1515-4327-ae98-f1d30f78e45a">14,939,919</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMzAtNy0xLTEtOTU1OA_3cebfc23-7264-4ddc-9953-b2de72843968">15,206,179</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- diluted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMzEtMS0xLTEtOTU1OA_206d45ec-0dfd-4dad-a09c-708e034903c8">14,880,887</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMzEtMy0xLTEtOTU1OA_3069879d-a3f8-4c09-bc47-66a88a16ffee">15,134,583</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMzEtNS0xLTEtOTU1OA_680872eb-8fa6-4a35-8e4b-96a35c60f7b4">15,139,904</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMzEtNy0xLTEtOTU1OA_74c47ba6-d296-4d83-a36d-d18b2064f105">15,206,179</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.</span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMy0xLTEtMS05NTU4_89bfef20-b1e6-47a1-9dc7-06a201e0829a">281,459</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMy0zLTEtMS05NTU4_fee615d1-5da9-49f1-89bc-c9c0d4a4e145">2,503,438</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfNC0xLTEtMS05NTU4_34dd9ba9-dc08-41b3-82bc-363744572af1">1,491,004</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfNC0zLTEtMS05NTU4_5d8096f7-9702-46a6-93db-e69127d604a8">2,334,811</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfNS0xLTEtMS05NTU4_5f0e04d7-a344-4a4b-9c88-542330d012a4">1,209,545</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfNS0zLTEtMS05NTU4_960860b7-f805-41c7-895a-ac3c5e8bf7e7">4,838,249</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) from continuing operations to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfNy0xLTEtMS05NTU4_ee98fdcd-e62c-4b78-a6f6-82432089e45e">3,529,245</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfNy0zLTEtMS05NTU4_c94fdef7-2015-4ca1-ac13-6e31fcd40fd2">3,524,684</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfOC0xLTEtMS05NTU4_a3a99d85-8b3f-4c71-b706-09dbc9f771e0">517,081</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfOC0zLTEtMS05NTU4_7ad89641-b6e2-4fd2-a657-a14bc60fad4f">805,338</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in non-cash contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfOS0xLTEtMS05NTU4_4e9f354a-5943-4277-a009-e945dcf7cb59">632,646</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfOS0zLTEtMS05NTU4_0e2e4688-563d-479b-87bd-e057de35e705">806,390</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease (increase) in cash surrender value of life insurance policies over premiums paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="cpix:IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTAtMS0xLTEtOTU1OA_9afe2f51-0b85-42b2-9a50-dbbce7721d86">52,070</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="cpix:IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTAtMy0xLTEtOTU1OA_33d45e09-c9b4-436b-9181-f8a415404be2">169,406</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncash interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTEtMS0xLTEtOTU1OA_9ebcbfae-b3f1-4dd6-9460-56a8bb51eefe">33,943</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTEtMy0xLTEtOTU1OA_e65dfc73-2a12-4051-ad8f-221d3db3618d">36,197</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on forgiveness of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrealizedGainLossOnInvestments" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTItMS0xLTEtOTU1OA_a4383df0-61d1-447f-af4c-33329a82adb5">2,187,140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:fixed-zero" name="us-gaap:UnrealizedGainLossOnInvestments" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTItMy0xLTEtOTU1OA_40ed77d8-fec4-414d-a305-19e4a0be869b">—</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net changes in assets and liabilities affecting operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTQtMS0xLTEtOTU1OA_2e2d328c-bd25-44f4-9295-f1401a59a137">2,527,183</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTQtMy0xLTEtOTU1OA_b0ea097f-859d-472a-8adb-5d2e95b91f6b">1,817,490</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTUtMS0xLTEtOTU1OA_57d3a116-49a7-439a-89e8-e5e19e852dd6">2,555,393</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTUtMy0xLTEtOTU1OA_a03c6e2d-7ef8-4f3b-82ac-4a8639060a8d">1,696,668</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTYtMS0xLTEtOTU1OA_9310532c-e3ef-4b11-9d1a-3db005ddf056">1,627,350</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTYtMy0xLTEtOTU1OA_ce8bf223-c5ed-4abe-a55f-0c73f0333954">1,962,024</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="cpix:IncreaseDecreaseInCurrentOperatingLiabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTctMS0xLTEtOTU1OA_f73493d4-2516-49ec-8d56-5424edcf497a">2,873,596</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="cpix:IncreaseDecreaseInCurrentOperatingLiabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTctMy0xLTEtOTU1OA_90aee167-8384-48a9-b892-c44c544c27f9">3,248,450</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTgtMS0xLTEtOTU1OA_0fb1458a-c29a-41df-a17b-c96348b3efa4">943,439</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTgtMy0xLTEtOTU1OA_62404fce-cf1b-44c8-ab3e-c0704d7899d9">1,585,584</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTktMS0xLTEtOTU1OA_3bf04005-f194-4bbd-9382-7d432fd4761a">2,891,759</ix:nonFraction> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTktMy0xLTEtOTU1OA_c76cd51f-6dd2-4cd4-87e6-10a6acff5d68">2,395,054</ix:nonFraction> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjAtMS0xLTEtOTU1OA_e654619d-3272-4f04-b314-4c818df3b60e">1,491,004</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjAtMy0xLTEtOTU1OA_d3129d7a-782c-4e0c-91fc-872a74d1f0d0">2,166,086</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjEtMS0xLTEtOTU1OA_870ac2ae-ade4-471d-852e-ec36975d6c63">4,382,763</ix:nonFraction> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjEtMy0xLTEtOTU1OA_da16e351-3095-4cfd-a84b-3d53cf653613">4,561,140</ix:nonFraction> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjMtMS0xLTEtOTU1OA_ebcb64fe-ac43-4ffc-84db-23880130db8c">94,485</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjMtMy0xLTEtOTU1OA_c915a898-b0c5-4818-98ef-324aa659c261">95,189</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from surrender of life insurance policies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:fixed-zero" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjQtMS0xLTEtMTA1NDY_f298de6e-c85e-4bb4-ab7a-380f560ce1f3">—</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjQtMy0xLTEtMTA1NDY_2ad0b218-2536-4817-9596-c380cf4d417b">460,888</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note receivable investment funding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireInvestments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjQtMS0xLTEtOTU1OA_eda3c378-0513-4882-ae8b-862d975224d5">200,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:fixed-zero" name="us-gaap:PaymentsToAcquireInvestments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjQtMy0xLTEtOTU1OA_6ee9712a-80e4-48a6-a397-7907f29acbc2">—</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjUtMS0xLTEtOTU1OA_926d3e0c-7e31-4710-8d16-a3218196a913">180,613</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjUtMy0xLTEtOTU1OA_c5095c68-b18f-4f34-a68d-5cf4036cb471">1,807,467</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjYtMS0xLTEtOTU1OA_ffc6f38a-fb40-46d2-ac84-cbfe38356f13">475,098</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjYtMy0xLTEtOTU1OA_6f7754a7-2950-49c4-baa9-9a2c64dc0c97">1,441,768</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings on line of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromRepaymentsOfLinesOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjktMS0xLTEtOTU1OA_ae85fed8-ca82-4f11-982e-bdfcaea8dc0c">45,000,000</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromRepaymentsOfLinesOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjktMy0xLTEtOTU1OA_d8c83a67-e135-47b0-ab0b-00cc3a205b5b">44,000,000</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments on line of credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfNotesPayable" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzAtMS0xLTEtOTU1OA_f4a8db35-27de-4a2e-ab10-732838abc052">45,000,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfNotesPayable" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzAtMy0xLTEtOTU1OA_a51d2968-02b4-430b-8aa3-9eeccb17cc54">45,500,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzEtMS0xLTEtOTU1OA_27389069-bbbc-4c75-888a-953e490697fe">1,792,573</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzEtMy0xLTEtOTU1OA_48a6634a-dce4-400b-8685-2f29b34ee020">834,014</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of subsidiary shares from noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:fixed-zero" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzItMS0xLTEtOTU1OA_3b6a4a18-d9aa-4aab-9615-0a1d8230b5ff">—</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzItMy0xLTEtOTU1OA_1802f395-adcf-41ce-beb8-248285472068">800,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzMtMS0xLTEtOTU1OA_74417a53-889d-4979-88af-96c305f4ae88">1,025,657</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzMtMy0xLTEtOTU1OA_d948002e-b969-4bdc-8231-cc4de64dc7d0">1,551,463</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzQtMS0xLTEtOTU1OA_f00c6231-ecc8-41b8-a509-e8f50d9ec00b">2,818,230</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzQtMy0xLTEtOTU1OA_1980d3ac-9334-43dd-936f-70067baf296b">4,685,477</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzUtMS0xLTEtOTU1OA_24c47d4f-6042-4d09-a4f6-f84d25ec3405">1,089,435</ix:nonFraction> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzUtMy0xLTEtOTU1OA_7b68fff9-947a-49a5-be2d-249a99935a48">1,566,105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzYtMS0xLTEtOTU1OA_0919de68-75d1-4a72-9895-f28f493019e9">24,753,796</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fa410e0219e41c3b8a23d8140a1ca8c_I20191231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzYtMy0xLTEtOTU1OA_860d7006-5a2c-4bbb-990c-33f7a028878c">28,212,635</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzctMS0xLTEtOTU1OA_f5e31f82-39b9-4de8-92d4-0c82043a1730">25,843,231</ix:nonFraction> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ae7216a773d47d889c5f34d67e867fe_I20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzctMy0xLTEtOTU1OA_978bbe5f-89a2-4ad4-924d-4fe9b1a75eb2">26,646,530</ix:nonFraction> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_25"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:31.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.757%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Retained earnings (deficit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total equity</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i90ac8e9aca0748058577add35fc3a6f9_I20191231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfMi0xLTEtMS05NTU4_249ec781-bdca-4a10-8125-8603765510a3">15,263,555</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90ac8e9aca0748058577add35fc3a6f9_I20191231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfMi0zLTEtMS05NTU4_870e48c4-b831-428c-aeff-6b2a40dc00cb">49,914,478</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f67242cec184569be979f0eab3bb2dd_I20191231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfMi01LTEtMS05NTU4_567665d0-f88c-4f2f-b952-5721a65712f5">1,208,395</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1925af7a08774bc4a2752a9cd6b75c35_I20191231" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfMi03LTEtMS05NTU4_36f12a5f-6da4-44a5-94e5-e768c1bca7fc">37,620</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fa410e0219e41c3b8a23d8140a1ca8c_I20191231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfMi05LTEtMS05NTU4_77241509-dc84-4f83-b3f4-a8f8e12ef9f3">51,085,253</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf2c0f582f1a48b1b7132666868a1789_D20200101-20200331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfMy0xLTEtMS05NTU4_aa9262da-6fcb-458a-b15e-7dc3624dd465">219,850</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf2c0f582f1a48b1b7132666868a1789_D20200101-20200331" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfMy0zLTEtMS05NTU4_6563001a-87be-4d8b-82e2-adb204cbd866">264,574</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4167fc9dfbd441ed853e3173c4f077bf_D20200101-20200331" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfMy05LTEtMS05NTU4_2f4d8726-1de5-4065-8f2e-477ffc8fbfa2">264,574</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iaf2c0f582f1a48b1b7132666868a1789_D20200101-20200331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfNC0xLTEtMS05NTU4_1775f463-8b18-4147-90cb-757703376146">164,866</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf2c0f582f1a48b1b7132666868a1789_D20200101-20200331" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfNC0zLTEtMS05NTU4_f53c8451-abaa-44b6-a448-fbbbb3a488f4">441,624</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4167fc9dfbd441ed853e3173c4f077bf_D20200101-20200331" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfNC05LTEtMS05NTU4_88fcf9e9-412f-4903-88c1-e80ad0d62b0f">441,624</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4f1350ea2fc4eb18dc553f1c359d775_D20200101-20200331" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfNS01LTEtMS05NTU4_e05d9dae-6d70-4646-b1a5-c4246b2829b5">1,055,620</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94a852cb675745e89723e30ec61bfcee_D20200101-20200331" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfNS03LTEtMS05NTU4_df04729c-97ac-4b13-85aa-2902531e1579">9,525</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4167fc9dfbd441ed853e3173c4f077bf_D20200101-20200331" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfNS05LTEtMS05NTU4_494a1d21-b392-46e3-8a13-738fde1c33ee">1,065,145</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i98ca8db1bbc14991a38ad2f127cdc3f7_I20200331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfNi0xLTEtMS05NTU4_54089366-d285-48d9-a06a-eb833875fbd1">15,318,539</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98ca8db1bbc14991a38ad2f127cdc3f7_I20200331" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfNi0zLTEtMS05NTU4_8611b822-a493-4416-8f88-f23e7f8414ac">49,737,428</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ade7c2b96049c891663efff729f1ef_I20200331" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfNi01LTEtMS05NTU4_eab4248e-a346-4ea9-8ea5-e8e431160c1d">152,775</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia79d5a078419401d86bc7174c913bcf6_I20200331" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfNi03LTEtMS05NTU4_0aee0b40-0b28-41c0-8fc8-11f58ff8bd26">47,145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8cac0f57d4c4aa1bf61accf6f74bfda_I20200331" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfNi05LTEtMS05NTU4_f134c8c7-20db-4387-bd25-7f968ffc3628">49,843,058</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:31.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.757%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i98ca8db1bbc14991a38ad2f127cdc3f7_I20200331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfMS0xLTEtMS05NTU4_5bfae5c9-3e1a-4eef-a52c-4ba0f1f3ec03">15,318,539</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98ca8db1bbc14991a38ad2f127cdc3f7_I20200331" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfMS0zLTEtMS05NTU4_b5ef76f9-1ec4-433c-b5b6-17af7dd32a3f">49,737,428</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ade7c2b96049c891663efff729f1ef_I20200331" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfMS01LTEtMS05NTU4_fe236be2-a610-49ec-87d8-5280e1433e0d">152,775</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia79d5a078419401d86bc7174c913bcf6_I20200331" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfMS03LTEtMS05NTU4_df26d6b8-d73e-4ab8-9f83-bbed51a74fd1">47,145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8cac0f57d4c4aa1bf61accf6f74bfda_I20200331" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfMS05LTEtMS05NTU4_c915cc4c-08d2-4087-bb3e-42c158d86c4f">49,843,058</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i62b7e40824ec46c1a5d32166d46d8910_D20200401-20200630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfMi0xLTEtMS05NTU4_d4cfa378-3e97-4226-9f36-cfada6799107">4,200</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62b7e40824ec46c1a5d32166d46d8910_D20200401-20200630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfMi0zLTEtMS05NTU4_478d70a1-0421-4ea7-bace-469cc002673c">278,349</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i374ad433cb0d4675ae41fef76147919d_D20200401-20200630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfMi05LTEtMS05NTU4_6b0d670b-02c0-42cc-9616-e33cb046b7bd">278,349</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i62b7e40824ec46c1a5d32166d46d8910_D20200401-20200630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfMy0xLTEtMS05NTU4_548841a5-a7fe-4c8f-9b0d-aed043cc0421">141,463</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62b7e40824ec46c1a5d32166d46d8910_D20200401-20200630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfMy0zLTEtMS05NTU4_5e038516-2bee-4e44-b618-aafe273d4184">769,648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i374ad433cb0d4675ae41fef76147919d_D20200401-20200630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfMy05LTEtMS05NTU4_1fe53f37-d0ff-4dfa-8134-e5bf6512d102">769,648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7d9f053c7b34fd799481310c6ca1498_D20200401-20200630" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfNC01LTEtMS05NTU4_ea0a7385-18e0-45e3-9407-ab943f001e46">918,275</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06622f546c724e4289669409575c7f9d_D20200401-20200630" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfNC03LTEtMS05NTU4_c202d4bd-4445-42ef-b424-f112d53358b5">22,314</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i374ad433cb0d4675ae41fef76147919d_D20200401-20200630" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfNC05LTEtMS05NTU4_9e4e5268-37ae-4e06-9ed6-0bb9098f08ee">940,589</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5c699d5da91427e80a66ec6b1991b3a_I20200630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfNS0xLTEtMS05NTU4_ba6e9aef-46ff-43b9-b878-63a20e112f39">15,181,276</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5c699d5da91427e80a66ec6b1991b3a_I20200630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfNS0zLTEtMS05NTU4_ae912d4a-a419-4caf-8c49-de60e29cfb21">49,246,129</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70a1ecea99f7485195b3405682bd0c55_I20200630" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfNS01LTEtMS05NTU4_b0ee6887-8eef-4bbb-8054-7681ab6e31ec">765,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fb60215b0504a758fcf2dfe00ea4b97_I20200630" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfNS03LTEtMS05NTU4_28ea7e25-8915-42e9-b1b1-e76c15087935">69,459</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00b5fc7364e347f39acdca8004cef0f9_I20200630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfNS05LTEtMS05NTU4_cd97b5f7-7028-4dea-9797-50d5b9f33f13">48,411,170</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:31.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.757%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5c699d5da91427e80a66ec6b1991b3a_I20200630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfMC0xLTEtMS05NTU4_1c203fe2-7e6c-4fcb-9c67-a0836994c554">15,181,276</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5c699d5da91427e80a66ec6b1991b3a_I20200630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfMC0zLTEtMS05NTU4_99d65948-277a-4607-b69e-c3fb47ca8650">49,246,129</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70a1ecea99f7485195b3405682bd0c55_I20200630" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfMC01LTEtMS05NTU4_4a10dfdb-303d-467b-83df-a3dcab39e02d">765,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fb60215b0504a758fcf2dfe00ea4b97_I20200630" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfMC03LTEtMS05NTU4_132d0d50-1764-4f1d-a4a1-6f70c7c05f5a">69,459</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00b5fc7364e347f39acdca8004cef0f9_I20200630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfMC05LTEtMS05NTU4_8d4cc7d0-10d9-4e36-a097-78c1845f90af">48,411,170</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i786c6ae7dd8d4840bb2995fce1423b07_D20200701-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfMS0xLTEtMS05NTU4_f5763c6c-263b-4113-af40-f9c3eb0a0921">4,450</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i786c6ae7dd8d4840bb2995fce1423b07_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfMS0zLTEtMS05NTU4_69e7894c-997a-43c8-9c42-5e40f06986e0">262,415</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfMS05LTEtMS05NTU4_7e1d0225-6b3d-4e13-ac7c-b5fc997896f9">262,415</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i786c6ae7dd8d4840bb2995fce1423b07_D20200701-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfNC0xLTEtMS05NTU4_90846027-9740-4424-9c38-aec27c588373">101,354</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i786c6ae7dd8d4840bb2995fce1423b07_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfNC0zLTEtMS05NTU4_dfb96313-1a84-4e4d-a62b-78e38155311d">332,504</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfNC05LTEtMS05NTU4_55cd4e29-c0f6-4bfc-9a74-b3af62d6a38e">332,504</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c344dec4461400991796893b71c39f3_D20200701-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfNS01LTEtMS05NTU4_62f43be1-5943-4466-a95c-8abde503d415">481,737</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1cdf0875abf4833a9b0038791a1ea6c_D20200701-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfNS03LTEtMS05NTU4_1e0050b6-80e6-45f8-9b89-20b381a71206">15,967</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfNS05LTEtMS05NTU4_4f3390c0-88a2-4ae0-994d-e8d11a4352d8">497,704</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1e43169536834b7daa78040307754845_I20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfNi0xLTEtMS05NTU4_321a406d-5ff5-4794-ad2d-02192e50d59f">15,084,372</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,084,372 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e43169536834b7daa78040307754845_I20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfNi0zLTEtMS05NTU4_6cf60caa-0d71-47b9-b84e-0c83df3122c6">49,176,040</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1adc976609fe48d4b014ec48f05e022c_I20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfNi01LTEtMS05NTU4_c01b96b7-c824-405a-b3ad-bc340d6c26b0">1,247,237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i169b3e774913430bb6c450a8d1cd8300_I20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfNi03LTEtMS05NTU4_4e47f670-e308-4daf-8767-cc9dfb6e4532">85,426</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ae7216a773d47d889c5f34d67e867fe_I20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfNi05LTEtMS05NTU4_bfde1c53-8ddb-4a1c-a27e-5c5949897d3e">47,843,377</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:31.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.757%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:31.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.757%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Retained earnings (deficit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total equity</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i659fa119f70c4793a43053cddb879d71_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfMi0xLTEtMS05NTU4_7057cc7e-0b59-4ae3-9bff-60cdd185c2d1">14,988,429</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i659fa119f70c4793a43053cddb879d71_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfMi0zLTEtMS05NTU4_04aad0b1-30c4-4ea9-8c85-7eadc6329b3a">49,121,523</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50909170032a4c00a004f6dd1808751c_I20201231" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfMi01LTEtMS05NTU4_134c4d4b-8582-480c-abfd-edc4fc3b5b73">2,131,013</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42e8ab4712444a43a1f231cb65ac3dcd_I20201231" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfMi03LTEtMS05NTU4_2844278d-dff4-4ebd-95ec-f5bdda877b84">117,116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfMi05LTEtMS05NTU4_38a0f3f4-23af-4b4f-b382-4f44689f4eee">46,873,394</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idecbe529c8e14131b56433eb5e130916_D20210101-20210331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfMy0xLTEtMS05NTU4_f7574844-4415-4104-a39e-24dc40d3967f">187,759</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idecbe529c8e14131b56433eb5e130916_D20210101-20210331" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfMy0zLTEtMS05NTU4_39c408b4-5326-4ef0-8db1-91b7443aef10">162,960</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c8473bff64c498ab624fafa4cca5132_D20210101-20210331" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfMy05LTEtMS05NTU4_80dd1e2a-1faa-4304-bacb-a245970d3b8f">162,960</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="idecbe529c8e14131b56433eb5e130916_D20210101-20210331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfNC0xLTEtMS05NTU4_1efaf449-3113-4fb4-8146-3e31a727ee9a">91,724</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idecbe529c8e14131b56433eb5e130916_D20210101-20210331" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfNC0zLTEtMS05NTU4_6b4b8000-6c07-4605-89cd-79d6da8ce99d">303,088</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c8473bff64c498ab624fafa4cca5132_D20210101-20210331" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfNC05LTEtMS05NTU4_bf24bea5-836f-44bd-8f74-ec90a1aaab61">303,088</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i781a96ef93c24d05bb7f12625a033ec0_D20210101-20210331" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfNS01LTEtMS05NTU4_31948089-7fbc-4e01-89b3-e4de20e48278">166,828</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i38154999f15f41cca19a77a5f4d0ccac_D20210101-20210331" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfNS03LTEtMS05NTU4_edf6efd5-2f19-4adb-933f-aa4d76c1d65a">22,167</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c8473bff64c498ab624fafa4cca5132_D20210101-20210331" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfNS05LTEtMS05NTU4_f3adc67d-9fcf-484c-b8e3-4b3953e8bfcd">144,661</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d845908b01747ac9d721fff45f53abf_I20210331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfNi0xLTEtMS05NTU4_eed539f4-4f00-4335-8742-e54d7ee5d7fe">15,084,464</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d845908b01747ac9d721fff45f53abf_I20210331" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfNi0zLTEtMS05NTU4_3681e437-53cd-4eff-aae2-556ddd42dab1">48,981,395</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32deafcb20a948cf995118abdf3ce1a4_I20210331" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfNi01LTEtMS05NTU4_83fef89f-98c5-4766-b63f-489ddd93e58a">1,964,185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2593ac397b63496686231e5a4d277b3b_I20210331" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfNi03LTEtMS05NTU4_3ceb856f-31f0-4939-bf14-e49625105dd7">139,283</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8320ae6bb40c49b4b91522210805d996_I20210331" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfNi05LTEtMS05NTU4_d82bb52f-c66b-46c2-8206-2f24681b9542">46,877,927</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:31.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.757%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d845908b01747ac9d721fff45f53abf_I20210331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfMS0xLTEtMS05NTU4_eed539f4-4f00-4335-8742-e54d7ee5d7fe">15,084,464</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d845908b01747ac9d721fff45f53abf_I20210331" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfMS0zLTEtMS05NTU4_3681e437-53cd-4eff-aae2-556ddd42dab1">48,981,395</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32deafcb20a948cf995118abdf3ce1a4_I20210331" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfMS01LTEtMS05NTU4_83fef89f-98c5-4766-b63f-489ddd93e58a">1,964,185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2593ac397b63496686231e5a4d277b3b_I20210331" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfMS03LTEtMS05NTU4_3ceb856f-31f0-4939-bf14-e49625105dd7">139,283</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8320ae6bb40c49b4b91522210805d996_I20210331" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfMS05LTEtMS05NTU4_d82bb52f-c66b-46c2-8206-2f24681b9542">46,877,927</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief227cab10a245ff9baa903632237a80_D20210401-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfMi0zLTEtMS05NTU4_0ea014be-e665-481a-a9d0-b00ea2aa91b8">191,954</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83fce5d3edda4b1cbab16d0e4a53c979_D20210401-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfMi05LTEtMS05NTU4_881bb181-1369-496b-8b7d-14238b167570">191,954</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ief227cab10a245ff9baa903632237a80_D20210401-20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfMy0xLTEtMS05NTU4_5d25d73a-3bd3-4372-b246-162f8e5bec85">158,405</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief227cab10a245ff9baa903632237a80_D20210401-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfMy0zLTEtMS05NTU4_a8b15ca7-722b-4183-94ca-19c176e2260a">484,965</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83fce5d3edda4b1cbab16d0e4a53c979_D20210401-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfMy05LTEtMS05NTU4_f0f44ab9-6591-48bd-a1e1-071a34ce8e9e">484,965</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe562d54463741e8949d25484a516053_D20210401-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfNC01LTEtMS05NTU4_2d024e0b-c223-46cc-96f3-231eb3a685d2">1,228,560</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f91139b751f41ee943e86bdb734f2f4_D20210401-20210630" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfNC03LTEtMS05NTU4_22fe06fd-d63c-49af-a421-db55884b35bb">5,069</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83fce5d3edda4b1cbab16d0e4a53c979_D20210401-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfNC05LTEtMS05NTU4_c23b1e29-ce32-40a8-b16b-34dedbbf01db">1,223,491</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7ea7194dbc454dbdbc6632db38bf6066_I20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfNS0xLTEtMS05NTU4_dcc08780-96f8-4ffe-9174-8c6bfdb9acb0">14,926,059</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ea7194dbc454dbdbc6632db38bf6066_I20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfNS0zLTEtMS05NTU4_705b4090-f883-42e7-97b6-503eae1789be">48,688,384</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic49c90ad54954ba9a5f89e54eb1dfedb_I20210630" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfNS01LTEtMS05NTU4_6476049d-65f5-4999-aa4b-150e410bba73">735,625</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1e3b4d188524c1791c80059e8f7515a_I20210630" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfNS03LTEtMS05NTU4_a9046c90-144e-4d48-be67-98e3ee61a55b">144,352</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64b2d71ddb0c448d9959f1b9a74a7dad_I20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfNS05LTEtMS05NTU4_97ec6cbf-7a4f-49be-b398-310dbe615c6b">47,808,407</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:31.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.757%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7ea7194dbc454dbdbc6632db38bf6066_I20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfMS0xLTEtMS05NTU4_4e8dc3a0-51a6-4572-a2bd-824edb0988e6">14,926,059</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ea7194dbc454dbdbc6632db38bf6066_I20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfMS0zLTEtMS05NTU4_a3b29f55-e4d1-4600-98ba-bfe88d4b8015">48,688,384</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic49c90ad54954ba9a5f89e54eb1dfedb_I20210630" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfMS01LTEtMS05NTU4_142089ed-56e3-477f-9f4d-9163676c17c7">735,625</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1e3b4d188524c1791c80059e8f7515a_I20210630" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfMS03LTEtMS05NTU4_507da33e-e52a-46bb-a4b2-c010cdec7854">144,352</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64b2d71ddb0c448d9959f1b9a74a7dad_I20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfMS05LTEtMS05NTU4_e33e63bd-631c-4d12-93c3-91b8d135ad90">47,808,407</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10df7b4f9a35418da7673ef6ae315d51_D20210701-20210930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfMi0xLTEtMS05NTU4_81d6eb07-e689-4ff0-9df5-18284e21cc0d">875</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10df7b4f9a35418da7673ef6ae315d51_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfMi0zLTEtMS05NTU4_f24ef08c-4098-4b4e-90e9-ca8f2947a940">162,167</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfMi05LTEtMS05NTU4_169057ed-308d-4e43-bcac-1ee1eceedb54">162,167</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i10df7b4f9a35418da7673ef6ae315d51_D20210701-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfMy0xLTEtMS05NTU4_0f04d063-90b1-4855-9ea8-e0b45a74bb2d">76,408</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10df7b4f9a35418da7673ef6ae315d51_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfMy0zLTEtMS05NTU4_5f9244e3-7211-427c-b9a3-053f221d3623">237,616</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfMy05LTEtMS05NTU4_9ddf6a86-bd00-480e-8c87-2b6bc6f20ce4">237,616</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae1347d2d1d84aa3a135e3245bdf0d90_D20210701-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfNC01LTEtMS0xMDI2Nw_cbeaa059-71c9-4b37-b89d-73d8fd6d7c0f">1,055,278</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cc79eb883d54f61bdec225f436b82c9_D20210701-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfNC03LTEtMS0xMTgyMw_bba45812-ec40-4220-90ee-24ee4964cd26">31,415</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfNC05LTEtMS05NTU4_341bb227-f07f-4bc9-9d1b-3939ea4b1db3">1,086,693</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i56aafc7718c145c8b150a8e54f33a5d2_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfNS0xLTEtMS05NTU4_8dc93544-2123-452a-829f-d0d73c3b0bef">14,850,526</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56aafc7718c145c8b150a8e54f33a5d2_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfNS0zLTEtMS05NTU4_909af3b1-353b-4168-8cfa-408168fb7c16">48,612,935</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1da3f9dccc043f1b509c4e381803002_I20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfNS01LTEtMS05NTU4_41b7e1e7-83aa-4dbd-a223-934a3f5e6d50">1,790,903</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied663adb59564577989ed6d27ea6493f_I20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfNS03LTEtMS05NTU4_b0d20a4f-9c66-44f0-8a11-94010dd8c102">175,767</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfNS05LTEtMS05NTU4_270319a0-ab49-4b31-8eaa-3c63149042c5">46,646,265</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:31.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.757%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_28"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_31"></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1) <ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zMS9mcmFnOjc4MTgyYzdiODkwMzRkOTdhYWUyNDJlZGY3MzU3NmU5L3RleHRyZWdpb246NzgxODJjN2I4OTAzNGQ5N2FhZTI0MmVkZjczNTc2ZTlfMTAwMzE_454135b1-1a94-46f8-8aba-ffa26ed95177" continuedAt="ie7d20157115b462f9cc97b78b68913e7" escape="true">ORGANIZATION AND BASIS OF PRESENTATION</ix:nonNumeric></span></div><ix:continuation id="ie7d20157115b462f9cc97b78b68913e7" continuedAt="ie6458d9bf1e64e9ea4de62c7044807f1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland Pharmaceuticals Inc. (“Cumberland,” the “Company,” or as used in the context of “we,” “us,” or “our”) is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The Company's primary target markets are hospital acute care, gastroenterology and rheumatology. These medical specialties are characterized by relatively concentrated prescriber bases that the Company believes can be penetrated effectively by small, targeted sales forces. Cumberland is dedicated to providing innovative products that improve quality of care for patients and address unmet or poorly met medical needs. The Company promotes its approved products through its hospital and field sales forces in the United States and is establishing a network of international partners to bring its medicines to patients in their countries.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland focuses its resources on maximizing the commercial potential of its products, as well as developing new product candidates, and has both internal development and commercial capabilities. The Company’s products are manufactured by third parties, which are overseen by Cumberland’s quality control and manufacturing professionals. The Company works closely with its third-party distribution partners to make its products available in the United States.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited condensed consolidated financial statements of the Company have been prepared on a basis consistent with the December 31, 2020, audited consolidated financial statements and include all adjustments, consisting of only normal recurring adjustments, necessary to fairly present the information set forth herein. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited condensed consolidated financial statements have been prepared in accordance with the regulations of the Securities and Exchange Commission (the “SEC”), and certain information and disclosures have been condensed or omitted as permitted by the SEC for interim period presentation. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended December 31, 2020 (the “2020 Annual Report on Form 10-K”). The results of operations for the three and nine months ended September 30, 2021, are not necessarily indicative of the results to be expected for the entire fiscal year or any future period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Discontinued Operations</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed further in Note 9, during May 2019, Cumberland entered into a Dissolution Agreement ("Dissolution Agreement") with Clinigen Healthcare Limited ("Clinigen") in which the Company returned the exclusive rights to commercialize Ethyol</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Totect</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the United States to Clinigen. Under the terms of the Dissolution Agreement, Cumberland is no longer involved directly or indirectly with the distribution, marketing and promotion of either Ethyol or Totect or any competing products following December 31, 2019. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's exit from Ethyol and Totect meets the accounting criteria to be reported as discontinued operations and the discontinued operating results have been presented in the financial statements and footnotes to reflect the discontinued status of Ethyol and Totect. Refer to Note 9, for additional information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revision of prior period condensed consolidated statement of cash flows presentation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has made a revision to prior period amounts to conform to the current year presentation of the cash surrender value of life insurance policies over premiums paid on the condensed consolidated statement of cash flows. The revised amounts were previously included as net changes in assets affecting operating activities. These revisions have no net effect on the reported net cash provided by operating activities nor any impact on the reported operating results or balance sheet for the 2020 period presented. </span></div><div style="margin-bottom:8pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Pandemic </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the U.S. declared a health care emergency following the outbreak of the SARS-CoV-2, a novel strain of coronavirus that causes COVID-19, a respiratory illness. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland has remained open for business, as the Company is considered to be essential by the United States Department of Homeland Security. The Company has implemented measures to address the impact of the novel coronavirus on the business and taken appropriate action to protect its employees, secure the supply chain, and support the patients who can benefit from its medicines. All of the Company's employees have been given the opportunity to work remotely, and those that wish to work from Cumberland's office and laboratories are encouraged to practice the behaviors outlined by the Centers for Disease Control. </span></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><ix:continuation id="ie6458d9bf1e64e9ea4de62c7044807f1" continuedAt="i1821fbfe3bc44050837995ac5e4925a6"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the pandemic, Cumberland has faced the same headwinds affecting other companies that rely on hospital admissions and patient visits to drive revenue. Our business and our clinical studies were impacted as less patients sought elective surgeries and our access to medical facilities was substantially limited. During 2020 and 2021, we carefully monitored our supply chain during the pandemic including the flow of raw materials into the plants that manufacture our products as well as the batches of finished product emerging from those facilities. Several of our brands were negatively impacted by the lockdowns and postponement of physician office visits and elective procedures. However, we are fortunate to have a diversified product portfolio, with other brands delivering a strong performance.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland relies on third-party organizations around the world to supply components, manufacture and distribute its products. The Company is aware that it may experience revenue loss, supply interruptions, time delays and incur unplanned expenses as a result of the impact of the ongoing COVID-19 pandemic. The Company continues to monitor the COVID-19 pandemic situation both in the U.S. and internationally in order to maintain its employees’ safety and well-being, while also keeping its business operating. Given the uncertainty, magnitude and impact of such changes, the Company is unable to quantify the impact on the future results as of the date of this filing.</span></div><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zMS9mcmFnOjc4MTgyYzdiODkwMzRkOTdhYWUyNDJlZGY3MzU3NmU5L3RleHRyZWdpb246NzgxODJjN2I4OTAzNGQ5N2FhZTI0MmVkZjczNTc2ZTlfMTAwMzI_3a7841ca-7519-41ae-91eb-bbe84bc731f4" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Guidance</span></div><div style="margin-bottom:6pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements - Not Yet Adopted</span></div><div style="margin-bottom:6pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board ("FASB") issued ASU No. 2016-13, “Financial Instruments-Credit Losses,” which changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, companies will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, companies will measure credit losses in a manner similar to what they do today, except that the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. Companies will have to disclose additional information, including information they use to track credit quality by year of origination for most financing receivables. Companies will apply the ASU’s provisions as a cumulative-effect adjustment, if any, to retained earnings as of the beginning of the first reporting period in which the guidance is adopted.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related to ASU No. 2016-13 discussed above, in May 2019, the FASB issued ASU 2019-05, "Financial Instruments-Credit Losses (Topic 326): Targeted Transition Relief" which provides transition relief for ASU 2016-13 by providing entities with an alternative to irrevocably elect the fair value option for eligible financial assets measured at amortized cost upon adoption of the new credit losses standard. Certain eligibility requirements must be met and the election must be applied on an instrument-by-instrument basis. The election is not available for either available-for-sale or held-to-maturity debt securities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will adopt both ASU 2016-13 and ASU 2019-05 on January 1, 2023. The adoption of ASU 2016-13 and ASU 2019-05 are not expected to have a material impact on the Company’s consolidated financial statements.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Policies:</span></div><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zMS9mcmFnOjc4MTgyYzdiODkwMzRkOTdhYWUyNDJlZGY3MzU3NmU5L3RleHRyZWdpb246NzgxODJjN2I4OTAzNGQ5N2FhZTI0MmVkZjczNTc2ZTlfMTAwMzU_2fff1938-59dd-444d-801f-b299631abdd1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management of the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates under different assumptions and conditions. The Company's most significant estimates include: (1) its allowances for chargebacks and accruals for rebates and product returns, (2) the allowances for obsolescent or unmarketable inventory and (3) valuation of a contingent consideration liability associated with a business combination.</span></div></ix:nonNumeric><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zMS9mcmFnOjc4MTgyYzdiODkwMzRkOTdhYWUyNDJlZGY3MzU3NmU5L3RleHRyZWdpb246NzgxODJjN2I4OTAzNGQ5N2FhZTI0MmVkZjczNTc2ZTlfMTAwMzY_7ccfbc10-8b2c-455c-a58c-8d7144bc8c96" continuedAt="i792e6e2739284229b8035d6ae4505a35" escape="true">Operating Segments</ix:nonNumeric></span></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1821fbfe3bc44050837995ac5e4925a6"><ix:continuation id="i792e6e2739284229b8035d6ae4505a35">The Company has <ix:nonFraction unitRef="segment" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zMS9mcmFnOjc4MTgyYzdiODkwMzRkOTdhYWUyNDJlZGY3MzU3NmU5L3RleHRyZWdpb246NzgxODJjN2I4OTAzNGQ5N2FhZTI0MmVkZjczNTc2ZTlfOTIyNQ_1e7893e3-e3b9-4055-b4eb-4c6de5ad02f0">one</ix:nonFraction> operating segment which is specialty pharmaceutical products. Management has chosen to organize the Company based on the type of products sold. Operating segments are identified as components of an enterprise about which separate discrete financial information is evaluated by the chief operating decision maker, or decision-making group, in making decisions regarding resource allocation and assessing performance. The Company, which uses consolidated financial information in determining how to allocate resources and assess performance, has concluded that our specialty pharmaceutical products compete in similar economic markets and similar circumstances. Substantially all of the Company’s assets are located in the United States and total revenues are primarily attributable to U.S. customers.</ix:continuation></ix:continuation> </span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_34"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2) <ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RleHRyZWdpb246ZDJjZmQ4YzNmMGQzNDFlZjg1YzRkNGRjMzY5NDc2M2VfNDI1_26b21939-0832-4e2d-99c4-98d2376f2724" continuedAt="ia18c050a6c684061a1c53868a588c0a0" escape="true">EARNINGS (LOSS) PER SHARE</ix:nonNumeric></span></div><ix:continuation id="ia18c050a6c684061a1c53868a588c0a0"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RleHRyZWdpb246ZDJjZmQ4YzNmMGQzNDFlZjg1YzRkNGRjMzY5NDc2M2VfNDI3_45196b7b-e2ff-4caa-a182-02ca58cf409d" continuedAt="i31c80e73c7384c1d9d551454027859c9" escape="true">The following table reconciles the numerator and denominator used to calculate diluted earnings (loss) per share for the three and nine months ended September 30, 2021 and 2020:</ix:nonNumeric></span></div><div style="text-align:justify"><ix:continuation id="i31c80e73c7384c1d9d551454027859c9"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfMy0xLTEtMS05NTU4_3656b68a-e37c-4633-8dd8-a003efd3e39e">1,583,480</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfMy0zLTEtMS05NTU4_ec6850d2-e817-4b14-9487-ff3e910e4c91">1,275,620</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb58760ea84940319b35492cd1910735_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfNC0xLTEtMS05NTU4_86849bd9-9c34-42dc-a4b6-2061e77af27b">496,787</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca7f9fa06d14f85a52cbd81ac170d2c_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfNC0zLTEtMS05NTU4_0fe8db84-b272-4c9f-a304-4c34cd7b14a3">777,916</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfNS0xLTEtMS05NTU4_06c37d4c-3b8e-4e9d-9a49-fdc7ea9995d1">1,086,693</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfNS0zLTEtMS05NTU4_1cc0f468-27ca-4623-bd4d-04fecde16f42">497,704</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss at subsidiary attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfNi0xLTEtMS05NTU4_95b61dfc-d977-4115-94c6-54e0d0af5a99">31,415</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfNi0zLTEtMS05NTU4_2141b745-6e38-4f81-959c-3756a18c45c0">15,967</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to common shareholders</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfNy0xLTEtMS05NTU4_8e25e5e8-98f3-44fe-bcfe-7cb6ae67a6e0">1,055,278</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfNy0zLTEtMS05NTU4_4df57ef8-bc72-4d47-97d5-a0535ac6e0d4">481,737</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding – basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfOS0xLTEtMS05NTU4_b5e1a767-1b86-4012-89bc-7628a19420c8">14,880,887</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfOS0zLTEtMS05NTU4_7ddc136a-92bb-439a-a38a-0bfad779387e">15,134,583</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of other securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" format="ixt:fixed-zero" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfMTAtMS0xLTEtOTU1OA_bf99d36d-91d8-4d26-9d88-a39c983f0874">—</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" format="ixt:fixed-zero" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfMTAtMy0xLTEtOTU1OA_2f272c37-da51-4356-beb0-a57c619788e9">—</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding – diluted</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfMTEtMS0xLTEtOTU1OA_206d45ec-0dfd-4dad-a09c-708e034903c8">14,880,887</ix:nonFraction> </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfMTEtMy0xLTEtOTU1OA_3069879d-a3f8-4c09-bc47-66a88a16ffee">15,134,583</ix:nonFraction> </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:58.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.518%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfNC0xLTEtMS05NTU4_4c64bffd-ba77-41a6-8d18-51bfc653c845">1,209,545</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfNC0zLTEtMS05NTU4_85fb5be7-0aae-4020-9da3-9e25c9015f6a">4,838,249</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45bdfab35dd74d60ac86fc023b908b73_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfNS0xLTEtMS05NTU4_1acd7b61-10d3-4d57-a3bb-db27abac79f0">1,491,004</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c8802e62b74a919450a1c6017bba7e_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfNS0zLTEtMS05NTU4_841b8fa5-722e-49de-805f-6e1ba99049bf">2,334,811</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfNi0xLTEtMS05NTU4_4dba1ef6-53d1-42f8-8c8d-2ffd0332f6c6">281,459</ix:nonFraction> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfNi0zLTEtMS05NTU4_72f6cf1b-b278-4755-bba1-690b049afff5">2,503,438</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) at subsidiary attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfNy0xLTEtMS05NTU4_ce0a12c3-7567-454b-93ce-355822e98dea">58,651</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfNy0zLTEtMS05NTU4_f17bcff7-0f96-4279-931e-32336eb1034d">47,806</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to common shareholders</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfOC0xLTEtMS05NTU4_5cb25c6b-5d1e-43e1-a9db-72676163fbcd">340,110</ix:nonFraction> </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfOC0zLTEtMS05NTU4_f7aef4bc-6f7d-491b-8a3f-1c613544acf4">2,455,632</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding – basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfMTAtMS0xLTEtOTU1OA_8cdb33ce-1515-4327-ae98-f1d30f78e45a">14,939,919</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfMTAtMy0xLTEtOTU1OA_3cebfc23-7264-4ddc-9953-b2de72843968">15,206,179</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of other securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfMTEtMS0xLTEtOTU1OA_605da32d-fcf5-4109-8a79-0d27864d7f97">199,985</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:fixed-zero" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfMTEtMy0xLTEtOTU1OA_b7b9a4ed-aabc-4e09-b4f1-13c2ea1d4302">—</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding – diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfMTItMS0xLTEtOTU1OA_680872eb-8fa6-4a35-8e4b-96a35c60f7b4">15,139,904</ix:nonFraction> </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfMTItMy0xLTEtOTU1OA_74c47ba6-d296-4d83-a36d-d18b2064f105">15,206,179</ix:nonFraction> </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021 and 2020, restricted stock awards and options to purchase <ix:nonFraction unitRef="shares" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RleHRyZWdpb246ZDJjZmQ4YzNmMGQzNDFlZjg1YzRkNGRjMzY5NDc2M2VfMjQ4_c4b236a3-aad2-42f6-9b3f-a778532730c3">158,900</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RleHRyZWdpb246ZDJjZmQ4YzNmMGQzNDFlZjg1YzRkNGRjMzY5NDc2M2VfMjU1_c475d801-9266-4d56-8a11-b84fca1875bd">197,210</ix:nonFraction> shares of common stock, respectively, were outstanding but were not included in the computation of diluted earnings per share because the effect would be antidilutive.</span></div></ix:continuation><div id="i8e8bdb91dc894234b9d87e17a18b54fd_37"></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3) <ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RleHRyZWdpb246ZmFiNDdlMmJmMGFlNDcxNzhiN2Q4ZmM2ZmYzMTEzNjBfMjU3NQ_1531aca6-8f7d-4f5a-92b9-225d8b4fdab2" continuedAt="i800249fa2b024bb6ba439a72dbcef57e" escape="true">REVENUES</ix:nonNumeric></span></div><ix:continuation id="i800249fa2b024bb6ba439a72dbcef57e" continuedAt="i5701a740fb47444c934aaad5d65be907"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Revenues</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for revenues from contracts with customers under ASC 606, which became effective January 1, 2018. </span></div><div style="margin-top:8pt;text-align:justify"><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RleHRyZWdpb246ZmFiNDdlMmJmMGFlNDcxNzhiN2Q4ZmM2ZmYzMTEzNjBfMjU3OQ_6e8723dd-0e9c-4e15-94e7-da617c69baec" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s net revenues consisted of the following for the three and nine months ended September 30, 2021 and 2020:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kristalose</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b064560ae764b05aee16232fc2b982f_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMy0xLTEtMS05NTU4_b715d0d9-0526-4ec0-b9c5-9d63854e4b5b">4,012,746</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9189ef3c405466780ff2b301ce69072_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMy0zLTEtMS05NTU4_40ba5e81-fcb0-4362-9f31-7b796c2c6e45">3,615,557</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib543c8c5c4a0438eb3b83a9549c72767_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMy01LTEtMS05NTU4_c4cec850-b5cd-4b3e-a364-57a695a932fc">12,286,729</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i851181d1e03446adb4d2b6f666a489e7_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMy03LTEtMS05NTU4_c3aff0bd-99da-4696-a1fb-f112b43c42d9">10,387,046</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vibativ</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343ad32279094a2585bfa47056ea0769_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNC0xLTEtMS05NTU4_d2a514f6-bc85-4d76-84a3-581ae3ca6690">1,896,584</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf76fee1053a41f897bb2b308eda43b7_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNC0zLTEtMS05NTU4_63f7b646-7f06-4718-81cf-677173d193cd">2,813,249</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a175b2126f3439e978ef755a5187703_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNC01LTEtMS05NTU4_797af799-1dd4-496c-b11b-64ff4c9660b0">8,799,891</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1221e6e62b0d4437aa038a1593455cdb_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNC03LTEtMS05NTU4_18885835-bca3-4034-ae40-ec1503683622">8,551,125</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Caldolor</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide5a86375216464d9ebfdf112640aff3_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNS0xLTEtMS05NTU4_4ecd3416-3be0-4137-b77a-084667a1bde0">1,255,669</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d2eab230e924fb094455dfdb93d19f6_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNS0zLTEtMS05NTU4_96821b96-9f8c-4cda-8d66-222bf9410a62">1,416,146</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib32ee538452d4d108fd0d0249f232e4e_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNS01LTEtMS05NTU4_63e26ee5-444b-420f-bbdf-8d62b3f3f1f9">3,734,273</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie38185217cb649a98c782f849b956b81_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNS03LTEtMS05NTU4_f35bed30-7729-4eee-ae38-6037a38c4f22">3,677,434</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vaprisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb5e5973ac81495ca434caa4250ad1e6_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNi0xLTEtMS05NTU4_bcdc676d-e769-47f8-9e93-4a6af5dae191">325,774</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2cff2563f6434383fad1a3433a95bf_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNi0zLTEtMS05NTU4_14b486ec-0bd1-4898-bb20-f5e8383adc00">406,162</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87b67bdb94e6413eab1ada4bb36a71b7_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNi01LTEtMS05NTU4_531a4f67-3812-4d7b-b851-f55ca5fa72ea">1,861,130</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70e186cdc2a444de9d34c6b0a9840fa3_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNi03LTEtMS05NTU4_c31d8057-e712-41e2-9a8c-fb2cec4a248d">790,817</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acetadote</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0301ef84e6814fc1afd5bda0bb02be0c_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNy0xLTEtMS05NTU4_be1eda32-358a-4637-973c-011b99e02535">368,733</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10d6fa0a80234f6fbdf7f486df4beed1_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNy0zLTEtMS05NTU4_8332fef3-e4a9-44d8-ad11-1ef54e387727">218,462</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2b0e3ce8dc46a892511cbd1f0b38cf_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNy01LTEtMS05NTU4_40b59073-22bc-4624-b110-4dcc10f7f41d">638,704</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2075e961d64a4c4184f2117135160c9e_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNy03LTEtMS05NTU4_f267816f-c3dc-49ff-b1c1-3e8d6c459f9a">1,527,173</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omeclamox-Pak</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67bca755a168477fb7af6f54edd41311_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfOC0xLTEtMS05NTU4_45967abd-c12f-4676-9e2c-1e3bc25499eb">22,689</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369b52ac1f754a4a9275b8917dc3bb9d_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfOC0zLTEtMS05NTU4_a978c324-8dac-4cc2-adbe-bf474d3b5e4d">516,066</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2206c2c78e3347cf9fd2bb7625961847_D20210101-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfOC01LTEtMS05NTU4_eed0fb91-555b-4171-94dc-a07afa3ca379">451,683</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64299c3a88d84d888de7a4e8264da6a1_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfOC03LTEtMS05NTU4_dacbc3b7-5e42-48e1-b1ab-ebba0035bb20">640,435</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RediTrex</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica59276837544b3e89921005c9db373f_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfOS0xLTEtMS05NTU4_2feb4625-fa02-4d92-9863-fbba89eb19a8">11,459</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d8203f933864c8d869320c4b6ce16d2_D20200701-20200930" decimals="0" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfOS0zLTEtMS05NTU4_90e04b12-42da-42f9-ad8f-f506afdf6003">—</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if79d16ca01cf493f84c3a1bcbcf07c1d_D20210101-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfOS01LTEtMS05NTU4_1a62f132-804a-4a37-8260-0b224d0637d8">13,291</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3900d92fcea4358838f65d608ad8088_D20200101-20200930" decimals="0" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfOS03LTEtMS05NTU4_4a6e8da3-122d-455f-b241-eaff3c73e5ab">—</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d6efd6bd2c041769f9fbf0d1a3e5685_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMTAtMS0xLTEtOTU1OA_fc5c19a4-ab1e-4bd2-b9cf-4004082f324d">178,886</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1571108ca25f4e179a9d14073629ae96_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMTAtMy0xLTEtOTU1OA_79c09d38-4aa3-4992-8f2c-de5df9d3ffc3">265,047</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cf12a139ea74881b685de000f63434e_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMTAtNS0xLTEtOTU1OA_558f692d-3089-4277-8ea5-29151151b7f3">809,429</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbd3b5d4865547179a8bf7fbe50a430c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMTAtNy0xLTEtOTU1OA_fac5f00f-89f8-4736-a229-122f163e68dc">1,605,570</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMTEtMS0xLTEtOTU1OA_b6ac83bd-0458-4369-9a85-f470187e7f82">8,072,540</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMTEtMy0xLTEtOTU1OA_19f350b8-1c28-49a7-bf10-2f42e94db843">9,250,689</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMTEtNS0xLTEtOTU1OA_0094e52f-9c3c-4142-a794-86eaf014acc6">27,665,182</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMTEtNy0xLTEtOTU1OA_bc779da5-b1ab-41b7-b6de-50878abe327d">27,179,600</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Omeclamox-Pak revenue for the first, second and third quarter of 2021 was the result of Cumberland currently being out of commercial inventory of this product. The packager for our Omeclamox-Pak product encountered financial difficulties due to the impact of COVID-19. They are under new management and are in the process of a reorganization. Discussions with the packager are ongoing. In the third quarter of 2021, the amounts noted were normal adjustments by channel partners. Net revenue was negatively impacted by product returns during the periods. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Revenues</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreements with international partners for commercialization of the Company's products with associated payments included in other revenues. Those agreements provide that each of the partners are responsible for seeking regulatory approvals for the product, and following approval, each partner will be responsible for the ongoing distribution and sales in the respective international territories. The Company provides a dossier for product registration and maintains responsibility for the relevant intellectual property. Cumberland is typically entitled to receive a non-refundable, up-front payment at the time each agreement is executed as consideration for the product dossier and for the rights to the distinct intellectual property rights in the respective international territory. These agreements also typically provide for additional payments upon a partner’s achievement of a defined regulatory approval and sales milestones. The Company may also be entitled to receive royalties on future sales of the products and a transfer price on supplies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual payments associated with the partner’s achievement of regulatory approvals, sales milestones and royalties on future sales are recognized as revenue upon occurrence, or at such time that the Company has a high degree of confidence that the revenue would not be reversed in a subsequent period.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5701a740fb47444c934aaad5d65be907">Other revenues also include funding from federal grant programs including those secured by CET through the Small Business Administration as well as lease income generated by CET’s Life Sciences Center. The Life Sciences Center is a research center that provides scientists with access to flexible lab space and other resources to develop biomedical products. Grant revenue from these programs totaled approximately $<ix:nonFraction unitRef="usd" contextRef="i7beb09efdc954e3387adf27b4cc99538_D20210701-20210930" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RleHRyZWdpb246ZmFiNDdlMmJmMGFlNDcxNzhiN2Q4ZmM2ZmYzMTEzNjBfMjUxNQ_e38456b6-7808-436d-8cb6-1af633fc202d">0.02</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9c591eb458184e3baae21c9c26245264_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RleHRyZWdpb246ZmFiNDdlMmJmMGFlNDcxNzhiN2Q4ZmM2ZmYzMTEzNjBfMjUyMg_484f8b73-8f0c-41ba-ae46-dd3d1f82e948">0.1</ix:nonFraction> million for the three months ended September 30, 2021 and 2020</ix:continuation>, and $<ix:nonFraction unitRef="usd" contextRef="i32601382eaeb463ba862531b12def23c_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RleHRyZWdpb246ZmFiNDdlMmJmMGFlNDcxNzhiN2Q4ZmM2ZmYzMTEzNjBfMTA5OTUxMTYzMDM3MQ_e3a1a333-4731-4893-82f3-be05efc8581a">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i76c8b1e743d441a3ad6f81bc894366dd_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RleHRyZWdpb246ZmFiNDdlMmJmMGFlNDcxNzhiN2Q4ZmM2ZmYzMTEzNjBfMTA5OTUxMTYzMDM4NA_1550654f-ba5a-4006-b699-93b2f67aeb94">0.7</ix:nonFraction> million for the nine months ended September 30, 2021 and 2020, respectively.</span></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_40"></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(4) <ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RleHRyZWdpb246NDg0YmI5ZDIyZGUzNDk5OGI0ZWJkOGQ5ZWY1OThjYTBfMjE2NQ_f9f5755f-ff5c-4d39-8f56-b7c16e52bfc6" continuedAt="i3306631bc5bd4bb788812298eb9003ee" escape="true">INVENTORIES</ix:nonNumeric></span></div><div style="text-align:justify"><ix:continuation id="i3306631bc5bd4bb788812298eb9003ee" continuedAt="i95e2d05784524731ad974b68cb95cc0a"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company works closely with third parties to manufacture and package finished goods for sale.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the arrangements with the manufacturer or packager, the Company will either take title to the finished goods at the time of shipment or at the time of arrival at the Company’s warehouses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company then holds such goods in inventory until distribution and sale. These finished goods inventories are stated at the lower of cost or net realizable value with cost determined using the first-in, first-out method.</span></ix:continuation></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><ix:continuation id="i95e2d05784524731ad974b68cb95cc0a"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates inventory for potential losses due to excess, obsolete or slow-moving goods by comparing sales history and projections to the inventory on hand. When evidence indicates that the carrying value may not be recoverable, a charge is taken to reduce the inventory to its current net realizable value. At September 30, 2021 and December 31, 2020, the Company had recognized and maintained cumulative net realizable value charges for potential obsolescence and discontinuance losses of approximately $<ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InventoryValuationReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RleHRyZWdpb246NDg0YmI5ZDIyZGUzNDk5OGI0ZWJkOGQ5ZWY1OThjYTBfMTAzOA_fa408c45-20a7-4a34-a5ed-e06b546e3fa2">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InventoryValuationReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RleHRyZWdpb246NDg0YmI5ZDIyZGUzNDk5OGI0ZWJkOGQ5ZWY1OThjYTBfMTA0NQ_127d42c6-8d00-406d-9c1e-194145fbe302">0.2</ix:nonFraction> million, respectively. </span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is responsible for the purchase of the active pharmaceutical ingredient (“API”) for Kristalose and maintains the inventory at third-party packagers. As that API is consumed in production, the value of the API is transferred from raw materials to finished goods. API for the Company's Vaprisol brand is also included in the raw materials inventory at September 30, 2021 and December 31, 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consigned inventory represents Authorized Generic inventory stored with Perrigo until shipment. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Vibativ acquisition, Cumberland acquired API and work in process inventories of $<ix:nonFraction unitRef="usd" contextRef="i890f0fecec4a4eb899b3171ad304df32_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RleHRyZWdpb246NDg0YmI5ZDIyZGUzNDk5OGI0ZWJkOGQ5ZWY1OThjYTBfMTYzNA_d3cebd19-55eb-470b-bfec-5b243c70155c">15.6</ix:nonFraction> million that were all initially classified as non-current inventories at the date of acquisition. At September 30, 2021 and December 31, 2020, total non-current inventory, including Vibativ and ifetroban, was $<ix:nonFraction unitRef="usd" contextRef="i5d7014c036534d1ab07ea1c7138ece74_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RleHRyZWdpb246NDg0YmI5ZDIyZGUzNDk5OGI0ZWJkOGQ5ZWY1OThjYTBfMTA5OTUxMTYyOTk0NQ_4ab0569c-c14e-4492-9b69-18f6d19f72c8">9.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i890f0fecec4a4eb899b3171ad304df32_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RleHRyZWdpb246NDg0YmI5ZDIyZGUzNDk5OGI0ZWJkOGQ5ZWY1OThjYTBfMTA5OTUxMTYyOTk1NA_874de2f0-2f47-4f8f-9188-998b4b02e087">11.7</ix:nonFraction> million, respectively. The Company had $<ix:nonFraction unitRef="usd" contextRef="i5d7014c036534d1ab07ea1c7138ece74_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RleHRyZWdpb246NDg0YmI5ZDIyZGUzNDk5OGI0ZWJkOGQ5ZWY1OThjYTBfMTg0OQ_2ed9aba5-9edc-492b-8cdc-1e3a690c1101">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i890f0fecec4a4eb899b3171ad304df32_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RleHRyZWdpb246NDg0YmI5ZDIyZGUzNDk5OGI0ZWJkOGQ5ZWY1OThjYTBfMTg1Ng_5eea83b7-3275-4299-b37f-fff4ff11c4fa">2.1</ix:nonFraction> million of Vibativ finished goods included in non-current inventory at September 30, 2021 and December 31, 2020, respectively. The Company also has obtained $<ix:nonFraction unitRef="usd" contextRef="i2fb3c2ea35a146918884002eb0319cb9_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RleHRyZWdpb246NDg0YmI5ZDIyZGUzNDk5OGI0ZWJkOGQ5ZWY1OThjYTBfMTk3OA_b3d9ee24-5d32-4dfb-8196-00c2d48a3aba"><ix:nonFraction unitRef="usd" contextRef="i85407d87b0cc40608f88c792ee3187bc_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RleHRyZWdpb246NDg0YmI5ZDIyZGUzNDk5OGI0ZWJkOGQ5ZWY1OThjYTBfMTk3OA_f0bd8122-1a02-4f83-ac77-b4afdd80cd26">0.4</ix:nonFraction></ix:nonFraction> million of finished goods in non-current inventory for API related to its ifetroban clinical initiatives at September 30, 2021 and December 31, 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RleHRyZWdpb246NDg0YmI5ZDIyZGUzNDk5OGI0ZWJkOGQ5ZWY1OThjYTBfMjE2Ng_6d16846e-cb06-47a4-8900-fd09792f72f2" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021 and December 31, 2020 the Company's net inventories consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:57.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.681%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and work in process</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfMi0yLTEtMS05NTU4_52255f9a-f9a5-44b9-a075-0b0113724cc3">13,782,630</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfMi00LTEtMS05NTU4_082938bd-a415-430e-947d-2f7f7b9e89ca"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfMi00LTEtMS05NTU4_906783ec-d2af-4d21-9732-091f7e7352c1">16,223,162</ix:nonFraction></ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consigned inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfMy0yLTEtMS05NTU4_0d78d7c6-ff7a-4083-890b-d2408268a4cc">144,583</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfMy00LTEtMS05NTU4_51de1e87-e7ef-4372-b545-96bb85039d94"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfMy00LTEtMS05NTU4_564a45e6-e8c7-4bb4-8024-c3d990ff3216">128,005</ix:nonFraction></ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfNC0yLTEtMS05NTU4_7fdd8ea8-8cfa-497a-9b82-c7679d7efe1f">5,812,293</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfNC00LTEtMS05NTU4_2c8730e5-fba8-4578-a00b-a080bdb48a68"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfNC00LTEtMS05NTU4_a80a1ef7-1394-4e54-a23b-aadacdab3e00">5,943,732</ix:nonFraction></ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfNS0yLTEtMS05NTU4_663fc4b7-39e2-46f6-8f84-d3070a4649d0">19,739,506</ix:nonFraction> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfNS00LTEtMS05NTU4_3adbed54-4d5e-4360-b3d0-2d5d89425076">22,294,899</ix:nonFraction> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">less non-current inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfNi0yLTEtMS05NTU4_1b1b0259-48c4-487b-b5cf-3651f88ef0e4">9,476,737</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfNi00LTEtMS05NTU4_e8de5d18-2729-4ad0-b514-412dd551c3b3">11,656,742</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories classified as current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfNy0yLTEtMS05NTU4_ff6d04fc-6a3f-4dfd-bfc0-a29604136553">10,262,769</ix:nonFraction> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfNy00LTEtMS05NTU4_bf4ebc7e-94e4-46f3-badc-bae858aaf1d8">10,638,157</ix:nonFraction> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="i8e8bdb91dc894234b9d87e17a18b54fd_43"></div><div style="margin-top:8pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(5) <ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RleHRyZWdpb246OThjNTVkMmNjZTEwNDcxZmJkMTkwMjYyODEzYmNmNGVfMTk3OA_fd0673d3-5ce2-4535-a5d9-f1aeac19171d" continuedAt="i7a75ec14f686481c9a6bbcb7a00999f6" escape="true">LEASES</ix:nonNumeric></span></div><ix:continuation id="i7a75ec14f686481c9a6bbcb7a00999f6"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland’s significant operating leases include the lease of approximately <ix:nonFraction unitRef="sqft" contextRef="ifd0c03fd249e4e64a76675f06c950be1_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AreaOfRealEstateProperty" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RleHRyZWdpb246OThjNTVkMmNjZTEwNDcxZmJkMTkwMjYyODEzYmNmNGVfOTQ_ce1e9220-ef32-45fc-b7cf-e49ef510d576">25,500</ix:nonFraction> square feet of office space in Nashville, Tennessee for its corporate headquarters. This lease currently expires in October 2022. The Company's operating leases also include the lease of approximately <ix:nonFraction unitRef="sqft" contextRef="i67e0bde90efc45a7a814f5c68fb0096f_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AreaOfRealEstateProperty" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RleHRyZWdpb246OThjNTVkMmNjZTEwNDcxZmJkMTkwMjYyODEzYmNmNGVfMzAw_eb4a03e1-b8ae-40a3-85ec-d570c5113a29">14,200</ix:nonFraction> square feet of wet laboratory and office space in Nashville, Tennessee by CET, our majority-owned subsidiary, where it operates the CET Life Sciences Center. This lease currently expires in April 2023. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities are recorded as the present value of remaining lease payments not yet paid for the lease term discounted using the incremental borrowing rate associated with each lease. Operating lease right-of-use assets represent operating lease liabilities adjusted for lease incentives and initial direct costs. As Cumberland’s leases do not contain implicit borrowing rates, the incremental borrowing rates were calculated based on information available at January 1, 2019. Incremental borrowing rates reflect the Company’s estimated interest rates for collateralized borrowings over similar lease terms. The weighted-average incremental borrowing rate used to discount the present value of the remaining lease payments is <ix:nonFraction unitRef="number" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RleHRyZWdpb246OThjNTVkMmNjZTEwNDcxZmJkMTkwMjYyODEzYmNmNGVfMTI0OA_2d76f378-da2f-4b82-a7c3-0b40798dc339">7.42</ix:nonFraction>%. The weighted-average remaining lease term at September 30, 2021 is <ix:nonNumeric contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RleHRyZWdpb246OThjNTVkMmNjZTEwNDcxZmJkMTkwMjYyODEzYmNmNGVfMTMwMw_cb651dca-3da6-49f5-a8c2-d4898c278cdc">1.2</ix:nonNumeric> years.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lease Position</span></div><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="cpix:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RleHRyZWdpb246OThjNTVkMmNjZTEwNDcxZmJkMTkwMjYyODEzYmNmNGVfMTk3OQ_ead4bb19-3276-4229-a689-d63dbe2018b6" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021 and December 31, 2020 , the Company's lease assets and liabilities were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right-of-Use Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjAxNTUzNDY5NGIyNjQwNWNiODgzODJlYmJmZTZlZGI3L3RhYmxlcmFuZ2U6MDE1NTM0Njk0YjI2NDA1Y2I4ODM4MmViYmZlNmVkYjdfMS0yLTEtMS05NTU4_03898100-deee-4659-8993-7d7a00a7e0cb">1,282,275</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjAxNTUzNDY5NGIyNjQwNWNiODgzODJlYmJmZTZlZGI3L3RhYmxlcmFuZ2U6MDE1NTM0Njk0YjI2NDA1Y2I4ODM4MmViYmZlNmVkYjdfMS00LTEtMS05NTU4_37ee8221-5fb0-4021-9da4-00c47ee19b21">2,028,148</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjU2YWY4M2IxZDI4ZTQ0YmJhNzYyMjhiYjFmYzhhNGQ2L3RhYmxlcmFuZ2U6NTZhZjgzYjFkMjhlNDRiYmE3NjIyOGJiMWZjOGE0ZDZfMS0yLTEtMS05NTU4_2e433f39-34c1-4921-a1eb-2c04de7596b4">1,094,187</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjU2YWY4M2IxZDI4ZTQ0YmJhNzYyMjhiYjFmYzhhNGQ2L3RhYmxlcmFuZ2U6NTZhZjgzYjFkMjhlNDRiYmE3NjIyOGJiMWZjOGE0ZDZfMS00LTEtMS05NTU4_5444717e-03d4-4aae-b706-03fe5eee67e4">1,016,779</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease noncurrent liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjU2YWY4M2IxZDI4ZTQ0YmJhNzYyMjhiYjFmYzhhNGQ2L3RhYmxlcmFuZ2U6NTZhZjgzYjFkMjhlNDRiYmE3NjIyOGJiMWZjOGE0ZDZfMy0yLTEtMS05NTU4_ac21f239-47a9-4048-b4e5-fb6a30904c23">229,605</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjU2YWY4M2IxZDI4ZTQ0YmJhNzYyMjhiYjFmYzhhNGQ2L3RhYmxlcmFuZ2U6NTZhZjgzYjFkMjhlNDRiYmE3NjIyOGJiMWZjOGE0ZDZfMy00LTEtMS05NTU4_33c77651-a926-495c-b2e7-10d92b256397">1,059,693</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="cpix:LeaseLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjU2YWY4M2IxZDI4ZTQ0YmJhNzYyMjhiYjFmYzhhNGQ2L3RhYmxlcmFuZ2U6NTZhZjgzYjFkMjhlNDRiYmE3NjIyOGJiMWZjOGE0ZDZfNC0yLTEtMS05NTU4_94ab13ee-3a95-4fd1-9cd5-7e087475d25a">1,323,792</ix:nonFraction> </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" format="ixt:num-dot-decimal" name="cpix:LeaseLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjU2YWY4M2IxZDI4ZTQ0YmJhNzYyMjhiYjFmYzhhNGQ2L3RhYmxlcmFuZ2U6NTZhZjgzYjFkMjhlNDRiYmE3NjIyOGJiMWZjOGE0ZDZfNC00LTEtMS05NTU4_44b00de6-b348-4030-8772-2419a4261b7f">2,076,472</ix:nonFraction> </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumulative future minimum sublease income under non-cancelable operating subleases totals approximately $<ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LessorOperatingLeasePaymentsToBeReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RleHRyZWdpb246OThjNTVkMmNjZTEwNDcxZmJkMTkwMjYyODEzYmNmNGVfMTUxMA_061ec92c-9b5e-42ad-91fe-7b3b9071690b">0.1</ix:nonFraction> million and will be paid through the leases ending in October 2022 and April 2023. Future minimum lease payments under non-cancelable operating leases (with initial or remaining lease terms in excess of one year) are as follows:</span></div></ix:nonNumeric><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RleHRyZWdpb246OThjNTVkMmNjZTEwNDcxZmJkMTkwMjYyODEzYmNmNGVfMTk4MA_c7686295-6060-4904-bb25-afd463471d17" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.554%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity of Lease Liabilities at September 30, 2021</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjg1MDVmNWNhNDVjNDQ1ZjQ4NWMwZmRmYjdhNjZiOGNiL3RhYmxlcmFuZ2U6ODUwNWY1Y2E0NWM0NDVmNDg1YzBmZGZiN2E2NmI4Y2JfMS0yLTEtMS05NTU4_f3c41a5d-d2ee-41de-86f2-480ce6f9126d">295,038</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjg1MDVmNWNhNDVjNDQ1ZjQ4NWMwZmRmYjdhNjZiOGNiL3RhYmxlcmFuZ2U6ODUwNWY1Y2E0NWM0NDVmNDg1YzBmZGZiN2E2NmI4Y2JfMi0yLTEtMS05NTU4_898b543d-e22f-4964-8f2e-6b6b708fff94">1,019,313</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjg1MDVmNWNhNDVjNDQ1ZjQ4NWMwZmRmYjdhNjZiOGNiL3RhYmxlcmFuZ2U6ODUwNWY1Y2E0NWM0NDVmNDg1YzBmZGZiN2E2NmI4Y2JfMy0yLTEtMS05NTU4_3235881e-2165-4f96-974f-908e882f6170">92,478</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:fixed-zero" name="cpix:LesseeOperatingLeaseLiabilityToBePaidAfterYearThree" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjg1MDVmNWNhNDVjNDQ1ZjQ4NWMwZmRmYjdhNjZiOGNiL3RhYmxlcmFuZ2U6ODUwNWY1Y2E0NWM0NDVmNDg1YzBmZGZiN2E2NmI4Y2JfNC0yLTEtMS05NTU4_0d2752e6-9c2a-4171-a5f4-d3080d1919c7">—</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjg1MDVmNWNhNDVjNDQ1ZjQ4NWMwZmRmYjdhNjZiOGNiL3RhYmxlcmFuZ2U6ODUwNWY1Y2E0NWM0NDVmNDg1YzBmZGZiN2E2NmI4Y2JfNS0yLTEtMS05NTU4_720a3b83-65b9-4f98-a558-db21838b1bf5">1,406,829</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjg1MDVmNWNhNDVjNDQ1ZjQ4NWMwZmRmYjdhNjZiOGNiL3RhYmxlcmFuZ2U6ODUwNWY1Y2E0NWM0NDVmNDg1YzBmZGZiN2E2NmI4Y2JfNi0yLTEtMS05NTU4_5d86e601-a637-4f97-9354-bd1465bb2393">83,037</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjg1MDVmNWNhNDVjNDQ1ZjQ4NWMwZmRmYjdhNjZiOGNiL3RhYmxlcmFuZ2U6ODUwNWY1Y2E0NWM0NDVmNDg1YzBmZGZiN2E2NmI4Y2JfNy0yLTEtMS05NTU4_a41f1f70-093b-4656-99e8-82c60f0845f6">1,323,792</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense is recognized over the expected term of the lease, including renewal option periods, if applicable, on a straight-line basis as a component of general and administrative expense. <ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="cpix:ScheduleofRentExpenseandSubleaseIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RleHRyZWdpb246OThjNTVkMmNjZTEwNDcxZmJkMTkwMjYyODEzYmNmNGVfMTk4MQ_a07552b5-81b7-4736-b9cc-308851fc4066" continuedAt="iff5578d4c721480bb7b9b6c777ec77f4" escape="true">Rent expense and sublease income were as follows:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:center"><ix:continuation id="iff5578d4c721480bb7b9b6c777ec77f4"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjg1MmFmZTE3YmM5YzQzMjFhZjFkNWUzYmIzOTg5YmVlL3RhYmxlcmFuZ2U6ODUyYWZlMTdiYzljNDMyMWFmMWQ1ZTNiYjM5ODliZWVfMi0yLTEtMS05NTU4_8485dfdd-3037-4ef3-bba8-bb574a0c3dfe">910,975</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjg1MmFmZTE3YmM5YzQzMjFhZjFkNWUzYmIzOTg5YmVlL3RhYmxlcmFuZ2U6ODUyYWZlMTdiYzljNDMyMWFmMWQ1ZTNiYjM5ODliZWVfMi00LTEtMS05NTU4_55241f73-83e6-4f7b-b9df-e0aabd4c2ecb">871,441</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SubleaseIncome" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjg1MmFmZTE3YmM5YzQzMjFhZjFkNWUzYmIzOTg5YmVlL3RhYmxlcmFuZ2U6ODUyYWZlMTdiYzljNDMyMWFmMWQ1ZTNiYjM5ODliZWVfNC0yLTEtMS05NTU4_611e8fc1-afa2-4c67-8e71-090664bde8a9">526,868</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SubleaseIncome" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjg1MmFmZTE3YmM5YzQzMjFhZjFkNWUzYmIzOTg5YmVlL3RhYmxlcmFuZ2U6ODUyYWZlMTdiYzljNDMyMWFmMWQ1ZTNiYjM5ODliZWVfNC00LTEtMS05NTU4_6a8b050e-4a9d-4c02-86b9-097156bea41c">491,391</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div id="i8e8bdb91dc894234b9d87e17a18b54fd_46"></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(6) <ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNzgyMQ_8c6372ab-cab9-431c-b845-9b651f6d39d6" continuedAt="i548a0f76fb814dfaa542b9683241a2d8" escape="true">SHAREHOLDERS’ EQUITY AND DEBT</ix:nonNumeric></span></div><ix:continuation id="i548a0f76fb814dfaa542b9683241a2d8" continuedAt="iaf3051136c9041bab61fc8905e1d2ff5"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share repurchases</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland currently has a share repurchase program to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="i6b60adc716c54226bd1b0d9f82b62a4c_I20100513" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfMTMz_ba3f64fa-d60b-4ff9-b70f-3cf9b8753d17">10</ix:nonFraction> million of its common stock pursuant to Rule 10b-18 of the Securities Exchange Act of 1934. In January 2019, the Company's Board of Directors established the current $<ix:nonFraction unitRef="usd" contextRef="i2d045c0da7504a3081ac01dc90d95aed_I20160131" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfMjk0_f678e4c8-a8f2-4356-884c-b1b9cb73b5be">10</ix:nonFraction> million repurchase program to replace the prior authorizations. During the nine months ended September 30, 2021 and September 30, 2020, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i3eac19ab71204baa8b814cd80e8e55ab_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNDAw_73296c1c-97fa-4ffc-a460-0f989cbe74bc">326,537</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="i545187d4937e41ec99d80966b809dd78_D20200101-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNDE0_15811f22-c3a0-4556-9429-51b724444c33">407,683</ix:nonFraction> shares, respectively, of common stock for approximately $<ix:nonFraction unitRef="usd" contextRef="i3eac19ab71204baa8b814cd80e8e55ab_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNDcz_9cfa7502-61ab-47e0-b1ba-c818b27b3958">1.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i545187d4937e41ec99d80966b809dd78_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNDgw_aa52c0d5-afa4-473f-8330-856d30d985a8">1.5</ix:nonFraction> million, respectively. At September 30, 2021, approximately $<ix:nonFraction unitRef="usd" contextRef="i56aafc7718c145c8b150a8e54f33a5d2_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfMTA5OTUxMTYzNTY0NA_9dedc84d-11d4-4922-988e-3accc0a508b2">5.2</ix:nonFraction> million of common shares was left to repurchase under this program.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share purchases and sales</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the Company's March 2021 trading window, several members of Cumberland's Board of Directors entered into share purchase agreements of the Company's stock pursuant to Rule 10b-18 of the Securities Exchange Act of 1934. These purchases are designed to increase ownership in the Company by the members of the Board. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Sales</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2017, Cumberland filed a Shelf Registration on Form S-3 with the SEC associated with the sale of up to $<ix:nonFraction unitRef="usd" contextRef="i4b890701c9304f309d867768f2a90a7b_D20171101-20171130" decimals="-6" format="ixt:num-dot-decimal" name="cpix:StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfMTA2OA_4c7de529-a4f9-4d42-8a56-f199caf47357">100</ix:nonFraction> million in corporate securities. The Shelf Registration was declared effective in January 2018. It also included an At the Market ("ATM") feature that allowed the Company to sell common shares at market prices, along with an agreement with B. Riley FBR Inc. to support such a placement of shares. The Company filed an updated Form S-3 with the SEC in December 2020, which was declared effective in January 2021. The Company does not currently have an ATM feature in place. Cumberland plans to continue to evaluate the market for its common shares, and if favorable, will further evaluate whether or not to enter into an ATM feature through B. Riley FBR, Inc. that would allow the Company to issue shares of its common stock. The Company did not issue any shares under an ATM during the nine months ended September 30, 2021 or September 30, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Share Grants and Incentive Stock Options</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2021 and September 30, 2020, the Company issued <ix:nonFraction unitRef="shares" contextRef="ib59b0ab18a9847a48768cc76def0c5ce_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfMTk1NA_8bcf9678-fe0e-4b49-8484-996291110dd8">36,850</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="i7109429b4bb94262ab81694be586f875_D20200101-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfMTk2OA_73466c05-659c-4db3-a7a7-b3179610f089">230,491</ix:nonFraction> shares of restricted stock to employees and directors, respectively. Restricted stock issued to employees generally cliff-vests on the fourth anniversary of the date of grant and for directors on the <ix:nonNumeric contextRef="i448fcba2bca740069897cf519754695f_D20210101-20210930" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNzgxOQ_f7c65f96-fee8-4b79-8bad-5ee313476e7c">one-year</ix:nonNumeric> anniversary of the date of grant. During the nine months ended September 30, 2021, the Company also issued <ix:nonFraction unitRef="shares" contextRef="ie91a73f23b39413ca4897ecef5e9c6b9_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfMjI1Mw_87214b05-94bd-4f76-ad7b-47faea6bfb95">174,800</ix:nonFraction> incentive stock options to employees that cliff-vest on the fourth anniversary of the date of grant, that are set to expire in March and May 2031. Stock compensation expense is presented as a component of general and administrative expense in the condensed consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Agreement</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2021, the Company and Pinnacle Bank entered into a Fourth Amendment to the Revolving Credit Note and Fifth Amendment ("Fifth Amendment") to the Revolving Credit Loan Agreement to renew the Revolving Credit Loan. </span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The original Pinnacle Agreement was dated July 2017. Beginning on August 14, 2018, and continuing until October 7, 2020, the Company and Pinnacle Bank entered into a series of amendments to extend and update the Revolving Credit Note and Revolving Credit Agreement. The most recent amendment dated October 28, 2021, extends the maturity date three years through October 1, 2024.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with prior Amendments, the Fifth Amendment provides for a principal balance available for borrowing of up to $<ix:nonFraction unitRef="usd" contextRef="ie35d5d79a31d4a97ada4dc5eb118435d_I20211028" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfMTY0OTI2NzQ1NTc1OQ_c3038ab4-da2d-4b1c-ade8-9e3ba9509a53">15</ix:nonFraction> million. The Company has the right to request an increase of up to an additional $<ix:nonFraction unitRef="usd" contextRef="ie35d5d79a31d4a97ada4dc5eb118435d_I20211028" decimals="INF" format="ixt:num-dot-decimal" name="cpix:LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfMTY0OTI2NzQ1NTc0Nw_3185ae6b-bd95-4c31-b6d7-66ca9a182154">5</ix:nonFraction> million providing a maximum principal available of up to $<ix:nonFraction unitRef="usd" contextRef="ie35d5d79a31d4a97ada4dc5eb118435d_I20211028" decimals="INF" format="ixt:num-dot-decimal" name="cpix:LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfMTY0OTI2NzQ1NTc3Mg_6a4b7f13-2028-469c-a8c0-781290ece41d">20</ix:nonFraction> million upon the satisfaction of certain conditions and with the approval of Pinnacle Bank. Also consistent with prior Amendments, the Company is required to maintain either a Funded Debt Ratio covenant or a Tangible Capital Ratio covenant. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate on the Pinnacle Agreement is based on LIBOR plus an interest rate spread. The pricing under the Fourth Amendment provides for an interest rate spread of <ix:nonFraction unitRef="number" contextRef="i433310853533429eb0bd0de42c8cb8c0_D20200814-20200814" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNDU2MA_13cb7560-a435-4e9f-832d-f16665891a2a">1.75</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i7857ace04dd14acd90de8bfdfc44e2ad_D20200814-20200814" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNDU2Ng_51026c1a-824b-4d54-9b38-9a25058087c7">2.75</ix:nonFraction>% above LIBOR with a minimum LIBOR of <ix:nonFraction unitRef="number" contextRef="ia066a8f68c2c4b2bb8d23f93616af446_D20200814-20200814" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNDYwNQ_d013790f-b4c3-4b49-bdec-497369f4088d">0.90</ix:nonFraction>%. The applicable interest rate under the Pinnacle Agreement was <ix:nonFraction unitRef="number" contextRef="i0c79a3c371c84f16b64c6d20ef3f26bd_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNDY3MQ_38ab6b8e-37e5-4857-b49c-d9fd0e5c894d">3.65</ix:nonFraction>% at September 30, 2021. In addition, a fee of <ix:nonFraction unitRef="number" contextRef="i29e07103e7b54d69af01f448919f0979_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNDcwNA_aba009bb-7351-49e8-bfa8-8c0659d42168">0.25</ix:nonFraction>% per year is charged on the unused line of credit. Interest and the unused line fee are payable quarterly. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021 and December 31, 2020, the Company had $<ix:nonFraction unitRef="usd" contextRef="i5729693e898c46118beacc910390b13c_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongTermLineOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfMTA5OTUxMTYzNzEwNQ_ef5585e4-2165-4512-834e-32005b7646ea">15.0</ix:nonFraction> million in borrowings outstanding under its revolving credit facility. The Company was in compliance with the Tangible Capital Ratio financial covenant as of September 30, 2021. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the line of credit are collateralized by substantially all of our assets.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><ix:continuation id="iaf3051136c9041bab61fc8905e1d2ff5" continuedAt="i8e003613d8ac49a9906ea5da8fcac683"><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Paycheck Protection Program Loan</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 20, 2020, Cumberland received the funding of a loan from Pinnacle Bank in the amount of $<ix:nonFraction unitRef="usd" contextRef="i8f0ec15fc71f49aca22d17a26142e958_D20200420-20200420" decimals="0" format="ixt:num-dot-decimal" name="cpix:TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNTA0OA_1da139ea-f756-4e1a-8669-4516fdb4a578">2,187,140</ix:nonFraction> pursuant to the Paycheck Protection Program (the “PPP”) under the Federal Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"), which was enacted March 27, 2020. The PPP is administered by the U.S. Small Business Administration ("SBA").</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the PPP requirements, loan funds were used to maintain payroll, continue group health care benefits, and pay for rent and utilities during the pandemic. We applied for this loan after carefully considering, with our bank, the eligibility criteria to participate in this program, and determining that Cumberland met those criteria. We evaluated and provided information on our payroll and other qualifying expenses to determine the amount of PPP funds to apply for. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the PPP, certain amounts of the loan may be forgiven if they are used for qualifying expenses as described in the CARES Act. Cumberland used the PPP loan funds for such qualifying expenses. Due to assistance from our PPP loan, the Company did not lay off or furlough any employees as a result of the COVID-19 pandemic.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland elected to account for the proceeds of the loan as a government grant under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Accounting Standard 20 ("IAS 20"), Accounting for Government Grants and Disclosure of Government Assistance. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The permitted analogous use of IAS 20 outlines a model for the accounting for government assistance, including forgivable loans. As a result, the Company recorded the $<ix:nonFraction unitRef="usd" contextRef="i8f0ec15fc71f49aca22d17a26142e958_D20200420-20200420" decimals="0" format="ixt:num-dot-decimal" name="cpix:TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNjQ5NQ_d6a212ef-2458-4366-8178-0386b71460d8">2,187,140</ix:nonFraction> as a deferred income liability, which was included as a component of other current liabilities on the condensed consolidated balance sheet at December 31, 2020. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, Cumberland submitted a request for the loan’s forgiveness. On June 11, 2021, the Company received a formal notice from the SBA that the full amount of the loan was forgiven. The Company accounted for the forgiveness of the PPP loan under IAS 20 and recorded the $<ix:nonFraction unitRef="usd" contextRef="i8f0ec15fc71f49aca22d17a26142e958_D20200420-20200420" decimals="0" format="ixt:num-dot-decimal" name="cpix:TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNjkzOQ_d6a212ef-2458-4366-8178-0386b71460d8">2,187,140</ix:nonFraction> as other income.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Joint Venture Agreement</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><ix:continuation id="i8e003613d8ac49a9906ea5da8fcac683" continuedAt="i892dbf29d9f948768157aed023cda2d9"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, Cumberland entered into an agreement with WinHealth Investment (Singapore) Ltd creating </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">WHC Biopharmaceuticals, Pte. Ltd</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i892dbf29d9f948768157aed023cda2d9">. The joint venture, as a limited liability company, will focus on acquiring, developing, registering, and commercializing development stage and commercial stage biopharmaceuticals for China, Hong Kong and other Asian markets. The agreement provides for initial investment from WinHealth in the form of a $<ix:nonFraction unitRef="usd" contextRef="i7f3eb3a61d724b16837687fe50bb6592_I20200831" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNzQyNQ_2a0d5b15-3e25-4b82-a442-1d8962f94a7e">0.2</ix:nonFraction> million equity contribution and an initial investment from Cumberland in the form of a $<ix:nonFraction unitRef="usd" contextRef="i10ede8aae6b6477eb6df1f13d1f8042a_I20200831" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNzUwNw_027896fa-37c5-41ab-b0ed-802eeef9025a">0.2</ix:nonFraction> million convertible note, which was funded during the first quarter 2021. The joint venture will seek additional future capital from additional investors and has entered into exclusive option agreements to license intellectual property from both Cumberland Pharmaceuticals Inc. and Cumberland Emerging Technologies.</ix:continuation> </span></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_49"></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(7) <ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80OS9mcmFnOjIwYTZlMDE2NzJiODRhMmJhZDBlYmZiMmE5NTk4Mzc4L3RleHRyZWdpb246MjBhNmUwMTY3MmI4NGEyYmFkMGViZmIyYTk1OTgzNzhfNjM3_aefd03d2-4c10-402c-92ed-1179f799f7f2" continuedAt="ia95b10adf9794e929105da4b0863c77c" escape="true">INCOME TAXES</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia95b10adf9794e929105da4b0863c77c" continuedAt="i90e9d51a2ac343e1b947ad79267b26b7">As of September 30, 2021, the Company has approximately $<ix:nonFraction unitRef="usd" contextRef="ic25c3441c5a0477ebd8c769c3ea98555_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80OS9mcmFnOjIwYTZlMDE2NzJiODRhMmJhZDBlYmZiMmE5NTk4Mzc4L3RleHRyZWdpb246MjBhNmUwMTY3MmI4NGEyYmFkMGViZmIyYTk1OTgzNzhfNjI_3db0aa8b-d565-4727-8e06-406c0492c7df">56.5</ix:nonFraction> million in federal net operating loss carryforwards including approximately $<ix:nonFraction unitRef="usd" contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80OS9mcmFnOjIwYTZlMDE2NzJiODRhMmJhZDBlYmZiMmE5NTk4Mzc4L3RleHRyZWdpb246MjBhNmUwMTY3MmI4NGEyYmFkMGViZmIyYTk1OTgzNzhfMTMz_063fd305-aa10-4eb0-be91-efc233c5669c">44.1</ix:nonFraction> million of net operating loss carryforwards resulting from the exercise of nonqualified stock options. These have historically been used to significantly offset income tax obligations. The Company expects it will continue to pay minimal income taxes during 2021 and beyond, through the continued utilization of these net operating loss carryforwards, on any taxable income generated from our operations. </ix:continuation></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i90e9d51a2ac343e1b947ad79267b26b7">The Company does not allocate any portion of its income tax expense (benefit) to discontinued operations.</ix:continuation> </span></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_52"></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(8) <ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81Mi9mcmFnOjkxYTMyNzA3NTQwODRlNzdiM2VmZjk4YWYwYTBhM2UxL3RleHRyZWdpb246OTFhMzI3MDc1NDA4NGU3N2IzZWZmOThhZjBhMGEzZTFfMTAyNg_6b27aa50-4a22-41f8-b835-f7fd88901262" continuedAt="ide6ffa74dfb64afcbffc2a1b31a77697" escape="true">COLLABORATIVE AGREEMENTS</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><ix:continuation id="ide6ffa74dfb64afcbffc2a1b31a77697"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland is a party to several collaborative arrangements with research institutions to identify and pursue promising pharmaceutical product candidates. The funding for these programs is primarily provided through Federal Small Business Administration (SBIR/STTR) and other grant awards. The Company has determined that these collaborative agreements, with the exception of the collaborative payment received related to RediTrex, do not meet the criteria for accounting under ASC Topic 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The agreements do not specifically designate each party’s rights and obligations to each other under the collaborative arrangements. Except for patent defense costs, expenses incurred by one party are not required to be reimbursed by the other party. Expenses incurred under these collaborative agreements are included in research and development expenses and funding received from grants are recorded as net revenues in the condensed consolidated statements of operations.</span></ix:continuation></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_55"></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(9) <ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfNTg0MA_f24487e3-6f8c-4766-8223-21f98b90ef57" continuedAt="i591f039c0ac14589a9653e5a508d99e2" escape="true">ADDITIONS AND RETURN OF PRODUCT RIGHTS</ix:nonNumeric></span></div><ix:continuation id="i591f039c0ac14589a9653e5a508d99e2" continuedAt="i01059d77cfe8401493354b0c8a1fe8d6"><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vibativ</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During November 2018, the Company closed on an agreement with Theravance Biopharma ("Theravance") to acquire the global responsibility for Vibativ including the marketing, distribution, manufacturing and regulatory activities associated with the brand. Vibativ is a patented, Food and Drug Administration ("FDA") approved injectable anti-infective for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia and complicated skin and skin structure infections. It addresses a range of Gram-positive bacterial pathogens, including those that are considered difficult-to-treat and multidrug-resistant. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland has accounted for the transaction as a business combination in accordance with ASC 805 and the product sales are included in the results of operations subsequent to the acquisition date. The Company made an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i57f795672a2a465e9209a65e0162f0b4_D20181101-20181130" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfOTcw_7e4f4541-973e-41c9-a96b-acda0c69e7b1">20.0</ix:nonFraction> million at the closing of the transaction and a $<ix:nonFraction unitRef="usd" contextRef="i57f795672a2a465e9209a65e0162f0b4_D20181101-20181130" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OtherPaymentsToAcquireBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMTAxMw_c6c619d0-5a9a-4862-93bd-bac082c859aa">5.0</ix:nonFraction> million milestone payment in early April 2019. In addition, Cumberland has agreed to pay a royalty of up to <ix:nonFraction unitRef="number" contextRef="i57f795672a2a465e9209a65e0162f0b4_D20181101-20181130" decimals="2" name="cpix:TieredRoyaltyPaymentsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMTExNg_5fd215db-2c05-4ad5-b957-dc4f3234dda8">20</ix:nonFraction>% of on-going net sales of the product. The future royalty payments were required to be recognized at their acquisition-date fair value as a contingent consideration liability, as part of the contingent consideration transferred in the business combination. Cumberland prepared the valuations of the contingent consideration liability utilizing significant unobservable inputs. As a result, the valuation is classified as Level 3 fair value measurement. </span></div><div style="margin-top:6pt;text-align:justify"><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfNTg0MQ_63cc83b6-0c84-430b-a0a8-ef4bdcc80d71" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the fair value of the contingent consideration liability that is remeasured on a recurring basis. The contingent consideration earned and accrued in operating expenses is paid to Theravance quarterly.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i890f0fecec4a4eb899b3171ad304df32_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjUyYWJlY2FiYzBlZDQ5NDRhNzg4YWIwNGI1NGUwMGFiL3RhYmxlcmFuZ2U6NTJhYmVjYWJjMGVkNDk0NGE3ODhhYjA0YjU0ZTAwYWJfOS0xLTEtMS05NTU4_c401baa2-4241-454e-a8e6-3422141524c2">8,200,552</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment of royalty during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id08ba9ef8fce4ef0b1aebddae7a819be_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRoyalties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjUyYWJlY2FiYzBlZDQ5NDRhNzg4YWIwNGI1NGUwMGFiL3RhYmxlcmFuZ2U6NTJhYmVjYWJjMGVkNDk0NGE3ODhhYjA0YjU0ZTAwYWJfMTAtMS0xLTEtOTU1OA_71c82430-fe1a-4523-a9f5-0a188f0f9b04">1,792,573</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration included in operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id08ba9ef8fce4ef0b1aebddae7a819be_D20210101-20210930" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjUyYWJlY2FiYzBlZDQ5NDRhNzg4YWIwNGI1NGUwMGFiL3RhYmxlcmFuZ2U6NTJhYmVjYWJjMGVkNDk0NGE3ODhhYjA0YjU0ZTAwYWJfMTEtMS0xLTEtOTU1OA_8b843a3f-4aba-4599-b011-5eb43b1a13ae">632,646</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration earned and accrued in operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id08ba9ef8fce4ef0b1aebddae7a819be_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="cpix:BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjUyYWJlY2FiYzBlZDQ5NDRhNzg4YWIwNGI1NGUwMGFiL3RhYmxlcmFuZ2U6NTJhYmVjYWJjMGVkNDk0NGE3ODhhYjA0YjU0ZTAwYWJfMTItMS0xLTEtOTU1OA_65741f33-d908-4e37-a326-ec83e12aa2ec">1,134,333</ix:nonFraction> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d7014c036534d1ab07ea1c7138ece74_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjUyYWJlY2FiYzBlZDQ5NDRhNzg4YWIwNGI1NGUwMGFiL3RhYmxlcmFuZ2U6NTJhYmVjYWJjMGVkNDk0NGE3ODhhYjA0YjU0ZTAwYWJfMTMtMS0xLTEtOTU1OA_ce52186d-c37c-470b-ba63-7b153ebc19ac">6,909,666</ix:nonFraction> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></ix:nonNumeric></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration liability of $<ix:nonFraction unitRef="usd" contextRef="i5d7014c036534d1ab07ea1c7138ece74_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMTg2Mw_58008847-255d-4a78-a316-fa566ad4af7d">6.9</ix:nonFraction> million was classified as other current liabilities of $<ix:nonFraction unitRef="usd" contextRef="i0463cd68913447b0aec736a9a21b1701_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMTkxMw_e02dcf8f-caeb-4136-9ec8-9659b0b2055f">2.6</ix:nonFraction> million and other long-term liabilities of $<ix:nonFraction unitRef="usd" contextRef="icf562c30b2d9493a84db87baebada783_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMTk1MQ_c38a5770-195c-4619-a4be-92536441a70c">4.3</ix:nonFraction> million on the condensed consolidated balance sheet as of September 30, 2021. </span></div></ix:continuation><div style="margin-top:8pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><ix:continuation id="i01059d77cfe8401493354b0c8a1fe8d6"><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RediTrex</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2016, the Company announced an agreement with the Nordic Group B.V. ("Nordic") to acquire the exclusive U.S. rights to Nordic’s injectable methotrexate product line designed for the treatment of active rheumatoid arthritis, juvenile idiopathic arthritis, severe psoriatic arthritis, and severe disabling psoriasis. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As consideration for the license Cumberland paid a deposit of $<ix:nonFraction unitRef="usd" contextRef="if7d1c3dbcd4b4c6eabe94af067f29d41_D20161101-20161130" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMjQwOQ_8fb3a4e5-219e-441b-96b5-99345081c6ac">100,000</ix:nonFraction> at closing. The Company provided $<ix:nonFraction unitRef="usd" contextRef="if7d1c3dbcd4b4c6eabe94af067f29d41_D20161101-20161130" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMjQ0Ng_6a25e1fb-d000-4426-9285-cd2deeea1d71">0.9</ix:nonFraction> million in consideration through a grant of <ix:nonFraction unitRef="shares" contextRef="ibb1ab73ec0354946b843823c167cac73_D20161101-20161130" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMjQ4NQ_376179ad-b353-4db2-a58c-98ba484c18c2">180,000</ix:nonFraction> restricted shares of Cumberland common stock to be vested upon the FDA approval of the first Nordic product. Cumberland also agreed to provide Nordic a series of payments tied to the products’ FDA approval, launch and achievement of certain sales milestones. Under the terms of the agreement, Cumberland is responsible for the product registration and commercialization in the U.S. Nordic is responsible for product manufacturing and supply. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 27, 2019, Cumberland received FDA approval for the first Nordic injectable product and authorization to market them under the RediTrex brand name. The <ix:nonFraction unitRef="shares" contextRef="ibb1ab73ec0354946b843823c167cac73_D20161101-20161130" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMzA5Ng_170486f0-3188-4903-b50d-941bb79e6dd6">180,000</ix:nonFraction> shares of restricted Cumberland common stock previously provided to Nordic vested upon approval and were valued at $<ix:nonFraction unitRef="usd" contextRef="i9fbce1ec780d49a78a390da0ae5f4c6c_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMzIxNA_9bd7c5af-5bc2-4dd2-b7ba-9cb4a7cebe1a">0.9</ix:nonFraction> million on the vesting date. The FDA approval also resulted in a $<ix:nonFraction unitRef="usd" contextRef="i0a2ac195a36045adacdf507f9366ba39_I20200731" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMzI3NA_994c2cb0-774d-4e92-b009-1c78a3f5f6d5">1.0</ix:nonFraction> million milestone payment due to Nordic. During December 2020, Cumberland introduced RediTrex and the launch that will take place in late 2021 will result in a $<ix:nonFraction unitRef="usd" contextRef="i0899d206bf0144cb8f97b035bbc59bdc_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMzQzMA_3bf9017b-3a43-424d-b1de-5b5a7f6c6e64">1.0</ix:nonFraction> million milestone payment due to Nordic. This milestone payment will be paid during 2022 and is included as a current liability at September 30, 2021.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland has approximately $<ix:nonFraction unitRef="usd" contextRef="iab3199a2232b4c38950a9c717c8b9171_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMzU5Ng_991683b6-233c-4928-af4f-17b9d058d786">2.7</ix:nonFraction> million in net intangible assets related to RediTrex at September 30, 2021. </span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ethyol and Totect </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2016, Cumberland entered into an agreement with Clinigen for the rights and responsibilities associated with the commercialization of Ethyol in the United States. In 2017, the Company entered into another agreement with Clinigen for the rights and responsibilities associated with the commercialization of Totect in the United States. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Early in 2019, Cumberland announced a strategic review of the Company's brands, capabilities, and international partners. This review followed an accelerated business development initiative, which resulted in a series of transactions. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During May 2019, Cumberland entered into the Dissolution Agreement with Clinigen in which the Company returned the exclusive rights to commercialize Ethyol and Totect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the United States to Clinigen. Under the final terms of the Dissolution Agreement, Cumberland was no longer responsible for the distribution, marketing and promotion of either Ethyol or Totect or any competing products after December 31, 2019.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In exchange for the return of these product license rights and the non-compete provisions of the Dissolution Agreement, Cumberland is receiving $<ix:nonFraction unitRef="usd" contextRef="i3c783d360e1948c18a55f375b9840bca_D20191001-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfNDgwOA_ebb4201e-3fc7-4588-94e9-1841362a7215">5</ix:nonFraction> million in financial consideration paid in quarterly installments over the two-years following the transition date. Cumberland recorded the first four quarterly installments totaling $<ix:nonFraction unitRef="usd" contextRef="i54eac56082574a4c986a915dc06c3af5_D20210101-20210630" decimals="-5" format="ixt:num-dot-decimal" name="cpix:ProceedsFromSaleOfIntangibleAssetsInstallmentPayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfNDk4Ng_6c047bc2-19b9-467a-82a2-09a37b7365dd">3.0</ix:nonFraction> million during 2020 and the next three installments totaling $<ix:nonFraction unitRef="usd" contextRef="i45bdfab35dd74d60ac86fc023b908b73_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfNTA0MA_8a646cfd-70b9-46ad-a20c-f4a22a2f4631">1.5</ix:nonFraction> million during the nine months ended September 30, 2021, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as discontinued operations. The Company will record the last remaining quarterly installment in the fourth quarter of 2021.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exit from Ethyol and Totect meets the accounting criteria to be reported as discontinued operations. December 31, 2019, as the transition date, was the final day Cumberland was responsible for the products. Cumberland was responsible for the products through December 31, 2019 and beginning on January 1, 2020, the products' rights transitioned back to Clinigen. As a result, January 1, 2020, was the first day of discontinued operations for the Ethyol and Totect products.</span></div><ix:nonNumeric contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfNTg0Mg_3c327a04-eb39-4424-bbb1-9960eed76f96" escape="true"><div style="margin-top:8pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dissolution payments from Clinigen are reflected as revenue from discontinued operations. The Company does not </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">incur expenses associated with these payments from Clinigen. </span></div><div style="margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb58760ea84940319b35492cd1910735_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfMy0yLTEtMS05NTU4_86849bd9-9c34-42dc-a4b6-2061e77af27b">496,787</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca7f9fa06d14f85a52cbd81ac170d2c_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfMy00LTEtMS05NTU4_0fe8db84-b272-4c9f-a304-4c34cd7b14a3">777,916</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45bdfab35dd74d60ac86fc023b908b73_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfMy01LTEtMS05NTU4_1acd7b61-10d3-4d57-a3bb-db27abac79f0">1,491,004</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c8802e62b74a919450a1c6017bba7e_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfMy03LTEtMS05NTU4_841b8fa5-722e-49de-805f-6e1ba99049bf">2,334,811</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs of products sold</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb58760ea84940319b35492cd1910735_D20210701-20210930" decimals="0" format="ixt:fixed-zero" name="us-gaap:CostOfGoodsAndServicesSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNC0yLTEtMS05NTU4_b370ba5e-0f89-4b8c-8e72-b4654071f9b9">—</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca7f9fa06d14f85a52cbd81ac170d2c_D20200701-20200930" decimals="0" format="ixt:fixed-zero" name="us-gaap:CostOfGoodsAndServicesSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNC00LTEtMS05NTU4_4f087064-ec6f-423b-b86f-0953ea7019c3">—</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45bdfab35dd74d60ac86fc023b908b73_D20210101-20210930" decimals="0" format="ixt:fixed-zero" name="us-gaap:CostOfGoodsAndServicesSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNC01LTEtMS05NTU4_155b8afc-8ab1-457d-92e1-03a857618626">—</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c8802e62b74a919450a1c6017bba7e_D20200101-20200930" decimals="0" format="ixt:fixed-zero" name="us-gaap:CostOfGoodsAndServicesSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNC03LTEtMS05NTU4_c03493ea-11f9-4d62-83fb-b13be2887ec5">—</ix:nonFraction> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, Marketing and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb58760ea84940319b35492cd1910735_D20210701-20210930" decimals="0" format="ixt:fixed-zero" name="us-gaap:SellingAndMarketingExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNS0yLTEtMS05NTU4_7f78e0b8-872e-4890-b770-0a08422c7bcd">—</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca7f9fa06d14f85a52cbd81ac170d2c_D20200701-20200930" decimals="0" format="ixt:fixed-zero" name="us-gaap:SellingAndMarketingExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNS00LTEtMS05NTU4_11ac3d95-7e50-479f-ab22-21b3694b4b6a">—</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45bdfab35dd74d60ac86fc023b908b73_D20210101-20210930" decimals="0" format="ixt:fixed-zero" name="us-gaap:SellingAndMarketingExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNS01LTEtMS05NTU4_34178999-de8e-4b4e-ac90-824fd32e5090">—</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c8802e62b74a919450a1c6017bba7e_D20200101-20200930" decimals="0" format="ixt:fixed-zero" name="us-gaap:SellingAndMarketingExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNS03LTEtMS05NTU4_edecd593-95d2-431b-81e9-20a787b68ed8">—</ix:nonFraction> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb58760ea84940319b35492cd1910735_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNi0yLTEtMS05NTU4_bbd547b7-4377-470d-90d9-78decf2db53b">496,787</ix:nonFraction> </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca7f9fa06d14f85a52cbd81ac170d2c_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNi00LTEtMS05NTU4_3386f327-073b-4e39-8b3a-fea616e5490c">777,916</ix:nonFraction> </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45bdfab35dd74d60ac86fc023b908b73_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNi01LTEtMS05NTU4_b296a3be-7468-4125-abbc-ab4924871a99">1,491,004</ix:nonFraction> </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c8802e62b74a919450a1c6017bba7e_D20200101-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNi03LTEtMS05NTU4_4f55d8cf-b278-4038-beef-abe1a03978de">2,334,811</ix:nonFraction> </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_58"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure regarding forward-looking statements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion contains certain forward-looking statements which reflect management’s current views of future events and operations. These statements involve certain risks and uncertainties, and actual results may differ materially from them. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ significantly from the results discussed in these forward-looking statements. Some important factors which may cause results to differ from expectations include: availability of additional debt and equity capital; market conditions at the time additional capital is required; our ability to continue to acquire branded products; product sales; management of our growth and integration of our acquisitions and impacts on our business as well as national and international markets and economies resulting from the COVID-19 pandemic. While forward-looking statements reflect our beliefs and best judgment based upon current information, they are not guarantees of future performance. Other important factors that may cause actual results to differ materially from forward-looking statements are discussed in the sections entitled “Risk Factors” and “Special Note Regarding Forward-Looking Statements” of our Annual Report on Form 10-K for the year ended December 31, 2020, and our other filings with the SEC.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not undertake to publicly update or revise any of our forward-looking statements, even in the event that experience or future changes indicate that the anticipated results will not be realized. The following presentation of management’s discussion and analysis of financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included in this report on Form 10-Q.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div><span><br/></span></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_61"></div><div style="-sec-extract:summary;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OVERVIEW</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland Pharmaceuticals Inc. (“Cumberland,” the “Company,” or as used in the context of “we,” “us,” or “our”), is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. We are dedicated to providing innovative products that improve the quality of care for patients and address poorly met medical needs. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary target markets are hospital acute care, gastroenterology and rheumatology. These medical specialties are characterized by relatively concentrated prescriber bases that we believe can be served effectively by small, targeted sales forces. We promote our approved products through our hospital and field sales forces in the United States and are establishing a network of international partners to register and provide our medicines to patients in their countries.</span></div><div style="margin-top:8pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our portfolio of FDA approved brands include:</span></div><div style="margin-bottom:6pt;margin-top:8pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Acetadote</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">acetylcysteine</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) Injection, for the treatment of acetaminophen poisoning; </span></div><div style="margin-bottom:6pt;margin-top:8pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Caldolor</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ibuprofen</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) Injection, for the treatment of pain and fever;</span></div><div style="margin-bottom:6pt;margin-top:8pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Kristalose</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">lactulose</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) for Oral Solution, a prescription laxative, for the treatment of constipation;</span></div><div style="margin-bottom:6pt;margin-top:8pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Omeclamox</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">-Pak</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">omeprazole, clarithromycin, and amoxicillin</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) for the treatment of Helicobacter pylori (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">H. pylori</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) infection and related duodenal ulcer disease;</span></div><div style="margin-bottom:6pt;margin-top:8pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">RediTrex</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">methotrexate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) Injection,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the treatment of active rheumatoid, juvenile idiopathic and severe psoriatic arthritis, as well as disabling psoriasis;</span></div><div style="margin-bottom:6pt;margin-top:8pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">•</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Vaprisol</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">conivaptan</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) Injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; and</span></div><div style="margin-bottom:6pt;margin-top:8pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Vibativ</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">telavancin</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) Injection, for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to these commercial brands, we have Phase II clinical programs underway evaluating our ifetroban product candidates being used by patients with cardiomyopathy associated with Duchenne Muscular Dystrophy (“DMD”), a degenerative disease, Systemic Sclerosis (“SSc”), a deadly autoimmune condition, and Aspirin-Exacerbated Respiratory Disease (“AERD”), a severe form of asthma. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland has built core competencies in both the development and commercialization of pharmaceutical products. We have established the capabilities needed to acquire, develop and commercialize branded pharmaceuticals in the U.S. and believe we can leverage this existing infrastructure to support our expected growth. Our management team consists of pharmaceutical industry veterans experienced in business development, product development, regulatory, manufacturing, sales, marketing and finance. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business development team identifies, evaluates, and negotiates product acquisition, licensing and co-promotion agreements. Our product development team creates proprietary product formulations, manages our clinical studies, prepares all regulatory submissions and staffs our medical call center. Our quality and manufacturing professionals oversee the manufacturing, release and shipment of our products. Our marketing and sales team is responsible for our commercial activities, and we work closely with our distribution partners to ensure availability and delivery of our products.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Growth Strategy</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland's growth strategy involves maximizing the potential of our existing brands while continuing to build a portfolio of differentiated products. We currently feature seven FDA products approved for sale in the United States.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our international partners, we are working to bring our medicines to patients in their countries. We also look for opportunities to expand our products into additional patient populations through clinical trials, new presentations and our support for select, investigator-initiated studies. We actively pursue opportunities to acquire additional marketed products, as well as late-stage development product candidates in our target medical specialties. Our clinical team is developing a pipeline of new product candidates largely to address poorly met medical needs.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are supplementing these activities with the earlier stage drug development at Cumberland Emerging Technologies (“CET”), our majority-owned subsidiary. CET partners with academic research institutions to identify and support the progress of promising new product candidates, which Cumberland has the opportunity to further develop and commercialize.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specifically, we are seeking long-term sustainable growth by:</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supporting and expanding the use of our marketed products </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to evaluate our products following their FDA approval to determine if additional clinical data could expand their market and use. We will continue to explore opportunities for label expansion to bring our products to new patient populations. As examples, we have secured pediatric approval, expanding the labeling for both our Acetadote and Caldolor brands. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selectively adding complementary brands - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our product development activities, we are also seeking to acquire products or late-stage development product candidates to continue building a portfolio of complementary brands. We focus on under-promoted, FDA-approved drugs as well as late-stage development products that address poorly met medical needs. We will continue to target product acquisition candidates that are competitively differentiated, have valuable intellectual property or other protective features, and allow us to leverage our existing infrastructure. Our acquisition of Vibativ is an example of this strategy.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Progressing our clinical pipeline and incubating future product opportunities at CET -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We believe it is important to build a pipeline of innovative new product opportunities, such as we are doing through our ifetroban Phase II development programs. We are also supplementing our acquisition and late-stage development activities with early-stage drug development activities at CET. CET partners with universities and other research organizations to develop promising, early-stage product candidates, which Cumberland has the opportunity to further develop and commercialize. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leveraging our infrastructure through co-promotion partnerships - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our commercial infrastructure can help drive prescription volume and product sales. We look for strategic partners that can complement our capabilities and enhance opportunities for our brands. For example, our co-promotion partnerships have allowed us to expand support for Kristalose across the United States.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Building an international market -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have established our own commercial capabilities, including two sales divisions, to cover the U.S. market for our products. We are also building a network of select international partners to register our products and make them available to patients in their countries. We will continue to develop and expand our network of international partners while supporting our partners’ registration and commercialization efforts in their respective territories. The acquisition of Vibativ resulted in several new international partners and market opportunities.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Managing our operations with financial discipline -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We continually work to manage our expenses in line with our revenues in order to deliver positive cash flow from operations. We remain in a strong financial position, with favorable gross margins and a strong balance sheet. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were incorporated in 1999 and have been headquartered in Nashville, Tennessee since inception. During 2009, we completed an initial public offering of our common shares and listing on the Nasdaq stock exchange. Our website address is www.cumberlandpharma.com. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make available through our website our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and all material press releases and other reports as soon as reasonably practicable after their filing with the U.S. Securities and Exchange Commission, (“SEC”). These filings are also available to the public at </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:8pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RECENT DEVELOPMENTS</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Pandemic </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In early 2020, the U.S. declared a health care emergency following the outbreak of SARS-CoV-2, a novel strain of coronavirus that causes COVID-19, a respiratory illness. The Company has managed through the resulting COVID-19 pandemic, continuing to operate our business – keeping facilities open and our organization intact. We moved quickly to ensure the health and safety of our team. We also maintained our ongoing compliance with the many laws and regulations that apply to us as a publicly traded pharmaceutical company.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the pandemic, Cumberland faced the same challenges affecting other companies that rely on hospital admissions and patient visits to drive revenue. Our business and our clinical studies were impacted, as fewer patients sought elective surgeries and our access to medical facilities was substantially limited. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carefully monitored our supply chain, including the flow of raw materials and the batches of finished products emerging from the facilities that manufacture our products. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several of our brands were negatively impacted by the lockdowns and postponement of physician office visits and elective procedures. However, we are fortunate to have a diversified product portfolio that includes other brands that have delivered a strong performance during the pandemic.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall, we have been able to continue the delivery of our products while addressing the interests of our shareholders, employees, partners and community.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RediTrex Launch</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In late 2019, we received approval from the U.S. Food and Drug Administration (“FDA”) for our New Drug Application for RediTrex, our methotrexate product line. RediTrex is a new line of pre-filled syringes specifically designed for ease of handling and dosing accuracy for the subcutaneous administration of methotrexate in patients with arthritis and psoriasis.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In late 2020, we received initial product supplies and then provided shipments of RediTrex to select accounts. Due to the pandemic, we delayed the national launch of the product, which was implemented during the third quarter of 2021.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RediTrex treats patients with severe, active rheumatoid arthritis, and polyarticular juvenile idiopathic arthritis who have difficulty tolerating or responding to orally delivered methotrexate. It is also approved for symptomatic control of severe, recalcitrant, disabling psoriasis in adults who are not adequately responsive to other forms of therapy.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With more than 54 million Americans living with some form of arthritis, the disease is among the most common causes of work disability in the U.S., according to the CDC. The oral form of methotrexate is typically the first line of treatment for rheumatoid arthritis. As the disease progresses, the dose must be increased to stay effective, often causing intolerable gastrointestinal side effects. Injectable methotrexate has been proven to be more effective than oral delivery, with fewer gastrointestinal reactions. Because of the increased efficacy and tolerability, injectable methotrexate can delay the need to move to costly biologics, lowering overall patient treatment costs. Once disease progression requires the use of biologics, continuing the treatment of injectable methotrexate along with the biologic has been shown to increase overall efficacy.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other injectable methotrexate options available may not optimally meet the needs of arthritis patients who are offered either a vial and syringe for self-injection, or the use of an expensive autoinjector. The vial and syringe method can be difficult for a patient to handle due to limited dexterity in their hands. Additionally, obtaining the exact dose needed while preventing skin exposure to the caustic methotrexate can be quite challenging for many patients. The autoinjectors provide a better alternative to the vial and syringe, but they remove injection control from the patient and can be painful to administer. They are also the most expensive methotrexate delivery.</span></div><div style="margin-top:8pt;text-align:justify"><span><br/></span></div><div style="margin-top:8pt;text-align:justify"><span><br/></span></div><div style="margin-top:8pt;text-align:justify"><span><br/></span></div><div style="margin-top:8pt;text-align:justify"><span><br/></span></div><div style="margin-top:8pt;text-align:justify"><span><br/></span></div><div style="margin-top:8pt;text-align:justify"><span><br/></span></div><div style="margin-top:8pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESG Report</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, we released our second annual Sustainability Report (the "2020 Sustainability Report"), which details Cumberland’s activities pertaining to our environmental, social and governance (“ESG”) matters. After issuing our inaugural ESG report last year (the "2019 Sustainability Report"), we remain committed to sustainability and to maintaining transparency of our corporate operations. As the largest biopharmaceutical company founded and headquartered in the Mid-South, we hold ourselves to the highest standards of ethical practices and understand the importance of recognizing and addressing our impact on our constituents, the community and the environment.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Sustainability Report notes that in 2020 we provided nearly 2.5 million patient doses of our products, safely disposed of over 4,000 pounds of expired and damaged products and had no product recalls. We also had no Company brands listed on the FDA’s MedWatch Safety Alerts for Human Medical Products, no Company product issues identified by FDA from their Adverse Event Reporting System and no clinical trials terminated due to failure to practice good clinical standards.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Sustainability Report also highlights several initiatives we implemented as part of our commitment to delivering high-quality pharmaceutical products to improve patient care. For example, we continued a program to serialize all commercial products sold in the United States, allowing us to track every unit distributed, which helps to prevent counterfeit drugs from entering the market under the Cumberland brand. In addition, through our coupon program, Cumberland can cover up to 90% of patient prescription costs for our gastrointestinal products.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Sustainability Report also highlights our investment in our employees through our continuing education programs, employee development initiatives and employee recognition awards. Cumberland’s workforce is 46% women – and 18% of our employees are minorities.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ifetroban Clinical Studies</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been evaluating our ifetroban product candidate in a series of clinical studies. We are sponsoring Phase II clinical programs to evaluate our ifetroban product candidates in 1) patients with cardiomyopathy associated with Duchenne Muscular Dystrophy, a rare, fatal, genetic neuromuscular disease that results in deterioration of the skeletal, heart and lung muscles, 2) Systemic Sclerosis or scleroderma, a debilitating autoimmune disorder characterized by diffuse fibrosis of the skin and internal organs and 3) Aspirin-Exacerbated Respiratory Disease, a severe form of asthma. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enrollment in these clinical studies was interrupted due to the COVID-19 pandemic. However, many of our clinical study sites have reopened and resumed screening of patients for potential participation into our studies. We are awaiting results from the studies underway before deciding on the best development path for the registration of ifetroban, our first new chemical entity.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, our Board of Directors approved a new clinical program for the use of ifetroban to treat Progressive Fibrosing Interstitial Lung Diseases (“PF-ILDs”). Nonclinical studies are complete, and the resulting manuscript has been prepared and submitted for publication. A Phase II clinical study is planned and an application to the FDA is in preparation to support this new clinical program.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional pilot preclinical and clinical studies of ifetroban are underway, including several investigator-initiated trials. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Omeclamox-Pak Supply Update</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland has partnered with a select group of FDA-approved facilities to manufacture its line of branded pharmaceutical products and has been carefully monitoring its supply chain during the pandemic. The packager for our Omeclamox-Pak product encountered financial difficulties due to the impact of COVID-19, and their operations are currently suspended. We are awaiting the resumption of those operations, while also exploring other alternatives to restart the product’s packaging. Meanwhile, we informed the FDA of a shortage of the Omeclamox-Pak effective October 14, 2020 and have not provided a date for the availability of new inventory.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Renal Colic Study</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A clinical trial studying the comparison of intravenous ibuprofen with injectable ketorolac in renal colic pain management demonstrated that ibuprofen is the more rapid-acting drug in controlling pain caused by kidney stones. The study also indicated that the complete relief from pain with ibuprofen was twice as much as that of ketorolac. The findings build upon a body of medical evidence supporting the use of our Caldolor product for the treatment of patient pain. </span></div><div style="margin-top:8pt;text-align:justify"><span><br/></span></div><div style="margin-top:8pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="margin-top:8pt;text-align:justify"><span><br/></span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hyponatremia Publication</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Outcome Predictive Evaluation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(HOPE)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> COVID-19 Registry Analysis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an international study of over 4,000 patients published in November 2020, found that patients hospitalized with COVID-19 had a high risk of developing hyponatremia. These COVID-19 patients also had a higher incidence of mortality due to their hyponatremia. The study results support the use of an intravenous vaptan to treat hyponatremia in critically ill patients afflicted with COVID-19. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hyponatremia, an imbalance of serum sodium to body water, is the most common electrolyte disorder among hospitalized patients. Our Vaprisol product is one of two branded prescription products indicated for the treatment of hyponatremia, and the only intravenously administered branded treatment. Vaprisol has a proven day-1 response rate to normalize serum sodium levels in hyponatremic patients and move them out of the Intensive Care Unit as efficiently as possible.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Line of Credit</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2021, we entered into an amendment to renew our Revolving Credit Loan Agreement with Pinnacle Bank. The amendment extended the term of the loan agreement for a three-year period ending in October 2024. The facility provides for a principal balance available for borrowing up to $15 million and an opportunity to request an increase in availability to $20 million. The interest rate on funds borrowed under the facility ranges from 30-day LIBOR plus 175 to 275 basis points depending on the funded debt ratio.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vibativ International Agreements</span></div><div style="margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">On August 25, 2021, we signed an agreement with Verity Pharmaceuticals International Limited to license and commercialize Vibativ in Puerto Rico. Verity is a specialty pharmaceutical company with commercial operations in the U.S. and Canada.</span></div><div style="margin-top:8pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vibativ is a patented, FDA-approved injectable anti-infective for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, and complicated skin and skin structure infections. It addresses a range of Gram-positive bacterial pathogens, including those that are considered difficult-to-treat and multidrug-resistant. In November 2018, Cumberland reached an agreement to acquire Vibativ from Theravance Biopharma and assume global responsibility for the product.</span></div><div style="margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">SciClone Pharmaceuticals (Holdings) Limited has licensed our Vibativ product for sale and distribution in China. In February 2021, SciClone completed an initial public offering and listing of their shares on the Hong Kong stock exchange. In June 2021, SciClone submitted an application to the Chinese regulatory authority for the approval of Vibativ in that country. In October 2021, we were informed by SciClone that the filing was accepted by the regulatory agency for review. SciClone expects a review period of up to twelve months for their application and believes that the potential for Vibativ in China may be significant.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the challenges of operating during a pandemic, Cumberland remains committed to our mission of providing innovative products that improve the quality of care for patients and address poorly met medical needs. We are working to fulfill this mission by building a portfolio of innovative and differentiated products through a multifaceted strategy that includes development of new candidates and acquisition of established brands. Our resulting, diversified product line has enabled us to weather external challenges, while our team has remained responsive to the evolving medical market. We are prepared for and look forward to future opportunities to carry out our mission.</span></div><div style="margin-top:8pt;text-align:justify"><span><br/></span></div><div style="margin-top:8pt;text-align:justify"><span><br/></span></div><div style="margin-top:8pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_64"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND SIGNIFICANT JUDGMENTS AND ESTIMATES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please see a discussion of our critical accounting policies and significant judgments and estimates in Note 1 to the Company's Condensed Consolidated Financial Statements accompanying this report and the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 2020 Annual Report on Form 10-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Estimates and Judgments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. We base our estimates on past experience and on other factors we deem reasonable given the circumstances. Past results help form the basis of our judgments about the carrying value of assets and liabilities that cannot be determined from other sources. Actual results could differ from these estimates. These estimates, judgments and assumptions are most critical with respect to our accounting for revenue recognition, inventories, fair value of contingent consideration liability associated with a business combination, share-based compensation and intangible assets.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_67"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three months ended September 30, 2021 compared to the three months ended September 30, 2020 </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the unaudited interim statements of operations for continuing operations for the three months ended September 30, 2021 and 2020:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.131%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,072,540 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,250,689 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,178,149)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328,027 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,142,839 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(814,812)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,800,288 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,587,842 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,446 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,453,873 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,230,335 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,538 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,039,799 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,381,273 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341,474)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013,948 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117,086 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103,138)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,635,935 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,459,375 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(823,440)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,563,395)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,208,686)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(354,709)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,394 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,004 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,610)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,021)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,189 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,576,022)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,271,892)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304,130)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense) benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,458)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,728)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,730)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,583,480)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,275,620)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307,860)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes net revenues by product for the periods presented: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.131%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kristalose</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,012,746 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,615,557 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397,189 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vibativ</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,896,584 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813,249 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(916,665)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Caldolor</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255,669 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,416,146 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160,477)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vaprisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,774 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406,162 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,388)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acetadote</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,733 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,462 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,271 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omeclamox-Pak</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,689 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,066 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(493,377)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RediTrex</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,459 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,459 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,886 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,047 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,161)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,072,540 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,250,689 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,178,149)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net revenues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net revenues for the three months ended September 30, 2021, were $8.1 million compared to $9.3 million for the three months ended September 30, 2020. As detailed in the table above, net revenue increased for two of our marketed products: Kristalose and Acetadote during the quarter. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kristalose revenue increased by 11.0% during the third quarter of 2021 to $4.0 million, when compared to the prior year period. The increase was primarily the result of growth in shipments of the product to our wholesale customers.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acetadote revenue includes net sales of our Acetadote brand and our share of net sales from our Authorized Generic. During the quarter, there was an increase of $0.2 million in the product's revenue when compared to the prior year period as a result of higher sales volumes for the Authorized Generic.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vaprisol revenue was $0.3 million for the third quarter of 2021, a decrease of $0.1 million. This decrease of net sales compared to the third quarter of 2020 is primarily due to cyclical buying trends.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Caldolor revenue was $1.3 million for the third quarter of 2021, a decrease of $0.2 million compared to the same period last year. The decrease was the result of lower international shipments of the product, due to order timing.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vibativ revenue was $1.9 million for the three months ended September 30, 2021, compared to $2.8 million the same period last year. The decrease was a result of customer buying patterns during the year.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Omeclamox-Pak had no sales for the third quarter of 2021, as Cumberland is currently out of commercial inventory of this product. The packager for our Omeclamox-Pak product encountered financial difficulties, and currently is under new management and a reorganization. We are in discussions about the resumption of packaging the product. Net revenue for the third quarter of 2021 was positively impacted by various revenue adjustments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Co</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">st of products sold for the third quarter of 2021 and 2020 were $1.3 million and $2.1 million, respectively. Cost of products sold, as a percentage of net revenues, were 16.5% during the three months ended September 30, 2021, compared to 23.2% during the three months ended September 30, 2020. This change in costs of products sold as a percentage of revenue was attributable to a change in the product sales mix, particularly the increase of Kristalose product sales. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling and marketing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Selling and marketing expense for the third quarter of 2021 increased $0.2 million compared to the prior year period. This increase is primarily attributable to an increase in marketing spending for Kristalose and Vibativ. Lower royalty costs were partially offset by an increase in direct promotional spending, meeting costs and travel expenses during the third quarter of 2021. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Research and development costs for the third quarter of 2021 and 2020 were $1.5 million and $1.2 million, respectively. A portion of our research and development costs is variable based on the number of trials, study sites, number of patients and the cost per patient in each of our clinical programs. We continue to fund our ongoing clinical initiatives associated with our pipeline products. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. General and administrative expense for the third quarter of 2021 were $2.0 million, which were $0.3 million lower than the third quarter of 2020. There were declines in salaries and stock-based compensation expense.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the statements of operations discussed above reflect the following impacts from Vibativ:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Impact of Vibativ</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,896,584 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813,249 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407,386 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945,067 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty and operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455,814 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vibativ contribution</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033,384 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,217,682 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> The Vibativ inventory included in the costs of product sold during the period was acquired and paid for by Cumberland as part of the acquisition of the brand during 2018.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Amortization expense is the ratable use of our capitalized intangible assets including product and license rights, patents, trademarks and patent defense costs. Amortization for the three months ended September 30, 2021, and three months ended September 30, 2020, totaled approximately $1.0 million and $1.1 million, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Income tax expense for the three months ended September 30, 2021, was comparable to the income tax expense for the three months ended September 30, 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, we had approximately $44 million of net operating loss carryforwards resulting from the exercise of nonqualified stock options that have historically been used to significantly offset income tax obligations. We expect to continue to pay minimal income taxes during 2021 and beyond, through the continued utilization of these net operating loss carryforwards, on any taxable income generated from our operations. </span></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_70"></div><div><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine months ended September 30, 2021 compared to the nine months ended September 30, 2020 </span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the unaudited interim statements of operations for continuing operations for the nine months ended September 30, 2021 and 2020:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,665,182 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,179,600 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485,582 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,486,005 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,387,002 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(900,997)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,709,445 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,160,924 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548,521 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,071,638 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,374,392 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302,754)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,367,438 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,608,321 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240,883)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,354,080 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,284,610 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,470 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,988,606 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,815,249 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(826,643)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,323,424)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,635,649)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,312,225 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,411 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,553 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,142)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,187,140 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,187,140 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,297)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(227,730)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,433 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,187,170)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,792,826)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,605,656 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense) benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,375)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,423)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,048 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,209,545)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,838,249)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,628,704 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes net revenues by product for the periods presented: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.680%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.154%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kristalose</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,286,729 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,387,046 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,899,683 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vibativ</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,799,891 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,551,125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,766 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Caldolor</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,734,273 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,677,434 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,839 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vaprisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861,130 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790,817 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070,313 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acetadote</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638,704 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,527,173 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(888,469)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omeclamox-Pak</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(451,683)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640,435 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,092,118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RediTrex</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,291)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,291)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,429 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605,570 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(796,141)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,665,182 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,179,600 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485,582 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net revenues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net revenues for the nine months ended September 30, 2021, were $27.7 million compared to $27.2 million for the nine months ended September 30, 2020. As detailed in the table above, net revenue increased for our marketed products: Kristalose, Vibativ, Caldolor and Vaprisol during the first nine months of 2021 resulting in an overall 1.8% revenue increase. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kristalose revenue was $12.3 million during the first nine months of 2021, an increase of $1.9 million when compared with the prior year period. Revenue increased due to continued strong sales volume from our Foxland distributor and other wholesalers.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vibativ revenue was $8.8 million for the nine months ended September 30, 2021, an increase of $0.2 million over the same period last year. The 2.9% increase in net revenue was a result of improved sales volume for the product during the first quarter of 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vaprisol revenue was $1.9 million for the first nine months of 2021, which is an increase of net sales of $1.1 million compared to the first nine months of 2020 primarily due to increased sales volumes which is the result of increased utilization in supporting patients impacted by COVID-19 infections.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Omeclamox-Pak had no sales for the nine months ended September 30, 2021, as Cumberland is currently out of commercial inventory of this product. The packager for our Omeclamox-Pak product encountered financial difficulties and currently is under new management and a reorganization. We are in discussions about the resumption of packaging the product. Net revenue for the first three quarters of 2021 was negatively impacted by product returns during the period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acetadote revenue includes net sales of our Acetadote brand and our share of net sales from our Authorized Generic. There was a decrease of $0.9 million in the product's year to date revenue for the nine months ended September 30, 2021, when compared to the prior year period as a result of lower sales volumes for our Authorized Generic.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Caldolor revenue was $3.7 million for the first three quarters of 2021, an increase of $0.1 million compared to the same period last year. Domestic shipments of the RTU bag product increased in the third quarter of 2021. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Co</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">st of products sold for first nine months of 2021 and 2020 were $5.5 million and $6.4 million, respectively. In 2021, we have realized savings for the Authorized Generic of $0.4 million, Omeclamox-Pak of $0.2 million and Vibativ of $0.3 million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling and marketing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Selling and marketing expense for the nine months ended September 30, 2021, increased $0.5 million compared to the prior year period. This increase is primarily attributable to increases in royalty costs as well as an increase in direct sales promotion costs and dispensing fees. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Research and development costs were $4.1 million for the first nine months of 2021 compared to $4.4 million for the same period last year. A portion of our research and development costs is variable based on the number of trials, study sites, cost of the per patient study protocol and patients involved in the development of our new product candidates. We continue to fund our ongoing clinical initiatives associated with our pipeline products. We experienced a decrease in study activity and salaries offset by an increase in our consulting fees. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. General and administrative expense for the nine months ended September 30, 2021, remained consistent with $6.4 million from $6.6 million during the nine months ended September 30, 2020. In 2021, we experienced lower salary and non cash stock based compensation expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the statements of operations discussed above reflect the following impacts from Vibativ:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:57.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.721%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Impact of Vibativ</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,799,891 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,551,126 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,542,348 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,765,812 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty and operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,725,889 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403,677 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vibativ contribution</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,531,654 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,381,637 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> The Vibativ inventory included in the costs of product sold during the period was acquired and paid for by Cumberland as part of the acquisition of the brand during 2018.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Amortization expense is the ratable use of our capitalized intangible assets including product and license rights, patents, trademarks and patent defense costs. Amortization for the nine months ended September 30, 2021, and nine months ended September 30, 2020, totaled approximately $3.4 million and $3.3 million, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Income tax expense (benefit) for the nine months ended September 30, 2021, as a percentage of income (loss) from continuing operations before income taxes, was 1.9% compared to 0.9% for the nine months ended September 30, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div><span><br/></span></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_73"></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Working Capital</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary sources of liquidity are cash equivalents, cash flows from operations and the amounts borrowed and available under our line of credit. We believe that our internally generated cash flows, existing working capital and our line of credit will be adequate to finance internal growth, finance business development initiatives, and fund capital expenditures for the foreseeable future. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our liquidity and working capital as of September 30, 2021 and December 31, 2020:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:58.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.461%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:7pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,843,231 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,753,796 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital (current assets less current liabilities)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,270,145 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,302,146 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current ratio (multiple of current assets to current liabilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving line of credit availability</span></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our net changes in cash and cash equivalents for the nine months ended September 30, 2021 and September 30, 2020:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:58.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.461%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,382,763 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,561,140 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(475,098)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,441,768)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,818,230)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,685,477)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089,435 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,566,105)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net $1.1 million increase in cash and cash equivalents for the nine months ended September 30, 2021, was primarily attributable to cash provided by operating activities, partially offset by cash used in investing and financing activities. Cash provided by operating activities of $4.4 million was positively impacted by decreases in inventory of $2.6 million and accounts receivable of $2.5 million, as well as the add back of non-cash expenses of depreciation, amortization and share-based compensation expense totaling $4.0 million. Operating activities were also offset by the decrease in accounts payable of $2.9 million and the forgiveness of our PPP Loan of $2.2 million. Cash used in investing activities was the result of additions to intangibles of $0.2 million and the payment of $0.2 million to the WHC JV. Our financing activities included the $1.0 million in cash used to repurchase shares of our common stock as well as the $1.8 million used for the payment of royalties to Theravance for sales of Vibativ. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net $1.6 million decrease in cash and cash equivalents for the nine months ended September 30, 2020, was primarily attributable to cash used in investing and financing activities. Cash provided by operating activities of $4.6 million was positively impacted by decreases in inventory of $1.7 million, as well as the add back of non-cash expenses of depreciation, amortization and share-based compensation expense totaling $4.3 million. Cash used by investing activities was the result of additions to intangibles of $1.8 million, including the payment of $1.0 million for RediTrex, equipment of $0.1 million and partially offset by proceeds from surrender of life insurance policies of $0.4 million. Our financing activities included the net repayment of $1.5 million on our revolving line of credit, the $1.6 million in cash used to repurchase shares of our common stock as well as the $0.8 million used for the repurchase of a portion of CET's shares. </span></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="margin-top:8pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Agreement</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2021, the Company and Pinnacle Bank entered into a Fourth Amendment to the Revolving Credit Note and Fifth Amendment ("Fifth Amendment") to the Revolving Credit Loan Agreement to renew the Revolving Credit Loan. </span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The original Pinnacle Agreement was dated July 2017. Beginning on August 14, 2018, and continuing until October 7, 2020, the Company and Pinnacle Bank entered into a series of amendments to extend and update the Revolving Credit Note and Revolving Credit Agreement. The most recent amendment dated October 28, 2021, extends the maturity date three years through October 1, 2024.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with prior Amendments, the Fifth Amendment provides for a principal balance available for borrowing of up to $15 million. The Company has the right to request an increase of up to an additional $5 million providing a maximum principal available of up to $20 million upon the satisfaction of certain conditions and with the approval of Pinnacle Bank. Also consistent with prior Amendments, the Company is required to maintain either a Funded Debt Ratio covenant or a Tangible Capital Ratio covenant. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate on the Pinnacle Agreement is based on LIBOR plus an interest rate spread. The pricing under the Fourth Amendment provides for an interest rate spread of 1.75% to 2.75% above LIBOR with a minimum LIBOR of 0.90%. The applicable interest rate under the Pinnacle Agreement was 3.65% at September 30, 2021. In addition, a fee of 0.25% per year is charged on the unused line of credit. Interest and the unused line fee are payable quarterly. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021 and December 31, 2020, the Company had $15.0 million in borrowings outstanding under its revolving credit facility. The Company was in compliance with the Tangible Capital Ratio financial covenant as of September 30, 2021. </span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Paycheck Protection Program Loan</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 20, 2020, Cumberland received the funding of a loan from Pinnacle Bank in the aggregate amount of $2,187,140 pursuant to the Paycheck Protection Program (the “PPP”) under the Federal Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"), which was enacted March 27, 2020. For a summary of the material terms of the Paycheck Protection Program loan, see Note 6 to the accompanying unaudited condensed consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under the terms of the PPP, certain amounts of the loan may be forgiven if they are used for qualifying expenses as described in the CARES Act, including qualifying payroll costs, covered rent payments, and covered utilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cumberland used the PPP loan funds for such qualifying expenses. Due to assistance from our PPP loan, the Company did not lay off or furlough any employees as a result of the COVID-19 pandemic.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, Cumberland submitted a request for the loan’s forgiveness. On June 11, 2021, the Company received a formal notice from the SBA that the full amount of the loan was forgiven. </span></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_76"></div><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OFF-BALANCE SHEET ARRANGEMENTS</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2021 and 2020, we did not engage in any off-balance sheet arrangements.</span></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_79"></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to market risk related to changes in interest rates on our cash on deposit in highly-liquid money market accounts and our revolving credit facility. We do not utilize derivative financial instruments or other market risk-sensitive instruments to manage exposure to interest rate changes. The main objective of our cash investment activities is to preserve principal while maximizing interest income through low-risk investments. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our interest rate risk related to our cash and cash equivalents is not material. The risk related to interest rates for these accounts would produce less income than expected if market interest rates fall. Based on current interest rates, we do not believe we are exposed to significant downside risk related to a change in interest on our money market accounts at September 30, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate risk related to borrowings under our line of credit is based on LIBOR plus an interest rate spread. The pricing under the Fourth Amendment of the Pinnacle Agreement provides for an interest rate spread of 1.75% to 2.75% above LIBOR with a minimum LIBOR of 0.90%. The applicable interest rate under the Pinnacle Agreement was 3.65% at September 30, 2021. As of September 30, 2021, we had $15.0 million in borrowings outstanding under our revolving credit facility. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exchange Rate Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we operate primarily in the United States, we are exposed to foreign currency risk. Currently, we do not utilize financial instruments to hedge exposure to foreign currency fluctuations. We believe our exposure to foreign currency fluctuation is minimal as our purchases in foreign currency have a maximum exposure of 90 days based on invoice terms with a portion of the exposure being limited to 30 days based on the due date of the invoice. Foreign currency exchange gains and losses were immaterial for the nine months ended September 30, 2021 and 2020. Neither a five percent increase nor decrease from current exchange rates would have a material effect on our operating results or financial condition.</span></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_82"></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms and is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2021, there has not been any change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II – OTHER INFORMATION</span></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_88"></div><div style="-sec-extract:summary;margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_91"></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition to the other information set forth in this quarterly report, an investor should consider the risk factors included in the Company's Annual Report on Form 10-K for the year ended December 31, 2020.</span></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_94"></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchases of Equity Securities</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have a share repurchase program to purchase up to $10 million of our common stock pursuant to Rule 10b-18 of the Exchange Act. In January 2019, our Board of Directors established the current $10 million repurchase program to replace the prior authorizations for repurchases of our outstanding common stock. </span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity, by month, during the three months ended September 30, 2021:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:37.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.574%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.207%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares or Units</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchased, which were also Part of the Publicly Announced Plans or Programs</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Price Paid</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">per Share</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(or Unit)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Number</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(or Approximate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dollar Value) of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares (or Units)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">that May Yet Be</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchased Under</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">the Plans or</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">        Programs</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,264</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.28 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,273,299 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,424</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.98 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,200,518 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,720</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.84 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,164,448 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,408</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Of this amount, 281 shares were repurchased directly through private purchases at the then-current fair market value of common stock.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_97"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.617%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.722%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="pinnaclelocrenewal4thloa.htm">Fourth Amendment to Revolving Credit Note and Fifth Amendment to Revolving Credit Loan Agreement, dated as of October 28, 2021, by and between Cumberland Pharmaceuticals Inc. and Pinnacle Bank</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="pinnaclelocrenewal4thloa.htm">.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2021q3-exhibit311.htm">Certification of Chief Executive Officer Pursuant to Rule 13-14(a) of the Securities Exchange Act of 1934 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2021q3-exhibit312.htm">Certification of Chief Financial Officer Pursuant to Rule 13-14(a) of the Securities Exchange Act of 1934 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2021q3-exhibit321.htm">Certification of Chief Executive and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INLINE XBRL INSTANCE DOCUMENT - THE INSTANCE DOCUMENT DOES NOT APPEAR IN THE INTERACTIVE DATA FILE BECAUSE ITS XBRL TAGS ARE EMBEDDED WITHIN THE INLINE XBRL DOCUMENT.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVER PAGE INTERACTIVE DATA FILE (FORMATTED AS INLINE XBRL AND CONTAINED IN EXHIBIT 101)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith.</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i8e8bdb91dc894234b9d87e17a18b54fd_100"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:8.288%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.184%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.072%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.184%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.416%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumberland Pharmaceuticals Inc.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 12, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ John Hamm</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John Hamm</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer and Duly Authorized Officer</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div></body></html> </XBRL> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>2 <FILENAME>pinnaclelocrenewal4thloa.htm <DESCRIPTION>EX-10.1 <TEXT> <HTML> <HEAD><!-- Document generated by Workiva Inc --> <TITLE>pinnaclelocrenewal4thloa</TITLE> </HEAD> <BODY bgcolor="white"> <DIV align="center"> <DIV style="margin-left:1em;width:1055;"><!-- pinnaclelocrenewal4thloa001.jpg --> <DIV style="padding-top:2em;"> <IMG src="pinnaclelocrenewal4thloa001.jpg" title="slide1" width="1055" height="1365"> <DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV> <P><HR noshade><P> <DIV style="page-break-before:always;"> </DIV> </DIV> <!-- pinnaclelocrenewal4thloa002.jpg --> <DIV style="padding-top:2em;"> <IMG src="pinnaclelocrenewal4thloa002.jpg" title="slide2" width="1055" height="1365"> <DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV> <P><HR noshade><P> <DIV style="page-break-before:always;"> </DIV> </DIV> <!-- pinnaclelocrenewal4thloa003.jpg --> <DIV style="padding-top:2em;"> <IMG src="pinnaclelocrenewal4thloa003.jpg" title="slide3" width="1055" height="1365"> <DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV> <P><HR noshade><P> <DIV style="page-break-before:always;"> </DIV> </DIV> <!-- pinnaclelocrenewal4thloa004.jpg --> <DIV style="padding-top:2em;"> <IMG src="pinnaclelocrenewal4thloa004.jpg" title="slide4" width="1055" height="1365"> <DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV> <P><HR noshade><P> <DIV style="page-break-before:always;"> </DIV> </DIV> <!-- pinnaclelocrenewal4thloa005.jpg --> <DIV style="padding-top:2em;"> <IMG src="pinnaclelocrenewal4thloa005.jpg" title="slide5" width="1055" height="1365"> <DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV> <P><HR noshade><P> <DIV style="page-break-before:always;"> </DIV> </DIV> <!-- pinnaclelocrenewal4thloa006.jpg --> <DIV style="padding-top:2em;"> <IMG src="pinnaclelocrenewal4thloa006.jpg" title="slide6" width="1055" height="1365"> <DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV> <P><HR noshade><P> <DIV style="page-break-before:always;"> </DIV> </DIV> <!-- pinnaclelocrenewal4thloa007.jpg --> <DIV style="padding-top:2em;"> <IMG src="pinnaclelocrenewal4thloa007.jpg" title="slide7" width="1055" height="1365"> <DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV> <P><HR noshade><P> <DIV style="page-break-before:always;"> </DIV> </DIV> <!-- pinnaclelocrenewal4thloa008.jpg --> <DIV style="padding-top:2em;"> <IMG src="pinnaclelocrenewal4thloa008.jpg" title="slide8" width="1055" height="1365"> <DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV> <P><HR noshade><P> <DIV style="page-break-before:always;"> </DIV> </DIV> <!-- pinnaclelocrenewal4thloa009.jpg --> <DIV style="padding-top:2em;"> <IMG src="pinnaclelocrenewal4thloa009.jpg" title="slide9" width="1055" height="1365"> <DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV> <P><HR noshade><P> <DIV style="page-break-before:always;"> </DIV> </DIV> <!-- pinnaclelocrenewal4thloa010.jpg --> <DIV style="padding-top:2em;"> <IMG src="pinnaclelocrenewal4thloa010.jpg" title="slide10" width="1055" height="1365"> <DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV> <P><HR noshade><P> <DIV style="page-break-before:always;"> </DIV> </DIV> <!-- pinnaclelocrenewal4thloa011.jpg --> <DIV style="padding-top:2em;"> <IMG src="pinnaclelocrenewal4thloa011.jpg" title="slide11" width="1055" height="1365"> <DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV> <P><HR noshade><P> <DIV style="page-break-before:always;"> </DIV> </DIV> <!-- pinnaclelocrenewal4thloa012.jpg --> <DIV style="padding-top:2em;"> <IMG src="pinnaclelocrenewal4thloa012.jpg" title="slide12" width="1055" height="1365"> <DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV> <P><HR noshade><P> <DIV style="page-break-before:always;"> </DIV> </DIV> </DIV> </DIV> </BODY> </HTML> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-31.1 <SEQUENCE>3 <FILENAME>a2021q3-exhibit311.htm <DESCRIPTION>EX-31.1 <TEXT> <!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head> <!-- Document created using Wdesk --> <!-- Copyright 2021 Workiva --> <title>Document</title></head><body><div id="iec8d24f8977245be9e2e34239cfc7104_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="-sec-extract:summary;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, A.J. Kazimi, certify that:</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Form 10-Q of Cumberland Pharmaceuticals Inc.;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></td></tr></table></div><div style="padding-left:30pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div><div style="padding-left:30pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div><div style="padding-left:30pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div><div style="padding-left:30pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):</font></div></td></tr></table></div><div style="padding-left:30pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and</font></div><div style="padding-left:30pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:50.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.164%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 12, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ A.J. Kazimi</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A.J. Kazimi</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-31.2 <SEQUENCE>4 <FILENAME>a2021q3-exhibit312.htm <DESCRIPTION>EX-31.2 <TEXT> <!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head> <!-- Document created using Wdesk --> <!-- Copyright 2021 Workiva --> <title>Document</title></head><body><div id="i505c341806a14ae8b2571f5af0ece1f6_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="-sec-extract:summary;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, John Hamm, certify that:</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Form 10-Q of Cumberland Pharmaceuticals Inc.;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></td></tr></table></div><div style="padding-left:30pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div><div style="padding-left:30pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div><div style="padding-left:30pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div><div style="padding-left:30pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):</font></div></td></tr></table></div><div style="padding-left:30pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and</font></div><div style="padding-left:30pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:50.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.158%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.164%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 12, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ John Hamm</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John Hamm</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-32.1 <SEQUENCE>5 <FILENAME>a2021q3-exhibit321.htm <DESCRIPTION>EX-32.1 <TEXT> <!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head> <!-- Document created using Wdesk --> <!-- Copyright 2021 Workiva --> <title>Document</title></head><body><div id="i5acacdbde8d243829df171f957781a98_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="-sec-extract:summary;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE AND</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2021 of Cumberland Pharmaceuticals Inc. (the “Company”), as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, A.J. Kazimi, Chief Executive Officer and John Hamm, Chief Financial Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. section 1350), that:</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:38.888%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ A. J. Kazimi</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A.J. Kazimi</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 12, 2021</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ John Hamm</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John Hamm</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 12, 2021</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:right"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-101.SCH <SEQUENCE>6 <FILENAME>cpix-20210930.xsd <DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT <TEXT> <XBRL> <?xml version="1.0" encoding="UTF-8"?> <!--XBRL Document Created with Wdesk from Workiva--> <!--Copyright 2021 Workiva--> <!--r:719f38f6-81ec-4e77-a876-c86386f0dd09,g:3c5f884f-ec0b-48db-97a2-96993ede30b3--> <xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cpix="http://www.cumberlandpharma.com/20210930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cumberlandpharma.com/20210930"> <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/> <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/> <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/> <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/> <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/> <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/> <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/> <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/> <xs:annotation> <xs:appinfo> <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cpix-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/> <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cpix-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/> <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cpix-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/> <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cpix-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/> <link:roleType id="CoverPage" roleURI="http://www.cumberlandpharma.com/role/CoverPage"> <link:definition>0001001 - Document - Cover Page</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets"> <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheetsParenthetical"> <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations"> <link:definition>1003004 - Statement - Condensed Consolidated Statements of Operations</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows"> <link:definition>1004005 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="CondensedConsolidatedStatementofEquity" roleURI="http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementofEquity"> <link:definition>1005006 - Statement - Condensed Consolidated Statement of Equity</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="OrganizationandBasisofPresentation" roleURI="http://www.cumberlandpharma.com/role/OrganizationandBasisofPresentation"> <link:definition>2101101 - Disclosure - Organization and Basis of Presentation</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="OrganizationandBasisofPresentationPolicies" roleURI="http://www.cumberlandpharma.com/role/OrganizationandBasisofPresentationPolicies"> <link:definition>2202201 - Disclosure - Organization and Basis of Presentation (Policies)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="OrganizationandBasisofPresentationOrganizationDetails" roleURI="http://www.cumberlandpharma.com/role/OrganizationandBasisofPresentationOrganizationDetails"> <link:definition>2403401 - Disclosure - Organization and Basis of Presentation Organization (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="EarningsLossPerShare" roleURI="http://www.cumberlandpharma.com/role/EarningsLossPerShare"> <link:definition>2104102 - Disclosure - Earnings (Loss) Per Share</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="EarningsLossPerShareTables" roleURI="http://www.cumberlandpharma.com/role/EarningsLossPerShareTables"> <link:definition>2305301 - Disclosure - Earnings (Loss) Per Share (Tables)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="EarningsLossPerShareDetails" roleURI="http://www.cumberlandpharma.com/role/EarningsLossPerShareDetails"> <link:definition>2406402 - Disclosure - Earnings (Loss) Per Share (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="EarningsLossPerShareDetailsTextual" roleURI="http://www.cumberlandpharma.com/role/EarningsLossPerShareDetailsTextual"> <link:definition>2407403 - Disclosure - Earnings (Loss) Per Share (Details Textual)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="Revenues" roleURI="http://www.cumberlandpharma.com/role/Revenues"> <link:definition>2108103 - Disclosure - Revenues</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="RevenuesTables" roleURI="http://www.cumberlandpharma.com/role/RevenuesTables"> <link:definition>2309302 - Disclosure - Revenues (Tables)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="RevenuesDetails" roleURI="http://www.cumberlandpharma.com/role/RevenuesDetails"> <link:definition>2410404 - Disclosure - Revenues (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="Inventories" roleURI="http://www.cumberlandpharma.com/role/Inventories"> <link:definition>2111104 - Disclosure - Inventories</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="InventoriesTables" roleURI="http://www.cumberlandpharma.com/role/InventoriesTables"> <link:definition>2312303 - Disclosure - Inventories (Tables)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="InventoriesNarrativeDetails" roleURI="http://www.cumberlandpharma.com/role/InventoriesNarrativeDetails"> <link:definition>2413405 - Disclosure - Inventories (Narrative) (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="InventoriesScheduleofInventoriesDetails" roleURI="http://www.cumberlandpharma.com/role/InventoriesScheduleofInventoriesDetails"> <link:definition>2414406 - Disclosure - Inventories (Schedule of Inventories) (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="Leases" roleURI="http://www.cumberlandpharma.com/role/Leases"> <link:definition>2115105 - Disclosure - Leases</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="LeasesTables" roleURI="http://www.cumberlandpharma.com/role/LeasesTables"> <link:definition>2316304 - Disclosure - Leases (Tables)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.cumberlandpharma.com/role/LeasesNarrativeDetails"> <link:definition>2417407 - Disclosure - Leases (Narrative) (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="LeasesLeasePositionDetails" roleURI="http://www.cumberlandpharma.com/role/LeasesLeasePositionDetails"> <link:definition>2418408 - Disclosure - Leases (Lease Position) (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails" roleURI="http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails"> <link:definition>2419409 - Disclosure - Leases (Schedule of Lease Liabilities Maturity and Future Minimum Lease Commitments) (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails_1" roleURI="http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails_1"> <link:definition>2419409 - Disclosure - Leases (Schedule of Lease Liabilities Maturity and Future Minimum Lease Commitments) (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="LeasesRentExpenseDetails" roleURI="http://www.cumberlandpharma.com/role/LeasesRentExpenseDetails"> <link:definition>2420410 - Disclosure - Leases - Rent Expense (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="ShareholdersEquityandDebt" roleURI="http://www.cumberlandpharma.com/role/ShareholdersEquityandDebt"> <link:definition>2121106 - Disclosure - Shareholders' Equity and Debt</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="ShareholdersEquityandDebtShareholdersEquityDetails" roleURI="http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails"> <link:definition>2422411 - Disclosure - Shareholders' Equity and Debt (Shareholders' Equity) (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="ShareholdersEquityandDebtDebtDetails" roleURI="http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails"> <link:definition>2423412 - Disclosure - Shareholders' Equity and Debt (Debt) (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="IncomeTaxes" roleURI="http://www.cumberlandpharma.com/role/IncomeTaxes"> <link:definition>2124107 - Disclosure - Income Taxes</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="IncomeTaxesDetailsTextual" roleURI="http://www.cumberlandpharma.com/role/IncomeTaxesDetailsTextual"> <link:definition>2425413 - Disclosure - Income Taxes (Details Textual)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="CollaborativeAgreements" roleURI="http://www.cumberlandpharma.com/role/CollaborativeAgreements"> <link:definition>2126108 - Disclosure - Collaborative Agreements</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="AdditionsandReturnsofProductRights" roleURI="http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRights"> <link:definition>2127109 - Disclosure - Additions and Returns of Product Rights</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="AdditionsandReturnsofProductRightsTables" roleURI="http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsTables"> <link:definition>2328305 - Disclosure - Additions and Returns of Product Rights (Tables)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="AdditionsandReturnsofProductRightsNarrativeDetails" roleURI="http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails"> <link:definition>2429414 - Disclosure - Additions and Returns of Product Rights - Narrative (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="AdditionsandReturnsofProductRightsChangeinConsiderationDetails" roleURI="http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsChangeinConsiderationDetails"> <link:definition>2430415 - Disclosure - Additions and Returns of Product Rights - Change in Consideration (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType id="AdditionsandReturnsofProductRightsDissolutionPaymentsDetails" roleURI="http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsDissolutionPaymentsDetails"> <link:definition>2431416 - Disclosure - Additions and Returns of Product Rights - Dissolution Payments (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> </xs:appinfo> </xs:annotation> <xs:element id="cpix_FifthAmendmentMember" abstract="true" name="FifthAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/> <xs:element id="cpix_VIBATIVMember" abstract="true" name="VIBATIVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/> <xs:element id="cpix_EquityAndDebtAbstract" abstract="true" name="EquityAndDebtAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/> <xs:element id="cpix_LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/> <xs:element id="cpix_MethotrexateMember" abstract="true" name="MethotrexateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/> <xs:element id="cpix_OmeclamoxPakMember" abstract="true" name="OmeclamoxPakMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/> <xs:element id="cpix_BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses" abstract="false" name="BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/> <xs:element id="cpix_AcetadoteMember" abstract="true" name="AcetadoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/> <xs:element id="cpix_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/> <xs:element id="cpix_WinHealthInvestmentSingaporeLtdDomain" abstract="true" name="WinHealthInvestmentSingaporeLtdDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/> <xs:element id="cpix_TieredRoyaltyPaymentsPercentage" abstract="false" name="TieredRoyaltyPaymentsPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/> <xs:element id="cpix_OtherLongTermObligationsExcludingCurrentPortion" abstract="false" name="OtherLongTermObligationsExcludingCurrentPortion" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/> <xs:element id="cpix_ProceedsFromSaleOfIntangibleAssetsInstallmentPayment" abstract="false" name="ProceedsFromSaleOfIntangibleAssetsInstallmentPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/> <xs:element id="cpix_RediTrexMember" abstract="true" name="RediTrexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/> <xs:element id="cpix_StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities" abstract="false" name="StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/> <xs:element id="cpix_VaprisolMember" abstract="true" name="VaprisolMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/> <xs:element id="cpix_OtherProductsMember" abstract="true" name="OtherProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/> <xs:element id="cpix_ClinigenHealthcareLimitedMember" abstract="true" name="ClinigenHealthcareLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/> <xs:element id="cpix_ProductsAbstract" abstract="true" name="ProductsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/> <xs:element id="cpix_ShareholdersEquityTextualAbstract" abstract="true" name="ShareholdersEquityTextualAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/> <xs:element id="cpix_IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy" abstract="false" name="IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/> <xs:element id="cpix_IfetrobanClinicalMember" abstract="true" name="IfetrobanClinicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/> <xs:element id="cpix_LeaseLiability" abstract="false" name="LeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/> <xs:element id="cpix_IncentiveStockOptionsMember" abstract="true" name="IncentiveStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/> <xs:element id="cpix_KristaloseMember" abstract="true" name="KristaloseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/> <xs:element id="cpix_TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived" abstract="false" name="TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/> <xs:element id="cpix_DenominatorAbstract" abstract="true" name="DenominatorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/> <xs:element id="cpix_IncreaseDecreaseInCurrentOperatingLiabilities" abstract="false" name="IncreaseDecreaseInCurrentOperatingLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/> <xs:element id="cpix_ScheduleofRentExpenseandSubleaseIncomeTableTextBlock" abstract="false" name="ScheduleofRentExpenseandSubleaseIncomeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/> <xs:element id="cpix_CaldolorMember" abstract="true" name="CaldolorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/> <xs:element id="cpix_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/> <xs:element id="cpix_NumeratorAbstract" abstract="true" name="NumeratorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/> <xs:element id="cpix_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/> <xs:element id="cpix_PinnacleBankMember" abstract="true" name="PinnacleBankMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/> </xs:schema> </XBRL> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-101.CAL <SEQUENCE>7 <FILENAME>cpix-20210930_cal.xml <DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT <TEXT> <XBRL> <?xml version="1.0" encoding="UTF-8"?> <!--XBRL Document Created with Wdesk from Workiva--> <!--Copyright 2021 Workiva--> <!--r:719f38f6-81ec-4e77-a876-c86386f0dd09,g:3c5f884f-ec0b-48db-97a2-96993ede30b3--> <link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cpix-20210930.xsd#CondensedConsolidatedBalanceSheets"/> <link:calculationLink xlink:role="http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e4003107-004c-4714-940c-b61f654c9bd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_64972964-85b1-487a-a055-fd804563a77b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermLineOfCredit"/> <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e4003107-004c-4714-940c-b61f654c9bd3" xlink:to="loc_us-gaap_LongTermLineOfCredit_64972964-85b1-487a-a055-fd804563a77b" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5be4e0d0-c95e-4755-86c8-6247a813dc2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/> <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e4003107-004c-4714-940c-b61f654c9bd3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5be4e0d0-c95e-4755-86c8-6247a813dc2d" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f35fc2e0-24d5-4cbe-96d9-1e6e85bb2518" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/> <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e4003107-004c-4714-940c-b61f654c9bd3" xlink:to="loc_us-gaap_LiabilitiesCurrent_f35fc2e0-24d5-4cbe-96d9-1e6e85bb2518" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_OtherLongTermObligationsExcludingCurrentPortion_2555fe07-2204-4110-a53d-05b767e7fb02" xlink:href="cpix-20210930.xsd#cpix_OtherLongTermObligationsExcludingCurrentPortion"/> <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e4003107-004c-4714-940c-b61f654c9bd3" xlink:to="loc_cpix_OtherLongTermObligationsExcludingCurrentPortion_2555fe07-2204-4110-a53d-05b767e7fb02" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_fe4ab760-0063-4a61-ad29-24523e3f5326" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_3477e6cb-c241-4d81-b772-4848b710b367" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/> <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fe4ab760-0063-4a61-ad29-24523e3f5326" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_3477e6cb-c241-4d81-b772-4848b710b367" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_43ce7d8b-f775-483d-8c93-36ddd5d4cf0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/> <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fe4ab760-0063-4a61-ad29-24523e3f5326" xlink:to="loc_us-gaap_AccountsPayableCurrent_43ce7d8b-f775-483d-8c93-36ddd5d4cf0b" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_11217f44-8f4f-4b68-99b0-488b44217d04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/> <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fe4ab760-0063-4a61-ad29-24523e3f5326" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_11217f44-8f4f-4b68-99b0-488b44217d04" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_144ccf69-e450-421c-a845-4cb95334bdf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e48e6dfd-abee-45e3-87b8-195510677691" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/> <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_144ccf69-e450-421c-a845-4cb95334bdf9" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e48e6dfd-abee-45e3-87b8-195510677691" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_f20594d5-49cf-41b9-9160-2033a580198d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/> <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_144ccf69-e450-421c-a845-4cb95334bdf9" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_f20594d5-49cf-41b9-9160-2033a580198d" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_d702f0b9-bb74-4d2d-bbdb-acb7037b65bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/> <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_144ccf69-e450-421c-a845-4cb95334bdf9" xlink:to="loc_us-gaap_OtherAssetsCurrent_d702f0b9-bb74-4d2d-bbdb-acb7037b65bc" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_49e1087b-e824-423f-a61a-1afc490b63ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/> <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_144ccf69-e450-421c-a845-4cb95334bdf9" xlink:to="loc_us-gaap_InventoryNet_49e1087b-e824-423f-a61a-1afc490b63ba" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_95412670-2e88-4884-a56d-a46d91b00d4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2fb17838-81f5-4ba6-9b75-3865a0e39914" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/> <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_95412670-2e88-4884-a56d-a46d91b00d4e" xlink:to="loc_us-gaap_StockholdersEquity_2fb17838-81f5-4ba6-9b75-3865a0e39914" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_827cdc1e-d407-4334-8434-47e90c1327e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/> <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_95412670-2e88-4884-a56d-a46d91b00d4e" xlink:to="loc_us-gaap_MinorityInterest_827cdc1e-d407-4334-8434-47e90c1327e5" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2d5bc770-4ee4-4158-a751-b355e66ff249" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_1bf45b1f-5e8f-4b49-9eb6-f509bf380212" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/> <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2d5bc770-4ee4-4158-a751-b355e66ff249" xlink:to="loc_us-gaap_CommonStockValue_1bf45b1f-5e8f-4b49-9eb6-f509bf380212" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7498f726-0989-41a4-85eb-caadaa8f13d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/> <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2d5bc770-4ee4-4158-a751-b355e66ff249" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7498f726-0989-41a4-85eb-caadaa8f13d1" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_54478ead-aece-4391-b8f5-4608f90c02ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1092dc2b-8386-40bc-ac38-a3f0d0a56db2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/> <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_54478ead-aece-4391-b8f5-4608f90c02ca" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_1092dc2b-8386-40bc-ac38-a3f0d0a56db2" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_705325fc-f0eb-43b7-930c-258ee1edf509" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/> <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_54478ead-aece-4391-b8f5-4608f90c02ca" xlink:to="loc_us-gaap_Goodwill_705325fc-f0eb-43b7-930c-258ee1edf509" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_d99c7d67-a956-4c56-a68a-0e26dd58b6a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNoncurrent"/> <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_54478ead-aece-4391-b8f5-4608f90c02ca" xlink:to="loc_us-gaap_InventoryNoncurrent_d99c7d67-a956-4c56-a68a-0e26dd58b6a5" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7f3540b2-5dbe-44ab-80df-b6365ad1e934" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/> <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_54478ead-aece-4391-b8f5-4608f90c02ca" xlink:to="loc_us-gaap_AssetsCurrent_7f3540b2-5dbe-44ab-80df-b6365ad1e934" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8e39237d-5674-490e-887c-08dfd2292415" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/> <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_54478ead-aece-4391-b8f5-4608f90c02ca" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8e39237d-5674-490e-887c-08dfd2292415" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_59498bfe-40e1-4628-845d-1adc45942c5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/> <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_54478ead-aece-4391-b8f5-4608f90c02ca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_59498bfe-40e1-4628-845d-1adc45942c5d" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_da7b1abf-d135-4079-be75-07ebca09be00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/> <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_54478ead-aece-4391-b8f5-4608f90c02ca" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_da7b1abf-d135-4079-be75-07ebca09be00" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_fccd38fc-a457-4fd3-b5a2-1140c9149677" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ec42281e-1571-46e4-8f17-e5617d58ba3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/> <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fccd38fc-a457-4fd3-b5a2-1140c9149677" xlink:to="loc_us-gaap_Liabilities_ec42281e-1571-46e4-8f17-e5617d58ba3a" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_eba1a74b-a051-43a1-894d-af5b4877fb69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/> <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fccd38fc-a457-4fd3-b5a2-1140c9149677" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_eba1a74b-a051-43a1-894d-af5b4877fb69" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_24efd215-4a48-42be-ad47-7a82c74d3ed5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/> <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fccd38fc-a457-4fd3-b5a2-1140c9149677" xlink:to="loc_us-gaap_CommitmentsAndContingencies_24efd215-4a48-42be-ad47-7a82c74d3ed5" xlink:type="arc"/> </link:calculationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="cpix-20210930.xsd#CondensedConsolidatedStatementsofOperations"/> <link:calculationLink xlink:role="http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ed75a6bc-0d7f-4806-85a7-a3fbdf52ccd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d97e4eb5-2b80-48bb-b209-ef62fdde52bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/> <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_ed75a6bc-0d7f-4806-85a7-a3fbdf52ccd3" xlink:to="loc_us-gaap_ProfitLoss_d97e4eb5-2b80-48bb-b209-ef62fdde52bb" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3da773fd-7511-4c98-b99f-6406284ac318" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/> <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_ed75a6bc-0d7f-4806-85a7-a3fbdf52ccd3" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3da773fd-7511-4c98-b99f-6406284ac318" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_86782b05-5094-45e4-990b-e29d8f6f2343" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1fc60daa-b2f0-48c7-8244-d3d98c87cbdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/> <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_86782b05-5094-45e4-990b-e29d8f6f2343" xlink:to="loc_us-gaap_OperatingIncomeLoss_1fc60daa-b2f0-48c7-8244-d3d98c87cbdc" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_da778fb1-aa9f-45be-ac2f-cbdaf592291f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome"/> <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_86782b05-5094-45e4-990b-e29d8f6f2343" xlink:to="loc_us-gaap_OtherIncome_da778fb1-aa9f-45be-ac2f-cbdaf592291f" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_365dd086-28bb-48f2-a427-396f19c52129" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/> <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_86782b05-5094-45e4-990b-e29d8f6f2343" xlink:to="loc_us-gaap_InvestmentIncomeInterest_365dd086-28bb-48f2-a427-396f19c52129" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e30205b1-8903-4cb3-aacc-2ad6ac638bb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/> <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_86782b05-5094-45e4-990b-e29d8f6f2343" xlink:to="loc_us-gaap_InterestExpense_e30205b1-8903-4cb3-aacc-2ad6ac638bb3" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2c59603e-855a-408e-9af9-7309a3f307a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bd2ac9c4-bb33-4e6b-b122-0390ff8d5e3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/> <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2c59603e-855a-408e-9af9-7309a3f307a5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bd2ac9c4-bb33-4e6b-b122-0390ff8d5e3f" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5f5bf62c-8ff7-49d1-8657-237351144468" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/> <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2c59603e-855a-408e-9af9-7309a3f307a5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5f5bf62c-8ff7-49d1-8657-237351144468" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_5121d56d-600e-4acb-9103-04ad3ea2f2e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_01490ee9-53c4-4ebf-94f9-51c2b302afac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/> <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_5121d56d-600e-4acb-9103-04ad3ea2f2e3" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_01490ee9-53c4-4ebf-94f9-51c2b302afac" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_7a5ead24-35cb-4129-b9ce-8c190f350b1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/> <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_5121d56d-600e-4acb-9103-04ad3ea2f2e3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_7a5ead24-35cb-4129-b9ce-8c190f350b1a" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4b0c1e5f-2789-473c-bb13-a664505cf619" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b3faedc2-c010-4242-b086-9f4afbc8c3fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/> <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_4b0c1e5f-2789-473c-bb13-a664505cf619" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b3faedc2-c010-4242-b086-9f4afbc8c3fd" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_8eb5830f-8121-4cf8-9e6c-4699744433a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/> <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_4b0c1e5f-2789-473c-bb13-a664505cf619" xlink:to="loc_us-gaap_CostsAndExpenses_8eb5830f-8121-4cf8-9e6c-4699744433a0" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_e2c63134-b726-447f-9056-f56dff03392a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_0cfca2ed-04a9-4f1e-9c34-9d3e3ff844d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/> <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_e2c63134-b726-447f-9056-f56dff03392a" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_0cfca2ed-04a9-4f1e-9c34-9d3e3ff844d7" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_461d80e3-7035-423c-b6a7-ad4d629b226f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/> <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_e2c63134-b726-447f-9056-f56dff03392a" xlink:to="loc_us-gaap_SellingAndMarketingExpense_461d80e3-7035-423c-b6a7-ad4d629b226f" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_58b33898-f4bf-4761-8359-f10996d4c571" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/> <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_e2c63134-b726-447f-9056-f56dff03392a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_58b33898-f4bf-4761-8359-f10996d4c571" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_7ab9ef31-a24c-4f65-ac40-df0b47d80d3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/> <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_e2c63134-b726-447f-9056-f56dff03392a" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_7ab9ef31-a24c-4f65-ac40-df0b47d80d3f" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_33654aa3-bc14-4827-bc51-28e7a9bcb955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/> <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_e2c63134-b726-447f-9056-f56dff03392a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_33654aa3-bc14-4827-bc51-28e7a9bcb955" xlink:type="arc"/> </link:calculationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cpix-20210930.xsd#CondensedConsolidatedStatementsofCashFlows"/> <link:calculationLink xlink:role="http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6949e094-1464-42be-a52f-964eb36a978f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_63a4717d-40c0-4f27-a001-1893b0aae178" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/> <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6949e094-1464-42be-a52f-964eb36a978f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_63a4717d-40c0-4f27-a001-1893b0aae178" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e167ff76-956c-491c-b9da-cca9367466ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/> <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6949e094-1464-42be-a52f-964eb36a978f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e167ff76-956c-491c-b9da-cca9367466ff" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_29cb7dc7-78f7-41f1-80e3-aa0728ba3e9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/> <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6949e094-1464-42be-a52f-964eb36a978f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_29cb7dc7-78f7-41f1-80e3-aa0728ba3e9f" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_daf39174-d00a-4398-9db5-2c7e398f651e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_52f0222c-6d31-47f2-9d91-4700e3d34d24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/> <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_daf39174-d00a-4398-9db5-2c7e398f651e" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_52f0222c-6d31-47f2-9d91-4700e3d34d24" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_0b38b3d6-5f1a-45bd-82fc-8e6d60837122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/> <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_daf39174-d00a-4398-9db5-2c7e398f651e" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_0b38b3d6-5f1a-45bd-82fc-8e6d60837122" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_3823a233-ef8f-458a-8ae7-281871ee92dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit"/> <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_daf39174-d00a-4398-9db5-2c7e398f651e" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_3823a233-ef8f-458a-8ae7-281871ee92dc" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d08f452b-7617-4d27-89d2-29251e55cafa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/> <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_daf39174-d00a-4398-9db5-2c7e398f651e" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d08f452b-7617-4d27-89d2-29251e55cafa" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_5394ce0e-6282-459e-a76e-80be63bd484f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/> <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_daf39174-d00a-4398-9db5-2c7e398f651e" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_5394ce0e-6282-459e-a76e-80be63bd484f" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_deae3397-f9ad-4fb8-b177-bdd36de6b429" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_IncreaseDecreaseInCurrentOperatingLiabilities_e5048cd4-70fa-4712-99ff-efa4bb7c1869" xlink:href="cpix-20210930.xsd#cpix_IncreaseDecreaseInCurrentOperatingLiabilities"/> <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_deae3397-f9ad-4fb8-b177-bdd36de6b429" xlink:to="loc_cpix_IncreaseDecreaseInCurrentOperatingLiabilities_e5048cd4-70fa-4712-99ff-efa4bb7c1869" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy_b861336b-f091-4724-acba-56963599811e" xlink:href="cpix-20210930.xsd#cpix_IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy"/> <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_deae3397-f9ad-4fb8-b177-bdd36de6b429" xlink:to="loc_cpix_IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy_b861336b-f091-4724-acba-56963599811e" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_273ca052-5376-43a8-815d-a2f241cd6960" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/> <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_deae3397-f9ad-4fb8-b177-bdd36de6b429" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_273ca052-5376-43a8-815d-a2f241cd6960" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_f5fad902-5811-4398-a656-e7274f809ab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/> <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_deae3397-f9ad-4fb8-b177-bdd36de6b429" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_f5fad902-5811-4398-a656-e7274f809ab2" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_2ea25a2d-722e-4fbc-ae58-a53ee94a8f16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/> <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_deae3397-f9ad-4fb8-b177-bdd36de6b429" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_2ea25a2d-722e-4fbc-ae58-a53ee94a8f16" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_15e7615f-24ec-4fcf-9145-af7c3230cedb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/> <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_deae3397-f9ad-4fb8-b177-bdd36de6b429" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_15e7615f-24ec-4fcf-9145-af7c3230cedb" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_986322b6-9757-411e-9321-5dc50e92e340" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/> <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_deae3397-f9ad-4fb8-b177-bdd36de6b429" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_986322b6-9757-411e-9321-5dc50e92e340" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_49461836-13c8-47a6-9e86-4137705f7320" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/> <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_deae3397-f9ad-4fb8-b177-bdd36de6b429" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_49461836-13c8-47a6-9e86-4137705f7320" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7707ed01-b965-4b73-821c-b2104a9b8ecb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/> <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_deae3397-f9ad-4fb8-b177-bdd36de6b429" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7707ed01-b965-4b73-821c-b2104a9b8ecb" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities_04ebf13b-2a29-4c47-94c4-3e06c0c2a5ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities"/> <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_deae3397-f9ad-4fb8-b177-bdd36de6b429" xlink:to="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities_04ebf13b-2a29-4c47-94c4-3e06c0c2a5ef" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_8d5fd757-5b72-4e59-b7f7-2d8d1dc23490" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/> <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_deae3397-f9ad-4fb8-b177-bdd36de6b429" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_8d5fd757-5b72-4e59-b7f7-2d8d1dc23490" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_42c52023-3e07-4382-8abd-82a3733d2d4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/> <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_deae3397-f9ad-4fb8-b177-bdd36de6b429" xlink:to="loc_us-gaap_ShareBasedCompensation_42c52023-3e07-4382-8abd-82a3733d2d4b" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a65cec70-b375-4a42-8b49-32e875e4fb43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_a8dc8e78-a9ad-4d5c-b8bf-6d0582a9feeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/> <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a65cec70-b375-4a42-8b49-32e875e4fb43" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_a8dc8e78-a9ad-4d5c-b8bf-6d0582a9feeb" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_102fe69b-9f94-4d98-8494-36ac7ff5b051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/> <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a65cec70-b375-4a42-8b49-32e875e4fb43" xlink:to="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_102fe69b-9f94-4d98-8494-36ac7ff5b051" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_90a6702f-b088-42dc-8d29-2167786813c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f0bcf3f1-9e23-4a6a-b014-390e615e6e83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/> <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_90a6702f-b088-42dc-8d29-2167786813c6" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f0bcf3f1-9e23-4a6a-b014-390e615e6e83" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_4384f04a-5f7b-4a9f-920b-4d0ea51cbd6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/> <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_90a6702f-b088-42dc-8d29-2167786813c6" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_4384f04a-5f7b-4a9f-920b-4d0ea51cbd6f" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_6d12cd8a-f99c-4dfa-b1a9-66f372496bff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/> <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_90a6702f-b088-42dc-8d29-2167786813c6" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_6d12cd8a-f99c-4dfa-b1a9-66f372496bff" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_b8fd5b3e-9a59-432d-b0bf-1cb1f5fe8f58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/> <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_90a6702f-b088-42dc-8d29-2167786813c6" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_b8fd5b3e-9a59-432d-b0bf-1cb1f5fe8f58" xlink:type="arc"/> </link:calculationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/EarningsLossPerShareDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#EarningsLossPerShareDetails"/> <link:calculationLink xlink:role="http://www.cumberlandpharma.com/role/EarningsLossPerShareDetails" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f541458d-2b5b-4ca2-8325-b81776d69c83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d899237b-05c1-4530-b4cb-fc1c1521615b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/> <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f541458d-2b5b-4ca2-8325-b81776d69c83" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d899237b-05c1-4530-b4cb-fc1c1521615b" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_c3cb0ad8-53c5-47f0-9e1d-49513579c1f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/> <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f541458d-2b5b-4ca2-8325-b81776d69c83" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_c3cb0ad8-53c5-47f0-9e1d-49513579c1f6" xlink:type="arc"/> </link:calculationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/InventoriesScheduleofInventoriesDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#InventoriesScheduleofInventoriesDetails"/> <link:calculationLink xlink:role="http://www.cumberlandpharma.com/role/InventoriesScheduleofInventoriesDetails" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross_0ab44e21-04c4-49b8-80d1-c1651bf4fd64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryGross"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_014e6776-600d-42ec-82c0-9d4f06601713" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/> <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryGross_0ab44e21-04c4-49b8-80d1-c1651bf4fd64" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_014e6776-600d-42ec-82c0-9d4f06601713" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_1c9b9ac0-1194-4567-8eb6-18b5747b60af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment"/> <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryGross_0ab44e21-04c4-49b8-80d1-c1651bf4fd64" xlink:to="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_1c9b9ac0-1194-4567-8eb6-18b5747b60af" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_57b6da38-0f82-43de-9ea4-d5ba097bbcfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/> <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryGross_0ab44e21-04c4-49b8-80d1-c1651bf4fd64" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_57b6da38-0f82-43de-9ea4-d5ba097bbcfd" xlink:type="arc"/> </link:calculationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails"/> <link:calculationLink xlink:role="http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_08fbcbca-4b07-487a-b90c-371d46dc62c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_fa946240-7a89-447b-a8f7-0c0b7e957894" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/> <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_08fbcbca-4b07-487a-b90c-371d46dc62c6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_fa946240-7a89-447b-a8f7-0c0b7e957894" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0cf579d3-e96a-4a97-9241-0a865c0d76d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/> <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_08fbcbca-4b07-487a-b90c-371d46dc62c6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0cf579d3-e96a-4a97-9241-0a865c0d76d0" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b971c154-086b-4a1c-ab14-8f7ef7d4b1b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/> <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_08fbcbca-4b07-487a-b90c-371d46dc62c6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b971c154-086b-4a1c-ab14-8f7ef7d4b1b9" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree_f658ec76-ee52-4ebf-979e-14bfa6d7a58c" xlink:href="cpix-20210930.xsd#cpix_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree"/> <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_08fbcbca-4b07-487a-b90c-371d46dc62c6" xlink:to="loc_cpix_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree_f658ec76-ee52-4ebf-979e-14bfa6d7a58c" xlink:type="arc"/> </link:calculationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails_1" xlink:type="simple" xlink:href="cpix-20210930.xsd#LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails_1"/> <link:calculationLink xlink:role="http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails_1" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a2734bc3-caae-4b08-a965-7d9d24d86acc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7d9096df-2b76-4ad9-9046-a0ac1ac1778d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/> <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a2734bc3-caae-4b08-a965-7d9d24d86acc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7d9096df-2b76-4ad9-9046-a0ac1ac1778d" xlink:type="arc"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_db9d7923-8f0f-43b8-bff7-0f87b61f6148" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/> <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a2734bc3-caae-4b08-a965-7d9d24d86acc" xlink:to="loc_us-gaap_OperatingLeaseLiability_db9d7923-8f0f-43b8-bff7-0f87b61f6148" xlink:type="arc"/> </link:calculationLink> </link:linkbase> </XBRL> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-101.DEF <SEQUENCE>8 <FILENAME>cpix-20210930_def.xml <DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT <TEXT> <XBRL> <?xml version="1.0" encoding="UTF-8"?> <!--XBRL Document Created with Wdesk from Workiva--> <!--Copyright 2021 Workiva--> <!--r:719f38f6-81ec-4e77-a876-c86386f0dd09,g:3c5f884f-ec0b-48db-97a2-96993ede30b3--> <link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"> <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/> <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/> <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/> <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/> <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementofEquity" xlink:type="simple" xlink:href="cpix-20210930.xsd#CondensedConsolidatedStatementofEquity"/> <link:definitionLink xlink:role="http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementofEquity" xlink:type="extended" id="i6a54cc750a854548a9c68e4a1f8736a9_CondensedConsolidatedStatementofEquity"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f7c2e9a6-a36a-4563-a86c-80c1462f6f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1beabf0f-f1e7-4ae4-8f05-4e00568019c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f7c2e9a6-a36a-4563-a86c-80c1462f6f63" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1beabf0f-f1e7-4ae4-8f05-4e00568019c7" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2eea1cc5-8e2f-4469-8b3e-02b3f9ab92ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1beabf0f-f1e7-4ae4-8f05-4e00568019c7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2eea1cc5-8e2f-4469-8b3e-02b3f9ab92ca" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_3fc53be7-de5a-4bc2-a466-e48647c29ebf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1beabf0f-f1e7-4ae4-8f05-4e00568019c7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_3fc53be7-de5a-4bc2-a466-e48647c29ebf" xlink:type="arc" order="2"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9ac63f16-655b-43be-a4e3-fef0c786814f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1beabf0f-f1e7-4ae4-8f05-4e00568019c7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9ac63f16-655b-43be-a4e3-fef0c786814f" xlink:type="arc" order="3"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a616b102-9203-43f3-ad9a-8794e1dea0b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1beabf0f-f1e7-4ae4-8f05-4e00568019c7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a616b102-9203-43f3-ad9a-8794e1dea0b8" xlink:type="arc" order="4"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_02261b60-5b81-4cea-97de-5518756f4827" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1beabf0f-f1e7-4ae4-8f05-4e00568019c7" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_02261b60-5b81-4cea-97de-5518756f4827" xlink:type="arc" order="5"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_50403b23-09a6-463c-a646-4a8a4af80ca6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1beabf0f-f1e7-4ae4-8f05-4e00568019c7" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_50403b23-09a6-463c-a646-4a8a4af80ca6" xlink:type="arc" order="6"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0cf9e5e3-0e1f-4fb2-86c3-a5c4f6c85d03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1beabf0f-f1e7-4ae4-8f05-4e00568019c7" xlink:to="loc_us-gaap_ProfitLoss_0cf9e5e3-0e1f-4fb2-86c3-a5c4f6c85d03" xlink:type="arc" order="7"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7a25ff65-d2f8-40b3-8800-bc96f35ea165" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_115063ec-ba4d-423a-891f-54a20007d878" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_48306e8f-4abb-4cef-95d8-dd77dd686950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f7c2e9a6-a36a-4563-a86c-80c1462f6f63" xlink:to="loc_us-gaap_StatementTable_48306e8f-4abb-4cef-95d8-dd77dd686950" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b3dd39aa-22ee-4410-b263-056381d6530c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_48306e8f-4abb-4cef-95d8-dd77dd686950" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b3dd39aa-22ee-4410-b263-056381d6530c" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b3dd39aa-22ee-4410-b263-056381d6530c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b3dd39aa-22ee-4410-b263-056381d6530c" xlink:to="loc_us-gaap_EquityComponentDomain_b3dd39aa-22ee-4410-b263-056381d6530c_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9b72bcee-bd37-4a30-b13d-9f72fa193fca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b3dd39aa-22ee-4410-b263-056381d6530c" xlink:to="loc_us-gaap_EquityComponentDomain_9b72bcee-bd37-4a30-b13d-9f72fa193fca" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_94341e32-a24a-4a97-b865-262cfefbee68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9b72bcee-bd37-4a30-b13d-9f72fa193fca" xlink:to="loc_us-gaap_CommonStockMember_94341e32-a24a-4a97-b865-262cfefbee68" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a8892951-fb38-4532-a2ab-f15f8516eb75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9b72bcee-bd37-4a30-b13d-9f72fa193fca" xlink:to="loc_us-gaap_RetainedEarningsMember_a8892951-fb38-4532-a2ab-f15f8516eb75" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_97242877-524d-4dce-ae96-c586ca3ab29e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9b72bcee-bd37-4a30-b13d-9f72fa193fca" xlink:to="loc_us-gaap_NoncontrollingInterestMember_97242877-524d-4dce-ae96-c586ca3ab29e" xlink:type="arc" order="2"/> </link:definitionLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/RevenuesDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#RevenuesDetails"/> <link:definitionLink xlink:role="http://www.cumberlandpharma.com/role/RevenuesDetails" xlink:type="extended" id="ic1019e4191f0414d8243fc457f1074ba_RevenuesDetails"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_734d2712-5858-4a27-a866-f899e4111979" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_cabf3418-a5ae-4f2d-bfa2-00edf4297517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_734d2712-5858-4a27-a866-f899e4111979" xlink:to="loc_us-gaap_RevenuesAbstract_cabf3418-a5ae-4f2d-bfa2-00edf4297517" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_ProductsAbstract_b7f59a5d-573f-4c4b-907f-2d14d80f41f7" xlink:href="cpix-20210930.xsd#cpix_ProductsAbstract"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_cabf3418-a5ae-4f2d-bfa2-00edf4297517" xlink:to="loc_cpix_ProductsAbstract_b7f59a5d-573f-4c4b-907f-2d14d80f41f7" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a9b697b5-652d-4f60-a2d7-25b146d15337" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cpix_ProductsAbstract_b7f59a5d-573f-4c4b-907f-2d14d80f41f7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a9b697b5-652d-4f60-a2d7-25b146d15337" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_e425ca26-2d14-444f-b7fd-a4ca025fb0e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_734d2712-5858-4a27-a866-f899e4111979" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_e425ca26-2d14-444f-b7fd-a4ca025fb0e4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/> <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ea85ad4b-cddd-4c70-a69b-d422c9f973f7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_e425ca26-2d14-444f-b7fd-a4ca025fb0e4" xlink:to="loc_srt_ProductOrServiceAxis_ea85ad4b-cddd-4c70-a69b-d422c9f973f7" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ea85ad4b-cddd-4c70-a69b-d422c9f973f7_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_ea85ad4b-cddd-4c70-a69b-d422c9f973f7" xlink:to="loc_srt_ProductsAndServicesDomain_ea85ad4b-cddd-4c70-a69b-d422c9f973f7_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c5dd95e8-54d6-4959-883d-f9a456f42934" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_ea85ad4b-cddd-4c70-a69b-d422c9f973f7" xlink:to="loc_srt_ProductsAndServicesDomain_c5dd95e8-54d6-4959-883d-f9a456f42934" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_AcetadoteMember_da36bad0-a580-4de6-bc72-a3d26324cd1b" xlink:href="cpix-20210930.xsd#cpix_AcetadoteMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c5dd95e8-54d6-4959-883d-f9a456f42934" xlink:to="loc_cpix_AcetadoteMember_da36bad0-a580-4de6-bc72-a3d26324cd1b" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_OmeclamoxPakMember_c27b32ff-3a9d-4ae8-9470-f838a0bc70a1" xlink:href="cpix-20210930.xsd#cpix_OmeclamoxPakMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c5dd95e8-54d6-4959-883d-f9a456f42934" xlink:to="loc_cpix_OmeclamoxPakMember_c27b32ff-3a9d-4ae8-9470-f838a0bc70a1" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_KristaloseMember_8d10004d-9f1a-4b2f-8c06-0d85a0805803" xlink:href="cpix-20210930.xsd#cpix_KristaloseMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c5dd95e8-54d6-4959-883d-f9a456f42934" xlink:to="loc_cpix_KristaloseMember_8d10004d-9f1a-4b2f-8c06-0d85a0805803" xlink:type="arc" order="2"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_VaprisolMember_a433841e-56a8-4f31-a0f5-1c9ac4523065" xlink:href="cpix-20210930.xsd#cpix_VaprisolMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c5dd95e8-54d6-4959-883d-f9a456f42934" xlink:to="loc_cpix_VaprisolMember_a433841e-56a8-4f31-a0f5-1c9ac4523065" xlink:type="arc" order="3"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_CaldolorMember_b0abc34d-da75-403b-a6be-5392060ff765" xlink:href="cpix-20210930.xsd#cpix_CaldolorMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c5dd95e8-54d6-4959-883d-f9a456f42934" xlink:to="loc_cpix_CaldolorMember_b0abc34d-da75-403b-a6be-5392060ff765" xlink:type="arc" order="4"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_VIBATIVMember_453c4bfa-ffbc-4f55-a4a0-59ed179c71c4" xlink:href="cpix-20210930.xsd#cpix_VIBATIVMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c5dd95e8-54d6-4959-883d-f9a456f42934" xlink:to="loc_cpix_VIBATIVMember_453c4bfa-ffbc-4f55-a4a0-59ed179c71c4" xlink:type="arc" order="5"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_RediTrexMember_f65bdec8-433e-480f-96ba-4ca60e7d5249" xlink:href="cpix-20210930.xsd#cpix_RediTrexMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c5dd95e8-54d6-4959-883d-f9a456f42934" xlink:to="loc_cpix_RediTrexMember_f65bdec8-433e-480f-96ba-4ca60e7d5249" xlink:type="arc" order="6"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_OtherProductsMember_6c40e545-0aff-4bd1-bad2-a8cc67cad621" xlink:href="cpix-20210930.xsd#cpix_OtherProductsMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c5dd95e8-54d6-4959-883d-f9a456f42934" xlink:to="loc_cpix_OtherProductsMember_6c40e545-0aff-4bd1-bad2-a8cc67cad621" xlink:type="arc" order="7"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember_6fa6505e-2e11-48e7-9bb7-b40fa8f1d88d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrantMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c5dd95e8-54d6-4959-883d-f9a456f42934" xlink:to="loc_us-gaap_GrantMember_6fa6505e-2e11-48e7-9bb7-b40fa8f1d88d" xlink:type="arc" order="8"/> </link:definitionLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/InventoriesNarrativeDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#InventoriesNarrativeDetails"/> <link:definitionLink xlink:role="http://www.cumberlandpharma.com/role/InventoriesNarrativeDetails" xlink:type="extended" id="id49804daf3d24475bdbf1f8d946201e9_InventoriesNarrativeDetails"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_2677b945-1379-4f43-b473-fcbb33c8672a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLineItems"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_6ceb65bc-3f32-448c-bd36-e8d24a182c40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_2677b945-1379-4f43-b473-fcbb33c8672a" xlink:to="loc_us-gaap_InventoryValuationReserves_6ceb65bc-3f32-448c-bd36-e8d24a182c40" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_bdc2f651-0530-4433-920f-195aa7565b4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNoncurrent"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_2677b945-1379-4f43-b473-fcbb33c8672a" xlink:to="loc_us-gaap_InventoryNoncurrent_bdc2f651-0530-4433-920f-195aa7565b4e" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_bbf4892d-163a-4e3d-a2e7-2b4988289caa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_2677b945-1379-4f43-b473-fcbb33c8672a" xlink:to="loc_us-gaap_InventoryFinishedGoods_bbf4892d-163a-4e3d-a2e7-2b4988289caa" xlink:type="arc" order="2"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_0db0db49-31ad-434a-8794-a060fe279721" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_2677b945-1379-4f43-b473-fcbb33c8672a" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_0db0db49-31ad-434a-8794-a060fe279721" xlink:type="arc" order="3"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_a0b336b1-ce47-4233-8c49-b2149cbf97b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryCurrentTable"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InventoryLineItems_2677b945-1379-4f43-b473-fcbb33c8672a" xlink:to="loc_us-gaap_InventoryCurrentTable_a0b336b1-ce47-4233-8c49-b2149cbf97b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_14e80154-b32c-4526-a987-e7dae298d58a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InventoryCurrentTable_a0b336b1-ce47-4233-8c49-b2149cbf97b0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_14e80154-b32c-4526-a987-e7dae298d58a" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_14e80154-b32c-4526-a987-e7dae298d58a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_14e80154-b32c-4526-a987-e7dae298d58a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_14e80154-b32c-4526-a987-e7dae298d58a_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_080a77a9-fbcc-4871-ad9a-9b29db13a53f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_14e80154-b32c-4526-a987-e7dae298d58a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_080a77a9-fbcc-4871-ad9a-9b29db13a53f" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_IfetrobanClinicalMember_762200de-c65f-4d46-92dd-adda1c9d1347" xlink:href="cpix-20210930.xsd#cpix_IfetrobanClinicalMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_080a77a9-fbcc-4871-ad9a-9b29db13a53f" xlink:to="loc_cpix_IfetrobanClinicalMember_762200de-c65f-4d46-92dd-adda1c9d1347" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_VIBATIVMember_d981f915-b2c0-4e48-8935-37217a2cc260" xlink:href="cpix-20210930.xsd#cpix_VIBATIVMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_080a77a9-fbcc-4871-ad9a-9b29db13a53f" xlink:to="loc_cpix_VIBATIVMember_d981f915-b2c0-4e48-8935-37217a2cc260" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryAxis_12a92061-068d-47a8-b4fa-e0f6209b630d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PublicUtilitiesInventoryAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InventoryCurrentTable_a0b336b1-ce47-4233-8c49-b2149cbf97b0" xlink:to="loc_us-gaap_PublicUtilitiesInventoryAxis_12a92061-068d-47a8-b4fa-e0f6209b630d" xlink:type="arc" order="2"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_12a92061-068d-47a8-b4fa-e0f6209b630d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis_12a92061-068d-47a8-b4fa-e0f6209b630d" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_12a92061-068d-47a8-b4fa-e0f6209b630d_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_62ea1003-d7f0-4193-9fa7-15a5f1339c82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis_12a92061-068d-47a8-b4fa-e0f6209b630d" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_62ea1003-d7f0-4193-9fa7-15a5f1339c82" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_IfetrobanClinicalMember_f4ca23e0-d093-45be-91fe-e13d47a86b56" xlink:href="cpix-20210930.xsd#cpix_IfetrobanClinicalMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_62ea1003-d7f0-4193-9fa7-15a5f1339c82" xlink:to="loc_cpix_IfetrobanClinicalMember_f4ca23e0-d093-45be-91fe-e13d47a86b56" xlink:type="arc" order="0"/> </link:definitionLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#LeasesNarrativeDetails"/> <link:definitionLink xlink:role="http://www.cumberlandpharma.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i8937210d1feb445ab11fbac33ab5b41d_LeasesNarrativeDetails"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_1605487e-e0f6-4306-b5ca-7782f823edcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_2d366c01-a172-4ddd-becb-3cd44be795e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AreaOfRealEstateProperty"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1605487e-e0f6-4306-b5ca-7782f823edcd" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_2d366c01-a172-4ddd-becb-3cd44be795e9" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_bc317288-facc-46d7-8afe-50d71f1d6181" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1605487e-e0f6-4306-b5ca-7782f823edcd" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_bc317288-facc-46d7-8afe-50d71f1d6181" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_47cadbee-2542-4917-9e1b-fac050365ff2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1605487e-e0f6-4306-b5ca-7782f823edcd" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_47cadbee-2542-4917-9e1b-fac050365ff2" xlink:type="arc" order="2"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_677942a7-adcf-467b-be5c-ee7208957a17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1605487e-e0f6-4306-b5ca-7782f823edcd" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_677942a7-adcf-467b-be5c-ee7208957a17" xlink:type="arc" order="3"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_3bd25538-a25a-4f95-ac3a-183935816b0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1605487e-e0f6-4306-b5ca-7782f823edcd" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_3bd25538-a25a-4f95-ac3a-183935816b0d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_744461e7-343f-4ce0-88e8-462cd55aea36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_3bd25538-a25a-4f95-ac3a-183935816b0d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_744461e7-343f-4ce0-88e8-462cd55aea36" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_744461e7-343f-4ce0-88e8-462cd55aea36_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_744461e7-343f-4ce0-88e8-462cd55aea36" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_744461e7-343f-4ce0-88e8-462cd55aea36_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8fb4ce31-a05c-40ef-92f7-f9e38d139381" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_744461e7-343f-4ce0-88e8-462cd55aea36" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8fb4ce31-a05c-40ef-92f7-f9e38d139381" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_3fc8fde7-facd-4ec6-81d3-b7eed954ffac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8fb4ce31-a05c-40ef-92f7-f9e38d139381" xlink:to="loc_us-gaap_BuildingMember_3fc8fde7-facd-4ec6-81d3-b7eed954ffac" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_srt_OfficeBuildingMember_d1b199e9-1204-4946-b7ca-596cc966f447" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OfficeBuildingMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8fb4ce31-a05c-40ef-92f7-f9e38d139381" xlink:to="loc_srt_OfficeBuildingMember_d1b199e9-1204-4946-b7ca-596cc966f447" xlink:type="arc" order="1"/> </link:definitionLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#ShareholdersEquityandDebtShareholdersEquityDetails"/> <link:definitionLink xlink:role="http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" xlink:type="extended" id="ie40cd2367fa14173b739e55366816b88_ShareholdersEquityandDebtShareholdersEquityDetails"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e2d7da7-4ea8-4146-be48-882ec29b6419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_ShareholdersEquityTextualAbstract_dce969f5-2d4b-419b-a3a1-22d26930068b" xlink:href="cpix-20210930.xsd#cpix_ShareholdersEquityTextualAbstract"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e2d7da7-4ea8-4146-be48-882ec29b6419" xlink:to="loc_cpix_ShareholdersEquityTextualAbstract_dce969f5-2d4b-419b-a3a1-22d26930068b" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_a899ac8b-6845-402d-a04e-be85c00dec06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cpix_ShareholdersEquityTextualAbstract_dce969f5-2d4b-419b-a3a1-22d26930068b" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_a899ac8b-6845-402d-a04e-be85c00dec06" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_5f8700fb-8183-4a3e-8204-72cad17effcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cpix_ShareholdersEquityTextualAbstract_dce969f5-2d4b-419b-a3a1-22d26930068b" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_5f8700fb-8183-4a3e-8204-72cad17effcb" xlink:type="arc" order="2"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_28de0e93-1d84-4a8d-bcbd-f9fc6ee2438a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cpix_ShareholdersEquityTextualAbstract_dce969f5-2d4b-419b-a3a1-22d26930068b" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_28de0e93-1d84-4a8d-bcbd-f9fc6ee2438a" xlink:type="arc" order="3"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_157796a8-03d2-4355-9e26-67e8f44f04c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cpix_ShareholdersEquityTextualAbstract_dce969f5-2d4b-419b-a3a1-22d26930068b" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_157796a8-03d2-4355-9e26-67e8f44f04c4" xlink:type="arc" order="4"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities_a02c5b3f-77e9-406d-ad14-19bcc22189b9" xlink:href="cpix-20210930.xsd#cpix_StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cpix_ShareholdersEquityTextualAbstract_dce969f5-2d4b-419b-a3a1-22d26930068b" xlink:to="loc_cpix_StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities_a02c5b3f-77e9-406d-ad14-19bcc22189b9" xlink:type="arc" order="5"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0125cc7e-b8e5-4a55-b545-65ed3bb675d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cpix_ShareholdersEquityTextualAbstract_dce969f5-2d4b-419b-a3a1-22d26930068b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0125cc7e-b8e5-4a55-b545-65ed3bb675d6" xlink:type="arc" order="6"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_36ce7cc7-bbb1-4df2-891c-29d7f7bccfdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cpix_ShareholdersEquityTextualAbstract_dce969f5-2d4b-419b-a3a1-22d26930068b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_36ce7cc7-bbb1-4df2-891c-29d7f7bccfdd" xlink:type="arc" order="7"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41dc7f81-ea80-40fe-9466-2dfb24a12be8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e2d7da7-4ea8-4146-be48-882ec29b6419" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41dc7f81-ea80-40fe-9466-2dfb24a12be8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d32074c5-5f6d-47b6-9172-975d23300470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41dc7f81-ea80-40fe-9466-2dfb24a12be8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d32074c5-5f6d-47b6-9172-975d23300470" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d32074c5-5f6d-47b6-9172-975d23300470_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d32074c5-5f6d-47b6-9172-975d23300470" xlink:to="loc_us-gaap_EquityComponentDomain_d32074c5-5f6d-47b6-9172-975d23300470_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6d214517-3496-46ea-b310-30f77abd0996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d32074c5-5f6d-47b6-9172-975d23300470" xlink:to="loc_us-gaap_EquityComponentDomain_6d214517-3496-46ea-b310-30f77abd0996" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3dccb701-ecec-4cf5-a759-0ec3baa98c2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6d214517-3496-46ea-b310-30f77abd0996" xlink:to="loc_us-gaap_CommonStockMember_3dccb701-ecec-4cf5-a759-0ec3baa98c2a" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_41ae3094-cee4-4790-8a7f-6effec343507" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41dc7f81-ea80-40fe-9466-2dfb24a12be8" xlink:to="loc_srt_TitleOfIndividualAxis_41ae3094-cee4-4790-8a7f-6effec343507" xlink:type="arc" order="2"/> <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_41ae3094-cee4-4790-8a7f-6effec343507_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_41ae3094-cee4-4790-8a7f-6effec343507" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_41ae3094-cee4-4790-8a7f-6effec343507_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_710fbba4-f8bf-413c-b4d8-a4a63861569e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_41ae3094-cee4-4790-8a7f-6effec343507" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_710fbba4-f8bf-413c-b4d8-a4a63861569e" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_c81f76fa-d84c-4861-870c-10246eb57530" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_710fbba4-f8bf-413c-b4d8-a4a63861569e" xlink:to="loc_srt_DirectorMember_c81f76fa-d84c-4861-870c-10246eb57530" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bf4734b9-db34-4a30-b055-516c4bd90cda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41dc7f81-ea80-40fe-9466-2dfb24a12be8" xlink:to="loc_us-gaap_AwardTypeAxis_bf4734b9-db34-4a30-b055-516c4bd90cda" xlink:type="arc" order="3"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bf4734b9-db34-4a30-b055-516c4bd90cda_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_bf4734b9-db34-4a30-b055-516c4bd90cda" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bf4734b9-db34-4a30-b055-516c4bd90cda_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c91843c0-6910-4bf2-91ce-aecef678f90a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_bf4734b9-db34-4a30-b055-516c4bd90cda" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c91843c0-6910-4bf2-91ce-aecef678f90a" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_fa712a3e-6ba7-4031-9718-f1b31b804988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c91843c0-6910-4bf2-91ce-aecef678f90a" xlink:to="loc_us-gaap_RestrictedStockMember_fa712a3e-6ba7-4031-9718-f1b31b804988" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_IncentiveStockOptionsMember_f1b2e523-068c-4244-afae-aa23f410c504" xlink:href="cpix-20210930.xsd#cpix_IncentiveStockOptionsMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c91843c0-6910-4bf2-91ce-aecef678f90a" xlink:to="loc_cpix_IncentiveStockOptionsMember_f1b2e523-068c-4244-afae-aa23f410c504" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_cd0a5b70-ff7b-4dc1-8255-7fc05e87e5e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41dc7f81-ea80-40fe-9466-2dfb24a12be8" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_cd0a5b70-ff7b-4dc1-8255-7fc05e87e5e5" xlink:type="arc" order="4"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_cd0a5b70-ff7b-4dc1-8255-7fc05e87e5e5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_cd0a5b70-ff7b-4dc1-8255-7fc05e87e5e5" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_cd0a5b70-ff7b-4dc1-8255-7fc05e87e5e5_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_b1874aba-29cf-4026-bf29-9e9098194f28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_cd0a5b70-ff7b-4dc1-8255-7fc05e87e5e5" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_b1874aba-29cf-4026-bf29-9e9098194f28" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_PinnacleBankMember_aca55c95-33f0-41d2-93f8-44354c26b34b" xlink:href="cpix-20210930.xsd#cpix_PinnacleBankMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_b1874aba-29cf-4026-bf29-9e9098194f28" xlink:to="loc_cpix_PinnacleBankMember_aca55c95-33f0-41d2-93f8-44354c26b34b" xlink:type="arc" order="0"/> </link:definitionLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#ShareholdersEquityandDebtDebtDetails"/> <link:definitionLink xlink:role="http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" xlink:type="extended" id="ie57126931e58445e89c8a08ae64ab57d_ShareholdersEquityandDebtDebtDetails"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_4342889b-966b-49b2-a0d0-a0209fd6d59c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_4342889b-966b-49b2-a0d0-a0209fd6d59c" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount_b15a0fc3-1dd8-4590-b882-1c6b5fc45389" xlink:href="cpix-20210930.xsd#cpix_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:to="loc_cpix_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount_b15a0fc3-1dd8-4590-b882-1c6b5fc45389" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity_0411c40d-3134-458d-9a69-815c52a7e0c8" xlink:href="cpix-20210930.xsd#cpix_LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:to="loc_cpix_LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity_0411c40d-3134-458d-9a69-815c52a7e0c8" xlink:type="arc" order="2"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_22d0e154-ec5d-40b7-96df-ed7ae7b5f597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_22d0e154-ec5d-40b7-96df-ed7ae7b5f597" xlink:type="arc" order="3"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3502b971-58b5-484a-996d-f56df0013cfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3502b971-58b5-484a-996d-f56df0013cfc" xlink:type="arc" order="4"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_5a321987-37bf-48e5-8a47-082f153f030f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_5a321987-37bf-48e5-8a47-082f153f030f" xlink:type="arc" order="5"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived_cc8ecf62-dd77-4011-9a81-87d2e3da5973" xlink:href="cpix-20210930.xsd#cpix_TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:to="loc_cpix_TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived_cc8ecf62-dd77-4011-9a81-87d2e3da5973" xlink:type="arc" order="6"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_4d15000e-ff90-49dc-b56d-4e2dc6257ec7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermLineOfCredit"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:to="loc_us-gaap_LongTermLineOfCredit_4d15000e-ff90-49dc-b56d-4e2dc6257ec7" xlink:type="arc" order="7"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_a4e49abf-46a3-44d7-82d5-edc64d35e2fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_a4e49abf-46a3-44d7-82d5-edc64d35e2fc" xlink:type="arc" order="8"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_47b529f0-bd21-4b1d-943b-5af2709f30ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_47b529f0-bd21-4b1d-943b-5af2709f30ba" xlink:type="arc" order="9"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_01c9923a-72fd-45af-ac69-a5257d0f792e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_01c9923a-72fd-45af-ac69-a5257d0f792e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_6864e921-e812-4edd-873e-8260d55a21f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_01c9923a-72fd-45af-ac69-a5257d0f792e" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_6864e921-e812-4edd-873e-8260d55a21f7" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_6864e921-e812-4edd-873e-8260d55a21f7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_6864e921-e812-4edd-873e-8260d55a21f7" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_6864e921-e812-4edd-873e-8260d55a21f7_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_d92cf7c3-acf0-445d-91b4-98ece5460a4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_6864e921-e812-4edd-873e-8260d55a21f7" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_d92cf7c3-acf0-445d-91b4-98ece5460a4d" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_PinnacleBankMember_9426523c-ee34-44cb-9b21-e8ee279e6bda" xlink:href="cpix-20210930.xsd#cpix_PinnacleBankMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_d92cf7c3-acf0-445d-91b4-98ece5460a4d" xlink:to="loc_cpix_PinnacleBankMember_9426523c-ee34-44cb-9b21-e8ee279e6bda" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cc405239-fcb9-47f7-9cf9-039cbdb4c098" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_01c9923a-72fd-45af-ac69-a5257d0f792e" xlink:to="loc_us-gaap_DebtInstrumentAxis_cc405239-fcb9-47f7-9cf9-039cbdb4c098" xlink:type="arc" order="2"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cc405239-fcb9-47f7-9cf9-039cbdb4c098_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_cc405239-fcb9-47f7-9cf9-039cbdb4c098" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cc405239-fcb9-47f7-9cf9-039cbdb4c098_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bbf31dc4-f31a-4748-9d12-c3ba40937f45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_cc405239-fcb9-47f7-9cf9-039cbdb4c098" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bbf31dc4-f31a-4748-9d12-c3ba40937f45" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_8de6865d-d462-41cd-af3e-15f891b60a13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bbf31dc4-f31a-4748-9d12-c3ba40937f45" xlink:to="loc_us-gaap_LineOfCreditMember_8de6865d-d462-41cd-af3e-15f891b60a13" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_FifthAmendmentMember_bbea2c9b-79d3-445d-a3ca-aaccf7d2c846" xlink:href="cpix-20210930.xsd#cpix_FifthAmendmentMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bbf31dc4-f31a-4748-9d12-c3ba40937f45" xlink:to="loc_cpix_FifthAmendmentMember_bbea2c9b-79d3-445d-a3ca-aaccf7d2c846" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e9f6b071-ea2f-4d19-9f4e-86307cb14ddd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_01c9923a-72fd-45af-ac69-a5257d0f792e" xlink:to="loc_us-gaap_CreditFacilityAxis_e9f6b071-ea2f-4d19-9f4e-86307cb14ddd" xlink:type="arc" order="3"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e9f6b071-ea2f-4d19-9f4e-86307cb14ddd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_e9f6b071-ea2f-4d19-9f4e-86307cb14ddd" xlink:to="loc_us-gaap_CreditFacilityDomain_e9f6b071-ea2f-4d19-9f4e-86307cb14ddd_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_af38b56e-af38-48bb-8364-72b3186bbee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_e9f6b071-ea2f-4d19-9f4e-86307cb14ddd" xlink:to="loc_us-gaap_CreditFacilityDomain_af38b56e-af38-48bb-8364-72b3186bbee3" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_95918447-3505-47af-ad1b-0592d35373b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_af38b56e-af38-48bb-8364-72b3186bbee3" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_95918447-3505-47af-ad1b-0592d35373b6" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_37e49cb7-02f9-4b86-b101-165a22600ed8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_01c9923a-72fd-45af-ac69-a5257d0f792e" xlink:to="loc_srt_RangeAxis_37e49cb7-02f9-4b86-b101-165a22600ed8" xlink:type="arc" order="4"/> <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_37e49cb7-02f9-4b86-b101-165a22600ed8_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_37e49cb7-02f9-4b86-b101-165a22600ed8" xlink:to="loc_srt_RangeMember_37e49cb7-02f9-4b86-b101-165a22600ed8_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7a943b86-710f-4c02-94a4-ba6342b423a5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_37e49cb7-02f9-4b86-b101-165a22600ed8" xlink:to="loc_srt_RangeMember_7a943b86-710f-4c02-94a4-ba6342b423a5" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_58342083-abf1-44ec-88f7-c13fc3267a80" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7a943b86-710f-4c02-94a4-ba6342b423a5" xlink:to="loc_srt_MinimumMember_58342083-abf1-44ec-88f7-c13fc3267a80" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ea1f666b-786a-4341-8820-986b3dc0ec6b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7a943b86-710f-4c02-94a4-ba6342b423a5" xlink:to="loc_srt_MaximumMember_ea1f666b-786a-4341-8820-986b3dc0ec6b" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_bfdfb4ef-0c0b-47f0-bd51-0f4cd6edaf10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_01c9923a-72fd-45af-ac69-a5257d0f792e" xlink:to="loc_us-gaap_VariableRateAxis_bfdfb4ef-0c0b-47f0-bd51-0f4cd6edaf10" xlink:type="arc" order="5"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_bfdfb4ef-0c0b-47f0-bd51-0f4cd6edaf10_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_bfdfb4ef-0c0b-47f0-bd51-0f4cd6edaf10" xlink:to="loc_us-gaap_VariableRateDomain_bfdfb4ef-0c0b-47f0-bd51-0f4cd6edaf10_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9f544c4e-7e90-4a11-8f60-9d1e9aba05a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_bfdfb4ef-0c0b-47f0-bd51-0f4cd6edaf10" xlink:to="loc_us-gaap_VariableRateDomain_9f544c4e-7e90-4a11-8f60-9d1e9aba05a7" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_f5d724d4-b1b7-422d-98c9-5860decfec72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_9f544c4e-7e90-4a11-8f60-9d1e9aba05a7" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_f5d724d4-b1b7-422d-98c9-5860decfec72" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a3b1fa9d-4cf7-4b7e-a15d-3b8cf5214470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_01c9923a-72fd-45af-ac69-a5257d0f792e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a3b1fa9d-4cf7-4b7e-a15d-3b8cf5214470" xlink:type="arc" order="6"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a3b1fa9d-4cf7-4b7e-a15d-3b8cf5214470_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a3b1fa9d-4cf7-4b7e-a15d-3b8cf5214470" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a3b1fa9d-4cf7-4b7e-a15d-3b8cf5214470_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1b4f56ad-9040-494c-b289-ae859ad917ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a3b1fa9d-4cf7-4b7e-a15d-3b8cf5214470" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1b4f56ad-9040-494c-b289-ae859ad917ba" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_d831bec9-5b8a-483f-9710-600e88c1faa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1b4f56ad-9040-494c-b289-ae859ad917ba" xlink:to="loc_us-gaap_ConvertibleDebtMember_d831bec9-5b8a-483f-9710-600e88c1faa1" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_41974df7-1702-4478-8286-3fc979ad0750" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_01c9923a-72fd-45af-ac69-a5257d0f792e" xlink:to="loc_srt_CounterpartyNameAxis_41974df7-1702-4478-8286-3fc979ad0750" xlink:type="arc" order="7"/> <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_41974df7-1702-4478-8286-3fc979ad0750_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_41974df7-1702-4478-8286-3fc979ad0750" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_41974df7-1702-4478-8286-3fc979ad0750_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ba476a30-0ed1-47b3-bce0-757a8d98986a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_41974df7-1702-4478-8286-3fc979ad0750" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ba476a30-0ed1-47b3-bce0-757a8d98986a" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_WinHealthInvestmentSingaporeLtdDomain_f6a8060e-a0bf-4a73-b18a-df0d3777553c" xlink:href="cpix-20210930.xsd#cpix_WinHealthInvestmentSingaporeLtdDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ba476a30-0ed1-47b3-bce0-757a8d98986a" xlink:to="loc_cpix_WinHealthInvestmentSingaporeLtdDomain_f6a8060e-a0bf-4a73-b18a-df0d3777553c" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_735b1b51-6332-4d24-b5a6-497cfb878f10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_01c9923a-72fd-45af-ac69-a5257d0f792e" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_735b1b51-6332-4d24-b5a6-497cfb878f10" xlink:type="arc" order="8"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_735b1b51-6332-4d24-b5a6-497cfb878f10_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_735b1b51-6332-4d24-b5a6-497cfb878f10" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_735b1b51-6332-4d24-b5a6-497cfb878f10_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_675fa301-8020-4ef1-9e39-0531b0875be7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_735b1b51-6332-4d24-b5a6-497cfb878f10" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_675fa301-8020-4ef1-9e39-0531b0875be7" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_87926cf0-c5a8-4783-9759-8a912f95af1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_675fa301-8020-4ef1-9e39-0531b0875be7" xlink:to="loc_us-gaap_SubsequentEventMember_87926cf0-c5a8-4783-9759-8a912f95af1a" xlink:type="arc" order="0"/> </link:definitionLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/IncomeTaxesDetailsTextual" xlink:type="simple" xlink:href="cpix-20210930.xsd#IncomeTaxesDetailsTextual"/> <link:definitionLink xlink:role="http://www.cumberlandpharma.com/role/IncomeTaxesDetailsTextual" xlink:type="extended" id="ie423d75232c545b38dde00ca44b48be9_IncomeTaxesDetailsTextual"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_2b9fa7b0-59ff-4c6e-8458-84e58541a496" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_dc041ee2-e7fb-4b58-8b16-73fad793b169" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2b9fa7b0-59ff-4c6e-8458-84e58541a496" xlink:to="loc_us-gaap_OperatingLossCarryforwards_dc041ee2-e7fb-4b58-8b16-73fad793b169" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_12e749c2-0c29-434c-bf52-a0475ce44ac0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2b9fa7b0-59ff-4c6e-8458-84e58541a496" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_12e749c2-0c29-434c-bf52-a0475ce44ac0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_f82cd8d9-ea8d-4bd9-a01b-3925e3e0ca63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_12e749c2-0c29-434c-bf52-a0475ce44ac0" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_f82cd8d9-ea8d-4bd9-a01b-3925e3e0ca63" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_f82cd8d9-ea8d-4bd9-a01b-3925e3e0ca63_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_f82cd8d9-ea8d-4bd9-a01b-3925e3e0ca63" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_f82cd8d9-ea8d-4bd9-a01b-3925e3e0ca63_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_13c626d2-9a2c-4fa7-aa11-4dcefbe71155" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_f82cd8d9-ea8d-4bd9-a01b-3925e3e0ca63" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_13c626d2-9a2c-4fa7-aa11-4dcefbe71155" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_f3ec2b82-7017-45e2-b743-54380977ea69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_13c626d2-9a2c-4fa7-aa11-4dcefbe71155" xlink:to="loc_us-gaap_DomesticCountryMember_f3ec2b82-7017-45e2-b743-54380977ea69" xlink:type="arc" order="0"/> </link:definitionLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#AdditionsandReturnsofProductRightsNarrativeDetails"/> <link:definitionLink xlink:role="http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails" xlink:type="extended" id="i20c93a90b4b247b39e45a0618edad295_AdditionsandReturnsofProductRightsNarrativeDetails"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_9c1a2f96-471d-456e-ab80-76d6f344d483" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_9c1a2f96-471d-456e-ab80-76d6f344d483" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPaymentsToAcquireBusinesses_42c4ef9e-6ea8-4026-b173-751816282868" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPaymentsToAcquireBusinesses"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:to="loc_us-gaap_OtherPaymentsToAcquireBusinesses_42c4ef9e-6ea8-4026-b173-751816282868" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_TieredRoyaltyPaymentsPercentage_7d7fe71d-78db-4b6a-92e7-6fbdd81abe94" xlink:href="cpix-20210930.xsd#cpix_TieredRoyaltyPaymentsPercentage"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:to="loc_cpix_TieredRoyaltyPaymentsPercentage_7d7fe71d-78db-4b6a-92e7-6fbdd81abe94" xlink:type="arc" order="2"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_4c947c7b-a8c5-4ab8-8c75-4f62023e5331" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_4c947c7b-a8c5-4ab8-8c75-4f62023e5331" xlink:type="arc" order="3"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_c13db486-f28a-43f0-a8c5-3c47cb6bebfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_c13db486-f28a-43f0-a8c5-3c47cb6bebfc" xlink:type="arc" order="4"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2dfdf1f2-5e47-4999-870f-25da027166c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2dfdf1f2-5e47-4999-870f-25da027166c4" xlink:type="arc" order="5"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_5cd5359e-b410-455f-bc81-0bf641fa18bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_5cd5359e-b410-455f-bc81-0bf641fa18bd" xlink:type="arc" order="6"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_dadd1450-b296-4708-9488-b0b765216fcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_dadd1450-b296-4708-9488-b0b765216fcc" xlink:type="arc" order="7"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets_93993c6c-dabe-4afe-97ed-ffcfb855715a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:to="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets_93993c6c-dabe-4afe-97ed-ffcfb855715a" xlink:type="arc" order="8"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_ProceedsFromSaleOfIntangibleAssetsInstallmentPayment_2b94563c-3af2-4bb3-980a-d08fa6701ba1" xlink:href="cpix-20210930.xsd#cpix_ProceedsFromSaleOfIntangibleAssetsInstallmentPayment"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:to="loc_cpix_ProceedsFromSaleOfIntangibleAssetsInstallmentPayment_2b94563c-3af2-4bb3-980a-d08fa6701ba1" xlink:type="arc" order="9"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_9a9f1ec0-c15a-4466-bfc2-d6a3d5f17cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_9a9f1ec0-c15a-4466-bfc2-d6a3d5f17cbe" xlink:type="arc" order="10"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20673524-8b4c-43bb-97aa-412ed7e82950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20673524-8b4c-43bb-97aa-412ed7e82950" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_310c4c54-a67c-4ea0-9ce2-0558ce1d9672" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20673524-8b4c-43bb-97aa-412ed7e82950" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_310c4c54-a67c-4ea0-9ce2-0558ce1d9672" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_310c4c54-a67c-4ea0-9ce2-0558ce1d9672_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_310c4c54-a67c-4ea0-9ce2-0558ce1d9672" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_310c4c54-a67c-4ea0-9ce2-0558ce1d9672_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_559237ab-2ebb-4cd0-90d2-9ecb0f6b87ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_310c4c54-a67c-4ea0-9ce2-0558ce1d9672" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_559237ab-2ebb-4cd0-90d2-9ecb0f6b87ba" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_VIBATIVMember_0e55168e-d2e5-42e5-8203-c9e286e0ae59" xlink:href="cpix-20210930.xsd#cpix_VIBATIVMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_559237ab-2ebb-4cd0-90d2-9ecb0f6b87ba" xlink:to="loc_cpix_VIBATIVMember_0e55168e-d2e5-42e5-8203-c9e286e0ae59" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_MethotrexateMember_1518488e-ed09-4d1e-9ef3-1d35173e328d" xlink:href="cpix-20210930.xsd#cpix_MethotrexateMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_559237ab-2ebb-4cd0-90d2-9ecb0f6b87ba" xlink:to="loc_cpix_MethotrexateMember_1518488e-ed09-4d1e-9ef3-1d35173e328d" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_da3d62f9-c1f6-4a0d-abbf-c43ee51cca4a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20673524-8b4c-43bb-97aa-412ed7e82950" xlink:to="loc_srt_CounterpartyNameAxis_da3d62f9-c1f6-4a0d-abbf-c43ee51cca4a" xlink:type="arc" order="2"/> <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_da3d62f9-c1f6-4a0d-abbf-c43ee51cca4a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_da3d62f9-c1f6-4a0d-abbf-c43ee51cca4a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_da3d62f9-c1f6-4a0d-abbf-c43ee51cca4a_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_270d9c0e-fa4a-4b7c-b301-e2e484aaeb6b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_da3d62f9-c1f6-4a0d-abbf-c43ee51cca4a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_270d9c0e-fa4a-4b7c-b301-e2e484aaeb6b" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_ClinigenHealthcareLimitedMember_f2507615-d2bc-4876-ba61-957136b2a54c" xlink:href="cpix-20210930.xsd#cpix_ClinigenHealthcareLimitedMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_270d9c0e-fa4a-4b7c-b301-e2e484aaeb6b" xlink:to="loc_cpix_ClinigenHealthcareLimitedMember_f2507615-d2bc-4876-ba61-957136b2a54c" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_05d54064-360d-4db8-bae2-91d4d395ae72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20673524-8b4c-43bb-97aa-412ed7e82950" xlink:to="loc_us-gaap_AwardTypeAxis_05d54064-360d-4db8-bae2-91d4d395ae72" xlink:type="arc" order="3"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_05d54064-360d-4db8-bae2-91d4d395ae72_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_05d54064-360d-4db8-bae2-91d4d395ae72" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_05d54064-360d-4db8-bae2-91d4d395ae72_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a30148bf-073f-49d7-832b-fe0dcfbb21d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_05d54064-360d-4db8-bae2-91d4d395ae72" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a30148bf-073f-49d7-832b-fe0dcfbb21d5" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_bb345acd-2fb3-430f-9e10-86d8e893249a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a30148bf-073f-49d7-832b-fe0dcfbb21d5" xlink:to="loc_us-gaap_RestrictedStockMember_bb345acd-2fb3-430f-9e10-86d8e893249a" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_a7064d94-240e-4007-b5ef-bfaea09e4900" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20673524-8b4c-43bb-97aa-412ed7e82950" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_a7064d94-240e-4007-b5ef-bfaea09e4900" xlink:type="arc" order="4"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a7064d94-240e-4007-b5ef-bfaea09e4900_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a7064d94-240e-4007-b5ef-bfaea09e4900" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a7064d94-240e-4007-b5ef-bfaea09e4900_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_61ac4cd5-5856-473a-b95d-c6f63d95effa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a7064d94-240e-4007-b5ef-bfaea09e4900" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_61ac4cd5-5856-473a-b95d-c6f63d95effa" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_42c04725-0271-4d1e-8d37-a546c8bf8b98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_61ac4cd5-5856-473a-b95d-c6f63d95effa" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_42c04725-0271-4d1e-8d37-a546c8bf8b98" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_43dd8daf-1c8d-447e-9574-9fb2ec91c375" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_61ac4cd5-5856-473a-b95d-c6f63d95effa" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_43dd8daf-1c8d-447e-9574-9fb2ec91c375" xlink:type="arc" order="1"/> </link:definitionLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsChangeinConsiderationDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#AdditionsandReturnsofProductRightsChangeinConsiderationDetails"/> <link:definitionLink xlink:role="http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsChangeinConsiderationDetails" xlink:type="extended" id="ibf2a4a012fa649b1acd99e8b536466d8_AdditionsandReturnsofProductRightsChangeinConsiderationDetails"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c7d7c39f-2747-4349-8157-5084f6d99ab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualRollForward_69719e0a-48c0-4796-8d5c-2b42027ad89a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualRollForward"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c7d7c39f-2747-4349-8157-5084f6d99ab4" xlink:to="loc_us-gaap_LossContingencyAccrualRollForward_69719e0a-48c0-4796-8d5c-2b42027ad89a" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_907d8116-5347-41c8-b2d7-f03415937612" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_69719e0a-48c0-4796-8d5c-2b42027ad89a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_907d8116-5347-41c8-b2d7-f03415937612" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_121ee9c3-7bc9-491f-8e79-2c926aa6ef59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRoyalties"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_69719e0a-48c0-4796-8d5c-2b42027ad89a" xlink:to="loc_us-gaap_PaymentsForRoyalties_121ee9c3-7bc9-491f-8e79-2c926aa6ef59" xlink:type="arc" order="2"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ee318128-bf86-4927-8e67-51fdc5b47ff7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_69719e0a-48c0-4796-8d5c-2b42027ad89a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ee318128-bf86-4927-8e67-51fdc5b47ff7" xlink:type="arc" order="3"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses_ac1ee07e-698f-46a8-b06e-ec16d17c1e15" xlink:href="cpix-20210930.xsd#cpix_BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_69719e0a-48c0-4796-8d5c-2b42027ad89a" xlink:to="loc_cpix_BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses_ac1ee07e-698f-46a8-b06e-ec16d17c1e15" xlink:type="arc" order="4"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e049554e-8d44-4e09-bba3-7f63810708ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_430dbb52-e367-4e81-b9fd-a4c71bfa1577" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c7d7c39f-2747-4349-8157-5084f6d99ab4" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_430dbb52-e367-4e81-b9fd-a4c71bfa1577" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7e648ce0-f9b4-4737-8d54-25bf96ed4285" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_430dbb52-e367-4e81-b9fd-a4c71bfa1577" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7e648ce0-f9b4-4737-8d54-25bf96ed4285" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7e648ce0-f9b4-4737-8d54-25bf96ed4285_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7e648ce0-f9b4-4737-8d54-25bf96ed4285" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7e648ce0-f9b4-4737-8d54-25bf96ed4285_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a447d0a-5e08-4530-bd4d-f58a112f826a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7e648ce0-f9b4-4737-8d54-25bf96ed4285" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a447d0a-5e08-4530-bd4d-f58a112f826a" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_VIBATIVMember_3c730611-9292-4681-9abc-9973fbe40a2d" xlink:href="cpix-20210930.xsd#cpix_VIBATIVMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a447d0a-5e08-4530-bd4d-f58a112f826a" xlink:to="loc_cpix_VIBATIVMember_3c730611-9292-4681-9abc-9973fbe40a2d" xlink:type="arc" order="0"/> </link:definitionLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsDissolutionPaymentsDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#AdditionsandReturnsofProductRightsDissolutionPaymentsDetails"/> <link:definitionLink xlink:role="http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsDissolutionPaymentsDetails" xlink:type="extended" id="i8f29be8322af466f882c541ec9191580_AdditionsandReturnsofProductRightsDissolutionPaymentsDetails"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5ffaf73d-e852-4b6a-8166-b950defb28eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_27d02636-cbfb-4208-b0e4-bf1d6e6f3ef7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5ffaf73d-e852-4b6a-8166-b950defb28eb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_27d02636-cbfb-4208-b0e4-bf1d6e6f3ef7" xlink:type="arc" order="0"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_874ee80e-526b-4260-8434-d695346293fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5ffaf73d-e852-4b6a-8166-b950defb28eb" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_874ee80e-526b-4260-8434-d695346293fa" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_176d68d4-abc5-412b-b5c1-941628452b93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5ffaf73d-e852-4b6a-8166-b950defb28eb" xlink:to="loc_us-gaap_SellingAndMarketingExpense_176d68d4-abc5-412b-b5c1-941628452b93" xlink:type="arc" order="2"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_96bb49e8-f2af-4ba7-a358-17a73cab9569" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5ffaf73d-e852-4b6a-8166-b950defb28eb" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_96bb49e8-f2af-4ba7-a358-17a73cab9569" xlink:type="arc" order="3"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d5178dc6-a611-4ff8-a504-8d579dab36f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5ffaf73d-e852-4b6a-8166-b950defb28eb" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d5178dc6-a611-4ff8-a504-8d579dab36f5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/> <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_9a4992ae-e38f-4cfd-955b-251316829cd8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d5178dc6-a611-4ff8-a504-8d579dab36f5" xlink:to="loc_srt_CounterpartyNameAxis_9a4992ae-e38f-4cfd-955b-251316829cd8" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9a4992ae-e38f-4cfd-955b-251316829cd8_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_9a4992ae-e38f-4cfd-955b-251316829cd8" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9a4992ae-e38f-4cfd-955b-251316829cd8_default" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_23e661db-e953-4963-8450-a34584c2c841" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_9a4992ae-e38f-4cfd-955b-251316829cd8" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_23e661db-e953-4963-8450-a34584c2c841" xlink:type="arc" order="1"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_ClinigenHealthcareLimitedMember_39221abf-bb00-4648-9275-c66638c9b9f0" xlink:href="cpix-20210930.xsd#cpix_ClinigenHealthcareLimitedMember"/> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_23e661db-e953-4963-8450-a34584c2c841" xlink:to="loc_cpix_ClinigenHealthcareLimitedMember_39221abf-bb00-4648-9275-c66638c9b9f0" xlink:type="arc" order="0"/> </link:definitionLink> </link:linkbase> </XBRL> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-101.LAB <SEQUENCE>9 <FILENAME>cpix-20210930_lab.xml <DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT <TEXT> <XBRL> <?xml version="1.0" encoding="UTF-8"?> <!--XBRL Document Created with Wdesk from Workiva--> <!--Copyright 2021 Workiva--> <!--r:719f38f6-81ec-4e77-a876-c86386f0dd09,g:3c5f884f-ec0b-48db-97a2-96993ede30b3--> <link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"> <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/> <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/> <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/> <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/> <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/> <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/> <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/> <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended"> <link:label id="lab_us-gaap_AreaOfRealEstateProperty_53122c63-c5a3-41e5-bbc1-911cb6a6584e_terseLabel_en-US" xlink:label="lab_us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Square feet of office space</link:label> <link:label id="lab_us-gaap_AreaOfRealEstateProperty_label_en-US" xlink:label="lab_us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area of Real Estate Property</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AreaOfRealEstateProperty"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AreaOfRealEstateProperty" xlink:to="lab_us-gaap_AreaOfRealEstateProperty" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_eff59604-03d3-4522-9111-f311736e5ace_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock granted in period, shares</link:label> <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_43bc5064-c5b9-4aef-8965-51bcfc38c3ca_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label> <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_63e20f0a-b79c-4d47-b116-0a8ff569973c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label> <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/> <link:label id="lab_dei_DocumentType_4973da7e-5c5b-46b6-a73d-2486c06af413_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label> <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/> <link:label id="lab_cpix_IfetrobanClinicalMember_2edb8e68-3877-45fd-aa10-c1d7240dbab2_terseLabel_en-US" xlink:label="lab_cpix_IfetrobanClinicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ifetroban Clinical</link:label> <link:label id="lab_cpix_IfetrobanClinicalMember_label_en-US" xlink:label="lab_cpix_IfetrobanClinicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ifetroban Clinical [Member]</link:label> <link:label id="lab_cpix_IfetrobanClinicalMember_documentation_en-US" xlink:label="lab_cpix_IfetrobanClinicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ifetroban Clinical</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_IfetrobanClinicalMember" xlink:href="cpix-20210930.xsd#cpix_IfetrobanClinicalMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_IfetrobanClinicalMember" xlink:to="lab_cpix_IfetrobanClinicalMember" xlink:type="arc" order="1"/> <link:label id="lab_cpix_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree_8e924892-a943-4c92-be31-aec73fcce9dc_terseLabel_en-US" xlink:label="lab_cpix_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After 2023</link:label> <link:label id="lab_cpix_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree_label_en-US" xlink:label="lab_cpix_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Three</link:label> <link:label id="lab_cpix_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree_documentation_en-US" xlink:label="lab_cpix_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Three</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree" xlink:href="cpix-20210930.xsd#cpix_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree" xlink:to="lab_cpix_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_ca73dfbc-dec0-4ce7-87e0-6edeaac0a643_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label> <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_902ce8d6-96ca-44c3-953f-f0dc920959c5_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs of products sold</link:label> <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_59b45991-fdac-4ec5-a269-3325f5bc3482_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from discontinued operations</link:label> <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_CostsAndExpenses_cf194dac-92a8-4022-a379-393e6a9a3959_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs and expenses</link:label> <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_StatementEquityComponentsAxis_75c770e2-4d64-4450-988a-7fd50929863a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label> <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_RestrictedStockMember_f20ccdaa-f327-411b-ac0a-8196c7ef3eff_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label> <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_cc024dd2-2d7d-4706-ac01-551833edacf6_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label> <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_2797d25c-a67e-4bbe-bfe8-23b9f9959e38_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label> <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/> <link:label id="lab_cpix_IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy_186dde54-7ee2-4127-b73f-e24067a294dd_negatedTerseLabel_en-US" xlink:label="lab_cpix_IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Cash Surrender Value Of Life Insurance Policy</link:label> <link:label id="lab_cpix_IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy_label_en-US" xlink:label="lab_cpix_IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Cash Surrender Value Of Life Insurance Policy</link:label> <link:label id="lab_cpix_IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy_documentation_en-US" xlink:label="lab_cpix_IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Cash Surrender Value Of Life Insurance Policy</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy" xlink:href="cpix-20210930.xsd#cpix_IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy" xlink:to="lab_cpix_IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_DebtInstrumentNameDomain_7fc27b9f-f7fc-4e5a-8f75-f8fef606c9dc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label> <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_82c55899-bef0-4440-b140-e9b8d8e58848_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings on line of credit</link:label> <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Lines of Credit</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/> <link:label id="lab_srt_MinimumMember_76f14be2-0c6c-4adb-a6aa-76ddaf7987e9_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label> <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label> <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_BalanceSheetLocationDomain_0724d942-bc2d-4049-8e62-6f0476b44fa8_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label> <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_e00ae53a-5f11-493d-a9da-e0160138de0a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from surrender of life insurance policies</link:label> <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_de881763-e3c9-45b4-8cfb-bde81b51bf1b_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of shares (in shares)</link:label> <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_0c385398-6e15-4cc4-88c3-47be1cc27ed9_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of shares (in shares)</link:label> <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_7de0ab09-7540-4fbf-8bb2-dc5c6a84e9d7_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label> <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_ae169b19-35ec-4b57-aeea-b5b1a31754be_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments on line of credit</link:label> <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_034fd878-7ca2-46eb-a4a7-c32f7ce86145_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease current liabilities</link:label> <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/> <link:label id="lab_cpix_AcetadoteMember_933bb8c8-b7e8-46c4-879b-d8b15932f474_terseLabel_en-US" xlink:label="lab_cpix_AcetadoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kristalose</link:label> <link:label id="lab_cpix_AcetadoteMember_label_en-US" xlink:label="lab_cpix_AcetadoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acetadote [Member]</link:label> <link:label id="lab_cpix_AcetadoteMember_documentation_en-US" xlink:label="lab_cpix_AcetadoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acetadote</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_AcetadoteMember" xlink:href="cpix-20210930.xsd#cpix_AcetadoteMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_AcetadoteMember" xlink:to="lab_cpix_AcetadoteMember" xlink:type="arc" order="1"/> <link:label id="lab_cpix_NumeratorAbstract_aaa0984d-2083-48f0-8d53-f43ad5f98271_verboseLabel_en-US" xlink:label="lab_cpix_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label> <link:label id="lab_cpix_NumeratorAbstract_label_en-US" xlink:label="lab_cpix_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator [Abstract]</link:label> <link:label id="lab_cpix_NumeratorAbstract_documentation_en-US" xlink:label="lab_cpix_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator.</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_NumeratorAbstract" xlink:href="cpix-20210930.xsd#cpix_NumeratorAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_NumeratorAbstract" xlink:to="lab_cpix_NumeratorAbstract" xlink:type="arc" order="1"/> <link:label id="lab_srt_RangeMember_29163441-182c-48a5-9789-6000af328134_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label> <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label> <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e4132c0b-77b3-4b85-a208-3c8d22c6694d_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label> <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_b85ea0dd-0e95-484d-8e66-6124b8c422d5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration</link:label> <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LineOfCreditMember_932cd9e8-e40e-4865-9e96-4c16c508bb04_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label> <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2d18257b-e985-44b9-9df3-3227bb78a7b3_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (income) loss at subsidiary attributable to noncontrolling interests</link:label> <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c2ca5d23-d16c-4be3-aec1-dc2aaf070515_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label> <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_6026a0e6-e2a3-4199-a380-3c77e08fb91b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label> <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/> <link:label id="lab_dei_EntityInteractiveDataCurrent_bd9e2a9e-a621-4fb7-a454-401a337625e0_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label> <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_RevenuesAbstract_8cea7edc-4721-417d-9dc0-36829c8aa653_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues</link:label> <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/> <link:label id="lab_dei_SecurityExchangeName_3253751f-36ed-4e40-8817-0b5c74cccb4e_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label> <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_04520593-6701-4e1a-ab0c-980acd2d50e1_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label> <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_871941ac-f9ba-4688-b304-e375d8ca0ea8_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHAREHOLDERS' EQUITY AND DEBT</link:label> <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_OperatingIncomeLoss_ca8e10b2-1b6c-46fc-bb17-9055bfa51eab_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label> <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LiabilitiesCurrent_1b228318-748c-46d8-96c9-7b897fd3928e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label> <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/> <link:label id="lab_dei_EntityRegistrantName_0def3d0d-f004-4221-bae9-e52d6dd30926_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label> <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_SubsequentEventTypeDomain_7cc02fa3-82cd-428f-85f8-7e0222bf6664_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label> <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_80a4f38b-7154-43e1-b1aa-71eda255297a_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label> <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_76babdfb-6f70-4f96-afd6-cb349e55bd85_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label> <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/> <link:label id="lab_cpix_ProductsAbstract_577cfc08-f57f-44d0-962e-70b47c8e5961_verboseLabel_en-US" xlink:label="lab_cpix_ProductsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products:</link:label> <link:label id="lab_cpix_ProductsAbstract_label_en-US" xlink:label="lab_cpix_ProductsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products [Abstract]</link:label> <link:label id="lab_cpix_ProductsAbstract_documentation_en-US" xlink:label="lab_cpix_ProductsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products.</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_ProductsAbstract" xlink:href="cpix-20210930.xsd#cpix_ProductsAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_ProductsAbstract" xlink:to="lab_cpix_ProductsAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_78efe3c5-bf5f-4d20-bf71-4ecff3496ea6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of remaining lease payments, percent</link:label> <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_VariableRateDomain_d9cc8467-ced2-4518-a965-74efa932c96f_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label> <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_7e8d0cc7-a455-45c7-b9df-050c0f4a7411_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities from continuing operations</link:label> <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_VariableRateAxis_9e0b0331-76a5-48f2-99be-16c179ca2c08_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label> <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2956d5e8-236e-4ebd-b1f4-d8eb68be6d8a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label> <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_CommitmentsAndContingencies_194ff133-87cb-4304-851c-74a6679db44a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label> <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_GrantMember_e464a8cd-1bd0-4f5f-99a9-7deee6df99ec_terseLabel_en-US" xlink:label="lab_us-gaap_GrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant</link:label> <link:label id="lab_us-gaap_GrantMember_label_en-US" xlink:label="lab_us-gaap_GrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant [Member]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrantMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrantMember" xlink:to="lab_us-gaap_GrantMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_2d4081cd-ac25-49c5-840b-5e45400bbbcf_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common shares</link:label> <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_AssetsAbstract_0ee5fdfc-31d2-4fc4-a90c-2071865f7de7_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label> <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8f02c089-5cd5-4372-8702-4d01626d8868_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock awards, vesting period</link:label> <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8d67fdeb-9d79-4305-b19e-9d9b7e23e14a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration included in operating expenses</link:label> <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2780d72f-a690-4a3a-92d2-8f0bb1103a81_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label> <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/> <link:label id="lab_dei_EntityAddressStateOrProvince_5d662eaa-05b3-4a7f-ba94-92a5bd4a5d75_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label> <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_AccountsPayableCurrent_3ad2a2c3-f707-48b8-925a-72eafec43ae8_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label> <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_SubleaseIncome_5fb414be-e4fd-4f6a-90b0-6d958478338a_terseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income</link:label> <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubleaseIncome"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/> <link:label id="lab_cpix_VIBATIVMember_0c30a938-8a43-4b66-ad4f-445a9ad71dff_terseLabel_en-US" xlink:label="lab_cpix_VIBATIVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vaprisol</link:label> <link:label id="lab_cpix_VIBATIVMember_label_en-US" xlink:label="lab_cpix_VIBATIVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VIBATIV [Member]</link:label> <link:label id="lab_cpix_VIBATIVMember_documentation_en-US" xlink:label="lab_cpix_VIBATIVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VIBATIV</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_VIBATIVMember" xlink:href="cpix-20210930.xsd#cpix_VIBATIVMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_VIBATIVMember" xlink:to="lab_cpix_VIBATIVMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_c0e8db43-8229-4ea3-9373-5a8be6ebf61d_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings (deficit)</link:label> <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/> <link:label id="lab_cpix_ProceedsFromSaleOfIntangibleAssetsInstallmentPayment_388ff33f-2455-4e6f-8bc7-547888fe53ca_terseLabel_en-US" xlink:label="lab_cpix_ProceedsFromSaleOfIntangibleAssetsInstallmentPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial consideration received in exchange for product license rights, installment payments</link:label> <link:label id="lab_cpix_ProceedsFromSaleOfIntangibleAssetsInstallmentPayment_label_en-US" xlink:label="lab_cpix_ProceedsFromSaleOfIntangibleAssetsInstallmentPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Intangible Assets, Installment Payment</link:label> <link:label id="lab_cpix_ProceedsFromSaleOfIntangibleAssetsInstallmentPayment_documentation_en-US" xlink:label="lab_cpix_ProceedsFromSaleOfIntangibleAssetsInstallmentPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Intangible Assets, Installment Payment</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_ProceedsFromSaleOfIntangibleAssetsInstallmentPayment" xlink:href="cpix-20210930.xsd#cpix_ProceedsFromSaleOfIntangibleAssetsInstallmentPayment"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_ProceedsFromSaleOfIntangibleAssetsInstallmentPayment" xlink:to="lab_cpix_ProceedsFromSaleOfIntangibleAssetsInstallmentPayment" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_9c6f561e-2381-4f60-85fa-b95dbc4c3e5c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label> <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/> <link:label id="lab_dei_EntityIncorporationStateCountryCode_8f0141da-d70e-448e-95f4-2e16634382c7_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label> <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_499b7bbb-86a7-46e4-b1d4-25f74007fad4_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label> <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_InventoryFinishedGoods_8f7493b6-8c21-42c1-bed8-44d208ba0f13_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label> <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9c1148e8-bbbf-4268-b9b3-59a7afc85052_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label> <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/> <link:label id="lab_cpix_DenominatorAbstract_6dd54e52-1e80-4dd5-bbd2-d9292db52182_verboseLabel_en-US" xlink:label="lab_cpix_DenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label> <link:label id="lab_cpix_DenominatorAbstract_label_en-US" xlink:label="lab_cpix_DenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator [Abstract]</link:label> <link:label id="lab_cpix_DenominatorAbstract_documentation_en-US" xlink:label="lab_cpix_DenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator.</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_DenominatorAbstract" xlink:href="cpix-20210930.xsd#cpix_DenominatorAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_DenominatorAbstract" xlink:to="lab_cpix_DenominatorAbstract" xlink:type="arc" order="1"/> <link:label id="lab_cpix_FifthAmendmentMember_db5d7000-7dc4-4192-ab57-6e26c21d6855_terseLabel_en-US" xlink:label="lab_cpix_FifthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fifth Amendment</link:label> <link:label id="lab_cpix_FifthAmendmentMember_label_en-US" xlink:label="lab_cpix_FifthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fifth Amendment [Member]</link:label> <link:label id="lab_cpix_FifthAmendmentMember_documentation_en-US" xlink:label="lab_cpix_FifthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fifth Amendment</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_FifthAmendmentMember" xlink:href="cpix-20210930.xsd#cpix_FifthAmendmentMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_FifthAmendmentMember" xlink:to="lab_cpix_FifthAmendmentMember" xlink:type="arc" order="1"/> <link:label id="lab_cpix_ClinigenHealthcareLimitedMember_d4521e68-1558-4ba1-983a-e14d277ee585_terseLabel_en-US" xlink:label="lab_cpix_ClinigenHealthcareLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinigen</link:label> <link:label id="lab_cpix_ClinigenHealthcareLimitedMember_label_en-US" xlink:label="lab_cpix_ClinigenHealthcareLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinigen Healthcare Limited [Member]</link:label> <link:label id="lab_cpix_ClinigenHealthcareLimitedMember_documentation_en-US" xlink:label="lab_cpix_ClinigenHealthcareLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinigen Healthcare Limited</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_ClinigenHealthcareLimitedMember" xlink:href="cpix-20210930.xsd#cpix_ClinigenHealthcareLimitedMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_ClinigenHealthcareLimitedMember" xlink:to="lab_cpix_ClinigenHealthcareLimitedMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2f0508eb-0369-4b0b-887e-e1570b32b80d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label> <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LossContingencyAccrualRollForward_8d565fed-ddc7-4cee-bf13-5502bc15466d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual [Roll Forward]</link:label> <link:label id="lab_us-gaap_LossContingencyAccrualRollForward_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual [Roll Forward]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualRollForward"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward" xlink:to="lab_us-gaap_LossContingencyAccrualRollForward" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_bd876098-12f8-4dc0-bc49-f590db8fe2f2_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity:</link:label> <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/> <link:label id="lab_dei_EntityAddressPostalZipCode_2cf58d3b-73da-418e-ae8a-41f1da3f4831_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label> <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/> <link:label id="lab_srt_OfficeBuildingMember_0be6bd85-529d-47f0-9209-93f2a4f85ac8_terseLabel_en-US" xlink:label="lab_srt_OfficeBuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wet Laboratory and Office Space</link:label> <link:label id="lab_srt_OfficeBuildingMember_label_en-US" xlink:label="lab_srt_OfficeBuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Building [Member]</link:label> <link:loc xlink:type="locator" xlink:label="loc_srt_OfficeBuildingMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OfficeBuildingMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OfficeBuildingMember" xlink:to="lab_srt_OfficeBuildingMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_fc38147a-1ece-40ab-b6f6-2bbf76a4aff3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per share attributable to common shareholders - Continuing operations - diluted (in dollars per share)</link:label> <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_Goodwill_29a9c681-c184-42b4-9079-c5d5a3ab9909_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label> <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets_ec570636-5157-4b18-86f4-2454f8a12347_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial consideration received in exchange for product license rights</link:label> <link:label id="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Intangible Assets</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:to="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_479010e3-6255-4b58-bd81-7c2ee7b66cda_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per share attributable to common shareholders - Discontinued operations - diluted (in dollars per share)</link:label> <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_BuildingMember_db7f47ee-7b0d-41de-9304-1f152b916967_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Space</link:label> <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/> <link:label id="lab_dei_DocumentTransitionReport_47e98205-d595-49c1-b514-b0fc1f88faa3_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label> <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/> <link:label id="lab_srt_TitleOfIndividualAxis_d5511c93-44b3-499f-8846-37e213b4af11_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label> <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label> <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_011a541b-c545-4bac-8c67-d9814fd60df5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible note</link:label> <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/> <link:label id="lab_cpix_LeaseLiability_29470c5d-3f12-46f1-a710-924280a09a27_terseLabel_en-US" xlink:label="lab_cpix_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label> <link:label id="lab_cpix_LeaseLiability_label_en-US" xlink:label="lab_cpix_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label> <link:label id="lab_cpix_LeaseLiability_documentation_en-US" xlink:label="lab_cpix_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_LeaseLiability" xlink:href="cpix-20210930.xsd#cpix_LeaseLiability"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_LeaseLiability" xlink:to="lab_cpix_LeaseLiability" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_OtherAssetsCurrent_ca085ba4-f858-4f35-b0de-fb41296b034a_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other current assets</link:label> <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/> <link:label id="lab_cpix_OtherProductsMember_87455a0e-6fb9-42f7-80fa-68ecfc487f4c_terseLabel_en-US" xlink:label="lab_cpix_OtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenue</link:label> <link:label id="lab_cpix_OtherProductsMember_label_en-US" xlink:label="lab_cpix_OtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products [Member]</link:label> <link:label id="lab_cpix_OtherProductsMember_documentation_en-US" xlink:label="lab_cpix_OtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_OtherProductsMember" xlink:href="cpix-20210930.xsd#cpix_OtherProductsMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_OtherProductsMember" xlink:to="lab_cpix_OtherProductsMember" xlink:type="arc" order="1"/> <link:label id="lab_dei_DocumentQuarterlyReport_35198936-37d3-4483-8844-459b5a79fecb_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label> <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_InventoryNet_ae3792e2-c631-4387-8e9a-e086e8681833_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label> <link:label id="lab_us-gaap_InventoryNet_4215c038-be8d-4958-acbc-e3fa1409bd00_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories classified as current</link:label> <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8ef24e24-1f0a-441c-81ac-3a9a7902c116_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues</link:label> <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8b35a748-7af9-4335-a0c6-60d41f586cd1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label> <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_InventoryLineItems_5e311987-f4a3-4651-87f2-c6e39bb6bd40_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label> <link:label id="lab_us-gaap_InventoryLineItems_label_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLineItems"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLineItems" xlink:to="lab_us-gaap_InventoryLineItems" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_8c85971e-a199-4f1a-ab5f-6de319bfc1d0_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label> <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_c21a0324-ce5f-4b94-ad50-638643793965_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest, Total</link:label> <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_a0d22e60-1e7c-42bd-a4ea-326d56868c8d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) from continuing operations</link:label> <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/> <link:label id="lab_cpix_VaprisolMember_c9c862c1-56ff-4dff-855b-0ea2131d4a0d_terseLabel_en-US" xlink:label="lab_cpix_VaprisolMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acetadote</link:label> <link:label id="lab_cpix_VaprisolMember_label_en-US" xlink:label="lab_cpix_VaprisolMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vaprisol [Member]</link:label> <link:label id="lab_cpix_VaprisolMember_documentation_en-US" xlink:label="lab_cpix_VaprisolMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vaprisol</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_VaprisolMember" xlink:href="cpix-20210930.xsd#cpix_VaprisolMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_VaprisolMember" xlink:to="lab_cpix_VaprisolMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_da4fa6dd-8bb1-4616-95c9-7a4ec23b1c15_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per share attributable to common shareholders - Discontinued operations - basic (in dollars per share)</link:label> <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_BusinessAcquisitionAxis_41786e5c-8e2e-4d69-ae25-8913442822f3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label> <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/> <link:label id="lab_cpix_ShareholdersEquityTextualAbstract_0df057f4-e969-4b18-b174-2debcbdab9c3_verboseLabel_en-US" xlink:label="lab_cpix_ShareholdersEquityTextualAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity (Textual) [Abstract]</link:label> <link:label id="lab_cpix_ShareholdersEquityTextualAbstract_label_en-US" xlink:label="lab_cpix_ShareholdersEquityTextualAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders Equity (Textual) [Abstract]</link:label> <link:label id="lab_cpix_ShareholdersEquityTextualAbstract_documentation_en-US" xlink:label="lab_cpix_ShareholdersEquityTextualAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders Equity.</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_ShareholdersEquityTextualAbstract" xlink:href="cpix-20210930.xsd#cpix_ShareholdersEquityTextualAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_ShareholdersEquityTextualAbstract" xlink:to="lab_cpix_ShareholdersEquityTextualAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_PublicUtilitiesInventoryAxis_fc48ad6b-a3e7-4e51-9e8a-0a1fd1871f3c_terseLabel_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Axis]</link:label> <link:label id="lab_us-gaap_PublicUtilitiesInventoryAxis_label_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Axis]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PublicUtilitiesInventoryAxis"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis" xlink:to="lab_us-gaap_PublicUtilitiesInventoryAxis" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_StatementLineItems_5f1d2149-001e-446a-81ca-d157736b5ead_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label> <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_f3eea710-2a1b-4013-9bae-79d29ca7802e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested restricted shares (in shares)</link:label> <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_CreditFacilityDomain_1ba101f8-38d5-4e66-b961-0185c06cf471_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label> <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d2d0e05f-0175-4841-9431-bb263e56d795_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">- diluted (in shares)</link:label> <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cb3b2c63-a2e1-47a6-8111-0390a4c05cd8_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares outstanding – diluted (in shares)</link:label> <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_EarningsPerShareBasic_cfed52b7-113b-424f-bd21-ab95c6b0e930_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per share attributable to common shareholders - basic (in dollars per share)</link:label> <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_c5ffd64a-98b6-432d-8e0d-a4cf6ae7d5b7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on forgiveness of debt</link:label> <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_NumberOfOperatingSegments_89510c6b-fb33-443d-92e9-e8e1f510c33c_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label> <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/> <link:label id="lab_dei_EntityFileNumber_cc029bc6-ab88-4096-8b26-d5db26edeb24_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label> <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_33cf3bc7-a2c9-47d6-ad32-af45a43963ac_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label> <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e98adeb8-bf70-4ab4-9b8a-79ccab7f208a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term</link:label> <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_InventoryCurrentTable_213e8445-5319-4962-9e77-084c80a447c9_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label> <link:label id="lab_us-gaap_InventoryCurrentTable_label_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryCurrentTable"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryCurrentTable" xlink:to="lab_us-gaap_InventoryCurrentTable" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_StatementTable_f66c38f3-3aaf-4a5d-a1a7-fe90627dac85_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label> <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_SellingAndMarketingExpense_126fb9c2-7ff2-48f7-b1b8-cce378809263_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and marketing</link:label> <link:label id="lab_us-gaap_SellingAndMarketingExpense_0b6e8a4a-7489-4476-8cd5-227c49296b6a_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, Marketing and other</link:label> <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/> <link:label id="lab_cpix_LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity_d86e6bfa-978e-41a4-96a7-2c477b6f927e_terseLabel_en-US" xlink:label="lab_cpix_LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total capacity</link:label> <link:label id="lab_cpix_LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity_label_en-US" xlink:label="lab_cpix_LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity, Total Capacity</link:label> <link:label id="lab_cpix_LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity_documentation_en-US" xlink:label="lab_cpix_LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity, Total Capacity</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity" xlink:href="cpix-20210930.xsd#cpix_LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity" xlink:to="lab_cpix_LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity" xlink:type="arc" order="1"/> <link:label id="lab_srt_RangeAxis_9a053f9f-f28b-4f3e-a29e-1e344d80163c_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label> <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label> <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/> <link:label id="lab_cpix_IncentiveStockOptionsMember_bbbabc3e-4bfd-4d13-97d6-6e8e666e9464_terseLabel_en-US" xlink:label="lab_cpix_IncentiveStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Stock Options</link:label> <link:label id="lab_cpix_IncentiveStockOptionsMember_label_en-US" xlink:label="lab_cpix_IncentiveStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Stock Options [Member]</link:label> <link:label id="lab_cpix_IncentiveStockOptionsMember_documentation_en-US" xlink:label="lab_cpix_IncentiveStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Stock Options</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_IncentiveStockOptionsMember" xlink:href="cpix-20210930.xsd#cpix_IncentiveStockOptionsMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_IncentiveStockOptionsMember" xlink:to="lab_cpix_IncentiveStockOptionsMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_CommonStockNoParValue_f88d40a1-3671-4c59-b0f8-e2c12659a1d7_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockNoParValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label> <link:label id="lab_us-gaap_CommonStockNoParValue_label_en-US" xlink:label="lab_us-gaap_CommonStockNoParValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, No Par Value</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNoParValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockNoParValue"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockNoParValue" xlink:to="lab_us-gaap_CommonStockNoParValue" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_CreditFacilityAxis_6bbab2a5-c081-44d3-97b5-8cf3a2e8cc72_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label> <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_1f00f27b-75c0-42c6-af3d-353a4fa6b743_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations</link:label> <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_efe1153e-f2db-4b6e-8d95-0069fa0f6f9d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Dissolution Payments</link:label> <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_16f76502-81df-4faf-8ef4-a27d5d6de634_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label> <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_0557589b-b9d7-425c-a3a3-f660a4df3408_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future minimum sublease income under noncancelable operating subleases</link:label> <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payments to be Received</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_InventoryValuationReserves_790c3166-66cc-4ea3-ac52-06912fc900c2_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Obsolescence and discontinuance losses</link:label> <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/> <link:label id="lab_cpix_OmeclamoxPakMember_88b68286-41ed-48c0-be03-fdaa4361e43f_terseLabel_en-US" xlink:label="lab_cpix_OmeclamoxPakMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vibativ</link:label> <link:label id="lab_cpix_OmeclamoxPakMember_label_en-US" xlink:label="lab_cpix_OmeclamoxPakMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Omeclamox-Pak [Member]</link:label> <link:label id="lab_cpix_OmeclamoxPakMember_documentation_en-US" xlink:label="lab_cpix_OmeclamoxPakMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Omeclamox-Pak</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_OmeclamoxPakMember" xlink:href="cpix-20210930.xsd#cpix_OmeclamoxPakMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_OmeclamoxPakMember" xlink:to="lab_cpix_OmeclamoxPakMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_BalanceSheetLocationAxis_753f970b-cf92-42f1-b10b-1aa7071d06f6_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label> <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/> <link:label id="lab_srt_CounterpartyNameAxis_01e7975c-887c-4e32-8413-f12209ee87f7_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label> <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label> <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_CommonStockValue_c2186f9f-5606-487d-90b3-e1de896d6ff8_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock—no par value; 100,000,000 shares authorized; 15,555,865 and 15,723,075 shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively</link:label> <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/> <link:label id="lab_dei_DocumentFiscalYearFocus_974abd40-3b52-46d2-bb40-ff8d6c7d4bd8_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label> <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/> <link:label id="lab_dei_EntitySmallBusiness_581e7106-c4bd-48e7-9d0e-7332600be996_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label> <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_23abc5cd-f288-4a26-b2e9-fe0dd0e5657c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity of Lease Liabilities at September 30, 2021</link:label> <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_64a498df-d457-4bf3-b66d-59cc46f97099_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label> <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/> <link:label id="lab_dei_EntityCurrentReportingStatus_6222381c-aafd-45b0-8d00-19b3a3eede08_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label> <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/> <link:label id="lab_dei_AmendmentFlag_27a2b547-750c-4944-89a9-4d66282b5b64_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label> <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_f474eade-6414-4f83-a24b-954e49e53a39_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of numerator and denominator</link:label> <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_PaymentsForRoyalties_32b66644-bd13-4d6b-9e00-ac9d0dffe640_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payment of royalty during the period</link:label> <link:label id="lab_us-gaap_PaymentsForRoyalties_label_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Royalties</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRoyalties"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRoyalties" xlink:to="lab_us-gaap_PaymentsForRoyalties" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_fbcba11d-525b-4e51-bb21-7c2ce2a8b792_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation (in shares)</link:label> <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d032a8bb-14c4-4387-9cfd-674232a4718d_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares outstanding</link:label> <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_fa250b4d-859a-43de-aa0b-41c92e933c09_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label> <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_MinorityInterest_15c9bcf1-c1b0-45d0-8481-2cc92d2038e0_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label> <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_OtherIncome_62fcabf4-dcc0-468c-a4a2-4d74ae3852e8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income</link:label> <link:label id="lab_us-gaap_OtherIncome_label_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncome" xlink:to="lab_us-gaap_OtherIncome" xlink:type="arc" order="1"/> <link:label id="lab_cpix_TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived_c3f4abd5-bfd8-46e3-a0c7-edb264cb63e7_terseLabel_en-US" xlink:label="lab_cpix_TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate amount</link:label> <link:label id="lab_cpix_TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived_label_en-US" xlink:label="lab_cpix_TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Coronavirus Aid, Relief, and Economic Security Act, Loan Proceeds Received</link:label> <link:label id="lab_cpix_TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived_documentation_en-US" xlink:label="lab_cpix_TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Coronavirus Aid, Relief, and Economic Security Act, Loan Proceeds Received</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived" xlink:href="cpix-20210930.xsd#cpix_TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived" xlink:to="lab_cpix_TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_8b54bad9-4bc8-4992-9237-288d26785db0_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COLLABORATIVE AGREEMENTS</link:label> <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ed62aaa9-66c4-4bf0-b522-d8bd20a6a283_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label> <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_CommonStockSharesIssued_b69d3bfc-0892-4865-b9e2-86aab2a2a7a6_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label> <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_28a66349-4256-4a05-9343-4b0d751f404c_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label> <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/> <link:label id="lab_cpix_RediTrexMember_ea39a773-977d-4589-8635-f829d585bc85_terseLabel_en-US" xlink:label="lab_cpix_RediTrexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RediTrex</link:label> <link:label id="lab_cpix_RediTrexMember_label_en-US" xlink:label="lab_cpix_RediTrexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RediTrex [Member]</link:label> <link:label id="lab_cpix_RediTrexMember_documentation_en-US" xlink:label="lab_cpix_RediTrexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RediTrex</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_RediTrexMember" xlink:href="cpix-20210930.xsd#cpix_RediTrexMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_RediTrexMember" xlink:to="lab_cpix_RediTrexMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_7e354796-622f-421c-b64a-a4a17bb4be67_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label> <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_OperatingLeaseLiability_6cf2f345-fbb0-4021-8928-4aab3e4a981d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label> <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_72b38963-a29b-478f-9dc4-78925c1a54f9_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label> <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/> <link:label id="lab_dei_EntityCentralIndexKey_5702aadc-db1e-4f1c-8b5c-fa0c7c2eb191_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label> <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_734c4912-f826-49d8-810c-b72bbe62f5e9_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label> <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_StockholdersEquity_a95036f7-7e62-480b-a7e1-48528b67a884_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders’ equity</link:label> <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/> <link:label id="lab_cpix_TieredRoyaltyPaymentsPercentage_452914e2-5636-44e4-bb03-5b6852fb5f79_terseLabel_en-US" xlink:label="lab_cpix_TieredRoyaltyPaymentsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of tiered royalty payments (up to)</link:label> <link:label id="lab_cpix_TieredRoyaltyPaymentsPercentage_label_en-US" xlink:label="lab_cpix_TieredRoyaltyPaymentsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tiered Royalty Payments, Percentage</link:label> <link:label id="lab_cpix_TieredRoyaltyPaymentsPercentage_documentation_en-US" xlink:label="lab_cpix_TieredRoyaltyPaymentsPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tiered Royalty Payments, Percentage</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_TieredRoyaltyPaymentsPercentage" xlink:href="cpix-20210930.xsd#cpix_TieredRoyaltyPaymentsPercentage"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_TieredRoyaltyPaymentsPercentage" xlink:to="lab_cpix_TieredRoyaltyPaymentsPercentage" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_787956c0-989a-4f42-ab0b-8625ed858c7a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label> <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_627ded66-2b20-45bf-8720-4d27db773279_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label> <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_8176324e-e5d3-403d-b002-ad16d0abaaef_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label> <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/> <link:label id="lab_dei_EntityAddressCityOrTown_f2498cd1-de8f-4a96-b43a-8d22b62200bd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label> <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_f04e246e-dd53-4b66-9941-0e38e0a26f20_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to intangible assets</link:label> <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_c7ca7495-dd4f-4ad2-be6b-3f597acfcb7c_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label> <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7e035316-0a75-4965-8f3c-d15efb6b3b5c_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock available for purchase through restricted stock awards and options (in shares)</link:label> <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_7f28e411-a27a-4033-98cf-e84d7186a512_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label> <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/> <link:label id="lab_cpix_PinnacleBankMember_37236e05-8837-4980-b7a6-1bb51feeeb3c_terseLabel_en-US" xlink:label="lab_cpix_PinnacleBankMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pinnacle Bank</link:label> <link:label id="lab_cpix_PinnacleBankMember_label_en-US" xlink:label="lab_cpix_PinnacleBankMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pinnacle Bank [Member]</link:label> <link:label id="lab_cpix_PinnacleBankMember_documentation_en-US" xlink:label="lab_cpix_PinnacleBankMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pinnacle Bank</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_PinnacleBankMember" xlink:href="cpix-20210930.xsd#cpix_PinnacleBankMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_PinnacleBankMember" xlink:to="lab_cpix_PinnacleBankMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3b92cfad-eb68-4831-a810-ffd6e7025ab0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label> <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_dd58aa43-c0e0-41b6-b7c3-cb9386bfb8a1_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of other securities (in shares)</link:label> <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_EquityComponentDomain_e4778377-dc94-4b1f-8619-52427a54565b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label> <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_cc980832-3ecf-4e14-9aa9-5f8526027d9f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of net revenue</link:label> <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_c02e0115-3c5b-4caa-8b63-0a61890eb63f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested common stock, value</link:label> <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/> <link:label id="lab_dei_EntityCommonStockSharesOutstanding_9df3209b-ef22-4c70-a086-5f32ed13eb19_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label> <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/> <link:label id="lab_cpix_OtherLongTermObligationsExcludingCurrentPortion_e668ff77-257b-47d5-95c1-53ed3836143d_verboseLabel_en-US" xlink:label="lab_cpix_OtherLongTermObligationsExcludingCurrentPortion" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label> <link:label id="lab_cpix_OtherLongTermObligationsExcludingCurrentPortion_label_en-US" xlink:label="lab_cpix_OtherLongTermObligationsExcludingCurrentPortion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long Term Obligations, Excluding Current Portion</link:label> <link:label id="lab_cpix_OtherLongTermObligationsExcludingCurrentPortion_documentation_en-US" xlink:label="lab_cpix_OtherLongTermObligationsExcludingCurrentPortion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long Term Obligations, Excluding Current Portion</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_OtherLongTermObligationsExcludingCurrentPortion" xlink:href="cpix-20210930.xsd#cpix_OtherLongTermObligationsExcludingCurrentPortion"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_OtherLongTermObligationsExcludingCurrentPortion" xlink:to="lab_cpix_OtherLongTermObligationsExcludingCurrentPortion" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e84ae1de-2dbb-4daf-8133-7a58abc10328_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label> <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/> <link:label id="lab_cpix_KristaloseMember_28f4d89a-c15d-41d9-b246-3894a0fc9c09_terseLabel_en-US" xlink:label="lab_cpix_KristaloseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Caldolor</link:label> <link:label id="lab_cpix_KristaloseMember_label_en-US" xlink:label="lab_cpix_KristaloseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kristalose [Member]</link:label> <link:label id="lab_cpix_KristaloseMember_documentation_en-US" xlink:label="lab_cpix_KristaloseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kristalose</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_KristaloseMember" xlink:href="cpix-20210930.xsd#cpix_KristaloseMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_KristaloseMember" xlink:to="lab_cpix_KristaloseMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8048c023-ff10-4ca2-834a-df5a64db3fe6_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label> <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_3fbf62b6-edc2-4f6a-a45c-bc78a871ea46_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label> <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/> <link:label id="lab_dei_EntityTaxIdentificationNumber_4e8ca241-b7fa-466b-9e86-c25408db27c3_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label> <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_ceb28ef1-a50c-4722-a67b-08fba54503ce_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label> <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_c09cc14f-554e-4944-abe4-452878647dca_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label> <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_NetIncomeLoss_f5f788e8-64c4-4151-9f0e-60134d4d2801_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to common shareholders</link:label> <link:label id="lab_us-gaap_NetIncomeLoss_99abd81b-81c8-4b1f-9427-aeaae3b6db7d_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to common shareholders</link:label> <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LineOfCreditFacilityTable_dcad1441-9055-40a9-924f-8b7dcd84b56c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label> <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_955f9b93-9103-45fb-a044-f44937c7398c_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net changes in assets and liabilities affecting operating activities:</link:label> <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_45b500b7-58e4-4d1b-85e9-9a5eb44f34cc_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label> <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_964865b5-0c07-4ccc-aba7-31122dc9aa23_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label> <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_OtherAssetsNoncurrent_118fcbbb-6bc4-48b5-880c-53759a8adc33_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label> <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_2e49a2c9-5628-403e-9357-97ce4ade7986_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label> <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_f4151a42-98b4-4c9f-a9c9-6bb3b8eae40c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVENTORIES</link:label> <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/> <link:label id="lab_cpix_AssetsAndLiabilitiesLesseeTableTextBlock_846bef98-c898-48b7-97ba-5ebd041261fa_terseLabel_en-US" xlink:label="lab_cpix_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Position</link:label> <link:label id="lab_cpix_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_cpix_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities, Lessee [Table Text Block]</link:label> <link:label id="lab_cpix_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_cpix_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities, Lessee</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="cpix-20210930.xsd#cpix_AssetsAndLiabilitiesLesseeTableTextBlock"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_cpix_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_f898277b-1b5e-4c0d-ad20-9bded4577a39_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUES</link:label> <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_Assets_cdb82503-acbe-464b-8ade-fb5c39eca066_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label> <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LongtermDebtTypeAxis_bf7e6ff1-d7ca-4b6d-87cf-9bd05cbe78df_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label> <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_2ba3cf16-3699-401d-b9e0-415fee2936c0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consigned inventory</link:label> <link:label id="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_label_en-US" xlink:label="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:to="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_AssetsCurrent_0093c07b-6df3-424c-aa63-27e96a59dc91_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label> <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/> <link:label id="lab_dei_CurrentFiscalYearEndDate_157b5115-f2b5-4356-9962-509836b105c4_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label> <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_OperatingLossCarryforwards_3b552ea7-e388-4755-86ac-bbe858b59fbb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label> <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_EarningsPerShareAbstract_5c7f472a-87d5-4dce-8c51-56cc2e7ac5f8_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per share attributable to common shareholders</link:label> <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/> <link:label id="lab_dei_Security12bTitle_5ad20417-31f7-464c-b944-5e5274966e34_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label> <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_389394dd-e6f7-420b-84c0-dbe48e359d99_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations income</link:label> <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_472cddc5-0309-4aeb-8a3c-6a4b62ca08d9_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label> <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_SubsequentEventTypeAxis_88d20df3-958e-492d-988d-7726396c5e1b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label> <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_StockholdersEquityAbstract_c239c088-c75b-4f42-9f67-bd8e3a086884_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders’ equity:</link:label> <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/> <link:label id="lab_dei_DocumentFiscalPeriodFocus_3a2cf5a6-5a04-4b35-b04e-54db2d742d2d_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label> <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_InterestExpense_85e96250-22c4-4fa9-a820-df01471f2ebc_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label> <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_723c9a4f-ac0f-42de-a4dc-30a6d52a9f8c_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label> <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/> <link:label id="lab_cpix_ScheduleofRentExpenseandSubleaseIncomeTableTextBlock_300e36e1-2e37-406e-91bd-25a16b8587d3_terseLabel_en-US" xlink:label="lab_cpix_ScheduleofRentExpenseandSubleaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Rent Expense and Sublease Income</link:label> <link:label id="lab_cpix_ScheduleofRentExpenseandSubleaseIncomeTableTextBlock_label_en-US" xlink:label="lab_cpix_ScheduleofRentExpenseandSubleaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Rent Expense and Sublease Income [Table Text Block]</link:label> <link:label id="lab_cpix_ScheduleofRentExpenseandSubleaseIncomeTableTextBlock_documentation_en-US" xlink:label="lab_cpix_ScheduleofRentExpenseandSubleaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Rent Expense and Sublease Income [Table Text Block]</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_ScheduleofRentExpenseandSubleaseIncomeTableTextBlock" xlink:href="cpix-20210930.xsd#cpix_ScheduleofRentExpenseandSubleaseIncomeTableTextBlock"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_ScheduleofRentExpenseandSubleaseIncomeTableTextBlock" xlink:to="lab_cpix_ScheduleofRentExpenseandSubleaseIncomeTableTextBlock" xlink:type="arc" order="1"/> <link:label id="lab_srt_ProductOrServiceAxis_11c9b705-b2a3-407b-b731-9fc8613db225_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label> <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label> <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_Liabilities_7e5c542a-1085-486a-80ed-c9ed03da2dac_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label> <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_acf1393a-281a-4a2b-baee-ca5b97551eaf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label> <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_8c8982b7-34b0-407a-ab9d-665dc133b1ab_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label> <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_350c8871-fd1f-4ec9-9394-3622893f9962_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Interest</link:label> <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/> <link:label id="lab_dei_EntityFilerCategory_667f8d3d-d872-47f8-9147-f4429967ff50_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label> <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_CommonStockMember_6074a57f-12d0-4deb-9683-56bf1953bcbd_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label> <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/> <link:label id="lab_srt_ProductsAndServicesDomain_834d7af3-ffe2-43f8-9afc-04c6b51fe35d_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label> <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label> <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_cf059fdd-947d-4a92-bd8c-c32b58fb741b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label> <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_e9eb1be1-8a8f-4908-8071-c94861326816_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of subsidiary shares from noncontrolling interest</link:label> <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Redeemable Noncontrolling Interest</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_PublicUtilitiesInventoryTypeDomain_74c9d446-7d65-48a2-a8ee-48734df7c320_terseLabel_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Domain]</link:label> <link:label id="lab_us-gaap_PublicUtilitiesInventoryTypeDomain_label_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Domain]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_OperatingLeaseExpense_e5b06698-4ce9-4ef4-bd20-004b766ec9c1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent expense</link:label> <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_ConvertibleDebtMember_829ba49f-6d0a-49b0-b93a-1f0b7c3f6e0a_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label> <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_7bb1f357-e7aa-4c5e-a3b3-687ebb5276db_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label> <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities_ccccbeb9-5041-4ea4-a31e-9740c8c97bb2_negatedLabel_en-US" xlink:label="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in non-cash contingent consideration</link:label> <link:label id="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities_label_en-US" xlink:label="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess Tax Benefit from Share-based Compensation, Operating Activities</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xlink:to="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_4c759502-6053-4212-a375-c2d9ff0066d8_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials and work in process</link:label> <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_DebtInstrumentAxis_2e004447-bf76-4e62-89ad-37cf69b59a59_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label> <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_e0cc4439-0b79-48a9-be11-40081737af33_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate spread</link:label> <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_InventoryGross_5bca70dd-6014-4c11-9f2b-db921bf491f5_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label> <link:label id="lab_us-gaap_InventoryGross_label_en-US" xlink:label="lab_us-gaap_InventoryGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Gross</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryGross"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryGross" xlink:to="lab_us-gaap_InventoryGross" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dd9315fe-768f-4e11-a03b-1d69610d366a_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) from continuing operations to net cash provided by operating activities:</link:label> <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_3e342199-0521-4d51-ab27-d8e0202a9462_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per share attributable to common shareholders - Continuing operations - basic (in dollars per share)</link:label> <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f41eac8d-50e6-48e8-95ae-8bbde1361621_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label> <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_f74f781c-0801-4210-94a1-13a1a886c4ca_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADDITIONS AND RETURN OF PRODUCT RIGHTS</link:label> <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_CommonStockSharesOutstanding_72c5fce0-715a-486e-b07e-b94630c158da_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label> <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a13079af-7b72-4e72-a526-07d5afd9ffb3_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Beginning of Period (in shares)</link:label> <link:label id="lab_us-gaap_CommonStockSharesOutstanding_9c319f54-bc96-434f-8699-f06bcd1e6b7a_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, End of Period (in shares)</link:label> <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_c3ca7a72-edd8-44de-a947-f1f089b17a59_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturity of Lease Liabilities</link:label> <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_2270b6a2-1d6e-43b3-a6ed-0d71cc99980b_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label> <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_307a4a61-a132-4842-be56-82d52f7b1974_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">- basic (in shares)</link:label> <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c98eb447-b910-4e00-bb4b-7651cbb73059_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares outstanding – basic (in shares)</link:label> <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_78d60bd6-0a4d-40c9-955d-311d1b9f131d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable rate</link:label> <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5fc8fd6f-85b1-4e05-b553-6f4fda3b320b_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations before income taxes</link:label> <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_CostsAndExpensesAbstract_217e1296-6bbc-4278-a5c0-a55cf788925a_verboseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses:</link:label> <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_9075284b-544d-4680-b5ef-9b7e01633aa4_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial investment in joint ventures</link:label> <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_735c9824-8609-4598-b51d-0a8b6a669153_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label> <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_SubsequentEventMember_f38136b6-78d1-43a2-bc32-7831e2185b5e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label> <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_DomesticCountryMember_2d648eea-bd0e-49ee-87f7-61204c5f2205_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label> <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_CommonStockSharesAuthorized_011337ce-4e43-4806-8109-692ef37df91d_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label> <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/> <link:label id="lab_cpix_BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses_847bdad1-9c7a-4d8c-a9c4-813ed553fd8c_terseLabel_en-US" xlink:label="lab_cpix_BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration earned and accrued in operating expenses</link:label> <link:label id="lab_cpix_BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses_label_en-US" xlink:label="lab_cpix_BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Earned and Accrued in Operating Expenses</link:label> <link:label id="lab_cpix_BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses_documentation_en-US" xlink:label="lab_cpix_BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Earned and Accrued in Operating Expenses</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses" xlink:href="cpix-20210930.xsd#cpix_BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses" xlink:to="lab_cpix_BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses" xlink:type="arc" order="1"/> <link:label id="lab_cpix_MethotrexateMember_35b03d9d-a9fb-4116-a681-93eb5684b774_terseLabel_en-US" xlink:label="lab_cpix_MethotrexateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Methotrexate</link:label> <link:label id="lab_cpix_MethotrexateMember_label_en-US" xlink:label="lab_cpix_MethotrexateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Methotrexate [Member]</link:label> <link:label id="lab_cpix_MethotrexateMember_documentation_en-US" xlink:label="lab_cpix_MethotrexateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Methotrexate [Member]</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_MethotrexateMember" xlink:href="cpix-20210930.xsd#cpix_MethotrexateMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_MethotrexateMember" xlink:to="lab_cpix_MethotrexateMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d89f28a9-1c25-48a1-9089-f8966b08780c_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label> <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3f6321e6-14db-4fc8-b348-b5e6a0733b1c_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Beginning of Period</link:label> <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_594691ae-a5a6-4cab-bc14-9b99d9cc2ae5_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, End of Period</link:label> <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_b01b0015-0479-45c5-a66e-953576f6002b_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ORGANIZATION AND BASIS OF PRESENTATION</link:label> <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_2538648d-3d3f-4b88-9adb-2efd2a42c284_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability recorded</link:label> <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_505de6ae-d947-4964-b8c1-6dda926cb69c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (expense) benefit</link:label> <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d779209d-254a-4f0f-97e7-b0caa099a54a_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label> <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9b63a889-7a60-40f3-9b0d-441e727f3807_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label> <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/> <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_4e879178-8e8d-43ac-ba8a-9797f0ee9117_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Relationship to Entity [Domain]</link:label> <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label> <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_16199268-8b0a-4640-8c66-436a05aa8106_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease noncurrent liabilities</link:label> <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_EarningsPerShareDiluted_1240090f-1bdc-4d52-908b-7c633bc16826_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per share attributable to common shareholders - diluted (in dollars per share)</link:label> <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/> <link:label id="lab_dei_LocalPhoneNumber_1f04919e-8c17-4d51-9fa8-7e1745b6322f_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label> <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0223f264-0fc8-44f6-8754-317a3872d05b_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net intangible assets</link:label> <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_4a91b963-fdcf-42c2-af73-dadc7f651e3b_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment to acquire business upon closing</link:label> <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_9f911661-7a86-4dc9-a5f5-b5e60fc586f6_terseLabel_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations</link:label> <link:label id="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Operating Activities, Discontinued Operations</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:to="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_UseOfEstimates_8e14c0a8-52b2-4559-9424-3518a5ba3708_verboseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label> <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_AssetsCurrentAbstract_86323d48-24c8-4d73-8ed4-50e8d2fb071b_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label> <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_InvestmentIncomeInterest_13127d95-71ca-46d1-b69b-01b00fc754f3_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label> <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_672c9548-8914-44be-be5b-30e81f996ea0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label> <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/> <link:label id="lab_dei_EntityAddressAddressLine1_cf1ecb56-e0a5-45a2-a0f9-8cd01689b134_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label> <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/> <link:label id="lab_dei_EntityAddressAddressLine2_5ab4b95a-5302-45b5-970c-7d6e555894ac_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label> <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_208c3654-6896-44e2-a5c1-5ab56906304c_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares left to repurchase</link:label> <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_d8db75ed-c5b7-44f9-b55b-97cd68e22da2_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets and other assets</link:label> <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/> <link:label id="lab_dei_EntityEmergingGrowthCompany_f042ac14-da1c-41af-be7f-7adc6c63ff11_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label> <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/> <link:label id="lab_cpix_EquityAndDebtAbstract_label_en-US" xlink:label="lab_cpix_EquityAndDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity and Debt [Abstract]</link:label> <link:label id="lab_cpix_EquityAndDebtAbstract_documentation_en-US" xlink:label="lab_cpix_EquityAndDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity and Debt [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_EquityAndDebtAbstract" xlink:href="cpix-20210930.xsd#cpix_EquityAndDebtAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_EquityAndDebtAbstract" xlink:to="lab_cpix_EquityAndDebtAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_OtherPaymentsToAcquireBusinesses_6f099b64-1c7b-4475-985e-8733e660de80_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPaymentsToAcquireBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Payments to Acquire Businesses</link:label> <link:label id="lab_us-gaap_OtherPaymentsToAcquireBusinesses_label_en-US" xlink:label="lab_us-gaap_OtherPaymentsToAcquireBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Payments to Acquire Businesses</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPaymentsToAcquireBusinesses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPaymentsToAcquireBusinesses"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPaymentsToAcquireBusinesses" xlink:to="lab_us-gaap_OtherPaymentsToAcquireBusinesses" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LongTermLineOfCredit_217c3632-1526-4638-9605-71663238639f_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermLineOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving line of credit</link:label> <link:label id="lab_us-gaap_LongTermLineOfCredit_label_en-US" xlink:label="lab_us-gaap_LongTermLineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit, Noncurrent</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermLineOfCredit"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermLineOfCredit" xlink:to="lab_us-gaap_LongTermLineOfCredit" xlink:type="arc" order="1"/> <link:label id="lab_cpix_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount_3b2d8ef7-1149-49ad-a167-2f0464643434_terseLabel_en-US" xlink:label="lab_cpix_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase amount (up to)</link:label> <link:label id="lab_cpix_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount_label_en-US" xlink:label="lab_cpix_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity, Increase Amount</link:label> <link:label id="lab_cpix_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount_documentation_en-US" xlink:label="lab_cpix_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity, Increase Amount</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount" xlink:href="cpix-20210930.xsd#cpix_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount" xlink:to="lab_cpix_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9c9bcaa5-e6d9-45a2-bb88-7b1fe1a477a1_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit, maximum borrowing capacity</link:label> <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_AwardTypeAxis_4868713f-e24a-4a83-b90b-7853da6f36de_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label> <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/> <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_a06368eb-4775-48fc-8826-fc7df6922418_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label> <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label> <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_285e4a77-60d3-4482-9d72-6bce3782c149_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to property and equipment</link:label> <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/> <link:label id="lab_cpix_IncreaseDecreaseInCurrentOperatingLiabilities_323bdd80-9781-4e97-82fd-5d95c2dc2d50_verboseLabel_en-US" xlink:label="lab_cpix_IncreaseDecreaseInCurrentOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and other current liabilities</link:label> <link:label id="lab_cpix_IncreaseDecreaseInCurrentOperatingLiabilities_label_en-US" xlink:label="lab_cpix_IncreaseDecreaseInCurrentOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IncreaseDecreaseInCurrentOperatingLiabilities</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_IncreaseDecreaseInCurrentOperatingLiabilities" xlink:href="cpix-20210930.xsd#cpix_IncreaseDecreaseInCurrentOperatingLiabilities"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_IncreaseDecreaseInCurrentOperatingLiabilities" xlink:to="lab_cpix_IncreaseDecreaseInCurrentOperatingLiabilities" xlink:type="arc" order="1"/> <link:label id="lab_dei_CityAreaCode_0bac5b57-6a98-4755-9c3b-4e3996763336_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label> <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/> <link:label id="lab_srt_MaximumMember_2cf3ca75-43ce-41b4-9f50-6b09a3d6642e_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label> <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label> <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_94549b6d-975a-4014-9c43-e2cd5fa7b163_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash interest expense</link:label> <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_NoncontrollingInterestMember_c5d673f9-e10c-4112-a427-bcc94ec6afe2_verboseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label> <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_55f4da64-5a56-4846-b6d5-5ccab035469e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label> <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/> <link:label id="lab_dei_DocumentPeriodEndDate_b42afebc-2bf7-4d96-a070-a7a979757be5_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label> <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_205776a3-dcc9-493d-8bb9-5b06f3761d2d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional liability</link:label> <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_3fd89bf6-b24b-4774-85ad-50d4241e0291_periodStartLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label> <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_12c7bec0-5458-4829-8651-d46866019ee5_periodEndLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label> <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_RetainedEarningsMember_6b41d781-2a3d-47db-a0ed-6ebbed5accac_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label> <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_29ae0167-a02d-43fc-9060-7051bac97b85_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payment of contingent consideration</link:label> <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_6a064833-cb99-4852-af28-10527e15ff3e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label> <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_1c21148b-8706-41f9-a398-fe2c091fbccf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note receivable investment funding</link:label> <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/> <link:label id="lab_srt_DirectorMember_3a3d4089-0f5f-4671-b480-cb0578108ee8_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director</link:label> <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label> <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f91ec9fe-5eb2-447b-8624-0be96211903c_verboseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase outstanding common shares</link:label> <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_56862f30-5e72-476e-8cca-e0bc829db362_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label> <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_ProfitLoss_b97a80b4-4ccd-44fb-ad73-6eaf7c4ddeed_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label> <link:label id="lab_us-gaap_ProfitLoss_a87bffb9-93e9-40d1-80ed-c65f2925c0f0_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label> <link:label id="lab_us-gaap_ProfitLoss_04068c5b-b4f1-46b5-8892-a16cd6a60ed2_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label> <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d3cc080c-61a4-46eb-970b-7e5d6aa3047f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label> <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/> <link:label id="lab_dei_TradingSymbol_07a406bc-237b-416b-9cec-6699b39a1f7c_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label> <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_3d7a4ee2-4f5e-409c-9577-116a3be0abee_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label> <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_960c23ec-ed4c-41af-90e1-649e121ffb15_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit, unused capacity, commitment fee percentage</link:label> <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LongtermDebtTypeDomain_9476bb3f-7abe-4a1b-bc7f-1b29353fd34c_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label> <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_551797b4-0db6-45dd-9849-0e3a9a6c0b49_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common shares</link:label> <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_c47972b7-fb0b-402a-854b-3534748e497a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of shares, value</link:label> <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_ShareBasedCompensation_3d4f1449-7ae5-498f-ab6f-fdcaf7b6e972_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label> <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/> <link:label id="lab_cpix_CaldolorMember_134a520a-14a6-4cf4-9a2b-fd95b8a7773f_terseLabel_en-US" xlink:label="lab_cpix_CaldolorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Omeclamox-Pak</link:label> <link:label id="lab_cpix_CaldolorMember_label_en-US" xlink:label="lab_cpix_CaldolorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Caldolor [Member]</link:label> <link:label id="lab_cpix_CaldolorMember_documentation_en-US" xlink:label="lab_cpix_CaldolorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Caldolor</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_CaldolorMember" xlink:href="cpix-20210930.xsd#cpix_CaldolorMember"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_CaldolorMember" xlink:to="lab_cpix_CaldolorMember" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_InventoryNoncurrent_d6f1665d-623a-485b-bbf5-036a9476a272_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current inventories</link:label> <link:label id="lab_us-gaap_InventoryNoncurrent_2832f2c1-039c-4688-8d62-4d8e2a942115_negatedLabel_en-US" xlink:label="lab_us-gaap_InventoryNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Noncurrent</link:label> <link:label id="lab_us-gaap_InventoryNoncurrent_label_en-US" xlink:label="lab_us-gaap_InventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Noncurrent</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNoncurrent"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNoncurrent" xlink:to="lab_us-gaap_InventoryNoncurrent" xlink:type="arc" order="1"/> <link:label id="lab_cpix_WinHealthInvestmentSingaporeLtdDomain_1ba0964d-de37-4b05-a2f0-3f097078b38c_terseLabel_en-US" xlink:label="lab_cpix_WinHealthInvestmentSingaporeLtdDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WinHealth</link:label> <link:label id="lab_cpix_WinHealthInvestmentSingaporeLtdDomain_label_en-US" xlink:label="lab_cpix_WinHealthInvestmentSingaporeLtdDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WinHealth Investment (Singapore) Ltd [Domain]</link:label> <link:label id="lab_cpix_WinHealthInvestmentSingaporeLtdDomain_documentation_en-US" xlink:label="lab_cpix_WinHealthInvestmentSingaporeLtdDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WinHealth Investment (Singapore) Ltd</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_WinHealthInvestmentSingaporeLtdDomain" xlink:href="cpix-20210930.xsd#cpix_WinHealthInvestmentSingaporeLtdDomain"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_WinHealthInvestmentSingaporeLtdDomain" xlink:to="lab_cpix_WinHealthInvestmentSingaporeLtdDomain" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_EarningsPerShareTextBlock_864fb04f-df21-4edb-87ec-96118fbc2200_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS (LOSS) PER SHARE</link:label> <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/> <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract_06434ada-7380-46cf-96e6-8590b71c8f40_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label> <link:label id="lab_us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net, Items Net of Reserve Alternative [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract" xlink:to="lab_us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_99ebd9d1-895d-4622-a1bd-2f986c8a7b3b_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label> <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/> <link:label id="lab_dei_EntityShellCompany_ada52eea-fe3d-474d-be7c-9ecdbd9821c1_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label> <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/> <link:label id="lab_cpix_StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities_3aec3ae6-0286-4705-9553-d6074cbac219_terseLabel_en-US" xlink:label="lab_cpix_StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shelf Registration, sale of corporate securities (up to)</link:label> <link:label id="lab_cpix_StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities_label_en-US" xlink:label="lab_cpix_StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities</link:label> <link:loc xlink:type="locator" xlink:label="loc_cpix_StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities" xlink:href="cpix-20210930.xsd#cpix_StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cpix_StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities" xlink:to="lab_cpix_StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_69298c49-f1b9-4cce-a646-91a6cb3a7016_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label> <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_IncomeTaxContingencyTable_97129af1-f923-4cc7-9bfc-2b4c675383eb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label> <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_88e03e95-b182-43c2-9362-6f74f7ae9170_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Guidance</link:label> <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/> <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/> </link:labelLink> </link:linkbase> </XBRL> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-101.PRE <SEQUENCE>10 <FILENAME>cpix-20210930_pre.xml <DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT <TEXT> <XBRL> <?xml version="1.0" encoding="UTF-8"?> <!--XBRL Document Created with Wdesk from Workiva--> <!--Copyright 2021 Workiva--> <!--r:719f38f6-81ec-4e77-a876-c86386f0dd09,g:3c5f884f-ec0b-48db-97a2-96993ede30b3--> <link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/CoverPage" xlink:type="simple" xlink:href="cpix-20210930.xsd#CoverPage"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/CoverPage" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_767fc1c4-937c-48e9-bf82-adb4cb8171ce" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_DocumentType_767fc1c4-937c-48e9-bf82-adb4cb8171ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_5af611e3-8bbd-4052-9a61-9afa0afededa" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_DocumentQuarterlyReport_5af611e3-8bbd-4052-9a61-9afa0afededa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_f2af0356-c9c1-4b04-81c0-671d3af10137" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_DocumentPeriodEndDate_f2af0356-c9c1-4b04-81c0-671d3af10137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_ea12d151-9211-45f4-9fd4-e021878ea7ee" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_DocumentTransitionReport_ea12d151-9211-45f4-9fd4-e021878ea7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_66a80edd-38cf-436f-8e1d-b08729caff81" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_EntityFileNumber_66a80edd-38cf-436f-8e1d-b08729caff81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7c2487bc-3812-4f32-80a2-e98548dbc446" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/> <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_EntityRegistrantName_7c2487bc-3812-4f32-80a2-e98548dbc446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_87bca601-5ef8-46aa-89cb-32ded20a85c1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/> <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_EntityIncorporationStateCountryCode_87bca601-5ef8-46aa-89cb-32ded20a85c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_b83f941b-5e39-4a2d-aca0-c83b7e88a686" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/> <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_EntityTaxIdentificationNumber_b83f941b-5e39-4a2d-aca0-c83b7e88a686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_60b0f726-fb04-4bd7-a166-6c4041c2433a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/> <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_EntityAddressAddressLine1_60b0f726-fb04-4bd7-a166-6c4041c2433a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_343e35ed-2b94-4058-9c8b-9fb2b1807cfb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2"/> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_EntityAddressAddressLine2_343e35ed-2b94-4058-9c8b-9fb2b1807cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_9b7c82b8-6ec5-4e6e-b793-0a3efef089a3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/> <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_EntityAddressCityOrTown_9b7c82b8-6ec5-4e6e-b793-0a3efef089a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_70046838-485c-4afc-87af-25a3dd7db0c6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/> <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_EntityAddressStateOrProvince_70046838-485c-4afc-87af-25a3dd7db0c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_34c70c34-d6e9-4e2d-a381-c560789a6ec0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/> <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_EntityAddressPostalZipCode_34c70c34-d6e9-4e2d-a381-c560789a6ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e5355c8d-bf8d-4356-b157-f62dec2038d9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/> <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_CityAreaCode_e5355c8d-bf8d-4356-b157-f62dec2038d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_3ae34a21-7bda-4c2c-9a3d-13466df9b610" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/> <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_LocalPhoneNumber_3ae34a21-7bda-4c2c-9a3d-13466df9b610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ff175e12-5981-4d36-bf5c-f5a0871281d7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/> <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_Security12bTitle_ff175e12-5981-4d36-bf5c-f5a0871281d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_fc19c8f4-9603-47d2-af10-36e92925c9fa" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/> <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_TradingSymbol_fc19c8f4-9603-47d2-af10-36e92925c9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_570cae4a-bc73-4c6b-8ae0-c2c4de1428a7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/> <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_SecurityExchangeName_570cae4a-bc73-4c6b-8ae0-c2c4de1428a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_4b35b9d8-1ba8-4af0-b050-a90a8a696787" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/> <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_EntityCurrentReportingStatus_4b35b9d8-1ba8-4af0-b050-a90a8a696787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_e1a61dd7-c3c8-4b8c-80c8-d59732708fc4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_EntityInteractiveDataCurrent_e1a61dd7-c3c8-4b8c-80c8-d59732708fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_c592aa78-c078-4244-ae0a-544c6e648f67" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/> <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_EntityFilerCategory_c592aa78-c078-4244-ae0a-544c6e648f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_3f18086c-dd9b-4b2b-9466-51ca4e29e7ce" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/> <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_EntitySmallBusiness_3f18086c-dd9b-4b2b-9466-51ca4e29e7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ad268d6d-6c12-4951-9ede-648e419df4d6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/> <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_EntityEmergingGrowthCompany_ad268d6d-6c12-4951-9ede-648e419df4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_452e9e5d-3130-4aef-8947-fe13eb2740f1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/> <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_EntityShellCompany_452e9e5d-3130-4aef-8947-fe13eb2740f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_691b8e9f-0fbd-4d3e-a096-9f702fea5b79" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/> <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_691b8e9f-0fbd-4d3e-a096-9f702fea5b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_cc87a5aa-16b4-4a96-be38-b6196277767b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/> <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_DocumentFiscalYearFocus_cc87a5aa-16b4-4a96-be38-b6196277767b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_af286829-e724-408f-bc85-a4719d1cbccb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/> <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_DocumentFiscalPeriodFocus_af286829-e724-408f-bc85-a4719d1cbccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_46d78685-c3de-4e12-91f6-26b850a2faec" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/> <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_AmendmentFlag_46d78685-c3de-4e12-91f6-26b850a2faec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_a266276b-71ff-4388-ab47-c6ca7bd450d7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/> <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_EntityCentralIndexKey_a266276b-71ff-4388-ab47-c6ca7bd450d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_1eccfaab-8ff8-49c1-b8d4-5cdb585ce839" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec77c3b6-0b4c-46b2-bddf-8f659c32e585" xlink:to="loc_dei_CurrentFiscalYearEndDate_1eccfaab-8ff8-49c1-b8d4-5cdb585ce839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cpix-20210930.xsd#CondensedConsolidatedBalanceSheets"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ffe66e6e-0f52-4929-a4c1-2d8e7ebba50f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_892ecf04-a4d5-41b5-baa6-e8ab6d880d3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ffe66e6e-0f52-4929-a4c1-2d8e7ebba50f" xlink:to="loc_us-gaap_AssetsAbstract_892ecf04-a4d5-41b5-baa6-e8ab6d880d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_571b98b9-c605-4830-ace9-d3808da40a6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_892ecf04-a4d5-41b5-baa6-e8ab6d880d3b" xlink:to="loc_us-gaap_AssetsCurrentAbstract_571b98b9-c605-4830-ace9-d3808da40a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_57679b11-f7bc-4532-952a-ce77d3d59bfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_571b98b9-c605-4830-ace9-d3808da40a6c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_57679b11-f7bc-4532-952a-ce77d3d59bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_f31798e1-097c-47a2-984e-ba70c4de8c87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_571b98b9-c605-4830-ace9-d3808da40a6c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_f31798e1-097c-47a2-984e-ba70c4de8c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_07becde2-a4a1-4c3a-8b22-e20ec4c41a9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_571b98b9-c605-4830-ace9-d3808da40a6c" xlink:to="loc_us-gaap_InventoryNet_07becde2-a4a1-4c3a-8b22-e20ec4c41a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_06bbda03-f407-480b-8284-f9ae255c7d8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_571b98b9-c605-4830-ace9-d3808da40a6c" xlink:to="loc_us-gaap_OtherAssetsCurrent_06bbda03-f407-480b-8284-f9ae255c7d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9cd36b5d-776b-48ff-94a7-b26179c4d756" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_571b98b9-c605-4830-ace9-d3808da40a6c" xlink:to="loc_us-gaap_AssetsCurrent_9cd36b5d-776b-48ff-94a7-b26179c4d756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_6149ec1f-e60a-447e-83e1-ca63a3cfcc8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNoncurrent"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_892ecf04-a4d5-41b5-baa6-e8ab6d880d3b" xlink:to="loc_us-gaap_InventoryNoncurrent_6149ec1f-e60a-447e-83e1-ca63a3cfcc8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_cb49b72e-3833-4463-9054-85238d2f419c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_892ecf04-a4d5-41b5-baa6-e8ab6d880d3b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_cb49b72e-3833-4463-9054-85238d2f419c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_45b8de28-2fdf-443b-87de-087656f66870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_892ecf04-a4d5-41b5-baa6-e8ab6d880d3b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_45b8de28-2fdf-443b-87de-087656f66870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0db4b9af-9714-4607-b35a-bc6f195db5c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_892ecf04-a4d5-41b5-baa6-e8ab6d880d3b" xlink:to="loc_us-gaap_Goodwill_0db4b9af-9714-4607-b35a-bc6f195db5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_558f0fae-488a-48a4-8f2e-964357a7aac4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/> <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_892ecf04-a4d5-41b5-baa6-e8ab6d880d3b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_558f0fae-488a-48a4-8f2e-964357a7aac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_4862fe3c-8a94-4700-8d7c-57876d9b2a08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/> <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_892ecf04-a4d5-41b5-baa6-e8ab6d880d3b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_4862fe3c-8a94-4700-8d7c-57876d9b2a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ed80c8ea-4ca3-4bec-a421-f8a4fe0d89cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/> <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_892ecf04-a4d5-41b5-baa6-e8ab6d880d3b" xlink:to="loc_us-gaap_Assets_ed80c8ea-4ca3-4bec-a421-f8a4fe0d89cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aaf21e52-670c-4128-a958-0ecb72348703" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ffe66e6e-0f52-4929-a4c1-2d8e7ebba50f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aaf21e52-670c-4128-a958-0ecb72348703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_859badf4-f8a0-4329-b157-0c687ab700ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aaf21e52-670c-4128-a958-0ecb72348703" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_859badf4-f8a0-4329-b157-0c687ab700ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_1b0455ef-cd46-49e7-9808-41dce04c4c53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_859badf4-f8a0-4329-b157-0c687ab700ed" xlink:to="loc_us-gaap_AccountsPayableCurrent_1b0455ef-cd46-49e7-9808-41dce04c4c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8250df14-4c01-45bd-abd4-034f9329ae5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_859badf4-f8a0-4329-b157-0c687ab700ed" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8250df14-4c01-45bd-abd4-034f9329ae5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_9d7204a1-83ba-4245-b862-ac8bb61c299e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_859badf4-f8a0-4329-b157-0c687ab700ed" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_9d7204a1-83ba-4245-b862-ac8bb61c299e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0a21f21a-2f11-438a-b78b-9ef6e3e5d75f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_859badf4-f8a0-4329-b157-0c687ab700ed" xlink:to="loc_us-gaap_LiabilitiesCurrent_0a21f21a-2f11-438a-b78b-9ef6e3e5d75f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_67990b7d-e67b-480d-ae8d-ebf22c58a672" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermLineOfCredit"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aaf21e52-670c-4128-a958-0ecb72348703" xlink:to="loc_us-gaap_LongTermLineOfCredit_67990b7d-e67b-480d-ae8d-ebf22c58a672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_da227c5f-3d02-49c5-b923-8103da7ee81c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aaf21e52-670c-4128-a958-0ecb72348703" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_da227c5f-3d02-49c5-b923-8103da7ee81c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_OtherLongTermObligationsExcludingCurrentPortion_e7653d40-136b-4397-9131-4a0ccb711d3a" xlink:href="cpix-20210930.xsd#cpix_OtherLongTermObligationsExcludingCurrentPortion"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aaf21e52-670c-4128-a958-0ecb72348703" xlink:to="loc_cpix_OtherLongTermObligationsExcludingCurrentPortion_e7653d40-136b-4397-9131-4a0ccb711d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6cfd5b66-7030-4f77-a2d0-864b595f9c2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aaf21e52-670c-4128-a958-0ecb72348703" xlink:to="loc_us-gaap_Liabilities_6cfd5b66-7030-4f77-a2d0-864b595f9c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_7d650878-0416-4782-a75a-b5b84f1e68ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/> <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aaf21e52-670c-4128-a958-0ecb72348703" xlink:to="loc_us-gaap_CommitmentsAndContingencies_7d650878-0416-4782-a75a-b5b84f1e68ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5eb4e3a3-7b1a-4670-91fc-06b7488cfcaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/> <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aaf21e52-670c-4128-a958-0ecb72348703" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5eb4e3a3-7b1a-4670-91fc-06b7488cfcaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_e9d74649-c0cb-4aef-b24f-4d6de9c4ba96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5eb4e3a3-7b1a-4670-91fc-06b7488cfcaa" xlink:to="loc_us-gaap_StockholdersEquityAbstract_e9d74649-c0cb-4aef-b24f-4d6de9c4ba96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c3563566-badb-4809-9864-cd5fe9b79deb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e9d74649-c0cb-4aef-b24f-4d6de9c4ba96" xlink:to="loc_us-gaap_CommonStockValue_c3563566-badb-4809-9864-cd5fe9b79deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7ff49158-360b-4d6b-8283-307fb2e30ab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e9d74649-c0cb-4aef-b24f-4d6de9c4ba96" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7ff49158-360b-4d6b-8283-307fb2e30ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2b17e17d-c6d4-4195-9ee1-21b0f5c82d9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e9d74649-c0cb-4aef-b24f-4d6de9c4ba96" xlink:to="loc_us-gaap_StockholdersEquity_2b17e17d-c6d4-4195-9ee1-21b0f5c82d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_833211f3-34bd-46e2-a1e5-16f480bee880" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5eb4e3a3-7b1a-4670-91fc-06b7488cfcaa" xlink:to="loc_us-gaap_MinorityInterest_833211f3-34bd-46e2-a1e5-16f480bee880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_062692e4-deef-4252-94b9-cf21359314ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5eb4e3a3-7b1a-4670-91fc-06b7488cfcaa" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_062692e4-deef-4252-94b9-cf21359314ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_88010f5d-a973-4ec5-9ac1-dafb30e231c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/> <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aaf21e52-670c-4128-a958-0ecb72348703" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_88010f5d-a973-4ec5-9ac1-dafb30e231c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="cpix-20210930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_3661f40e-d655-494e-8ced-ac1809f45286" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNoParValue_fb033667-066d-4f2e-96c6-4a789810cedb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockNoParValue"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3661f40e-d655-494e-8ced-ac1809f45286" xlink:to="loc_us-gaap_CommonStockNoParValue_fb033667-066d-4f2e-96c6-4a789810cedb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_2e1f6b0f-508f-45f9-8e01-d1feaabd6c6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3661f40e-d655-494e-8ced-ac1809f45286" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_2e1f6b0f-508f-45f9-8e01-d1feaabd6c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_01bc9d98-e6da-4a6e-be17-d88027f6ec2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3661f40e-d655-494e-8ced-ac1809f45286" xlink:to="loc_us-gaap_CommonStockSharesIssued_01bc9d98-e6da-4a6e-be17-d88027f6ec2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_47fabfcc-02d1-4c2e-a748-34fbf6d3fe0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3661f40e-d655-494e-8ced-ac1809f45286" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_47fabfcc-02d1-4c2e-a748-34fbf6d3fe0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="cpix-20210930.xsd#CondensedConsolidatedStatementsofOperations"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_1fdd9377-64c7-47d2-9a44-c30c010757d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_99474948-f526-46e9-9f68-30e3eb05ca03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1fdd9377-64c7-47d2-9a44-c30c010757d1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_99474948-f526-46e9-9f68-30e3eb05ca03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_d10b269e-78e8-4a58-9465-f7bf9ad50f92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1fdd9377-64c7-47d2-9a44-c30c010757d1" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_d10b269e-78e8-4a58-9465-f7bf9ad50f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_c72dd1e3-964f-4ff3-afc4-766a1eb81a5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d10b269e-78e8-4a58-9465-f7bf9ad50f92" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_c72dd1e3-964f-4ff3-afc4-766a1eb81a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_201b65f7-187a-4152-9383-77f749bf68b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d10b269e-78e8-4a58-9465-f7bf9ad50f92" xlink:to="loc_us-gaap_SellingAndMarketingExpense_201b65f7-187a-4152-9383-77f749bf68b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_34d87d3c-cdb8-4922-8520-693903d8eb33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d10b269e-78e8-4a58-9465-f7bf9ad50f92" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_34d87d3c-cdb8-4922-8520-693903d8eb33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_160b52e5-46fa-4155-99a4-74bf2eec6b65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d10b269e-78e8-4a58-9465-f7bf9ad50f92" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_160b52e5-46fa-4155-99a4-74bf2eec6b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_f8940f0e-c2b0-47cc-aaf7-58fd11a65b35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d10b269e-78e8-4a58-9465-f7bf9ad50f92" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_f8940f0e-c2b0-47cc-aaf7-58fd11a65b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_69033937-7a5d-41b9-b290-8965675f8b98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/> <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d10b269e-78e8-4a58-9465-f7bf9ad50f92" xlink:to="loc_us-gaap_CostsAndExpenses_69033937-7a5d-41b9-b290-8965675f8b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_de92a41f-aa67-4cc5-be0a-93555b7a083b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/> <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d10b269e-78e8-4a58-9465-f7bf9ad50f92" xlink:to="loc_us-gaap_OperatingIncomeLoss_de92a41f-aa67-4cc5-be0a-93555b7a083b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_9328ed96-381b-464a-b9cc-a432a2c97d84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1fdd9377-64c7-47d2-9a44-c30c010757d1" xlink:to="loc_us-gaap_InvestmentIncomeInterest_9328ed96-381b-464a-b9cc-a432a2c97d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_679076d1-bef2-4a45-a136-cd9459d7bffc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1fdd9377-64c7-47d2-9a44-c30c010757d1" xlink:to="loc_us-gaap_OtherIncome_679076d1-bef2-4a45-a136-cd9459d7bffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_7eb9064b-34b9-4dc9-87d7-2633c719c352" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1fdd9377-64c7-47d2-9a44-c30c010757d1" xlink:to="loc_us-gaap_InterestExpense_7eb9064b-34b9-4dc9-87d7-2633c719c352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_90b2c91b-6591-4449-a9cc-aa82209cb625" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/> <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1fdd9377-64c7-47d2-9a44-c30c010757d1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_90b2c91b-6591-4449-a9cc-aa82209cb625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_beefc4bc-fcf0-44b0-aa11-ba03e9647061" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/> <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1fdd9377-64c7-47d2-9a44-c30c010757d1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_beefc4bc-fcf0-44b0-aa11-ba03e9647061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_94b6d8ad-d542-4fb4-be01-83ad45b6327e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/> <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1fdd9377-64c7-47d2-9a44-c30c010757d1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_94b6d8ad-d542-4fb4-be01-83ad45b6327e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_48531f36-3b42-4c0a-841d-4e4800b1ec06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/> <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1fdd9377-64c7-47d2-9a44-c30c010757d1" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_48531f36-3b42-4c0a-841d-4e4800b1ec06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f6ceeb65-6f20-4490-940e-f464bc0f6afa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1fdd9377-64c7-47d2-9a44-c30c010757d1" xlink:to="loc_us-gaap_ProfitLoss_f6ceeb65-6f20-4490-940e-f464bc0f6afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_51f57c3a-faba-4611-a8b8-30c7afc3fb7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/> <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1fdd9377-64c7-47d2-9a44-c30c010757d1" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_51f57c3a-faba-4611-a8b8-30c7afc3fb7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_67c78635-0713-484b-81f9-666132a14f67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/> <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1fdd9377-64c7-47d2-9a44-c30c010757d1" xlink:to="loc_us-gaap_NetIncomeLoss_67c78635-0713-484b-81f9-666132a14f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d77a4f96-046d-453c-966e-9b1c0baace8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/> <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1fdd9377-64c7-47d2-9a44-c30c010757d1" xlink:to="loc_us-gaap_EarningsPerShareAbstract_d77a4f96-046d-453c-966e-9b1c0baace8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_fc89de75-287d-4f15-a5ce-0170f50d0bb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d77a4f96-046d-453c-966e-9b1c0baace8a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_fc89de75-287d-4f15-a5ce-0170f50d0bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_1aac7f2a-6814-429a-9d97-d1cebdd36318" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d77a4f96-046d-453c-966e-9b1c0baace8a" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_1aac7f2a-6814-429a-9d97-d1cebdd36318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b462ed0e-2216-4d34-a695-9fc6c74edd40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d77a4f96-046d-453c-966e-9b1c0baace8a" xlink:to="loc_us-gaap_EarningsPerShareBasic_b462ed0e-2216-4d34-a695-9fc6c74edd40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_c10f21f6-6877-4fe0-b67d-9b3210a5d631" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d77a4f96-046d-453c-966e-9b1c0baace8a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_c10f21f6-6877-4fe0-b67d-9b3210a5d631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_995d2976-8851-4581-9743-eb291d3c04bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d77a4f96-046d-453c-966e-9b1c0baace8a" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_995d2976-8851-4581-9743-eb291d3c04bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_1946fcbf-99f0-4bfd-9a3c-1b37b82ad853" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/> <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d77a4f96-046d-453c-966e-9b1c0baace8a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_1946fcbf-99f0-4bfd-9a3c-1b37b82ad853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_35d525fc-a104-4455-8cf4-22e30a13c7ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/> <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1fdd9377-64c7-47d2-9a44-c30c010757d1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_35d525fc-a104-4455-8cf4-22e30a13c7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_022a5d48-1e7c-4cff-91da-74030de19aa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_35d525fc-a104-4455-8cf4-22e30a13c7ce" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_022a5d48-1e7c-4cff-91da-74030de19aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_54124938-8b3e-4308-b636-181f9643661e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_35d525fc-a104-4455-8cf4-22e30a13c7ce" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_54124938-8b3e-4308-b636-181f9643661e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cpix-20210930.xsd#CondensedConsolidatedStatementsofCashFlows"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_3eaa57e0-d418-4736-b236-4d02b7ae1a48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b3b0e183-55b4-49f3-bd42-0ac6af7a2068" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3eaa57e0-d418-4736-b236-4d02b7ae1a48" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b3b0e183-55b4-49f3-bd42-0ac6af7a2068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3d31516b-441c-40f0-8ced-17cfd62e661b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b3b0e183-55b4-49f3-bd42-0ac6af7a2068" xlink:to="loc_us-gaap_ProfitLoss_3d31516b-441c-40f0-8ced-17cfd62e661b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_24968a04-237e-40d5-a399-722efdc58451" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b3b0e183-55b4-49f3-bd42-0ac6af7a2068" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_24968a04-237e-40d5-a399-722efdc58451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_25190442-77d4-4ca3-9912-d720884f6183" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b3b0e183-55b4-49f3-bd42-0ac6af7a2068" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_25190442-77d4-4ca3-9912-d720884f6183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f73dc048-4ff5-4fbf-a67e-32499150f2fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b3b0e183-55b4-49f3-bd42-0ac6af7a2068" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f73dc048-4ff5-4fbf-a67e-32499150f2fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9b8253d2-2c06-40c4-9703-13d87adc0ec8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f73dc048-4ff5-4fbf-a67e-32499150f2fe" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_9b8253d2-2c06-40c4-9703-13d87adc0ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_7a201ee6-2657-4420-9eb3-292c8ee8c1e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f73dc048-4ff5-4fbf-a67e-32499150f2fe" xlink:to="loc_us-gaap_ShareBasedCompensation_7a201ee6-2657-4420-9eb3-292c8ee8c1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities_192964bb-d347-4510-9915-4a68285ad8e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f73dc048-4ff5-4fbf-a67e-32499150f2fe" xlink:to="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities_192964bb-d347-4510-9915-4a68285ad8e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy_5f136bcd-f385-4aa7-83fb-73859436fb35" xlink:href="cpix-20210930.xsd#cpix_IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f73dc048-4ff5-4fbf-a67e-32499150f2fe" xlink:to="loc_cpix_IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy_5f136bcd-f385-4aa7-83fb-73859436fb35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_e0177350-6e8c-4202-bf7b-a2a89a6b001b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f73dc048-4ff5-4fbf-a67e-32499150f2fe" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_e0177350-6e8c-4202-bf7b-a2a89a6b001b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_17221856-b7ec-4ba2-809d-8c8562b40f07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/> <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f73dc048-4ff5-4fbf-a67e-32499150f2fe" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_17221856-b7ec-4ba2-809d-8c8562b40f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_69a67b3d-a6fb-4d48-95c4-48f2c464472d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/> <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f73dc048-4ff5-4fbf-a67e-32499150f2fe" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_69a67b3d-a6fb-4d48-95c4-48f2c464472d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ebf147ad-9afa-4512-876c-3a99e1d37f16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_69a67b3d-a6fb-4d48-95c4-48f2c464472d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ebf147ad-9afa-4512-876c-3a99e1d37f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_8a70a9b6-1317-455b-af54-c98847331cd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_69a67b3d-a6fb-4d48-95c4-48f2c464472d" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_8a70a9b6-1317-455b-af54-c98847331cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_9ea3cbdc-e10e-449b-8efc-26568a0b52e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_69a67b3d-a6fb-4d48-95c4-48f2c464472d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_9ea3cbdc-e10e-449b-8efc-26568a0b52e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_IncreaseDecreaseInCurrentOperatingLiabilities_8efc18d1-ed61-4478-aa4e-2e4bc45953da" xlink:href="cpix-20210930.xsd#cpix_IncreaseDecreaseInCurrentOperatingLiabilities"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_69a67b3d-a6fb-4d48-95c4-48f2c464472d" xlink:to="loc_cpix_IncreaseDecreaseInCurrentOperatingLiabilities_8efc18d1-ed61-4478-aa4e-2e4bc45953da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_fa91f269-91c6-402c-8887-9b86356892ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_69a67b3d-a6fb-4d48-95c4-48f2c464472d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_fa91f269-91c6-402c-8887-9b86356892ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_b3a849b5-bcd9-4138-9567-4fe8b7530b39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b3b0e183-55b4-49f3-bd42-0ac6af7a2068" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_b3a849b5-bcd9-4138-9567-4fe8b7530b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_78b3b31c-4500-4aee-946b-3d29f6f7bca1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/> <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b3b0e183-55b4-49f3-bd42-0ac6af7a2068" xlink:to="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_78b3b31c-4500-4aee-946b-3d29f6f7bca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c25f78a2-9fb8-4dad-880d-c3030c722bc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/> <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b3b0e183-55b4-49f3-bd42-0ac6af7a2068" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c25f78a2-9fb8-4dad-880d-c3030c722bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5579325a-03fc-4aed-8e84-42be530dc37f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3eaa57e0-d418-4736-b236-4d02b7ae1a48" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5579325a-03fc-4aed-8e84-42be530dc37f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6bff0715-f497-419d-883e-60ad3fdb7617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5579325a-03fc-4aed-8e84-42be530dc37f" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6bff0715-f497-419d-883e-60ad3fdb7617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_f49586e2-da3d-4892-840c-7eaea82ab584" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5579325a-03fc-4aed-8e84-42be530dc37f" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_f49586e2-da3d-4892-840c-7eaea82ab584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_99110fb5-84a5-44ee-bdc1-f7f728991af5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5579325a-03fc-4aed-8e84-42be530dc37f" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_99110fb5-84a5-44ee-bdc1-f7f728991af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_a2b72f66-cbda-4f3e-8c90-18947fe1696e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5579325a-03fc-4aed-8e84-42be530dc37f" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_a2b72f66-cbda-4f3e-8c90-18947fe1696e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_61657335-41ff-44c2-926a-fdb4870ca4e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5579325a-03fc-4aed-8e84-42be530dc37f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_61657335-41ff-44c2-926a-fdb4870ca4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ecef48a7-878c-4c9b-ad9f-fd2a67ba4642" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3eaa57e0-d418-4736-b236-4d02b7ae1a48" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ecef48a7-878c-4c9b-ad9f-fd2a67ba4642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_308233e3-e8a9-498b-a786-895cf90d31fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ecef48a7-878c-4c9b-ad9f-fd2a67ba4642" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_308233e3-e8a9-498b-a786-895cf90d31fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_c3d47f14-df8c-40f6-9215-50d3dff2f26c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ecef48a7-878c-4c9b-ad9f-fd2a67ba4642" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_c3d47f14-df8c-40f6-9215-50d3dff2f26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_199b14e1-dde3-4da4-b145-01912edfb1cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ecef48a7-878c-4c9b-ad9f-fd2a67ba4642" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_199b14e1-dde3-4da4-b145-01912edfb1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_cb3365f7-0231-4b1f-a240-a91d61a3292c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ecef48a7-878c-4c9b-ad9f-fd2a67ba4642" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_cb3365f7-0231-4b1f-a240-a91d61a3292c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b0135a9d-52a7-4174-8320-f49e40c03a07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ecef48a7-878c-4c9b-ad9f-fd2a67ba4642" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b0135a9d-52a7-4174-8320-f49e40c03a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6e1ec59c-d032-4dbd-81e2-78a8c70abfbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/> <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ecef48a7-878c-4c9b-ad9f-fd2a67ba4642" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6e1ec59c-d032-4dbd-81e2-78a8c70abfbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_84448874-d3b8-4397-997a-be5f0a54616a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/> <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ecef48a7-878c-4c9b-ad9f-fd2a67ba4642" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_84448874-d3b8-4397-997a-be5f0a54616a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4ebbc035-1114-4da6-b815-2c7f52d47ac7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/> <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ecef48a7-878c-4c9b-ad9f-fd2a67ba4642" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4ebbc035-1114-4da6-b815-2c7f52d47ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f4ba7273-b488-4d40-a2a6-e2e3cd0ef937" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/> <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ecef48a7-878c-4c9b-ad9f-fd2a67ba4642" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f4ba7273-b488-4d40-a2a6-e2e3cd0ef937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementofEquity" xlink:type="simple" xlink:href="cpix-20210930.xsd#CondensedConsolidatedStatementofEquity"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementofEquity" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_5dd9e7cd-72a8-41fe-b34e-002ec0a0a883" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_48306e8f-4abb-4cef-95d8-dd77dd686950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_5dd9e7cd-72a8-41fe-b34e-002ec0a0a883" xlink:to="loc_us-gaap_StatementTable_48306e8f-4abb-4cef-95d8-dd77dd686950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b3dd39aa-22ee-4410-b263-056381d6530c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_48306e8f-4abb-4cef-95d8-dd77dd686950" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b3dd39aa-22ee-4410-b263-056381d6530c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9b72bcee-bd37-4a30-b13d-9f72fa193fca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b3dd39aa-22ee-4410-b263-056381d6530c" xlink:to="loc_us-gaap_EquityComponentDomain_9b72bcee-bd37-4a30-b13d-9f72fa193fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_94341e32-a24a-4a97-b865-262cfefbee68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9b72bcee-bd37-4a30-b13d-9f72fa193fca" xlink:to="loc_us-gaap_CommonStockMember_94341e32-a24a-4a97-b865-262cfefbee68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a8892951-fb38-4532-a2ab-f15f8516eb75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9b72bcee-bd37-4a30-b13d-9f72fa193fca" xlink:to="loc_us-gaap_RetainedEarningsMember_a8892951-fb38-4532-a2ab-f15f8516eb75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_97242877-524d-4dce-ae96-c586ca3ab29e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9b72bcee-bd37-4a30-b13d-9f72fa193fca" xlink:to="loc_us-gaap_NoncontrollingInterestMember_97242877-524d-4dce-ae96-c586ca3ab29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f7c2e9a6-a36a-4563-a86c-80c1462f6f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_48306e8f-4abb-4cef-95d8-dd77dd686950" xlink:to="loc_us-gaap_StatementLineItems_f7c2e9a6-a36a-4563-a86c-80c1462f6f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1beabf0f-f1e7-4ae4-8f05-4e00568019c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f7c2e9a6-a36a-4563-a86c-80c1462f6f63" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1beabf0f-f1e7-4ae4-8f05-4e00568019c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2eea1cc5-8e2f-4469-8b3e-02b3f9ab92ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1beabf0f-f1e7-4ae4-8f05-4e00568019c7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2eea1cc5-8e2f-4469-8b3e-02b3f9ab92ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_3fc53be7-de5a-4bc2-a466-e48647c29ebf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1beabf0f-f1e7-4ae4-8f05-4e00568019c7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_3fc53be7-de5a-4bc2-a466-e48647c29ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9ac63f16-655b-43be-a4e3-fef0c786814f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1beabf0f-f1e7-4ae4-8f05-4e00568019c7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9ac63f16-655b-43be-a4e3-fef0c786814f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a616b102-9203-43f3-ad9a-8794e1dea0b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1beabf0f-f1e7-4ae4-8f05-4e00568019c7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a616b102-9203-43f3-ad9a-8794e1dea0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_02261b60-5b81-4cea-97de-5518756f4827" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1beabf0f-f1e7-4ae4-8f05-4e00568019c7" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_02261b60-5b81-4cea-97de-5518756f4827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_50403b23-09a6-463c-a646-4a8a4af80ca6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/> <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1beabf0f-f1e7-4ae4-8f05-4e00568019c7" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_50403b23-09a6-463c-a646-4a8a4af80ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0cf9e5e3-0e1f-4fb2-86c3-a5c4f6c85d03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/> <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1beabf0f-f1e7-4ae4-8f05-4e00568019c7" xlink:to="loc_us-gaap_ProfitLoss_0cf9e5e3-0e1f-4fb2-86c3-a5c4f6c85d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7a25ff65-d2f8-40b3-8800-bc96f35ea165" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/> <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1beabf0f-f1e7-4ae4-8f05-4e00568019c7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7a25ff65-d2f8-40b3-8800-bc96f35ea165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_115063ec-ba4d-423a-891f-54a20007d878" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/> <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1beabf0f-f1e7-4ae4-8f05-4e00568019c7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_115063ec-ba4d-423a-891f-54a20007d878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/OrganizationandBasisofPresentation" xlink:type="simple" xlink:href="cpix-20210930.xsd#OrganizationandBasisofPresentation"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/OrganizationandBasisofPresentation" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c794028d-83c8-45f3-96f9-72978d0066c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_2ce6a5ed-d482-4711-b050-accbef7e9886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c794028d-83c8-45f3-96f9-72978d0066c5" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_2ce6a5ed-d482-4711-b050-accbef7e9886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/OrganizationandBasisofPresentationPolicies" xlink:type="simple" xlink:href="cpix-20210930.xsd#OrganizationandBasisofPresentationPolicies"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/OrganizationandBasisofPresentationPolicies" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8d1bfef8-14db-4a0c-878f-68c1aca74543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f449f3bd-e568-4551-9e6c-6ca5771be21b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8d1bfef8-14db-4a0c-878f-68c1aca74543" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f449f3bd-e568-4551-9e6c-6ca5771be21b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_425c6430-f7e8-4143-9a06-6a914a2b0b90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8d1bfef8-14db-4a0c-878f-68c1aca74543" xlink:to="loc_us-gaap_UseOfEstimates_425c6430-f7e8-4143-9a06-6a914a2b0b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_374c61ac-504b-400c-b17e-8c094c724ec6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8d1bfef8-14db-4a0c-878f-68c1aca74543" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_374c61ac-504b-400c-b17e-8c094c724ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/OrganizationandBasisofPresentationOrganizationDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#OrganizationandBasisofPresentationOrganizationDetails"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/OrganizationandBasisofPresentationOrganizationDetails" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2b9c767a-d92a-4cf8-9e40-b2163b7a1c40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_5944d2e0-a8e9-4a72-810f-ceaea5607020" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2b9c767a-d92a-4cf8-9e40-b2163b7a1c40" xlink:to="loc_us-gaap_NumberOfOperatingSegments_5944d2e0-a8e9-4a72-810f-ceaea5607020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/EarningsLossPerShare" xlink:type="simple" xlink:href="cpix-20210930.xsd#EarningsLossPerShare"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/EarningsLossPerShare" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ae68cec4-8864-470a-82f2-2667df4514df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_5cee2f2a-35f5-4b7b-b59e-0e713f1663a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ae68cec4-8864-470a-82f2-2667df4514df" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_5cee2f2a-35f5-4b7b-b59e-0e713f1663a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/EarningsLossPerShareTables" xlink:type="simple" xlink:href="cpix-20210930.xsd#EarningsLossPerShareTables"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/EarningsLossPerShareTables" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_10f5c7f2-a8b0-4127-9405-d01c694c5762" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9a1b6629-35d3-46ba-a925-9d54c8a655e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_10f5c7f2-a8b0-4127-9405-d01c694c5762" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9a1b6629-35d3-46ba-a925-9d54c8a655e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/EarningsLossPerShareDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#EarningsLossPerShareDetails"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/EarningsLossPerShareDetails" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_12d1d28a-bea4-46ba-be33-ae526af00379" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_NumeratorAbstract_86730865-95e6-42f5-835f-6c23ec3e2bf6" xlink:href="cpix-20210930.xsd#cpix_NumeratorAbstract"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_12d1d28a-bea4-46ba-be33-ae526af00379" xlink:to="loc_cpix_NumeratorAbstract_86730865-95e6-42f5-835f-6c23ec3e2bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_f6c74408-8944-4be2-867f-fd536510202a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_NumeratorAbstract_86730865-95e6-42f5-835f-6c23ec3e2bf6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_f6c74408-8944-4be2-867f-fd536510202a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_15818b69-e2d0-42d8-8b60-de7f91753b4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_NumeratorAbstract_86730865-95e6-42f5-835f-6c23ec3e2bf6" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_15818b69-e2d0-42d8-8b60-de7f91753b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_66342459-6ec3-4360-9a72-1f003dd37c43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_NumeratorAbstract_86730865-95e6-42f5-835f-6c23ec3e2bf6" xlink:to="loc_us-gaap_ProfitLoss_66342459-6ec3-4360-9a72-1f003dd37c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_89b1cf34-683f-4e8c-b96c-ab7a232e46f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_NumeratorAbstract_86730865-95e6-42f5-835f-6c23ec3e2bf6" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_89b1cf34-683f-4e8c-b96c-ab7a232e46f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_08e838db-5a4a-4624-b629-f21d3c2de662" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_NumeratorAbstract_86730865-95e6-42f5-835f-6c23ec3e2bf6" xlink:to="loc_us-gaap_NetIncomeLoss_08e838db-5a4a-4624-b629-f21d3c2de662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_DenominatorAbstract_fdb25247-c122-48c7-af6d-ec8d2c7df86c" xlink:href="cpix-20210930.xsd#cpix_DenominatorAbstract"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_12d1d28a-bea4-46ba-be33-ae526af00379" xlink:to="loc_cpix_DenominatorAbstract_fdb25247-c122-48c7-af6d-ec8d2c7df86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_48d45f0f-ffd9-42cc-9a9b-0a43c97a8572" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_DenominatorAbstract_fdb25247-c122-48c7-af6d-ec8d2c7df86c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_48d45f0f-ffd9-42cc-9a9b-0a43c97a8572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_122aa0e3-2196-46bf-b354-f70cb294a817" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_DenominatorAbstract_fdb25247-c122-48c7-af6d-ec8d2c7df86c" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_122aa0e3-2196-46bf-b354-f70cb294a817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a199ebda-d62a-4cb4-9120-91270a02c4c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_DenominatorAbstract_fdb25247-c122-48c7-af6d-ec8d2c7df86c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a199ebda-d62a-4cb4-9120-91270a02c4c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/EarningsLossPerShareDetailsTextual" xlink:type="simple" xlink:href="cpix-20210930.xsd#EarningsLossPerShareDetailsTextual"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/EarningsLossPerShareDetailsTextual" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_15eeb482-8725-450a-b2f2-a714c83d016b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0e858139-342a-4307-8e5e-1bcd8fd82bf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_15eeb482-8725-450a-b2f2-a714c83d016b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0e858139-342a-4307-8e5e-1bcd8fd82bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/Revenues" xlink:type="simple" xlink:href="cpix-20210930.xsd#Revenues"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/Revenues" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_8205e82a-c4a5-4c7b-8ffa-f88bbdcee8f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_69a633d1-300f-4481-8ff0-c28dd9c8dd3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8205e82a-c4a5-4c7b-8ffa-f88bbdcee8f9" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_69a633d1-300f-4481-8ff0-c28dd9c8dd3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/RevenuesTables" xlink:type="simple" xlink:href="cpix-20210930.xsd#RevenuesTables"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/RevenuesTables" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_484aaab1-7e41-4e41-b42e-651e36d71fd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_cb22c3c7-74f8-4284-b941-3366be25968a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_484aaab1-7e41-4e41-b42e-651e36d71fd1" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_cb22c3c7-74f8-4284-b941-3366be25968a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/RevenuesDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#RevenuesDetails"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/RevenuesDetails" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_acf50e2a-fec3-4c13-847e-e2331b8fdc1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_e425ca26-2d14-444f-b7fd-a4ca025fb0e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_acf50e2a-fec3-4c13-847e-e2331b8fdc1a" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_e425ca26-2d14-444f-b7fd-a4ca025fb0e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ea85ad4b-cddd-4c70-a69b-d422c9f973f7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_e425ca26-2d14-444f-b7fd-a4ca025fb0e4" xlink:to="loc_srt_ProductOrServiceAxis_ea85ad4b-cddd-4c70-a69b-d422c9f973f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c5dd95e8-54d6-4959-883d-f9a456f42934" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_ea85ad4b-cddd-4c70-a69b-d422c9f973f7" xlink:to="loc_srt_ProductsAndServicesDomain_c5dd95e8-54d6-4959-883d-f9a456f42934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_AcetadoteMember_da36bad0-a580-4de6-bc72-a3d26324cd1b" xlink:href="cpix-20210930.xsd#cpix_AcetadoteMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c5dd95e8-54d6-4959-883d-f9a456f42934" xlink:to="loc_cpix_AcetadoteMember_da36bad0-a580-4de6-bc72-a3d26324cd1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_OmeclamoxPakMember_c27b32ff-3a9d-4ae8-9470-f838a0bc70a1" xlink:href="cpix-20210930.xsd#cpix_OmeclamoxPakMember"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c5dd95e8-54d6-4959-883d-f9a456f42934" xlink:to="loc_cpix_OmeclamoxPakMember_c27b32ff-3a9d-4ae8-9470-f838a0bc70a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_KristaloseMember_8d10004d-9f1a-4b2f-8c06-0d85a0805803" xlink:href="cpix-20210930.xsd#cpix_KristaloseMember"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c5dd95e8-54d6-4959-883d-f9a456f42934" xlink:to="loc_cpix_KristaloseMember_8d10004d-9f1a-4b2f-8c06-0d85a0805803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_VaprisolMember_a433841e-56a8-4f31-a0f5-1c9ac4523065" xlink:href="cpix-20210930.xsd#cpix_VaprisolMember"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c5dd95e8-54d6-4959-883d-f9a456f42934" xlink:to="loc_cpix_VaprisolMember_a433841e-56a8-4f31-a0f5-1c9ac4523065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_CaldolorMember_b0abc34d-da75-403b-a6be-5392060ff765" xlink:href="cpix-20210930.xsd#cpix_CaldolorMember"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c5dd95e8-54d6-4959-883d-f9a456f42934" xlink:to="loc_cpix_CaldolorMember_b0abc34d-da75-403b-a6be-5392060ff765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_VIBATIVMember_453c4bfa-ffbc-4f55-a4a0-59ed179c71c4" xlink:href="cpix-20210930.xsd#cpix_VIBATIVMember"/> <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c5dd95e8-54d6-4959-883d-f9a456f42934" xlink:to="loc_cpix_VIBATIVMember_453c4bfa-ffbc-4f55-a4a0-59ed179c71c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_RediTrexMember_f65bdec8-433e-480f-96ba-4ca60e7d5249" xlink:href="cpix-20210930.xsd#cpix_RediTrexMember"/> <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c5dd95e8-54d6-4959-883d-f9a456f42934" xlink:to="loc_cpix_RediTrexMember_f65bdec8-433e-480f-96ba-4ca60e7d5249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_OtherProductsMember_6c40e545-0aff-4bd1-bad2-a8cc67cad621" xlink:href="cpix-20210930.xsd#cpix_OtherProductsMember"/> <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c5dd95e8-54d6-4959-883d-f9a456f42934" xlink:to="loc_cpix_OtherProductsMember_6c40e545-0aff-4bd1-bad2-a8cc67cad621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember_6fa6505e-2e11-48e7-9bb7-b40fa8f1d88d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrantMember"/> <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c5dd95e8-54d6-4959-883d-f9a456f42934" xlink:to="loc_us-gaap_GrantMember_6fa6505e-2e11-48e7-9bb7-b40fa8f1d88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_734d2712-5858-4a27-a866-f899e4111979" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_e425ca26-2d14-444f-b7fd-a4ca025fb0e4" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_734d2712-5858-4a27-a866-f899e4111979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_cabf3418-a5ae-4f2d-bfa2-00edf4297517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_734d2712-5858-4a27-a866-f899e4111979" xlink:to="loc_us-gaap_RevenuesAbstract_cabf3418-a5ae-4f2d-bfa2-00edf4297517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_ProductsAbstract_b7f59a5d-573f-4c4b-907f-2d14d80f41f7" xlink:href="cpix-20210930.xsd#cpix_ProductsAbstract"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_cabf3418-a5ae-4f2d-bfa2-00edf4297517" xlink:to="loc_cpix_ProductsAbstract_b7f59a5d-573f-4c4b-907f-2d14d80f41f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a9b697b5-652d-4f60-a2d7-25b146d15337" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_ProductsAbstract_b7f59a5d-573f-4c4b-907f-2d14d80f41f7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a9b697b5-652d-4f60-a2d7-25b146d15337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/Inventories" xlink:type="simple" xlink:href="cpix-20210930.xsd#Inventories"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/Inventories" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_7f909bb7-9d3f-4cf0-9236-838dc6dab25a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_270b7c96-7876-46d0-9231-9ee55bbe146c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_7f909bb7-9d3f-4cf0-9236-838dc6dab25a" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_270b7c96-7876-46d0-9231-9ee55bbe146c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/InventoriesTables" xlink:type="simple" xlink:href="cpix-20210930.xsd#InventoriesTables"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/InventoriesTables" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_8cc79562-fe62-43bb-aabc-ae7826777a2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_2e5dce13-95ab-45b6-b7bd-88abe506ae76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8cc79562-fe62-43bb-aabc-ae7826777a2f" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_2e5dce13-95ab-45b6-b7bd-88abe506ae76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/InventoriesNarrativeDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#InventoriesNarrativeDetails"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/InventoriesNarrativeDetails" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_2a12e4ce-4331-4b43-b869-cea6438adddc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_a0b336b1-ce47-4233-8c49-b2149cbf97b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryCurrentTable"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_2a12e4ce-4331-4b43-b869-cea6438adddc" xlink:to="loc_us-gaap_InventoryCurrentTable_a0b336b1-ce47-4233-8c49-b2149cbf97b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_14e80154-b32c-4526-a987-e7dae298d58a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_a0b336b1-ce47-4233-8c49-b2149cbf97b0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_14e80154-b32c-4526-a987-e7dae298d58a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_080a77a9-fbcc-4871-ad9a-9b29db13a53f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_14e80154-b32c-4526-a987-e7dae298d58a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_080a77a9-fbcc-4871-ad9a-9b29db13a53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_IfetrobanClinicalMember_762200de-c65f-4d46-92dd-adda1c9d1347" xlink:href="cpix-20210930.xsd#cpix_IfetrobanClinicalMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_080a77a9-fbcc-4871-ad9a-9b29db13a53f" xlink:to="loc_cpix_IfetrobanClinicalMember_762200de-c65f-4d46-92dd-adda1c9d1347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_VIBATIVMember_d981f915-b2c0-4e48-8935-37217a2cc260" xlink:href="cpix-20210930.xsd#cpix_VIBATIVMember"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_080a77a9-fbcc-4871-ad9a-9b29db13a53f" xlink:to="loc_cpix_VIBATIVMember_d981f915-b2c0-4e48-8935-37217a2cc260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryAxis_12a92061-068d-47a8-b4fa-e0f6209b630d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PublicUtilitiesInventoryAxis"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_a0b336b1-ce47-4233-8c49-b2149cbf97b0" xlink:to="loc_us-gaap_PublicUtilitiesInventoryAxis_12a92061-068d-47a8-b4fa-e0f6209b630d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_62ea1003-d7f0-4193-9fa7-15a5f1339c82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis_12a92061-068d-47a8-b4fa-e0f6209b630d" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_62ea1003-d7f0-4193-9fa7-15a5f1339c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_IfetrobanClinicalMember_f4ca23e0-d093-45be-91fe-e13d47a86b56" xlink:href="cpix-20210930.xsd#cpix_IfetrobanClinicalMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_62ea1003-d7f0-4193-9fa7-15a5f1339c82" xlink:to="loc_cpix_IfetrobanClinicalMember_f4ca23e0-d093-45be-91fe-e13d47a86b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_2677b945-1379-4f43-b473-fcbb33c8672a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLineItems"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_a0b336b1-ce47-4233-8c49-b2149cbf97b0" xlink:to="loc_us-gaap_InventoryLineItems_2677b945-1379-4f43-b473-fcbb33c8672a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_6ceb65bc-3f32-448c-bd36-e8d24a182c40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_2677b945-1379-4f43-b473-fcbb33c8672a" xlink:to="loc_us-gaap_InventoryValuationReserves_6ceb65bc-3f32-448c-bd36-e8d24a182c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_bdc2f651-0530-4433-920f-195aa7565b4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNoncurrent"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_2677b945-1379-4f43-b473-fcbb33c8672a" xlink:to="loc_us-gaap_InventoryNoncurrent_bdc2f651-0530-4433-920f-195aa7565b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_bbf4892d-163a-4e3d-a2e7-2b4988289caa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_2677b945-1379-4f43-b473-fcbb33c8672a" xlink:to="loc_us-gaap_InventoryFinishedGoods_bbf4892d-163a-4e3d-a2e7-2b4988289caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_0db0db49-31ad-434a-8794-a060fe279721" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_2677b945-1379-4f43-b473-fcbb33c8672a" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_0db0db49-31ad-434a-8794-a060fe279721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/InventoriesScheduleofInventoriesDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#InventoriesScheduleofInventoriesDetails"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/InventoriesScheduleofInventoriesDetails" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_89ce02ce-599b-4087-880d-428939e90eb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract_8d8d0011-6408-4a14-a8e6-edd268f2f8bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_89ce02ce-599b-4087-880d-428939e90eb6" xlink:to="loc_us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract_8d8d0011-6408-4a14-a8e6-edd268f2f8bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_849ecab8-2876-45e1-ac41-957c2f94e0ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract_8d8d0011-6408-4a14-a8e6-edd268f2f8bf" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_849ecab8-2876-45e1-ac41-957c2f94e0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_908374e2-cef1-4937-87aa-466657568eed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract_8d8d0011-6408-4a14-a8e6-edd268f2f8bf" xlink:to="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_908374e2-cef1-4937-87aa-466657568eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_edfbfea3-6315-4cb1-8439-8102fd8137cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract_8d8d0011-6408-4a14-a8e6-edd268f2f8bf" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_edfbfea3-6315-4cb1-8439-8102fd8137cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross_a47530a9-4676-481b-8ad4-425ff1a6cd1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryGross"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract_8d8d0011-6408-4a14-a8e6-edd268f2f8bf" xlink:to="loc_us-gaap_InventoryGross_a47530a9-4676-481b-8ad4-425ff1a6cd1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_bbee3e60-5f78-4998-8356-b47cacb7edac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNoncurrent"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract_8d8d0011-6408-4a14-a8e6-edd268f2f8bf" xlink:to="loc_us-gaap_InventoryNoncurrent_bbee3e60-5f78-4998-8356-b47cacb7edac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ca4f3c80-d7d9-479c-a995-9c34c04519e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/> <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract_8d8d0011-6408-4a14-a8e6-edd268f2f8bf" xlink:to="loc_us-gaap_InventoryNet_ca4f3c80-d7d9-479c-a995-9c34c04519e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/Leases" xlink:type="simple" xlink:href="cpix-20210930.xsd#Leases"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/Leases" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9f093e96-382a-4296-919e-8b61c7a4a0b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_ad175d67-48a7-4380-b869-a14b80ee4179" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9f093e96-382a-4296-919e-8b61c7a4a0b0" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_ad175d67-48a7-4380-b869-a14b80ee4179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/LeasesTables" xlink:type="simple" xlink:href="cpix-20210930.xsd#LeasesTables"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/LeasesTables" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e68d60a7-a88e-4d1a-b56e-2910ec3117f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_AssetsAndLiabilitiesLesseeTableTextBlock_52331d12-f6b7-417e-8819-fc08c9b352fb" xlink:href="cpix-20210930.xsd#cpix_AssetsAndLiabilitiesLesseeTableTextBlock"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e68d60a7-a88e-4d1a-b56e-2910ec3117f0" xlink:to="loc_cpix_AssetsAndLiabilitiesLesseeTableTextBlock_52331d12-f6b7-417e-8819-fc08c9b352fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f55bbd5c-8aaa-4e58-842b-2887a81f62fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e68d60a7-a88e-4d1a-b56e-2910ec3117f0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f55bbd5c-8aaa-4e58-842b-2887a81f62fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_ScheduleofRentExpenseandSubleaseIncomeTableTextBlock_940cf193-130a-48c9-bcb7-192c357ec192" xlink:href="cpix-20210930.xsd#cpix_ScheduleofRentExpenseandSubleaseIncomeTableTextBlock"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e68d60a7-a88e-4d1a-b56e-2910ec3117f0" xlink:to="loc_cpix_ScheduleofRentExpenseandSubleaseIncomeTableTextBlock_940cf193-130a-48c9-bcb7-192c357ec192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#LeasesNarrativeDetails"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/LeasesNarrativeDetails" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_11ad2850-6117-4824-846c-ea3e74a633b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_3bd25538-a25a-4f95-ac3a-183935816b0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_11ad2850-6117-4824-846c-ea3e74a633b0" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_3bd25538-a25a-4f95-ac3a-183935816b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_744461e7-343f-4ce0-88e8-462cd55aea36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_3bd25538-a25a-4f95-ac3a-183935816b0d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_744461e7-343f-4ce0-88e8-462cd55aea36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8fb4ce31-a05c-40ef-92f7-f9e38d139381" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_744461e7-343f-4ce0-88e8-462cd55aea36" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8fb4ce31-a05c-40ef-92f7-f9e38d139381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_3fc8fde7-facd-4ec6-81d3-b7eed954ffac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8fb4ce31-a05c-40ef-92f7-f9e38d139381" xlink:to="loc_us-gaap_BuildingMember_3fc8fde7-facd-4ec6-81d3-b7eed954ffac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_srt_OfficeBuildingMember_d1b199e9-1204-4946-b7ca-596cc966f447" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OfficeBuildingMember"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8fb4ce31-a05c-40ef-92f7-f9e38d139381" xlink:to="loc_srt_OfficeBuildingMember_d1b199e9-1204-4946-b7ca-596cc966f447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_1605487e-e0f6-4306-b5ca-7782f823edcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_3bd25538-a25a-4f95-ac3a-183935816b0d" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_1605487e-e0f6-4306-b5ca-7782f823edcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_2d366c01-a172-4ddd-becb-3cd44be795e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AreaOfRealEstateProperty"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1605487e-e0f6-4306-b5ca-7782f823edcd" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_2d366c01-a172-4ddd-becb-3cd44be795e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_bc317288-facc-46d7-8afe-50d71f1d6181" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1605487e-e0f6-4306-b5ca-7782f823edcd" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_bc317288-facc-46d7-8afe-50d71f1d6181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_47cadbee-2542-4917-9e1b-fac050365ff2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1605487e-e0f6-4306-b5ca-7782f823edcd" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_47cadbee-2542-4917-9e1b-fac050365ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_677942a7-adcf-467b-be5c-ee7208957a17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1605487e-e0f6-4306-b5ca-7782f823edcd" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_677942a7-adcf-467b-be5c-ee7208957a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/LeasesLeasePositionDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#LeasesLeasePositionDetails"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/LeasesLeasePositionDetails" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_275e5ded-3c47-464d-ab05-f19b3914315e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e4d46404-3f3f-4ba1-a47f-92cd3d79cb8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_275e5ded-3c47-464d-ab05-f19b3914315e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e4d46404-3f3f-4ba1-a47f-92cd3d79cb8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ad6a6870-6979-417a-9f69-ecdfa83458a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_275e5ded-3c47-464d-ab05-f19b3914315e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ad6a6870-6979-417a-9f69-ecdfa83458a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_de22e49c-5bc4-44fd-96a1-29039a065f8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_275e5ded-3c47-464d-ab05-f19b3914315e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_de22e49c-5bc4-44fd-96a1-29039a065f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_LeaseLiability_70e790ed-cbe8-4db6-869b-36eb05ecdb9b" xlink:href="cpix-20210930.xsd#cpix_LeaseLiability"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_275e5ded-3c47-464d-ab05-f19b3914315e" xlink:to="loc_cpix_LeaseLiability_70e790ed-cbe8-4db6-869b-36eb05ecdb9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c557d582-cbd0-4ddd-9a90-e2a3b70b2db2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_b3493c17-e86d-4929-83f7-3a21f8b65ffd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c557d582-cbd0-4ddd-9a90-e2a3b70b2db2" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_b3493c17-e86d-4929-83f7-3a21f8b65ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2707376e-9766-4a7f-9974-cc459e830724" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_b3493c17-e86d-4929-83f7-3a21f8b65ffd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2707376e-9766-4a7f-9974-cc459e830724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2ff68d75-40ba-4ad0-8053-b417324a27e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_b3493c17-e86d-4929-83f7-3a21f8b65ffd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2ff68d75-40ba-4ad0-8053-b417324a27e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7173fe7b-5726-45bf-914d-f34acf5f88aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_b3493c17-e86d-4929-83f7-3a21f8b65ffd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7173fe7b-5726-45bf-914d-f34acf5f88aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree_74714087-3411-4d29-bbf6-e1767fb7ee48" xlink:href="cpix-20210930.xsd#cpix_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_b3493c17-e86d-4929-83f7-3a21f8b65ffd" xlink:to="loc_cpix_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree_74714087-3411-4d29-bbf6-e1767fb7ee48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_91b3d778-7999-4905-a18e-197d4a0b8aa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_b3493c17-e86d-4929-83f7-3a21f8b65ffd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_91b3d778-7999-4905-a18e-197d4a0b8aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_4c2a873a-6b85-4732-b948-71dda70989a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/> <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_b3493c17-e86d-4929-83f7-3a21f8b65ffd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_4c2a873a-6b85-4732-b948-71dda70989a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_0ddcab65-1ecd-4d27-9081-343ca5edc556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/> <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_b3493c17-e86d-4929-83f7-3a21f8b65ffd" xlink:to="loc_us-gaap_OperatingLeaseLiability_0ddcab65-1ecd-4d27-9081-343ca5edc556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails_1" xlink:type="simple" xlink:href="cpix-20210930.xsd#LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails_1"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails_1" xlink:type="extended"/> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/LeasesRentExpenseDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#LeasesRentExpenseDetails"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/LeasesRentExpenseDetails" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1ab5ec62-00d0-457e-a54b-68cdfc1f36b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_a68fd26b-1112-466d-b8f6-597b2df5b09a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1ab5ec62-00d0-457e-a54b-68cdfc1f36b3" xlink:to="loc_us-gaap_OperatingLeaseExpense_a68fd26b-1112-466d-b8f6-597b2df5b09a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_9f14da69-c232-4d66-bd63-cb42a0987ea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubleaseIncome"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1ab5ec62-00d0-457e-a54b-68cdfc1f36b3" xlink:to="loc_us-gaap_SubleaseIncome_9f14da69-c232-4d66-bd63-cb42a0987ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/ShareholdersEquityandDebt" xlink:type="simple" xlink:href="cpix-20210930.xsd#ShareholdersEquityandDebt"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/ShareholdersEquityandDebt" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_cpix_EquityAndDebtAbstract_b0f72f43-3386-4fb5-83ee-abf29b7446bb" xlink:href="cpix-20210930.xsd#cpix_EquityAndDebtAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_ba90729d-fc19-447a-97bf-d645b49ac822" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_EquityAndDebtAbstract_b0f72f43-3386-4fb5-83ee-abf29b7446bb" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_ba90729d-fc19-447a-97bf-d645b49ac822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#ShareholdersEquityandDebtShareholdersEquityDetails"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_cpix_EquityAndDebtAbstract_6f64fc3b-18f2-464a-b72b-7f003b3d83f6" xlink:href="cpix-20210930.xsd#cpix_EquityAndDebtAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41dc7f81-ea80-40fe-9466-2dfb24a12be8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_EquityAndDebtAbstract_6f64fc3b-18f2-464a-b72b-7f003b3d83f6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41dc7f81-ea80-40fe-9466-2dfb24a12be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d32074c5-5f6d-47b6-9172-975d23300470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41dc7f81-ea80-40fe-9466-2dfb24a12be8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d32074c5-5f6d-47b6-9172-975d23300470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6d214517-3496-46ea-b310-30f77abd0996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d32074c5-5f6d-47b6-9172-975d23300470" xlink:to="loc_us-gaap_EquityComponentDomain_6d214517-3496-46ea-b310-30f77abd0996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3dccb701-ecec-4cf5-a759-0ec3baa98c2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6d214517-3496-46ea-b310-30f77abd0996" xlink:to="loc_us-gaap_CommonStockMember_3dccb701-ecec-4cf5-a759-0ec3baa98c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_41ae3094-cee4-4790-8a7f-6effec343507" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41dc7f81-ea80-40fe-9466-2dfb24a12be8" xlink:to="loc_srt_TitleOfIndividualAxis_41ae3094-cee4-4790-8a7f-6effec343507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_710fbba4-f8bf-413c-b4d8-a4a63861569e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_41ae3094-cee4-4790-8a7f-6effec343507" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_710fbba4-f8bf-413c-b4d8-a4a63861569e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_c81f76fa-d84c-4861-870c-10246eb57530" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_710fbba4-f8bf-413c-b4d8-a4a63861569e" xlink:to="loc_srt_DirectorMember_c81f76fa-d84c-4861-870c-10246eb57530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bf4734b9-db34-4a30-b055-516c4bd90cda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41dc7f81-ea80-40fe-9466-2dfb24a12be8" xlink:to="loc_us-gaap_AwardTypeAxis_bf4734b9-db34-4a30-b055-516c4bd90cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c91843c0-6910-4bf2-91ce-aecef678f90a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_bf4734b9-db34-4a30-b055-516c4bd90cda" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c91843c0-6910-4bf2-91ce-aecef678f90a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_fa712a3e-6ba7-4031-9718-f1b31b804988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c91843c0-6910-4bf2-91ce-aecef678f90a" xlink:to="loc_us-gaap_RestrictedStockMember_fa712a3e-6ba7-4031-9718-f1b31b804988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_IncentiveStockOptionsMember_f1b2e523-068c-4244-afae-aa23f410c504" xlink:href="cpix-20210930.xsd#cpix_IncentiveStockOptionsMember"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c91843c0-6910-4bf2-91ce-aecef678f90a" xlink:to="loc_cpix_IncentiveStockOptionsMember_f1b2e523-068c-4244-afae-aa23f410c504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_cd0a5b70-ff7b-4dc1-8255-7fc05e87e5e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41dc7f81-ea80-40fe-9466-2dfb24a12be8" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_cd0a5b70-ff7b-4dc1-8255-7fc05e87e5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_b1874aba-29cf-4026-bf29-9e9098194f28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_cd0a5b70-ff7b-4dc1-8255-7fc05e87e5e5" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_b1874aba-29cf-4026-bf29-9e9098194f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_PinnacleBankMember_aca55c95-33f0-41d2-93f8-44354c26b34b" xlink:href="cpix-20210930.xsd#cpix_PinnacleBankMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_b1874aba-29cf-4026-bf29-9e9098194f28" xlink:to="loc_cpix_PinnacleBankMember_aca55c95-33f0-41d2-93f8-44354c26b34b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e2d7da7-4ea8-4146-be48-882ec29b6419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41dc7f81-ea80-40fe-9466-2dfb24a12be8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e2d7da7-4ea8-4146-be48-882ec29b6419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_ShareholdersEquityTextualAbstract_dce969f5-2d4b-419b-a3a1-22d26930068b" xlink:href="cpix-20210930.xsd#cpix_ShareholdersEquityTextualAbstract"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e2d7da7-4ea8-4146-be48-882ec29b6419" xlink:to="loc_cpix_ShareholdersEquityTextualAbstract_dce969f5-2d4b-419b-a3a1-22d26930068b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_a899ac8b-6845-402d-a04e-be85c00dec06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_ShareholdersEquityTextualAbstract_dce969f5-2d4b-419b-a3a1-22d26930068b" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_a899ac8b-6845-402d-a04e-be85c00dec06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_5f8700fb-8183-4a3e-8204-72cad17effcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_ShareholdersEquityTextualAbstract_dce969f5-2d4b-419b-a3a1-22d26930068b" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_5f8700fb-8183-4a3e-8204-72cad17effcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_28de0e93-1d84-4a8d-bcbd-f9fc6ee2438a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_ShareholdersEquityTextualAbstract_dce969f5-2d4b-419b-a3a1-22d26930068b" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_28de0e93-1d84-4a8d-bcbd-f9fc6ee2438a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_157796a8-03d2-4355-9e26-67e8f44f04c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_ShareholdersEquityTextualAbstract_dce969f5-2d4b-419b-a3a1-22d26930068b" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_157796a8-03d2-4355-9e26-67e8f44f04c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities_a02c5b3f-77e9-406d-ad14-19bcc22189b9" xlink:href="cpix-20210930.xsd#cpix_StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_ShareholdersEquityTextualAbstract_dce969f5-2d4b-419b-a3a1-22d26930068b" xlink:to="loc_cpix_StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities_a02c5b3f-77e9-406d-ad14-19bcc22189b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0125cc7e-b8e5-4a55-b545-65ed3bb675d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/> <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_ShareholdersEquityTextualAbstract_dce969f5-2d4b-419b-a3a1-22d26930068b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0125cc7e-b8e5-4a55-b545-65ed3bb675d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_36ce7cc7-bbb1-4df2-891c-29d7f7bccfdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/> <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_ShareholdersEquityTextualAbstract_dce969f5-2d4b-419b-a3a1-22d26930068b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_36ce7cc7-bbb1-4df2-891c-29d7f7bccfdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#ShareholdersEquityandDebtDebtDetails"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_cpix_EquityAndDebtAbstract_c09e9f12-4874-4f92-93c5-ea4f4ae3d877" xlink:href="cpix-20210930.xsd#cpix_EquityAndDebtAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_01c9923a-72fd-45af-ac69-a5257d0f792e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cpix_EquityAndDebtAbstract_c09e9f12-4874-4f92-93c5-ea4f4ae3d877" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_01c9923a-72fd-45af-ac69-a5257d0f792e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_6864e921-e812-4edd-873e-8260d55a21f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_01c9923a-72fd-45af-ac69-a5257d0f792e" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_6864e921-e812-4edd-873e-8260d55a21f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_d92cf7c3-acf0-445d-91b4-98ece5460a4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_6864e921-e812-4edd-873e-8260d55a21f7" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_d92cf7c3-acf0-445d-91b4-98ece5460a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_PinnacleBankMember_9426523c-ee34-44cb-9b21-e8ee279e6bda" xlink:href="cpix-20210930.xsd#cpix_PinnacleBankMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_d92cf7c3-acf0-445d-91b4-98ece5460a4d" xlink:to="loc_cpix_PinnacleBankMember_9426523c-ee34-44cb-9b21-e8ee279e6bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cc405239-fcb9-47f7-9cf9-039cbdb4c098" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_01c9923a-72fd-45af-ac69-a5257d0f792e" xlink:to="loc_us-gaap_DebtInstrumentAxis_cc405239-fcb9-47f7-9cf9-039cbdb4c098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bbf31dc4-f31a-4748-9d12-c3ba40937f45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_cc405239-fcb9-47f7-9cf9-039cbdb4c098" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bbf31dc4-f31a-4748-9d12-c3ba40937f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_8de6865d-d462-41cd-af3e-15f891b60a13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bbf31dc4-f31a-4748-9d12-c3ba40937f45" xlink:to="loc_us-gaap_LineOfCreditMember_8de6865d-d462-41cd-af3e-15f891b60a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_FifthAmendmentMember_bbea2c9b-79d3-445d-a3ca-aaccf7d2c846" xlink:href="cpix-20210930.xsd#cpix_FifthAmendmentMember"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bbf31dc4-f31a-4748-9d12-c3ba40937f45" xlink:to="loc_cpix_FifthAmendmentMember_bbea2c9b-79d3-445d-a3ca-aaccf7d2c846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e9f6b071-ea2f-4d19-9f4e-86307cb14ddd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_01c9923a-72fd-45af-ac69-a5257d0f792e" xlink:to="loc_us-gaap_CreditFacilityAxis_e9f6b071-ea2f-4d19-9f4e-86307cb14ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_af38b56e-af38-48bb-8364-72b3186bbee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_e9f6b071-ea2f-4d19-9f4e-86307cb14ddd" xlink:to="loc_us-gaap_CreditFacilityDomain_af38b56e-af38-48bb-8364-72b3186bbee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_95918447-3505-47af-ad1b-0592d35373b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_af38b56e-af38-48bb-8364-72b3186bbee3" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_95918447-3505-47af-ad1b-0592d35373b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_37e49cb7-02f9-4b86-b101-165a22600ed8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_01c9923a-72fd-45af-ac69-a5257d0f792e" xlink:to="loc_srt_RangeAxis_37e49cb7-02f9-4b86-b101-165a22600ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7a943b86-710f-4c02-94a4-ba6342b423a5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_37e49cb7-02f9-4b86-b101-165a22600ed8" xlink:to="loc_srt_RangeMember_7a943b86-710f-4c02-94a4-ba6342b423a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_58342083-abf1-44ec-88f7-c13fc3267a80" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7a943b86-710f-4c02-94a4-ba6342b423a5" xlink:to="loc_srt_MinimumMember_58342083-abf1-44ec-88f7-c13fc3267a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ea1f666b-786a-4341-8820-986b3dc0ec6b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7a943b86-710f-4c02-94a4-ba6342b423a5" xlink:to="loc_srt_MaximumMember_ea1f666b-786a-4341-8820-986b3dc0ec6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_bfdfb4ef-0c0b-47f0-bd51-0f4cd6edaf10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_01c9923a-72fd-45af-ac69-a5257d0f792e" xlink:to="loc_us-gaap_VariableRateAxis_bfdfb4ef-0c0b-47f0-bd51-0f4cd6edaf10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9f544c4e-7e90-4a11-8f60-9d1e9aba05a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_bfdfb4ef-0c0b-47f0-bd51-0f4cd6edaf10" xlink:to="loc_us-gaap_VariableRateDomain_9f544c4e-7e90-4a11-8f60-9d1e9aba05a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_f5d724d4-b1b7-422d-98c9-5860decfec72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_9f544c4e-7e90-4a11-8f60-9d1e9aba05a7" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_f5d724d4-b1b7-422d-98c9-5860decfec72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a3b1fa9d-4cf7-4b7e-a15d-3b8cf5214470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/> <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_01c9923a-72fd-45af-ac69-a5257d0f792e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a3b1fa9d-4cf7-4b7e-a15d-3b8cf5214470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1b4f56ad-9040-494c-b289-ae859ad917ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a3b1fa9d-4cf7-4b7e-a15d-3b8cf5214470" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1b4f56ad-9040-494c-b289-ae859ad917ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_d831bec9-5b8a-483f-9710-600e88c1faa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1b4f56ad-9040-494c-b289-ae859ad917ba" xlink:to="loc_us-gaap_ConvertibleDebtMember_d831bec9-5b8a-483f-9710-600e88c1faa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_41974df7-1702-4478-8286-3fc979ad0750" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/> <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_01c9923a-72fd-45af-ac69-a5257d0f792e" xlink:to="loc_srt_CounterpartyNameAxis_41974df7-1702-4478-8286-3fc979ad0750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ba476a30-0ed1-47b3-bce0-757a8d98986a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_41974df7-1702-4478-8286-3fc979ad0750" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ba476a30-0ed1-47b3-bce0-757a8d98986a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_WinHealthInvestmentSingaporeLtdDomain_f6a8060e-a0bf-4a73-b18a-df0d3777553c" xlink:href="cpix-20210930.xsd#cpix_WinHealthInvestmentSingaporeLtdDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ba476a30-0ed1-47b3-bce0-757a8d98986a" xlink:to="loc_cpix_WinHealthInvestmentSingaporeLtdDomain_f6a8060e-a0bf-4a73-b18a-df0d3777553c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_735b1b51-6332-4d24-b5a6-497cfb878f10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/> <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_01c9923a-72fd-45af-ac69-a5257d0f792e" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_735b1b51-6332-4d24-b5a6-497cfb878f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_675fa301-8020-4ef1-9e39-0531b0875be7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_735b1b51-6332-4d24-b5a6-497cfb878f10" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_675fa301-8020-4ef1-9e39-0531b0875be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_87926cf0-c5a8-4783-9759-8a912f95af1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_675fa301-8020-4ef1-9e39-0531b0875be7" xlink:to="loc_us-gaap_SubsequentEventMember_87926cf0-c5a8-4783-9759-8a912f95af1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/> <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_01c9923a-72fd-45af-ac69-a5257d0f792e" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_4342889b-966b-49b2-a0d0-a0209fd6d59c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_4342889b-966b-49b2-a0d0-a0209fd6d59c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount_b15a0fc3-1dd8-4590-b882-1c6b5fc45389" xlink:href="cpix-20210930.xsd#cpix_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:to="loc_cpix_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount_b15a0fc3-1dd8-4590-b882-1c6b5fc45389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity_0411c40d-3134-458d-9a69-815c52a7e0c8" xlink:href="cpix-20210930.xsd#cpix_LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:to="loc_cpix_LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity_0411c40d-3134-458d-9a69-815c52a7e0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_22d0e154-ec5d-40b7-96df-ed7ae7b5f597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_22d0e154-ec5d-40b7-96df-ed7ae7b5f597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3502b971-58b5-484a-996d-f56df0013cfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3502b971-58b5-484a-996d-f56df0013cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_5a321987-37bf-48e5-8a47-082f153f030f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/> <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_5a321987-37bf-48e5-8a47-082f153f030f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived_cc8ecf62-dd77-4011-9a81-87d2e3da5973" xlink:href="cpix-20210930.xsd#cpix_TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived"/> <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:to="loc_cpix_TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived_cc8ecf62-dd77-4011-9a81-87d2e3da5973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_4d15000e-ff90-49dc-b56d-4e2dc6257ec7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermLineOfCredit"/> <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:to="loc_us-gaap_LongTermLineOfCredit_4d15000e-ff90-49dc-b56d-4e2dc6257ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_a4e49abf-46a3-44d7-82d5-edc64d35e2fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/> <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_a4e49abf-46a3-44d7-82d5-edc64d35e2fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_47b529f0-bd21-4b1d-943b-5af2709f30ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_107d8361-6c54-4f69-82ff-ae58438b3065" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_47b529f0-bd21-4b1d-943b-5af2709f30ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/IncomeTaxes" xlink:type="simple" xlink:href="cpix-20210930.xsd#IncomeTaxes"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/IncomeTaxes" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ce0d0b0f-c128-46d8-b2f9-372029be3a99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_af305417-447c-4022-aac0-490a9da59466" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ce0d0b0f-c128-46d8-b2f9-372029be3a99" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_af305417-447c-4022-aac0-490a9da59466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/IncomeTaxesDetailsTextual" xlink:type="simple" xlink:href="cpix-20210930.xsd#IncomeTaxesDetailsTextual"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/IncomeTaxesDetailsTextual" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f6ebda8e-8616-4e4c-893e-28c78f9dace3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_12e749c2-0c29-434c-bf52-a0475ce44ac0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f6ebda8e-8616-4e4c-893e-28c78f9dace3" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_12e749c2-0c29-434c-bf52-a0475ce44ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_f82cd8d9-ea8d-4bd9-a01b-3925e3e0ca63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_12e749c2-0c29-434c-bf52-a0475ce44ac0" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_f82cd8d9-ea8d-4bd9-a01b-3925e3e0ca63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_13c626d2-9a2c-4fa7-aa11-4dcefbe71155" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_f82cd8d9-ea8d-4bd9-a01b-3925e3e0ca63" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_13c626d2-9a2c-4fa7-aa11-4dcefbe71155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_f3ec2b82-7017-45e2-b743-54380977ea69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_13c626d2-9a2c-4fa7-aa11-4dcefbe71155" xlink:to="loc_us-gaap_DomesticCountryMember_f3ec2b82-7017-45e2-b743-54380977ea69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_2b9fa7b0-59ff-4c6e-8458-84e58541a496" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_12e749c2-0c29-434c-bf52-a0475ce44ac0" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_2b9fa7b0-59ff-4c6e-8458-84e58541a496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_dc041ee2-e7fb-4b58-8b16-73fad793b169" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2b9fa7b0-59ff-4c6e-8458-84e58541a496" xlink:to="loc_us-gaap_OperatingLossCarryforwards_dc041ee2-e7fb-4b58-8b16-73fad793b169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/CollaborativeAgreements" xlink:type="simple" xlink:href="cpix-20210930.xsd#CollaborativeAgreements"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/CollaborativeAgreements" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_48f9da30-4449-4233-8765-dcd99f3390c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_3b113f4d-6bc6-4b8a-b9f2-da34a73ac59d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_48f9da30-4449-4233-8765-dcd99f3390c8" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_3b113f4d-6bc6-4b8a-b9f2-da34a73ac59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRights" xlink:type="simple" xlink:href="cpix-20210930.xsd#AdditionsandReturnsofProductRights"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRights" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_e8df8145-a24a-4de8-ae8f-8472d6dbac3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_bb59baa3-6eb3-4333-8a16-86ea562aec46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_e8df8145-a24a-4de8-ae8f-8472d6dbac3f" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_bb59baa3-6eb3-4333-8a16-86ea562aec46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsTables" xlink:type="simple" xlink:href="cpix-20210930.xsd#AdditionsandReturnsofProductRightsTables"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsTables" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_b91027c4-ebc1-45b6-a14e-a0be68517371" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_7a63d797-e7b7-4124-a794-e0e68af96d77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b91027c4-ebc1-45b6-a14e-a0be68517371" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_7a63d797-e7b7-4124-a794-e0e68af96d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_32885043-b411-4575-a33d-23fae15e7173" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b91027c4-ebc1-45b6-a14e-a0be68517371" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_32885043-b411-4575-a33d-23fae15e7173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#AdditionsandReturnsofProductRightsNarrativeDetails"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_94ecfb0d-2da9-497e-8f6c-a30e45b95377" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20673524-8b4c-43bb-97aa-412ed7e82950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_94ecfb0d-2da9-497e-8f6c-a30e45b95377" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20673524-8b4c-43bb-97aa-412ed7e82950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_310c4c54-a67c-4ea0-9ce2-0558ce1d9672" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20673524-8b4c-43bb-97aa-412ed7e82950" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_310c4c54-a67c-4ea0-9ce2-0558ce1d9672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_559237ab-2ebb-4cd0-90d2-9ecb0f6b87ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_310c4c54-a67c-4ea0-9ce2-0558ce1d9672" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_559237ab-2ebb-4cd0-90d2-9ecb0f6b87ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_VIBATIVMember_0e55168e-d2e5-42e5-8203-c9e286e0ae59" xlink:href="cpix-20210930.xsd#cpix_VIBATIVMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_559237ab-2ebb-4cd0-90d2-9ecb0f6b87ba" xlink:to="loc_cpix_VIBATIVMember_0e55168e-d2e5-42e5-8203-c9e286e0ae59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_MethotrexateMember_1518488e-ed09-4d1e-9ef3-1d35173e328d" xlink:href="cpix-20210930.xsd#cpix_MethotrexateMember"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_559237ab-2ebb-4cd0-90d2-9ecb0f6b87ba" xlink:to="loc_cpix_MethotrexateMember_1518488e-ed09-4d1e-9ef3-1d35173e328d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_da3d62f9-c1f6-4a0d-abbf-c43ee51cca4a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20673524-8b4c-43bb-97aa-412ed7e82950" xlink:to="loc_srt_CounterpartyNameAxis_da3d62f9-c1f6-4a0d-abbf-c43ee51cca4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_270d9c0e-fa4a-4b7c-b301-e2e484aaeb6b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_da3d62f9-c1f6-4a0d-abbf-c43ee51cca4a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_270d9c0e-fa4a-4b7c-b301-e2e484aaeb6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_ClinigenHealthcareLimitedMember_f2507615-d2bc-4876-ba61-957136b2a54c" xlink:href="cpix-20210930.xsd#cpix_ClinigenHealthcareLimitedMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_270d9c0e-fa4a-4b7c-b301-e2e484aaeb6b" xlink:to="loc_cpix_ClinigenHealthcareLimitedMember_f2507615-d2bc-4876-ba61-957136b2a54c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_05d54064-360d-4db8-bae2-91d4d395ae72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20673524-8b4c-43bb-97aa-412ed7e82950" xlink:to="loc_us-gaap_AwardTypeAxis_05d54064-360d-4db8-bae2-91d4d395ae72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a30148bf-073f-49d7-832b-fe0dcfbb21d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_05d54064-360d-4db8-bae2-91d4d395ae72" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a30148bf-073f-49d7-832b-fe0dcfbb21d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_bb345acd-2fb3-430f-9e10-86d8e893249a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a30148bf-073f-49d7-832b-fe0dcfbb21d5" xlink:to="loc_us-gaap_RestrictedStockMember_bb345acd-2fb3-430f-9e10-86d8e893249a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_a7064d94-240e-4007-b5ef-bfaea09e4900" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20673524-8b4c-43bb-97aa-412ed7e82950" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_a7064d94-240e-4007-b5ef-bfaea09e4900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_61ac4cd5-5856-473a-b95d-c6f63d95effa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a7064d94-240e-4007-b5ef-bfaea09e4900" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_61ac4cd5-5856-473a-b95d-c6f63d95effa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_42c04725-0271-4d1e-8d37-a546c8bf8b98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_61ac4cd5-5856-473a-b95d-c6f63d95effa" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_42c04725-0271-4d1e-8d37-a546c8bf8b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_43dd8daf-1c8d-447e-9574-9fb2ec91c375" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_61ac4cd5-5856-473a-b95d-c6f63d95effa" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_43dd8daf-1c8d-447e-9574-9fb2ec91c375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_20673524-8b4c-43bb-97aa-412ed7e82950" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_9c1a2f96-471d-456e-ab80-76d6f344d483" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_9c1a2f96-471d-456e-ab80-76d6f344d483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPaymentsToAcquireBusinesses_42c4ef9e-6ea8-4026-b173-751816282868" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPaymentsToAcquireBusinesses"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:to="loc_us-gaap_OtherPaymentsToAcquireBusinesses_42c4ef9e-6ea8-4026-b173-751816282868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_TieredRoyaltyPaymentsPercentage_7d7fe71d-78db-4b6a-92e7-6fbdd81abe94" xlink:href="cpix-20210930.xsd#cpix_TieredRoyaltyPaymentsPercentage"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:to="loc_cpix_TieredRoyaltyPaymentsPercentage_7d7fe71d-78db-4b6a-92e7-6fbdd81abe94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_4c947c7b-a8c5-4ab8-8c75-4f62023e5331" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_4c947c7b-a8c5-4ab8-8c75-4f62023e5331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_c13db486-f28a-43f0-a8c5-3c47cb6bebfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_c13db486-f28a-43f0-a8c5-3c47cb6bebfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2dfdf1f2-5e47-4999-870f-25da027166c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/> <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2dfdf1f2-5e47-4999-870f-25da027166c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_5cd5359e-b410-455f-bc81-0bf641fa18bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/> <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_5cd5359e-b410-455f-bc81-0bf641fa18bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_dadd1450-b296-4708-9488-b0b765216fcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/> <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_dadd1450-b296-4708-9488-b0b765216fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets_93993c6c-dabe-4afe-97ed-ffcfb855715a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets"/> <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:to="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets_93993c6c-dabe-4afe-97ed-ffcfb855715a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_ProceedsFromSaleOfIntangibleAssetsInstallmentPayment_2b94563c-3af2-4bb3-980a-d08fa6701ba1" xlink:href="cpix-20210930.xsd#cpix_ProceedsFromSaleOfIntangibleAssetsInstallmentPayment"/> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:to="loc_cpix_ProceedsFromSaleOfIntangibleAssetsInstallmentPayment_2b94563c-3af2-4bb3-980a-d08fa6701ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_9a9f1ec0-c15a-4466-bfc2-d6a3d5f17cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/> <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d8dec2bb-d3fa-4dde-b4f3-6296f7e75fe5" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_9a9f1ec0-c15a-4466-bfc2-d6a3d5f17cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsChangeinConsiderationDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#AdditionsandReturnsofProductRightsChangeinConsiderationDetails"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsChangeinConsiderationDetails" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_aea67cc1-ddf8-4fd0-829b-7a38d8a1a549" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_430dbb52-e367-4e81-b9fd-a4c71bfa1577" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_aea67cc1-ddf8-4fd0-829b-7a38d8a1a549" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_430dbb52-e367-4e81-b9fd-a4c71bfa1577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7e648ce0-f9b4-4737-8d54-25bf96ed4285" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_430dbb52-e367-4e81-b9fd-a4c71bfa1577" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7e648ce0-f9b4-4737-8d54-25bf96ed4285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a447d0a-5e08-4530-bd4d-f58a112f826a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7e648ce0-f9b4-4737-8d54-25bf96ed4285" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a447d0a-5e08-4530-bd4d-f58a112f826a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_VIBATIVMember_3c730611-9292-4681-9abc-9973fbe40a2d" xlink:href="cpix-20210930.xsd#cpix_VIBATIVMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a447d0a-5e08-4530-bd4d-f58a112f826a" xlink:to="loc_cpix_VIBATIVMember_3c730611-9292-4681-9abc-9973fbe40a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c7d7c39f-2747-4349-8157-5084f6d99ab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_430dbb52-e367-4e81-b9fd-a4c71bfa1577" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_c7d7c39f-2747-4349-8157-5084f6d99ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualRollForward_69719e0a-48c0-4796-8d5c-2b42027ad89a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualRollForward"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c7d7c39f-2747-4349-8157-5084f6d99ab4" xlink:to="loc_us-gaap_LossContingencyAccrualRollForward_69719e0a-48c0-4796-8d5c-2b42027ad89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_907d8116-5347-41c8-b2d7-f03415937612" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_69719e0a-48c0-4796-8d5c-2b42027ad89a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_907d8116-5347-41c8-b2d7-f03415937612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_121ee9c3-7bc9-491f-8e79-2c926aa6ef59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRoyalties"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_69719e0a-48c0-4796-8d5c-2b42027ad89a" xlink:to="loc_us-gaap_PaymentsForRoyalties_121ee9c3-7bc9-491f-8e79-2c926aa6ef59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ee318128-bf86-4927-8e67-51fdc5b47ff7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_69719e0a-48c0-4796-8d5c-2b42027ad89a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ee318128-bf86-4927-8e67-51fdc5b47ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses_ac1ee07e-698f-46a8-b06e-ec16d17c1e15" xlink:href="cpix-20210930.xsd#cpix_BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_69719e0a-48c0-4796-8d5c-2b42027ad89a" xlink:to="loc_cpix_BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses_ac1ee07e-698f-46a8-b06e-ec16d17c1e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e049554e-8d44-4e09-bba3-7f63810708ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/> <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_69719e0a-48c0-4796-8d5c-2b42027ad89a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e049554e-8d44-4e09-bba3-7f63810708ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/> </link:presentationLink> <link:roleRef roleURI="http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsDissolutionPaymentsDetails" xlink:type="simple" xlink:href="cpix-20210930.xsd#AdditionsandReturnsofProductRightsDissolutionPaymentsDetails"/> <link:presentationLink xlink:role="http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsDissolutionPaymentsDetails" xlink:type="extended"> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_b53702ec-5b65-4b3f-97cc-ff54b6fceeb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d5178dc6-a611-4ff8-a504-8d579dab36f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b53702ec-5b65-4b3f-97cc-ff54b6fceeb9" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d5178dc6-a611-4ff8-a504-8d579dab36f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_9a4992ae-e38f-4cfd-955b-251316829cd8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d5178dc6-a611-4ff8-a504-8d579dab36f5" xlink:to="loc_srt_CounterpartyNameAxis_9a4992ae-e38f-4cfd-955b-251316829cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_23e661db-e953-4963-8450-a34584c2c841" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_9a4992ae-e38f-4cfd-955b-251316829cd8" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_23e661db-e953-4963-8450-a34584c2c841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_cpix_ClinigenHealthcareLimitedMember_39221abf-bb00-4648-9275-c66638c9b9f0" xlink:href="cpix-20210930.xsd#cpix_ClinigenHealthcareLimitedMember"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_23e661db-e953-4963-8450-a34584c2c841" xlink:to="loc_cpix_ClinigenHealthcareLimitedMember_39221abf-bb00-4648-9275-c66638c9b9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5ffaf73d-e852-4b6a-8166-b950defb28eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d5178dc6-a611-4ff8-a504-8d579dab36f5" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_5ffaf73d-e852-4b6a-8166-b950defb28eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_27d02636-cbfb-4208-b0e4-bf1d6e6f3ef7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/> <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5ffaf73d-e852-4b6a-8166-b950defb28eb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_27d02636-cbfb-4208-b0e4-bf1d6e6f3ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_874ee80e-526b-4260-8434-d695346293fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/> <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5ffaf73d-e852-4b6a-8166-b950defb28eb" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_874ee80e-526b-4260-8434-d695346293fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_176d68d4-abc5-412b-b5c1-941628452b93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/> <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5ffaf73d-e852-4b6a-8166-b950defb28eb" xlink:to="loc_us-gaap_SellingAndMarketingExpense_176d68d4-abc5-412b-b5c1-941628452b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_96bb49e8-f2af-4ba7-a358-17a73cab9569" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/> <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5ffaf73d-e852-4b6a-8166-b950defb28eb" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_96bb49e8-f2af-4ba7-a358-17a73cab9569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/> </link:presentationLink> </link:linkbase> </XBRL> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>11 <FILENAME>pinnaclelocrenewal4thloa001.jpg <DESCRIPTION>GRAPHIC <TEXT> begin 644 pinnaclelocrenewal4thloa001.jpg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˝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end </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>12 <FILENAME>pinnaclelocrenewal4thloa002.jpg <DESCRIPTION>GRAPHIC <TEXT> begin 644 pinnaclelocrenewal4thloa002.jpg M_]C_X 02D9)1@ ! @ 0 ! #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_ MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P 1" 55!!\# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#WE/\ CYD^ M@J:H$_X^9/H*GH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@"!/^/J3Z"IZ@3_CZD^@J>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** *Z?\?4GT%6*@3_ (^9/H*GH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@"NG_ !\R_5:L57CYN)?^ U8H **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@"O%_Q\2_A5BJ\7_'Q+^%6* "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH K0?ZZ7_ '@/TJS5>'_7 M3?\ 73_V6K% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5 MH?\ 7S?]=/\ V6K-5H?]=-_UT_\ 9:LT %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110!6M_]=-_UT'_H-6:JVW^ON/\ KI_[**M4 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110!4MO]=.?^FG],5;JI:<O. M?^FAJW0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %2S^]/ M_P!=35NJECUN/^NIJW0 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4453U'5+/2;<3WLIC1FV*%1G9FQG 5023@'H M.U %RBJ.D:QI^NZ>E_IETMQ;.2 Z@CD=00<$'ZU>H **** "BBB@ HI"0H)) M Y)/:L&'QCI$\T"!KI([B18K>=[6013,QPH1\8.>WMS0!OT444 %%0SW45O M;S3.6985+.(U+L,#.-HR2<=J=#,L\$<R!@LBA@&4J<$9Y!Y!]C0!)1110 45 M3O-5L=/N+2WNKA8I;R3RK=#G,C8S@5<H **P[/QAH%_JBZ;;:@K73EQ&IC=1 M(4)#;&("MC!Z$]*W* "BD) !)( '4FL^RUJTO[A8K<3D/%YT<IA81R)G&5;& M#V_ @]#F@#1HK/UC6;+0]+N-1O786]OCS3&A<KDCL.>XJ\CK(BNI^5@"* '4 M45E:MXCTK0Y[2#4+AXY;MMD"I!)(9&XX&U3SR* -6BBB@ HHHH ***KVM]:W MIG%M<1RF"4PRA#G8XZJ??F@"Q1110 4444 %%%% !1110 4444 %%%% !111 M0 45#=W=O86DUW=2K%;PH7DD;HJCJ:ACU6PE>SC6ZCWWL1EMD)P9$ !) /H& M'YT 7**** "BHYIHK>"2>9U2*-2[NQX50,DFBWN(;JVBN+>19(94#QNIR&4C M((]L4 24444 %%%% !1110 45%-=6]N\*3S1QM,_EQ!V WM@G ]3@$X]JEH M**KW=_:6 B-W<Q0^=(L,>]@-[L<!1ZDFK% !1110 45 ][:QWD5F]S$MS*I: M.$N-[ =2!U(J>@ HHHH **** "BBB@ HJ"\O;73[5[J\N(K>WC&7EE<*J_4F MIE964,I!4C(([T +14<\\-M!)//*D4,:EGD=@%4#J23TI8I8YX4FAD62*10R M.IR&!Y!!]* 'T444 %%075Y;648DNKB*!&8(&D<*"QZ 9[GTJ>@ HHHH *** M* "BBB@ HIOF1^;Y6]?,V[MF><>N/2G4 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 5+'I/\ ]=35NJECTG_ZZFK= !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4<JL5)0)Y@ MY0L. :DJCJ6DV^JI$)WN(S$^]'MYWB8>HRI!P: ,+P+&UE9:GIL\4*7EI?R? M:&@SLE9PL@<9Z9#CCMBNKJ@-&T\:<=/-N&MF8.RLQ)=MP;<Q)R3D Y)S5^@ MHHHH **** (;N2&*SGDN6"P+&QD8]EQS^E>=VC7?A!M+L[EK?6/"TUQ$MC<, M!Y]HS']T".C*.,-U&?8"O0=0CGEL)H[=())77:$G)V,#U!QSTS7(6OA;4K*6 M!H;/362W;=!#)?7+Q1'L51LJI'; X[4 0-?>)]8O-4ETV[MX(K+4&@C+3A41 M4V[@Z>42V1D_?'WAC&*NP2ZGJ[7=_#KQLQ::F\!@VH8EBC?:RME22S 9R2,% MABJUUX/N[W5GU.XTK1WN9"IE_P!+G"2E?NET"[6Q[@]!4K^%;R35FU-M*T@7 M,C!Y=EY.J2L.C.@7:Q'J0: ,NRO;W3=!\?ZC#J$HN+?4+DQ-(JN%98TVG[OT M&.F .*U+#6+_ %S4;#23?RVI;18;^::!%$CR.<<$@@ 8)P!W].*;/X5U"X74 MD>QTT1ZDVZZ1;^X57) !. , D 9QC.*=-X9U:2.Q$<%A!)8Q>3;S0WTZR+'P M"I;;R.!P<]* ,=O$'B.[L-%A753:W3ZQ+I=S/';1L)@A;YP&! /R]N,YXKKO M#-UJ$DVLVM_=F[6SO?)AG=55V7RT?#!5 XW]0.:R7\-7Y734?3].$>G2"2V6 M._G7:_/S'CYF.3DG.<G/6M?2])ETN>\N8+5%GO7$EP6NY) S 8!^;IQQQZ#T MH 3Q1@G1>G&J0?\ LU;^X>_Y5@:GIESK#0F[M0IM9/,MVBO73#XX; &"1VSF MH+BPU^YU"WO7M]-\RW618PMY,HPX .0%P3QP>U #[BPAU/Q'IGV> );:.SR& M1 OF%"@B ]@V3Z8 ^D_B?4I["RM([:3R9;V]BLQ/@'RMYQN (P3Q@9[D5S] MCX-N-/N;>5+&U*12^8$;5;J1 V<[MC_*3GGGOSUKLKW3[74[![.\@66"0#<G MOUR#U!!YS0!RUQ<:E97VN:*]Y-=P?V2UW;SRHK21,=R%3@ -R,@=>M:7@5)5 M\#Z*99Y)2UE$1YB!=HV#"@ #@>IR3ZU>_P"$>TXV]]"T<C_;D\NXD:9S(ZXQ MMWYW 8SP#W/K5G3--MM(T^*QM!*+>$!8UDE:0JHZ %B3@=AVH \YU6"?_A"? M'N^[N)S]ME0+*5/\$6.<9]L9P !Q6IJ&N:IX6EOO/NGOUBTAKU(9(T18Y%<+ MM&T [?F'4D\=:Z.[\*Z1>PW\4T,OEW[B2Y5+B1 [ 9P&XS@9QC.!FIO^$>T MXZG_ &@\<LEQ]F^RGS)W96B[J5)P<]\CF@#,T1/$?]HPSW=[!<Z9/;;R&D1V M5\@J4*1)E<'OGJ/QK^*?^1R\&_\ 7W/_ .B6K6T?PMI6A7$D]C%*K.NQ1),[ MK$G!V(&)"KD#@>@]!4FK>';#6I[2XNQ.)[-B]O)%.T9C8]Q@X)^H- %?Q;K4 MF@>'9[Z$+YH>.-2ZEE3>ZIN(') W9QWZ=ZR[G5-1T+5Y["YU>*XA?2Y;Q+F^ M1$\B1&5>?+504.\'&,\'GFM<^%].FM[B&]\^^%Q'Y3FZE+D)G.%_N\@'(P<@ M>@J,^$-*EMKF&\6>]^T0?9WDN92["/.0H/;GG/7('H* .<MO$>JQS:U:O>S, MMOI0OXKB\MTC=6RP/R@+\AVY&X9]:O\ AG5-4NKC0Y;[4O/75-*:Z: 0(BQN MOE<@@9Z2<@GKR,=!=C\"Z.DUU+(]_.]W:FTN#->R.9(_0DG\.,=3ZU/:^$M/ MLY])FBENP=+A:"V!F) 0]0?7@ ?\!% %S7]1ETO1;BYMHO.N\".WB_ORL=J# MZ;B,^V:XO085\*>/HM*C\\6>LV?F;I@1ONHA\[9;DEEY/N:[N\TVWOKBTGG\ MPM:2>;&JN0N[!&2!P<9XSTJOJV@V&MM:->I,S6DOG0F.=XRC]-WRD<_XF@#C M==\2:RFH:K:V.H"#4[:[@AL],$2/]HB?;F4Y&X_>;[I 78,^^E:S>(+_ ,6Z MAIJZY EKIIMY) MF-\N\%BA.[@87J.>:SCX7OYM<U":XAUN*XNKEW2[L=2$< M*Q\*A*[@VX(!D;3G%=7IGARVTW5KK5%N+F6\NXT2X+R'8Y4 [>@(QQ]30!@ M:+JOB755M]4+PI9&XD5XLIL>(.RX7^(.N.I.#SQ5?0M4\6ZVNFZQ 52PO'+2 MQ3-$8HXCD#8% <L#CJV#ST[=#;^#='M=6&H0QSJP<RK;_:'\A7))+"/.T'D] MO?K26G@W2K"]>YMC=Q*7,J6ZW#>3&YS\RQYV@\GMCF@#EAKWB1=$\.Z@NJ0M M/?ZA_9\L3VJ^4<M(OF<8;(V= <5=U3Q5JNBP:W;R&&ZN;6>VBMI1'L'[_@;A MG'RG)ZC-;:>#=-2PL+,2W9BL;O[9!F;)$N2<DXY&6;CW-$_@S2;N;6GNEFN$ MUC9]IBE8%5*+M4IQE2![T 8FLZIXQT[1]9NQ#;PI' K6CR;9)!(6"E2%.TYS MD$CCN#2>(-5UVP@U.QGO(_,?0[B]BFAA"&*2/&Y1DGC#+S^-:#?#W2FTV\LO MM>I$7:K'),]SYD@13G8K.#M&>3CK@5=N?"-I>7:SW5[?3 :>^G-&\B[7B<88 MG"YW' )((Z#MQ0!>T"&:WT"PBN+@W$JP(#(5QGY15+QCJ>HZ3X>:[TLP_:OM M$,2B9-P(>14QU&/O=?\ ]=.@T":SDT=;;4KYX;'>L@FGSYR%2 & #$$K@]@ MM6];T2#7;.*UN9KB.*.=)_W#[2Q0Y )QTR ?P% '.W6J>([?6H]$MY;:]N3# M)>2RHBQE$+[40(S'CKR2<X_&GMKVK6DVC6&M/:Z=/=QS&6X W)O4_(BDG )4 MACGT('MJ:[X3T_7[NTO)I+JVO+4GR[FSF,4FT]5)'8__ *JP->\,S3:O81P1 M:REA:P-Y4^FWB+)YSL2Y?S#DDX!W#))8YH GLM=UR[T+1;NYDM;::]E<21QV MKF1D ;;Y:%CG.T$L> #FDL_$6N:EI_A][=[&";499X9C+;N^WR]_S* XP3LZ M'/7K5FS\(FZCM;G4;_5#=6K2?997N )XXW50R.R_*QRIYY^M6+7P58V(TU;6 M^U"--/GDGA3S58,SYW;BRDD'+=_XC0!EWM[J^J:1XAM/[0M$.FVYMYV6V),T MGDAW(!;Y5^;:!R<@G/:KVCWUU&_A[3T%OY,^BF96:,ETD00CKG&TB3IC/'6K MUSX3TZYOM0N]]U"^HQ"*[6&4JLH"[02.QQQD<T^T\-V]E?:?=17=V?L-JUI% M$[JRF,[<YRNXGY%YS_"/>@#"T;Q-KMYHVD:I>+IZQWE[]E>&&)\X+L@=7+D? MP@XP<COSPJ^)]8N(YY;:&W$JZN-.%I)"Q=$R!YAP<GY3OZ8VCZFM6V\(V=KH M=GI,5Y>B&SN5N('+KO5E;<!G;@KDG@CI7+V6CZ[%J=[=0R:U::C=2RR%2EM+ M;)N?Y<.V3M "\#G'0"@#N-;NI[#0+^\MQ$T]O;/*HE!*$JI." <XXK+GU75? M[3T>SM#8HE_:/*3)$Q,;)L)( 89&&QCCZ]JV[ZR74=,N+*9V5+B%HG:/&0&& M#C.?6LZ+PU#%?Z;>_;KQY=/MVMHMY3#*V,EOEY/RKR,=/KD YVUUK5M5U+PP M\MQ! S75[#<Q0 E)#%N4<$Y'0G!SU!J<^)?$&H7&H/HFE_:(K*_:S*.(U60( MP$AWF4$'KCY2/7.>+T'@BSMHK98M2U)9+:XFN8YA(@?=*#O!^3&#DGID9X-2 M?\(78#5+F]BN[^&*ZF\^XLXY\03/W++C//< @'O0!E1^)/$$=GK>KW/]G-8: M7/<Q?9XHG6641@X.\L0.<=NF:N-JGBR W4ITE+F!;-I8\!(R9@!A% D<L#SU M .1UYK2M?#-G;VFJ6DLL]U;:E+)+/%.5(!?[P7 & :JV7@VWL[%[7^UM6G'E M>3$\]P&:!<@_)\N,\#D@]* ,.Y\176L: UWIFM0%(M0LT81V[1S*&F56CD4M ME>3U'4 COFO0!G R03WP*P3X4MYH+S[3>7,MU>/ \MT BOF%@T> %V\$9Z<Y M-6(-.OX?$;7;:A/+9&S6)H9&&#(&^^ #C.3WR..* (-9U.>T\1^'K)8+>2 M"]GE5WD4EXRL3,"G8=,$^AJAI_B:\N_$YTF=K6UFCGF#VDL+K*\"@^7)&Y.U MLD D ="?2MC4]#74M4TJ_-U+"^G2M*BH%(?<NT@Y!XVDCCUJJOA6!M3M;NXO M)[E;2XEN;:*4)^[>3.?F R0-QP"?3TH S/B.95TO1F@19)AK5H8U=MH9M_ ) M[#/>F3^+=1TPZO!J"6<EQ;7-K;VS0(RAS/C&0S')7)/!&0.U;^OZ$FO06D;W M,L'V6ZCNT:, DNARH.0>,U3OO!]AJ4^KM=37$D6IK%YD>0/*>,85T.,@CCUY MH Q/$GBCQ1X:TC4]1GTVSDM[98FAF/R!BSA&0H)&.?F!!R!UJ_)K>O6NHVFE MW$-E+>W323!K:-V6.W78!E6898LV,[@ .<4Z?P':W^B76F:EJ^K7R7*HC233 M@LH5PXVC;CJ!DD$^]7M=\+0:W)97 OKNROK+(AN[9E#X888'(((/TH P[FX\ M07&J>'VN;&UM=3$UU&-[[HRFSB3"DGI_#NZ]^]0OXOU^#3[^6X@T\3Z-?I#J M02.1E:W;:?-C^;*D*Q)!W=/PKHH_"\<,-H4U&]-Y;2/(+N5E=W9QAMP(QC& M ,8%1W=K'H>DW<=KIESJD]])(TJ@*3-(X_Y:'@!<87.. !0!;T[5'U/5;P6 MSP2:=;HD8D4'<TQ&YAG.-H4Q]NI//%9?BK7]3T3[5);?81%#827,:RH\LDSI MR1M4C:H&,L<C+#TYU?#.B1^'O#ECI:;28(P'91PSGEC^9-4=9\()K%_=W/\ M:M]:I>68L[B&'9MDC&[^\I(^^>E $4^LZQ<>(QING-IRQ2Z<+R*69'<@[PO( M##(.?;^E9VF^+=8N?^$5N;F&Q6VUL;'B1'WQL(RVX-NQ@XZ8R,]36K8^$38: ME%J":M=/<1Z<FG@O&F-B\@].N[FH;?P-#!9Z#;?VG=NNBS^;;L0@+#IM; Z8 MR/H: *=IXJUS5#;WFFZ6)K"2\,+(8L,(E<HS^9Y@&>,[=GMGO48\3^(5L)]1 MDCTP6MOJYL&C5)-\B?:!#N!W84C.>AS[5I0^![:UU"::UU348+.:X%R]A'(H MA\P-NX&,A2>2H.#41\"1OHE_I;ZO>-'>WOVUWV1AEDWASC"\ L ?PH S/%FH MZCK?A3Q0+3[+#96GF6A$\3,\Q4#>RD, N"2!P>15V^\1ZM'J-_H^BV2W$^F6 MT19FB\P/*RDA.'7:, <G/7I5BZ\"07!U=8M6O[:#5AFZ@BV;#)P"ZY7()QSZ MYJ27P9G5AJ=MKFI6UVULMM<21^63<*O1FRF-W/44 9.J:]J.M>'O$=O';0VC M6.F8NXI@7/FO"79%8,,;00,X.2?:NLT+_D7-,Q%Y?^B18CX^7Y!QQ6-/X%M= MU[_9^H7EA'?6RVUU%'L=955"BD[U)!VG!((S6]9:<MGI$.G&>:=(XA%YLA = MAC') '.* .7T_P 6:E+XBL-,N4L9/MT=PV+;?BW>+'R&3)63K@X P1TIVG^* M-7FL=!OKF"P\C4[D6S+"SD@D.0X)[?(."._6I-,\"#3;[2[@:W?3+I<+PVL4 MJ1;41EP0<*">@[]JFM_!GV72])L$U:Y:/3+H7,+/&A+8R-IXZ89AZ\^U &)X MAUJ?7?!S:E#%;?8#J<4,0D0L[*MP$\P'C:21TQT[UUGBC5I="\,ZAJD"1226 ML1D5)20K8[<<_P#UZR7\!0#3I=,M]5O8-->Y6Y%N C;&#A\*S*3C<,XK:\0Z M,-?\/7FDO<-"MS'L:4+N(&1GCCTH Q;CQ'JUG<Z;9SVENUWJ#-)'%;AG,<*K MELY(#-DJ."!R35=_%VK6NF1W&J::NF@WKV\ES/&[1)&%RLA4<@,3C).!@Y-: MNK>%QJUIIQ_M"XMM2T\ P7L (; #93H0V.0:$\-W<:0,=;N9Y@TC7!N4#QW M <*"IC& % 48 QCGKDT 9UCKFKW?BC1()7M%M;K3YKB2. [PQ!0 AP2".<C' M8G.:GM_%<Y\1VFE7,%JDES-+#Y$<V^6#8K,K/CCYE3('!&1UIVE>"H=%FTA[ M.]D"Z?!+ 5= ?,61P[?[O(]^./>F:=X+DTU](6/5I'@TN>2:%)(06?S X8.V M>3AVYX^E %30?$^H?V3J-SJ.R:;^UY;*V6,-C._: 0 2% &>YP#5EO%][!<W M5M<:+<!Q<PVUG*%=8[EI,9^\H("\Y.#P#4EQX,-SH=SI;:G*JF]:]M)DCVO; M2&4R<$'YL,QQFENO"NH:CI?E7WB":34$GCGM[N* 1K"R9QB,'!SELY/.<= * M ,O18[YOB[J\EX(<II<*[H2=O+Y'!Y['\O?%='X@UJ;18HY5CM1!LD>6>ZN! M$B;1\J]"26) X]#[ Q:7X?O+/Q!=:Q=ZHEQ+=01PR1QVHC7Y,X(RS$=6XSW] MA2ZKH-[>ZU%J-GJ@M2MK):O$\'FJ0Q!W+\PPW YYXH QSX_2>WTDVL-M'/J5 MD;J)+RX,2LV0/*5MN"V<_IZBNR@D:6".1XS&[*"R$Y*DCI^%<C)X(NGT"+1' MU2VGL$LQ:^5<V.\94G;(,2##@$<^V>*ZFPM!8:=:V8D>001)%O<Y9MH R?<X MH LT444 %%%% !1110 4444 %%%% !1110 4444 %%%% %+3SE9\_P#/9JNU M1T[[L_\ UV:KU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% '*:KXB9_&-MX:M+UK69[22>218-Y5LJ(QR",<L3]!R*U++7+%C:V<VH0RW MKYBW*I599%'SA#T/.> >*RSYT?Q1><V=V;9]+2W%P(&,8D$C/M+8QT(YZ=LY MK%33+^^\)Z3X7N=/N(+ZRN(%><1DPA(F#>8LG3E1@#KDX( H U-6\07]AHOC M&Y2;,FF2;;4[%^7,$3@'CGYG/7M6\VN6<-M:23NPDN8Q(D4<;2/@XR=J@G R M,GH*Y'5K2]U/1?'-K;6%WYMW*&MA)"R><!#$GRDXS\R-^GK5]!=Z;XP.L-9W M4VFW^GQ1 Q0LSVSH20K1CY@#N/0<'KCK0!OGQ#I(:S7[=$QO%9K;;EA*%&3M M(ZX Z4VV\1Z1>6J7-M?1RQ/<?9E903F7^YC&<UR;>&]0M?"%G-;VLAU*RU-M M2M[,R#A6E8F(D9'W'(/;)SFIM \+:AIWB9DNY%FLHV_M+S%! >\D0QO@>G#M MCMO'H* .M35["2]%FERK3DLH4 X)7[PSTR,\C/%/T[4K35K);NRF$L#,RAP" M.5)4]?<&N/TVVU2P\6*=.AOH=/N+J=KZRN4W1)DL1/%(>FXX.P'^(\5V&F7D ME_8I<26<]HS,P\F< . &(!('J!G\: +=%%% !1110 4444 (1D8HVCZTM% " M;1Z#\J-H]!^5+10 FT>@_*DV#T_2G44 (% - &*6B@!,4;1Z#\J6B@!-H]!^ M5+BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** #%&*** "BBB@ Q1110 4444 %%%% !1110 48HH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** * M.F\QRG_IL]7JH:5_Q[N?^FK_ /H57Z "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "@T44 )2T44 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 9^E?\>K?]=7_]"K0K.T@YLL]S(Q_\>K1H **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBN>\(:Q>ZU87TE^(1-;W\]K^Y4A<(V!U- '0T5F: MJ^LEXHM(2T5B&:2:[#,@ '"@*0<DD<] >M5O"FKWVLZ3)+J5K';WD%S+;2B M$DQLR-M+*3SC_ T ;E%%% !1110 45R-KX@U*3Q[J>D7,]E%IVGVZW#OY15F M5AQEB^!M[G'/M6[!K^CW,R0P:M8RRO'YJI'<(Q9/[P /3WH T:*Q](\3Z5K> MFS:A:W48MH9'1W=@NW:Q&X\\ XR,XXJP^NZ3'"TKZI9+&L@A+M<( '/1<Y^] M[=: -"BLR3Q%HL-HET^K60MY&*I+YZE6(." <\X/7T[T^37-)AA2:75+)(I( MQ(CM.H5D/ 8'/(/K0!H45DVGB'3[S7[W18YA]LM%5G0G!.X9X'MQ^=:U !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 9NB\Z>/]]O\ T(UI5F:'_P @ MR/\ WF_G6G0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 (3@$URG@6&>WL=7%Q;7$#2: MK<S()HF0LC/E6&X#((KK** .6U+Q-<2:/92V&F:HKWX.7-F[/:KT)9 #\WH. MA]<5I>'KB*6P:&WL+ZT@MV\M/MD;(\G );#?,>2>3U.:UZ* "BBB@ HHIC@D M<#GZT <!;SBT^*/B*YGM[H6TMA&B2BVD9&9!\P!"\G^=5="-M::/X&_T&XAE MM9&^T_Z"ZM&?LTB,6PO=RO/?@UVC>'+-W+,]Z23DXO)0/R#8IO\ PC5C_?OO M_ Z7_P"*H X!+34T\ PQ0V>H&33]<>XO+>%6CE>$2N_R$XW=58;<]*?KT5M> MZ)<W5CHNH&.:_LVDN+J.5YYV1OF_=L"0JIQNXSDCM7>?\(U9?W[[_P #I?\ MXJI%T"TV!2;GCIFZD;^;4 <SK]LVG>,K2_-AJ+Z7/9- S:8K[HY3)N)94^;# M9'([]>E9&K64]KIXDT33[[3)4L5C6PFM3=PWL1>0B!\;MK?,2<G^/';->@2Z M)9R^5O67]T<KB=Q^?/-2+I5JH8;9/F.3^\;_ !H P=%$]KXP\2W%U87$9NEM MI8V$3,KA(0&4.!@D'(QGZ5T]K<"[LX+D1R1B6-9 DJ[77(SAAV/J*K6FE6]E M</-")-S]=\K,/R)P*OT %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!E MZ$<Z9&?]IOYUJ5E: <Z5$?4L?UK5H **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@#)T#C2(/Q_G6M69H&/['@^E:= !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 9=AKEMJ6IZE9VP9ET]UBFE_A\P@DJ/] MT8S]:L1:C:WRSQZ=?6D\\8Y"2!]A[;@#D5PWAUC;>#/%EK>6,E_=6]]=K<P1 ML=]UN .<CYN58#/7CBI?!\Z?\),1^\'FZ5"D:_8I($3RW;<B[QD[=R\DG.[\ M* .PT;5%U:Q,NP1SQ2-!<1!MWERJ<,N>_J#W!!K0KD? 09E\23E&6.;7;EHR MPQN V*2/;*D?A774 %%%% "'I7*:[X@U*T\5Z+HMB+<+J'F%Y)024"*6. /I M75M]TUP?B42+\2O"<XCE,"K<*\B(6525.,D= 3B@#L/[2M58(;N#>6V &11E MO0>_(XJ&TURSOKR^M+>=7ELGV3 ?PDC->=W&GZ?'I&L21Z?MN%UQ94;[.Q?; MO3YEXSC[W3M5B[6[V>-K?38)8]0GD66#"$&5?+4G:W09Y'UH ]";4K,*[&\A M 1=S'S%&T>I]J<E] ZEDN8G4-M+*P(!QTX[UY9>_V-JWA[4[NVL]1:8:4T$J M20LBQ\C"%<?,^[.,=,5>U:P32%\.7-K!)9Z*BE[UK*+E7* ([@ ENA&<'K0! MZ'_:5H81-]L@\HD@.)!@XZ_EWJ+^V['^T8K 749N)8?/0 Y#)G&0?QKS&\LM M+BTZUN=)GGM=D]Q/$U_;EK>Y+*N]67'RANW'K6]H4\3:_HMQ<Z>MB]SI(CC@ M$9*QN&!"@XXXZ9H [R9W2%V4C< <;NAXKAO^$[U"/PL^OR6=NT$-PT,D*.=Q M DV9!QC/?%=R[!8V+-A1UX[5XOIVB2#PU;ZO';SWALM1FEN=,EWE9D+G+A#_ M !C@C\: /89-1MX(T:XN(X"P! D8#T_3FHGUJSCU6#37N$%U/&\D<>>2H(Y_ M6O/O%.H0:K<RBVM6"R:6[PW,EN[L^2?W2KCY3G&2>:M6<MNOBKP_?SJ<R:0T M*2O&VXR;E&WIP1[^] '?M?6Z7(MFN8O/;.V+<-Q^@JRIRH)KRGP_';7$D-KK MRW_]O6NHM+PAY.]BI#@<ICCKCBO3=/O[;4;7S[60O%O9-Q1EY4D$<^X/- &3 MXL\07/AZUL9;:V@N'N[R.S5)93'\SD@'(4],<\=*W!*JJ/-=%8 ;ANX!KAOB MC>6EM:^'A<3(C+K5O/@N 51=VYR/[H!Y/;(K,U5?#][XF\7M</83D:3#*@?: M0'VR#<.Q/S)\W4;@.] 'HQU&T74DTXW"?:WB,PBSSL! S^9%6/,3?LWKO_NY MYKS[0Y-'D\0>&[N7[&TUUHH$,SA2TDJE 0&/)8#(]1S6!X;AT[5+^T_M;5K^ M+Q#:WADN;1[:(2,P8Y)<1[_*VG!RV-N1T H ]@5T8X5U)Z\&A98V!*NI ZX/ M2O)+6PMQ\-K_ %+P\BB^CN+B*2:U(,HMOM)=E /^P 0#U'UI]I'X6N--U>YA M\4W,L<UI!!/-':I$D(:3$>X1HH//!!_A)!XH ]+U'6=/TJVCN+RZCBBDF2!" M6'+LP 'ZY/H,GM5_K7DLMU8)I\B7VCZ,]O:ZO9K-?640^RNC$$N <A2 K<G M@UZM"\4EO&\#(T+*#&4^Z5QQC';% #C(@<(74,>@SS6?I.J'4+:229(X9$N9 MH-BR;@=CE<@D#KC/2N(6YMH?&\WD3P:CY^IJDUM<';=6L@'#QD<M$ ,XZ ^ M]8LQT>+P9>:U!]D>^@\0ES<%@Q3_ $O(P<\ I@\8R.: /83(@<(74,>@SS7, MWOBN:UM_%+_8EW:+&'CS)Q-F+?SQQZ5Q6LZMI!\275VDUO:S6NMV8G>>1FF9 M%8!G&3A(L,1QD')SC(J[K%_8M:_$L1SP@B&-6^8#+&#;_P"A<?7B@#TJSEDG MLH)I4\N22-69/[I(R14I95QN8#)P,GJ:@L+B*ZT^WN()%EADC5D=#D,"."#7 MF_Q#O[*XDURR2:&VU*TL8IHGNLEF(WN/LR]0V =SCI@ C@D 'IY=5(#, 3P, MGK0S*N-S 9.!D]:\VN=4\/ZAJFHV_B2\A6"XMH9--NG;@1[/F:)CG$F_=TYX M7K@4MW?:/<Z]K>F>*3]EC>&'^S'GW!_+*8W1;LXE#'L-V<<'% 'I#.J#+L%' MJ3BA6#*&4@@]P:X/^Q?#^J>/;ZPU"%+MUT^UFCBG<G+!I S%<_>P(\Y%8IU[ M2['0M L%U&W@FL]=/VBW60*T,8EESN4=%P1UXH ]5WJ'";AN/.,\TZO(;=M- MO]8OX=8UJYM-9@U<^7"(4,[J9?W0C;:7V;<<*< 9[&O7)-_E/Y>/,VG;GIGM M0 NY=^W<-V,XSS0"#G!Z=:\NLW@NO"]E>1K&?&*7T44Y/RW'G>:/-1L<[?+# M''W0HZ<4S5(--BT7QU>0NT5Y:WFZ)OM3EHV$415ERW!+!L'VQT&* /5:*9'( MLL:R1N'1@&5E.00>A!KRCQGJ=M%=:O>6MVD%[;7]K$6N;@^<""AVPQ\!(\%F M+<[OFXQR #OH/$#3^(=8TD6>UM/ABF64R<2AU)Z8^7!!'>KFAZE_;.@V&I^5 MY7VN!)O+W9V[@#C/?K7+Z=<P2?$+Q8Z31LB6%KN8,"%^5SS^!K8\"LK> M!* MD$?88AD'N% - '045YYXXU2P'B!=.DN5CNETV67_ $V79:Q@G ?:1\\F1@<\ M#-0Z:MAK^N^&X[NZ-P)?#QDDC6Y8!W#1 $A3R<[_ ,1[< 'I-(64$ L 3T!/ M6O)+<6]GH'A^]AN7^U+XC%I)(TY8I$)Y%\OD\+LQQ[YK0N([6^M/%]QJ@SK5 MA-.UH9>'MXP"(#%Z X'(ZDGZ4 >F45YYI>MV^F^(K[_A(;BWL)I]&LY9$F/E MB23]YYAP>IW$#CT [5#HZ:9J=OX'-QJ,QN)=.*>7'>NOFE8UR"%;G# Y]Q@] M,4 >ARW,,$T$4DBK).Q2)3U8A2Q _!2?PJ:O,;.2QDGT-]1GC=+;7M0MUDN9 M=VP 2[$W,?9,#V%6GO1;^-TE:.WU*TGU/[.DT<S)/93[""C+G#)A2>PY)H ] M$HJ&[GCM;.>XE<I%%&SNP&2H R37D^DZR;/4-(N+"XB::]TNZ=83/YLUP0JO M&\H&!YA8-P 3U&3V /3-1U5M/U#2[;[*TB7\[0>:' $9$;N..IR$-:5>46>I MZ%>7W@:_AOK>2^N)V^UNTW[QI# RG<">/GX''? ZUI):WUEKU_X2MXG6SO;B M.^AFR<1V^1YR@GT954#_ *:>U 'HM%>4W&L6K>*)GAU+$D&OQ0.]S=E92,@/ M'&@P!$.G.<X)Z\T:E#''I?CRZAU#4?,LKC]PINY,0GRT8D8;G+$]>P'O0!ZM M17F]YJ-CJ6N^(+'Q!J1TT>3$^FRB8IB$#=YL9/&_=U[]NU0ZC?KJ'B'6;#5- M>@TR$01/9"X5PPC,?^MC8NH#Y+9X)&,<CB@#O];U%M'T.^U);<W'V2!IC$&" ME@HR>3[ U:MIOM%K#.%V^8@?&>F1FO)WNUNM'\96NLZG--<6-@%M!-<-&7B- MO\CE,C+.Q!.03E@#Z5Z?HL\5UH=A/!(LD3VZ%64\$;10!>HKA]=U6*UN_%L- MS?\ D!-+ADA5IMFUB)1E>>#NV#COBJEE'_:M[X09]4O##=Z0QFACNI$\QE6, M[CAO<@^OK0!Z'67I.MPZO/J<443H;"[:U<OCYF"J21[?-7!KK)CNM#TR74IE MTJ?5KZ!IO.8EPC$11&3.<$MZ\[0.E0K?)X8CUBW@G9+:?Q/%!/.96S#$\<;, M2V<CD;22>YZ4 >K45YWJEC?6EG=+;^*9";B^LA&MLS#[*LDH1L%G;(8'.#QD M'L<5W.GV":=;F&.:XE4NSEKB5I&R>3R>WM0!.TT:SK 7 E=2ZIW(! )_\>'Y MU5TG4X]7L?M444L0$LL+)+C<&C=D;H2.JGO6');QO\48I&:7<FD,R@2L%!\T M _+G'IV["N;22[TS3]/O[>_N<W'BB2V,7F8B$3W4JLNT<-GKELD'IB@#TZBO M.[74]1UM-2N?[7M],DL=1:-S-,X\E$?@&/(5E9/7USG(KT2@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** ,KP^P.B6N#_#6K61X<7_B1VI_V?ZU MKT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !17-?$"UBN_ >LK+"LI2U>2,$9*N <$> M]<LNHW.DZ+JW@[Q!*;BX&G32Z?=2 '[1"$) ;_;7!_+/U /3J*YZ359(=2ET M30;&U>6R@669'8PQH&SL1<*>3@GT&/>J&G>*KC7-;T)]/6-=-OK&XFECE;$B MLCHG0 ]"2!S@Y/H,@'845QL?CF:YO&DL]*>ZTV.]-B\D)=YMP;!D"!"/+!!Y MW9X_"NDU6^FT^P:>"REO)=RHL49QU(&2>RC.2>P% %ZBN#U?QO>_V+-<:7;6 MQN+?5HM/D_T@2(P;:<HP&#D,!R!CGTKLFENO[-,P@C6[\K=Y+2?*'Q]TL!TS MQG'X4 1Q:5:0:K-J,">5/.@6<1@!9L=&88Y8= ?0X],6IHS+"\8D>,LI&],; ME]QGO7FUSK$VN^$_"6L:E9+]IEU:V:+[,=Q)W'^\ %W$8QDCWKHI?&JZ?9:A M)J]F+2YM;E+=81*'$ID ,9W <9!Y]-IH Z.RLX=/LH;2V39#"@1!G/ ]^YJQ M6)HWB$ZK?75H]E)$80KI<)N>"93_ '7*KD@\$8_^MSVI-;I\6X5GM9KB-M&: M3RXXRXWB7&YE]=O&?H* .\HKSKP]XIM;.;Q?=,9DM+2[C,-C*-DB%E52 C?= M#.>.@Y[5IW_C/4-(L]1GO=!>3['"+C=;R$QE"2"I9E'SC'( /!S0!V+9*G'6 MLB\T%+RZ-S)J&HP\#Y(;ID08]!VJA_PF,=M?75MJEA+9>3I[:D"7#DPJVTA@ M/NOG' SUZU7UG4+Z^T75;6^T?R[673);B.99-ZJ0O"/P 'SSP2./QH T&\*P M.^XZGJY_[?6I4\+QI,L@U75R1ZWC$'ZUFZ!XHN9=.TN&XTIHGNM,%S:[;A6, MNQ$)!'\.=PP3^.#Q3;7QU<74&BW"Z!<B'5U*P,9ER)-I8*1V4@$[O09Q0!JO MX<+%]NJZDN_JHD7'_H-.F\//,B*NL:E$%&,)(H&/^^:KP^*)Y]-EECTF4WD5 M[]BD@$H*(XP2Q?'" 'KCVQ567QS&FBQ:A%ILMRS:A_9[Q6\JOA\D95OXAG&. MG7M0!=/AABFQM9U0KZ&5"!^&RIXM!:%<'4]0F(^ZTDPR/R6N4DUI[+XB+>ZE M:-:7#:"P6S\T2,\GVC"HI7AF; QCU]J[NPENI[-)+VU2VG89:%)?,V^Q; Y^ MG'N: ,J;PU]H<LVKZO&>X2\(!J+_ (1-/^@QK8^E\W^%6?$6O2Z%%:-%IEQ? M-<W"VZK"Z+M9LXR6(]/I[USGB77_ .U/"OB:PELI[*\L(X_,CD*L"KG*LK*2 M"#M/Y4 ;?_"*(.FL:UUZ_;F_PI#X2C(7_B;ZR-O3_33Q^E7SJY_MNZTI+<M< M0VBW2'?A7#,RA<XX.5/KQBLN'QM;7,&E-%:N)-3M6N8%FD6,';CY QX+G(P! M]: +-MX;^S7B7 U/5'*?PRWA<-['(Z5O#IS57[3,VE?:EM66<P^8+>1@I#;< M[2>W/%<'=:O<7NB>"M4U*RD>[FO8&C6"0'S2T+'=MR%&3V/3U% 'HQ16SN4' M(QR.WI35BC5RZQH'/!8#DUSLWC.TL=,O+K4[:6REM+A+>2"1T8EG"E<,#MP0 MV<YXP<U+X=\66?B*ZO+:V3Y[4(S.DBR(P?.,,IZ_*<CZ4 ;HBC!4B-04^[Q] MWZ4OEIYGF;%WXQNQSCZUD^)+Z6UTY+>TD$=[?2BUMW(SL9@27_X"H9O^ UF> M"M8N)] GL;TR7.J:1(UI<A3DRE?N,"Q&=RX.3CG- '5!57. !DY.!U-(L:1J M51%53V P*Y:V\<PW+:4XTG4$L]3 6VN650K2%2P3!.1G!P2 #CTYJK%\1[6? M2(]831=332C.()+J41*(R6"YVAR2,G&0* .R$<:Q^6$4)_= X_*GUPT5Y#!X MA\>R7:226EM:V[21HYRR^2[,!SP3D],5KVNO0B#3;32[&>X>:R2Z6)I0#%$0 M-N]F)R3G ZYP?2@#H#&AD$A1=X& V.<4S[/ $*>3'M)R5VC&:P9_%R1V5O<I MI5^WFVCWCJZ*GE1KC(8DXW<\ 9S6;J.HR1>.]*O+2TN[TW.D3;((B!_RTB8, M=Q 7@\G/H* .Q,$+$DQ(2<9)4<XZ4&WA;=F&,[OO94<_6N.E\00Z_)X7O;1; MB!&U:2&6*4;65EAF!5@"1U'K6G>^,M/LIFW*SV\=R+669)$.QRP7[F[<0&.# MQQUY'- '0JJHH50 HZ #I36BC=MS1JS8QDC/'I6+XQBNKCPQ<VUG=O:7%Q)# M D\9(,9>5$SQ@_Q5BZ)XDOE\%21W,;2Z[93'3"GWO-N!A48_[)!#$^FX]J . MU9$<J6125.5R.GTI&BC=E9T5F7E21G'TK@_!&JW.G^!S>:G->:C>R7TL)(+2 M,[A_+4#/W5^4>@')K6?QU8P:8;R>RO59=0_LZ2&-%=UFR..#\PY!R,_3/% ' M3^5'YGF;%WXQNQS^=((T1F944%N6('7ZU@2^+!'-;V?]E7G]J3Q23K8LT8<1 MH<;B=Q7GL 34/_"36&I+HDWD:E$EY>-' <!/G56R)!NSMX;CGE: .E\J/S/, MV+OZ;L<_G3ZY5O'=DDU^C:9J@2PNEM;B4PJ$1F95#9+<@[@>,G'..E=50!$+ M6W%P;@01"<C:9 @W8],]:/LMN01Y$6"<GY!R:S=5\00:2\RO:7<_D6K7<K0H MNU(U/<L0">#P,G@^U17?BBTMYC#!;W5Y,+07ICME4OY1) (5F!8G:>%R>/<9 M -I$2*-8XU5$4855& !Z 57GTZQNG9[BRMYG90I:2)6) .0.1TJ6YN8;.UEN M;B18H(4,DCL<!5 R2?PKE(=8FOO'>E@66IVMO+IUR^+@JL<@#Q;6VAS@C)Z@ M,-XX] #J(["SBFDFCM($EE!$CK& SCW..:EBAC@B$<,:1QKT5% _ 5SD?CS M1)9K%$DD*7TWDP2 *59O4C.0#SR0*LVGBRPN[7[9Y5Q%8_9Y;D7<@7RS'&VU MCPQ/?(R.1^5 &Q+:V\[J\T$4C)]UG0$CZ9^IIBV-FDL<JVL"R1@A'$8!7/7! M[9R?SK$?QA;Q)(\^EZI$JV9O5+0J=\8QG #$AN<X;!K)OO&VE:GHR3R6FOVU ME+)"8KF.W:(2%F&T!L],X!SU[9'- '9+9VJ!@MM" SESA ,L>I^OO2RVEM/* MDLUO%))']QW0$KSG@]N0*XF3Q*OA_P 6>(8Y;?5M03]Q*(;5#-Y*["6;!("K MG'3\N#6U/XTTE+>TEMV>[^U0?:8UB**1'_>.]EQSP!U)S@<' !MRV5I-<)<2 MVT,DR#"2/&"R_0]13&TVPDFCF>RMFECQL<Q*67!R,'''/-8Z^++"^L;>33X+ MR^-U 9ECM4&]%R5.XD@(<@C!(.0<=#3O ]T]YX+TJYDEEE>6'<7E;<[<GJ?6 M@#4&E:<(_+%A:A-_F;?)7&[^]C'7WJ3[#9_:OM7V6#[1U\WRQO\ 3KUK O\ MQO::?8W]W)INI/'877V:Y")'N0E58.07'R'>O/U[<TW6?%%@ECK\,T>J0IIL M*&XGME 8;U# 1L#]X C.< 9]* .IZU2BT?2X)EFATVSCE4Y5T@4,#[$"LBSU M]KOQ"="2TNO*6PCN/M3,N2'R <@Y[$=,Y]N:Q_ _BR*30='LKS^T);B9GA%U M)"YC9PSD*9#U.U??ZT =?%I&F03":'3K2.4'(=(%# _7%6S&AD$A1=X!4-CD M ]1G\!^5<O\ \)5I.D:?J=].^I-##J1MI?.C9RDC!3A1U$?S#'Z9R,ZFE>(+ M75[RZM(H;J&>V2.1TN(MAVOG:<>^T\'D=Z +4NDZ;.[O-I]I([LK,SPJ2S Y M!.1R00,4G]CZ9^]_XEUI^^P9?W"_/@DC=QSR3U]:H76N7$7BRVT6/3YY89;5 MII+A"O[L[@HZL#C[V>">5QWQS7@[QK =+CM+X:C(XU&2R6ZE4R*6>5O*5G/4 MXPO&<<9QD4 =M+I>GSM;--8VLAMB# 7A4^41TVY'R_A1>:7IVH/$][86MR\) MW1--"KE#ZC(X_"L74/'>B:;<R1322,D4ZV\LT85DCD) P><\$C) (!XZ\5)X MW\Y/!VIW-O=7%M<6L#SQ202%"&521G'4>H/% &I=:1IE].L]WIUI<3*,+)+ MKL/H2*M0Q16\2Q0QI'&HPJ(H ]@*X*T\2ZHVA:YHFL2"V\2Z;923": ?),@ M7*RI^.,C Y[=AT;ZM!HBPZ9MO]1N8;</*8T\QPH!PSDD8+;6QW.#B@#1NM)T MZ^F6:[T^UN)54HKS0J[!3U )'0Y/%1C0M($\4XTJQ$T(*Q2?9TW(#U ...IZ M>M9,/C"&\\0:786-O)<6U]9->"X4 87<H4\D<<G/?I4DWC72(98\M,UM)<BU M6[1-T/FDXQN!Z9XSC&<C/!H OCPYH8LC9#1M.%H9/-, M4V%^F[;C&?>G1:! MHUO!/!#I-A'#<?ZZ-+9 LG^\ ,'\:T<UB:IXJTK2)9TNI)\6ZAKAXK=Y$A!Z M;V4$+QS@]N: )AX9T(6GV1=&L%M?,\PP+;H(R^,;BH&"<=R*U:P+OQGHEE<W MEO/<2K+:0K/(GD/EHV8*&3CYQDCE<U;O_$.GZ:B-<&XRT7G%8[:1V1.[,%4[ M1]<=#Z&@">YTC3[R^AOKBSADNH5*1S,OS*#U -54\,:''8+8+I5I]E23S5B, M8*J^<[AGH:E.OZ9Y=O)'=>>MQ&98OLZ-,70=6P@)QR.?7BJ+>-?#JPQR_P!J M1%)8A-'M#,77(' R3ST R.<]#0!:F\,:%<:J-4FTFS>^!!\]H@6R._N?>M: MN7D\<Z:VI:';60EO(M5WLD\$3,JJO&3@?WB 1_#U.*ZB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** ,KP[_P @*U_W:U:R] XT2S _N5J4 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% &9XATR?6= O=-M[E;:2YC,?G-&7V ]3C(YQG'- M5/$OA>W\4>'6TV^8>>%#1W"#!20#[PZ\'N,]#BMJ::.W0/*X12RH"?[S$*!^ M)('XU1AU<2^([G1S;NK06T=SYI88<.S+@#V*'K0!GW&@WL'B2?6M*O(DDNX5 MAN8;A-RG;G8ZD<@C)R.ASVJK9>#Y-&N=#DTNZA L+>2UG\^-F,J.ZNS+AAM; M<I]1\WM765$UQ$EPENTBB:16=$)Y8+C)'TW#\Z .3T?PIK6@W L]/UN%-"^T MF=;=[;=-&I;<8U?=@@G/)&>36AXQ\/W?B/1XK*TO4MBEPDLBR*62=%SF-\$' M:<C/TKH:JV-U+=Q.\UI+:E970+*1E@#@,,$\'J* ..N/!>L7.GW\+7VG">?4 M(+^,QV[)&K1A!L*[C\N(QSG/6NUA29K*-+EHS.8P)3$"%W8YV@\XSTS3Y98X M(FEED6.-1EF<X 'N:?0!Y\G@?6%TCP_ISWFGF+1;Z.ZB9(W4R*G0-R>3DY(_ M*K>N^"K[73K!>]@@>>>"XLGC4DQ/$" 7SP<CTKMJ* ,G0[76X(I&UO48+J8X M"+;0>6B@=^<DL?KC@<50N]#U3_A-5U^SGM#&+#[&8)@P/W]^[(_"NEJ*WN(K MJ+S8)%DC)*AE/&02#^H- ')3^!6U*/7)M0OD^W:LD2^9;P[5@\L[DP"<L00" M2>N.PXI\WAOQ'J?AO4-*U?7[:9[F#R$DCL]H SR[#<,L1Z$ >AKKZRYM:CA\ M2VNBM$_F7%M)<+*2 OR,HVCU/S9^@H Q]6\'/K>KO=WMW$T,^EMIUQ%'&5/+ M!]ZG<<$,!@'/'<U%;^'O%#Z3<6&I:_;7"&UDMH=EMLW%EVAY#GG SP,<]378 MU1O-26SO]-M6C+-?3-$K \)MC>3)_P"^,?C0!S5OX6U>UDT)XY[%CI6GM8_, M7'F9"+NZ<<(..>II;/PIJMM:>%;=KRU*Z*Y,N%;]Z-AC&/0A6/XUT&D:Q%J[ M:@L4,D?V*\>T?S,?,RA3N&">#N&.]:5 '$/X2UF22<F[L1 ^K-?FV96=)T*@ M!'/'0C/0C./2GQ>%-72RCMWGT\LFL_VD7C1T#+G=MV\X.<C.>@'7K7:44 <5 MXC\$R^(/$;ZC(T B6Q^S0?.RR12AO,24$#@AL#'I^57[&7Q/:MHEIJ,EA<2E MG6_D@5R2H1BCC@!<D '/<\5TU% ''^/[B>"'0/LKPB=M8@"K.Y5&X?@D<XSC ML>U&H^&=4U33-;,\MG'?ZFL<*A6=HX8HR2HS@%CEF).!][VKKF56/S*#CU%. MH Y;4=%U^77(M6TR]L;6>:Q6TNEFC:41D,6#Q]-Q!8CYL#%9:^#-7_X16VT& M[?3-0M(K5K<Q2!H@'SE)58*QW <$<9ZY%=[48GA:=H!*AF50[1AAN"G(!(ZX M.#^1H JZ78RV.A6EA/<&>6&W6%YB,;R%QG%<PGAW78]*\.6?EZ8[Z--&1(;B M1=Z)&8QQL/)!)]L=^M=H[JB,[L%51DDG K,GUN&'5]-T\1R2?VA'))%,N-@ M" 'GG/(/% ',ZQX-U76AK!DGL[::6^AO;"6-F<QO$H5=X*CJ!U!.,]\<]-H\ M>MA'DUJ:R,A556*S5MBD9RVYN3G/3'&.]:=+0!SNH^'1KGB!9=8L;"ZTN" K M;QR,SN)&*EF*E=O08')(Y]3BA8^&)O#_ (NFU#28=-L]"FM5CN;=696WKN(D M "[1UQUZ<UM:[XBLO#T=L]ZD["YF$$7DQ[MTA^ZOL3VSZ5$/$.F7,\&G7\$U MI/>*1';WT!42^JYY0GVSF@#GO#.E7>M>$/"8ODMH[.R2"[5HIF9Y"B?NP1M& MWDY/)Z8Y!K-\(Z3>>(_A;::3(;>.PFN'$DL<S"0Q"<LR[=N,G!7KT.?:O2(K M2V@MOLT-O%';X(\I$ 7!ZC XK$N-6L- ENK:QT6ZE$2K/<C3K="%+< D9!9L M+G !. /:@"C<^&-2EO/%\B/:"/6[5(8-TC91EB,?S?+TYSQFH8/#&N:;=Z3J M6GW%D;NWTY-/O+:9V\J94^ZRL%R""2>G?%=J*6@#C-8\-:YJMS'+<7-C<H;" M2W,,FY(X9WZRH #NX.T ].N>:M6FC:Q;7VCW[BREGM-->RG3SF52Q,9#J=A_ MYY]"!C/?%;.E:Q;:M:RW$2R1+%<26S"8!3O1RA[GN.*T* .-MO"5[:#27CDM M7FAU674;TDE 3(KJ0@"\X#CKC.WMGB6RT;Q-I=_J$-G>Z>^F7=XURCRAA-;A MWW.H7!5NIQDCDY/I6E-XHL8=5N].\J\DGLT22?RK=G"*PR#QUX!X&3P:TM/U M"TU6PAOK&=9[:9=T<B]"/Z?2@"OK5I<WFGK%:"$S+/#*/.<JOR2*_4 ]=N/Q MK)7PIL\:R^(!(GER0H[6W_3RJL@?=CIL=E_'.#QCIF95 +, "0.3WI: .%M/ M"^OVOA5-*2:R67^T#<SA9G"30M(SM'NV;ESD#('K44'@S4XK0VZ6NDP0KK46 MIQP0S.$55 &S[@Y^4'.,$D]*[^L?4/$$%A>FT6TO+N:-%EF6UC#F&-B0&()! M(RK<*">#Q0!@>*5NCXLTZ;24L?[0MK60R-<7)A;RW8!0IPP895LY4XXY&>8[ M+3[F_P!*T,Z?IEK;)I&H,?*%[O5U560LKA?FR7)YP<@UUVH:1INJJBZCI]K> M*ARHN(5DV_3(XK/7Q#I5KHINX(I%M(;H67EQQ;=DGF"+&WC #&@"BV@ZG+8Z M_!-%8L=0N_M$/[YB%PJ*-WR<$>6#QGD^W.S:7EY)K-]:3PPK!$D;PR1LQ)#9 MR&R ,@KV)X(SBM*B@#C/%/A_6M9N;V)!97EA<69A@AN)&C%M+CE\!6WD\8)Q MC'N:HZOX2U75M-LHY;*S&H6UC'#;WL-T\4EM. P9L@?-']SY<=S]:] JM87L M>H6BW,4<T:,6 6:)HVX)'*L 1T_*@"CK^BOKOA:\TB2?9+<V_E^:!P'QP<>F M16'#I_B34-3TB?4+&SMXX+.XM+LI<EBWF;/F0;>.8P<$]Z[2B@#AO#NCZ_HT M-OI,FEZ9)#9?+#J9D&YHN,+LVYWXXSD#C/US8?!.HW\-XAM$T07VGR0WT<,^ M^*:=B-KH@R% P<]"=V/<^E$A022 !R2:JG4+8:JNF[F^U- ;@+M.-@8+G/3J M>E '+Q1^+[W0I]-U#3]/A;[));F6.Y+>>Y7:& V_(O.><GC&.:76=*US4/". MCVMM:P17]M<V\LL+3_N\1'/W@.02J]!W'I7944 <PUCJMIK>KWD%E%<1ZC#$ M$S,!Y3HA7#@CE>>HR?:L&/P=K'AFZL;G0X[+4U%I':7<-X?+SLSAT(!V\L<C MGBO1:* .+CTKQ%IFNKJMO;6-U]LM$@O;:.0PK$ZLQ5D)!RH#D'N>OM6MX-TR M]T;PG8:9?I$MQ:Q^6?*D+JP!X.2!^5;M** .+UKP4VK^([V1Y572=1M4%Y$" M=SS1DA#UX&&!X_N>]1MX9U5?AKJ.ERLEUK-["PE92%4N0%'/3 4#\N*[BB@# MEK2SU6VUJVO/L&8VTM+:7$R[HI$+-C'0YR #^=9.FZ-KFG>%_#EFVF-+<Z=> MM-.HGC&5Q)T.<$GS/T/3BN_HH \YUC1O$5_I^MV\6D(#=:K#>0%KI!E5"9!] M/]4/7[WM72Z=:7Z>,M3OYK(QVEU:6\:2>8IPR;R00#G_ ):8_P" GVKH:* , M"]MM0A\5V^I6UF+FW-HUO)B4(R'>&!P>N<$=:Y]-'UF/PS9V*Z(/-MM9^VJG MVE,+$+@S<'/7!VX_&N_HH \WT_PIK&CZCJ-M!HVDWMK>7;74-_=;2]OO(+*R M8RV.<8(YKL/%5E<:EX5U2QM(_,N+FV>*-=P'+#')/;FKM[J5KIYC6XD8/(&* M(D;.S!1DD*H)P/ZCUI]C>V^HV4-Y:R>9;S*'C?!&X'H<'F@#F_%OAA_$^DQW M$"O9:M C^2203M88>)L$@AAQGMP:$TG4])\8ZOJ]M$M]9ZI!&'AWA7BDC4A1 MSQL()]\GI7644 <)H?A&\\.:KH4L2FZCM[&:VN&$@ C9Y%<;0<$KG</RJ/0? M#.HZ&[Z?+H>EW\7VLRQ:D^U6$;/N;<I!;<,MCG'3I7?UB0^*]&N#*(+F64PN M8Y/+MI6V,.JG"\$>E %G1]2FU)+O[19_99+>X:#9YHDR %(.1Q_%TYP017%K MHFIZ1XPUJ?\ X1N'6(-4E$D5U)*BB$$ %'#9.T'N >!TKO[.2VFLXIK,QM;R M+OC:,?*0><CZYJ>@#SSQ5H>JZKJ$&LV.E*MWH9C-E$P3_2VWC>,YX0 ?+G!R M2<=*N2?V[I?B:YUF'1);ZSU6TA$UM'*BS6TD8.%.Y@I!W$'!_P#K]O10!YSK MFE:A'XFM-;NO#,.J64UBEK+9VY5Y;5PS-E<[0R_-@GC].="VN9='UG3K:+P\ M\,8TZ9VM[$HP@_> @8XR3CMW/U-=M5#^QK$:V=8$3"^,(@,@D8 H"3@KG!Y/ MI0!Q6F:5JFB:AX?O)--GFC:6^,ZP[2UM]HD1TW#/.,8.,X]^_HE5;V_M-/C$ MEW.D2MG;GJV 2<#J> 3^%/L[RWU"SAN[259;>9 \<B]&4]#0!/1110 4444 M%%%% !1110 4444 %%%% !1110 4444 9N@_\@2S_P"N0K2K-T'_ ) EG_UR M%:5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110!RWCJWM;K2K".] -N=3M0^YRHP9 #DY M'8UGWMM%=>.M4B2ZDC,.AP@!)RG.^;!9@<\9!Z]\UV5Y96NH6SVU[;0W,#_> MCF0.I_ U470-'2Y>X72[-9GB\EI! H8QXQM)Q]W QTH \WMM8_M[PYHJ3W, MEWJ"Z4]Q-:SW1@A54)7SW=5+%LC 'U)QU.QX9B_M#6O#&I7,LKW/_".AV<R$ M;V+1\GGGJ:ZT>&]#$5O$-&L/+MF+0+]F3$9)R2HQQSSQ4ZZ/IB/;.NG6BM:D MF B%1Y6>NWCC/M0!>[5YO$+R[\+Z5$-6U"&1M>FMVG2<^8T8FE&TDYSPHZ], M5Z16;)X?T>:(12Z59/&)C<!&@4@2GJ^,?>]^M '"ZQ9RI8>,=-EN+B;3+=;5 MK=)IVD9'(!?YB=Q!^4X)(SFKU]=.?&Z>'I+XV-BMEYEKYDTP-PQ)WX<2*25P M, DXY/T["71].G%V);&W?[8NVXS&/WHQCYO7BH+KPUHE[806%UI5G+:V^!#$ M\0(C_P!WTH X>&QN+O7M'TRX\5:K=Q7-C<,UQ9W/E+*8W"J<#/\ "<$@\D9S M3-/EN]3DU877B9=.N-/U%H09)7WQQQD;< N%8,HY)4Y+'VQZ$ND::ES;W"V% ML)K=-D,@B&Z)<8PI[#'85%<>'=&N]3CU*XTNTDOHR"EPT0+@CH<^W;TH Y&& MYNAXP\N^:XNK"_NYXK6^M+U@B$(RF"2,' *[6PPP<KG/6MCX=6\=MX&T](RQ M'[PG<Q8Y\QO6MR+2-.@N/M$5A;)-YC2[UB .]OO-GU.3DU)9Z=9:>)!96D%L M)6WN(8PFYO4XZF@#!\8+J#BP.G,LTD<CRR6'VAX'NHPN"%92.02#@\&N<L[" MP\2>)]$G^UZC"D>D.R1O.T<[YDVLK,"&X/4@CH.<5WU]I=AJ1B-]96]R826C M,T8;83U(STJ./1-*AN;>YCTZT2>VC\J&185#1I_=4XX')X% '&374,MIHFC& M[N[JZ<W&R![LQ),L;,-TTH!;Y=O &<G&1QD.T.\FO-)\!7%W.996GD5I&;); M%O,HR>YX'/4UU/\ PBOA[RHXO[#TXQQN9$0VJ85CC) QP3@?E4ZZ#I""W":7 M9J+:0RP 0*/*<G)9>."3W% &7X1:5Y?$+2]/[8F"''50J#\>A'X4>,;F..WT M^V-[<PSW%VBPV]N_EFZ(Y\MGZHOJ1SCUZ'<M=.L[*6XEM;2&"2X?S)FC0*9& M]6QU//4U'J>DZ?K-L+?4K*"[A#!PDR!@&'?F@#SJR\1W%L-%LKS4C!8S:Q>V M\\_VAG*K&6\J/S6YVD[1D\D=Q6K+?V^GZSI6C+KMS)9W=[/(UQY^<-@,EL9, MD_Q9QD$C ^O4#PSH8LI[(:19"UN'\R6$0KL9L8SC'7 IDGA709=)72GTBT-@ MC;U@$0"AO[W'?WH YC6K>Z TC3M.\27I,VLO#-/'/ETC,;R&/)SD@ 8S5>." M70KKQ=:1ZSJ4_P!FTF.>)KJ[9W#D2DN#T!R%' KL/\ A%]$%M:6ZZ9;K#9O MYENBK@1MZC'>GZCX=T?5IUGU#3;:YE5#&'DC!.T]L^G_ .N@#@K;4;_Q!<:' MI$VJM:?:- BN=S2NKS2L=K-N1U)8!0<$GJ<BN_T".>+0K2*YU!=0FC38]TO_ M "U()&?TJ&?PIX?N;*WLYM&L7M;9BT,1@7;&2<G QQD]?7O6K%%'!"D42+'& MBA511@*!T '84 >;^-M7N8KG7'TR\NII],@@EE47'D1V?);C'^M9P!P1P._. M*WM&M(%^(WB.X!?S3;VG!D)!R'SQGV'TK6O/"V@ZC>O>WNCV5Q<2*%>26%6+ M =,YZ_6ITT33(]374DL8%O5C$2S!!N" 8 !^AQ0!2\:_\B-K_P#V#Y__ $6: MPK_3@^M>#K:WO+J&/RKAC(LQ=V7RUR-S9.#ZCD=B*[::"*YMY()XTDAD4HZ. M,JRD8(([BLR'PQHUL]JT%A'$;12L&PD>6#UQ@]^_K0!Q$/B#4(-/M[)]14"; M7[BR%Q<3L"(D+%4\SDY) 7)Y[9[CM/#MK?627L5]J"71-P7C02&0P(5!"%F^ M8\Y//8BGIX7T2/3[FP&FP-:7+^9-"XW*[_WB#GGWZU<T_3++2;;[-86L=O#G M<5C&,GU/J: .;\>D ^&"2 /[?MNOT>H/B43+I^CV=L^-1FU2 VH!PP8')8>@ M SDUT>KZ!INO+;+J5N9A;2B:(>8R[7'0_*1G\:?:Z+IMG<?:(;.,7 &T3-\[ M@>@8Y('7C/>@#AK6_P!<\3IK%Y!JD.F'3]2>%&>=@L4<1!.],;6!!.2W]*UK M"UM[#Q)XJU"2^GA6 QOOFN':*/\ <Y+%=V& ST/3 QBMN[\*Z#?:FNI76D6D MMZI!$SQ@MD="?4CWJ4:!I8NKNY^QH9KQ2MRQ8GS1C&&!.",<>PH XRQO+V=; MQ?MNHM;3Z']KBN);C#ROG(E55/[K.?N@],9'6M.TU&YDN/ Y-W*QN[1VG'F' M$I\@-EAW.[G-;MIX9T6PD22VTZ"-TB,(8#)V'^'GM[5#:^#O#ME<PW%MH]I' M-"VZ)PG*'V]* .*N($N--M8WEN8Q)XNGC)@F:,\S28/'H0#^'&*]1'2LD>&M M'%FUI]AC,#3?:"C$G][G.\9/#9[UJ@!0 !@#B@#S34IM=A\8^,IM :V-Q%96 MA9)(R[GY7^Y@@;@,D YR<5HVDVDZ=\/]'M-)UBX%M<RQQ6\B;3/.6DW-&O0* MQ^8$\;>?2NKM]%T^TU.XU*"V"WMP LTVXEI ,8!R><8&/2J<W@_0)H3$VFQJ MAG^T 1LR;9.3N7!&T\GIB@#C;"]OM5TL0W\EW$UIXH6U1&N,NL8*L$9U/SXW M8R2>@Y[U>-UK/B#7-=L['45LGTV18(4-PP*87(E9=IW@DXPQQ\OKS72'PCH? MV"XL5LMEO<7/VN14E=3YW'S@@Y4_*.A'ZTW4/!OA_5+FWN;O34>:W18T8.RY M1>BM@C<OL<B@#9M69K2%GD21RBEGC^ZQQU'L:X*:XET[QOXPU-9I9&L=)BFC MA9_D.%D;!XZ9!_,UZ"JA5"J !@ =JS(O#^G0ZQ=ZLD4GVR[01SL9W*NH& - MA.WCZ=SZF@#F+6>_LO\ A&-3BUJ6]35'6.ZCF8;)?,0N'C7^#:1T'&.O/-9E MR)9?A]JP!\F9_$+?[6QC?K^>*[G3_#NEZ6T1M+=HUA#"%#*[)$#UV*20N?;% M56\&:&^F76G-;3-:W5Q]JF0W4I+2Y!W;MV1R >#UH SYWO\ 6KW7?)U*YLI- M*D\JVB@(56;RE</)N'S9+8QG&%_&LL>*+R*UTG5M0U![6SU?2V)$2H1!<JH< M% P.2PW#!SD@5UUSX=TVZNC<R12B9HA#(R7$B>:@Z!\,-_\ P+/4U9O=*L=0 MBMX[NUCE2WE2:)6'".OW2/I0!ROA#5]4U>&VM+FZ>.[L(98]1!5'+3>8T:Y( M&!C8S8'J.U4[34-:O]$\*W4&N2)]LO'@F<P(3*N)2&Y'!P@XQC\L5VL.DV5M M)>R00^5)>OYEP\;%2[;0N<@\< =/K61#X%T""WM+>*"Z2&SE,]O&+Z<+&Y.= MP&_KDG\SZF@#-OM:U?2]$UU(9I]0N=/O(XO/,*>8L+I&[/M10K%0[?PXX&0> M:N>'9]5F\0:BAOGO-"CCC-K/(JEG=AEAN &0N/?[V,\8$'B/PI))877]E)-* MUY<137L3WSJ\BQD$&-FR%?Y$ Z# QD<&K?A?16T]FGQK-NI0I]FU"^$XR2#N M #, 1C'7N: %\?!CX%U;:\R'R>L)PW4?IZ^V:IZG9WT_C?3K6UU"6W7^RYA- M<JJ&7:)(^F05!)QSM]:ZB_L+?4[">RNXS);SH4D4,5R#[C!'X5GQ>&;"&]CO M$DOS/'$T(=[Z9R4;J#N8]\'U! ]* .1M_%6L7EAX9T^":&2[U-+CS+AI!"SB M%L#:2C ,PY/R^N,=NP\.0ZW!ITB:]<03W/GN8VA.<1'[H8[5RPZ9P,U1D\!> M'I-'CTO['(MO%,9X2+B0O$YZE'+97Z X]JV-+TJTT>R%I9HRQ!BQ+NSLS'J6 M9B23]: ,/5;^[O/&5MX<ANY;&$V37LD\.WS)</L$8W*0 .I(YZ=.^);>++TZ ME%X<GN6#OJLVG_V@=HD,:1"0'&-N\EE7.,=\9KL]3T6RU9[>6X1UGMF+03Q. M4DC)&#AAV(ZCH:J7GA'1KW1GTJ6UQ;M+Y^Y7/F"3=NW[_O;L]\Y[=* ,B>^U M'2-7TS0;C63,VHWDIBNF2,210I&K",Y&TL6XR1R#ZU*S:WI,NE6\^JM>M)JC M0-MC3+P,C.HDXSN4+U7'N#5N;P-H4^BC2YK:22(2^<)FF8S>9_?\PG=G@#KT M&.E2/X.T=M*33_+G54E$ZSBX?SQ(!C?YF=V<<=>G'2@#'U'5-=ATKQ$UC?![ MFRU6.*!IH5;;$R0L5PH&<>8V.K=LD\U%=#Q5;^+]/TH>)=\-]!<2R-]BB7R0 MFW;Y8P23EA]XD8S6D?A_HGV:\MT?442]D62XQ?2DR$#C)+'_ !_#%:5QX<M+ MK6K'5I9KLW=DA2(B8JI!^]N X.>,_04 <:=:\8ZK?ZK:Z))#)_9DR6HF:2-% M>10"[2(4)(8YX4KBDO\ 6O$B0>,;A-9$2Z.X:WC2UC.?W:OM)(.5Y(Z;N^>U M=5?^"M#U'5CJ4ULZSN )Q%*R)< =!(H.''7KU'!S3)O!.E31:E&7O FI@"[" MW+8DQ_+@!>,<#% $<]Y>ZUJVKZ;I^KOIUUIR($6-(WWLZ;@S[U8[<D# P>#S MR,8%_KWBC5-?U?2="D"R:9'&A?S(HPTC+DLRO&Y9<_W2O&>>0:Z.[\#:)?2V MTTR7(G@A6 S1W+H\L8Z+(RD%NG>GZEX*T35+^.]EMY(;A$$1:UF:'S(QC"-M M(R.!0!MVC2O9P-.8S,8U,AB/R%L<[?;/2N).NZOK&E^)=3TV[>V;2+F:WM[5 M8T=9C"H8E]REOF)(PI&!COS7=(BQ1K&BA44!551@ #L*QIO"NF3WMY<E9E%Z M%%W"DI$4^.[+[@ 'U'!R": .<WW>K?$'P[>+=W,$<FD/=&*-4*KN:/<N2A.& MX!/7C@BN[<E86*%5(4X+=!]?:LZ70;6;7X-9,MREU#%Y*JDQ5"F<D%>AYQ^0 M]*T98DGA>*091U*L,XR#P: .#TGQ%JDNMV]LVHM>P7FGSS+.($2#S(V49AP- MQ3D_>)SP0<5!X9UKQ'=:/X:UK4=3$L6H7!@FM1;(F0WF;6W 9SE5Z8&.Q/)W M+7X?:-936DMO/J2-:(\< -[(P1&&"H!) 'M^>:LP>#M-MK#3+&*6[6WTR;SK M91,>&SGD]QR>OK0!T->:>![C791XLEL(;-P=9N2@G=E&_CC@'CIWKTEUWHR[ MBN01E>H^E<SI?@F+14F2PUS5XEFG:YD!DB;=(PP6.8SU_+@>E $>KZQ<Z%XM MTIKR^\O1KZ.2$Q-&H6*<!63Y\9^8;QC..*I3>*]6EO=)T^&';<:DDUVH2 "2 M.!?N+AW WD$$DD 8/&<5NW7A33K_ ,/PZ->F>Y@B=7$DS[I2P;=DMCJ>0?8F MD\0>%K/Q UK.\UQ9WUHQ:WO+5]DL>1@C.#D'N#0!BQ:OXNCO-(LKR/3K>:\G MGB;S8BS;$4LK_))@$@<KZ]ZR]3\0:Q=Z=I:K=QK-%XI33KF2%"@=$E(&1N[X M7(!YSBNN3PK:I-IT_P!KO6FL97F$KRAFF=EVDR$CGCC P,?A5/\ X06Q$%S& ME]?*T^HKJ8D)C)CN V[<HV8P?0@B@#J!G R03W(KD7\0:G?'Q!/ITEI##H[O M$L4J%VFD1-S;L$;5/08&>">>E=:BE8U4NSD LV,M[G&!^5<_<^$+:74-1N[ M>]O+3^TH_+O8H67;+QMW?,#M;'&5Q^= ',SZG>:UX[\%74)2"&XT^:Z$3QEB MF]%W X89XX![>]>C(BQJ%10JCH , 5CGPS9#6=-U.-YXI-/@:V@B1AY?ED8P M01D]!W["MJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,[0O\ MD"6?_7(5HUG:'QHMF/\ ID*T: "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#D?B/JE_H M_A,WFFW;VMP+B)-Z*K<,V",,".]0^,;K6/"^D?V[8ZE+<PVCQ_:K2Y2,B6,D M*2K!05;G/I[5+\1M+U+6O# L-+LGNIVN(Y,"1$"A6#')9AZ=LT>);#5/%NG_ M -B#3Y=/LYV1KFZGDC8[58,4548DDD 9.!C- &IJ'BK3=-1GE-Q+''&)9W@@ M:00(1D,^!\HQSZXYZ5BZGK"ZQXGCT2*;4XK1[-95NK&*0#S'8;'W@8V@+UY4 M[B#TJEJ.BW]CXMU.XC\*V6MV6I1Q>2\GE+]G9$"%7+@DH=BGC\LUJQ#4+7QG MB+1I?LQTZ.U6XC"+ CJ6;INW!.0.!GV[T :&G^)=+G%M:Q7<T\CQ.8I&A<?: M/+X<J<88\=JL1^(M.EMM/N$DE,-_)Y4#>2_+<\'CY>AZXZ5Q]A8Z[<>*M U+ M4=%NO.MC<1W=Q)=*45G7&Z- W"=0. 3GGGFDBM_$<5CH>G#0)\:=J:R32">( MK+'^\.Y?F]U)S@]N: -.[\3R>'[7Q1?7?GW:6FH1PV\:KG;OAA*KQT&YSS[^ MIKK([J.2S%UAXXRF\^:A1E'N&P1^-<#K&F:MJVF^+K2+2[B-KB^@NK9I"H$Z MQB$$+SD$^2<9Q]X=.<=GJ%N^M>'+RUV26[WEK)%ME W(64CD X[^M &-IOBV M"3PQ+XKU*9[73)6_<Q&/<8HPY0,=HR2QY] "!V).A;^+='NT+6UQ)*?.:%52 M!RSLHR2HQEE (^8<<]:Y V4UU\&!HUE82W-]%$MI+;(P#1SHXWY)..",^^1V M-:/B_2KN[U?1=:BT%-8MX8I(KG3Y_++('VD,H8[=P(P?\F@#H(/%.DW5K;7% MM</,+EV2-(XG:0E<[LIC<,8YR../44V/Q;HLVGPWL-VTL4\ABA$<+L\C@9*J M@&XD8.<#C!]*XN]@O;34M(OM*\/+8ZJOGLUK:1Q,8[5C@&1-RJ6)(.0PY!'/ M-6+:WOK30-*M=(T;5HK*&]D%_#*$CNGRI.]&WX"EFZJ1Z#O0!U%SXTT.TTRS MU":XF$%Y(8H-MM(SLX)!7:%R#D$8([57U3Q;IPT6XDCEOHI/LC3,8K21GMQ@ MX,@VG9T/WO0FN:L=*UG3-*T&Q;1KI_LNMRW,NR59/+BR^T[F;+9\P>_RG/OH MWFG:KI^I>)84TB75+36TW1M#*B;&\K84DWL,#@8(SUH MV&HWLFJ>$5>ZD9+ MS2I99T.,.ZK"0Q]_G:M<>*M(^U16[7#H9IG@CD>%UC=UZJ'(VGH<<\X.,UA6 MECJ<.I^$O-TN<)9:=);73K(A$3NL8'1LG!B.2.F169X>\.WNC-'IDOA#2[BX MM)"\>L.(\2INW*>A?S.<<^F<T =C!XGTJ<.RSR)$D!N?-DA=(VB'\:L0 PY' M3U'K5G3]7M-3>>.W\Y98"HECFA>)EW#(.& ."/Y&N%TW0]1M;2[\K1KE=+NM M/D$VB7$JE8YBZ[EB8$D!AYAQD#.WIVZ/PEI]_IGVZVEENWTQ6C^P+>$&2)=O MS)D$D@' &?0]>I +^J>)=+T=V6\FD7RU#RM'"\BQ*3@%RH(0'WQT-9.M:XTG MB;3-%MYKV*WNK:2=[BRA,A;[JI\VT@+\^XL.A"YP#5(VU_H]_P")+%M+NK^W MU=GN;>:$#:&= AB<Y^7&T?-TP:L6.FWVE^(_#\3V<TL%IHQLI;F+!C$A,>.I MSC]V>W<>^ #?EO[?0=/LUU2_9R[K;BXD3'F2'IG:,#./I5>3Q7I,?]J;I9LZ M8RI= 6\A*EN@'R_-GCIGK4WB+3&UGP_>V$<C12RQYBD7JKJ0RG\& KC],\,: MY_PDECJ5]L4:C&MSK C8@":)MT* 9[94<=?+/KR 7(O&D&F^*O$D&K7L@M+7 M[,UN@@+&-&CW.Q"KD#+#)/3@5TVH:_I^F+F=Y6Q'YI$$+R[4Y^8[ <#@\GTK MD+[3M2-[X^*:5<R#4[2.*S=0N)6$)C(Z\<G//8&J5]IMY:ZRNI7/A.?5[6]L M((6A#*)+:2/*E2,X(.[.?:@#HU\9VVIZK?Z5IZS_ +O3Q=1WJQG:=P.",KC& M,$,3@YQVJ/P9XOM=5TC1[:[O3+JMU:[V8Q$+(X&6 8#;N Y*CD>E4HM.U+3_ M !+>2KHLGV:?1(K9/LK(8XG17_=C+ XY ''ITK.L].U&'1O <+:5>AK"4_:P ML>##\ICR>?5L\=LF@#MY/$^DQ:C%8O<,))93 DGE/Y1DY^3S,;=W&,9SGCK4 M>G^+M#U6_2RL;T3W#F0;5C;Y3&<-N./EZCKUR,5R>@:%-IUS;:?=>$4FN;2[ MW)JKRHT;)NW>;R=WF8/IRW4BMSP%8W6GZ+=PWME):3/?3S;9 N65W)4Y!.>, M#\* -6^\3:/IUY)9W5ZB7<<7G& *6D9/55 RWX9Z4EQXGTFWTVUO_M1F@NAF M#[/&TK2<9.U5!)QWXX[UDS6-Y'\4H]5^R2O8_P!CM;&95! D\W=MZY/ ],=/ M6L#P]I^I:-/H6JSZ9>O%%:3V%Q;B/+VQ,V\2!<_,".#M!X ZT =5>>,]*MX- M*F@D:Y34K@6\1B4G:>K;L#(([@\Y],'%Z/4K=]:OH1J43+:V\;2VVT#R"2Y+ ML_N ..VW/>N)72=0LKR+Q VEW$\,FMR7[6D: SQQO"8E)3/7=AL Y /KG%GQ M'INH^(KSQ-9V=M/"UQIEO;V\TL;(DC))([+NQC^,#T.?K0!V-IKFF7LSPP7D M;2I$)BC95O+/1\'&5]^E%IKFFWMW]D@NE-QL\P1LI5F7IN4$#</<5S&HKJ/B MG0M16WT*73M1>Q:#[1=A8Y"V0?*4C)*'!R20.1UYQ<T&9]2O[6ZNO#-U97MO M"T<ES=D'8>Z1MDE@2<YP!C\J ->77+=?$2Z'LF%PUJUSY@0[0H=4 ![G+?AC MFL?0_%EFSM9:AJ<4EX^HW%I!P 6V.VT':, X'?&:LW:RVWCNTO#8SS02V#V_ MGQ1[A$P<-AO0$?J*YFT@NX?#"*VE7_G'Q"+HQ_9FWB/[1YF\C'38/Z4 =K>> M(M*T^[6VNKL1N2 6*L40G& S ;5)R, D9J&+Q=X>GOOL,6L6;W6]H_*60%MR MC+?D >?:N0@T^:QU36-.U;PQ=ZLFH:@;B&YB53"Z'!'F?, NWGJ.W'-:&CZ3 MJ,FC>,[..%K2YOM0NFMI9U*JRNBJK CG&0>: .HM]>TJ[N1;PWL;2F,RJ.0' M08RRD\,.1R,T6NN:9>WGV2WO(WN-GF*G(+KTW+G[R^XR*XDV=]XDT";27\-W M6G7\5A);_:[I\QHS+M*Q')+!L8/ X]>!6RJ3ZYKGA^[%A<6KZ9YCW7VB-EV% MX=OEJ2,/RV25R/E]Z &^&]:NO$=Y=7$6I-'#:ZA/%]F-L-LD*@*HR>0<C=G/ M<@CIB2#Q*MEXLUZRU?4[:*TMH[>2W$FV/:'#EN>IQM'-3^"8I8=(NDN+&:TN M&O[F619$*[M\K,I!_B&TJ,^U8\\1/B7QI,UA=,9M.BA@E^QR$281PZHVWGED MX'7\* .ON=8TVS8+<7UO&QB,V&D&?+'5_P#=]^E%YK.FV$BI=7L,3,N[YFX" M] 2>P)XR>]><ZK_:=]I;P6^C:C%OT)8898;39++*008I&(W*JD9VY .3UR ; M.IQZAYT6I:7;:M9:K%8VT: V[207B\DQ2)@A64D\DC&>M '4^.-0U#2O!VH: MCIEPD%U;)Y@9XPX(!YAIFN:=J:&.VU"VN)XT5IDBE4E,]R!TJCXWLY[_P M7JUK;0//-+ 0L2?>;D<#WKGM8T*Y\2:H9](6>QCAT>:R$D\;PY=\;$ (!PN" M21QR,=Z .RMM;TN\E$=MJ%M*[1F5524$E <%AZC/>F?\)#HVUV.J6@"1"=BT MRC$9. _/\.>,]*X*VTRXU?0[NUBT#5+36EL)K9KG4+F1D1F4 K&S,<ACCH M*M++%J/A^]GN?#&KQ:A#I<MNQN4>7+/C]W&"3ORQSD#@*,XH [:SUO2]0G,% MGJ%K<2A-^R*4,=O'.!VY'YU9N+NWM0IN)DCWG:NYL%CZ#UKA]-EGCUSP:D%E M>)#'I<MO<EK.15B)6+:I)4!3NC_3WJWXO:.S\4>&-35+B2XMY9E*0V[S?N63 M#G:@+9'RX(&,GF@#7O->L+G3UET_7M-BS-&GG-(LBG+#*8W#YB,@?6M"#5=/ MN;^>P@O()+NW&9H$D!>/ZCJ.M><7EE:)X':WTN.\NYSK,=S<JMA*CJYE#M\A M7< %Z$]A70^*-.U6+7+/4]"4^=?0MIMRP!_=*<LDQX_@.[KUW 4 = _B#1X[ M2"Z?4[1;><%HI#*NV0#J0>X%))XCT2%4,FKV"^8H=,W"993T(YY!KBM:M'T' MQC:3_P!E:Q<:*-+2RA_LMI&:%D8G#!"#@KCD^E3Z+9:=:>)M*N(M#OK2&+39 MQ%YUM+(T1:7> 6(.&*ESC.1NV^E '=VMU;WMLES:SQSP2#*21L&5A[$5EZ1X MJTG6K2^N;:Y18K*5XIS(P&S:2-Q] 0,@FLGX9F\'A$17\5Q#<QW4VZ.>)HV4 M%RPX('&&S7-V>GZO;>%F$>F7&^R\1M>7%FL3 RP"0G]WD?.,[6&/[M 'I5GJ M5CJ!D6TNX9VCQO6-P2N1D9';(KGO$>NZM9>+- T736LHUU03[Y;F!Y"GEJ&X M"NN<]*2QMI[WXA2:Y;1RQZ>=,6VD,T+Q,\OF%AA6 / [X[X]:Q_'<%M+XY\) MS:A:32Z;;BZ-RX@=T4L@V E0>2R]/:@#H=.UO4!XLN/#^HI!.\=FEVMW:Q-& M@!<KL969L'C(Y.0#6I;ZWI=W</;V^HVLLR+N:-)E)"]SC/3WKSM=!NI_$.L/ MX4AEM='O]&DC=W5XEDNCO5"N\;N,CD<#FN@B634[7PJMM97-K)93J\R20O$( M56%T9<E<'DA1C@YSTH W3XHT ==;T[A6?_CY3HIP3U[&IFUW25ADF.IVGE1R M^2[^<N%D_N=?O>U>=V6A0K\,==F;0G_M:8W:*38D7#[W;9C*[B,%3_\ JKH= M5B2Q\3>'=5ATYSI:Q3(YBMB#;NZKM=DQE1A6!..,\XH Z5-:TJ2WAG34K0PS M/LB<3KAV_N@YY/M0-9TQOM.-1M"+7'V@^<N(LYQNYXZ'K7"2^'+G4M*\83VM MO)']JNUN],#KM)EC12)%'!&Y@0,]O4&JVFZ1KTWB19[RQ>*Q\1*ES?I@YMC" M<HC'C&Y=JD>I;TH ]#O-;TK3Y8XKS4;6W>0 HLLRJ2"< \GH3Q4<OB#2$N?L MAU6Q6Z,@B6)IE+>8WW5VYSD^E<-J,,</BCQ!::YI.LW5MJ.U[9[(RM',HC53 M$WEG@Y!^]QSV%;N@V,3>,_$%Q)I;Q;1:K#--;X#8CYV.1S@\'!ZB@#8T#61J ML%Q#,T7V^QF-O=K%G:''\2@\A6'(STSCG%:]<-X?N$LM<\9ZN\%R\3ZA%!B& M)I';8BJ2%7)(!8\CL#Z5W .: %HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#/T7_D"V?\ UR%: M%4-&_P"01:?]<A5^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** (H[6"*>6>.)4DEQYC*,;L="??WJ6BB@#+U/P[I>KW$5Q>6[&>(%4FBF> M)P#VW(0<>U7[:VBM+=((0PC08 9BQ_,DDU+10 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 5C:MX<MM5O8;[[5>V=Y#&T23VDVQMA()4@@J02!V[#TK9H MH J6.GPZ>D@B:5VD;>\DLA=F.,<D^P Q5NBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ I&&Y2,D9'44M% %>RLH-/M$MK=2L:Y/+%BQ)R22>22222>I-6* M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** *&C?\@FT_ZY"K]4='&-*M1_TR%7J "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHILDB0Q/+(P5$4LS'H .M #J* MXB[\1:E=>#AXBMKF*SMYKN%H5>,9%L950[BW&6!+>P./>NBM];T_61=VNE:G M ]W"/FV88QD]"5/44 :M%9?A_64US2ENPGERJ[PSQ9SY<B,59?S'Y$5J4 %% M%% >*:7 ZY_*E894C./>O.9=7U1OB)J>BRZVEM906<=S'NCC&"QQ@EAR!@^ MAH ]'HKD_"OB22[T:[N-4FMB+6[>W%U"-L4RC!#KU]<<=P:T5\6:*;<SF_A1 M!(D3;VVE7;HI'8F@#;IH8'L:R[7Q+I-]%=26][$ZVC;;@EL"/ZUA>)?%D2^% M]1O-&U")+JS:,N"N2H+ <J2, @]: .SHK%M_$FDR?:534+=VMTWRC?@JHZM] M..M1IXT\//)Y8U6U#&(3#,GWD/0CUZ]J -ZBL9?%.COID6HI>Q/;3,5C96SO M(Z@#N1[4LGBC1XK&VO7OX%M[EBL+EN'.,X'ZT :P<%MO.:=7&Z5XH^V^*[E4 MO8I-'738KF-BN,$NRD[N^=M=597L%_;)<6[;XG!*MZCUH L9 I-P/X54U26: M#3;J: J)HX7="PR,@=QWKA(/&6J0:+X9U6Y>TN1J4D<4EM%'AP7S\R')X7 R M,?C0!Z/16=?ZWI^EX^VW*0C!8ENP'4GT'O4%SXGT:U5S/J-LGEA6<&49 /0X M'8^M &OD4H.:YB\UFXC\3:#!:W,3V%_',6VKNW[5!!#9]S6M!K.GS3BWBNX7 ME+LFT/DEEZCZCC(H T:*S5U[3GO19K=PFX+%%CW\L0,D#U(H_M[3A>?9&NX1 M<%R@3?SNYX^O'2@#2HK)'B;1F,074K1C*Y1,3 @L.H^M2VVN:=>+</;7D$JV M_P#KBD@(3C//IQ0!HT5D+XFTAC/_ *?;#R #*3*HV ]"?K3IO$>E01W#O>P? MZ-#YTH#C*I_>/M0!JT52TO5+;6-.M[^S;?!.@=3Z C/-2:A<FSTZXN5C:4PQ ML_EKU; )P* +&?3FEKA_#OB#6];M=-U."2PN;.Z;_2(8U*R6H/8G)RP[C KJ M)=:T^"X,$MY LH<)M:0 [CT'UH T*3.<5RLGQ#T"+3K^]>Z BLK@VT@SR7!Q MQ[5I#43)JL&R]M#;/;M+Y)_UK$'[X.?N]J -FBLV+7M+N)8HH;^UD>4$HJR@ MEL=<>M/FUBPMY#'-=P1MN"X:0#D]!SW]J +]%(K!E##H1FEH ***YKQCK^H> M&K6TO[2S6]MC-Y=Q;JA\W;M9BRMG' 4\$'.>HH Z6BN=O-<GOM*TS4/#US92 M6]Y.D9DGC=QL8D9 #*<@CH:V6U"SCNUM)+NW6Z896$R .?HN<T 6:*R1XET? M^U[G2SJ$"W=M&))4:0#:"">_< $GT'6K?]J:>988OMUMYDP#1)YRYD!Z%1GD M?2@"W15%KW[1Y#:?<V<L?G[)B7W< '(7'\6<<'MFLF^\502:/KT^CSV\MYI( MD#I*<C<BACP#G'49XY!H Z2BJEGJ%O=KM2XA:=$5I8T<$QY&>1U'XU5N/$FC M6VGW-\VIVKP6R[I6CF5MOH.#U..* -6BJ1U?3EM8+F2^MHX9_P#5N\R@-[ Y MP?PJRT\**&:5%!&X$L!D>OZB@"2BHVFB2+S6D18\ [RP Y]ZP=.UC4M1LM5* MG3DN;6^-O"Q9C$RX1LD]<X8].^* .BHJ*6Z@@8++-'&2,@.X%,N+ZTM(EEN; MF&&-B KR2!02>@!- %BBD!!&0<@T$XY/2@!:*K07]G<QR26]W!*D9P[1R!@I M]"1TJ43Q,S*)4+*,L PR!ZF@"2BH?M5N8C*)XO+!P7WC&?K7-:SXWM;3PU<: MQI0BU!+>Z6VD19,')D"'''/)XZ ]<T =714+S;HYA;F.29 <(7XW=@<=*;#. MZVT1O/)AG,>Z1%DRJD#YL$@9 ]<4 6**ADNK>&W^T2SQ)#Q^\9P%YZ<]*D5U M=0RL&4C((.0: '4457M;ZVO5D:UG241R-$Y0YVLIP0?H010!8HHS10 45GWF MJ10VVH?96AN+RRA,CVXE (.TE0W7;G!Y(I^D7_\ :FBV&H&/R_M5O'/LSG;N M4-C/?&: +M%&:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH I: M5QIEJ/\ ID*NU3TS_D&6W^X*N4 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !5'6;22_T+4+.%MLMQ;21(WH64@']:O44 >;I:W.H?!_2K:.RDFF MMGMTFMU&YOW,P$@QW(V-Q6_8V;WGCJ?Q L,L%HNFK9CSXC&TC^87)P<' &!D MCO[5L[-+TBX:0R0VKWLJKM:7:)9#P-JDXW'V&3QG-798TFB>*10R.I5E/<'K M0!R_@"&1=#N[IEVQWNHW-U#SR8WD.T_B!GZ$5U=,BBC@B2*&-8XT 5408"CT M I] !144MU;P30PRSQQRSL5B1G ,A R0H[\ GBI: $;.#CK7FDNG^=\4]5OK MW1+BZT^33H[>*4P!TWKDL #^%>EL,J:R9?#FDS2O+)9*S.=S'<W)]>#[4 >9 MQ^'M8&@W36MG(FF0ZK'>66E/)M?[.OWU&#P222!GM6G>6MOJ>FW-U;>&[V$W M=W:-(UPN^:8)+DED+$@*.]=M_P (QHO_ #X+_P!]/_C44?A_P_<22I%;0R/" MWER!9&)0X!VGG@X(./<4 <=KNGZE<:GK<NGZ;/*%:SE6,IMCNUB;<Z*?7!Q@ M^E.\1W1UKPIJ]S:^&[R&:Y$4;^=:_OIBK*<;1U4*#S7<P^']-M\F&V\O=UVN M:F.EV;9^0\_[9H X770B>([Z6VLKG9-H)MD>*V;#.6)1.!UP?PJ'2HI!+X#6 MYLKKS;.S:.?=;G$,GE*,$^N5.*[Y]'LC&4,;X((XD8$9]P>*A7P]IJPI%Y+L MB<KNE=C^>>>IH \ZT_[?:&WC;1KM4_MBZ=[E;8M)"CL2C(#T#9QGM4-G8WB: M9X?AETJ\+6FORRR"2%F*)A\.3C_:%>D?\(QI&,?8SCG_ ):R=^O>D/A?2223 M;/DYS^^D_P : .%\4Z7J;^,YKW3K>>1;6SBF%OY!\FZ"NQ,>?[V""/?%>BZ5 M?#4;"*Y2"6 ./]5-&4:/U4CUJC+X9T6.(M- RQJ"26N) /KNIP\+Z,P#+;2 MG/.?M,G/_CU %K6Y7BT:^98VD;[.X5$4L6)4\=/I7EFAZ/<:+I6@^);#2+B> M[LH/LM_9&-O-&>KH#QD9Y]1Q7I0\+Z3VMI!CUN)/_BJ!X:TI&W"W<-G.?M$G M7_OJ@#B;V^>T\67E]>:?JUWI.JV<0MWM(W_=D!@8V0$$9)SSQS46F+I>D^,+ MN&XTEX8_[*@BCB6W,VT'?F/> <$CKDUZ+_9UF 4!D4G(XF?//XUE0>#-/M]> MN-5$]^TUQ&L;*;EMF!TX![4 <IHNB7N@OX/LI89Y6M([LR (2J;QE%+=!QQ6 M5:27D^O>&YQI5]9B'4;A9H([8B.VWA@"6_CR2&S_ (5ZB-%M//DEW71,@P1] MIDVCZ#/!I;?1;2!<*]U(,YS+<R,1^M '%^&=0?[-IVBZCX=O'U;3Y2K3/#B- M>H,PD/!SGH.:I:)'%=V%KH>O:-?SZK971F+/O\DN&)\[S.AZ].?I7H,>C6D. M_#W1W_WKF0X^G/%$6E6<$:Q^9<, ,9EN9"3^9H \UDMK:3PDA_LEN/$"RM#] ME(8QB4'=@#D;><U:U>TFNM4\66^E6KEIK*UV(L+1K/Y98LJM@#.TX_&NW;PU M82.9#<ZB0>,+>RA1],-2CPU8#_EMJ/\ X,)O_BZ //\ 4Y+#5]!U:ZM]"U)+ MD::89&O(6/E<KB%0>OU'YU=OXXGUK3X;2V=';0IH@HM6')4;%)V[1C'0FNS/ MAG3R<F74?_ ^;_XNE/AO3R,&742/^PA-_P#%T ,\*2A_#&FX21"L"(ZR1&,A M@H!X..]:.IW$MMIEQ/#$9Y8XRZ1#JY S@>_%4/\ A&;#&!-J(]/]/F_^*I/^ M$7L_^?G4O_ ^7_&@#B5L;?\ X2+2=7\-VEW87]U<(^IVHC94,?&_<.FX#ICU MJI86%O\ :]0TCQ!9ZQ->MJ+SQQP^8(;A=V48$<# ZY(KT$^%[,YS<ZER<G_3 MI?\ &C_A%[/_ )^=2_\ Z7_ .*H \YNK6Y?P9XMTP6=S]L_M=KK#1$[HC,K M J?XOE!KI))(9/B%:7$<;_9UTB52?L[ #+ X^[U(!XKHAX7M 21<ZD"?^GZ7 M_&FCPI9+C%WJG'(_T^7_ !H \\L;:UAT'PD]M8-!*NKYDQ;L&5<N,GY>.H'/ MK39)=.$FKZ3?Z@([<:W]I^TRV4C-PP)7.TKC=D YZ5Z.?#%KDYN]3YSS]OE[ M_C6(GP\M$E:/^V=;:Q8DM:->GRVR<G/>@#K;.\MYY)K>$N7@V[\QLJ_,,C:2 M &&/3.*MU%;Q+#;I$@(1!M4$D\#Z\U+0 5A^(;ZVM;K1HYRV9;Y0-HSM^1AN M;_9R0,^XK<HH \^FT2]\-^)K.#3(-_A_4+U)6A3I93#DD#LC8^@/IQG++Q_\ M(UXCT74@H\33W,TMO&W^MG<X\B1#Z#Y0".!M[<UZK32!NS@9]: ..T>U1/%^ ML6NJI'/=7%A:HTC0_+. CB3'&,$]1[URTFDZII_V*ZL=,>>;PO=M;Q!80'NX MY7^ZOHJQNO/J2>V:]<HH X#4M-318_!@E@02PZ@#<R1)D!WC?><]E+G^5$[V MUIHOCVT5!%+))/(D:QD;]]O&,C YR^?J<UW]% 'FEU9:5::W:);P+!:3:!<K M<-:+M9\[#R1U;AR,\YS65>+J,G@S7-(#1ZM''I<;VU]!;&.0H'P(G7'W@ 3C MJ.<]:]@HH \W\0:G;W%]:6]BDENSZ2_DW@MI)1AC@PQH!M#DH,DC('%4-,_L M2XU'P0FI"T,ZZ)(LRW. =RB,*&#>A67&?0UZO32JDY*@GUQ0!X[H^IV=K9>& MIKV:*3P[;WUZLKCYHH)_,)A#@# !RIZ?-GC -3-JGAQ/"'B!K;[-'9)KD;V MVU/D'S1#<G&/X)#QVS7K>Q<8VC'IBC8N,;1CTQ0!P%S;>&=1\9:_/>VMI/\ M\2N$J[P[M_$GF%#CYCM,0RN3T%<['JUCIDOA2\U*:!(V\/-9O;7NY8U9=JDY M"M\S=",=!U['V/ ]*Q+[0)KC6#J5IJUQ:2/&(I(Q%'(C 9Q]]25Z]B,\9Z4 M0>!+.SL/!VGVUE=VMXB)A[BUQL=\_-TZ^F3R<<U:\6WD>G^$M4N9;.6\B2W8 M/;Q$@NI&#R.0,')(Z $U=TS38-+M/(AR2S&220@ R.W+,< #)/H /2KG6@#R MHW&GWX\3Q6\MK=))X>C(2VMF5"5$@7:#DOC*8//8=JFT:UT32=<\'0VT=O#- M/I<D=SL3:92RIMW\=2RR8W=P17IV .@QVJ.YB>:VECBE,$KH5295!*''# $$ M$CKSQ0!Y_H>E3VOB*;PFUG&^BZ=<'4HI&P1LDR8X\>JR;SS_ '!7*ZK/:V?P M=UNS\U(KY=599(]V'#_:,@?7:N?H,UZWHFD/I<,K7-[+?WL[;I[J5%5GQP MH "CL/<^M:113P5![]* /,M1N/#6EZ[XIL"^FV\$^CPOY.4"/(OF]N[X*'UZ M4Z"VT36-4\$"[CL[M6T>4.),.&PL6T,.AY$O![AO2O2_+0\E%)^E($0'(50> MG2@#R*;4-*M/"'AFY%W;RV%GJ<\4MIY@,4@S(5#=1D#!&?7W%=3\.M+TRVCU M74[&YL9Y;^Z:5DLY ZVZ$Y6+(].3T YX]:U]<\,C5;ZTO8+I;::V$@"O;I+& M^_:"64]\*,$$5:T31?[*\^229)KB?;O>.!85 7. %7ZDY.3SZ &M7D<D^F M:9X>OA8Q6L,4/B&2+65MXU#BS^T2 !@!G9@J/]W(KURHEM;=6E98(@9?]80@ M^?Z^M '':79QV7Q#9-"2&+1Y--$EU%;X$(F+#RV"C@,5YXZCGTKMJB@MH+92 MMO!'$"<D1H%S^52T >;#^RK+QWXWFNOLD%S]B@>)Y-JMM,3;RN??;G'M6?I, M,&F7'@:;3)RMSJ6FS)/*TAD,A$"E%.3T5A@#MC%>I365K<.7FMH9&*[27C!) M&<XY[9IJZ=8J8RMG;@QG*$1+\OTXXH \R\(QZ?J0T:[FUU(?$,=P3=1"(+=R MN,AXI>=S+P3R.!C&,5ZM4"V-HEV]VEK MRXPTPC =AZ%NIJ>@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** *>E_\@RV_P"N8JY5/3.--M?>,?RS M5R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH Q=5U:XAUC3]'L1"+J[624R3 LL<: 9. MT$$DEE &1W.>*S!K^M?:;#1Y[6SMM8N9)69FR\0@C/\ K H;.6R,*6'?)XJ[ MXA\*0Z[?6.H1WUU8:C8EO)N;8C.&ZJ0P((HE\,,T-G(FIW)U.T=Y([V;#EF9 M=K;D&%*D8^48Q@4 8M[XOUNSCN[,6%G)J=IJ%M:MEF2*:.<C8R]2IYP<D@8/ M7I46L>(M=AT[Q58RR6,%_I]BMW!+;JY!C8/D<GAAMX/N..*V;GP>EU92+)?2 M+?SW4-W/>1Q@,[Q8V Y 4;1@<]_4U+J/A*VU&[UBXDN94;4[$64@4#"*-W( M]_FH H7^K^)8-4TS2=/BTNXGNK*2=I[@R1JK(R@G:-QQAU&,YSSD8JO?>,K_ M $W6;>VNXK)5EU".Q-O$3)+M?&)2P.$!)^XP!QS[5MQ>'94UVRU234YI7M;9 M[;RVC4*ZL02>!P<JO_?/>L:?X?R.LT<.N3Q0G4UU.%# C;)0VXACU8>@XQ[] M* +JZMXDO=5U.TL;'2Q%8W(A,D]PX+@QHXP O7#C/;T]:BTGQ9>:MI6EO%91 M+J=Q=O!=VK,1]F6,GS2<\\?*/JX'>M*RL9M#?6=1NKPW4=S*UVR1VQ#)A H5 M0"2WR(HZ9)!/?%9_AC3+6?6]3\416MQ;'4 BQQW"%&VA5W/M/0L0/KM!H D\ M<HW]CV4T-M%/=0ZE:- LAV_/YZ#&[!VYSC..AJK<^,[G2;/7FU2SA:XTL0$) M:NQ63SN$&6 Q\W7V[5L>)-&O=;M+:"SU)+$PW,=P6:W\W<48,HQN&/F -9.H M^!5U>]U>2_U%FMM36-7BBAV-&8_]6ROD\CYLY!!ST&.0"K?>*_$NFVNHW,NB MQ2P0")H97W6X<NP4I@EB2"1SP,9Z=#=GU_6[6ZM]-N;6T_M&?S)O]#5[A8H% MP 64["268+P<=3[4V3P9?7VDS6FJ>([JZN)%CC\]85C"HC[QA.1N) RQR>.U M:&O^&?[7N[74;34)M.U2T#+#=1*K_*W565N&% &;#KFH3WGA^+5='MX9KJYF MA;S?OH41F62,'. 0O<Y&<50;QEXAM]-FU:[TZP33[746LY0DCF251-Y6Y,X MP?7.<'[M;S^%FDO](O9-4N)+C3I)90TB*?-:0$-G&,#!P ,8JO<^##=^'I]' MDU6;RI[UKQG$2Y!,GF[1[;\GU[9H T?$NMMH6EI/%"L]U//':VT3-M5I9&"K MDXX'<_2L>Z\3ZKI-_?Z=>V]I<746FMJ%M)#NCC<)PZ-DL00<8/<'M6_KNBVV MOZ3+I]TTB(Y5EDC.&1E(*L#Z@@5DOX3N;M;ZXU'5!<:E<63V,5PEL$6"-LY( M3<<DDC)S_".G.0"WX6U'5M7TB#4=2M[*".ZACGMUMI&8[67=\VX#!Y'3/>N> MO_&5[INF>)=0@TBR\S3+Y8)!YQ!E4A ')"\M\PX.,#N<<]=H>G/I&A6&FR3K M.;2!(!*L>S<%& <9.#@#/-<O=^ [V\T[Q!9R:W"%UFY6X9A9',6TC@?O.>%4 M?@?7@ W-+U74IM<NM-U*UMH7CMHKF,P2%^'9U*L2!R"G4=:H>*?%-YH,TPCM M[801V;7"RSR',T@)_=JJC/ &2W09%7K71=0B\42ZQ<:I%+%):);?9DM=F-I) MW;MQ/5GXQW'I576?"4VIZK=WD&K26L=[8FRN(_(60E?FP58_=^\<C!S['F@" MK<^*=9DUZ+2M/TFV9Y=-%^KSW##:"0-K +USD<9Z@\5'9^,[V\M?#%_]B@BL M=7?R)B[MOAEPV !CD$J0#4MCX/U*QU2WOQKD4DD&E_V:-UEC(!R'R)!R#CCT M&,YYK*N-%&F^%+7P&\EW?74XW6]Y%;M&L0$F[>SY(!0\]>>!WY .QT34;C4X M;N>:&-(5NI(K9T;/FQJ<;_;Y@P_#/>N>U'QE?6^E7NO6UG$^D6-R8)4D#":5 M5<(\B$<8#9X(YVDY'2NLL+*'3M/M[*W7;#!&L: ]< 8Y]ZYMO!;?9[_34U'_ M (D]_<-<36SP;I 6;<RK)N "DCH5)Y/- &'J][?ZIH_C^&_-O):VD!%L@0G: M#!O4\]#R"??Z5H:-XMNX'T>WU*TM[>SOM,:ZMF24M*!&JL0P( R5.>.F#Z9K M0U7PI>7SZXMOJL4%MJUNL#Q/:;_+(7864AU_A[=CS[4V?PG?7.H:1=3:K;E; M&VDM98ULR!.CX#<^9E>%7&,\Y/?% &=I_CG5-3GLY;30YI+.\61D9K>=/* 4 MF,O(4V8; Y4G&>]:7@SQ%J_B;3[?4[K3K6UL)X69"DY=RX;;R,# X/?M4>C^ M$]6T2V^QV_B)I;"!9!9VTML!LR"%5W#9=5STXS@<]JTO"6@S>&?#MOH\MU'= M+;%A'*L1C)4G/(R><D_I0!BW%C:2_&*UDDM8'<:,\@9HP3O$R@-]0">:W/$. MN/I*65O:PI/J%_.+>VCD)"9QDLQ )"@ GI5"_P##NLR>+O[?L=5LHV%H;1(+ MBR9U5"0Q.5D4DE@/H.U-NO"E_J&V\O=7235+>X2XLY8[<I# 57&SRRY+*<MD M[@3D<\"@"./Q9J$4NHZ;=Z; VLV:QR"*&?\ <R1.0-^\C*A>=V1VXSFJ<WCV M>WT3Q#>M9VT[Z0\>U[>?=#.L@4J5;'4;N?PJSJ7@>768[RXO-1$6I71AW/!$ M?)V1,2J%"V64YYR>3CIBH=4\$:EJ&FZ[:MJUN6U?R3(QMBH1D !V@-P,*H ) M)X/)H W;#6KR;Q!-I-]816[K;+=1O'<&3*EBN&&T8/'8D>]<UX]L;2Y\7^## M/:PRE[UXW+QAMRA<[3GJ,\XK?@T;51XMBUF>]M?*^PBUF@CA8%F!+;@2W W' MWX_.JGBGPWJVM:UI%_87UG;KIKF5$G@9]\AX.<,.,8X^O- &;XD$/A7Q/X;N MM+06D5]>?8[J"%=L<JOC!*C@$'N!FKLWC&[M],?7Y;"+^P1.(PXD/G[-VSS- MN,8W=LYQS[5=@\-7-YJUKJGB"\@O+BTS]EAMX#%#"2,,V"S%B>.2<#TJD/!4 MJZ<=!^VPGP\;CSOLYA(E"[_,\H.&QMW=\9QQ[T 69?$6ISWER^DZ7'>6-G<_ M9+@>=MF:0$!B@QMPNX9W$=#^+;SQ/>VN@^(;[[';F;2+ATV>:VV1%1),YVY# M;7QCID=<5%_PB6JVFJ7QTK73::;J,[7%S"8 TB.WWS&^?EW>X..M5M8\%:OJ M$FO06VNI;:?JP#O#]GW.K[%0_-G[I"C/&: )K_Q=JT5WJ5M8Z'%+]CM([SSI M;L*IC8,>0%)#?(< 9S@Y(XS/I'BZYO[O3?M6EK:66J6[3VDQN0[850QWJ!A> M#D')Z<XI(/"VI+?ZE+<:G;20WNFQV)"6Q5E9%8!OOGC+N<>X';)CMO"6HPKX M;C>_M)(M)MS;2QFW;]^K+L)SNX.T#UY)]A0!#9>/IM0U&SCM]$NI+.[<B.5( MI]RKT61LQ! A..0YQG-0Z;X^OKNVTO4+G0UMM.OKTV.\70=Q(7**0N!\N5(/ M0^F>][0/"^LZ&\-BNMK)H=N[-#!Y.)@N<JC/GD GTY''2J<'@C48?"^F:5_: M%J9;#5%OUD\EMK .TFTC/7<QY]* +'AS7/$.HZ7KL\EK:W%S:ZA-;VL2S;0V MQL%"=HP!V;DG)R!795S6FZ!J>D6^MQ65];#[9=/=VK20EC$[G+A^<,.F,8_& MNEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH IZ;_ ,@VT_ZYK_Z#5RJ>F_\ (-M/^N:_ M^@U<H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** #%%%% !1BBB@ MHHHH **** "BBB@ HHHH ,4444 &*,444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!4T_ M_D'VO_7-?_0:MU5L?^/&W_W%_E5J@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "D) (&>32URV@73ZSJ.N:H85::SO M)=/M%D; 58P WKC<^<D#. OIB@#IT=7 *L&##((.<CUIU<%=WL ^&UEXDTW3 MUL6LXUO(;>!@ B[@73( RI&<\>_4"NY@E2X@CFC.4D4.IQV(R* )**** "BB MB@!KRQQ@%W50?[QQ0CI(NY&5E]0<BN&^)2PWEKIND.DKM?W: ^4,NL:?,[+T MQP/7FJ&@7UM8OJGBI8WM-"NHX5M;49#.X+#=MSA2QP,?G0!Z5D>M&1ZUQUSX MOEM;'5;N>Q/EZ="LK%) =S$9,8_VAQTSSQ4D/BR3[;9P7^G26D=Y:M<1-(RE MP5 +*RCIP: .K61'+!75BIP<'.#3LUY[X5U46^F6T[0N=2\03RWD=N6QA2>- MQ/0!=M:-CXS%U837+VGERB^DL((=X)N)%.,JV>F<\^U '8YHKB?$'B)X](O( M;S3;V,M<Q6<?DOAI?,P R'VS^E.U/QM!I%_?:;%;2W+V%JDSD./NX).2>AP! MUZYH [2BN5E\5>8T$%G8M+?2VGVMHI"$$2<8W,>_/^-7/"VOGQ)I/]H+83VL M;,50S;<R8X)&.HSG![XH WJ3<N<;AGIUI:X+PI;1:IXCU_7F'[H7;V=L <H! M'\KL!TR6SSWH [S<I. 1GTS0&4C(88^M<#J&E7NHV_B?4-(:2/4+A!;6Y8L! M\@PV >!D]Q4.BWFC2Z.==C^T64NEVTL-_9.2/F"\B0=R""0>^: /1 ZL<!@3 MUX-+G/2O,-,T2.T^';ZDS2QWLD+7\<R.P>/(WHO7! ! QTKNO#=]-J?AG3+Z MY39/<6T<DBXZ$J": -6DR/44V5PD3.QP ,D^U<3\.XS<:1<:Y*[DZG<RW$2L MQ(2+<0@4'IP,_C0!W&1ZBEK@--:'4?B%KFKO+(MKI21V8W2$1F4 L[$=,A2H MKCK*\GO=)TZWM&OK;7-2O6O+*XN'9(TCSG:K$X8;?X.>N: /;RRCJ0,>]&1C M.1BN#M7F\5>([W?+C1-+E^RK&CX^T7 #EB/X5SC'K3-*O\ ^S?%GB:R25_[ M*L+2*XV9R(GVL64'GL <4 >@45XSH!GU*+18-.^W#61<+J%XTTC@16[L6PVX MX;*@ 9Z^U>R(."3WH =1110 45RGBG5+C_A(O#_ (=AD:&+5GF,\R9#A(D# ME5.>-W0GJ!TJOXJ"^%5LM<TT-$%NXX;J!&PD\<C;22N<;P<$-U]>* .SHKE+ M[QS'8KJ+/HVH[--F6.[=O*"QJP4AP=_S A@<#GU KJ@00"#D'H10 M%9?B54 M;PQJF^22)5M9'\R-RC+A2<@CD8Q7)>#_ !%-IGAG4K'5))+N_P!&*C.XO)<+ M*-\/7^([MN/44 >@T5YA\.KJ]M+3Q3JNMW%Q<SVM_+ R+*\FW9RRHI..I&*Z ME_&EK"FK"33[X7&EQ+/<0 1,WED$[@0Y4]#QG/'2@#IJ*YFW\917$-H?[)U& M&>^(%G!.(U,P(+%LAR H R2>>1@$D"L;Q#JSWSZ!>)::G:W-MK:VLMN"07^1 MF*C#;'4E5^;. ,].: ._H-96CZY%K$U_ MK<VT]C,(9HYPN<E0P(*L01@CO7 M*^.;R\BU)?[1LM73PW!"'DN],G",LI/+. =VQ5_F3SQ@ [^BJ]B(AI]L()&E MA$2^7([%BRX&"2>22.YJQ0 45A^(- CUM4:YU6_L[>%&.VTN#""3_$S#K@#C ML.>M<;IE]JVIZ?X6T.]O+D+?/<32W*N4FFMHN8\L.?GRF3U(^M 'IU%<7IEM M<Z@-<\/'4KN*"ROE591(6F,#QJ^P2=1R2,\D#CWI?!\%[:ZOXBTW^T;N\TJV MDCCM)9VWO&Y4F1 YY;;E?I^= '9T5S'@&:XF\+YN;F:YD2[N8_-F?<[!9G R M?H*Z>@ HK!?6YV\:?V!]BE,!L/M)N5( 4EBO7.1TQP,Y/H,USW@[Q9;6^@Z1 M:W8OY%NKJ:UAO91N1W\Q]BDD[B2,#.,<8S0!W]%<M+X_T2&^CMV>0Q277V-; MA=I3S<XQ@-OQD$;MN,]ZZF@ HKB_'\R6LF@R'4;RS%QJ45M*8+EXE:,ABP.T MX[#GK4TUQ8VVGZMJ,&LZE-IUO;O:SQPNTKQ.!DR(QR=P!Z\CC/K0!UU%<W_P ME>FV)T^QVZC<7%S;++ %MVD>5-HY) QGD9)QR:L6_BK3KNPT^ZMUN9#J!<6\ M(B.\E,[@<\+C:1R0* -RBN:E\=Z)#;Z;,S71742ZP".V>0EE)#*0H/(((Q5J M+Q9I,MG<7(DF M[G[(\30/YGG<80)C))R* -NBN6UGQ5I"Z9J<=Q=:A:&S=( M[EK>%_-@+#<K9"D8('7IVK0U#Q/IFF7%Q!/)(7MHEFN/*B9_*1CA2V!QG\\ MGI0!LT5S2WES_P +*>R^U2-:_P!DB;R"1M5_-VYQZX]:Z6@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** *UB,64"^B"K-068_T6+_<%3T %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !161K'B"#2KJSL4B>ZU&]8BWM8B S #+,23A5 ZG M\LU%_;6HV^LV&GWNDJBWC.JW,%SYD:E49L'*JV?E],>_:@#<HI-PSC(SZ49Y M'O0 M%97B+63H&A7>IK;?:?LT9D:(2!"5'4YP:T+:;[3:PSA=HD17QGID9H MEHHJ*2YABGB@>15EESY:$\M@9./I0!+1161K_B.P\-VL%QJ#E$FG2$$#.-QP M6/H!W/\ C0!KT4@.:BN[N"QM);JYD6.")2[NW0 4 345DR:T4\5P:)]F.);- M[KS]_'RLJ[<?\"ZUK4 %<SHME+HVJ:SIZ*RK>W$E_:S,A9,N!O4X(Y#\XR,A MN.AQTU59+B=+](?LC?93$SO=&10J,",+MSGD9.>G% ')W/AV>W\$6/A!Y6O# M,R0//%"8PL"N&=FRQ .T8'/)(XZUV<4:0Q)'&H5$4*H'8#I4=G=V]_:1W5K* MLL$J[DD7HP]14] !1FJ>J:E#I5DUS,&?Y@D<2<O*Y.%11W)-9EQXHMK*.[^U MHL4EH(EE7SEQYKXP@)QQ\R?,0%^;V. #?S1GBN<N?%+1>)XM"@TYKB>6U^UQ MR+,H0IG!Y/O2R^+(K.V8W]A=V]V;G[+#:!0[W#8!!C/"L,'.<X&#G!H QM9+ M+\0;34YI)&M[&!XTA2T=OF<#+;AP>@_6L)]-4:3=6$,\^Q=0^W6/F:?(PC). MXHX[C)XKN#KMW!J6GVE[I%Q;QWKM&LPD5UC<*6"MCH3@^U2ZUX@TS0;C3H;^ M;8^H7'D0].N/O'VS@9]6% 'G^O:J]S8:5H;R!YKB^2:9!8/$@CC_ 'FTJ,DY M* 9]ZTM62WU>#4GEFN8[VYM6M+>06,C);QM][ P,EN,GVKLM8U-=)6S+V=S< M13W*0,\6&$19@ S G)&2.@-4++Q=%<0W<UUIUW8QV=P(+DW"@>4" 5?_ '#D M9/;()XR0 <T#+;:A:W-A>21>5IXLFW:;*=N#D,@Z#G&0:H0:?+9VGAYK;49/ MMVD-("TFFRE)5D&&)&>&[YKUA=K*&7!!Y!'>DEDBAB>65E2-%+,S' 4#J2: M/.K^>?4[G1YKN\<_8KEKB4+ILG/& %^F>IJG?6$=UINM(MY/'?ZI<AY+@V$A MVP@C$>,<\#\S7H$FL1)K%CIXMY'6]A>6.X!7RSMP2.N<X(/3'/6M(H"../I0 M!X[KWB*RN]?,CR6D26T7V>2WO/-MI9LX.1M!RIQ@ ^M=MX<\4:>V@VG_ !+[ MJP4)M6W^SN0@' Q@=/3VKJ3;QL59E#,O1B,D?B:<$QGD\F@#(_X2?3_2Z_\ M 9_\*Y+3)CH-C<Z7I=TOV)Y9)('FMI?,AWL6(P%PV">"37HNT>IHV"@#@_M; MV$6FKI=_)BU#>='/:R 3ENI) )!SGMWK%U+3C>V>M&.[2.ZU>:(S!K68HD:8 MPHP 22,Y)]:]6V+Z?I67JFJKI=[IMN;*>9;Z?R/-C"[8CC(W<YYP>@['\0#E MKF>/5K Z9J,XCTXJJ/%;6LH,BC'RY(X' Z5T4'B+2X((X8Q.J(H556V? _" MMO8*8CQ2EQ&ZL8VV/M(.TXS@^_(H Y/Q%K<.IZ#>V.GW$D%Q<1-<EM)A,C M&>!6?9ZC-8V&GV5M<PPV]G"$VK:S$R%0 HR1P.Y[\"N_V"C8OI^E 'E<,&SP M!JNA-J/_ !,-1>9I;D6LNT^8W)^[G.WC\!5F2"QO-1T9KJ\>/3M'*O;V\%I( M6=U7:&9B. !V KTKRD_NC\A1Y2?W1^5 'G6G7<&A7&J+IEQ$UO?7$EROG0R! MH9''S<!3N&[G&1CWJG=6EH/"&HZ18:C)]NU-RUY>3VLF9=W7@+QQ\OTKU'RU M_P BCRU]!^5 '!Q36D7BG3-0T^=(1]E%E<PO;R 2 $%-IQV^8<]C79::+\1W M'V]K<L9W\GR 1B+/R!L_Q8Z]JLM"IQ@E<'/''\J> !0 M%%5;R]-I):H+6YG M\^81%H4#"+()W/R,+QC//44 9VOZ$VIR65_:2)#JFG.TEI*X)3+#:R.!_"PX MXY'451U'0M2\2W%G'K,=I;:?:7"W!@MYFE-PR@[=Q*KM4$YQ@YQVKJ:* .'U MGPWK>HZ5XKM%CL@^K2HUNWGMA5"*GS?)P<1@\9^\?3GL+ 7 L+<7<<<=P(P) M%C?<H;'.#@9'X58HH SM?M;F^\/:C9V6T7-Q;20QEG*A692 <@'&,YK 7PC- M<ZUI.L7#I%);6BQ7%HCEDEDC.8B6P,A6)/3TKL*PX_$D<VJ):P6%Y/;-,]NU M[$BM$DJ]5;!W 9!&[&,T <O;>%?$\'A[Q79V\MI:7FJW\EY;31W#':)&&Y"= MH(.T$;AZ]L41>#]9MW\0/;V>E0IJ>F):1PPS.-CA2I+,4^;[Q.>IX'O76^(_ M$=CX6THZEJ(E^SAU0F)-Q!/3C-27^LIIVCC4IK.[:/ +Q1H#(@/J,]N^,T 8 M=WX?U=M+T"ZLFM8M9TA-@CD<M#*I0(ZE@ 1G (..HHNM+\37W]E3W?\ 9\DU MM?K=O%'(R)&H0IL4[26/SLV3CICOQHW_ (JM[.]-E%8:A>W4<:RSQ6D(<VZM MG!?) R<'@$GCI5>Z\<:;:Z7I>I-;WKVVINL=N4B!)=ONJ1G@G!H FT+3M3M- M>UZ[OHK=8;ZX62 Q2ECM5%0!@5&#A0>IZTFLP>(;\WVG6\.G)87,7E)=O*QD MB#+AB8]N&/I\P]\]*FM_%%C+J$>GW,=S87<IQ#'>1%/-XS\C<J?IG-;= &#" M]YI6L:5HEI;1-I*614REF,L9C 5<]L8QSU)SZ<[U8NF>)K75M9O]+AM;R.>P M.V=I8MJ*3T&<\Y'(]J9K7BFST+4;&QNK:[>6^;9;F&,,KM_=SG@]* *WB>U\ M07LT$.F6VGSV&TFXBNIF3S6SPK (V4[D<9Z=,@Q/H^LW9TG5KI+%-7T^:0B& MW=EB:%UVF,L03GHV<8R,8[U)/XXLH=:N])33=6GN[7!E6"UW@ ]&X/0]JU8= M>TR;2'U1;N-;.,$R2/\ +Y9'4,#RK \$'G- &&-)\0:?97]SIPLCJFHWXGG5 MY2$CB "X5MARVU5&2N,DG'&#?\-VVKV-K/;7>GZ?:6T?_'K%;W+RL222V]V4 M<Y(YQW-3)XEM?,M5N;>[LUNG,<+W,.Q6?G"GG@D D9QGZD"J=YXULK/79M&- MAJDUY%&)66WM3(-A.-PP>F>* )O!^F7VD:(UIJ$<*3&YFF_<R%UP\C/C) Z; ML=*WZQCXIT?^Q;?5X[L2V-Q*D,<D:DY9FV 8QD<]<],5LT 84NG7Z>-%U:%( M)+-[#[-(&<JZL'+ @8P0<XZUSH\+ZX/#F@69ALS<Z?JWVZ7$Y"LH=VP#MSGY M_3M7?T4 <1H'A_Q#H$C:9%'I<VF+>&6*[D+>>L3.792FW!;D@-D8ZX/2NWJC M=:M:6>J6.G3.1<WWF>0H4D-L7<W/;BKU ',^+-(U'5;G1)+""WD^P7Z7<AFF M*$A01M7 /)SW]*TO$%I<7_AG4[.VC#W%S:20HI8 ;F4@<_C5V\NDL;*:ZD21 MTA0N5B0NQ [!1R34L<BRQ)(N=K ,,C'!]J .-L],UBWUW0[R33?W5EI+VLVV M="?,.TX SS]SK_M>U95EH_B>WT^QM&TIS:+>7,EW;B\2)I!(Y>,AU).T;B&7 M(SCN*[^[OX+%[=9O-S<2B&/RXF?YCZ[0=HX/)P!ZU:H \\T?0];TK1/#MBVD M _V=J<T\HAN4.(V,H4KDC/\ K<]CA>F3BJLWA_Q+]HU.\L]-"7,6N?VG:+/- M'LN$V>65^5B5.,GG':O3 <]*6@#A?$D7B?7O"&J6_P#820SW2)##:"ZC9Q\V M6=WR%QC "C/3KSQ7\3:3X@UJXU-&TIY;:2UC-@$NTC$3XRXE&[YGSP#RH'<9 M)KT+-% '(VEAJ;?$F36)=-EALI=*2V\QI(SMD#[R" Q/?&<=?;FNNHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@""WXMHL?W14]0P?ZI/]T5 M-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 <%XAGBT7XHZ-K.HND.G36,EFMQ(<+%+N MW<G^'(.,_6NDU+68GLKZWTJY2?4ELI)X4A_>$';\AXR.21@'KVS6K/;P74+0 MW$,<T38W)(H93SGD&F6UE:62E;6U@@#=1%&%S^5 'FELGVW3/!VJZ>2FM2WD M4%\RLQDDC ;STDR<\;2>>A'&*K11V@T/4=4FOI?M.G>(A'#,]Z[B*/ST7:-S M<#86_"O4XK&SMYY)X+6".:3EY$C 9OJ1UJ)M'TQT='TZS97?S'!@4AF_O'CD M\GGWH \I\0W5EJNA^-3KD\$>K6MQ+%8K+(%D6W 0QA!_=;!/'7-;PU/3;&;6 M8I;ZW@6ZT"VFB5Y@HD;$P9EYY/W!Q[5V\^C:5=2K+<:;9S2*@C5Y(%8A1T4$ MCI[4Z32=-FE@EET^U>2W4I"S0J3&I&"%..!]* /*_#FMV<UKX9M_$5Z@TEM* MD:.6XGVQO<B3:RLV>2J8P#TW>N*V8(=!35?"3?VB+VVM_M<=M>W,@!=E*[0K M\;@.0.N<=Z[B?1-)N;1+2?3+*6VC;<D+P*44^H4C -2OIMA*+<265LPMCF - M$I\HXQ\O'R\>E %JN(U#3%\:2ZQF"*6T6)].MWEF(4-D,\B@*<_.$&<_\LZ[ M>H+6QM+)76TM88!(V]Q%&%W-TR<=3P* /,O^$EDO_A]HEY+<K'>:?JUM;7K[ M_N%)-K%B>Q7!)/'-9/B74;;5;KX@6UM>0S(+>R:W"3;P=I!=UY/0GG'3O7KC M:-I;0SPMIMF8I_\ 7(8%VR=_F&.?QI_]EZ>(WC%C;!'C\IE\E<,G]TC'3D\4 M <C)9Z?J'C71[>&9#:0:5,X^RW+)O_>(HY1AN48;\:RM&U![^[\,6>I/++IM MQ;W8&^8NDDZ2$*KMGYBJ XR3SSU&:]$&F6"LC+8VP9(_*4B)<JG3:..![4V7 M2=-FL/L$NGVKV?7[.T*F/KG[N,=>: /+I;5Y_LUNVHW:Z8OB?[/:R)>,N83& M2R*P/*AQ@=Q@@$<ULWEA;Z?XQ71K:2X^P/H%QNM9+F213\XP<,QYY89KN#I. MFM##"VGVIBA_U2&%=L?^Z,<?A4S6EL]TETUO$;A%VK*4&]1Z ]<<G\Z /+[2 MR%S\)=!U/3IF>YT?RKQHH9B!)L(:2-@,\E>>F?S-=QX81;M+S71([C59!+$" MS86%5"QX4G R!N/ Y?GI3]2T266S%AI<MMIUG,7%VL=O\SJXY*$$!6Z\D'K6 MO!#';6\<$*!(HU"(HZ* , 4 <KXHW-XS\&QNS"V-U<,PSA2XA8IGWSG'XUO7 M&AZ5=S7,MQIUK+)=1B*=GB!,B Y ;U _H/2G:IID>J6R1L[1R12K-#*HYCD4 MY!_F".X)%7%#! &(+8Y(& 3]* /.-6LI)OB[IUGIVH/IIBT0A7MXXV*J)#A< M." ,8[=J=KMG/H>M>!KO4[QKNVLIIX;J\E&!YDB81VY(7GOGBNFN?#(GUEM4 M7^S1=[@R3OIR-*N!@?/G/ XJS-IFJ7$+PSZE:RQ.-KH]B&5AZ$%N: +TEW:+ M<6T$DT1FG),*9R6P,DCZ#O\ XUY[XAL=2\966JW.FV-K=P2_Z)93O=%&@,,A M+.HV<[G'][D(M=39^&9-.5ELI=-M@R[6$.F(F1Z<-TIEKX?UG383;Z=J>DVE MKN)6&+2-JC/L)0,_A0!+X4U:W\5>&-.U.6-'G4#S%8 F.9?E;Z'.?P-.\66] MO%X)U\".-%>RN';@ ,Q0\GWSBIO#^A_V*EQN&G^9.X9FLK$6V[_> 8[CR>:F MUO2CK5D+%YO+M)''VE0N6D0<[ >P) !Z\9'?( *OA2\#>'='M+F>+^T!IT,L MD._YPNT#<0><9XSZU%X]A^T> =<CV,Q^QNP"YSD#(Z?2M(:5 NMIJ:A5D2U- MLH5 /E+!N3U(&!@=!SZU=DC2:)XI45XW4JR,,A@>H(]* .#N-*M[J^\%6RW4 M\$:P3R9CG8._[M<J&SD Y/0Y Z8K+.MF.UTS3_[4:#3Y=6O+<7-U+(WRQD^7 M&S[U?!)ZEOX0#QQ7H4.@:-;26TD&DV,3VH(@9+=%,0.<[<#Y<Y/3UI!X>T46 M4ED-(L/LLK^8\'V=-C/_ 'BN,$\=: */A2VELX-0MY=:&J;+MR,*0+?.#Y0) M9B<9[DXSCM5+Q3;37/BCPU#'J%Y:QSRSQRK;S,@=1$S=N^1P>V:Z6SL;33K9 M;:QM8;:!<E8H8PBC/7@<4EQI]E>3V\]S:0336S;H))(PS1'U4GH>!T]* . U M#S;W5M8T-?$2Z8=-AA%M),\AE$?EAC*&\Q0YR&R2#TYINH7>I76J:Y;>?J%S M+_9EO_9LEH601RNK9+ $!6+!6^?H/8\]Y>:+I6H745S>Z;9W-Q%CRY9H%=DP M<C!(R.>:Y74O!;WVOWM]<:9HNI+<NK1RW9=)( %"[< ,& VYZKR30 :8EQI7 MBFRTS4+^:;=H+/=237+D-*LB@L,GC[S<CG&/2LVWG-WI'@2079DSJC?OGE+% M@$FXW$DDD#%=?8^%M,@TO3[2]M;?4)+%<137,(=D.<_+NR5 XQR> .35I= T M9!$$TFQ412F>/%N@V2'&7''#<#GKQ0!Q,6HEO$%E>6FH3W$%QK<D#32W#+P( MW!A6'&W8N!\QP<C..<U023_A'_#FM7=O)-"9->>VN9A<R-Y$#3 ,XW$X;!^] MC.37H4GAK09I'DET73G=Y/-9FM4)+_WB<=?>I1HNE++=R#3K3?>?\?)\E?WW M^]QS^- '%>)Y+G2KO5[;3KVX%I+H$]VRB=V:"6/[CJQ8E=W3 Z[2>>:6ZTW4 M;/PG9^);35=6N;^)(;ZY@-R2ERN%,B;!A1\N< #MBNS70]*2TFM!I]OY$V!+ M'Y8Q(!T#>H'3!XQQTJIJ^FZC+80Z;HKV-E:,C0S%XB6BC*X'E*,+GZ\?RH C M\,WCZS]KUQ9Y&LKMPMG&6.T1)QOVGH6;<?IMJ+QFE])IMJFGGS)3<C=:"Y-N MUVNULHLBD%2/O\'G9BMZTM8;&R@M+=0D,$:QHH[*!@5%?Z99ZFD27MNLPB?S M(\Y!5L$9!'0X)'XT <;H_B)+O4O"XMY[Q8;J&]CE2[ERVZ(K\K#HS Y^;KCZ MUEPWM_JMOI[6^O7L<4WB2ZM/,@F#!X,2%0"<\80!3GC.>N,=[<>&]$NK2VM+ MC2K.2WMFWPQ-""J'O@>_?UK!USP=!--I,.E:1I\=I'J2WMY@^7OP&'0+\Q^< MGDCICO0!R^IZMJ7AV]UC2XM3NCIO]HV4/VVZF+FU652THWD[L<#H00&[=:L^ M+8KW0]"U"2S\47'-Q:/%;)*SO"&?:?G9F8AN3@\?*?6O05T/2UTZ;3_L$!M) MB6EB9-P<GJ6SU/N?2JH\(^'ETW^STTBT2T,@E,21[0SCHQQU(]Z .7U:W?P) M=:5JTFM:Q=:8MQ)'??:K@R@"13L8J,# ;'0=_I5OS-3@F\+7%S>7*37^H2O< M6_FDH%>*1UCP>R[5 '3()[UV4UM!<VY@GA2:$XRDB[@<=,@]:KWVDV&IR6TE M[:QS/;2>;"SCF-O4>] '!7NN76E^(?M-RUU)O>Z>RGMKII;:\"*^V!XP<1LO M R!DE#[U9@O+J/1?"^OV^H75Q<:A>6Z72-.[1.LQ(=0A.%V$\8'&SGO756WA M?1+/4!?V^G0QW(=I%<9^5FSN8#. 3DY.,U)!X=TFUO%NH+)(Y$9G0*3L1F^\ MRIG:K'N0,F@#G?"MCJ-SK.J7=[X@U&Y2QU&6WBMRR+&R[!]\!><;_4=!6OXS MU>?0O"=]J%NI,D:JH8#/E[F"E\8.=H.[\*T-/T>PTJ2YDLH/*:ZD\V8[V.]_ M[QR>I[GOWJW+%'-$\4J+)&ZE61AD,#U!'<4 <E.]UI'BK0[:RN[J[LM369+E M)YVEP%0,)4)/R\G!QQR,#I1\.[6&WT?49(PP:75+LN2Y;)$K*#R>N /KBN@T M_0]/TL@VD+J5C\I"\SR;$X^5=Q.T<#@8' ]*=IVCV&D^<+&#R%F;?(H=BI;N MV"<9.>3U/&>@H Y#XQ0//\/+D)C"SPEF)P%!<#)_$BNC\1SQ)X<F4R+F<)%$ M <^8[$!0/7-:EU:V]]:R6UW!'/!(-KQR*&5AZ$&J%MX<TFUDA>.U+>0<P++* M\BPGU16)"'_= H YS7-"OI?$-UK?A754@UB%(X[RSG&Z&X4#<JMW4D'J/TY- M8FMZL/$7@[P9J,-E]F,^O6Y,"\@,&D#8QU&037H-WH.F7MRUS-:*+AUVO-$S M1NZ_W692"P]CQ3;CPWHUS#:0RZ=!Y5F=UO&HVK$?50, 'W% '+_%"$7>FZ-: MVS1C59-4A-EDG<&!Y88YV@<D]N/:N\JC!I%A;7S7L=LOVMEV&=R7?;Z;CD@5 M>H Y3PPZOXI\7E6!'VZ(9![B! ?UK+\<W<,OB;P5'&X?=JK?,I! *85@?<$X M_ UT</A#1K>ZN+J"*ZAGN6W3R17TZM(?5B'YILG@S0)%L@;)P+$DVVRXE7RB M3DL,-]XGDGJ: .8T^._N/BKXL?3KZSAEBM[6,K/;M)G*9SPZ]".>OWATKC[. M;R]!9+TR-':^+ VL7*-F.9LGYQP,+N"\'V]:]93PAHT5_<7\4-S'=W)S--'> MS*TF.F2'Y ]*O0Z-IEOI\EA%86Z6DN?,A$8VOGKN'<GU- '-_%(Y^']\D>3< M220K;A>6:3S5VA?>N>U676[;XCZE-I"Q/J$?AU&V2)N+'S.=O(&[/(SD5W\/ MAW2X9H9?L[2M <PB>9Y5A/JBN2%/;( XXIR:!IJ:X^M+ XU!T\MIO.?E?[NW M.,>V.O- '/>#]#T:Y\ :3:VL\MS9K(EVDCX#B59/,((' PP((^O/>J]AK%XO MC*&TU:>]MVEN9Q:M$5DM+V,;MJ\#*.@ R#U*GUXZRQT73]-N[JYLX##)=.9) M@LC;'<]6VYV@GU S4<'A_3;:]2[CAD\U'>1-\\CJC/G<54L54G)Z#N: +6H3 MBUTZZN#-' (HG<RR?=3 )W'V'4UY[;>)-7TBYOI;B6YN;>+0?M\:710&>53\ MSJ%R44@CY3T]*]%NK6&]LYK2YC$D$\;1R(>C*PP1^1K)M/!V@65S'<PZ>/-C MA-N&>1W_ '9X*$,3D8XP: .3,,\GBSP+=RZQ/?RW,%TQFP@3)@SN15&!U]^ M.O)-;3[SQ'<Z)8:FWB&Y\X:N;!T>! K1M,T>YEQRXR,<@#&,>O90>"M MGLW MALY%-DQ:V'VJ7$)/7:-V #Z"HI/ ^CO916:?;(8(;HW<:Q73KME)SD'.>N3] M2: ,+4+W6=)\/>+HDUNYFGTY4EMKF6.,NN8PY4_+@C.1TX!XJ5KK7+[QC9Z9 M;ZU):6\VABZ?$".0^]5RN1UY[Y'7CN-R;P;I4[:N9&NV&K +=*;EL,!TQSQZ M<=N*2T\':=9:G%J*7%^]U%;FV1Y+IVVQG^'G\_J : .>MO$.M?8/",SWB,;G M4I;"\_=#]^%,BAO]D_N\\'J?3BK UO44\<'2K^_O;!9Y9%M4:&)H+B/8VWRW M"$K(IVDAB0>>.0*TX/ 6C6\.GQ1M>^7I]PUQ;+]I;Y'8Y/X9SQ[GUJW#X6L8 M=16[,UW*$N7NXH))=T<<K[MS*.H^\W&<#/ H XS0[G6+;X<:9=:;J^9YM5\H MR7$2RJZO=LAZ8/.[<3G/H16AK%YK6DL]G_PDLES=V]C-=B.WLX_-D(8D&0%2 MJ1@#:.023UXK97P-ID=@+&.YU".T6Y^TI#'<E51]Q<!<= &)(QWQG.!5C5O" M6GZQ?M>32WD$TD'V>4VUPT7FQYR%;'49)_.@#G--N]2U7QIH=W+J;1I-H*WC MVJHNS<S1[PN1G!P.221V-10>)=;E\,Z?XNCOT:WN;I$DTXQ)Y:Q/+Y>%8#=O M&0<DXZ\=JZ.R\%Z;I\^F36\U\LNG0F"-C<,2\9(.Q_5<@<<"E@\&:;;R826[ M^QBY^UK8F0>0LF=V0N,XW?-MSM!YQ0!F:#J'B'5O$NLPRZE;QV.FW_E"-;4; MI4*YV[MW&,CG'K]!VM8^D^'+71]4U/4()[EY=1D$LZRL"H89QM QP<5L4 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!'""(U![ "I*:HP,4Z@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH Y?6M1:]\6:?X7CF>%)8&O+IXG*.8U("H&' M(RW7V&.]5[F'Q:(KORK6VE==0#Q[KMD$]N-Q X'[O!V C^+:V>#3=3M_[,^) M>FZW(K):75D]A+-_ C[@Z;C_ YY /<X%=E0!Y_:V@NOBSK%L]]J/V:.P23[ M.+R01AY,AB &XXZ8Q@].U<EH_B*RA^']YJ=[K^J+KB/((R;F8Y?<1& I.QAP M,CZYKJHKR*R^(.K:V+_1GMKBU2!$.I(K[D]1CC/UXK&T?[18> [GPP]YX;+3 MK*GVA]55D D8DDKMSP#QSUH ] DU2\L_"$%_/ DVI-;1?N4.%DN' 4'L"Y MSV%9G@74[RYL]0T;5;@S:II5PT$TO(,B-DH_XC/Y5DVPTU;;0]$O-:TJXTG3 M[<>9,NH*CR3*,)\H.0HY_BZD>E,@M[+3?B%:ZEX?U'27LKJ 6UY$^I;I)&W? M*R@ELD?*!^5 &QI_AS5[6.Q7^VM3/V:_DDS-.LGFVY/W9./FSCC^[N/I5O2- M1DMO%-]X:E+ND%M'=6DDCEG,3$J58DY.&'!/.#STR>DQ7#*MQ+XUUWQ-:)"\ M5EIRV,#3.8XY6#>9(=^#PO0G'7CL: .ZHJGI-W/J&CV=Y<VK6L\\*2/ QR8R M1DJ?I5R@#(U3Q!#IE['9BTN[NY>%Y_+MU7Y8UQEB691U( &<FJ,_C;3HSI0@ MM;^[_M6$RVGV>#.\ 9P<D;3R.N ,\D"H/$VC:QJ>L6[PQ6EWIBV[H;6YF9%6 M<GB5@%.\!<C:?6J>C>'=8LO^$26XM;;_ (E%O+#.Z7!/WEVC:-O/W0?QQ[T M:4OC:QBT_3+MK+4,ZA<M:QP>2/-212P*L,\'*D=:L1>+;*2RN)WM[J&:"[^P MFUD5?-:<@$(N&*G(8'.<8Y)/CP[KLEQICO:6J"UUJ;4'_ -)SF.0N<#Y> MHW_I[\1WGA;7KJ6\NXE@@N4UA-4M$,^Y)<(B%)/EX.%)R,]?QH WYO&=A:PZ M@UY:WEM-8;#/;NJ&0(V,2 *Q!7)QD'C!JY?^([/3KF\MYH[AGM+07DGEQ[LQ MDD<8[Y4_E6!J_A6[U\ZMJ+PI:7UUIZ6,$3R[@ &\QBY7(Y; &,X SWP$FT?Q M+J&J:I>W5MIT*7FD&R2*.X9F5\N1DE0""6/I@$=<<@&KIWC/3=2N;=%CN((+ MN!I[6YN$\M)PHR^W)R,#!Y R,D9 S4UKXILKFXM8V@NH(KM&DMIY4 CF51DD M$$E1CD;@,CI7-S^#]3OK/PM8SI#'%IVGS6EVZRY.7MS#E!CGUYQUJ_HNF^(G MT>#0=7M;2"UM[8VTEW#-O:X384 5=OR'&"2?3CK0!<A\=Z'->6UOYSQK=1O+ M!,V-CJB[R<@DK\O/S 55753J/B_0+BW^WQ6MU9S2*LAQ%*N%*MM!^]SWYP16 M19>$M9F\--X;N+#3K"".W:![^!P9+KY"JG:%RO.TL222 1SG-:>DV/B1[W0) M=1T^S@&G1RP3LESNW@JH5U&WH=HX)S0!V=%%% ''6WBW1M,T?4=7:?59K;^U M&@E$T;.T,A*J55>JH/0]R>Y K=TK7K75KBZMX8[B&>V"-)%<1%&"N"5.#V.# M[\'-<3>>&]>F\.>(+-=-!N-0UH7L*B=-HC#1GDYZ_NSQ[BNKT^WU >,=4O9[ M$PV<]K;Q12F526,9D)RH.1GS?_'?>@#?JO?WT&FV$][=,5@@0R.P4D@#V')J MQ69XBAU.?P_>Q:/*L6H-&1"['&#]<'!QG!]: &:3X@MM6O;RR2"YM[JS"&:& MX0*P5P2IX)'.#[^H%:U<5X/T._TSQ'JNH3Z?]EMM1M[=P'NC-(DB;@P<GDL= MV<Y(Z?AVM %74;^#2].N+^Y\SR+=#))Y:%R%'4X'-8ECXYTC4;V"TMUNS)<P MM-;%X"BW R0C'@D=*O>*O\ D4-;_P"O"?\ ]%M6!9:3?:X_A:[O+3[(NE1B M4OYB-YS&,* FP\+W.<= ,'L ;!\7Z6+;1KG,WDZO*(K9O+_C/0-Z=_RK TOQ ME::--J%IJUQ?2@:K-"MR\3-%"NX!0\F-JCGIV%9T/AWQ/]A\+V,NE6VW1;]9 M9)?M0Q*@+891C(X.>>^.#SC2O?#^L76CZ_H8LU5-3OI)4O#(A1(G*DDKG=N M!XQUQS0!I6^IS1>+?%"7,]P]I:VUH\<<:ES'N$FXJJ@G)P#^'H*N6>LV=KH^ MCB.:]O6O84-MO7?/*NT-N?H!@$9)P.?4UE0Z;J]CXTUJ\CLII=/NK"**+$J9 M=X^.<MQP['GT/M65%HOB/1G\.:U:Z:+JXLM-72[S3_/4':"/WB-TSD D'MB@ M#N=&UBSUW38[^Q=VA<E<.A5E8'!!!Z$$5?JGICW\MH9-1@C@F9V(A1MVQ<\ MMT)QR<<<X[9JY0!F:QKMIH@MQ.D\TURY2&"WC,DDA +'"CL "360GC2&?Q'I M6FP6-V\5_9&Z$GDG*9957</X0,MDGIQ2^---DU*&R4:7<WL,+F4R64ZQ7,$@ MQL:,LP!ZMD'M6=I6D>)+3Q%HNIZA&EY+_9CV5U*) #&QE#AFXY^4 ''?/UH MV8/&FCW%S%#$\Y^T>;]E?RCMN3%]\1]R0<_7'&:@T7QK9ZIX<_MJ6VNK>)YF MBB1H27E^8A=@&=QP.<="#Z5RFF>'O$UUXF\/ZMJ>F,MQ97%P;RX:Z4JX8%5, M: _*H'; )[\T6_A37SX-T>S;2K9[O1+]I/LUS(K1WB%GS@] ,/QGTZ4 =A;^ M.-%N/+0/<QSO<BT,$ENZR)*1G:PQQQR/7!QG!JM)\1M BLWN7^WA8GV3H;*7 M=;]#F08^48(//7MFL^\M-1"Z88?"D5KC489Y([-HCY:)G+,?E!/S< 9XSSSB MB]M]4GMO',2:)=[M039:/F/]]F!8?[W !!;GL?7B@#H-6\5Z9H\OES_:97$0 MGD%O TGE1<_.^!P.#[\&JQ\>:"9UABGN)W>V2Z006LDA:)NC !<D>OIT/-8- M[8:I%KD>L?\ "*1:K;WME##+;3M&)K65-W][*[3NYP?3TYOVNGZE9^)[B^FT MG*'1(K<-9LHC\U68LB*2#CYAC./NF@#07QC92ZUI-C;P7$\6IVIN89XXB5VY M7&?08))STX]:Z2O/O#FE:U!-X4GN-+DA33M/DLKA&>/<C'8 _7E<+G@Y]J]! MH *\^UCQG]M\*C4[5K[3C#J4<3,T6Q703E""S#!&%.0IR#P:]!KS2]TO6AX5 MBT9-%NI)H-8^T>8CQ['C^T--N&6!^Z0.0.?SH [+3_%&DZE%>RP7#JME@SB: M%XV0$9!PP!((Z'O4FG^(].U+4)=/A>:.\BC$K6]Q \+E"<;@' R,\9%<EKVA M:OK>H^*+6"Q:**\MK3[/<3E?+D>%RY0X.0&SC./6M7PK8C[:UX_A.+195MQ& M\C,C.[$Y*J5)^08SSC)/3CD ZVF32K!"\KABJ*6(12QP/0#DGV%/IDC%(V<* MSE03M7J?84 <1X7\2G5++2]8OM4O(6OY7C%HUJ?(+,S!%5]G4 #G=SSFM;Q% MXQLM#TC4[N..6YGL&1)81&R[6<X7)(^Z?49_6N6LM'UVT^&_AZU72Y_[0TO4 M(II;;>@9T60D[3NP<AO6I-2T[7-5M?%$K^'Y%^VM9RV]N\Z9E6-E+(V#PV ? M;WH [>#7=/N;J2UCDE%Q'"+AH7@D1_+/\0#*"?3C//%4)_''ARVL[*[EU'$% M]N^S.(9&\S:<' "]<]JSM0FU:V\5VNMP:%>W=O)IC0&&-HEDBD,@;YLN!C [ M9_&N<\/:)K<%IX$,^D7,8TV6X^TABF460':V-V<?-R.O!XH [>7QEHL, F:: MX*"!;B0I:RMY,;9(:3"_)P#UQTK:AGBN8(YX9%DBD4.CJ<AE(R"*\_U/0[B# MQ?K-U<>%DUNTU)8F@D5D!B98PA5]Q'RG .0#WX-=QI=J;+2K2V,-O"T42JT= MN"(U('(4'G;GI0!<K+U/Q%IFD2-'=W#"1(S-(D<;2-'&.KL%!VJ,'D\5J5QF MH2:II'BO4)!H,VJZ=JL,2 V^TE'4%2L@8@;"#U[<]: -K4O%6CZ4$-Q<NQ>' MS\00O*1%_?8(#M7W..A]*=-XFT>%@#>B0%8WW0HTJJK_ '"64$ 'MDUQNI:9 M?6'BZ74KOPU)JUEJ-A%;O#:.K"W=1@IAMH*'/7_]517^DW]MJ!FTK0+C3=0C MB@5/LFV6TNP -T<H. F2 QP>,CL* .Z3Q#IDFJ'3DF=K@2F$E87*"0+N*;\ M;=P7G&:BMO%.CWFIG3H+EFN/G"?NG"R%/OA&(PY'?!-<S'9ZA;>,#-IMA?60 MFOV-[$R![6=,'$X8_<<C (&"3^9R]*M=<FU_PWJ-[H^H1O:W%RES&J(D$(D1 M@OEH"/E'=B,GU- '26OC*SU?P\VH?;FTM1>_9UE> MNQ*54#<O)8+V^[GVK< MU#Q#I>E2O%>7)C:.,2R8C=Q&A) 9RH(4<'DXZ'TKSV73M3A^'TFC?V3?/<V^ MK;P5BR)$^TF3<N#DC:.OJ0*W1#>:=KOB0R:5<7=OJZ1R6\\<08D^7L,4G]T# M&1D8^8Y- &_<^*]"M+E;:74H?/>(3)&F79T/0J%!W>O';FM&QOK74[&&]LIE MFMIEW1R+T85Q&@V5YH6JZ%9SV-U)'IVC2P2W$4)*&5C$^T'OPA'UXK9\ Q7- MOX3B@N[6XMITN)R8YTVMAI6=3],,/UH Z:J>I:K8Z1 LU]<+"CN(T!!+.QZ* MJCEC[ 5<KEO$EK=Q^)_#VL0V;W=M:-/%<)$NYT$BJ X'?!7G'.#0!?;Q;H*6 M4%X^IPQP3S>0C297]YG!4@C*GZXJ]IFJ66LV*7NGW"W%LY(6100"0<'K[BO, M]8TBY^TW&L1:=>S6]_K]G.+9+)_,6*'(=V3&0&.>H&>">M>K@Y /K0 M<YJF MH7]KXUT&TBN0+*]2X$L'ECED3<#NZ]^GM71UR/B S-XZ\->7:WCQPK<>9/'; M.\<>]-JY8# Y'X4 ;PUS2C>&S_M&V^T!_+\OS1G?_=^OMUI_]KZ=]M^Q?;K? M[3NV^5Y@W;NN,>OMUKS^'3-0E\ 6WAJ6QNDUJWND/F^6XBW+.&\[S<;2"N3U M)SVJW&M]#XJ5M.AOS'-JK?;;&[MR8D7Y\7,4FT!0=HXR<DXH [6'5].N+QK. M&^MY+E=P,2R M\IPW'L>OI5VO.O#L.HP>(],:VM+X:3+]H>2WU"U97TY\=$D M(&Y6)X'(XKT6@ JD-8TTWXL!?VWVML@0^:-Q(Z@#U'I5FX$K6TJP,%F*$(QZ M!L<'\Z\MT^SN[_P7H>AS6MW'KEAJB-(QC;$165G:5GQ]TKG!!Y) H Z8^(+W M6O$6JZ7H>H:?&^G+%@2KYGFNQ)<'!R% P..=Q/I785QWAEL>._%ZM%*IEF@= M':-@KJL04X8C!P:[&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH ;)%'-&T<J*Z,,,K#((]Q3JX_6AK5 M]XVM]*L]<FL+*33WN)%AAC9@RN%&&92?XAGZ>]9=M=>)/$D.H7&F:W'92V%] M):'S-I0",@99=AR6&23D8R,=* /1**\TN_\ A*%TWQ3J)\5SH-*ED:VB6VAV MG9&LA5CMR0<[>,>O/2IX+_7-;\2RI_;=QI]K%IEK?/;PP1M\S9+*"PS_ G\ M_3B@#T2BO._#U]XKUN/3-?2_M18SS%IXGN%,?DEB-@01 JZ\#)<\@YJI9^)M M8TJ6^FU2\NY;ZWLIKM]/98VM[E!C9);R*H(0#.023R/2@#TX@,"" 0>"#3(H M8H(4AAC2.)%"HB+A5 X ["O.]/U#QA/:VVI37MM;V5Q:.[R3W,4F6V%U:%5 MC7!&&R&+<=<XS3_#FI^()XO"EU?:[+=+K(E$\1MHD"8A=U*E5!R"O?(/I0!Z M&K!L[2#@X.#T-#.J+N9@H]2<5YYHLLFE>!KF^77[K==ZC*J2S1I*Y/VED_=J M%&7=1T.1GG &:QM7O]1UGPEJ-K>75[";3Q!#:QL619O++(0'*_*2-V?J!UQ0 M!ZH+^$ZH=/Q)YXA$Y/EG9M+%?O=,Y!XZU:KDQ=ZBWCVXT4:C*+<:*DR-L3<L MID*%_NX)^7.",>U9VA>(-2U.VL["XO94U;3[F;^U"L:#>D6>,8( ;?'C&#][ M'2@#O:*\T\/ZCXN\2V>G:[#?P6EG=3N)4:=2%B+,H5$,7WQ@$$L<D<\'%6+. M]UJ'2M$U6[U^>4RZF+62$P1K'(C2LGS87.[..00!Z=Z /0Z*\VT_7?$_B3[9 MJ>EW-G;6]K?M $N)ML:QH1D.GEDY(YSO')[5H6&M:LGBB2QU>ZFL[EO.,$#P MJ;2Z0#*&.3&Y2JC+ G\J .YHKBO!>IW]Q?W%IJM[>_VDENCW%G<Q*%5L\R1. MHP4.<8Y(P*V?%^N2^'/"U[JL, FE@4;5;.W)8+DX[#.3]* -RLF/Q'I\NJ1V M$;3.\CO&LJPL8BZ#YEWXQD8(^H(ZBL:2\U;2_%&DZ6^IRZA::M#,#,\<2O;O M&FX.FQ "ISC# \XY[%/AQ92VWAE9GO[BX$T\[>7*$VH?.?)!"@Y/4Y)]L4 = MA17-^,M=GT6TTZ&V/ESZE?PV"SX!\C>3E\'@D ' /&>OI6?/-KZZWJ>@6^L2 M/,VG"]LKJ2*(/&X8IL8!-I4D YQD<\T =I17 VGBJ\O-%BU2&\,O]EZ2]SJ< M&U%\VX"D!#\N5^:.0G&.W'-5[/4/&3V-OJCWB+:3V$DS^>(642;-Z>6J@-C@ MC#$\4 >C5#=745E:2W4[%884+N54L0 ,G@9)_"O-[C4O%UOHGAC5E\0I(^JS MV<+VQL8P@\U<DD_>_(COC' %_P#M?7+6V\:63ZJ9[C1[=)[:[DMXPWS0ER"J M@*>5XX[]Z .]CD66))$.5<!@2,<&J=SJ]C::I9Z;//LN[S?]GCV,=^T;FY P M, 'J:Y75O$4\%YIMK=:L=)MY]-:Z^VA(_P![,,?N_G4J, EL 9/&,=\T#7=6 MNO UW=7,5OJDD=U.S26W$>Z$#&P,.<-W/7MVH ]$N[6&^M);6YC$D$JE)$)( M#*>H..U0I)9:8MK8(5A781#&,D!4'/T &.OM7 ^9KFHQ:3#<:[,MU;Z]-9&X MA@C42!8Y2&9"I&<#&.G/0D UNWUM;ZOJ6NSWMSY&G6M@]@9AA3$77?,X8],+ MY?/L?>@#7L_$VC:A-!#:W\4CW&[R."!-MY.PD8;&#TS6M7F]D^H>&=2T70M? MMH]0TP3K%I6JPC8T<FTA4D4'KM)&>X]><+>:YXJ@T?6-974+/R]&OI8S;"VP M+J)",AB22IP3C'X^P!Z/17"0>(-3\1KKEYI>H?8(M)E:*.%HD99F50Q,I8$A M3R,*01UR:31)[S5_'-OJ@OYX8+C0[:Z:SPK(/,+_ "Y(SP1G/4_3B@#NV8*I M8YP!G@9JEIVLZ?JXF-A=1S&!_+E49#1MZ,IY!^M7J\P:RO-%GO/%VBQF:2*_ MNH]3LHP?])A$[X8?[:@Y!';CUR >A6&K66IM<+9SB5K>3RI1M(*-Z'(ZU=KS M2P\0RIHT]SHS"1M;UV1+27C[I3);#< _(1@]^W:M6XNO&=KX<U6ZN);*"XLP M9K=I%5A-&%RP?!PK<'!''/2@#MJ*\WNM3U?Q#X GUF/5&LDN[N$V\4 1C#$9 M%C*,V.222Q'X=,BO0[=)([>..68S2*@#2%0"YQR<#@9]J ):J6>J6-_<74%I M=132VK^7.J-GRV_NGWX-6ZX;P3QXL\;?]A!/_0* .YHKB]=\<1KX<UFYT5G6 M^TZ(2.EY92H!SC&&"\_G]*4W_B(>,9=!&JV!,UB;U7%H<V^'5-H7?\P.<Y)] M?I0!V=%<)IOBS4=7NM"TV*:"*YN[::>YG6$L/W;[,*"<#+ D]<8]Z8_BO6U' MV,BU2\AUU=,>5X6*21LNY7 ##!VD9&?RH [ZJD>IV<NIS:<EPC7D*+))".JJ M>A-<1K5_K4NE:AI\]_$MQ;:O9P"Y@@V[HY&B8 J2>07]><8[U/<1:W/\2M0& MFSVL0CTF!9)Y8=Y#%Y"H"AAU(/))P!0!W=%9/AC59M;\,Z=J5PB1S7$"O(J? M=#=\9[9K6H SXM=TB?4VTV+4[-[Y<[K=9E,@QU^7.>*T*X/6[8:;XVT"].BV MT&F0W!A6\MBH<RS*8U#* "%R<=3R0:UF\:Z1?/>V.D:C!-JEO%(WDO&^ 4ZY MX'TZT =-BDKA8?$WB,VWAN64Z66UQ $58) (&,7F!B=_S#@Y7CKU];*>++Z. M$65PENVHOJQTM)HXV$6=@?>4+$_=.,;N2.HSP =C17"ZUXHUG04UFS+V5U>V M=B-1MY'C95>+<5964'[P(X(/.1TYJY%X@U9-1^S7@M!%/I$FH1/!&VZ)E*@J M<M\P^<'^'I0!TEWJ5G8S6T-U<1Q274GE0*QYD;K@5;KR_P#XFFH>&O ,K744 MU[+=Q2I).K=H)&.\Y)8\'TS^M=KX>O-2GDU.TU26UFGLKD1"6VC**ZF-'&5) M."-^.O:@#;J*XN(+6!I[B:.&)?O22,%4=N2:EKSF]GUW5_B3J:6?D26F@6\; M16L[,%EGD3<#A>^"P!.<>G- 'HB,KH'5@RL,@@Y!%+7,6?CS0Y--TNXO[R*Q MN-0A61+>5OF!.1CZ9!&>*RK_ ,3>)[33_$%^L6EYRN"DFZ= JL1][Y" W M7D$]ACD [W%&*XR3Q;J&D+<3ZS%:O;C3#J$8M58,I# &,[B=WWEPWR]^*L1Z M]JMO+H+WC64D&KDQA8H61HG,;2*<ER&&%P>!Z^U '5XJM>W]GIL'GWMU%;Q9 M"AY7"@D] ,]_:N)M?%OB+R].NKR+2EMKG6'TQTC5PQPSJ'4EN.4^[@YZY':E MJ(UB^\">)SJ-U:S>7?2"'9$RG]W,O4EC@?+@ =!W- 'IE%<_IFI:N?$MWI>I M)9%%M4N8WM@P*AG9=C;B=WW<Y&/I6OJ$\UKI]Q/;Q+--'&62-Y @8@="QX ] MZ +-%<+IOC'4KG^T4<V%P\&F?;HI((G2/?E@4W%B) "OWU.#S4]GXIU:WO=+ M36H+".WOK":\+6[-F'RPK$'=P1M8?YZ@'5W%[:VDD*7%Q%$\[^7$KN 9&]!Z MFK%>5:IJM_KMUX#U:YA@MX+O4A)%"A+.@(^7+=#D<]!7JM $?GQ?:/(\U/.* M[_+W#=MSC..N,]ZAFU&RM[E+:>\MXIY!E(GE568>P)R:YQ1$OQ;=4A19#H@= MY .7S-@9^FVJ?CKPWI%[I5S']AAFUK4I%CM97YE$F!@ANJJJ@L0., ^O(!W. M*,5CMXAT:QU"#1[C5;9-0(1%A=\.Q(XX]ZYP>+O$BV$VH2Z+9?9X=2^PE([H MEY/WWDY4D ##^O7T% '=T5QMUXVFT>75HM9T](GL+.*['V:4R"0.Q0+DJ/X@ M!GZ^E6I/$&KV&NV&EW]A;.^HQ2M;/!(P1947=Y3D@\8_B ]?EH ZBF22)$NZ M1U1<@98X&3TKB]*\;:E?Z3I.JS:1!%9W]X+3Y;DEUW.RA@-N",C'7-9VMWNH MWG@O7KO4K>TG>RU(?9%0$E2DRC'(^O(]3TH ](HKG]*U^^N/$-QHVIZ=':3K M;+=PF*<RAHRQ7!.T88$#.,CGK704 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &=)HEC+K,6K,DOVV)2 MBR"=P-IZKM!P1QG&.O/6J%UX)\.WFK_VI-IL9NB0S$,RH[ Y!9 =K')ZD&JM MWJ^I)\1['18;F 6,MD]U+&T67^5MH ;/ )(['H:NWU[>+XKT[3[>Z18I8)9Y MHFBR2J%!\I]RXH P],\*O=^(=>N-7M+N.":_6>%1<Y@N4"J%W(&YP5R00.H' M.*ZB#0["WUNYUB-)!?7,:QRN9G*E1T&TG:,>P[GU-<?H?B?7O$6ER7MA<V(O MDN]DVE20D201;PO)+ [L<Y(QU&*NMJFN7/Q U#0(+^WAMXK%;J)S;;V4EMN# M\PR._:@#2A\$Z%!JLM^EJVZ20S&$RL81(>KB/.T-[XJ73/"6EZ5*CPK<2K%" MT$,=S.TJPQMC<J!B< X&?H!5+1?$5\?%-WX:UE(/ML4 N8)[9&5)XL[22"3M M;/;)[\U=\9:S<^'O"6H:K:+&\]L@95E0LI^8#D @]^N>* *EIX T"PBNX;6& MXCBN8VC\L7#E80PPWE@GY"<\D?3I2V_@72K5-+2*XU!4TQF:U7[4WRYZCW&, MCZ$BMC1;BZN]#L;J],)N9X$ED\E2J L,X ))XSCK7/V>OZQ/J'BB*0V/DZ20 ML!6%]SDQ[_F^?&.0.* +4O@70Y;"ZLO+N$@N+@7.U+AQY4@8MF/G"<DGCU^E M.C\#Z!':7EJ+69HKR1)9MUS*Q+KRK@ELJW Y*/%^L+\.K?Q;(=.P(O-FM MC$Z[ANV[5?><'Z@UJS>))]0UVWT/2%6*Y>T6\N)[A"PMXS]U=F1ER2._'7GI M0!JQ:%8Q:R-6 F-Z+<6PD:9S^['(4C.#SDY.3D]:L0:996VH75_#;1I=76WS MY0/F?:,#/T%8D>LWUCXFCT'49H97O86EL;A(BN2@^=77=U'4$8R/>N=C\9^( M/^$%_P"$GE_L_,5TT36BP.//02!/D.\D/D-ZCVXH Z>T\%:#8ZN=2M[-DF,A MF">:YB60]7"9VAN<9 I8O!VD0V2V:+>"!+G[4BB\E!23U!W9Z\XSU)/>M]3N M4'!&1G![5C6WB?3KOQ-=Z#$TGVNU17<E"%).> ?8 9[<_6@"M+X'T&76GU0V MC+-*RR2Q+(1%*X.0S(."0><^O-26W@_2;6Z$RI/(BF4QP33,\<9DX<JIZ9!/ M_?1]:LQ^)]"EGDA35[,O&GF,/. &T=3GH0._I4EGX@T?4+M;6SU*VGG:(3". M.0,2G'/'U'YT 1Z5X>LM(N&G@>YD?RE@3[1.TGEQ@Y"KGH/UX%7[NTM[^TEM M;J%)K>92DD;C(8'J#59=<TJ343IZ:A;F[!(\H2#=D9R/<C!R.HI(-?T>YNX[ M2#5+*6XDW;(DG5F;;UP ><4 5]-\-6.E$- UP[I#Y$,DTID:&/\ NH3T' _( M>E2Z%H5MX?LFL[26Y>$N7 GF,FTGDXST!.3]2:NW5Y;6-NUQ=W$<$*D O(P4 M DX')]S5==;TIK%+Y=1M3:._EK,)5V,V<;0>YR",4 /U32[36+"2RO8O,A?! MX)!4CD,".00>013+'2;>PN)[E6EEN9U19)IG+,RJ"%'H ,GIW))Y-4;WQAH= MB=/+W\#QWMPUNDJ2J55@I)R<^H ^K#UJ"/Q78:K:ZXNGW]M;RZ:[0M<7!'EJ MP4'>1D?*"<=LD&@#6M-'T^RANXH+2)4O)7FN%*Y$K/\ >+9ZYZ?2L:V\!Z+9 MB5;?[6D3+(D<7VAFC@#\-Y:G(4D9&1T!.*UEUG3K>&-;O5;%9O*61R9E7((' MS $]#VJ:?4["VM$NY[VWCMW("2M( K9Z8/>@#)F\':=-I6EZ<T]Z(-,D62VQ M.=RLOW23WV]![4VX\&:=<RZM(]Q?!M6 6[VW!&Y1T4>@QQ].*TAX@T8VIN1J MUB8 VTR"X4KG&<9SUQVJ[#/%<PI-!*DL3C*NC!E8>H(ZT <1J'A^[&O0_N=; M>QM[)+:VFT^_5'X)+>9EE/\ < QG.,FM#1O#$Y.GWNKW5[)>6$LIM/-N [+& M_&)"!AVQU//7 )QFNKK*\1Z_:^&=#N-4NU=TBP%C099V)PJCZF@"DG@[3XX# M$MS?Y^V&^63[0=ZS$%2P/N&.1TYK3?1[%]-O-/:'-M>>;YZ[B"_F$[^1SSD_ M2L6^O?%&EZ:=5N&TJ:"%3-<VL<$BND0Y;;)O(9@/]D X[5M+KFDM;B?^TK01 M&-9-S3*!M;[IY/0T 9EIX.L;:\M9Y+J_NX[,[K6WNI_,C@;& R@C)(&<$DXS M67H&@?;FUA]2BU"*&?5)+A;69ML<J9RI*^A[CO@9%=G%+'/$DL,BR1NH9'0Y M# ]"".HK,D\06!UJ?1(KR!=32!9%CD8=6W8&,@D_+D@=B/6@"&\\+VEW>W-R MMQ=VQO(Q'=QV\@59P.F[@D''&5(..*E_X1RP76+;4XA-#/;VZVRK%*50Q*25 M4J.H!-4/!OBF/Q!X=TVYO)K:+4;J-G-NK@,<,1E5R3CBMR34["*\%G)?6R73 M=(6E4.?^ YS0!:K-TG1TTA;I8[JYG6YG>X83%3M9CEMNU1P3VK2JK%J=A/=O M:0WUM)<IG="DJEUQURH.10!CW7@G1+O0I='>W9+1[AKE!&VUH9"V[*$?=P2< M>QQTI(_!E@D%M&UU?RM%<I=22S3[WN&3[HD)'S*.PX K8AU73KAY4@O[65X> M95296*?[V#Q^-8_B#Q*EEHTEWI5W87,\;Q%D+[\QO(J$@*<_Q<'I0 C>"]-, M&JVZ3WD<&I2>;+$DV%CDW;M\8Q\ISCVX'%6[32;FTUR.Y&H7LULMGY+I/-N5 MWW A]N.&P&R>^15P37!UDPB6T^S+!N,>3YV_=UQT"8_'-*FK:=(\Z1ZA:LT& M?.59E)CYQ\W/'XT 7*Q=*\-V^CZOJ6HP75T[ZC)YD\<A0IN[$84$8''7ZYK2 MMM0LKQG6UNX)V0*S"*0,5##()P>XZ4ZZO+:QA,UW<0V\0.-\KA%S]30!4UO2 M(->T:YTNZDEC@N%VNT1 ;&0>"01V]*H_\(K#_P ) -<_M&^^W_8S9E\QX*9S MDC9C.[YO3('&.*7Q'XDMM%T'^T8I[5S,R1VY>50CEV"ALYY49W'!Z U>T>6^ MFLVDO;FQN=SDPS62E4>/ P<%FP<YZ$CI0!C0>!K"UL+"W@O+U9]/F>:UNBR& M6/><NO"@,K$G((/7Z5:G\*6<]O;QFYN4DAO1?F9-@>2;GYF^7!ZXP . !VJS M;ZRM]KMWIUIM9; *+MW4C#L,JJGH3CDGMD#KG%.?6;_3].L=2O1926K,([QK M9V81[F"I(A[J"1N&.^<\<@"WOA*UOVU$RWM\IOIH9V\MT'E/%MV%/EX^ZO7/ M2GP>&(K?4IK]=2U%IIK5;63?(C!E7.&/R_>RS'/N>W%:6J:I::+ID^H7TRQ6 M\"[F8GKZ >Y/ 'K65+K\P\3VEK$UD^D364ET]R)>5VLHSG[I7Y@/USVH K6/ MAFXTC4M$AT^_OQIUA!)'*DLJF.52#M4J ,L"P.['1<=375&J[WUI%:"[DNH$ MMB ?.:0!,'H=W2I(9X;F%9H)4EB<95T8,I'L10!D66@2PSPR7VL7VHBW8O"E MP(PJM@C<=B@L0"<9)Z_2M2\MA>64]JSNBS1M&70X901C(]^:=/.D$1=Y(T[ MR-M&>W-8GA/Q ^N>$;+6+_[/;R3[PX1L("'91@D_[- $$?@V)(?#\3:G>,NB M-F X0&3 V@-\O0+\O&./?FI&\&V3M>.]Q<M)/>B_C<L UO, !E, <8 &#G(Z MUHW^NV&G7&GP3S+OU"7RH I')VEL]?NX'7U(]:O-<0),L+31K*W1"P#'\* , M.\\*0:E9W\-[>W4DE]$L$TZ[%;RE)(0?+@#+-VR<TX^&EDU"WO+C4+J9XK-K M)E8(!)&V-V["YR2JG((Z>];I( R3@5R>K>,MGAVVUG1(H;ZWEO4MG+/C ,GE MY '7G&/8@T 30^"[>+3]&L_[3U QZ1,);8AD!R!@!B$Y !(QW!.<U#JWAJ^A MMM7GT;4[^.]U&>*4;6C B=<+NY ^7:!N'.0OO74K/$Z,ZRHRJ2&8,"!CKFJ. MIZYI^DZ+<ZM<3J;2W0LS1L#GV'."3T ]Z -%00 "<G')K$OO#:7.JS:E:W]S M97-Q;BWG,(4B11G!(8'YADX-;2G<H8=",TUYXDD6-Y45W^ZI8 GZ"@"*PL+; M3+"&RLXA%;PJ$C0'.!7/W'@M;BRUNT.KWHAU>8RS+A#LR,%4R.!@*/P%2R^( M;M/$FLZ<EO#)'8Z?'=1@L5+NV_(+<X'RCM^=7O#&K3:YX9T_5+B%(9;J$2&- M&R!GI@_2@"G-X1MKG5%N[BXDEA^P_8'M61"DD77GC.<\Y!'2F67A"*U&F+)J M-W<QZ6I6RCDV!8SMV G &XA>!FMO4;^'3--NK^XSY-O$TKXZD 9P/>J/ACQ# M!XGT*#4X8VA+DI+"QR8I <,IX'0^U &3+X$AGTRRL9-3NR+34CJ22;4W&4LS M<_+C&68XQWJ2[\%)=6&JV/\ :]ZMMJ-Q]I,>(R(GWASLRN<$@<$G]:ZJB@#( MBT:1/$)UA[^5I&M5MGA"*(V )8'IG.6;OWJSK.F1:UHUYIDTDD<5U$T3O&<, M 1@XK)U_7=3T/0Y]0>RM2R7J0JIF/,32! _3[W(^7/OGC%=)0!R7_"&3BYN) MAKMRYFT[^S]LD,9"H.AX YY8_4^@Q4Q\)R23Z/+/J/G#3K:2U=7MQB>-PJL# M@\<**OZ?K,EYXDUC2GMUC6P6!ED#Y,GF!CR,<8V^]22:M-%XHM]):T7R)[22 MX2Y$O.Y&164IC_;4YS^% ',0?#F6"VTJV'B&[:#2;GS[,-"A9!S\I)'/7CT] M.F.[HJKJ-S/:632VUJ;F;<BK$&VYW,%R3@X SD\=!0!G'0)#XR7Q MZ5Q9_8 MVM_*&&3<6SNSD'<:J77AS6)M8GU&'Q&8#(ICCC^PQOY*^BEN?<^I[=*@L/%N MIZA?:M8Q:'$;K2R@G1;W(9F4L A*#/3OBNJBD\V%)"C(64-M88*Y['WH KPV M$*)"9D2>XC509W0;V('WL^M8$_A&ZET>;3X]9,8DU$WXD^S E3YOFA0,X(W\ M\Y]*ZJB@#F=1\'PZOJFHW.H7/FVU[9+9- L>TJJL6#!L]=Q)Z>GI4]OX>N1= M6-S?7Z74NGQ,EH?(*89EVEW^8[FQQQM'+<<C&_10!QL'@>>W\/Z5H\6L%8M. MO!=I)]G^9R&+!3\W3);].F.;%SX5OY;#4K*+5H$AO+W[6F^S+&+YPY7(D&[Y M@.>.,_AU5% '/0>';N/QH_B&34(7#V2V;6ZVQ7@'=N#;SCYL]NG'O70USLGB M6ZFUFYLM,THWD5E/%!=S?: A0O@G:N#NV@@G)7VSBNBH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .. M\10:A8^.-&UZWL)KRR2WEM+H6Z[I(PQ!5MO4C([>]7(%FU/QE%J<5M<16EK8 M20;YXFC,DDCHV%5@#@!.3C'S#'>MEM6TY+S[&U_:K=9"^29E#Y/0;<YIS:C8 MK>BR:\MQ=GI 95WGC/W<YZ4 >>W=K-JL&E:M-H6H67BZ&:%9)+>$JI 8!M[_ M '&0KGC.1T]:NP.VG?%/7-3NK&^^SO9P00S0VDLJN>"W*J>AQ79OJFGQW8LW MOK9;EB (6F4.2>GRYS3IK^RM&1+B\MX6=MJ"255+'T&3R: .;TC3KK4O&UWX MHN;::TA2U%A:0SKMD=-V]I".P). #SQVI?B;!<7?P]U6VM()Y[B41JD<$;.S M?O%)X ST!KK 0P!!!![BD9U099@H]SB@#F--\0I;:+H]K'I^I2W4B0P&-K*: M,1]%9G8IA0.3SU XK&TR>0ZMXW3[!J"K=8EMY&LY LH\H(0I*\G=V_'UKT!2 M&&5((]133-%_ST3_ +Z% 'DD.A6:_#.RL)/#]X/$<,#_ &8QV,BR1S[MP8R; M=H&=IR3C (KK+2TU+0O$::I<Q37,.H64$%Z8E,C13QJ?FVJ.5()!(Z''K78" M6)B )$)/8,*2::*WA>::1(XD&6=V"JH]230!R#6\NN>/+'74@N8=.TFVF0/+ M;LC32N,$*C88J%[XY/ SVY'1/#=TGAJWU6WT6:+7-&OY9C!<0D?:XRQ;"AAC M=M8;2.05]Z]<AGAN(5F@ECEB89#HP92/J*598V.!(I/H&% $.FWRZCI\5VL% MQ!Y@R8KB(QR(>A!!]_P/;(KAY[769/&/C&T@-U;MJ-E"NGW+1.80RQ,#\X!" M_,3[Y.0#7H511W-O-++%%/'))"0)$1P2A/0$=J /.M/1;K1[>TN/#6LQZIIF MGR0>=/O,<9,6P^6=Q#[B%&%!]>,5)IL,\>C^$H;:PNK6>&RE@DS9R+Y4QC$> M7P.,N"<^G.>]>C8HQ0!YAIME>ZAX6\-Z%+87%MJ>EZA!+<":)MJK&26<28VG M<#Q@\Y(]:Z;PC9VP;5K@V#17+:G<2&6:V:-G!8[2"P&1MQTKJ<44 <[XQ@BG MTNV25+\8NT9)[%6>2V8!BLFU0=P!P",=ZY"XDUM+?2+^^TBYN;.UO+E9CID+ MP3ONX2?RAAN?FST^\3WKU&F"1#(T8=3(H!*YY .<''X'\J .!CDM-/NM%U2# M2-4M;26]G,@EADDF9WBP'=/F89(Q^&>]1/NM]+\?6L=I>27D\LTB1?97*R!X ME5-A PV?2O0FEC21(VD17DSL4L 6QUP.]/H X+37MAXITR>XTJZ+0Z(@%P^G MR?NI!R5W%<AMI(P.>HZ\5R_]I0:'IO@:Y:TU#[5IYNH_L<EJX8+M4,6'4, R M8(!!W&O9L5CZKX=M]4O(KT7=[9WD4;1)/:S;2$)!(P05Y(';- 'G-I9V4/AR MTGL+W4H+XW]Q<C48M/DV6TK*"4DC*Y*%2%SSS7<^&=2NH]#T6WU/3S;7EUOC M"06Y2--H8@L,?)N5<X/<XK;T^Q73[40+/<3G.6EN)3(['U)/3Z# ] *M4 %< MUXZTBYUCPTRV,7FWUK/%=V\9;:'9&!VGZC</KBNEHH Y'6==CU7PQ=65E:73 MZE?6Q@6S>%D>-G7!WY& %W9)Z<<9K'TK0+#0?%J+=6;/%8Z'%!]N:V;:[@L& M.X#&[;@=<XXKT;%&* .=\"S>=X'T?,;1M';+"492I!3Y>0>>U12W45AX]NGN M1(B7&EPB.3RF*DH\[.-P&!@,#SZUT]% 'E_AB'3;'PCX-$45Q;RQWV^8M 0X MD,<BONX^[EL9/;%0Z4J3Q?V-XE@UM]76_:40*C^5._F%DD615P% QR6&-OX5 MZM320O4@?6@"IJ\%U<:+?P64GEW<EO(D#YQM<J0ISVYQ7F6A1V<MC807VB:S M<ZWI%M-%]BF0B-?W1#8<+M(? R3RWXUZU1B@#RSP_,!KND7EU#.ELFCS120 M"R=(;4#RR(<L,LPPP))YXZ4D=AI=G\(H+FUTZ.&]>.V2X>*UQ,["5&8-@;CT M)_"O5,44 <#K'FZAXGUJ'2B?M<_A\)"_ED!I-SD#)&,X9>O3-<_;PV5_X9C9 M[/61J5AI5S;/%/&4BMOW10K]T!MS!=H&3T/&*]>I 01D'(]10!S/@+3=-LO" M6FS6-C#;S2VD0N'6'8[NHPV\XR2&W=:J:[+=V'Q"T:^N5G;1C;20;D4LD-PQ MX9P/NY7Y=WN>G-=E2 @DX(..#B@#RK68?LOAB0M"XL9O$4=Q:PK QQ;AE+$( M!D+D.W3O[BO4XY$FA26-@R.H92.X/2GXI@EC9MH=2?0&@#B/ <4L.I^,+:^< M23?VJ[N&YS&Z KQZ;?Y5G7\T,7P)F0QDXLQ (]I!5RP51C'4$CBN_;3+<ZHN MHINCN0GER,F!YJ\X#\<X)R/3Z$BB\TZ&^GMI)V=D@?S!#D;&?^%F&,G'4<XS MSC(& #&\2VTP^'.H6Q1I)ET\H50%B2$YP.IK,NAH>J^,]&GF@BEM8M/F>W\Z M A$?>FW@C . V,^E=Q2<9QGGTH \7M'\J+0?.6\_L:TOKZ*5;:W+FW9W)B9@ M0?EV-P<="?6O2O"-MI]MIEPFF07D=N]U))OND*&5FP2Z@@':2>.!T/:M_%% M'!ZO=65G\1-WB. &QEL0FG3R+NBC?)\U3Z.WR\^B@5R>@7UFF@>$K*6 Q20M M=;+JZC8P0L9&^79T>3'W<],]\XKVBC% 'D^A2V5GH?@:2\8>1:75S;RR31D; M&V2!58$<'.WC_"HHTL+J_P!7T[Q#/J<>KG4VF@@@@C:2< AHC&YC)&% 'W@! MCL,UZ[10 C*'4JP!4C!!'!KQVTFTRW^$6BV-T8HWDU**.ZB!".NVXW/O PPP MO7N,BO8Z* /(-6.D:+J?C2UBT\-:&"RQ:6A\I2?F#%MG\.67=Z@\]:S]0*W& MC?$"..2"^1HK2>!H+8Q1'LS(O(XX&<\XZU[?10!6T^:VN-/@DM'C>W*@(T1! M4@<<8^E>2^.M3M9[_P 1Q_8Q;WENMJBO=1F22X42<M#GB-5^8DCKD=*]CHH M\^DOK5?'_B8&XC&=%C(.X8XWD\_1E/XUM?#R5)?A_HA0Y"VJH?9EX(_,&NGH MH Y3Q%='4]9L/#UE-:F;?]LN1*V=JQE652H()+,0?HI-9&BM'H?Q"U;P[=-# M-#K47]H"-4.Q92")4(.?O!2W/:O0J* /-M'TN6WU>7PA/:L=*T^Y;4D;RODD MB8AHHOPD+GW$8[9KG]$O]-E\2>&+JP>&WAGOKJ.6*5F:ZRRD8F8GG)"X7&.G M)KVC:,DXY/>F"WA!R(D!#%\[1]X]3]?>@#QO4KFPMO NKP1SPHD'B=AL#CY5 M$X(_#:,_2K'CV^TF?4/$FZ)8=0L[:V,5S=;F=CDD?9AP4 .,N#C/4=Z]8>QM M)=WF6L#[FW'=&#D^OUI[6T#ER\,;%UVL2H.X>A]10!YSJ&G^']3\7^)I-:-L M\365L]MYTVU7&R3++R Q''(SC/'6J_AJ>YMO%'AR+47*ZD?#LD?EW+[7:3S5 M(4YYSA?TKTV2TMIF1I;>)V3[I9 2OT]*#:6S3B<V\1F'20H-WY]: /(O!XL- M3N-&FU+6I4\16MTWG6OV8+<,Y8[ED;&XKCDYX ^E>Q]JC$$2S-,L2"5QAG"C M)^IJ2@#@/!UW;/\ $3QK&MQ$7>>W**'&6 C(./7%<WJ,6FZSXA\06WB75QI] M];W1-IYD(\P0 QF%NN3R=J]2>AKUR.RM(I3+';0I(<Y=8P#^=.>V@DE65X8 MWD3[KLH)7Z&@#RG5-/L[B;XAM-*\S6"1W-L&G8K',+?=Y@7.-VX?ICIQ6K:3 M67B?Q'J\7B$K]B-A;7%A'+(51860F1P>!D,0"W;'M7=G2]/+2M]AM<RX$A\E M?GQTSQSU/YTV71M+GMX[>73K22",;4C>!2JCT Q@4 >9Q6@UC5_".GZQ>WLL M=SIMR''VJ1#. 1L+;2,Y7G/?C.:NM<16'BI+@-#JED=4BL4FBG9;BPDX01,K M9#)QU&"<D\]:]!DTS3Y;N*ZDL;9[F(!8YFB4N@'0 XR.IIJ:/ID=T;I-.M%N M"_F&40*'+\_-G&<\GGW- "ZI+<P:1>S6:;[J.!VA3&=SA25&._.*X#36!LO! MVJZ5=2S7]_<1+J4@F+F93$QD\P$_PD8&?N]!CI7I>*HVNC:98WDUY::?;07, MXQ++%$JL_P!2!S0!S?@^TL8/$WBUK9@9/[07<=Y)YB0G/KAB_7WKLJJVVF6% MG/)/:V-M!-+_ *R2*)59^_) YJU0 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 <'=P1-\;[!FB0LNBNX M)49#>81GZX)%;5U;"3QS:NNU&.F3CS @W@^9'@@^W-3:OX9AU+5K35X+J:RU M.U0QI<1!6W(>J,K @C]:L6.DR07;WEY>O>7;1>4'**BHO4A5'J>3DGH/2@#S M^SB3PM+9:)XFTE9;0WZ26.N0*#YDQD#J9>I5B>">XSVYK7TBP@N/BQXJDEMH M9$6UM5.] ?O+DCGUQS]*T(?!!32['29]8NKG3;-XY%BE1-[%&#*"X'W<C&,9 MQQFII_"MVGB>]UW3=8-I->1)'-&]LLJX08&.010!E:,/[&^*>I:+9 C3KFQ6 M^,*_<AEW[3@8XR.<#BK/Q74'X9ZP2 2%B(SV_>I6[I.A0Z7<W5XTTES?WFTW M%S+U?:,* !PJC)P!^M1^*] /B?P]<:/]J%M'<%?,D\O>< AL#D8.0.>>] %G M0H?LWA_3H=@C*6T:E0,8.T9K@Q96J#XF.MM$'"-AM@R,VV[K]3GZUV*Z1JSQ M6T-QK2&*!D8^1:^6TA0@@,=YX)'( &<D=*SE\'WH77P^L1,=:7$V+/ C^382 MOS_W?7OS[4 >?)<>5\&[%FT">)XXU\K50(\0'S/]:"K>8,9],UVFDRIX@\>W MQNI6GMM-L[;[)&X^23S5+&;;Z\ GD58_P"$)OY/#$7AR?7R=,2-87$5FJRO M&,#;N+$#IUQFM6?PU&ES:7NF3FSO;6W%LCE?,22(=$D7(W =0000>_:@#"N) MVTKXK6=A8P(EKJ.GR272(,*70G$A'3=P%SW!]A7":%LU'P#H&EPZ4MOJ.HW; M^5JLB*B*5F9SM=3NW8! ! Z5ZY::(\>H/JMY.L^IR0+;F14V)&@Y*HN20"V2 M<DGIZ"LFT\ 65OX/7PW+>3S6\3F2VFP%EMWW%@RL.X8D_I0!U]>:2:AJ>D>+ M/'E[IEK9NEM%;W,IG=AG;!NV@*.2>><_SKT2RAEMK.*&>X>YD10K3.H#/[D# MC/TK NO"33W'B*6._P!@UR%(9E:'=Y85"F5Y'\)/7OS[4 9_B/QG>:3I\.H0 M0V4=F]F+I9;B0L9W(SY*(OS XYWD8'IU(TAXDG7Q#IMO-##'IFHV33P7#-AA M(H#%".GW3G/L?2LZZ\ //=3SQZU+%]ITT:;./LZ'=&!C(S]TXZX'Y=M'4/!\ M.K^&=/T:_O)7%F\3>=&/+9PG!& >,J2./7- &9%XSU"XAL;<6D<.HW<#7A3R M)9Q#!NQ&61!NW-QZ <Y.< ]-H=]=:EHUO=WMD]E<N")('!!4AB,\@'!QD9YP M15#7/#!U*]L-0L-0ETR_LE:.*:*-7!1L91E/!'''H>:U=-M)+&PCMYKN6[E! M9GGEP&<LQ8\ <X '0 "@#G-6\6WD>HZE9:19_:9K!%WJ8)G\R1ANV HI"\ M8Y/<].,U0O/$.H>=XC^SZ3:66IV>DQW(FD;>Y!#MM8@?PX.!R,]\&M:\\)3' M7+K5-)UJYTQ[T*+Q(XTD$I48##<#M;'&137\(RR:KJUP^H V^HZ<+%D,1,B@ M @-N+<G#'/'/M0!GWK:FM[X4NVLK2YUADF4['VH<Q=W(W8Z$\'GL:L'QG-!: M6D<]HK:C<WUQ9JD*R.G[EF#/A5+=%S@#J>PR1=/A_5#>:)<'5X7.F[E=3:8\ MX,-I/#<';CIQG)]JH7'@>ZFM"5UHQW\-])?6=U%;A?(>0DNI!8[D.3P?UH A ME\9:]!;V;/X>423ZD+ &65H1+E<K(H9=P'7.1QCC/;L+!KQ["%M0CACNRO[U M(6+(#[$X)KFY_"NJWCZ7+>:Z9Y;2]2\EW0 (Q4 !$4'Y1@OSR<GGTKK>@H X M"'Q]JYTW5M2FT&'[)I-Y);712[.["$!C&"OS8SGG;4FO?$*33]4OK#3=.:[E ML=HD!28F1B-VQ=D;*#@CEB.M9WAK2;S68/$=@U^D>FW&LW37$/DGS'B9\_(^ M<;7&1G!XS@UO7OA'44\176K:'KC:=]O"K>0M;K*K;5VAEST;'^>U %,^+_$] MWK5WIVF>&(':U2&64SWP0A9%W!2-O#<$=\8IUGXWU>[TK3-2_P"$?C\F_G:V M2-+P&3S,/@X*@;<I@G.1R<'OJZ1X?OM,\1:IJ#Z@DT%Y##&B.C%U,:[59FW? M,2"<\#/'2J4?A#4+/2=(L+/5(-NFW+7*M+;$F0EC\IP_ P[_ /COH<@%BW\2 MZG)9ZLK:,&U'3YUA\B*XS&^Y58-O8+A0&Y..,=ZJR^-Y_P"Q=3O[.PMKYK"\ M2V(@N_DE#!""K;>N9 ,>QYJOJ?@?5-3CUI'U>"-;^]BNT"P-@>6 CY;YEPJ M],<CTXJ6X\):Y-;:M'_;%ENU":"?/V,@1/&$' W]/W:<'WH F;QI<:;=ZE#K MVEK9+:6(OE:"X\[>FXJ5^ZN&S@>GO6;!\2+F:QN;D:([>7927B@><B@(-Q5V M>)1G&<;=P./H:T[_ ,(W.LZU/<ZG<VTEE<Z=]@FABC97(SOW*VXX.[V/%0#P MAKIT.YTF;Q&);7[(]G;*UOCY679F0[LN0O3ISS[4 6;?Q3JDUW!;S:/':_;; M&6ZLVDN-Q+($^610OR_?'0FN:GO+S6_AIH6IZJD+W3ZE:RI(CYX,X&<$<'!( MP,\8YZUTJ>&-5.LZ-?SZE;.+*R>TG58&'FAL9*_-\I^5?7H:H+X)U5/"&FZ" M-3M#]@NTF24VS<HC;E4C=USU/IV[T :<GBFXLM<U6PU*SBMH;2S:]MYQ,6$\ M:_>.-O!'&1DGD8S6SHMY=:AHUI>7MJMK<3QB1H%DWA,\@;L#)QC/O7*Z]#8^ M*_$.FZ9#OEN]-N-]](B,B)$5^:,DC#!R5&T'H#Z5W% '+WGBF\_XFTVE:?#= MVVE,R732W!B<NJAF5!M(.%(Y)&3^=1GQ9J5WK*66DZ*EW ]G!>K.]V(L1RDC ME2O7Y3QS^%/F\*WD=SK"Z=?PPV>KY:YCEB9V1RNUF0[@.1C@CL*FTOPY=:7X MC-Y'=0'3UL(K&.#RSY@6/)4E\X)^9L\>E &_<L$M9G*[@J$E?7CI7%Z;XL$& MC^%X=,T) -6AD\BW6X"K"40MC)'(Z\]?8]*[*\BEGL;B*%T25XV5&<$J&(P" M0,9%<CIW@O4+%/"JG4;9_P"PS*&_<,/-5UV\?-P0I//KB@"U;^,7FL@ALHQJ MIU%]-%JL^Y/-7DMOVYV!?F)VY]JR[/7%\-'Q->:C:P07$FJ11I;VK%UDE>&+ M&#M!.?O$[<]>IZR?\('>[[F[34H(M2_M5M3M)TA)$9<!7C8;OF4A1TQ4T_@F M_P!3@U,ZEJD'VJYNH[VVFM;<H;::-55&&6.>% (]SS0!1U3Q;JM_X7\2)!IQ MMI[.T+BZ6218RK(<E&:-6WJ1TP![UI6NEZ?I_B?1Q)X>TZVOW@F*7%I(3Y80 M!=OW5W95^I_H#4MSX>\0:CH.IV6H:U;37%Y;"U5DMV2)$P0S[-W+G=UR!P.. MM7GTO59]9TO4)KBRS:1R)*J1,-^_;DCYN/NCUZT 8UEX\O+I#<R:,D-E%JAT MV>4W62K;U164;>1EN>1CWI?$NMOHVF^*;S2;&)-0M5@WRD_ZTL!@XQR0&Z=Z M:O@S51X?N-,;4K5FDU,:A&_D-A/W@D*8SS\PZY[U8U'PCJ.JVGB*"YU&V0:L ML8C,4+?NBG )RW.0!Z4 /U+QC+IMS'IKVL#ZK]F^T21K+(T2C=@#<L9;)]U M]ZJ6.HMJOB.QUFSTYH;RXT6?_1[K,3;EFC 5C@D#.><=#FK%QX5UD:S:Z[9: MO:PZL+7[+>;[4M!.H)(.W=N!![[NWX5<32M1LM:MM6N]3@EM[6Q>"=I(2'?) M#L^0<#E!@8Z9H @L/&,E_I=I.M@L5]/J#6+6<DWS1E7(<DA3R%!;''UZ9Z2[ MNX;&RGO+F3RX((VEE<@G:JC)/'L*Y'PQ96NI>+=4\46+RMI\ZJEN'1D5Y"J^ M9(H8#@[$7/J&_'K-1L8M3TR[T^XW>3=0O#)M.#M92IQ[X- &/9^([F:2&6ZT MMK?3I[9[F.[$V_"* 1O4#Y25.>">A%9EC\0K>]N+8K8LUK<HSQO!*)9%PNY0 M\8'RE@"!R>< ]:L:-H7B"WLSI6K:G9SZ5'"UO'Y$#+/(FTJ-[$[1@$=!U Y] M8=&\/^*M.T]M'DUBR.G0V\D-K,D3?: ,%8]QSCY00>!GY10!9L?&/G7Z6FH6 M#6+RVCWD<9E#R+&N,B1 /D8A@0.>AYXJ.T\=VDVBW>MSPA-)AA$R7$4RR%LX M!C91]V3) V\CD<UG:;X-UVSN=-N'O-,BFM+*:T:6WA;>Y=5Q*2V=S[E!.1W/ M7-10?#V>^CU&/5EL;7[=9BVF.F[@)I X<3,I ;(]^O6@"W%\2[!9IQ>6KQQ M);_:$E@D$X(SC8V!\K\J,<C)ZU&M[J%Q\4=(:ZL7LDDTV?:OV@.7&Y3AE' ( M_$<]3BI9/#'B36O#=UHNOZG8B,Q*D$MG$P=G5@R2/G !!4<+P<FI]/T7Q2=> MT[5-3N]+WVUM):S"!'8S*S*=W.-I.P?0^N> #5\7ZK<Z)X2U/4K-$>>W@9DW MG !Z9Z'..N.]0MK]ZMQ::;'IT<VK20?:)H1<[8XH\[0V\KSD\ !?7ICFYXET ME]=\,ZCI<<JQ274#1J[#(!/3/M6-+HOB*/5+37+:73GU%;0V=S;.72&1-Q92 MK8+*03Z'/MUH V]#UJ#7=/:YA1XGCE>":)^L<B'#+GH>>XKE=:O)++XJ6!L[ M6>[NI-)ES!')M!^<;22QP!D'GGKTKI/#6BOHFG3132*]Q<W,MU,4^Z'D8L0N M><#@<U3U30KYO&%EXAT_[,\D-H]I)#.[)N4G<"" >A[8YS0!4_X6#IXTF"XD MA,-[-<26OV.:15V2Q_ZP%^FU?[PSU&!DXK7\/Z_%KUO<LL$D$]K.T$T;\@,I MZJV!N4]0:YF;P%J-M#8W^EZG$-<M+RXO"\Z?N9&GQYB8 R%X !Z]?P[#2(M3 MCM&.KSV\MT[EMMNA$<:X "KGD],Y/<F@#)U'Q5<6FOMHUIH-[>W0@%P"DL2J MR;MI.6;COUP21CWK/3XC6URFFM8:+JE[]OC=HQ"L>59#AT;+#D<>W(P:J7SZ MO'\69SI":=)(=(B#QWDK1DKYK\J55CP>OX5:TGP;>Z'/X<6TEM9(-/$YNR[, M&=YL;BG!& 1P#VH T)/%X^S75U!IES+;6#%;Z021CR"J;G4#=EF7(!QQUP3B MIX?%5K/KT&F)!-LN;0WEM=Y7RID&,X.<Y&>A%9S>'-6LY];M=/-C)INKR/,Y MN6820R2 +)@!2'7 R 2.>,TNL^"OM>B:)IVGW/D?V:Z)YC?>: J4E7.#RRG\ MP/K0!(NOV.H:QX:=K2^62^2>6T<2 1A0A)+@-R"N",@_>'0],CQ'K:ZPOAZ] ML;6\^R_VU;QQWOF!$<>:%;Y=V2IP0"1_.MG6- OKSQ+HES:0V0TVRAFAG1W9 M)"DBA<( N!@ =_RZUS\/@WQ5::38:+#<Z5+8Z;J,=U:S2M(LC1HQ<(ZA<9R> MH- &WJ7Q%T33IKV-I#*;*=;>81R1[][''RH6#'!X/'KUP:S/'/B$7W@O7'TR M*\D2SD$)O+>8(JR#&[&&!95R >,9/?!Q=@\/>(](UG4/['N=-;3-0NFNW-VC MF6!W^_L"C##TR1BLR?P=XFL=*U31='ETN73[NZ^TQRW<CK*F6#,I"J0>1P>* M /1B,@@]Z\S\-^*AH5IK$EW9:I+IJZU,@O7.]((RRHN2S;B 0<D XKTJ'S#! M'YP02[1O"$E0W?&>U</#X/U4:1JN@W$UO)IVH7\D[3B9A)'$[!BBH5(SP>=V M/FSB@#9MO%UO-+K<<]G=6SZ0@DE$NW]XA#$,F&.00O?'45MV5R;RQ@N3$\/G M1K)Y<F-RY&<''&:X76M,LO$/CK2DTZXBFABA>/55A<,OE1NK1QN1T/F#H>2 MW;->@T <'8Q3WGQ4\0VTM_J)LXK.(I MY(L:-(N"0 < \'&.G)%<E8>)+.U^ M&\5[/XBUA==*.\9:XFD\R0.0BX?*%> #^/-=[9Z=K5GXVU[4ELH&M+Z&%(7- MQSNB4@9&.AW?ABL.PT#Q+%\/AX4ET?3W+0O";F6[RB[F)W;0A.1G(]P* .KO M=6OK'P<NH26ROJC6\8%NO1KAP%"]>F]@.O2LWP!JNI7-A>Z3K<HEU;2;@V\\ MG_/12,H_XC^5.L_#U["V@Z5<A9]+TRU&^7?@RS@!4.WK@#<>O4CTJ"30=3T[ MXB1:SI%HG]GW%N(=0#3X,A'W7"GNHP.>V1[T =A--';PO--(L<4:EG=C@*!U M)-8L/BJSDN[:WDM[R#[8C/:22Q?+<!1D[0"2#CD!@"1VJ]KFF?VSH-_IAE\K M[7 \/F8SMW#&<5S5OI.N7L^@-JELD4NBEWDEBD5ENF\LHNP<$9SD[@,=!GL M:NA>,-/\12;=/@OVCW,IFDM66,,O4%CQFN@K!\)65_I^B&WU&WB@G%S-(!%) MO!5Y&<'.!S\V/PK>H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** ,6#77;Q1J&DSPQ10VMM%.D_FYW!RP MP00,<KZFM:2>*$ R2(@/3<P&:X+58/#U_P",O$*:O]DF>#2H7$<[ A /-+-M M/&1N7GJ-W'6L.74=(O=+T2T=+1[D^'@(KNZ!FBS@*T4: X,N5YYR,=#TH ]: M,T2RB,R()#T4L,G\*7S$^;YU^3[W/3ZUYC>Q(?"_A3QG;Q17EYI:PB=K<;FF MB(\MU!ZE@3P">N?6HO$,%UI$7AV[U -8VEU>RW>L3PQ*XAF<#R]P(*D*3MR0 M?N@]: /4T=9$#HP93T(.0:K:I=36.E7=W!$DTL$32+&[[ V!G&<''Y5S_@.P MTNQTV^_L>]N+RSFNVE$LBJL9<@;O*V@#9GC@8R#BMGQ$C2>&=61%+.UG,%49 MR3L/''/Y<T 3Z=>K?6%M<?*LDL*2M&&R5W '^M61(A<H'7>!DKGD"O+-/MK, MZMX5N?"LT$VH&U8:E(DYES'Y0P)3D_Q8"Y[@ <#C/\)Q:->7&EO<ZQ?1>*(Y M]T]LMLJSM)D[A(PCW,AZG<V,4 >Q[TW[-R[\9VYYQZXIU>1^&%T^\FLIM5U6 MXB\36UZ7NK1+>*.8OO\ F+-L#&(H<GYL;?H!6?"^EV/A2/4TG@2_B\0E8IFE M!:-//Y"Y/"[<DCH>IH ]LICRQQ+ND=4&<98XIV<C(Z5YY\0;S3)-5ATVZCB^ MU?V=/+"]W\T//&%3^*7CCI@$GGI0!Z&S*JEF(51R23@"A6#*&4@@C(([UY%9 M3Z5K5_\ #W[?-#=>;IDZ7*SR9WE47AP3R-ROUZX/I43/HM\OA6R>ZMVMHM9O M8 JS[2D(>3RUR""!CR\#TQ0!["CK(NY&#+Z@Y% DC9 X=2I. P/!.<?SKQY[ MJPLAJ.F@PKHUOXG3[5;QX,:0&//S*.D?F!?;(Q5CQ'8^18^)UT6-/[#1;*41 MVF#%'*LJM(55>F$"LV/K0!ZT'4L5# L.HSR*-REBN1N R1GFO,-6U31M1U'Q MC+9W=O)'-X?1O,C?:)'7S1D,/O8^09&>P]JK)Y.F0^'YM%EC35K[0+@DK)N> MXF$<9CW9/S$-NQGT('2@#U?>I<H&&X#)&>12AE+%002.HSTKRW29]$NM%75/ M#FX^*(M,E22"+.]I=N6\X=SO!P6/)Z9JE:/IXT?^U?"VHO/XC339#);1(BNQ M(&\S +DLIY&3DL.^: /3;W59+37-*T];</'>^=NEW8\LHH8#'?//Y5IUY=H] MQX4_M[PA>:1<V:SS13)+AAYTC-&/]9_$6W CGU->HT 94&LF7Q)?Z4\'EI:V M\,XF+??WEQC&.,;*U<UP>NZ9HNK^--2M=>=8[;^RK<H&NS$K 23$M@$ [<CK MG'7O6;F]T+PYX9\4W+Z@\EHJP7T,C,6DADRJLR9^^I*^_)Z\4 >G5#=74%C: M375S*L4$*%Y';HJ@9)JAX>TYM.TL&52+JZ=KJYR<_O7.6'T'W1[ 52\>*S> MM="@D_8I. /]DT 2W7B/[/XGTC25M/,@U.&62.Z$H &Q=Q&W'/!'.1UK=S7E M\L.C7_B#P)IULL+63V=TY6V<*C9C7(^4]V5LCOSGO6=/J#)IFG67VZ.+PZNL M7MI<3.?,2.-6;R(VR?N=.IQP.M 'L-07L\EM933PP^<\:EA'OV[L>]<]X&M+ M2TTFX6PUIM4LS<,8W CBX!*1XXVC/0<#D5N:NP31;YRVT+;R$MDC'RGTY_* M@#&T/Q3<:[H%MK-OI$GV>X=0J"8,X7>49B,=B,X],U8'B07FJW6GZ3:&]DLS MMN93($CC?^YNP<MZ@#CN:YOX8V3W/@7PY<IJ-RB6QF9K=&4))EG7:V!DXR&& M3U_"G^ ;R#3;O7="OY5AU-=3GN DN%:>-SE9!Z@@'IG&* .MTK5'U(72RV,] MI+;3F!UEVD,=H;<I!.5(88/'TJGHWBS3=<UC5-,M&;S]/<*Q/20="R^H# J? M<>],U[Q!%;^'I+G39XIIYY!:VC*V5:9SM!!Z$#DG']TUQVHV]WX+U_P]KMU] MBMK+8FDWGDR,V\-EA(V5'1AD]3[F@#U&BD!# $$$'D$5R/C01_VGX:\Z^GLX MI+\Q2/'<M$&4Q.=I((')51GKSP10!U^:,UY+J22Z+::REG=30:+::Q9?9RTQ M58B6'GJK$Y*Y89'0?-Z&I-;UNUN]1\:?8]85HDTJ%XFMKO 60%@2I4]<E ?7 M(!ZT >K45P'B+3A91V*:3/'?R3>;,VGWUW(RWP 0%ED)(5U^4KVRQ(I-(UO2 MX=0TFYN;W[+:7>A@XOKGER&4?,6.&;&>>] 'H&:,UY#%K.F:OI7ABSFOEN)# M92/(+JYV6R[>&:0_>9U(^49]\CK5VUE;6+KX?13ZE=LEYILQNA%>.OG,L2?> MVMR<EL]^N>E 'I<]W;VQB$\J1F:01QACC<QZ >_!J:O)V:WECT,7!\R.T\47 M5OYD[L?*0-(0NXGI@+U]*]7 & * (I;N"&>""255EG8K$AZN0"3C\ :FS M7(^)K:TE\8^%GN@N-]PH+-M_Y9Y Z^H'UKGKJ_O)O!.J:RKW,/B6TO&C\OS2 MQ202@+&$^Z5*$#&.<D]3F@#T^BD7)49ZXYK@O&RO)XW\)VGVZ\M[>^:YAG6& MY>,. @*C@\')QD<\XH [[-9>OZU'H&E_;Y;>6>,2QQL(L97>P7/)Z D5Y]:S M3Z?J<,3ZA</IMIXB%O:SS7#$&-H7+QEB?F"N .<\BJNKZJEYH_C6"+43,J:K M;"/;/N\I2T0)')XW ^W% 'K-U.;:TFG$3RF*-G$:8W/@9P,\9/O5"UUDW>FZ M3?0V-P\>HK&Y"8/D*Z;LMST' X]:YV.WN=-\<SV5OJ5[<V<FDO-<0W5P\HC? M> K#/W2?FX&!@'CBJ41DCTWX<R)>30!U@C=5D8)(OV8G:5'!R0!S0!Z)17G. MA:A;ZW:_;[[7IK'5[?4F%S MPZ@*LK!(3$3C!7 S@GD\YKT6@!<U"MW;M=O: M+*AN$02-&#\P4D@$CW(/Y5Q_C:ZO[6\AFM7ENK:"VDDN;"WNVMI@F?\ 7JP( MW;<$;3ZUGZ*VG2>,=6U:26X"Q:3:W2W4DSY"&-\EES@\#."#S0!Z*2 ,FH;6 MZM[VVCN;69)H)!E)$.58>H-><:-J-Q<7NG1?;+M[2^T6YE_TB\:22;#+MD(S MA&(+<+TZ=N,ZUU&YTKP1X)M8+P6=MJ!*W%Q/++M4[#M7<K J">P(Z>F<@'K^ M:,UY?*E_:OI]M_PE4UT\NMQQ2"TF?;%%)$Q\LLS,6^[D9)(S]*@C%X]OX_?^ MV-6 THR-9*+V3]T5C+CDG)&0."2,4 >KYHS7FVI:I=:KXRO]&EUQ=*ABT^*6 MV9F=!(6!W2*R2)D@D#!W#@\=:-.&H:AXE-C=^(KJZM4T6*Y:2SE,2S.6=0X( M.1D '@C)]N* /07>U6\B5VA%U(K&,,1O8#KCN0,C/UJQ7F6A,^H>+/!U_<W$ MTT\NAR.TAD8;B"F"0#C/S<^I^@KTV@ HS7&2SRZO\0]1T2[NKNVM[?3XYK:* MWG>$R[B0\F4()P<* 3CV[USFBW>MZX?"*7FKZA;F[CO$G:%PAG6%L(W3@G/) M[XH ]6HJ.WB\BWBA\R238@7?(<LV!U)[FN8\0K=S^,?#]G#J=S:6\\=R9XX6 M \T($('L>3SU Z8ZT =7FLO7M<M_#VF_;KJ*:2+S4B/E*"06. 3DCC) _&N( MTS4]1LYO(NM2N9+6V\1?88;F>7F6(J<HQ_BP^!D]^*K^++NYNM%\76;W4C16 M^JV:0$G<8@QA8@9_VB3CM0!Z7?7B:?I]Q>2)(Z01M(RQC+$ 9.!ZU2LM=AU" MTTNZM[6[:'45WQMY?$2[2P,A!^4'H/<BN5NOM^G>(-8TQ]5N;VTN-$FNV2XV MDQR@A/E( VJ03\H %5-(O;JU3X;6\-[+'#=V;+-; C;(%M]P)XSP2._I0!Z' M!:6UJTC6]O%"TK;I#&@4N?4XZFI\UPGAB>?7+.U\0OKTT,S7KI/:E]T07<56 M (2 #]T[L;N?>LS3-7U*?7M$E@UFXOM/U"ZN;>2Y.V..7",1Y4620%*8W]^^ M<Y(!Z%>ZC#9:?<7A$DR0 [DMU\QR1V '4^U6P>*\MT5+VR^&6IW-MJMXEQ%J M$[^:SAF;;*5()([]3WS736]Y?ZYXIU[3OM\MA#IHACA6#;O<NA8NVY3QT QZ M&@#K*6O,]*U;7O$M]X<8:I/IZWNF3R7*Q1Q\LDBJ'4,",G(/?CH!S74>!]4O M-5\/-)?3BXFANIK?SMH4R!'*AB!QG [4 =)250UW4&TG0-0U%%5WM;>295;. M"54D XY[5R9U74K*7PM<0ZM+J$6LD12H\2@89-_FIA?EVXZ'/!]LT =%+XGL M$U1;&..ZG;SQ;R300,\4,AQA78< \CZ9YQ6U7$?#NU:%O$C&ZGEQK5RF)""" M05^;@=3W[>U=O0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 -,:$DE021@G% 1!C"J,=..E<[_:MO'XG MUA$TRY-[:V44C,)5Q/'E]H4;L Y#<G!_2H],\8'4+O2(I-)NK6+58FDMI970 M[MJ;R-H)(&.A.,T =.%4+M 'IBD>-)$9)%#HPP589!%>>K>1#4M:U77-/E" MV6H+Y%Q'<C<K*D82% ""=Q.<?=)8YKH+SQ='ID\MOJ%C-#<_99+N&)75_-1! ME@#G 8#G!X]": .C1%C0(BA5 P !@"EKCX/'3RZ79ZFWA_4DLKMH$BFW1,"9 M6"C@/N !([<U+_PF<WGZC:?\(_J)O+%1++"K1D>41D-NW;<G!PH).1^- '4J MB)]U0N?08HV*&W;1N]<<USFH>,(K-4:#3[FY!L?M[L"J*D7IEC@OQ]W]:=)K MU\WBO2[&WLO,L+NRDN&DWJ&&&C&<'L _0<G=[4 =#L3<6VKD]3BFM;PLI5HD M*GJ"HP:YNRUW3[+3;R^6VO$>?4G@^S.P>1Y]P3:O. "5SU ')XI;WQK:Z>-5 MCN;"\CN].MOM;6[;,RPYQO0AB" >N2#[4 =-BFO#'(R,\:LR'*E@"5/3CTKG M])\5_P!I:Q'IT^E7=BUQ;&ZMGG:,B6,%0>%8D'YAP:7Q-K6H:3?Z)!8V8N5O M;MHI?WBJ<"-F &?7!.?]GWH W!:6PC6,6\01>B[!@?A4*:3IL3J\>GVJ.IR& M6%00?RK(N_%T5NE_<16-Q/8Z?*8KNY5E"I@?.5&<MM[\?3-;R/%=VJNC;H9D MR&4D94CJ.XXH ;%96MN7,-M#&9/OE(P-WUQUI\4$,$7E0Q)''S\B* /R%<%X M4\9"WT/PS:WUA>I;WD$5O%J$A4QR3[<;3\VX9(."1S6C_P +#TW^THX!$7MI M+G[*L\<\;-OW%<F(-O"[@1G'H>AS0!UODQ9SY:9(VYVCIZ4S[);#R_\ 1XOW M9RGR#Y3ZCTZFJFMZO'H>F/?RV\\\:,JLL !8;F"YP2.,D5EIXPACBU)M0TZ\ ML)+%(Y/)EV,\JR$A-NUB"S,I4#/7% '01V\,4DDD<,:/)C>RJ 6QZGO2K!$D MIE6)!(1@L%&2/3-9%EXC2?5UTJ\LKBPO9(?/ABF*MYD8."0RD@$'J,]QUK%\ M=SSV^K^$O)GFB$NKQQR!)"H=2#P0#@CZT =8FGV43*T=G;HR$LI6)05)ZD<5 M9KG+_P 70V45U=)875QI]G(8KJZC*!8R,;B%+!F"YY('8XS5>^\=6MI?7EK# MIFH7OV2W6ZDEMQ&8S"REMX+.,C /OZ9H Z*YT^RO7C>ZM()VC.4,L88H?49' M%9>H:'>:EK<,T^K/_9$>QSIRP+AY4;<K,_WL9"G'M27'BB".YM+6VL[N\NKF MT-XD,(0$1# R2S 9RP&,UGM\1-$6PTZZ8R1C4%=[=)WCA)13@L2[A0.>,G)[ M"@#KJ:Z+(C(ZAD8896&01Z&N2M_B'IUY;Z?+9Z?J5TU_'*\$<,2L28VPZGYL M C(.<XY'/-=%=:A]DTA]1EM;C$<7FO H4R*,9(QG&1]>U #QIE@I0BQM@4&$ M(B7Y1SP...I_.G)86<<+PQVD"Q/]]%C 5OJ,<US@\>V"Z;'?W-C?6EO.8Q;- M=*D8GWJ6X); ))8@?6H&^).CBV>6.WO9WCNULWBMT61A(P)7&UB&!P<$$] M* .OAABMXA%#&D<:]$10 /P%$L4<T;1RHKHW56&0?PKF)O'FGVUIJ,UU9:A# M+I\T<5S;M$&D0/\ <?Y6(*G/4&IY/&%I#A)[2[M[AGD$<%SLA9U3;EP78#:= MXQSGKQP< &[!:V]JA2W@CA0G)6- HS^%1W>FV%_M^V65O<[?N^=$KX^F16'; M^-M/OHK0Z?;W-W+<K(RPIL5U$;;6SN8 G/'!.?IS3[_QGIU@(Q)',9FMENGA M)2-XXVSC(=A\W!^49/'TR ;DEE:RQI');0O'']Q6C!"_0=J=/;074?EW$$<R M YVR(&&?7!KG!XXLIIUAL]/U&[>2R6^B\J)0)(F[@LP Q[XYX&:C7QD+R_\ M#JZ?9SS6FKQ2S!\*"JH!V+#&"PSUXZ9H ZM$6-%1%"JHP% P /2L/Q#H4NM7 MFD./LK6]G<F::*XC+B12C)@#IT8GGVHC\56DFHQVOV>Z6.6Z>SCN&0!'F0$L MH&=W\+<XQQUK-OO$<4GA?6+O58;NVM8+N2U9[1AOVB3RP0<Y!SC/3K0!TS:? M9/9&R:T@-J1M,!C!0CTVXQ35TO3EC\M;"U"; FT0KC:.@QCH/2JAU^W7Q,N@ MM!<K=/ ;A'*CRV0'!(.<]>,8S^%4W\8Z?'%:LR2K)=*TD,<CQQEHU(!?+,!C MD8YR<]* -:XTK3KR"."YL+6>&/[D<L*LJ_0$<4Z73;"=[=YK*WD:V_U#/$I, M7^[D?+T'2J^@Z[9>(])CU+3V<P2%EPZX8$'!!'X5G)XQLGU""U:UO(UN;B6V MMYG15662/.X ;MV/E(!( H UI-&TN81"73K-Q$28PT"G9GKCCC-*=*TX^5FP MM3Y)S'F%?D.<Y'''/-8EMXYTR[$;16VH&,W@L9)&MRJPS%]@5L^I(Z9QD9P> M*QOB!X@6?P?K0TPWY-DWE27=HX58I01E2<AB!D9P"!W[T =>N@:.ML]LNDV( M@=Q(T0MTVLPZ,1C!/O6C55KJ.UTLW<[$1Q0^;(W7@+DFN4AU)KWP5_;NIRZA M -0:.14LI#NA0R?NPN< 9!7<>^3VQ@ ZZZLK6\$8NK:&<1N)$$L8;:PZ,,]# M[U&VF6$EZMZ]E;-=K]V<Q*9!]&QGO67-<6MWXIGTLW.I1W)T\DHCE(MA8#>I M'\8)QN'2E\+ZI=7\.HVEZ=USIUZ]HTA&#*H 9'(P,$JPSCC/2@#>KF/$'AI] M=\0:3=S0V,]C9"59(;E2Q?S 2!C (V@CW]*SM4U^[U73/%]FMO>6/\ 9D<@ MBN8I%4Y6(.,D,3SG(P.G7!XK7TSQ18SNMI*+B!DLQ=":XC*)+$ -SJQZ@9&< MXZYH TI=%TN;3/[-DTZU:Q[6YA7RQSGA<8'/--CT+1XHI8H]*L4CF4)*BVZ M2*.@88Y ]ZH6'C#3M0U2UL(X[F-[N%IK9Y(\+,B]2.<@X.<, <5G_$*[;3M* MT^[74KBPC_M""*>6&3;^Y9L/GJ.G.<9&* .@@T+2;:RN+.#3K6*VN,^=$D0" MR9ZY'>JX\+:"!:*-)M,69W6X\L?NCG.5].>:RM+O-*DUD-IOBI[Y+>!Y;F(W M(GCV'@$L#A2"/RSQWK2L?%.G:@RK"+D.]H;R-'@8-)%G&Y1C)[<=3D4 6GT+ M29-474WTRT:^7I<&%=X]\XSFM'%<'JOC*SU[PGJ4NCOJ4!2U-Q%=^0\*MM8 MA7(YYX./>NG_ .$@L1XC&@L95OVA\]5,9VLGJ&Z=: )[[1=,U.6.6^L+>XDC M!"/)&&(!ZC/H?2D.BZ7]M2\_LZU^TI%Y*R>4NY4Z;1QTQD8J33=1@U6R6[MA M)Y3%@/,0J3@D'@^XKF]$O;KQ?<ZA?&[FM]*@G>UM8K=BC2%>&D=NO7H.GJ#0 M!LVOAG0K*:*:UTBRADB+&-HX%!4L,-CCN*D'A[1QICZ8-,M/L+L6:W\H;">N M=O2N4M?&R:%JFO:5KT\\D6E-"T=YY)9GCD4$;P@QD$XW< _7KIR>/=)$-\88 M[QYK6T>\6)[9XS/$O\2%@-R].?QH T/^$3\/B*",:-9*D#%HE6$+L8XR1COP M.?:I'\-:*[7A;3;<F].;GY/]=W^;UZ]Z?X?U-]9T&QU"2%H7G@21D*D#)4$X MSVYX-4I=9L;;Q%J"27UZTEI9I)+:+;LR*I)^=<+EB>AP3T]C0!9NO"V@W]O; MP7>D6<T5LNR%9(@?+7T'H*D;P]I#737)TZW\XP^07V<^7C&S_=QVZ54TWQAH MVJW5G;VLTK&]C:2W=H65)=H!8*Q&"P!Y';!]*I_$:YNK'P-J%]97<]K<VP61 M)(6P<[@,'U�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˪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ʓ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ⅅ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end </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>13 <FILENAME>pinnaclelocrenewal4thloa003.jpg <DESCRIPTION>GRAPHIC <TEXT> begin 644 pinnaclelocrenewal4thloa003.jpg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�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�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end </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>14 <FILENAME>pinnaclelocrenewal4thloa004.jpg <DESCRIPTION>GRAPHIC <TEXT> begin 644 pinnaclelocrenewal4thloa004.jpg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ᝫ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b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end </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>15 <FILENAME>pinnaclelocrenewal4thloa005.jpg <DESCRIPTION>GRAPHIC <TEXT> begin 644 pinnaclelocrenewal4thloa005.jpg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�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	:@& MX+ML\H'H6W8P#C@]ZX+Q(M]'K_B)[3PY/J4-QID"1(]L_E,ROR.G) ;=@<_+ MCKTCBL+B6Y\437MIKUW;WUK:%9VMC%.[*Q!**%&"N00N/X??) /2+#5;#5%E M-C=Q7 B;9)Y;9V'&<'TJY7)^"3>E=1^TRM=P>8GV>_EM#!+<+M_C! +%?NYP M.E=90 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %:P_X\(/]P59 MJ"S_ ./6+_<%3T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%0W<K06<\R+N>.-F5?4@9Q7#:'>QZK8:%XB_X2*5 M;N1'6XMC)E)Y",F/9G"[2#C SC')ZT =_17E7AN_UK6K;1_$-UXBLH+9;AC< MH9G!?KNB9"=@P!D>@YJ;POK5VVK://)J%Q-97L5W+-<SS "<ICYA%R(E&.,$ M9'4#F@#T^BO*H_$VM:+9W<E^+B?45TV:XMKB.;S;.\ *GS .-I4$< 8PQSCB ME.K>(;+1;?Q*=9LYH1I\CI:0R22&YDV$@D,<#:<L=O92,4 >@W&LPV_B"RT= MH9C-=Q22I( -@"8SGG.>1V[UIUYW;0*WC7P?>#5+BX\_3KAR99MXD.U,X],[ MLX''RC@5N>-M9ETJUTN&.22"._U"*UFN$X,4;'DAN@/ &?3- '445YCXJO\ M5-#D\16MEJET8(]+BO(F:3>\$GF[<!CR 0,X/X5V_AZUEATN*>:^N[N2YC25 MC<.&VDJ,A< 8'?% &O4-S.+6UEG:.201H7*1(7=L#H%')/M7G7BJ\UBQ\1:G MI=OJ%^'U*TCETL1M]V=7VLB\?=P=S>@!/:C1]9U'7O#&IZO#?W<$-IHZ0*5; MK=*A>5QN!Y&57/?GTH [)/$4'GZ1!/:7=M+J:DQ+,@7RV"%BC\\-@'CFIM(U MRTUI[]+42!K&Z:UE$BX^=0,X]N?TKE8[R2ZN_AU+=2AYKB!YG+CEW^R\G/3J MWZU;\!+(+GQ46QY9UVXV^O\ #G^E '945R.HZDU_XV;PZ]_-8QQV N8S"^QI M7)93SU(48.!CGKD"N?\ [6UF[\26GA6+58YC#IAE-Z)S%]IF#;<Y4$G;AOE' M4@Y/% 'IU%>8:GJ^HVVF3VA\0O?ZE9:3+<2BQ*QJC+_RU:3^+L @'KFG^(M9 MU2.RM[^6ZNTL/[-A>:;3I!YUI*^3YCQ<;D.,=>,-0!Z917FQU76?$6K^((+# M4H;!],F2.$RW+($5<%G9 N'5L'J>*[/7M2N-+\+7VI01K/<V]JTJ*H)5F"YS MZX[_ $H UJ2O/GU"_LQX.O[/5+F\&J3I%=+*P9)5=2Q8+CY2O.,8X&#FJ+7> MK0:%<ZL=>OI)[37#:I'(R;'C%P(\$!1G@_IP!0!ZA16=KMXNGZ#?79O$L_+A M8BX==PC..#M[\XX[UQ_A#5;^3Q9'8S7%ZUK+HT=T%O9%9W?S,>9@$[,C^$'B M@#T TM<IXVN-4MXK)M/6XF@#.UU!9S".X9!CYDR#G;DY'&<BL33+V^U_6=+M M;7Q#?KI\VB>>[A$21W#A-W*G#>O)[X/- 'HU%>4Z?XDUR[71= GN]L\TETKW M;3>4TZQ.44;MIP3@]!D[1ZFKUG?ZQ!KUGX4U37/,:9IY6NK=P'5552L&XK]X M9W$XS@B@#O;N^BLGMED25C<3"%/+C+ $@G+8Z#CJ:S=3\566F74]O]GO;J2V M5'N!:0^9Y(<X7<,Y.<'@9.!FN>OYM6T=/#=E)KSWCOK*V]S,NU2R$%EC?J<X M SR,YYSFH[&Q:'QOXSN8M0O5EA@@<#?D9:)R"<\';S@$8''6@#N=/O8]1L(; MR*.9(Y1N59HRC@>ZGD59KS&T\3:S>_\ "(Z7'=JLU_I[74\SR!&E8#A<[&QW M/ Y]JMVFJZU%XHTSPMJ>M1-))!-/)<VNT/(P8[8^5P" "3@9./S .RT?6;37 M+:>>T$H6&=[>194*,'0X(P:M7ES'964]U*&,<,;2,$4L< 9. .M<K\.8WBTG M5DEF\V8:Q=B1_5@^">@Z]?QJIJ.JW6NZEXLTJ*_>SCTNT B2,+NE9HRQ9L@D MJ.!@8ZT =CIFH0:MI=KJ%L&\BYB66/>,':1D9%6Z\IAU6^@\(Z1;:9J4J7$6 M@&X^S6\:$HP0;99&;HG; &2:LZ=?W6I^-/#5S<W-PTO_ CHOG6,@*SOMW#& M.AQ_+&,4 >F$ \$9I))$BC:21U1%&69C@ >YKSGPWJGBOQ#;:?K45[8Q6<MT M?.CDN,XCW%3$$\H88<8.\Y(]ZUOB;"]QX32!;B6%9KVWB<QD LK2 8/'OGZ@ M4 =E17&"[U'5/%>JZ%%JDUI!IMG%MDC"&661QG>V0<@8Z 9/TK1\#ZW<^(O M!NG:I>*JW$RL)-HP"58KG'OC/XT =%17E\FK>(YK+Q=J,&O,%T6\D6" VZ!6 M$8!97.,D8R!C'/.>PTK2\U[5_$.JLFL2VMC:0VERMLMNC,2Z;V3)&<'!'KR/ M2@#OJ0UYQ_PDFKKX:T+Q'#J/VEM0OXHIK18U\O8[%=B\;@RX SGJ#]*MOKVJ MV6OZQH,VI"6]FE@&E[H4!2.3.YC@ -LPQYS]WWH [*WU&WN;Z[LXO,\VUV>; MNC95^8$C!(PW3MFHGUBSCUV+1V9Q>2P-<(/+.TH#@_-TSST_^M7'ZEXLU#1) M?&+S7 GBTW[)]E$D:@1F88YVX) )!^@I9Y'T/QC#J%UJ<VHHN@W,P#A!N*M& MS;-H'# =.V.M '?U7O;"TU&V:VOK6&Y@;K',@=3^!KC?#UWXEU1=#U@ZA9BR MO%W7$+3!@^5)VQJ(P592#QN/W3G/)K:\5ZC/I]M9"WOEM7FND1E2+S9I5[K$ MN"-WN00!G.* %>/PYX/59Q;167VF18?,CA9BQ)P 2 <#)[\5I6^J6MUJ=YIT M3.;BS6-I@4( #[MN">OW3TKSJ76[[6O ^J?V@6:6R\01VBEU4.46>(C=M^7< M-V#CCBNPLHU/Q"U>7=\RZ=:*%]07FR?T'YT =%17.ZOKK0^*]'T"*1H'O!), M\NT'*H"=@SD9)Z\= >Y!K$UB_P#$FF7.AV"ZU;O/=ZD]M+)Y*']V1N7<,##A M<=,9R* .]HKSNV\6:I:7DVD7EV+B=];&GPW;1*NV,HK$D#"[L' XZGH<8I/$ MOB'7O#PU^VCU!9W@LXK^TFD@7=&IEV-&P ;IP?>@#T6BN$UK4/$7A^&U>\U M"6\MI&DDN9["T030+M&P",[LQ@YRW)Y'3OT^BWXNO#5C?27279>U21YXUP)# MM^8@=N<\=NE &I7,^*[WPO$B1^(5#F)/-5E@D=X%)V[]T8)CR>,Y'(]JY[_A M)M;N/#%MXPM+^/[))>*KZ<\2[1"9?*"[P-V_)!)SCV[5H:3;W#?%'Q"WVZ41 M)!:LT01,2 A\ G&1CVP?6@#J=,TC3]'@,.GVL<"M@MM&2V.Y)Y/XU>KGO%VJ M7VDZ=;W%G#<R1FX"W)M(UDFCBVL2R*P()!"YX/&?K6/H7B.[N]2\/0_VNE_% M?6MR\K) J!BC#:?56 8 KTR#0!W-4-3UG3]&6W;4+D0BXF6"+*D[W;H. :X: MQ\9:@UM9Z?)?1-?W>L7%B+J6)<1I&?[HP-Q!4#_>Z&G>+(=<ALM+@N;^UN;@ M>(K?['*T?(0[MOFJNT$@Y^[C(H ]&K'U;Q1HNB7<5KJ-^D$\J[TC*L2P]1@' MTJGX=U/4)]=US2M0GCG>P: I)'%Y8(DCW'C)[@]^F*P_&\MTGC_P7]B@CFN0 M]V469S&C9C7.6 )&!D]#0!UFG:AHVLS_ &RPN+:YGB3860CS$4\X(Z@' .#5 M^XMH;N!X+B-9(G&&1NC#T/J/:O,GU>YT3XA:WJFLV:17<6B&2&&U8R1R1JP. M2Y"G.X8^[T[\<Z,&K^-YH(;U;6W2UDLY)9)9O+*(^S<A0(Y8J2,8/(SGG% ' MH"JJ*%4!5 P !@ 4,0H))P!U-><6WC+6K1O#-YJ$UM<6>L6LLLD$-N4:+RX@ M^0VX[B?3 %;>DZAKNM6^CZS:75D=/NV+W%OMYBB(.T!N[@X!Z#/:@#H=+U6Q MUFR%YI]PMQ;EV02*#@E3@XSUY'6KE>.^$]:UC1_"^B7YN[=[&]U@VCV_V?YS MYDCY??GKD= ,=*V-2\1>*[/2/$&JKJ&GTQ+&EJV90/+RI);Y1\W7DYSR M.* /2J*XZSUC7;;6[JRU"XL)V;2_M\05##'$V[;M9B22O3YOTK*@\8ZPIU.( MM'-)!HO]HI,UJRQ"1=VY5Y4O&<?*WMWH [G4=5L=*%N;VX6'[1,L$0()+NQP M *NUY5K&IZM/X,T/7-8N()H9KZPN$BM;<ADY+-W.XGC &.E=WX:U9]=TP:H MMQ;26T[,84A4YC4'&')/+<<X ]^I -JBHKGSOLLOV=T2;8=C.I90V.,@$9' MXBO.=,\5^)WL_#.LWKV4FGZK<K:2V\,)#1ER55]Q/J.GICJ>: /2Z*\]LO$O MBCQ!(FHZ+:)_9ZWA@:*5(P#&K89MYDW;N^-GXGO%_P )%XMET+7]72YTJ.+2 M[BZB$7V5R9!$, YW\<@^M 'H]%<*FI^+6UG2]/:]TQ6U&Q:=B+5L6[+LR1\_ MSGYN^!_(K;^)]2N_#.EWB7%N&FNY8+F98&\Q@CNH\N'DESM!(YP,_@ =S17G M-KXTUN_TSPI)9BQ%QJD\\$YG1@ 4W#( .>Q)]\#C-6(_%NL6MI)977D3ZH^M M-IL$B0X3:%5]Y7>/X3TW#J* .^HKS_4_$?C#1X('N["P(FU2*TB)4AI8W'7: MKMM.0><GJ..*R]?\7:ZNEZQIC3V\6I66HVML;FVB9$:.4;A@%B0<@@\]#0!Z M<+RV-X;,7$1N@GF&'>-X7.-VWKC)'-35QSK>?\+"15E@^V_V X$AC/E^9YJ\ M[<YVY[9SCO5/2?%^L:CI_P!A=;*/Q#'J1LIH?+8QHHRQ?&[)&Q20<X)H [VB ML?Q3K\7ACP[=:M+"TP@ "QJ<;F8A5&>PR1DUCW6O:[HM_P#9=233[C[19SSV MLENKQ@21#<5<$GC!&"/0^M '845SGA34]<UFRAU+4;>P@LKFVCE@2!W:3<1D MELC 'H!GW-='0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $%J- MMM%G^X!4]0P?\>\7^Z*FH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH *R+3POH=AJTFJ6FEVT-])G=,B8//7'89]J MUF8*I8YP!G@9/Y5RUEXJT;3M L+F;5+R[@N[EX(;F>!B\C[VX("C&,$#@<"@ M#3@\+Z';:K-JD.EVR7LV?,F"<G/7VY[^M5K7P3X9LYEFM]$LXY%9F#*G(+#! M_#!Z=*EL_%>DWL%[*LTD0LI1#.L\3(ZL<8&TC))S@#&2:P=,\1SS?$#6H[J> MX@TRVT^.<0W*>6(NFYL8ST]?>@#H=,\+Z+H\GF6%A'"WEF(<LV$)R0 2< D# M.*;IWA+0-)NYKJPTFU@FF!5V1.H/4>P/H.*A3QCI4EV+0M/'</;-=0I-"R&6 M, DE<CT'0\^U<3I6M'4=!T[Q5J^NZUIYDN2DD4"DV\F96"(!@@ %NIY&<T M =M:>!_#-C>QWEMHUM'/$VZ-L$[#G.0"<#\*U=0TVSU:R>SO[:.XMW^]'(,C MV/L?>L:\\=:%8RW\,DUPTM@?])2.UD8QC^\?E^[[]*5==L)-=G:#59YWBTW[ M2+%(CL,9((E#;?F)X &3WXH NR>&M(EL)K*2S#P3D&8,[$R8Z;FSE@.P)K1M MK>*TM8K:W01PPH(XT'15 P!^58.E^,;+4-"T[4I(+B&2_P +#;^66=WQDA<# MY@.>>!@9XK#\2^+!=6>C7>A:E+'_ ,3N&QNXMFT\D[D<,,@\?KWH [B6RMIK MN"ZDA1Y[<,(I".4W8#8^N!58:)IJZ3+I:VD:V,N[?"N0&W$EL]^235>#Q3H] MS+J<4=TWF:6NZ\5X73RA@G/S 9&%)XS6E:7,=[:0W,._RY4#KO4J<$9&0>10 M!F#PKHJ_V?BR'_$N.;3,CGR><\<_Y''2K6G:-8:2UPUC!Y1N9/-F.]F+O_>. M2>?>C6-9L-!T]K_4YS!:J0&D\MGP3TR%!-9EKXY\-W@G,6HX\BW^U.)89(SY M6,[U#*"PQZ9H N:QX9T7Q 8FU73H+IHLA&<<J/3(YQ4=[X3T'4;>U@NM*MGB MM!B!0NWRQZ#&,"J=A\0/#6IB0VE^\B)M&[[-* Q8[0JY7YFSQ@<U:;Q?HT>G MWE[//+!'9,%N4EMW$D6?NEDQN .00<8H 9<^"O#5VZ--HUJQ2(0#"[1L P!@ M>E2?\(EH8C2,6("+"MOL\Q\-&N<*PS\PY/7/4TRZ\5:,+&*47\D:75H]U#*E MN[8B &9,;3C&1]ZBU\1:;#HFFS-J$E\UU"/(9(29KK:OS,(P,^YXP/:@!][X M1\/ZEJ/V^\TFVFNB I=E^\!TR.A_'T%;3*&4JP!!&"#WKA_!/BIY_"SW^M7L MDDC:A);Q%H?WC\_*H1%R3UX SUK9A\:Z%<6SRQW,A=+@VIMS"XF\[GY-F,YX M/Y4 6K#PUH^EM&;*Q2'R@XB 9B(]WWM@)^7..<8J$>#]!%DUF+ ?9VG^T,GF MO@R_W^O6LGP-KUQK-[XACGEN)1:WWEQ-.H1E3'W2@ Q@@^YS[5J^*?$D?AFR MLYW@>9KF\BM41%)/S'D@#DG:&P.YP* -6ZLK:^LI+*ZA2:VD78\<@W!A[YK. MTWPGH6D7<=U8:9#!/'&8UD7.0I[9)KG8_$[V/Q$U6UO[V[-@MA%/#;K:,_EY MY8G8A88'KZ^PQT%QXNT.UABEDOLK+:?;5V1.Y\C /F$*"0O/?% %V_TBQU.2 M&2[A+R0;O+=9&1EW#!P5(/.*X^?P:Q\=6D\.E+%HL%C]D62VO'MW0@[@?D8% MA_#@^N:W3XJ@_P"$SM] 2%V$UA]L$ZJS#EPJC ' QN)8X'0=ZZ&@#)O/#&BW M^FPZ==:;;R6D!W11E?N'U!'.?7UJO<^#/#UWI*:7-I<+6<<AE1 64JYZL&!W M9_&K>J>(-+T5E2_N?+=HWE"+&TC;%&6;:H)P!U-9MQXTL(]8T6Q@CFN8M5A> M>.>&-F"H!D' !)S^G>@"Y_PBFB"UM+9;!%AM)_M$"JS+LESG?P>6SW-$?A?2 M8M3O=16";[5?(8[AS=2D.I[;2V!CM@<=L5KNP1&<YPHR<#)_(5YWJ?CTWWA> M'5[*2?3HXM5C@G\R$\P^85/++CD#)V\CI0!T]QX*\/W6EVFG3:>'MK1MUN/. MD#1'.?E?=N ]LXX%+<^#/#]U!90R::BK9$FV:&1XGC).20RD'KSUZU);>+-# MNK2\NHM03R;/:;AG5DV;N5X8 G/;'7M5JSUO3[^^FL;><FZA19)(7C9&56 ( M.& ]?Z=: $TG0M-T**6+3+1;=)7WN%).YO7DU6U'PKHNJW_VZ[LRUT8_*:2. M9XRZ?W6VL-P]CFCQ-XB3PW807+VLUP9KF.W"1*Q(W'!/ )X&>,<G [U7'B'3 MO[=F4ZR0L.G_ &F2Q: J8D!!,K$C(.& VGGG.* $D\!^&I?*SIN!' ;<!)Y% M!B))V$!OF&3T.:L0>$=$M9;"6"T:.2PC\JW=9Y RIG.PG=\RY[-D557Q_P"% MV\K&K1[90QC<QN$?;C(5MN">1P#GD5H0^)-'N-/FOXK^)K:"3RI7Y&Q\@;2. MH;)'&,\T 5K7P;X?L=5?4K;3ECN7D\TXD?9OY^;9G;GD\XXR:T-7T>SUS3GL M;Z-GA9E8;'*,K*<A@00001FC3]8L=4DNH[.??):R>5.C(R-&W7!# '\>AIVH MZI9Z3;"XO9A%&6"+A2S.QZ*J@$L3Z $T 4+CPII5Q=0W16YCNHH1 +B*ZD21 MHP<[68-EA]>:U+6U@L;2*UM8DA@B4)'&@P% ["L'5?&%E#X1U+6M-D-PUJKH M$,+@K*/X70@,O.,Y XYJ7PN+^>U%_=ZO->1W$,>V*6U6(Q.!\^, 9!)].W4T M 8/AKP?+_:WB"XUFRGBBO-0>XBC^U9CGC8Y =%8@X(S@_P![O776^BV-KJUS MJD,<BW=TH69O/<JX' ^0G:,=L#U]:34==TS221?72Q$*';Y2=JDX!; . 3P, M]:8?$>DK!J$QNP(].D\N[.QOW3>_'3G.1Q0!!;>%-)M+A)(89!''(98K<S.8 M8Y"2=ZH3M!R2>G&>*O2:58RZM#JDELC7T,311S'.54G) [?C]?4U7O/$FCV$ M:27%]&JO#YXV@N?*_OD*#A>>IXKGI/&5OI_C&_CU+5H$TG[!#<6H"CG<3DC& M2_ SQV/XT ;\GAG2)YM2EFM/-;4E5+L22NRRA1A?E)P,=B ,55T_P3H>G3VT M\4-P\EM&T4)FNY9 D;=4"EMNW';'8>E;MO/%<V\=Q!(LD,JAT=3D,I&00?3% M9^H>(](TN=H;V]2*1$#N,$[%)P"Q ^4$^M %#2/ WA_0]4.H:?9O%-SL7SG* M1YZ[5)P,Y/\ 3%7=:\.:=K[6CWR2^9:2>;!)%*T;(WJ"I'I5:Q\6Z=?:SJ^G M*SQG3,>=*ZL%QC+')& ![GG&1QS27/C/18=*U"_ANUG%C")I(T!#%2/E(!'1 MNQZ<T 0OX#T1K*[LT%Y'!=W(NIE2[D^:0<[LDYSD ^Y ]!6C;:!:6NMRZNLE MR]W+"L+%YF*[%Z#'3CG\SZU'%XITE]*M+^6Z6&.Z3=$C [FP,G:N,M@=P/>H MV\9^&U2%SK-IMFB,L>),[E!P2/QR,=<B@"QKGAW3O$,,,=_$Q:"020RQ.4DB M8=U8<BJ2>"M(B-B8EN(S93-/&1,Q+2MPSL3DLQ'&3VZ5+;>,O#EY/:P6^LVD MDUT<0QB3YG.2.G;D$<]:LW_B/1]+N5M[[48()6(7#M@ GH">BYP<9QG% %&7 MP3H\\=ZLZSRF[N%NG=I3N29>CH1]T_3TJ2Y\(Z;>:?=6ETUQ.;Q42YG>7,DJ MKRH)[#/.%QW]34MQXM\/6MP]O/K%FDR2B%XS*-ROTP14MOKUG<^(+W1HRWVF MS2-I,@XRX) 'T !_&@!EUX<M+NYM;EY[M;BVA:!94F*ED;&0WKG Z^E7--TV MUTC3H+"QB\JV@79&F2<#ZGDU9=TCC:21@J*"S,QP !W-9EGXET;4/.^RZE;R M>3'YKX;&$_O\]5_VAQ0!63PAI,8\M5G%I]H^T_8_.;R?,SNSL]-WS8Z9[58M M_#]M;:_=:TD]R;FZ"K(ID^0JHPHV@=LGWYJ73]>TG59FAT_4;6ZD1 [+#*&( M4]"<5+>ZMIVFR0I?7UO;-,2(A-(%WD=<9H BU72$U46Q-U<VLEM-YT<ELX5@ MVUEP<@@C#'C%93>!=)^RV$44EY;RV4DDD5S#-ME)?._+8Z-GG&/;%7XO%.@S MVZW$6L63PM,( ZS*09",A<^I]*@\1Z^NGZ-K#Z?<VKZEI]L;AH9/FVC&1N4$ M'D#B@#-?X:^'Y-+GT^07;Q2W)N@S7#%XY3GYE/K@]\YP,YQ5I_!%@\$"&]U MS1727?VEY1)*\B#"%BRG(4=!C'M5_3/$&GZIFUMM0M9;](5>6%'!*$CN,^M8 M?AGQ-?Z[X9L+ZYN].L[J>]:$AU(615<C8@+9W' [GZ4 ;NG^'X-/UO4-62YN MI+B_""99&79\HPN ,8'%0:SX6M];U2QU&6^OK>>Q#?9S;NJA"PPQY4Y)&!^ M%7;S7=*TZ[BM+W4+:WN)1E(Y9 I(_'Z'ZXHN-<TJTOX[&XU"VBNI" L3R@,2 M>@Q[]O6@"E;^$]-CGN;BZ,]_<W,!MI9KR3>QB.<H,8"@Y[ 9JE8^ -*TZW>W M@NM1,7EO' DER76V#@AC&", D$C/)Y/K5K_A+-,N_P"UK>RU&T2ZL-R,\[XC M5@!R>?NAF /N"*O3:Q9:9IUM/JFHVL0=!^^9@B2'&25R>G>@#,3P3I\:Z&$N MKT?V+N%J2ZDX; (;Y>1@8[<5'IW@+2M*GW6EQ?I;K*9X[,W!,$<F<A@GL>1G M(K8DU_1HH89I=6L8XIUW1.]P@#CU!)YJS:7UIJ$)FLKJ"YB!VEX9 ZY],CO0 M!S8^'VEKH5KHZW=^MM:W?VR)A(F]9.2.=O0$D_C4C^!K*73-2T^74=1DM]2E M\ZY#/'EGR"2/DXS@=/05U%<5K'Q M(]"\07.D2037>E,$VR,"'Y4%@ <E06Q MGU% %^_\#Z?JDOF7MY?RYL_L3KYBJ'CSGG"@YW '/MZ9%1Q> K!%.^_U*21] M/.G2.\X.Z(^V, \G'^/-:VBZO#J-E K7-L]^($>YABD4F-B!D$ DCFG+X@T9 MY98EU6Q,D(+2*+A<J!U)YZ#O0!GR^#[*7P_I^C&\O5M["1)()%=/,!3[F3MQ MQ].PJK<>#OL.F:G%H=]?6TMX=Z113K''')D?.,+\HXY ZC/'2MJ'Q#HMS%)+ M!JUA)'$N^1DN$(1>F3SP/K4]AJ=CJD)FL+R"ZC!VEH9 P!]#CH: "5IK32&9 MP]S/%!R$',C!>P]S7(^!_"^SPQHO]J"^\ZQ)D2SN@H6&7)&X87)ZG&20,^O3 MJ-2O)+>YL(HKRQMS-. Z7+?-*F.5C&1ELD>M2#5]-:^^PC4+0W>2OD"9?,R! MDC;G.<4 85OX#L;359;FVO;V*SGF^T3Z>LO[F27.=Q'7J <9QQZ<58A\'V<. MC:GI0O;UK?47DDG+,A;<_P!_!V\9_P#U8KH'=(HVD=@J*"69C@ #N:JQ:MIL M\\<$.H6LDTB>8D:3*6=?[P /(]Z *">&H4U#3[[[?>M-86[6\6XIAE.,[OEY M/"_D/?.<O@*RB73C#J6I+-I\\D]O,TJLR^9_K%Y7!#<]02,FN@.K:<+W[$;^ MU%WG;Y'G+OSC.-N<YQS5R@#E;7P#IEE_98@N[Y1IDTDUL"Z':9#E@<KR.OYF MHK_X>Z?J,-_'<7M\WVJZ%Y&V]0UO/C&]"!GI@8/& /K70-KFD+/+ VJ60EA! M,D9N$W(!UR,\8[YJ5-2L))8(DO;9I+A/,A195)D7^\HSR/<4 <Y<^!_M5C:P MOKFH-<P7279NI"KN[H,)P1@ >@'/?-07OP[MK^[U6YFU2[#:A+%.P54 CDC^ MXPXYP,C!X.?I75?VE8_;_L/VRW^V8S]G\U?,QC/W<YZ<T#4K%KXV(O;<W@&3 M;B5?, QG[N<]* ,630YK+5H_$$NIWMS+:V1@DA2W0F=!\QX5<[BP!PN.>.E5 MO#^GQZCXFOO%4VEW%C++"EM ERNR4J.6=E[9RHYY^3MFNG6[MWN'MEGB,Z8W M1!QN7(R,CJ.*<LT3R%%D1G7JH8$B@"GK>C6FOZ/<Z7?*6MYUPVTX((.01[@@ M&LA_"ES<*?MFL/<R1V<EK;226Z[HO, #.<8W,0 .PKHXYXI21'*CD==K XH2 MXAD#%)48+R=K XH H>']*?0]!L]+>Z-U]EC$:RL@4E1T&!Z# _"M.F)+&[%4 MD5B!D@'.*?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $,'^I0 M>BBIJB@_U2?[HJ6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@!"< G!/L*\VL_#^N6WAWPW:MI,IFT_6'O)U$T7$9 M:0Y!WX)_>#CV/MGTJB@#S'7?"VOWU_KES9681VU"UU"T\V5-LWDIM*'#9!)Y M&>..HI;WP_X@\17OB"232!IT>JZ?%"DD]RA:-TR<$)D[2< ]/I7?7NLZ?I]] M9V=U<".XO'*6Z;22YZ]AQ^-7Z //_#-AJ]I;PK/X.T^RDL[8PO<1O$T]TP7: M-A&-N3R2Q_\ K4D\/ZY#\.='T6'1)!=V5Y#)+&US%A@KF1F4[NYXP?6O2+B> M*TMI;B=Q'#$I=W/10!DFDM;B*\M(;J!BT,R+(C%2I*D9'!Y'!Z&@#A=0T/6+ MR;QN4TR11JMK%':%I8OG9(RAS\W')SSV!^E0Z7HGB%/$B7L^FM$CZ NGO*TL M1V3*,YVJW*DC]:[ZYO;:S,(N)DB,\HABW'&]SG"CWX-6* /+6\.:]'HWA:X? M0+>ZFT6.2WN-/F>)A.C*HWH<E<_+WYS5[6=!U2^TG3OL7AVULO*UJ&]-K;-& MC"%%Y+\A2Y.>AZ8Y[UZ)10!Y_P")O#KW_C>U6RG5(]3@\O58MQ!:&)U8'CNW MW.>,$CUKJ8-8=_%%QHIL62.&V6=+@2 A@3C&T<KWQGK@^E3:;H6EZ/-<RZ?9 M102W3F29U'S.QYY)_E5\(H8N% 9L G')Q0!ROQ-_Y)SK7_7)?_0UK+U+0K[Q M!JO]JKIDMD+72);6.%F19))9%("J0<!5!(R<<FNQUC1K'7M-DT_4HFFM9""\ M8D9-V#D<J0>M6X($MK>*"($1QH$7+%C@# Y/)_&@#A+G1M;@\)^%9+33]U_H MC1--8M(@\T+&4<A@<9Y)'/?D9XK3M-!;4M>UW4;^R:*UO[6.T2.;:7*@-O) M) '(QWXK?.K6 UA=(^T+]O:$SB'!SL! SGH.2*NT <#H/A35=.\/:K#?;9[M M;-].L0A S H;8>3@%B><XQ@5GZ9H7B'0KCPMJ/\ 9LERME8O8WEFDD9>/)SY MB$MM.>._0>_'IM+0!X^GA7Q&FAV-Q_8BR3Z?JD]P;"6=<7,<G\602-R]N?S[ MZ+>'M6M?$>E^)--\,6MO%!*RR6$<B"<I(H#2,<A=XR>,GC\<>GU!=WMM80K+ M=3)#&SK&&<X!9C@#ZDF@#FO"6G:E::UXANKZPDM8KZZ$\&^2-B1C&"$)P?Q[ MTOCO2K[4;31Y["W:Y?3]5@O)(48!G1,Y"Y(&>?6MJ37M*CN+V![^%9+&-9;D M%O\ 5*<X)_(_IZBK-A?6VIV$%]9R^;;3H'C?!&Y3T.#S0!RL=AJD?B_6]4_L MN5[:\T^*.)#+%EI%!RI&[CKC/3K7,RZ'XIN-.BTN[T:8V\>B"TC%I<1(6G"[ M?WK[LE0.<<CIQ7K%% '$:58:I;>,K34[G1YE1]&CLV99(V\F17)8$[NAXY&: MZ/0-7?6]*6\DLI+.3S'C>&1@Q5E8J>1P1D'FM3K38XTBC6.-%1%&%51@ >@% M ''>+;?6+K5X88-+DO-,>SE1_(=(W>4Y 1V8@B/&.G?KFLK1=*U?3[WPC=2Z M+=G['I\EE<A7BRC?+@_?QMX/O[5Z!'?6DM]-91W$;74*J\L0;+(&Z$CMG%6* M "O,+?3=:M/"]IITVA7,]Q;:T+EU4Q[)8_-9RR_,>,8X..HZ\UZ?10!YAXH\ M/ZQJNJ^(38Z7(R2M9S1M(X1+DPGYE'/4@C!(_A// KI?"EOYES)?MX671I#" M(V>5E:60YR0".=HP.N,\<<5U5% '/>,8+J32K6:SM);M[6^M[EH8<;V1'!., MD9..U8FH66J2^-;_ %)-+N?L5QX?:W#80L)LEPN V<X...,_G7>44 >9:/H^ MIQ67@>";2KM6TV67[7]T"/((!SGD9(/':L:Z\.ZU>PZI+;Z+=2"+Q"^I"VN& M\K[5$W&%/'.03[ CJ:]FHH YSPM:0P_:[J#0I-)CN2A*S.#+*P!R6 ) R . M<GG-5?%MEJ(U[PYK-E:-=PZ=/+]IAC/S[)$";U'\6T9..M=;4-W>6UA:R75Y M/'!;QC+RRL%51[DT <#J.D7267C348;*X?\ MN..&UMXXF,A*Q%2S+_""2>O MI[BN\LKG[99QW'D3P;QGRITVNOU%223Q0P//+*D<**7:1V 55')))Z"DMKF" M\MH[FVE2:"1=R2(<JP]0: .#\9:=J+ZS-?Z+;:A%J8ABCC=%$EM>#<<QRJ> M!GJ<=35?6(M7BE\96*:'?7+:M"IMYX ICSY 1@26&,$=!DFO2:* /-K2/5M- MUR]N[WPW=WUCJ]C!"40JSPE(]IC=2V K$DYSCGZXDDLKM/$6JRRZ)*HET%;: M,01%HUD 8F)6 ''('''%>BT4 8'@B*Z@\%Z3;WL$T-Q!;K$\<RX92O'Y<<>U M<OXNL=4;Q#=WVBV>H1:BL4,2,(Q+;7R$\JX(PI7/4UZ/10!YW/!JEC)XVBAT M)[R6\<36V^(-%,#&JD')P<<G;U.#6!>Z)K5]=>)/)T[5)$O=)2.&6\B169T8 M$J N HZX7 Z#ZU[#'(DJ!XW5U/1E.13J /-KRWU/^U/#NIMHNHSZ?%8FSN(8 MW:.:!LCYPJL"1P![C\*DT[239^,-"N[?P[-:6'D7*@;=Y@9F!5I,YVL0#T)Q MGZUZ+5674K"!;AI;VVC%MCSR\JCRLC(W<_+QZT >:Z3IVH6O@S28KC2+QK^' M6UN94%N=P7S2Q?.,?=/]*LVVGWEM)K>E:QX>OM3-WJ#7-O*DK>1*&(V;SN^7 M;@9XX Z'OZ2CI+&LD;*Z, RLIR"#T(-1K=VS7;VBW$1N44.T(<;U4]"5Z@>] M 'F>L:==?V!X\632;EYKJY62WVVY;S1A%!4XYPP)^G-;_AE9X?&6M2RVETD5 M_;6<L$K0L%(2+# D_=()Q@\^U=9+>6T%Q!;S7$4<UP2L,;. TA R<#O@#-3T M <YX[TS4=7\&ZA9:4V+J15(7=MWJ&!9<^X!'XUSNH1RZ[J6GZE::5<6_V#3+ MI+R)X6CRSQ[5@&0-X# _=R.GK7HI( R>!5674K"#:9KVVCW' WRJ,G\30!S_ M ,.[..U\$Z8#9&VN1"$F#P&-RP)SG(!/UJC\1Y;: ^&IKJ SQIJ\9:-8O,9E MV/G"@$GMQ7;JRLH92"#T(-9.K^'K;6K[3;NXGN(WT^;SX5B*@%O]K()/I^- M'G^J:1-*/$NL6-A=?9+F_L)D7R"KN(F_>,L> V.?3)()JQJ0N]6UCQ:]MI.H M*E[H:QV[R6Y02L%;UY!.0,'GCI7I]% 'G%E8VNK:]X5N])L9+6/2H)/MCM:- M#M!0 1\@;CNW<#..3WK&M//A\%^$(GTR]$EIKGF3YM7W1QB1V+8QG&&7_(KV M"B@#S!+K^SM3UW1=>T*]U"34M0:[LC$A=)TR#&I;(V;=J]>!_/&\33-J%YJ, M":9<VCV^M02ND-F[^<@./.=]I)Z\*N.O0U[#=7EK8P&>[N(;>$'!DF<(H_$U M+')'-&LD3J\;#*LIR"/4&@#SMRHL?'MG+IMQ<222O-'%]F9ED#0H$P<8)W#. M.HQFDT^X.DZ]8W]_:W?]CW&D16=NQ@D;R9%^\C)C<"V.I'.!7H]% 'D5MI$N MFR^#5O--DD5;ZYF=5M&?R(G)\L' (49()!Q@]N#6SHNM6?A<^);F]MKR&UDU MEC'BU?!#J!N&0!M+*W/T]17H9( R3@"JLL%EJUO&7\NY@#B1=KY1F4\9QP<' ML>,CVH MUXWK4HM]'\>Z2]O<"]NK_P V!%MW(D5C'C# 8)."<9SP:]DJ);B! MF"K-&2>@#"@#S/5;>>/74;1;*YMTNO#<MO;F&U>-5F+$JIPHV'@]<8K(T^QL M-1\."W?1-;FUNPTRXB9KH.8X&\EAA0>#DXVJ!GD'MFO:** /&)M'6'X:^'KN MRTZ<"WN8VU46]OY5RP7<"3QD[6/OV/&..\\#Q:=]CO+S3;?4E2ZF#O/J&?,G M8#&0#S@=,X&:ZNF/)''MWNJ[CM7<<9/H/>@#CO&C01^(?"<LB99-0)+",L57 M81V'3<5K$T5I8/'D<=@)+NSEO+F26*]M&6:P8@DNCGC8_&/][UKT^B@"MJ&S M^S;KS "GDON!&<C!SQWKR;1X].M-&\"M:1>7?)/(LKM VY7:-P=_&<;V4<]L M5[%10!XU]FFO/ EGX<^RS1>)H=25I!L8,7\PL9B^.1L.=V?Z5[+3(Y8I=WER M(^QMK;2#@^A]Z?0!Y%9"ZGN[BSTR 7]M>1:@_EWUJ5N+&1@V59NA1W(X/)S4 M6DWT,DO@#,%_NT^&YMYR;63]W*8U503MZ9STZ#K7L5% 'E'AN2TNM(T[3KK2 M;L>*M/FF*[HV7$W.97DZ%3QG)))]>*G\'W&G7FFZ7#)IMRGBFP6=07MW4K(5 M96=WP 0>,Y).3ZUZA368*1D@9.!GN: /'O"W]BR1VDFK?VM)XCTN222>W$7S M*XW%F+;0""!GEN:J:?<Z=:V5U;/)%>:2^E2&/5+*,)>V\989CE'3<3@<]>>< M9Q[;10!X@][?V^AZI!IT5I=QV]O:DZCID6QIK7=S'( >'P>1P<9SQ6]K-KH\ MFL75SI'V5=-;0IFU%8AB,K@>3D 8WYSCOA37J"HJ9VJ%R<G QD^M(B)$H1%5 M%ZA5&* .5^'>F:=9^#M,N[.WB6>ZM(C<3*/FD8#D$]\$D5UM%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 -4;1BG444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5[Z<VUA<3*\, M;1QLRM.VV,$#@L>P]:X#3?%VI6^I7C75S)?6D6AOJ9W0K&KR(P#>4<!O+/(! M89[Y(KOK^QM]3T^>QNXQ);SH8Y%SU!K#M/ VCVLZRDWD["U:R(GNG=6A(QL( M)QCVH Y/6%U*XUOP+>W6IB=[J=I BPJ(XV9 1MQR0 <<DYQVHM_$/B^3PW)K M:ZE92O;ZB;,6IL\+,#((@6(;(P6! 'IR371V?PYT:S>R/VG4Y5L9#):QR7C; M82>R@8P/\G/-6HO!&EPZ4NG)->"!;L7BGSOF$H.<YQZ\_6@#"DUSQ#I?_"56 MMS?Q7DVFZ?'>07!M0BJQ5B5(!YSMXY_.IH]4\27Z^%Q;:E9P#5=-\R9I+7>R MR^4&+@;@".>!P![]*W;KPE87=SJ-Q+-=E]1MQ;7($N T8& ,8XX)Y]S1#X3L M+>;2I8Y[L/I<)@MOWN=J'&0>.> !] * .9M_$FM/HGAJXDNX))+C6C874BPC M]ZH>0 KV7A/3/-30>(=6E\7MI%]=S:9*UQ*D,3VJF*XAVG88Y,'+CACGCJ,< M<[$'@;3+>WMK=+B^\FVN_ML2&;(6;GYNGN>.G)J2#P;I\.J1WKSW4XAN)+J" M"60&.&5SEF7C/<\$D#/ H Y+3M7UK3? 6CWJZL9[J^U-;=FNH!( &F=3C!![ M9.2?08JYK^K>(-"@DMCK<=W=P63W ^S62^:[!F.9$Y5(@H SD$D^V*W7\#:4 MVG16'G7HMH;@7,*"X/[MP68%?3EB?R]*FU'P=I>IZI-J$[7:3SVWV6;R;AHQ M)'Z$"@#FK'5;R?QRVHW,\IAC\.1W?DQ@!%+,&91G)YV]>OOQ3SXB\11:=X?\ M0/+$UGJEU%'-8"$'R8Y3\A5QR2!C.>I/05TEKX0TVTNX+F-[LO%;+:$-.2)( ME)(5AW S_2F:?X/T_3HK:W6:ZFL[2;S[6VED!2!^<$8 )P22 Q.">* ,OPGJ MGB'7=1U66ZU"S2TL-3FLS!':',@0 9#%_EY.?XNIJQ\2[JXLO .HS6UR]O+^ M[4,@Y(9U4CU'!/2M70?#EKX?;4&MI[F7[==-=2B9@0';KC &,U8UO1[;7]&N M=+NS(L$Z@,T9PRD$$$'U! - ''ZQ;ZI+\1-)ATV^BM[@Z1*'N)H/,PN]>0N0 M,YQU]^#4%EXMUG5?"6BWL=W;P7%YYRS&*V,LS.C$*(HNA''S$G %=4GA>)=< MAU9M1OY+B&S-FH=U(*GDL?ESN)YSG\,<5E:=\-M)TM+/[-?:DLEHDD<<HF4, M4<DE3A0,9)/3.>_2@#)T[6M2UO4O =Y<71C^VPW4DT42@(71, \Y[$C^5>CL M"4(4X;'!(S@URUKX"TZSBT>.*]U$#2FD,!\\ D2 !E) Z<=L5U5 'E<?Q!U2 M"+3!?SVZW$>J266IQ+%C8BNH$@)/RJ-Z D]=W6M+5?$VN6_AVQU>.6V\J^U9 M8X5>W.X6S.0AY/WB &SC^(5T=[X,T2__ +5,UK\^J*JW#@\_+C!7T/ /U J; M7/#5GKVF6UA-)-;PVTT<T?V<@$%/NCD'B@#E-2??XI\;+Q\FA(O!S_!(?PZU MU'@V)8?!.A(F<?8(6Y]T!/\ .HKKP?97-]J=Z+J\BGU*W-M<LCKADV[1@%2 M0.AK5TG3H](TFUTZ&666*VB6)'E(+%0,#) ':@##U'5;^_\ $%WH&D745I<V MUF+AII(]^YV)"* > !C+'!X( QUJJNL:S>^(8?#BW-O:W<.F+=7=U'%Y@:4D M+M0$@!=V2<\D<#;UK1UGP?8:SK%MJQN+RSO[=?+$]G-Y;/'S\C<'CD],'WI@ M\%:=;3VMSIDUUIMU;P&W$]NREGC))(<.K!CN).<9SWH YG3?%_B/6UT"&U?3 M[6XNI;FWNFDA:1=T(!W* PX([>O>D_M+7]4&CVLVHK#=0:]-932Q1[5G6-&< M,5SZ#IG&:ZR'P?IELVFM;&> Z<7:'9)U9_OEN/F+=\U3C\!VJ*^[5M4=VOC? MB02HC+*00V"J# 8,0?TQ0!%?Z]JMEJ/B:!/L;&PT^.]M6:)NGSY5\,,D[.H( MQGI6?IGB;Q')K?AZWOY=.9-:LI+A8X(&40D(&7)+$MU&>E;USX0M[G4-6NVU M*_4ZG:BTFC#(51 ,#;E20>6[GEC4,'@>UM[O1+E=2U!I-(A,$&]HSN0\$-\G M/''&.!^- &99^*-9.B>%;NY:U:;4;\VMT$C.TJ?,P5YX(""H-/\ %?B3Q"]M MJ&BZ?OT]KSRY$D6( 0@D,2_FE@_3C;CD?4WX/AMIUO':1)JNK^39W0N;:+[2 M-D)!)VJ-N,?,??WY.;-CX"T[3-1>XL[[4X;5I1,=/2YQ;[P<YVXSU&<9Q^% M&]JD\EKI%[<1'$D4#NAQG!"DBO._"GB?4_\ A&_"]E+=H]]K<MQLN)(=PA2/ M<6R-PW,3C!X'/3C!],G@CN;:6WE7='*A1QG&01@URUO\/M/M].L+5=0U!I-. ME\RRN6:,R6_3*K\FTJ<<@@T 3>&M8U&;6-5T'5<37>GLC+=QQ[$FC<97(SPW M7(Z4[Q=K&J:0VCC35M6-[?I:.)PW\2L000>/NG/!ZUJZ9I,>F^>_G2W%S</O MGN)MN^0@8&=H 'XDFN?^(%E>W\&A1V"W7F1:M%,\MO%O,*!7!?!&." MPX/7WH P]6\<^(]'M_$=O<0Z6]]I203))''((Y(Y" <J6R&!([XZ_CK6VM^( MIM5L]"NIM+BU"YMWO#/;PNR1P@J%&UFY8L6[X %7=5\$P:KHE]82ZA<^=?NC M7=XRH9)0GW5P % &!T _4U/J'A1;NYL+ZVU*YL]3LX?LZW<:H3)'W5U(VD9Y MZ<&@#FKKQIKRZ%=72QVD#Z9J?V'49FA+*4W*/-C&_CKRISUZUH>(?$>IVVB> M(K^S33[BULC%#;B9"5E?($H.&YY8*!Z@CFMV'PQ81Z#=Z3*'N(KPNUU)+@M* M[_><\8!Z8P.,#'2JUSX/M'\%_P#"+V<\MI9^6(MZ ,Y&<MG(QECG)]S0!2U+ M6-0O[G5M'L7M(WL+ /=/<1,QD>1"55%## &23GJ!CO6#H_B:]L?#_AS1M+M MI)KEM)6YEV6OGE4^ZI \Q/XLYY/;UKI+CP2DNI_VC#J][;74UH+2[DB$?^DJ M!C)!4@-[@5 ?AY:0V6FQV.J:C:WFG(8H+U74R&,DG8PQM91G@8["@#=\/76H MWN@VEQJUK]EOV4B:+&,$$C..<9 !QGC-<[XS\3ZKH7VM[62QB2WMA/'')$\\ MLYSSE5(\M!C!8_I76V-FMC9QVRR2R[<DR2MN9V))))]223QQZ8KF]6\"0:KJ MFI7G]K:A;)J5NMO=10E,.J\8!925&.H&._K0!6O/%&M-K=W96,-@D<6D+J*O M.68Y)/RD C(X(XZ=?:H[/QK>/<^';N_-E:Z3K%LS;BIW13!0=A??C!Y(^7/& M.O-:,/@UH;VXN!K-Y)YVG#3]LB(?E&<,< 989;TZUCW?AM#HMCX';3[^^M(W MCD;4)$18XD#[B 0<[MN5X'\76@#J?#5YJ&HZ2+Z_\@?:)&DMUA0J!#_ 3DG) M(^;_ (%TIGBK5#I>A2-'.D$\[""*5P2$9NK8'7:H9OPK8BB2&%(HE"1HH55 MX '05FSZ/+<>(K75&OY?*MHV1+78NS+#!;/7/'Y9]30!QWPVOX;275_"T%]] MH6SE,]C+(I^:%^>AP3M8G/3DU>L/%.L3V-U9W L1KT>J"Q6..!_+5>#YA4OD MC8';(([5L7WA=;OQ;9>(8KZ6VGMHO):.-%(F0DDJQ(Z<_AVJ=/#5BGBN3Q"- M_P!KD@$)7=\@Q_%C^\0 /H* .=O?&6IV7B:"RDCL4MY-32R, 5I)5C8?+*SJ MVU=S8PI&<&H-5U3^T/#/CU9K*WMS:^;!YL?6;$0P6/=N1^@&:NO\/225C\1: MFD U :A'$1&P27=NSDJ21GH#Q[&K<O@J.>Q\0VDNH3&/6I?-<!%'E'I\OKP% M'/I0!E:KXFU/0="MGM5L5B@TR*X47"O(]P0/F550@H ,N01EATZTR6YU27X MAW,^CV]JUS+H4,F+ER%'[QCC@9)/3/&.OM5Z?X?^<USMUR\B2[LDLKE4BB/F M(J[1@E25]\>]6XO"%Q:7MO>V>MW*74=DME))-$DGF(I)!Q@889.#[#(/.0#" M_MG_ (2#5_ ^I26OV:X-U=Q30DY,;K&ZLN?JM6AXSUN_NA<:/HXN]-2\>W?: MC%I$5MI=7R%'0G!!R,<BM9/!5G:QZ''8W,UNND2O)&<*QE+@A]V1U.3T]>*@ ML? R:=>77V75[V+3;JX-Q+IZ;0FXG) ;&Y1D#.",CB@#I[FVBO+6:VG3?#,C M1R+DC<I&"./8UP5QI=D/C%IMLEM$EO#HC[850!,>8RX(],$UZ'6')X<63QC# MXC-W()(K4VH@"C:5))Y/7.3^E '/ZAXAFT2[;PYX7TSS7TZ-&>-H9)5PP+*@ MVG*YP!N.0,CW(G'B7Q-=Z@VFVVCV-M>?V8E[BZN&.QV8KM8!>>58=?0Y[5=U M/PE-<>(6UK2M9GTNZFB$-SY<2R"91TX;@,.F<5/#X7:TU87]KJ,RM_9WV$^: MHD9B&9A(6/4Y8DCO0!EZ=XRN]?.EV>E0VT5_<Z>-0G-R&:.--P7:H4@DEL\G MH!GGI4$'CK4;NWLX[?2K<WTFH3:;/$]R0L<T:EN#M.5P <]>V#UJ73OA_)I, MNDW=GJ^V^TZ!K;S7M@4FA.2%90P/!)((-7(_!26YT][>]V36^HR:C/(803<2 M."&[C:,,0.N,#TY .@TW[>=.@.J"W%]M_?"V)\O=_L[N<?6N8U#Q;J3G6+C1 MK2VGM-%=DNEG9A),RKN=8\<+@=SG)XP.M=E7)S>#YTU#57L-16WL=8YO;=H= MY#$89HVW *6!YR#0!F:A?3ZUXK\(S6R0FSOM/GG\FY!(PR(3N X)PP'XFNXM M[:"PLH[:UB$<$"!(XTZ*H' %8?\ PBD<6OZ-J-I=&"#2[5K2.U*;@R$8^]G( M( 'KTK?G1I;>2-)#&[*55P,E21UH X*#XAW-UHM_J]O9VCVUK9&=HQ.?-BF# M >5(I ([G<!@XK<OO$LVE7J_;H819?V9+?,\;%G#1E-RXQ@CYQ@UEP_#QI3? M2ZEJ$5Q=7.G-I_GQ6VQG4_\ +63+'?)P.>.E2'P)=W)MUU+Q#/<PQ6,EB\2V MZ1AXW !YY(/RJ<^H'N" :-E?ZSJ,D45_HUL=,O+0R-,D^X1Y'^K92/FR".1Q MUKE_!'B:\TW0?">FW>EQI;:B'A@G2YW/\HR&9-@ !_WJZ#0O"VL:5##!=>)9 MKRWM59;6,PA1R"%\P@Y<#/ R!T]!1;^"$@@\,Q?;V/\ 8;,RGRO]=D8YY^7] M: .K->"Z%;Z6/ NO9\+W-Y=K-<K%?16J,(#M&W#9W +P>!Q7O1S@XX/;-<CI MG@^_TKPY=:+!K,/E7#NQE^QG>H<G<!F3'?CCCWH R]-\8QZ/X=\.Z?\ :HM4 MO;FW?-Q&TDBCR^,_*C.QSQT'0Y(QS;MO&VKRRZ/:R>'#%=ZC)-&%FG:(*8QN MW ,F2I4YZ9ZC!I+CX<16MOHS:!J,FG7VE*4BN'02>8C$E@XXSDD_F?PU!X9O MAJ>D7[ZPTT]E+,\QEBR)A( "H 8! !@#/3)SSD S]*\=2:DUO9C3XQJ<M_< M61B$Y\L"$ N^[;G&"N!CDGZUG^([S4;R7PU=W>BK:W\.MF&*%IPP==C<A]O" ML0#T[4G_ K2_5C<P:ZMM?Q:C-?VT\=OD(9<!T8%OF&%7'XYSFMR\\+:C>)I MDDVLB6\L[Y;R21X/E<A=H55#?(N,^N3S0!5NO&]W;:=+.-'CDN(=5&F/"EUP M6.W#*Q09SN'4#%$_C/5;?^W4?P_%YNC1B:<B]_=NA3>-C>7DMC/&T#CK5.?P M#J\MU?2KK=JJ76I1:B$-HQ\MT.0!\_.?ES]*U;OPMJ-S)XE)U&WV:S;K H-N M<P@)L_O<\%C]3^% $&N>-;G3+*.]M],B:T:Q%YYEU="+?QGRD #%GQSZ#\:? M/XOU%M4L;#3M"%U+>6 OE\R[$6Q<J"&RI[M5!_ >KLP9-?B5VTM=.9FL]Y0 M8W1Y;Y-PZCGJ?;&K9>&-1MO$6FZG)J-NZ6FGBQ>-;<@R#@EL[N/F [=* ,3P MOJHL+W6=&TNSMY[]M7N)#;>=Y20Q )EV(4X&>!QR?H:]#7<4&X -CD Y -<$ M? .I)JQU:WU2S@U 7[723)9G.QP0\3'=\RGC'<<^O'=Q"00H)BADVC<4& 3W MP#VH Y+4/&\EGHEQKL.EF?2K>Z,#OYVV0HK[&D"[3P&R,$@G&>*M1>)KZ[\1 MW6EV6C":*V$#O<M=*H,<H8[@N#TV]._MWI_\(1<OI6HZ'+JBMHUY<-,(Q#B6 M%6?>45LX/S9Y()YK3TK0+C3O$VJZHUU$]O>QPQI L9!B$0(4 YY')SQUH L> M*-9'A_PSJ&JD*6MX2R!CP7/"@_5B!7">(8Y]/T_P1,PDO+V74XKB?:PS-,ZY M;&< #)P!P ,5W?BC15\0^&=0THD!KB$A"W0..5/_ 'T!7-6FGS^*] T";SA: MZGH=S&;B&:(X\Z- &0CC&<@Y&1@]Z %?Q!/XBT?Q'93V4NDZQHP\U0)1)L8* M7C<-@9!QR,<@^]=%X3UEO$'A73M4D $EQ"#(%Z;@<-^H-8]YHTVG:?XBU$QB MXUC6HQ"(H 2FX1^7&HSV[LQQW/ %;7A?1CX?\,V&E&02-;Q;68# +$DG]2: M*/B7Q6_A\RE=->>*"W^T3322>4FW.-B,00TG!.WCZUC23)?_ !7TUE9FM[G0 MF?;N."&?KQ[8Y%6O$GA#5=;U:\ECU*U^Q7-D;5(KB$N;8D8+QX(Y([GU[@8I M;;POK%OXDTW5S/8R&TTL6+)\R[VZ[NG SC\* )?AD/\ B@-.8DEF:8LS$DD^ M:_))KKJP?"&BW7A[PW;Z7=RPRO S[7BS@AF+<Y[_ #5O4 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %<EK7C(Z3XPTO2?)4V4[B* MZN3G$4C@^4GIDE3^!'2NGN[F.SM);F4.8XE+,$0LQ ] .2?I7G4_AN77O .H M7]QJ%^EQ=F346M_LX&R91\J ,GF8&U5P#SCC@T =W?ZYIFEW5K:WM[%!<73; M8(V/S2'(' ^I%-NO$&DV7VO[3?P1?8R@GWMC87&5!]R.@KC+^>]\7> K75XM M.N(=>TJ5+I(9;=E)E0Y8+N W!ASQ[#K2ZTEUI^B:7=7FD-+>75\;N\FBMOM, MEDQ!VE1C!91L0$\?+G!H Z:_\0V4OA[^TK#6K&W@>0(MW.-R9#?,NW(); ( MIBZM>CX@/H[O$;+^RQ=J F&#^9LY.>1@5YM?V]X_@/Q-:-IVI&9]<$\7GVS> M9*K,IS@#&<*2<>M=5J\LTOCR_DMM.N+L/X<>)%,3HDDF\N(RW&"01W[^M '0 MZCXDM)-!U6YT?4;.>ZM+1[@!7$@&%)!(!Z'%.\/>)++5K2R@:_MI-4>SBGG@ MC<;E+*I)QVZ]/>O/;+^U-1U+49?L&J-'=>&GM5:>P:)5F&XB),# 7!.,DY]3 M6II-@FHS^"Y-/L9;:72XC]NEDLVBV 1;2A+ 9);/ SW- '3>&/$PU/1KV\U" M2*'[+?S6K.<(GROA<<^A4?6MNPU.QU2 SV%W!=1*Q0O#(' 8=LCO7DDEI>S: M'97,=IJIM+'6;F:]BM4>*8H['8\> I; .<@Y&?3IW7@BSL((;^XTVQU&VM[F M4,SZ@S^;,^/F;#\XY SGDY].0"7Q+>>(K&VU*_L9+""RLK-IU$T+2O,ZJS,. M'78. ,\]33/"E]XBU+3[#5=4N--^Q75IYS1Q0M&\;'!7DNP(VYSTQQ5OQI*8 M_!>LJD<DLDMG+"D<:EF9G4J .>]<U-:7^H?!&&SL+>?[<MA#'Y#*4<F,KO7 M'7D*WUS[T =@GB/1)8;F9-6L6BML&=Q.I$6>FXYXJ:UU?3;ZYEMK2_MIYX@& MDCBE5F0'H2!TKRFXAT^\\/ZO=V.CZZ;Z;2V@GDU S2%6)4I&@?)<[@>1T"]L MU;U"QDGU#3(=#@N;2>;P]+;HX@D0*Y **QQ\IX;D\CKZ4 >CV^OZ/=WQL;;5 M+.:[!8&&.96?Y>O .>*4Z[I(<H=3L]P5W(\]<A5.&/7H#P:X2-7U2V\&IIEA M-;76ES1O=B6U9/(B5"LB[BN#GH ,YZ^]5=%M++_A6]Y]MTZ[AFDNY$>:VM6% MRJO-E7Y7<< @\9X'Y 'I>GZG8ZK;FXT^\@NH0VTR02!USZ9%+>:A9Z=")KVY MAMXB=H>5PHSZ9-<UX%&HJ-56_A@91.GE7T4!A-V-@^9D/1@, \=<CM4&N?:[ M/XD:)J$T,TNE?998-Z(76"8G.YL=,C S]: +_BCQ?:Z)X935+2XMIOM$B16S MEMT;%FP3D'D 9/4=*O\ A^;49[6:6]O;&]@>4FTN+0$;XNV[MNSGIQ7FFJ:5 M=P>$K^6.VN1!>^(1=6MN(7++#NSNVXRH."<8Z8]:]A4AE# Y!&0: *$NNZ3! M?"QFU.TCNST@:90_3/3.>G-,'B/1&M8;D:M9&">3RHI1.NUW_N@YY/M7!H+J M'QHCZ9!<313:P_VFRO+5V2 C(:YBDP ,C/?N!S@5G6TUQ8^'AI;Z1J,EQ;>( M5N)52R9PL0G#;E.,'(&!MS^1H ]1N=:TNSO$L[G4;6&YDQLBDF56;/3 )]C6 M-8>*!%K.M66LWMA;I:WB0VS$^7O#H' .YCEOFQQZ=*Y;3%$5SKNC:]X?O;^: M_P!0-W Z0';,AP8\OP$VX[D8Y%5/$MM%=6WCZ1-/FENYY8(X'^R.6<*J*0IV M\C<IZ<<9H ]<K@])\0^)M:U3Q!;V\^E1#2)S JR6SXF/S<EO,^3IZ&NPTEM^ MCV3<\P)U&#]T=0:\MTNRTR35O&J:[:7Z17=XYA=+>?+KELE=@Y[?6@#O] \4 MVNK>%(-=NC%91$,)C)( D;*Q4_,>,9'!K3AU;3KBUANH;ZVDMYFV12K*I5V] M >YKR&WT[Q+:>'O#%QJ]M>/IEC=2J\-NA2XBA90D;,J\Y'S'UP1GK6E<VNBP M0:6UCI>H?9'UU;F5KJWED:10C!Y-I4E5R5Z@9QTXH ],MM6T^\M9;JVOK::W MB)626.4,J$=02.!BL/7O%20^&I=5T*ZL+T0SQ1R$2>8H#.JG[IZ_,*X;7+>X M@NM<;1].EFLH=5L[U[2*!]MQ"B+Y@48PPWXR.G'M5SQ1=Z5J7A;4[W3M$NTA MN+NU::XDB9 \BN-W[L\D*H()Q@D]R* /2H-4T^ZCGD@O;>5+=BDS)*"(V'4, M>WXTS^V=,#W"?VA:[K90TX\Y<Q@]"W/ ^M>5^(ELX9?&UO8VR1PSZ;:F)8;< M["PSQA1PW(^G4]*T!9:?-\0?##1:?!]B;2'DD86_RN2#@,,8R,9Y_P * /19 M=7TV'3EU&6_MDLF 9;AI5$9!Z$-TJ5;^S:WBN%NH##,,QR>8-KC&>#WXYKR; M0YH(K'15:PN$B2^OF6[%K+(+4%C@"(#&6# L#CGBHK.UL[O0/ ]I>6[&.+5 M)TF%Q;D @,W!4C 4DH,=.<=J /0K#Q.M[XGOK%9+1M.ALH[J*ZCDSN#%@<GI M@;370PS17$2RPR))&W1T8$'\17DOBB*72?&-V^G6:'3[:RMS<:='%Y:7$"LY M=5(&."5)4<$$@]P?3](O;;4-)M;NS0QV\L89$*;2H/8CL1TH DFU&RM[F*VF MNX(YY2!'$\@#.>>@ZGH?RITM]:0L%EN848R+$ S@$NWW5^I["O(_%]S!<W6M M[+22UEM=2MG9?L\DDMP%(!EW<A4 Z!<?^/8KH;.SLK_Q]XGF@LK62[2VMIK- MIX!E9@C?,-PX()3)ZCC- '<C4;(WS6(NX#=JH8P>8-X![[>M6<UY)X,M-,N; MG1S?G6YO$%G/()+:4'9"_.]V)&-O?[V2>.37;^/HM3G\#ZI'I.\W9BX$?WF3 M(W@>Y7=[T ;EMJ%G>-*+:[@F,3%9!'(&V$=0<=*E6XA>5HEE1I% 9D# D ]" M17F^I6^G:K?6NIZ/#$MG'HMRM\ !A5*#RHW']X'=P>1BNE\"V&FV_A73+JTM M8$N9K.(7$RH!([A1N#MU)#9Z]* .D::-&57D168X4%@"?I3?M$!&?.CQN"9W M#[QZ#Z\C\ZXWXA6K6O\ 8_B.UL3=7>FWBAD099X7!5E'KR5^G-9G@O1+RUU8 M:/>VL26VBRM=H4!*M+,@VA2>H7,H_P"^: -_7_$.K:)X<UC4UM]/F:RG(C03 M-_JL#!; /SY/W>..]6(O$-TWQ ;P\\$0M_[,^VK*&)8G>$P1T'?]*X+4%C7X M8^,X($0;]9F\F-<C<IF4KM ZC ..W'I740HS?&1)E5C$?#P <#Y2?/SUH [9 MG55W,0 .Y-(LL;G".K'V.:Y;XDI!)X U5)T#DQ?NEQDF3(VX'KFN.U.S;2O% M=VOA>!+<S>%B;?[.,"202<$$?>?8,COQ0!ZTLJ.Q574D=0#FJ6N:@^E:%?:A M&L;-;0-*!*Q"G:,\D G]*X738["]U/P9>Z%'&LL:2+??9P%*(8_F$N.^_L>I MR>:ZOQRRIX$UTLP4?891DG')4@?K0!?T?4?[0T'3M1F"1-=6T<S*#P"RAL#/ MUJ]YB8!W+ANG/6O,='N[-[SPP-5:&31G\/QI"\^# MR,!P2?E#;1CGG@BN?& MF0VL?A:.^6,6\FORFS65O^70D;1S_ 3SS_>]Z /;A(K+N# KZ@\4+(KC*,&' MJ#FO';C4+'3]"\9V^G3VT45KJT+K;(VV-HRR I@<!6(8'MUS1=PQ/I7C#7-" MN+$W]S#$([.PG65X(P5$C?(>-V#T[ 9]* /81+&P)#J0.I!Z4X,K9VL#@X.# MT->*:N/"EQX?U?4M+NY[IGTX0R%84@@A(=&0,%1?WA/ QDX!["O6M$TW3M.T M]?[-@BBBN,3,8N1(Q ^;/<D8YH J6VO2S>,-0T5[9([>TMHYA<>;RQ<D8(QQ MT/?M[UMLZHNYF 7U)KSG5['0KGX@ZT/$/E+;/IL/E?:)"BM@MDCD L.,=QVK MG+2[N]/MO"4/BNXGM]-FL)8Q--$LBI*7.T.)%8#]WM&2.A/09H ]J!!&1TH9 MU098@#U)KGO!%K8V?AB&'3)[R>R$DGDRW6-S#<>5P!\N<XX'%<Q<:99:G\7= M42:TANV@TN.:.*3E1,&&"1G&<8Z]J /2-P! R,GH,TF]<@;AD]!FO%O#$>DZ MR-+EU36+U?$%O>@RVL=L%N"Y8Y#N%WLF,9).%''I266E64V@6EQI<TJ>((M= M>*W8RGS@IE(*N.PV L<CL?4Y /:\@$#/)I ZDD @D=0#TKR>PTZUGD\:ZAI^ M^?7=/O+AK)5F9C%F/ *IG!).X#@\C':H=*_X1U=+DUR'7KC[2^F2QSBSMDC: M-2N"TH4 E@V,,2"3CDC) !Z\LB.2%96(ZX.<4;UP3D8'4YZ5XG)+<:;X<UZW MTR&U^UP16GGW^D#='/ ';+,HZ/C.[.<C.>*9KL6B0>$O$%SI&N->&[2W+I!" ML,"-YJ#HH #E2V1UQN)% 'M=Q=06MM-<SRI'#"I>1V/" #))_"BVNHKNSANX M6S#-&LB,>,J1D'\J\O\ $%KI-CJ/BC2;8HD%QX=-X(/-)#S(9#OY/+8"'W S M3;F\T9[7PUI,"::KG3&F#73#[(&*A6)1?OR94^A'/>@#T^74+2"\M[26X1;B MYW&&,GE]HR<4VUN+B::[6>U$*12[(F\T,95V@[B /EY)&/;/>O)_#%YI]_>> M![O4FLG>.QN83+-@X:-U$?+?Q#J/3<<8S6U9:98^(X_'6BPS#S&ORR$,<QOY M:@-SVWJP_ T >D;AQR.>G/6EKR>VO-0U?P+?7Z6<EO=Z)IALK=MI5TF"@3LN M>X"J 1S]X5<\#+I$^KZ=>V6OF[O)+$B:V@A5%&,9,V!DMD\%N30!Z94<\T=O M!)/*P6.-2[L>P R37*?$&\DL],TTR.\>FR:C#'J#H^TB$YX)[*6VYYZ<=ZR4 MCAL?%/BB"W9(] _LE9)TCXBCE(/W<<*2G) Y.1[4 ='X<UW4];*W4VEQ0:9< M6ZSVMQ'<AR03]UUP"&QSQD#IFM:XU"-'N;>#;/?00>=]F#A68'(7D\#)4C-8 MG@"TLK;P/H[V<<(,MI$\KQ@99]HW;B.I!R.:HV?V%?B?KIEMX(KD6%N8I"H# M2#]YN8$_\!'_ $>E &[X6UW_A)/#=GJ_P!F^S?:58^5OW[<,5ZX&>F>E;%> M.^&+:TM]"\!:I%)(M[+>M;NSW#-F,K("N"<!<JN!CC/OS'HCV>L31WFH^()K M+Q!;:@QEM8XAYYD,A4(,Y9DQ@;?N@#H.20#V:C-9VO()?#VI(R[@UK*,>ORF MO-M.\007&J_#:"/55=A:S"[03_Q&%0H?GKN!QGO0!ZUFL3Q7XB'A?0GU1K1[ ME4D1"BN%QN.,DGZ^AKS70_)_L#PKK<FH7#7W]MFWDEDNV($9:0%,$X P%X]_ M>J&N7UMJW@G7+W49P=<BU01/&[E6AC\Q0J!2?NX7/U!/44 >Z4R1]D;N%+%0 M3M'4UY1?7]CK&O\ B"VUG7_[*N+>X7[&RD[_ "=JE#"0>2V"< $G=WK5\.Z6 MNH^)]>GN]1U&Y:PN8_)W74BJ"8@S93.!\Q/R]!TQ0!UOA?7H_$_AVTUB*!H$ MN-^(V;)&UV7K_P !J]J-U<6EA-/:V4E[.H^2WC=5+GTRQ 'UKR71[:5_@QHV MK6;.]QI$LMPT*R$+)&)F+HX'7Y>>?ZUI^()[C4/!.M>)8Y[NVCNYX!9[)GC) MMQ(J D9X#[G..."M 'IZ,61692A(!*GJ/;BG5Y[K-H]SX]U*V.H7Z6PT$7'E M173(N[>R\8.0/E!X(SWR.*RK+5[R\T3P4=2GGN+*[@G%S%')MDE=!A6)R"0. MIYZX.,XH ]7HKE_ %EJ-CX3MTU2ZEN+IV9B9)S*47/RKDD]!CBNHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **I:O>OINC7M]' M$LK6T#S"-GVAMHSC.#CIZ5R]IXG\13?V&SZ78[=7MRT:B9P87"!\N2/NE<\ M9SQGO0!VM%<=;^*=3DT&:XEMK*.ZM]2>QN)6EVP1*K8,OS$$C&/ESDDU4N/& MVJP^&X=1BTZTGG&I_8)5$CHK?/M#*"N>??I[T =L;NV6[6T-Q$+EE+K"7&\J M.I"]<>]35Y=<ZQ)HGQ%M+WQ!;6<6HSZ2\44=JQ*R2&<!!N8#!V@\G@?I71:K MXEU311965U!;RZI>L[1K:P32I'&B@DD*"S') XQUSVH Z^BO.;7Q%XKU+6/# MJ7%I#IHN)KA9(98Y%,@1,[BIP0"&R >XKT:@ HJMJ%Q+::?<7$-L]S+%&SK" MA ,A ^Z"?6N/M/'-W=7.H6L5I97,]KIOVY?L]R2I;)!C)V]1ZCC^@!W-12W$ M$#1K+-'&TK;8P[ %SZ#U-<=:^-[H-HMQJ-A#;6&J6LMR)%F+M L<8<EQC&"/ M0YY%9FJZA<:]?^"M1FL+>*SN=0$L#;R9E&PLH/ P&P"0#C@=: /2:**J:IJ, M&D:5=:C=-B"VB:1\=< =![T 6Z*X§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end </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>16 <FILENAME>pinnaclelocrenewal4thloa006.jpg <DESCRIPTION>GRAPHIC <TEXT> begin 644 pinnaclelocrenewal4thloa006.jpg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�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�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ţ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end </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>17 <FILENAME>pinnaclelocrenewal4thloa007.jpg <DESCRIPTION>GRAPHIC <TEXT> begin 644 pinnaclelocrenewal4thloa007.jpg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end </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>18 <FILENAME>pinnaclelocrenewal4thloa008.jpg <DESCRIPTION>GRAPHIC <TEXT> begin 644 pinnaclelocrenewal4thloa008.jpg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end </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>19 <FILENAME>pinnaclelocrenewal4thloa009.jpg <DESCRIPTION>GRAPHIC <TEXT> begin 644 pinnaclelocrenewal4thloa009.jpg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end </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>20 <FILENAME>pinnaclelocrenewal4thloa010.jpg <DESCRIPTION>GRAPHIC <TEXT> begin 644 pinnaclelocrenewal4thloa010.jpg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˗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end </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>21 <FILENAME>pinnaclelocrenewal4thloa011.jpg <DESCRIPTION>GRAPHIC <TEXT> begin 644 pinnaclelocrenewal4thloa011.jpg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end </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>22 <FILENAME>pinnaclelocrenewal4thloa012.jpg <DESCRIPTION>GRAPHIC <TEXT> begin 644 pinnaclelocrenewal4thloa012.jpg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�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�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�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end </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>23 <FILENAME>cpix-20210930_htm.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <XML> <?xml version="1.0" encoding="utf-8"?> <xbrl xml:lang="en-US" xmlns="http://www.xbrl.org/2003/instance" xmlns:cpix="http://www.cumberlandpharma.com/20210930" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"> <link:schemaRef xlink:href="cpix-20210930.xsd" xlink:type="simple"/> <context id="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="i997bd44925334429a7698804c0800bcd_I20211108"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> </entity> <period> <instant>2021-11-08</instant> </period> </context> <context id="i5fc3bb3df16548c98cacace445d903da_I20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> </entity> <period> <instant>2021-09-30</instant> </period> </context> <context id="idb172cb6365440839665fd6ec022472c_I20201231"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> </entity> <period> <startDate>2021-07-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> </entity> <period> <startDate>2020-07-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> </entity> <period> <startDate>2020-01-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="ieb58760ea84940319b35492cd1910735_D20210701-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cpix:ClinigenHealthcareLimitedMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-07-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="ifca7f9fa06d14f85a52cbd81ac170d2c_D20200701-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cpix:ClinigenHealthcareLimitedMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-07-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="i45bdfab35dd74d60ac86fc023b908b73_D20210101-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cpix:ClinigenHealthcareLimitedMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="ib8c8802e62b74a919450a1c6017bba7e_D20200101-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cpix:ClinigenHealthcareLimitedMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-01-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="i6fa410e0219e41c3b8a23d8140a1ca8c_I20191231"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> </entity> <period> <instant>2019-12-31</instant> </period> </context> <context id="i1ae7216a773d47d889c5f34d67e867fe_I20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> </entity> <period> <instant>2020-09-30</instant> </period> </context> <context id="i90ac8e9aca0748058577add35fc3a6f9_I20191231"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2019-12-31</instant> </period> </context> <context id="i7f67242cec184569be979f0eab3bb2dd_I20191231"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2019-12-31</instant> </period> </context> <context id="i1925af7a08774bc4a2752a9cd6b75c35_I20191231"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2019-12-31</instant> </period> </context> <context id="iaf2c0f582f1a48b1b7132666868a1789_D20200101-20200331"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-01-01</startDate> <endDate>2020-03-31</endDate> </period> </context> <context id="i4167fc9dfbd441ed853e3173c4f077bf_D20200101-20200331"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> </entity> <period> <startDate>2020-01-01</startDate> <endDate>2020-03-31</endDate> </period> </context> <context id="ic4f1350ea2fc4eb18dc553f1c359d775_D20200101-20200331"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-01-01</startDate> <endDate>2020-03-31</endDate> </period> </context> <context id="i94a852cb675745e89723e30ec61bfcee_D20200101-20200331"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-01-01</startDate> <endDate>2020-03-31</endDate> </period> </context> <context id="i98ca8db1bbc14991a38ad2f127cdc3f7_I20200331"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-03-31</instant> </period> </context> <context id="id9ade7c2b96049c891663efff729f1ef_I20200331"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-03-31</instant> </period> </context> <context id="ia79d5a078419401d86bc7174c913bcf6_I20200331"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-03-31</instant> </period> </context> <context id="if8cac0f57d4c4aa1bf61accf6f74bfda_I20200331"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> </entity> <period> <instant>2020-03-31</instant> </period> </context> <context id="i62b7e40824ec46c1a5d32166d46d8910_D20200401-20200630"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-04-01</startDate> <endDate>2020-06-30</endDate> </period> </context> <context id="i374ad433cb0d4675ae41fef76147919d_D20200401-20200630"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> </entity> <period> <startDate>2020-04-01</startDate> <endDate>2020-06-30</endDate> </period> </context> <context id="ia7d9f053c7b34fd799481310c6ca1498_D20200401-20200630"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-04-01</startDate> <endDate>2020-06-30</endDate> </period> </context> <context id="i06622f546c724e4289669409575c7f9d_D20200401-20200630"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-04-01</startDate> <endDate>2020-06-30</endDate> </period> </context> <context id="ib5c699d5da91427e80a66ec6b1991b3a_I20200630"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-06-30</instant> </period> </context> <context id="i70a1ecea99f7485195b3405682bd0c55_I20200630"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-06-30</instant> </period> </context> <context id="i9fb60215b0504a758fcf2dfe00ea4b97_I20200630"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-06-30</instant> </period> </context> <context id="i00b5fc7364e347f39acdca8004cef0f9_I20200630"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> </entity> <period> <instant>2020-06-30</instant> </period> </context> <context id="i786c6ae7dd8d4840bb2995fce1423b07_D20200701-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-07-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="i8c344dec4461400991796893b71c39f3_D20200701-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-07-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="id1cdf0875abf4833a9b0038791a1ea6c_D20200701-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-07-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="i1e43169536834b7daa78040307754845_I20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-09-30</instant> </period> </context> <context id="i1adc976609fe48d4b014ec48f05e022c_I20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-09-30</instant> </period> </context> <context id="i169b3e774913430bb6c450a8d1cd8300_I20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-09-30</instant> </period> </context> <context id="i659fa119f70c4793a43053cddb879d71_I20201231"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="i50909170032a4c00a004f6dd1808751c_I20201231"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="i42e8ab4712444a43a1f231cb65ac3dcd_I20201231"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="idecbe529c8e14131b56433eb5e130916_D20210101-20210331"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-03-31</endDate> </period> </context> <context id="i5c8473bff64c498ab624fafa4cca5132_D20210101-20210331"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-03-31</endDate> </period> </context> <context id="i781a96ef93c24d05bb7f12625a033ec0_D20210101-20210331"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-03-31</endDate> </period> </context> <context id="i38154999f15f41cca19a77a5f4d0ccac_D20210101-20210331"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-03-31</endDate> </period> </context> <context id="i9d845908b01747ac9d721fff45f53abf_I20210331"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-03-31</instant> </period> </context> <context id="i32deafcb20a948cf995118abdf3ce1a4_I20210331"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-03-31</instant> </period> </context> <context id="i2593ac397b63496686231e5a4d277b3b_I20210331"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-03-31</instant> </period> </context> <context id="i8320ae6bb40c49b4b91522210805d996_I20210331"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> </entity> <period> <instant>2021-03-31</instant> </period> </context> <context id="ief227cab10a245ff9baa903632237a80_D20210401-20210630"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-04-01</startDate> <endDate>2021-06-30</endDate> </period> </context> <context id="i83fce5d3edda4b1cbab16d0e4a53c979_D20210401-20210630"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> </entity> <period> <startDate>2021-04-01</startDate> <endDate>2021-06-30</endDate> </period> </context> <context id="ibe562d54463741e8949d25484a516053_D20210401-20210630"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-04-01</startDate> <endDate>2021-06-30</endDate> </period> </context> <context id="i1f91139b751f41ee943e86bdb734f2f4_D20210401-20210630"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-04-01</startDate> <endDate>2021-06-30</endDate> </period> </context> <context id="i7ea7194dbc454dbdbc6632db38bf6066_I20210630"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-06-30</instant> </period> </context> <context id="ic49c90ad54954ba9a5f89e54eb1dfedb_I20210630"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-06-30</instant> </period> </context> <context id="ie1e3b4d188524c1791c80059e8f7515a_I20210630"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-06-30</instant> </period> </context> <context id="i64b2d71ddb0c448d9959f1b9a74a7dad_I20210630"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> </entity> <period> <instant>2021-06-30</instant> </period> </context> <context id="i10df7b4f9a35418da7673ef6ae315d51_D20210701-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-07-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="iae1347d2d1d84aa3a135e3245bdf0d90_D20210701-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-07-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="i9cc79eb883d54f61bdec225f436b82c9_D20210701-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-07-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="i56aafc7718c145c8b150a8e54f33a5d2_I20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-09-30</instant> </period> </context> <context id="ib1da3f9dccc043f1b509c4e381803002_I20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-09-30</instant> </period> </context> <context id="ied663adb59564577989ed6d27ea6493f_I20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-09-30</instant> </period> </context> <context id="i2b064560ae764b05aee16232fc2b982f_D20210701-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:AcetadoteMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-07-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="if9189ef3c405466780ff2b301ce69072_D20200701-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:AcetadoteMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-07-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="ib543c8c5c4a0438eb3b83a9549c72767_D20210101-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:KristaloseMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="i851181d1e03446adb4d2b6f666a489e7_D20200101-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:KristaloseMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-01-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="i343ad32279094a2585bfa47056ea0769_D20210701-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:OmeclamoxPakMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-07-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="idf76fee1053a41f897bb2b308eda43b7_D20200701-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:OmeclamoxPakMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-07-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="i0a175b2126f3439e978ef755a5187703_D20210101-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:VIBATIVMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="i1221e6e62b0d4437aa038a1593455cdb_D20200101-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:VIBATIVMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-01-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="ide5a86375216464d9ebfdf112640aff3_D20210701-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:KristaloseMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-07-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="i2d2eab230e924fb094455dfdb93d19f6_D20200701-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:KristaloseMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-07-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="ib32ee538452d4d108fd0d0249f232e4e_D20210101-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:CaldolorMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="ie38185217cb649a98c782f849b956b81_D20200101-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:CaldolorMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-01-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="icb5e5973ac81495ca434caa4250ad1e6_D20210701-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:VIBATIVMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-07-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="i6f2cff2563f6434383fad1a3433a95bf_D20200701-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:VIBATIVMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-07-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="i87b67bdb94e6413eab1ada4bb36a71b7_D20210101-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:VaprisolMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="i70e186cdc2a444de9d34c6b0a9840fa3_D20200101-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:VaprisolMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-01-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="i0301ef84e6814fc1afd5bda0bb02be0c_D20210701-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:VaprisolMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-07-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="i10d6fa0a80234f6fbdf7f486df4beed1_D20200701-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:VaprisolMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-07-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="iba2b0e3ce8dc46a892511cbd1f0b38cf_D20210101-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:AcetadoteMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="i2075e961d64a4c4184f2117135160c9e_D20200101-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:AcetadoteMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-01-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="i67bca755a168477fb7af6f54edd41311_D20210701-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:CaldolorMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-07-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="i369b52ac1f754a4a9275b8917dc3bb9d_D20200701-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:CaldolorMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-07-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="i2206c2c78e3347cf9fd2bb7625961847_D20210101-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:OmeclamoxPakMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="i64299c3a88d84d888de7a4e8264da6a1_D20200101-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:OmeclamoxPakMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-01-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="ica59276837544b3e89921005c9db373f_D20210701-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:RediTrexMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-07-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="i8d8203f933864c8d869320c4b6ce16d2_D20200701-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:RediTrexMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-07-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="if79d16ca01cf493f84c3a1bcbcf07c1d_D20210101-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:RediTrexMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="id3900d92fcea4358838f65d608ad8088_D20200101-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:RediTrexMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-01-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="i5d6efd6bd2c041769f9fbf0d1a3e5685_D20210701-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:OtherProductsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-07-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="i1571108ca25f4e179a9d14073629ae96_D20200701-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:OtherProductsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-07-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="i8cf12a139ea74881b685de000f63434e_D20210101-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:OtherProductsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="idbd3b5d4865547179a8bf7fbe50a430c_D20200101-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cpix:OtherProductsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-01-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="i7beb09efdc954e3387adf27b4cc99538_D20210701-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-07-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="i9c591eb458184e3baae21c9c26245264_D20200701-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-07-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="i32601382eaeb463ba862531b12def23c_D20210101-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="i76c8b1e743d441a3ad6f81bc894366dd_D20200101-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-01-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="i890f0fecec4a4eb899b3171ad304df32_I20201231"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:VIBATIVMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="i5d7014c036534d1ab07ea1c7138ece74_I20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:VIBATIVMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-09-30</instant> </period> </context> <context id="i2fb3c2ea35a146918884002eb0319cb9_I20201231"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">cpix:IfetrobanClinicalMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="i85407d87b0cc40608f88c792ee3187bc_I20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">cpix:IfetrobanClinicalMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-09-30</instant> </period> </context> <context id="ifd0c03fd249e4e64a76675f06c950be1_I20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-09-30</instant> </period> </context> <context id="i67e0bde90efc45a7a814f5c68fb0096f_I20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">srt:OfficeBuildingMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-09-30</instant> </period> </context> <context id="i6b60adc716c54226bd1b0d9f82b62a4c_I20100513"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2010-05-13</instant> </period> </context> <context id="i2d045c0da7504a3081ac01dc90d95aed_I20160131"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2016-01-31</instant> </period> </context> <context id="i3eac19ab71204baa8b814cd80e8e55ab_D20210101-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="i545187d4937e41ec99d80966b809dd78_D20200101-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-01-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="i4b890701c9304f309d867768f2a90a7b_D20171101-20171130"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> </entity> <period> <startDate>2017-11-01</startDate> <endDate>2017-11-30</endDate> </period> </context> <context id="ib59b0ab18a9847a48768cc76def0c5ce_D20210101-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="i7109429b4bb94262ab81694be586f875_D20200101-20200930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-01-01</startDate> <endDate>2020-09-30</endDate> </period> </context> <context id="i448fcba2bca740069897cf519754695f_D20210101-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="ie91a73f23b39413ca4897ecef5e9c6b9_D20210101-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cpix:IncentiveStockOptionsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="ie35d5d79a31d4a97ada4dc5eb118435d_I20211028"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cpix:FifthAmendmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cpix:PinnacleBankMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-10-28</instant> </period> </context> <context id="i433310853533429eb0bd0de42c8cb8c0_D20200814-20200814"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cpix:PinnacleBankMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-08-14</startDate> <endDate>2020-08-14</endDate> </period> </context> <context id="i7857ace04dd14acd90de8bfdfc44e2ad_D20200814-20200814"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cpix:PinnacleBankMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-08-14</startDate> <endDate>2020-08-14</endDate> </period> </context> <context id="ia066a8f68c2c4b2bb8d23f93616af446_D20200814-20200814"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-08-14</startDate> <endDate>2020-08-14</endDate> </period> </context> <context id="i0c79a3c371c84f16b64c6d20ef3f26bd_I20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cpix:PinnacleBankMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-09-30</instant> </period> </context> <context id="i29e07103e7b54d69af01f448919f0979_D20210101-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cpix:PinnacleBankMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="i5729693e898c46118beacc910390b13c_I20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-09-30</instant> </period> </context> <context id="i8f0ec15fc71f49aca22d17a26142e958_D20200420-20200420"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cpix:PinnacleBankMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2020-04-20</startDate> <endDate>2020-04-20</endDate> </period> </context> <context id="i7f3eb3a61d724b16837687fe50bb6592_I20200831"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cpix:WinHealthInvestmentSingaporeLtdDomain</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-08-31</instant> </period> </context> <context id="i10ede8aae6b6477eb6df1f13d1f8042a_I20200831"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cpix:WinHealthInvestmentSingaporeLtdDomain</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-08-31</instant> </period> </context> <context id="ic25c3441c5a0477ebd8c769c3ea98555_I20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-09-30</instant> </period> </context> <context id="i57f795672a2a465e9209a65e0162f0b4_D20181101-20181130"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:VIBATIVMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2018-11-01</startDate> <endDate>2018-11-30</endDate> </period> </context> <context id="id08ba9ef8fce4ef0b1aebddae7a819be_D20210101-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:VIBATIVMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="i0463cd68913447b0aec736a9a21b1701_I20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:VIBATIVMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-09-30</instant> </period> </context> <context id="icf562c30b2d9493a84db87baebada783_I20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:VIBATIVMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-09-30</instant> </period> </context> <context id="if7d1c3dbcd4b4c6eabe94af067f29d41_D20161101-20161130"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:MethotrexateMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2016-11-01</startDate> <endDate>2016-11-30</endDate> </period> </context> <context id="ibb1ab73ec0354946b843823c167cac73_D20161101-20161130"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:MethotrexateMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2016-11-01</startDate> <endDate>2016-11-30</endDate> </period> </context> <context id="i9fbce1ec780d49a78a390da0ae5f4c6c_D20210101-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:MethotrexateMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="i0a2ac195a36045adacdf507f9366ba39_I20200731"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:MethotrexateMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-07-31</instant> </period> </context> <context id="i0899d206bf0144cb8f97b035bbc59bdc_I20201231"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:MethotrexateMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="iab3199a2232b4c38950a9c717c8b9171_I20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cpix:MethotrexateMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-09-30</instant> </period> </context> <context id="i3c783d360e1948c18a55f375b9840bca_D20191001-20210930"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> <segment> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cpix:ClinigenHealthcareLimitedMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2019-10-01</startDate> <endDate>2021-09-30</endDate> </period> </context> <context id="i54eac56082574a4c986a915dc06c3af5_D20210101-20210630"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-06-30</endDate> </period> </context> <unit id="shares"> <measure>shares</measure> </unit> <unit id="usd"> <measure>iso4217:USD</measure> </unit> <unit id="usdPerShare"> <divide> <unitNumerator> <measure>iso4217:USD</measure> </unitNumerator> <unitDenominator> <measure>shares</measure> </unitDenominator> </divide> </unit> <unit id="segment"> <measure>cpix:Segment</measure> </unit> <unit id="sqft"> <measure>utr:sqft</measure> </unit> <unit id="number"> <measure>pure</measure> </unit> <dei:DocumentFiscalYearFocus contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80L2ZyYWc6ODk0NTg5NTU0MWNiNGQzYWFjY2U2ZDFkODcxNmI4ODYvdGFibGU6NTczZThlZjFjZTVkNGNkNzljZTcwYWE4ZDQ3OWMyNWMvdGFibGVyYW5nZTo1NzNlOGVmMWNlNWQ0Y2Q3OWNlNzBhYThkNDc5YzI1Y181LTEtMS0xLTk1NTg_cb626646-506a-4773-ac71-5f2cad713dc8">2021</dei:DocumentFiscalYearFocus> <dei:DocumentFiscalPeriodFocus contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80L2ZyYWc6ODk0NTg5NTU0MWNiNGQzYWFjY2U2ZDFkODcxNmI4ODYvdGFibGU6NTczZThlZjFjZTVkNGNkNzljZTcwYWE4ZDQ3OWMyNWMvdGFibGVyYW5nZTo1NzNlOGVmMWNlNWQ0Y2Q3OWNlNzBhYThkNDc5YzI1Y182LTEtMS0xLTk1NTg_c6478a7c-da3a-4b2d-a18c-094fdad418d7">Q3</dei:DocumentFiscalPeriodFocus> <dei:AmendmentFlag contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80L2ZyYWc6ODk0NTg5NTU0MWNiNGQzYWFjY2U2ZDFkODcxNmI4ODYvdGFibGU6NTczZThlZjFjZTVkNGNkNzljZTcwYWE4ZDQ3OWMyNWMvdGFibGVyYW5nZTo1NzNlOGVmMWNlNWQ0Y2Q3OWNlNzBhYThkNDc5YzI1Y183LTEtMS0xLTk1NTg_28954d82-22f1-466a-afde-42cf97abdc80">false</dei:AmendmentFlag> <dei:CurrentFiscalYearEndDate contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80L2ZyYWc6ODk0NTg5NTU0MWNiNGQzYWFjY2U2ZDFkODcxNmI4ODYvdGV4dHJlZ2lvbjo4OTQ1ODk1NTQxY2I0ZDNhYWNjZTZkMWQ4NzE2Yjg4Nl83OA_2bdee78c-154e-4d86-88a8-03ce3ee1095d">--12-31</dei:CurrentFiscalYearEndDate> <dei:EntityCentralIndexKey contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80L2ZyYWc6ODk0NTg5NTU0MWNiNGQzYWFjY2U2ZDFkODcxNmI4ODYvdGV4dHJlZ2lvbjo4OTQ1ODk1NTQxY2I0ZDNhYWNjZTZkMWQ4NzE2Yjg4Nl83OQ_bfd22206-570a-4a0c-9502-ece83f38b7bb">0001087294</dei:EntityCentralIndexKey> <dei:DocumentType contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGV4dHJlZ2lvbjozZGQ5ZTk2YjM3YTk0MWJiYmZkZDMxMDNmZmJiM2ZjNF8xOTc0_413f7ba7-e2d7-436a-8c53-feb9f8cd07ef">10-Q</dei:DocumentType> <dei:DocumentQuarterlyReport contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6ZmZkZGI4YTQ0NDg5NGE1NmJhY2FlNTk3YzhhNjRkYjYvdGFibGVyYW5nZTpmZmRkYjhhNDQ0ODk0YTU2YmFjYWU1OTdjOGE2NGRiNl8wLTAtMS0xLTk1NTg_0193c29b-07e6-4626-b4b6-5b4b054e6863">true</dei:DocumentQuarterlyReport> <dei:DocumentPeriodEndDate contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGV4dHJlZ2lvbjozZGQ5ZTk2YjM3YTk0MWJiYmZkZDMxMDNmZmJiM2ZjNF8xMzA_b4ca3137-0810-4842-98d1-620cf0993095">2021-09-30</dei:DocumentPeriodEndDate> <dei:DocumentTransitionReport contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6YWM5M2U4YzMwNDdiNGJiMGE0MDNhYjdjMzdhZWY4YzAvdGFibGVyYW5nZTphYzkzZThjMzA0N2I0YmIwYTQwM2FiN2MzN2FlZjhjMF8wLTAtMS0xLTk1NTg_ce9f6d89-702f-45c0-8e61-a2522acd25a8">false</dei:DocumentTransitionReport> <dei:EntityFileNumber contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGV4dHJlZ2lvbjozZGQ5ZTk2YjM3YTk0MWJiYmZkZDMxMDNmZmJiM2ZjNF8xOTc4_36805ec4-cee7-4afa-801f-1742a659163e">001-33637</dei:EntityFileNumber> <dei:EntityRegistrantName contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGV4dHJlZ2lvbjozZGQ5ZTk2YjM3YTk0MWJiYmZkZDMxMDNmZmJiM2ZjNF8xOTY5_4cf731a1-abc1-422a-9c7b-5330e5e0ce7c">Cumberland Pharmaceuticals Inc.</dei:EntityRegistrantName> <dei:EntityIncorporationStateCountryCode contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6YTM3MjY2MzViN2FiNGVjZmIzOGE5YzQzM2IwZDMyMjgvdGFibGVyYW5nZTphMzcyNjYzNWI3YWI0ZWNmYjM4YTljNDMzYjBkMzIyOF8wLTAtMS0xLTk1NTg_8583c7e4-a8b7-4425-9c38-63f67826b600">TN</dei:EntityIncorporationStateCountryCode> <dei:EntityTaxIdentificationNumber contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6YTM3MjY2MzViN2FiNGVjZmIzOGE5YzQzM2IwZDMyMjgvdGFibGVyYW5nZTphMzcyNjYzNWI3YWI0ZWNmYjM4YTljNDMzYjBkMzIyOF8wLTItMS0xLTk1NTg_6f20bc22-eb7c-4658-b1b3-084391b2a373">62-1765329</dei:EntityTaxIdentificationNumber> <dei:EntityAddressAddressLine1 contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6YTM3MjY2MzViN2FiNGVjZmIzOGE5YzQzM2IwZDMyMjgvdGFibGVyYW5nZTphMzcyNjYzNWI3YWI0ZWNmYjM4YTljNDMzYjBkMzIyOF8zLTAtMS0xLTk1NTgvdGV4dHJlZ2lvbjo5ZTFmYTY1YWJjMTY0YmZlOTVlYWE5ZDY1N2EyMTdhNl81_b5979669-f620-46bc-9dbf-9c4cabcab966">2525 West End Avenue</dei:EntityAddressAddressLine1> <dei:EntityAddressAddressLine2 contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6YTM3MjY2MzViN2FiNGVjZmIzOGE5YzQzM2IwZDMyMjgvdGFibGVyYW5nZTphMzcyNjYzNWI3YWI0ZWNmYjM4YTljNDMzYjBkMzIyOF8zLTAtMS0xLTk1NTgvdGV4dHJlZ2lvbjo5ZTFmYTY1YWJjMTY0YmZlOTVlYWE5ZDY1N2EyMTdhNl85_e78457b9-2afe-4c2b-b82e-2f2567bd5d4c">Suite 950</dei:EntityAddressAddressLine2> <dei:EntityAddressCityOrTown contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6YTM3MjY2MzViN2FiNGVjZmIzOGE5YzQzM2IwZDMyMjgvdGFibGVyYW5nZTphMzcyNjYzNWI3YWI0ZWNmYjM4YTljNDMzYjBkMzIyOF8zLTAtMS0xLTk1NTgvdGV4dHJlZ2lvbjo5ZTFmYTY1YWJjMTY0YmZlOTVlYWE5ZDY1N2EyMTdhNl8xMw_75339330-5a44-452f-9806-700c80e6b3bf">Nashville</dei:EntityAddressCityOrTown> <dei:EntityAddressStateOrProvince contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6YTM3MjY2MzViN2FiNGVjZmIzOGE5YzQzM2IwZDMyMjgvdGFibGVyYW5nZTphMzcyNjYzNWI3YWI0ZWNmYjM4YTljNDMzYjBkMzIyOF8zLTAtMS0xLTk1NTgvdGV4dHJlZ2lvbjo5ZTFmYTY1YWJjMTY0YmZlOTVlYWE5ZDY1N2EyMTdhNl8xNw_4323f3b1-7adb-4ac9-b793-7e689744eb90">TN</dei:EntityAddressStateOrProvince> <dei:EntityAddressPostalZipCode contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6YTM3MjY2MzViN2FiNGVjZmIzOGE5YzQzM2IwZDMyMjgvdGFibGVyYW5nZTphMzcyNjYzNWI3YWI0ZWNmYjM4YTljNDMzYjBkMzIyOF8zLTItMS0xLTk1NTg_de47de8e-7def-40af-a663-b858ad864ead">37203</dei:EntityAddressPostalZipCode> <dei:CityAreaCode contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGV4dHJlZ2lvbjozZGQ5ZTk2YjM3YTk0MWJiYmZkZDMxMDNmZmJiM2ZjNF8xOTcw_431485a3-0c85-4366-8baf-d5389ef35036">615</dei:CityAreaCode> <dei:LocalPhoneNumber contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGV4dHJlZ2lvbjozZGQ5ZTk2YjM3YTk0MWJiYmZkZDMxMDNmZmJiM2ZjNF8xOTc5_d4442311-1438-4c31-8204-2a61f56d85ca">255-0068</dei:LocalPhoneNumber> <dei:Security12bTitle contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6OGVkMTI3NTMwNjQ2NDJhZjhkMDQ1M2M3Y2JlNDExMTQvdGFibGVyYW5nZTo4ZWQxMjc1MzA2NDY0MmFmOGQwNDUzYzdjYmU0MTExNF8yLTAtMS0xLTk1NTg_dbc6485a-9b04-48d9-ab1e-933fafa8d685">Common stock, no par value</dei:Security12bTitle> <dei:TradingSymbol contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6OGVkMTI3NTMwNjQ2NDJhZjhkMDQ1M2M3Y2JlNDExMTQvdGFibGVyYW5nZTo4ZWQxMjc1MzA2NDY0MmFmOGQwNDUzYzdjYmU0MTExNF8yLTItMS0xLTk1NTg_ce24b53b-7247-410b-ad91-432b01c6b5ac">CPIX</dei:TradingSymbol> <dei:SecurityExchangeName contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6OGVkMTI3NTMwNjQ2NDJhZjhkMDQ1M2M3Y2JlNDExMTQvdGFibGVyYW5nZTo4ZWQxMjc1MzA2NDY0MmFmOGQwNDUzYzdjYmU0MTExNF8yLTQtMS0xLTk1NTg_a291ec19-e1df-41ae-9b90-3e40561e3ef8">NASDAQ</dei:SecurityExchangeName> <dei:EntityCurrentReportingStatus contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGV4dHJlZ2lvbjozZGQ5ZTk2YjM3YTk0MWJiYmZkZDMxMDNmZmJiM2ZjNF8xOTcx_a1197e3d-0243-4955-858b-e5861b80cc79">Yes</dei:EntityCurrentReportingStatus> <dei:EntityInteractiveDataCurrent contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGV4dHJlZ2lvbjozZGQ5ZTk2YjM3YTk0MWJiYmZkZDMxMDNmZmJiM2ZjNF8xOTcz_0ecac0a7-c30d-45ed-afd0-a854de4113ed">Yes</dei:EntityInteractiveDataCurrent> <dei:EntityFilerCategory contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6MTlkZWY3YjM0OGE0NGQxMTg0Y2I0MDVkNjk3MTJlOTEvdGFibGVyYW5nZToxOWRlZjdiMzQ4YTQ0ZDExODRjYjQwNWQ2OTcxMmU5MV8xLTAtMS0xLTk1NTg_a13d1c57-8798-413c-b5aa-c8cb048eeeff">Non-accelerated Filer</dei:EntityFilerCategory> <dei:EntitySmallBusiness contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6MTlkZWY3YjM0OGE0NGQxMTg0Y2I0MDVkNjk3MTJlOTEvdGFibGVyYW5nZToxOWRlZjdiMzQ4YTQ0ZDExODRjYjQwNWQ2OTcxMmU5MV8xLTUtMS0xLTk1NTg_e9748f51-9a1a-4a17-b634-37be966893d1">true</dei:EntitySmallBusiness> <dei:EntityEmergingGrowthCompany contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGFibGU6MTlkZWY3YjM0OGE0NGQxMTg0Y2I0MDVkNjk3MTJlOTEvdGFibGVyYW5nZToxOWRlZjdiMzQ4YTQ0ZDExODRjYjQwNWQ2OTcxMmU5MV8yLTItMS0xLTk1NTg_821ed55f-0c00-421e-a584-5e383491ef49">false</dei:EntityEmergingGrowthCompany> <dei:EntityShellCompany contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGV4dHJlZ2lvbjozZGQ5ZTk2YjM3YTk0MWJiYmZkZDMxMDNmZmJiM2ZjNF8xOTcy_0ec90156-7610-4193-b1bb-515ad245e4fb">false</dei:EntityShellCompany> <dei:EntityCommonStockSharesOutstanding contextRef="i997bd44925334429a7698804c0800bcd_I20211108" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xL2ZyYWc6M2RkOWU5NmIzN2E5NDFiYmJmZGQzMTAzZmZiYjNmYzQvdGV4dHJlZ2lvbjozZGQ5ZTk2YjM3YTk0MWJiYmZkZDMxMDNmZmJiM2ZjNF8xOTM0_ab701435-31e9-4fbd-bbbe-411e26afa1cb" unitRef="shares">14809628</dei:EntityCommonStockSharesOutstanding> <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMy0xLTEtMS05NTU4_787d08f4-2adf-45cf-8ada-8543d9c4b7c2" unitRef="usd">25843231</us-gaap:CashAndCashEquivalentsAtCarryingValue> <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMy0zLTEtMS05NTU4_20b75322-7cc4-45af-a7b9-5bad822d5257" unitRef="usd">24753796</us-gaap:CashAndCashEquivalentsAtCarryingValue> <us-gaap:AccountsReceivableNetCurrent contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfNS0xLTEtMS05NTU4_6164065d-c25f-42e4-aed6-8dd4a5841b0f" unitRef="usd">9850530</us-gaap:AccountsReceivableNetCurrent> <us-gaap:AccountsReceivableNetCurrent contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfNS0zLTEtMS05NTU4_e5d96494-3cdc-41c5-8e4a-906eb5f179a1" unitRef="usd">12377713</us-gaap:AccountsReceivableNetCurrent> <us-gaap:InventoryNet contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfNi0xLTEtMS05NTU4_4091615e-1774-4c16-aa12-07e5ffc72fe1" unitRef="usd">10262769</us-gaap:InventoryNet> <us-gaap:InventoryNet contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfNi0zLTEtMS05NTU4_13de659e-a85f-4081-b06d-3f0c52b59079" unitRef="usd">10638157</us-gaap:InventoryNet> <us-gaap:OtherAssetsCurrent contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfNy0xLTEtMS05NTU4_568cd97a-6a6c-4229-9766-4c44f00313a8" unitRef="usd">1259098</us-gaap:OtherAssetsCurrent> <us-gaap:OtherAssetsCurrent contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfNy0zLTEtMS05NTU4_b5991ed0-da52-464e-8879-f96ae93c44a2" unitRef="usd">2199926</us-gaap:OtherAssetsCurrent> <us-gaap:AssetsCurrent contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfOC0xLTEtMS05NTU4_4f9a7cdd-26b3-4189-ab38-3d0c2752e571" unitRef="usd">47215628</us-gaap:AssetsCurrent> <us-gaap:AssetsCurrent contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfOC0zLTEtMS05NTU4_65f340e6-74d7-4cfb-8680-658c8b0c7355" unitRef="usd">49969592</us-gaap:AssetsCurrent> <us-gaap:InventoryNoncurrent contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfOS0xLTEtMS05NTU4_0a7c4539-54b6-4642-9ec1-09646f9defe7" unitRef="usd">9476737</us-gaap:InventoryNoncurrent> <us-gaap:InventoryNoncurrent contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfOS0zLTEtMS05NTU4_a3509e15-8629-4f7b-bfda-f1d4dc62d644" unitRef="usd">11656742</us-gaap:InventoryNoncurrent> <us-gaap:PropertyPlantAndEquipmentNet contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTAtMS0xLTEtOTU1OA_004f0d13-8464-41b7-9449-bf9485368979" unitRef="usd">493488</us-gaap:PropertyPlantAndEquipmentNet> <us-gaap:PropertyPlantAndEquipmentNet contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTAtMy0xLTEtOTU1OA_c827415f-8dde-4bd9-9046-8ad08abe9049" unitRef="usd">574169</us-gaap:PropertyPlantAndEquipmentNet> <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTEtMS0xLTEtOTU1OA_920a2aaf-4d92-4bf8-a5dc-58ff9573a845" unitRef="usd">24918830</us-gaap:FiniteLivedIntangibleAssetsNet> <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTEtMy0xLTEtOTU1OA_1a9fc573-d3af-4646-aafd-ca0c7bba6963" unitRef="usd">28118316</us-gaap:FiniteLivedIntangibleAssetsNet> <us-gaap:Goodwill contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTItMS0xLTEtOTU1OA_7254f054-db53-436c-9ae6-407968371295" unitRef="usd">882000</us-gaap:Goodwill> <us-gaap:Goodwill contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTItMy0xLTEtOTU1OA_713236f1-498e-41a5-9fa9-38897a12caf9" unitRef="usd">882000</us-gaap:Goodwill> <us-gaap:OperatingLeaseRightOfUseAsset contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTMtMS0xLTEtOTU1OA_03898100-deee-4659-8993-7d7a00a7e0cb" unitRef="usd">1282275</us-gaap:OperatingLeaseRightOfUseAsset> <us-gaap:OperatingLeaseRightOfUseAsset contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTMtMy0xLTEtOTU1OA_863fa60a-3bd3-4571-9ab0-fd2514ae1214" unitRef="usd">2028148</us-gaap:OperatingLeaseRightOfUseAsset> <us-gaap:OtherAssetsNoncurrent contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTQtMS0xLTEtOTU1OA_801dd865-0a0e-49e3-bc13-7bd89a23b7d2" unitRef="usd">3301816</us-gaap:OtherAssetsNoncurrent> <us-gaap:OtherAssetsNoncurrent contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTQtMy0xLTEtOTU1OA_3f1cd0a6-9066-4941-82a0-79fd010cd287" unitRef="usd">3234338</us-gaap:OtherAssetsNoncurrent> <us-gaap:Assets contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTUtMS0xLTEtOTU1OA_6706308c-7f71-4f21-972f-a8ad2870ec2e" unitRef="usd">87570774</us-gaap:Assets> <us-gaap:Assets contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTUtMy0xLTEtOTU1OA_82aecfa9-2487-419d-a33e-917eac28150e" unitRef="usd">96463305</us-gaap:Assets> <us-gaap:AccountsPayableCurrent contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTgtMS0xLTEtOTU1OA_e8ba911c-7e76-467c-b067-eb434552668d" unitRef="usd">9233383</us-gaap:AccountsPayableCurrent> <us-gaap:AccountsPayableCurrent contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTgtMy0xLTEtOTU1OA_be938f19-8780-42e5-8abd-ed1477094964" unitRef="usd">13396286</us-gaap:AccountsPayableCurrent> <us-gaap:OperatingLeaseLiabilityCurrent contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTktMS0xLTEtOTU1OA_2e433f39-34c1-4921-a1eb-2c04de7596b4" unitRef="usd">1094187</us-gaap:OperatingLeaseLiabilityCurrent> <us-gaap:OperatingLeaseLiabilityCurrent contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMTktMy0xLTEtOTU1OA_bf87e2d5-b8e2-423f-a2f7-8d0c2eb7ad8b" unitRef="usd">1016779</us-gaap:OperatingLeaseLiabilityCurrent> <us-gaap:OtherLiabilitiesCurrent contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjAtMS0xLTEtOTU1OA_3a3e9276-4446-462c-a7f5-4e7eef72aa6d" unitRef="usd">7617913</us-gaap:OtherLiabilitiesCurrent> <us-gaap:OtherLiabilitiesCurrent contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjAtMy0xLTEtOTU1OA_725654e5-26d7-4902-9849-bd17c75541fc" unitRef="usd">11254381</us-gaap:OtherLiabilitiesCurrent> <us-gaap:LiabilitiesCurrent contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjEtMS0xLTEtOTU1OA_d3d1b324-a332-4b6d-a876-cb7d8d486075" unitRef="usd">17945483</us-gaap:LiabilitiesCurrent> <us-gaap:LiabilitiesCurrent contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjEtMy0xLTEtOTU1OA_b49161b8-b618-488e-b4a6-773df0e33080" unitRef="usd">25667446</us-gaap:LiabilitiesCurrent> <us-gaap:LongTermLineOfCredit contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjItMS0xLTEtOTU1OA_af71ed23-ef84-4ab4-95f6-8d24a4bf3e9c" unitRef="usd">15000000</us-gaap:LongTermLineOfCredit> <us-gaap:LongTermLineOfCredit contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjItMy0xLTEtOTU1OA_7a2cac12-dbbc-42cb-9a68-445a8d1da521" unitRef="usd">15000000</us-gaap:LongTermLineOfCredit> <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjMtMS0xLTEtOTU1OA_ac21f239-47a9-4048-b4e5-fb6a30904c23" unitRef="usd">229605</us-gaap:OperatingLeaseLiabilityNoncurrent> <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjMtMy0xLTEtOTU1OA_04dacca8-58ff-48be-bfca-d19061523658" unitRef="usd">1059693</us-gaap:OperatingLeaseLiabilityNoncurrent> <cpix:OtherLongTermObligationsExcludingCurrentPortion contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjQtMS0xLTEtOTU1OA_c19e5623-3ca3-42df-8206-a6ce00f2578f" unitRef="usd">7749421</cpix:OtherLongTermObligationsExcludingCurrentPortion> <cpix:OtherLongTermObligationsExcludingCurrentPortion contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjQtMy0xLTEtOTU1OA_a62c5665-b11d-4da6-a66d-afb64849d36e" unitRef="usd">7862772</cpix:OtherLongTermObligationsExcludingCurrentPortion> <us-gaap:Liabilities contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjUtMS0xLTEtOTU1OA_73ff469a-33c7-4e34-b6de-c03e5cbf5c37" unitRef="usd">40924509</us-gaap:Liabilities> <us-gaap:Liabilities contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjUtMy0xLTEtOTU1OA_21c45af4-7bbb-4e9f-93c5-e8cc48452fdc" unitRef="usd">49589911</us-gaap:Liabilities> <us-gaap:CommitmentsAndContingencies contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjYtMS0xLTEtOTU1OA_66f332c8-513c-4391-89f7-80f43f532cdc" unitRef="usd" xsi:nil="true"/> <us-gaap:CommitmentsAndContingencies contextRef="idb172cb6365440839665fd6ec022472c_I20201231" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjYtMy0xLTEtOTU1OA_339a1c3d-e189-4d33-8982-7a811ac1d9a2" unitRef="usd" xsi:nil="true"/> <us-gaap:CommonStockNoParValue contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjktMC0xLTEtOTU1OC90ZXh0cmVnaW9uOjVjNjY5YmEwMWIwNzRiZWE5ZWZmYWFhMWRlZDI3YmRhXzE3_9a3bc384-8dfc-4d87-8e86-c41e535e62b9" unitRef="usdPerShare">0</us-gaap:CommonStockNoParValue> <us-gaap:CommonStockNoParValue contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjktMC0xLTEtOTU1OC90ZXh0cmVnaW9uOjVjNjY5YmEwMWIwNzRiZWE5ZWZmYWFhMWRlZDI3YmRhXzE3_d7c4882b-b860-43a2-8bfd-14b2f3796291" unitRef="usdPerShare">0</us-gaap:CommonStockNoParValue> <us-gaap:CommonStockSharesAuthorized contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjktMC0xLTEtOTU1OC90ZXh0cmVnaW9uOjVjNjY5YmEwMWIwNzRiZWE5ZWZmYWFhMWRlZDI3YmRhXzMx_1c740f40-7da7-456f-95fa-9268f3238850" unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized> <us-gaap:CommonStockSharesAuthorized contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjktMC0xLTEtOTU1OC90ZXh0cmVnaW9uOjVjNjY5YmEwMWIwNzRiZWE5ZWZmYWFhMWRlZDI3YmRhXzMx_53125269-be7e-42ef-9921-6f2a51910e59" unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized> <us-gaap:CommonStockSharesIssued contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjktMC0xLTEtOTU1OC90ZXh0cmVnaW9uOjVjNjY5YmEwMWIwNzRiZWE5ZWZmYWFhMWRlZDI3YmRhXzUz_6b190ba3-e572-4622-ba7a-b37fdcadfb15" unitRef="shares">14850526</us-gaap:CommonStockSharesIssued> <us-gaap:CommonStockSharesOutstanding contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjktMC0xLTEtOTU1OC90ZXh0cmVnaW9uOjVjNjY5YmEwMWIwNzRiZWE5ZWZmYWFhMWRlZDI3YmRhXzUz_bb67aab8-19d8-476d-8916-e107f319fb15" unitRef="shares">14850526</us-gaap:CommonStockSharesOutstanding> <us-gaap:CommonStockSharesIssued contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjktMC0xLTEtOTU1OC90ZXh0cmVnaW9uOjVjNjY5YmEwMWIwNzRiZWE5ZWZmYWFhMWRlZDI3YmRhXzYw_4c6882e3-b738-41e7-a85b-56aacaf9ed05" unitRef="shares">14988429</us-gaap:CommonStockSharesIssued> <us-gaap:CommonStockSharesOutstanding contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjktMC0xLTEtOTU1OC90ZXh0cmVnaW9uOjVjNjY5YmEwMWIwNzRiZWE5ZWZmYWFhMWRlZDI3YmRhXzYw_8d49a5ab-c46e-42ea-a4f8-80205bda09b4" unitRef="shares">14988429</us-gaap:CommonStockSharesOutstanding> <us-gaap:CommonStockValue contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjktMS0xLTEtOTU1OA_9c6d8501-d714-4356-87c0-7924d6ddc4ef" unitRef="usd">48612935</us-gaap:CommonStockValue> <us-gaap:CommonStockValue contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMjktMy0xLTEtOTU1OA_769b8ef2-f306-486a-9e63-a06957175847" unitRef="usd">49121523</us-gaap:CommonStockValue> <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMzAtMS0xLTEtOTU1OA_3b15b693-c359-4ce7-b87f-511e55fa1eef" unitRef="usd">-1790903</us-gaap:RetainedEarningsAccumulatedDeficit> <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMzAtMy0xLTEtOTU1OA_5d68e1b4-1c75-4931-a323-8e5fc3315e24" unitRef="usd">-2131013</us-gaap:RetainedEarningsAccumulatedDeficit> <us-gaap:StockholdersEquity contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMzEtMS0xLTEtOTU1OA_c5e3a62d-c398-4bf2-bdea-affe7c7df09f" unitRef="usd">46822032</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMzEtMy0xLTEtOTU1OA_c9407c7c-e82b-42a2-ab9c-ea2529d40ef9" unitRef="usd">46990510</us-gaap:StockholdersEquity> <us-gaap:MinorityInterest contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMzItMS0xLTEtOTU1OA_cad970f6-47ee-4c47-b6c9-68e9a38d0b2f" unitRef="usd">-175767</us-gaap:MinorityInterest> <us-gaap:MinorityInterest contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMzItMy0xLTEtOTU1OA_1ea42f2e-d2d2-4282-b4f5-ac7cb8cbeda9" unitRef="usd">-117116</us-gaap:MinorityInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMzMtMS0xLTEtOTU1OA_423074bc-2abb-4837-80ba-f1b03dfed65d" unitRef="usd">46646265</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMzMtMy0xLTEtOTU1OA_0ee8ed29-747b-41b1-85ea-72ef916138ac" unitRef="usd">46873394</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:LiabilitiesAndStockholdersEquity contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMzQtMS0xLTEtOTU1OA_0ab55b8c-68bc-426b-8dd2-9ef966d2fbfe" unitRef="usd">87570774</us-gaap:LiabilitiesAndStockholdersEquity> <us-gaap:LiabilitiesAndStockholdersEquity contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xNi9mcmFnOjFjODBkZjVjNWZjYzQ1ZmM5NTFmODhlNGUzYjZlN2YzL3RhYmxlOjk5MmE0M2QzNThjYjRmNzZhOTVhZDk3MTlkYjBkZWJjL3RhYmxlcmFuZ2U6OTkyYTQzZDM1OGNiNGY3NmE5NWFkOTcxOWRiMGRlYmNfMzQtMy0xLTEtOTU1OA_72a379ed-af9c-48c1-b7a0-22bff9f116e2" unitRef="usd">96463305</us-gaap:LiabilitiesAndStockholdersEquity> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMi0xLTEtMS05NTU4_6f46574a-47f1-4e7e-83a2-11d516edf5df" unitRef="usd">8072540</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMi0zLTEtMS05NTU4_781307c7-4873-440a-a67f-16f5e8051428" unitRef="usd">9250689</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMi01LTEtMS05NTU4_8fe8b1e2-7d0e-48d4-832c-abcbb47375bc" unitRef="usd">27665182</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMi03LTEtMS05NTU4_b207bca1-855a-42c8-a38f-b516c62c0810" unitRef="usd">27179600</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:CostOfGoodsAndServicesSold contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNC0xLTEtMS05NTU4_30ab3989-a784-4170-8210-f4be533b3726" unitRef="usd">1328027</us-gaap:CostOfGoodsAndServicesSold> <us-gaap:CostOfGoodsAndServicesSold contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNC0zLTEtMS05NTU4_1c21b574-e3de-4cec-ad57-4f7203ac943f" unitRef="usd">2142839</us-gaap:CostOfGoodsAndServicesSold> <us-gaap:CostOfGoodsAndServicesSold contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNC01LTEtMS05NTU4_2b82165b-3391-40fe-a80f-40a5f1978c1e" unitRef="usd">5486005</us-gaap:CostOfGoodsAndServicesSold> <us-gaap:CostOfGoodsAndServicesSold contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNC03LTEtMS05NTU4_e0b06033-3b40-42d4-9e09-9da2d367ea4e" unitRef="usd">6387002</us-gaap:CostOfGoodsAndServicesSold> <us-gaap:SellingAndMarketingExpense contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNS0xLTEtMS05NTU4_d52d2797-a9a4-423f-8498-e0bc613433b4" unitRef="usd">3800288</us-gaap:SellingAndMarketingExpense> <us-gaap:SellingAndMarketingExpense contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNS0zLTEtMS05NTU4_f398d241-1297-4a49-8c83-c0fda68dc2e6" unitRef="usd">3587842</us-gaap:SellingAndMarketingExpense> <us-gaap:SellingAndMarketingExpense contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNS01LTEtMS05NTU4_1e12fbb7-fcb2-46f9-a167-e40e704bcd35" unitRef="usd">11709445</us-gaap:SellingAndMarketingExpense> <us-gaap:SellingAndMarketingExpense contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNS03LTEtMS05NTU4_5730eef7-534c-4101-962f-a45a5ba9752c" unitRef="usd">11160924</us-gaap:SellingAndMarketingExpense> <us-gaap:ResearchAndDevelopmentExpense contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNi0xLTEtMS05NTU4_05867931-330e-4627-af39-5446206d6911" unitRef="usd">1453873</us-gaap:ResearchAndDevelopmentExpense> <us-gaap:ResearchAndDevelopmentExpense contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNi0zLTEtMS05NTU4_2e927709-7a9e-45c2-971b-eedb8d26f8cd" unitRef="usd">1230335</us-gaap:ResearchAndDevelopmentExpense> <us-gaap:ResearchAndDevelopmentExpense contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNi01LTEtMS05NTU4_3c87e122-3c97-43b7-b1da-8b80290d7f0a" unitRef="usd">4071638</us-gaap:ResearchAndDevelopmentExpense> <us-gaap:ResearchAndDevelopmentExpense contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNi03LTEtMS05NTU4_707984ff-0726-49c9-bee3-3fb751c02d13" unitRef="usd">4374392</us-gaap:ResearchAndDevelopmentExpense> <us-gaap:GeneralAndAdministrativeExpense contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNy0xLTEtMS05NTU4_7ad913a9-6ea3-457d-a36c-183a1bc3f50e" unitRef="usd">2039799</us-gaap:GeneralAndAdministrativeExpense> <us-gaap:GeneralAndAdministrativeExpense contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNy0zLTEtMS05NTU4_cd118aae-c492-4977-9b43-f06bef4041a6" unitRef="usd">2381273</us-gaap:GeneralAndAdministrativeExpense> <us-gaap:GeneralAndAdministrativeExpense contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNy01LTEtMS05NTU4_51a66d19-bed2-4820-943b-44d902fd58d7" unitRef="usd">6367438</us-gaap:GeneralAndAdministrativeExpense> <us-gaap:GeneralAndAdministrativeExpense contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfNy03LTEtMS05NTU4_2dea87ad-3e9a-4662-a320-d4b528758da6" unitRef="usd">6608321</us-gaap:GeneralAndAdministrativeExpense> <us-gaap:AmortizationOfIntangibleAssets contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfOC0xLTEtMS05NTU4_9eddcd2e-8186-4a8b-83dc-8a4d3cdabb2d" unitRef="usd">1013948</us-gaap:AmortizationOfIntangibleAssets> <us-gaap:AmortizationOfIntangibleAssets contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfOC0zLTEtMS05NTU4_a8010101-60c6-47cc-bc0d-16bc9147d98f" unitRef="usd">1117086</us-gaap:AmortizationOfIntangibleAssets> <us-gaap:AmortizationOfIntangibleAssets contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfOC01LTEtMS05NTU4_cefad2e7-9dff-44fd-bdce-dfe606df4451" unitRef="usd">3354080</us-gaap:AmortizationOfIntangibleAssets> <us-gaap:AmortizationOfIntangibleAssets contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfOC03LTEtMS05NTU4_887a51b6-b6be-4f90-b32b-ea605eea9dec" unitRef="usd">3284610</us-gaap:AmortizationOfIntangibleAssets> <us-gaap:CostsAndExpenses contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfOS0xLTEtMS05NTU4_9c2c75c1-9664-463c-b7ef-84f47727fa13" unitRef="usd">9635935</us-gaap:CostsAndExpenses> <us-gaap:CostsAndExpenses contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfOS0zLTEtMS05NTU4_30f0355f-3abd-47b9-b804-f2432eeab0bc" unitRef="usd">10459375</us-gaap:CostsAndExpenses> <us-gaap:CostsAndExpenses contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfOS01LTEtMS05NTU4_91cbb7d5-4f2f-4682-9016-39e0ee0e3387" unitRef="usd">30988606</us-gaap:CostsAndExpenses> <us-gaap:CostsAndExpenses contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfOS03LTEtMS05NTU4_10c21e8b-bb5c-47c1-927b-370d46368b2a" unitRef="usd">31815249</us-gaap:CostsAndExpenses> <us-gaap:OperatingIncomeLoss contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTAtMS0xLTEtOTU1OA_ae1a9867-e350-43ac-bfe5-1bea13f9f96e" unitRef="usd">-1563395</us-gaap:OperatingIncomeLoss> <us-gaap:OperatingIncomeLoss contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTAtMy0xLTEtOTU1OA_aed8b499-3963-46c0-8e86-e674dbcf5105" unitRef="usd">-1208686</us-gaap:OperatingIncomeLoss> <us-gaap:OperatingIncomeLoss contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTAtNS0xLTEtOTU1OA_7f0a5665-0b83-4f2a-bc2b-9d5a18a632c0" unitRef="usd">-3323424</us-gaap:OperatingIncomeLoss> <us-gaap:OperatingIncomeLoss contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTAtNy0xLTEtOTU1OA_285e5679-4ce2-4028-bb45-76b0e4029e6f" unitRef="usd">-4635649</us-gaap:OperatingIncomeLoss> <us-gaap:InvestmentIncomeInterest contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTEtMS0xLTEtOTU1OA_b79c0005-d793-42ad-8871-3e5affea3b4c" unitRef="usd">7394</us-gaap:InvestmentIncomeInterest> <us-gaap:InvestmentIncomeInterest contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTEtMy0xLTEtOTU1OA_33714327-17f9-432a-bbd7-05e7bdb63b6b" unitRef="usd">12004</us-gaap:InvestmentIncomeInterest> <us-gaap:InvestmentIncomeInterest contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTEtNS0xLTEtOTU1OA_e5c8d4b5-17d5-4c4a-8a7f-2f627a542e07" unitRef="usd">19411</us-gaap:InvestmentIncomeInterest> <us-gaap:InvestmentIncomeInterest contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTEtNy0xLTEtOTU1OA_41104900-f351-491a-bab1-b30b9fd15234" unitRef="usd">70553</us-gaap:InvestmentIncomeInterest> <us-gaap:OtherIncome contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTItMS0xLTEtOTU1OA_dd85f6d7-3a80-400d-b618-f051b8483b96" unitRef="usd">0</us-gaap:OtherIncome> <us-gaap:OtherIncome contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTItMy0xLTEtOTU1OA_9d09f8e6-d7c4-4f40-a2a4-b171d5f6123e" unitRef="usd">0</us-gaap:OtherIncome> <us-gaap:OtherIncome contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTItNS0xLTEtOTU1OA_0e4fd688-c910-4bc8-a68f-9b8c0c944e76" unitRef="usd">2187140</us-gaap:OtherIncome> <us-gaap:OtherIncome contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTItNy0xLTEtOTU1OA_55a923b2-ca81-4b0e-a82e-ebace9edccc2" unitRef="usd">0</us-gaap:OtherIncome> <us-gaap:InterestExpense contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTMtMS0xLTEtOTU1OA_67f8592b-00b5-4034-a33b-ecd29f48ef95" unitRef="usd">20021</us-gaap:InterestExpense> <us-gaap:InterestExpense contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTMtMy0xLTEtOTU1OA_1ddd391c-88a9-4c1f-bbe0-4f9e226a4b32" unitRef="usd">75210</us-gaap:InterestExpense> <us-gaap:InterestExpense contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTMtNS0xLTEtOTU1OA_65623fa4-671a-43c5-bde5-8562e9b49515" unitRef="usd">70297</us-gaap:InterestExpense> <us-gaap:InterestExpense contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTMtNy0xLTEtOTU1OA_bc5b3654-4886-420f-a374-45cc9684a22a" unitRef="usd">227730</us-gaap:InterestExpense> <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTQtMS0xLTEtOTU1OA_0c797158-a708-4ac6-8d37-0262cd0dd6fa" unitRef="usd">-1576022</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest> <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTQtMy0xLTEtOTU1OA_2569ea11-8714-4d6c-baf4-e91df255bc78" unitRef="usd">-1271892</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest> <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTQtNS0xLTEtOTU1OA_5e69759b-231d-41c7-ba19-5564cd6e1ce0" unitRef="usd">-1187170</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest> <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTQtNy0xLTEtOTU1OA_8b452270-9963-4838-9755-92ce0bae4762" unitRef="usd">-4792826</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest> <us-gaap:IncomeTaxExpenseBenefit contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTUtMS0xLTEtOTU1OA_b869375d-639f-4754-abf2-01920f3599d8" unitRef="usd">7458</us-gaap:IncomeTaxExpenseBenefit> <us-gaap:IncomeTaxExpenseBenefit contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTUtMy0xLTEtOTU1OA_aa81b9db-f796-42d9-83d8-c60ef02c0315" unitRef="usd">3728</us-gaap:IncomeTaxExpenseBenefit> <us-gaap:IncomeTaxExpenseBenefit contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTUtNS0xLTEtOTU1OA_30ff0664-3748-402f-8681-afd87fbec2c7" unitRef="usd">22375</us-gaap:IncomeTaxExpenseBenefit> <us-gaap:IncomeTaxExpenseBenefit contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTUtNy0xLTEtOTU1OA_335dcc55-efaa-477d-9b65-d9261b0045d2" unitRef="usd">45423</us-gaap:IncomeTaxExpenseBenefit> <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTYtMS0xLTEtOTU1OA_3656b68a-e37c-4633-8dd8-a003efd3e39e" unitRef="usd">-1583480</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTYtMy0xLTEtOTU1OA_ec6850d2-e817-4b14-9487-ff3e910e4c91" unitRef="usd">-1275620</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTYtNS0xLTEtOTU1OA_4c64bffd-ba77-41a6-8d18-51bfc653c845" unitRef="usd">-1209545</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTYtNy0xLTEtOTU1OA_85fb5be7-0aae-4020-9da3-9e25c9015f6a" unitRef="usd">-4838249</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ieb58760ea84940319b35492cd1910735_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTctMS0xLTEtOTU1OA_86849bd9-9c34-42dc-a4b6-2061e77af27b" unitRef="usd">496787</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ifca7f9fa06d14f85a52cbd81ac170d2c_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTctMy0xLTEtOTU1OA_0fe8db84-b272-4c9f-a304-4c34cd7b14a3" unitRef="usd">777916</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i45bdfab35dd74d60ac86fc023b908b73_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTctNS0xLTEtOTU1OA_1acd7b61-10d3-4d57-a3bb-db27abac79f0" unitRef="usd">1491004</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ib8c8802e62b74a919450a1c6017bba7e_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTctNy0xLTEtOTU1OA_841b8fa5-722e-49de-805f-6e1ba99049bf" unitRef="usd">2334811</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:ProfitLoss contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTgtMS0xLTEtOTU1OA_ff808f60-a689-42b1-b71a-d3683b123ee4" unitRef="usd">-1086693</us-gaap:ProfitLoss> <us-gaap:ProfitLoss contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTgtMy0xLTEtOTU1OA_4509f6be-b34d-4bbe-b84e-cdb293c90119" unitRef="usd">-497704</us-gaap:ProfitLoss> <us-gaap:ProfitLoss contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTgtNS0xLTEtOTU1OA_ae2476e8-c4f3-48c3-8213-5c212995ddb4" unitRef="usd">281459</us-gaap:ProfitLoss> <us-gaap:ProfitLoss contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTgtNy0xLTEtOTU1OA_3a624214-4eec-4a5b-928a-eb7a9881e84b" unitRef="usd">-2503438</us-gaap:ProfitLoss> <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTktMS0xLTEtOTU1OA_95b61dfc-d977-4115-94c6-54e0d0af5a99" unitRef="usd">-31415</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest> <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTktMy0xLTEtOTU1OA_2141b745-6e38-4f81-959c-3756a18c45c0" unitRef="usd">-15967</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest> <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTktNS0xLTEtOTU1OA_ce0a12c3-7567-454b-93ce-355822e98dea" unitRef="usd">-58651</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest> <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMTktNy0xLTEtOTU1OA_f17bcff7-0f96-4279-931e-32336eb1034d" unitRef="usd">-47806</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest> <us-gaap:NetIncomeLoss contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjAtMS0xLTEtOTU1OA_8e25e5e8-98f3-44fe-bcfe-7cb6ae67a6e0" unitRef="usd">-1055278</us-gaap:NetIncomeLoss> <us-gaap:NetIncomeLoss contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjAtMy0xLTEtOTU1OA_4df57ef8-bc72-4d47-97d5-a0535ac6e0d4" unitRef="usd">-481737</us-gaap:NetIncomeLoss> <us-gaap:NetIncomeLoss contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjAtNS0xLTEtOTU1OA_5cb25c6b-5d1e-43e1-a9db-72676163fbcd" unitRef="usd">340110</us-gaap:NetIncomeLoss> <us-gaap:NetIncomeLoss contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjAtNy0xLTEtOTU1OA_f7aef4bc-6f7d-491b-8a3f-1c613544acf4" unitRef="usd">-2455632</us-gaap:NetIncomeLoss> <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjItMS0xLTEtOTU1OA_c3ee7aaf-3a59-42cd-940a-86344d472155" unitRef="usdPerShare">-0.10</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare> <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjItMy0xLTEtOTU1OA_e9a75676-a793-4eb3-85fb-048dbf56209e" unitRef="usdPerShare">-0.08</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare> <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjItNS0xLTEtOTU1OA_b0a294d3-17b1-4601-a366-4fe9f21c4be0" unitRef="usdPerShare">-0.08</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare> <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjItNy0xLTEtOTU1OA_cda5bd02-15e1-473c-812c-74665fa1fe4d" unitRef="usdPerShare">-0.31</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare> <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjMtMS0xLTEtOTU1OA_37f3b733-baaf-4885-bf03-c35f039ca671" unitRef="usdPerShare">0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare> <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjMtMy0xLTEtOTU1OA_bab9de8c-5909-4833-b95a-6100886a552d" unitRef="usdPerShare">0.05</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare> <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjMtNS0xLTEtOTU1OA_928e6367-0e20-47fc-9aa7-165419cb71eb" unitRef="usdPerShare">0.10</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare> <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjMtNy0xLTEtOTU1OA_a5dbfd8d-da81-4d2e-99b3-639e22d701d2" unitRef="usdPerShare">0.15</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare> <us-gaap:EarningsPerShareBasic contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjQtMS0xLTEtOTU1OA_faad5f17-3f38-4945-98da-5539c2be542d" unitRef="usdPerShare">-0.07</us-gaap:EarningsPerShareBasic> <us-gaap:EarningsPerShareBasic contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjQtMy0xLTEtOTU1OA_86b37b93-22c3-4dfd-bfe1-cd362d65aa78" unitRef="usdPerShare">-0.03</us-gaap:EarningsPerShareBasic> <us-gaap:EarningsPerShareBasic contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjQtNS0xLTEtOTU1OA_a166b8d6-4829-434d-b0a4-41dcc0e1ab67" unitRef="usdPerShare">0.02</us-gaap:EarningsPerShareBasic> <us-gaap:EarningsPerShareBasic contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjQtNy0xLTEtOTU1OA_989cb314-176e-4a6d-903b-7ce71e9e7714" unitRef="usdPerShare">-0.16</us-gaap:EarningsPerShareBasic> <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjYtMS0xLTEtOTU1OA_2551170e-c478-440a-807a-3ecc39c0c8e9" unitRef="usdPerShare">-0.10</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare> <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjYtMy0xLTEtOTU1OA_e55be91d-017f-4f3b-8125-0783557edcc2" unitRef="usdPerShare">-0.08</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare> <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjYtNS0xLTEtOTU1OA_ed699d40-1314-4c13-bdb5-9ff9f8c481c8" unitRef="usdPerShare">-0.08</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare> <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjYtNy0xLTEtOTU1OA_65b47aa0-3662-4ea9-9da8-c2b69a32a832" unitRef="usdPerShare">-0.31</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare> <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjctMS0xLTEtOTU1OA_9765f3af-225f-496c-97ee-9241f98051c2" unitRef="usdPerShare">0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare> <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjctMy0xLTEtOTU1OA_15fc1ada-b89e-4061-a698-326ecf4cfdb3" unitRef="usdPerShare">0.05</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare> <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjctNS0xLTEtOTU1OA_b4bac775-1172-46db-b64d-6c3011ba516d" unitRef="usdPerShare">0.10</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare> <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjctNy0xLTEtOTU1OA_3624f2a6-007b-41dc-ac2a-0f85f44e9264" unitRef="usdPerShare">0.15</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare> <us-gaap:EarningsPerShareDiluted contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjgtMS0xLTEtOTU1OA_07e652a8-0c5b-47b7-9c3a-111848dece26" unitRef="usdPerShare">-0.07</us-gaap:EarningsPerShareDiluted> <us-gaap:EarningsPerShareDiluted contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjgtMy0xLTEtOTU1OA_fe830645-ab82-48af-85e3-456b5dcbc53d" unitRef="usdPerShare">-0.03</us-gaap:EarningsPerShareDiluted> <us-gaap:EarningsPerShareDiluted contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjgtNS0xLTEtOTU1OA_51ea79d0-37ad-4ad4-8e73-5b994ed87c28" unitRef="usdPerShare">0.02</us-gaap:EarningsPerShareDiluted> <us-gaap:EarningsPerShareDiluted contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMjgtNy0xLTEtOTU1OA_0307a832-9abe-4cc4-8ea6-470da96f1710" unitRef="usdPerShare">-0.16</us-gaap:EarningsPerShareDiluted> <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMzAtMS0xLTEtOTU1OA_b5e1a767-1b86-4012-89bc-7628a19420c8" unitRef="shares">14880887</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic> <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMzAtMy0xLTEtOTU1OA_7ddc136a-92bb-439a-a38a-0bfad779387e" unitRef="shares">15134583</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic> <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMzAtNS0xLTEtOTU1OA_8cdb33ce-1515-4327-ae98-f1d30f78e45a" unitRef="shares">14939919</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic> <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMzAtNy0xLTEtOTU1OA_3cebfc23-7264-4ddc-9953-b2de72843968" unitRef="shares">15206179</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic> <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMzEtMS0xLTEtOTU1OA_206d45ec-0dfd-4dad-a09c-708e034903c8" unitRef="shares">14880887</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding> <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMzEtMy0xLTEtOTU1OA_3069879d-a3f8-4c09-bc47-66a88a16ffee" unitRef="shares">15134583</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding> <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMzEtNS0xLTEtOTU1OA_680872eb-8fa6-4a35-8e4b-96a35c60f7b4" unitRef="shares">15139904</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding> <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8xOS9mcmFnOjJjNzgxMTExNjhiNzQ4ZmM4NDAyMWNiYWEzM2M3NDBhL3RhYmxlOmVkYWExN2U2OTVkZDRhNTE4ZWJiMTc0ZGU4MzQxYmViL3RhYmxlcmFuZ2U6ZWRhYTE3ZTY5NWRkNGE1MThlYmIxNzRkZTgzNDFiZWJfMzEtNy0xLTEtOTU1OA_74c47ba6-d296-4d83-a36d-d18b2064f105" unitRef="shares">15206179</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding> <us-gaap:ProfitLoss contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMy0xLTEtMS05NTU4_89bfef20-b1e6-47a1-9dc7-06a201e0829a" unitRef="usd">281459</us-gaap:ProfitLoss> <us-gaap:ProfitLoss contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMy0zLTEtMS05NTU4_fee615d1-5da9-49f1-89bc-c9c0d4a4e145" unitRef="usd">-2503438</us-gaap:ProfitLoss> <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfNC0xLTEtMS05NTU4_34dd9ba9-dc08-41b3-82bc-363744572af1" unitRef="usd">1491004</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax> <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfNC0zLTEtMS05NTU4_5d8096f7-9702-46a6-93db-e69127d604a8" unitRef="usd">2334811</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax> <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfNS0xLTEtMS05NTU4_5f0e04d7-a344-4a4b-9c88-542330d012a4" unitRef="usd">-1209545</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfNS0zLTEtMS05NTU4_960860b7-f805-41c7-895a-ac3c5e8bf7e7" unitRef="usd">-4838249</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:DepreciationDepletionAndAmortization contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfNy0xLTEtMS05NTU4_ee98fdcd-e62c-4b78-a6f6-82432089e45e" unitRef="usd">3529245</us-gaap:DepreciationDepletionAndAmortization> <us-gaap:DepreciationDepletionAndAmortization contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfNy0zLTEtMS05NTU4_c94fdef7-2015-4ca1-ac13-6e31fcd40fd2" unitRef="usd">3524684</us-gaap:DepreciationDepletionAndAmortization> <us-gaap:ShareBasedCompensation contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfOC0xLTEtMS05NTU4_a3a99d85-8b3f-4c71-b706-09dbc9f771e0" unitRef="usd">517081</us-gaap:ShareBasedCompensation> <us-gaap:ShareBasedCompensation contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfOC0zLTEtMS05NTU4_7ad89641-b6e2-4fd2-a657-a14bc60fad4f" unitRef="usd">805338</us-gaap:ShareBasedCompensation> <us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfOS0xLTEtMS05NTU4_4e9f354a-5943-4277-a009-e945dcf7cb59" unitRef="usd">632646</us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities> <us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfOS0zLTEtMS05NTU4_0e2e4688-563d-479b-87bd-e057de35e705" unitRef="usd">806390</us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities> <cpix:IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTAtMS0xLTEtOTU1OA_9afe2f51-0b85-42b2-9a50-dbbce7721d86" unitRef="usd">52070</cpix:IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy> <cpix:IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTAtMy0xLTEtOTU1OA_33d45e09-c9b4-436b-9181-f8a415404be2" unitRef="usd">-169406</cpix:IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy> <us-gaap:AmortizationOfFinancingCosts contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTEtMS0xLTEtOTU1OA_9ebcbfae-b3f1-4dd6-9460-56a8bb51eefe" unitRef="usd">33943</us-gaap:AmortizationOfFinancingCosts> <us-gaap:AmortizationOfFinancingCosts contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTEtMy0xLTEtOTU1OA_e65dfc73-2a12-4051-ad8f-221d3db3618d" unitRef="usd">36197</us-gaap:AmortizationOfFinancingCosts> <us-gaap:UnrealizedGainLossOnInvestments contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTItMS0xLTEtOTU1OA_a4383df0-61d1-447f-af4c-33329a82adb5" unitRef="usd">2187140</us-gaap:UnrealizedGainLossOnInvestments> <us-gaap:UnrealizedGainLossOnInvestments contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTItMy0xLTEtOTU1OA_40ed77d8-fec4-414d-a305-19e4a0be869b" unitRef="usd">0</us-gaap:UnrealizedGainLossOnInvestments> <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTQtMS0xLTEtOTU1OA_2e2d328c-bd25-44f4-9295-f1401a59a137" unitRef="usd">-2527183</us-gaap:IncreaseDecreaseInAccountsReceivable> <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTQtMy0xLTEtOTU1OA_b0ea097f-859d-472a-8adb-5d2e95b91f6b" unitRef="usd">1817490</us-gaap:IncreaseDecreaseInAccountsReceivable> <us-gaap:IncreaseDecreaseInInventories contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTUtMS0xLTEtOTU1OA_57d3a116-49a7-439a-89e8-e5e19e852dd6" unitRef="usd">-2555393</us-gaap:IncreaseDecreaseInInventories> <us-gaap:IncreaseDecreaseInInventories contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTUtMy0xLTEtOTU1OA_a03c6e2d-7ef8-4f3b-82ac-4a8639060a8d" unitRef="usd">-1696668</us-gaap:IncreaseDecreaseInInventories> <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTYtMS0xLTEtOTU1OA_9310532c-e3ef-4b11-9d1a-3db005ddf056" unitRef="usd">-1627350</us-gaap:IncreaseDecreaseInOtherOperatingAssets> <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTYtMy0xLTEtOTU1OA_ce8bf223-c5ed-4abe-a55f-0c73f0333954" unitRef="usd">-1962024</us-gaap:IncreaseDecreaseInOtherOperatingAssets> <cpix:IncreaseDecreaseInCurrentOperatingLiabilities contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTctMS0xLTEtOTU1OA_f73493d4-2516-49ec-8d56-5424edcf497a" unitRef="usd">-2873596</cpix:IncreaseDecreaseInCurrentOperatingLiabilities> <cpix:IncreaseDecreaseInCurrentOperatingLiabilities contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTctMy0xLTEtOTU1OA_90aee167-8384-48a9-b892-c44c544c27f9" unitRef="usd">3248450</cpix:IncreaseDecreaseInCurrentOperatingLiabilities> <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTgtMS0xLTEtOTU1OA_0fb1458a-c29a-41df-a17b-c96348b3efa4" unitRef="usd">-943439</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities> <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTgtMy0xLTEtOTU1OA_62404fce-cf1b-44c8-ab3e-c0704d7899d9" unitRef="usd">-1585584</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities> <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTktMS0xLTEtOTU1OA_3bf04005-f194-4bbd-9382-7d432fd4761a" unitRef="usd">2891759</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations> <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMTktMy0xLTEtOTU1OA_c76cd51f-6dd2-4cd4-87e6-10a6acff5d68" unitRef="usd">2395054</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations> <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjAtMS0xLTEtOTU1OA_e654619d-3272-4f04-b314-4c818df3b60e" unitRef="usd">1491004</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations> <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjAtMy0xLTEtOTU1OA_d3129d7a-782c-4e0c-91fc-872a74d1f0d0" unitRef="usd">2166086</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations> <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjEtMS0xLTEtOTU1OA_870ac2ae-ade4-471d-852e-ec36975d6c63" unitRef="usd">4382763</us-gaap:NetCashProvidedByUsedInOperatingActivities> <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjEtMy0xLTEtOTU1OA_da16e351-3095-4cfd-a84b-3d53cf653613" unitRef="usd">4561140</us-gaap:NetCashProvidedByUsedInOperatingActivities> <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjMtMS0xLTEtOTU1OA_ebcb64fe-ac43-4ffc-84db-23880130db8c" unitRef="usd">94485</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment> <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjMtMy0xLTEtOTU1OA_c915a898-b0c5-4818-98ef-324aa659c261" unitRef="usd">95189</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment> <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjQtMS0xLTEtMTA1NDY_f298de6e-c85e-4bb4-ab7a-380f560ce1f3" unitRef="usd">0</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities> <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjQtMy0xLTEtMTA1NDY_2ad0b218-2536-4817-9596-c380cf4d417b" unitRef="usd">460888</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities> <us-gaap:PaymentsToAcquireInvestments contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjQtMS0xLTEtOTU1OA_eda3c378-0513-4882-ae8b-862d975224d5" unitRef="usd">200000</us-gaap:PaymentsToAcquireInvestments> <us-gaap:PaymentsToAcquireInvestments contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjQtMy0xLTEtOTU1OA_6ee9712a-80e4-48a6-a397-7907f29acbc2" unitRef="usd">0</us-gaap:PaymentsToAcquireInvestments> <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjUtMS0xLTEtOTU1OA_926d3e0c-7e31-4710-8d16-a3218196a913" unitRef="usd">180613</us-gaap:PaymentsToAcquireIntangibleAssets> <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjUtMy0xLTEtOTU1OA_c5095c68-b18f-4f34-a68d-5cf4036cb471" unitRef="usd">1807467</us-gaap:PaymentsToAcquireIntangibleAssets> <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjYtMS0xLTEtOTU1OA_ffc6f38a-fb40-46d2-ac84-cbfe38356f13" unitRef="usd">-475098</us-gaap:NetCashProvidedByUsedInInvestingActivities> <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjYtMy0xLTEtOTU1OA_6f7754a7-2950-49c4-baa9-9a2c64dc0c97" unitRef="usd">-1441768</us-gaap:NetCashProvidedByUsedInInvestingActivities> <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjktMS0xLTEtOTU1OA_ae85fed8-ca82-4f11-982e-bdfcaea8dc0c" unitRef="usd">45000000</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit> <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMjktMy0xLTEtOTU1OA_d8c83a67-e135-47b0-ab0b-00cc3a205b5b" unitRef="usd">44000000</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit> <us-gaap:RepaymentsOfNotesPayable contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzAtMS0xLTEtOTU1OA_f4a8db35-27de-4a2e-ab10-732838abc052" unitRef="usd">45000000</us-gaap:RepaymentsOfNotesPayable> <us-gaap:RepaymentsOfNotesPayable contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzAtMy0xLTEtOTU1OA_a51d2968-02b4-430b-8aa3-9eeccb17cc54" unitRef="usd">45500000</us-gaap:RepaymentsOfNotesPayable> <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzEtMS0xLTEtOTU1OA_27389069-bbbc-4c75-888a-953e490697fe" unitRef="usd">1792573</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities> <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzEtMy0xLTEtOTU1OA_48a6634a-dce4-400b-8685-2f29b34ee020" unitRef="usd">834014</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities> <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzItMS0xLTEtOTU1OA_3b6a4a18-d9aa-4aab-9615-0a1d8230b5ff" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest> <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzItMy0xLTEtOTU1OA_1802f395-adcf-41ce-beb8-248285472068" unitRef="usd">800000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest> <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzMtMS0xLTEtOTU1OA_74417a53-889d-4979-88af-96c305f4ae88" unitRef="usd">1025657</us-gaap:PaymentsForRepurchaseOfCommonStock> <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzMtMy0xLTEtOTU1OA_d948002e-b969-4bdc-8231-cc4de64dc7d0" unitRef="usd">1551463</us-gaap:PaymentsForRepurchaseOfCommonStock> <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzQtMS0xLTEtOTU1OA_f00c6231-ecc8-41b8-a509-e8f50d9ec00b" unitRef="usd">-2818230</us-gaap:NetCashProvidedByUsedInFinancingActivities> <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzQtMy0xLTEtOTU1OA_1980d3ac-9334-43dd-936f-70067baf296b" unitRef="usd">-4685477</us-gaap:NetCashProvidedByUsedInFinancingActivities> <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzUtMS0xLTEtOTU1OA_24c47d4f-6042-4d09-a4f6-f84d25ec3405" unitRef="usd">1089435</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect> <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzUtMy0xLTEtOTU1OA_7b68fff9-947a-49a5-be2d-249a99935a48" unitRef="usd">-1566105</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect> <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzYtMS0xLTEtOTU1OA_0919de68-75d1-4a72-9895-f28f493019e9" unitRef="usd">24753796</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents> <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="i6fa410e0219e41c3b8a23d8140a1ca8c_I20191231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzYtMy0xLTEtOTU1OA_860d7006-5a2c-4bbb-990c-33f7a028878c" unitRef="usd">28212635</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents> <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzctMS0xLTEtOTU1OA_f5e31f82-39b9-4de8-92d4-0c82043a1730" unitRef="usd">25843231</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents> <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="i1ae7216a773d47d889c5f34d67e867fe_I20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yMi9mcmFnOjdmNmJmOWVkYmI0NTQ4YTY4Zjc1ZWM2N2QyNzhkYzcyL3RhYmxlOmRkNWYzZGQwZjdkMTRhNWQ4ZDFlMzIwZWE5YTEyNGM4L3RhYmxlcmFuZ2U6ZGQ1ZjNkZDBmN2QxNGE1ZDhkMWUzMjBlYTlhMTI0YzhfMzctMy0xLTEtOTU1OA_978bbe5f-89a2-4ad4-924d-4fe9b1a75eb2" unitRef="usd">26646530</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents> <us-gaap:CommonStockSharesOutstanding contextRef="i90ac8e9aca0748058577add35fc3a6f9_I20191231" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfMi0xLTEtMS05NTU4_249ec781-bdca-4a10-8125-8603765510a3" unitRef="shares">15263555</us-gaap:CommonStockSharesOutstanding> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i90ac8e9aca0748058577add35fc3a6f9_I20191231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfMi0zLTEtMS05NTU4_870e48c4-b831-428c-aeff-6b2a40dc00cb" unitRef="usd">49914478</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i7f67242cec184569be979f0eab3bb2dd_I20191231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfMi01LTEtMS05NTU4_567665d0-f88c-4f2f-b952-5721a65712f5" unitRef="usd">1208395</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i1925af7a08774bc4a2752a9cd6b75c35_I20191231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfMi03LTEtMS05NTU4_36f12a5f-6da4-44a5-94e5-e768c1bca7fc" unitRef="usd">-37620</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i6fa410e0219e41c3b8a23d8140a1ca8c_I20191231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfMi05LTEtMS05NTU4_77241509-dc84-4f83-b3f4-a8f8e12ef9f3" unitRef="usd">51085253</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="iaf2c0f582f1a48b1b7132666868a1789_D20200101-20200331" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfMy0xLTEtMS05NTU4_aa9262da-6fcb-458a-b15e-7dc3624dd465" unitRef="shares">219850</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation> <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="iaf2c0f582f1a48b1b7132666868a1789_D20200101-20200331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfMy0zLTEtMS05NTU4_6563001a-87be-4d8b-82e2-adb204cbd866" unitRef="usd">264574</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation> <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="i4167fc9dfbd441ed853e3173c4f077bf_D20200101-20200331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfMy05LTEtMS05NTU4_2f4d8726-1de5-4065-8f2e-477ffc8fbfa2" unitRef="usd">264574</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation> <us-gaap:StockRepurchasedDuringPeriodShares contextRef="iaf2c0f582f1a48b1b7132666868a1789_D20200101-20200331" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfNC0xLTEtMS05NTU4_1775f463-8b18-4147-90cb-757703376146" unitRef="shares">164866</us-gaap:StockRepurchasedDuringPeriodShares> <us-gaap:StockRepurchasedDuringPeriodValue contextRef="iaf2c0f582f1a48b1b7132666868a1789_D20200101-20200331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfNC0zLTEtMS05NTU4_f53c8451-abaa-44b6-a448-fbbbb3a488f4" unitRef="usd">441624</us-gaap:StockRepurchasedDuringPeriodValue> <us-gaap:StockRepurchasedDuringPeriodValue contextRef="i4167fc9dfbd441ed853e3173c4f077bf_D20200101-20200331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfNC05LTEtMS05NTU4_88fcf9e9-412f-4903-88c1-e80ad0d62b0f" unitRef="usd">441624</us-gaap:StockRepurchasedDuringPeriodValue> <us-gaap:ProfitLoss contextRef="ic4f1350ea2fc4eb18dc553f1c359d775_D20200101-20200331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfNS01LTEtMS05NTU4_e05d9dae-6d70-4646-b1a5-c4246b2829b5" unitRef="usd">-1055620</us-gaap:ProfitLoss> <us-gaap:ProfitLoss contextRef="i94a852cb675745e89723e30ec61bfcee_D20200101-20200331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfNS03LTEtMS05NTU4_df04729c-97ac-4b13-85aa-2902531e1579" unitRef="usd">-9525</us-gaap:ProfitLoss> <us-gaap:ProfitLoss contextRef="i4167fc9dfbd441ed853e3173c4f077bf_D20200101-20200331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfNS05LTEtMS05NTU4_494a1d21-b392-46e3-8a13-738fde1c33ee" unitRef="usd">-1065145</us-gaap:ProfitLoss> <us-gaap:CommonStockSharesOutstanding contextRef="i98ca8db1bbc14991a38ad2f127cdc3f7_I20200331" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfNi0xLTEtMS05NTU4_54089366-d285-48d9-a06a-eb833875fbd1" unitRef="shares">15318539</us-gaap:CommonStockSharesOutstanding> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i98ca8db1bbc14991a38ad2f127cdc3f7_I20200331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfNi0zLTEtMS05NTU4_8611b822-a493-4416-8f88-f23e7f8414ac" unitRef="usd">49737428</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="id9ade7c2b96049c891663efff729f1ef_I20200331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfNi01LTEtMS05NTU4_eab4248e-a346-4ea9-8ea5-e8e431160c1d" unitRef="usd">152775</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="ia79d5a078419401d86bc7174c913bcf6_I20200331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfNi03LTEtMS05NTU4_0aee0b40-0b28-41c0-8fc8-11f58ff8bd26" unitRef="usd">-47145</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="if8cac0f57d4c4aa1bf61accf6f74bfda_I20200331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjNkOGQ1NGE4MzFlZTQzNjlhOGI4OTg1Y2JkZDdkOGYyL3RhYmxlcmFuZ2U6M2Q4ZDU0YTgzMWVlNDM2OWE4Yjg5ODVjYmRkN2Q4ZjJfNi05LTEtMS05NTU4_f134c8c7-20db-4387-bd25-7f968ffc3628" unitRef="usd">49843058</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:CommonStockSharesOutstanding contextRef="i98ca8db1bbc14991a38ad2f127cdc3f7_I20200331" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfMS0xLTEtMS05NTU4_5bfae5c9-3e1a-4eef-a52c-4ba0f1f3ec03" unitRef="shares">15318539</us-gaap:CommonStockSharesOutstanding> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i98ca8db1bbc14991a38ad2f127cdc3f7_I20200331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfMS0zLTEtMS05NTU4_b5ef76f9-1ec4-433c-b5b6-17af7dd32a3f" unitRef="usd">49737428</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="id9ade7c2b96049c891663efff729f1ef_I20200331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfMS01LTEtMS05NTU4_fe236be2-a610-49ec-87d8-5280e1433e0d" unitRef="usd">152775</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="ia79d5a078419401d86bc7174c913bcf6_I20200331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfMS03LTEtMS05NTU4_df26d6b8-d73e-4ab8-9f83-bbed51a74fd1" unitRef="usd">-47145</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="if8cac0f57d4c4aa1bf61accf6f74bfda_I20200331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfMS05LTEtMS05NTU4_c915cc4c-08d2-4087-bb3e-42c158d86c4f" unitRef="usd">49843058</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="i62b7e40824ec46c1a5d32166d46d8910_D20200401-20200630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfMi0xLTEtMS05NTU4_d4cfa378-3e97-4226-9f36-cfada6799107" unitRef="shares">4200</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation> <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="i62b7e40824ec46c1a5d32166d46d8910_D20200401-20200630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfMi0zLTEtMS05NTU4_478d70a1-0421-4ea7-bace-469cc002673c" unitRef="usd">278349</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation> <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="i374ad433cb0d4675ae41fef76147919d_D20200401-20200630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfMi05LTEtMS05NTU4_6b0d670b-02c0-42cc-9616-e33cb046b7bd" unitRef="usd">278349</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation> <us-gaap:StockRepurchasedDuringPeriodShares contextRef="i62b7e40824ec46c1a5d32166d46d8910_D20200401-20200630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfMy0xLTEtMS05NTU4_548841a5-a7fe-4c8f-9b0d-aed043cc0421" unitRef="shares">141463</us-gaap:StockRepurchasedDuringPeriodShares> <us-gaap:StockRepurchasedDuringPeriodValue contextRef="i62b7e40824ec46c1a5d32166d46d8910_D20200401-20200630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfMy0zLTEtMS05NTU4_5e038516-2bee-4e44-b618-aafe273d4184" unitRef="usd">769648</us-gaap:StockRepurchasedDuringPeriodValue> <us-gaap:StockRepurchasedDuringPeriodValue contextRef="i374ad433cb0d4675ae41fef76147919d_D20200401-20200630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfMy05LTEtMS05NTU4_1fe53f37-d0ff-4dfa-8134-e5bf6512d102" unitRef="usd">769648</us-gaap:StockRepurchasedDuringPeriodValue> <us-gaap:ProfitLoss contextRef="ia7d9f053c7b34fd799481310c6ca1498_D20200401-20200630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfNC01LTEtMS05NTU4_ea0a7385-18e0-45e3-9407-ab943f001e46" unitRef="usd">-918275</us-gaap:ProfitLoss> <us-gaap:ProfitLoss contextRef="i06622f546c724e4289669409575c7f9d_D20200401-20200630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfNC03LTEtMS05NTU4_c202d4bd-4445-42ef-b424-f112d53358b5" unitRef="usd">-22314</us-gaap:ProfitLoss> <us-gaap:ProfitLoss contextRef="i374ad433cb0d4675ae41fef76147919d_D20200401-20200630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfNC05LTEtMS05NTU4_9e4e5268-37ae-4e06-9ed6-0bb9098f08ee" unitRef="usd">-940589</us-gaap:ProfitLoss> <us-gaap:CommonStockSharesOutstanding contextRef="ib5c699d5da91427e80a66ec6b1991b3a_I20200630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfNS0xLTEtMS05NTU4_ba6e9aef-46ff-43b9-b878-63a20e112f39" unitRef="shares">15181276</us-gaap:CommonStockSharesOutstanding> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="ib5c699d5da91427e80a66ec6b1991b3a_I20200630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfNS0zLTEtMS05NTU4_ae912d4a-a419-4caf-8c49-de60e29cfb21" unitRef="usd">49246129</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i70a1ecea99f7485195b3405682bd0c55_I20200630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfNS01LTEtMS05NTU4_b0ee6887-8eef-4bbb-8054-7681ab6e31ec" unitRef="usd">-765500</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i9fb60215b0504a758fcf2dfe00ea4b97_I20200630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfNS03LTEtMS05NTU4_28ea7e25-8915-42e9-b1b1-e76c15087935" unitRef="usd">-69459</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i00b5fc7364e347f39acdca8004cef0f9_I20200630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjA5YTFmYmRmMmVhMzQ1ODM5ZmJlYWM5NDVjM2RjNjI2L3RhYmxlcmFuZ2U6MDlhMWZiZGYyZWEzNDU4MzlmYmVhYzk0NWMzZGM2MjZfNS05LTEtMS05NTU4_cd97b5f7-7028-4dea-9797-50d5b9f33f13" unitRef="usd">48411170</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:CommonStockSharesOutstanding contextRef="ib5c699d5da91427e80a66ec6b1991b3a_I20200630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfMC0xLTEtMS05NTU4_1c203fe2-7e6c-4fcb-9c67-a0836994c554" unitRef="shares">15181276</us-gaap:CommonStockSharesOutstanding> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="ib5c699d5da91427e80a66ec6b1991b3a_I20200630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfMC0zLTEtMS05NTU4_99d65948-277a-4607-b69e-c3fb47ca8650" unitRef="usd">49246129</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i70a1ecea99f7485195b3405682bd0c55_I20200630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfMC01LTEtMS05NTU4_4a10dfdb-303d-467b-83df-a3dcab39e02d" unitRef="usd">-765500</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i9fb60215b0504a758fcf2dfe00ea4b97_I20200630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfMC03LTEtMS05NTU4_132d0d50-1764-4f1d-a4a1-6f70c7c05f5a" unitRef="usd">-69459</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i00b5fc7364e347f39acdca8004cef0f9_I20200630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfMC05LTEtMS05NTU4_8d4cc7d0-10d9-4e36-a097-78c1845f90af" unitRef="usd">48411170</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="i786c6ae7dd8d4840bb2995fce1423b07_D20200701-20200930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfMS0xLTEtMS05NTU4_f5763c6c-263b-4113-af40-f9c3eb0a0921" unitRef="shares">4450</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation> <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="i786c6ae7dd8d4840bb2995fce1423b07_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfMS0zLTEtMS05NTU4_69e7894c-997a-43c8-9c42-5e40f06986e0" unitRef="usd">262415</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation> <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfMS05LTEtMS05NTU4_7e1d0225-6b3d-4e13-ac7c-b5fc997896f9" unitRef="usd">262415</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation> <us-gaap:StockRepurchasedDuringPeriodShares contextRef="i786c6ae7dd8d4840bb2995fce1423b07_D20200701-20200930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfNC0xLTEtMS05NTU4_90846027-9740-4424-9c38-aec27c588373" unitRef="shares">101354</us-gaap:StockRepurchasedDuringPeriodShares> <us-gaap:StockRepurchasedDuringPeriodValue contextRef="i786c6ae7dd8d4840bb2995fce1423b07_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfNC0zLTEtMS05NTU4_dfb96313-1a84-4e4d-a62b-78e38155311d" unitRef="usd">332504</us-gaap:StockRepurchasedDuringPeriodValue> <us-gaap:StockRepurchasedDuringPeriodValue contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfNC05LTEtMS05NTU4_55cd4e29-c0f6-4bfc-9a74-b3af62d6a38e" unitRef="usd">332504</us-gaap:StockRepurchasedDuringPeriodValue> <us-gaap:ProfitLoss contextRef="i8c344dec4461400991796893b71c39f3_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfNS01LTEtMS05NTU4_62f43be1-5943-4466-a95c-8abde503d415" unitRef="usd">-481737</us-gaap:ProfitLoss> <us-gaap:ProfitLoss contextRef="id1cdf0875abf4833a9b0038791a1ea6c_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfNS03LTEtMS05NTU4_1e0050b6-80e6-45f8-9b89-20b381a71206" unitRef="usd">-15967</us-gaap:ProfitLoss> <us-gaap:ProfitLoss contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfNS05LTEtMS05NTU4_4f3390c0-88a2-4ae0-994d-e8d11a4352d8" unitRef="usd">-497704</us-gaap:ProfitLoss> <us-gaap:CommonStockSharesOutstanding contextRef="i1e43169536834b7daa78040307754845_I20200930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfNi0xLTEtMS05NTU4_321a406d-5ff5-4794-ad2d-02192e50d59f" unitRef="shares">15084372</us-gaap:CommonStockSharesOutstanding> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i1e43169536834b7daa78040307754845_I20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfNi0zLTEtMS05NTU4_6cf60caa-0d71-47b9-b84e-0c83df3122c6" unitRef="usd">49176040</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i1adc976609fe48d4b014ec48f05e022c_I20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfNi01LTEtMS05NTU4_c01b96b7-c824-405a-b3ad-bc340d6c26b0" unitRef="usd">-1247237</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i169b3e774913430bb6c450a8d1cd8300_I20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfNi03LTEtMS05NTU4_4e47f670-e308-4daf-8767-cc9dfb6e4532" unitRef="usd">-85426</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i1ae7216a773d47d889c5f34d67e867fe_I20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjkxZTY2MTlmZmQ3ZDRiNTJhYTAxZDEyOWMyM2M1NjJmL3RhYmxlcmFuZ2U6OTFlNjYxOWZmZDdkNGI1MmFhMDFkMTI5YzIzYzU2MmZfNi05LTEtMS05NTU4_bfde1c53-8ddb-4a1c-a27e-5c5949897d3e" unitRef="usd">47843377</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:CommonStockSharesOutstanding contextRef="i659fa119f70c4793a43053cddb879d71_I20201231" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfMi0xLTEtMS05NTU4_7057cc7e-0b59-4ae3-9bff-60cdd185c2d1" unitRef="shares">14988429</us-gaap:CommonStockSharesOutstanding> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i659fa119f70c4793a43053cddb879d71_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfMi0zLTEtMS05NTU4_04aad0b1-30c4-4ea9-8c85-7eadc6329b3a" unitRef="usd">49121523</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i50909170032a4c00a004f6dd1808751c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfMi01LTEtMS05NTU4_134c4d4b-8582-480c-abfd-edc4fc3b5b73" unitRef="usd">-2131013</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i42e8ab4712444a43a1f231cb65ac3dcd_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfMi03LTEtMS05NTU4_2844278d-dff4-4ebd-95ec-f5bdda877b84" unitRef="usd">-117116</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfMi05LTEtMS05NTU4_38a0f3f4-23af-4b4f-b382-4f44689f4eee" unitRef="usd">46873394</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="idecbe529c8e14131b56433eb5e130916_D20210101-20210331" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfMy0xLTEtMS05NTU4_f7574844-4415-4104-a39e-24dc40d3967f" unitRef="shares">187759</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation> <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="idecbe529c8e14131b56433eb5e130916_D20210101-20210331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfMy0zLTEtMS05NTU4_39c408b4-5326-4ef0-8db1-91b7443aef10" unitRef="usd">162960</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation> <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="i5c8473bff64c498ab624fafa4cca5132_D20210101-20210331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfMy05LTEtMS05NTU4_80dd1e2a-1faa-4304-bacb-a245970d3b8f" unitRef="usd">162960</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation> <us-gaap:StockRepurchasedDuringPeriodShares contextRef="idecbe529c8e14131b56433eb5e130916_D20210101-20210331" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfNC0xLTEtMS05NTU4_1efaf449-3113-4fb4-8146-3e31a727ee9a" unitRef="shares">91724</us-gaap:StockRepurchasedDuringPeriodShares> <us-gaap:StockRepurchasedDuringPeriodValue contextRef="idecbe529c8e14131b56433eb5e130916_D20210101-20210331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfNC0zLTEtMS05NTU4_6b4b8000-6c07-4605-89cd-79d6da8ce99d" unitRef="usd">303088</us-gaap:StockRepurchasedDuringPeriodValue> <us-gaap:StockRepurchasedDuringPeriodValue contextRef="i5c8473bff64c498ab624fafa4cca5132_D20210101-20210331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfNC05LTEtMS05NTU4_bf24bea5-836f-44bd-8f74-ec90a1aaab61" unitRef="usd">303088</us-gaap:StockRepurchasedDuringPeriodValue> <us-gaap:ProfitLoss contextRef="i781a96ef93c24d05bb7f12625a033ec0_D20210101-20210331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfNS01LTEtMS05NTU4_31948089-7fbc-4e01-89b3-e4de20e48278" unitRef="usd">166828</us-gaap:ProfitLoss> <us-gaap:ProfitLoss contextRef="i38154999f15f41cca19a77a5f4d0ccac_D20210101-20210331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfNS03LTEtMS05NTU4_edf6efd5-2f19-4adb-933f-aa4d76c1d65a" unitRef="usd">-22167</us-gaap:ProfitLoss> <us-gaap:ProfitLoss contextRef="i5c8473bff64c498ab624fafa4cca5132_D20210101-20210331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfNS05LTEtMS05NTU4_f3adc67d-9fcf-484c-b8e3-4b3953e8bfcd" unitRef="usd">144661</us-gaap:ProfitLoss> <us-gaap:CommonStockSharesOutstanding contextRef="i9d845908b01747ac9d721fff45f53abf_I20210331" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfNi0xLTEtMS05NTU4_eed539f4-4f00-4335-8742-e54d7ee5d7fe" unitRef="shares">15084464</us-gaap:CommonStockSharesOutstanding> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i9d845908b01747ac9d721fff45f53abf_I20210331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfNi0zLTEtMS05NTU4_3681e437-53cd-4eff-aae2-556ddd42dab1" unitRef="usd">48981395</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i32deafcb20a948cf995118abdf3ce1a4_I20210331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfNi01LTEtMS05NTU4_83fef89f-98c5-4766-b63f-489ddd93e58a" unitRef="usd">-1964185</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i2593ac397b63496686231e5a4d277b3b_I20210331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfNi03LTEtMS05NTU4_3ceb856f-31f0-4939-bf14-e49625105dd7" unitRef="usd">-139283</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i8320ae6bb40c49b4b91522210805d996_I20210331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjU5NDcxYjdiMDhkZjRjYzJiMjY1ODFjOTMyOTY4YmJiL3RhYmxlcmFuZ2U6NTk0NzFiN2IwOGRmNGNjMmIyNjU4MWM5MzI5NjhiYmJfNi05LTEtMS05NTU4_d82bb52f-c66b-46c2-8206-2f24681b9542" unitRef="usd">46877927</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:CommonStockSharesOutstanding contextRef="i9d845908b01747ac9d721fff45f53abf_I20210331" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfMS0xLTEtMS05NTU4_eed539f4-4f00-4335-8742-e54d7ee5d7fe" unitRef="shares">15084464</us-gaap:CommonStockSharesOutstanding> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i9d845908b01747ac9d721fff45f53abf_I20210331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfMS0zLTEtMS05NTU4_3681e437-53cd-4eff-aae2-556ddd42dab1" unitRef="usd">48981395</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i32deafcb20a948cf995118abdf3ce1a4_I20210331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfMS01LTEtMS05NTU4_83fef89f-98c5-4766-b63f-489ddd93e58a" unitRef="usd">-1964185</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i2593ac397b63496686231e5a4d277b3b_I20210331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfMS03LTEtMS05NTU4_3ceb856f-31f0-4939-bf14-e49625105dd7" unitRef="usd">-139283</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i8320ae6bb40c49b4b91522210805d996_I20210331" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfMS05LTEtMS05NTU4_d82bb52f-c66b-46c2-8206-2f24681b9542" unitRef="usd">46877927</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="ief227cab10a245ff9baa903632237a80_D20210401-20210630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfMi0zLTEtMS05NTU4_0ea014be-e665-481a-a9d0-b00ea2aa91b8" unitRef="usd">191954</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation> <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="i83fce5d3edda4b1cbab16d0e4a53c979_D20210401-20210630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfMi05LTEtMS05NTU4_881bb181-1369-496b-8b7d-14238b167570" unitRef="usd">191954</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation> <us-gaap:StockRepurchasedDuringPeriodShares contextRef="ief227cab10a245ff9baa903632237a80_D20210401-20210630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfMy0xLTEtMS05NTU4_5d25d73a-3bd3-4372-b246-162f8e5bec85" unitRef="shares">158405</us-gaap:StockRepurchasedDuringPeriodShares> <us-gaap:StockRepurchasedDuringPeriodValue contextRef="ief227cab10a245ff9baa903632237a80_D20210401-20210630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfMy0zLTEtMS05NTU4_a8b15ca7-722b-4183-94ca-19c176e2260a" unitRef="usd">484965</us-gaap:StockRepurchasedDuringPeriodValue> <us-gaap:StockRepurchasedDuringPeriodValue contextRef="i83fce5d3edda4b1cbab16d0e4a53c979_D20210401-20210630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfMy05LTEtMS05NTU4_f0f44ab9-6591-48bd-a1e1-071a34ce8e9e" unitRef="usd">484965</us-gaap:StockRepurchasedDuringPeriodValue> <us-gaap:ProfitLoss contextRef="ibe562d54463741e8949d25484a516053_D20210401-20210630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfNC01LTEtMS05NTU4_2d024e0b-c223-46cc-96f3-231eb3a685d2" unitRef="usd">1228560</us-gaap:ProfitLoss> <us-gaap:ProfitLoss contextRef="i1f91139b751f41ee943e86bdb734f2f4_D20210401-20210630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfNC03LTEtMS05NTU4_22fe06fd-d63c-49af-a421-db55884b35bb" unitRef="usd">-5069</us-gaap:ProfitLoss> <us-gaap:ProfitLoss contextRef="i83fce5d3edda4b1cbab16d0e4a53c979_D20210401-20210630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfNC05LTEtMS05NTU4_c23b1e29-ce32-40a8-b16b-34dedbbf01db" unitRef="usd">1223491</us-gaap:ProfitLoss> <us-gaap:CommonStockSharesOutstanding contextRef="i7ea7194dbc454dbdbc6632db38bf6066_I20210630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfNS0xLTEtMS05NTU4_dcc08780-96f8-4ffe-9174-8c6bfdb9acb0" unitRef="shares">14926059</us-gaap:CommonStockSharesOutstanding> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i7ea7194dbc454dbdbc6632db38bf6066_I20210630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfNS0zLTEtMS05NTU4_705b4090-f883-42e7-97b6-503eae1789be" unitRef="usd">48688384</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="ic49c90ad54954ba9a5f89e54eb1dfedb_I20210630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfNS01LTEtMS05NTU4_6476049d-65f5-4999-aa4b-150e410bba73" unitRef="usd">-735625</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="ie1e3b4d188524c1791c80059e8f7515a_I20210630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfNS03LTEtMS05NTU4_a9046c90-144e-4d48-be67-98e3ee61a55b" unitRef="usd">-144352</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i64b2d71ddb0c448d9959f1b9a74a7dad_I20210630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjhkYTkyNzEzNWJjODQ1YzViYzNkZTcxOTdhN2RiOWZlL3RhYmxlcmFuZ2U6OGRhOTI3MTM1YmM4NDVjNWJjM2RlNzE5N2E3ZGI5ZmVfNS05LTEtMS05NTU4_97ec6cbf-7a4f-49be-b398-310dbe615c6b" unitRef="usd">47808407</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:CommonStockSharesOutstanding contextRef="i7ea7194dbc454dbdbc6632db38bf6066_I20210630" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfMS0xLTEtMS05NTU4_4e8dc3a0-51a6-4572-a2bd-824edb0988e6" unitRef="shares">14926059</us-gaap:CommonStockSharesOutstanding> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i7ea7194dbc454dbdbc6632db38bf6066_I20210630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfMS0zLTEtMS05NTU4_a3b29f55-e4d1-4600-98ba-bfe88d4b8015" unitRef="usd">48688384</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="ic49c90ad54954ba9a5f89e54eb1dfedb_I20210630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfMS01LTEtMS05NTU4_142089ed-56e3-477f-9f4d-9163676c17c7" unitRef="usd">-735625</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="ie1e3b4d188524c1791c80059e8f7515a_I20210630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfMS03LTEtMS05NTU4_507da33e-e52a-46bb-a4b2-c010cdec7854" unitRef="usd">-144352</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i64b2d71ddb0c448d9959f1b9a74a7dad_I20210630" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfMS05LTEtMS05NTU4_e33e63bd-631c-4d12-93c3-91b8d135ad90" unitRef="usd">47808407</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="i10df7b4f9a35418da7673ef6ae315d51_D20210701-20210930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfMi0xLTEtMS05NTU4_81d6eb07-e689-4ff0-9df5-18284e21cc0d" unitRef="shares">875</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation> <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="i10df7b4f9a35418da7673ef6ae315d51_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfMi0zLTEtMS05NTU4_f24ef08c-4098-4b4e-90e9-ca8f2947a940" unitRef="usd">162167</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation> <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfMi05LTEtMS05NTU4_169057ed-308d-4e43-bcac-1ee1eceedb54" unitRef="usd">162167</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation> <us-gaap:StockRepurchasedDuringPeriodShares contextRef="i10df7b4f9a35418da7673ef6ae315d51_D20210701-20210930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfMy0xLTEtMS05NTU4_0f04d063-90b1-4855-9ea8-e0b45a74bb2d" unitRef="shares">76408</us-gaap:StockRepurchasedDuringPeriodShares> <us-gaap:StockRepurchasedDuringPeriodValue contextRef="i10df7b4f9a35418da7673ef6ae315d51_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfMy0zLTEtMS05NTU4_5f9244e3-7211-427c-b9a3-053f221d3623" unitRef="usd">237616</us-gaap:StockRepurchasedDuringPeriodValue> <us-gaap:StockRepurchasedDuringPeriodValue contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfMy05LTEtMS05NTU4_9ddf6a86-bd00-480e-8c87-2b6bc6f20ce4" unitRef="usd">237616</us-gaap:StockRepurchasedDuringPeriodValue> <us-gaap:ProfitLoss contextRef="iae1347d2d1d84aa3a135e3245bdf0d90_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfNC01LTEtMS0xMDI2Nw_cbeaa059-71c9-4b37-b89d-73d8fd6d7c0f" unitRef="usd">-1055278</us-gaap:ProfitLoss> <us-gaap:ProfitLoss contextRef="i9cc79eb883d54f61bdec225f436b82c9_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfNC03LTEtMS0xMTgyMw_bba45812-ec40-4220-90ee-24ee4964cd26" unitRef="usd">-31415</us-gaap:ProfitLoss> <us-gaap:ProfitLoss contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfNC05LTEtMS05NTU4_341bb227-f07f-4bc9-9d1b-3939ea4b1db3" unitRef="usd">-1086693</us-gaap:ProfitLoss> <us-gaap:CommonStockSharesOutstanding contextRef="i56aafc7718c145c8b150a8e54f33a5d2_I20210930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfNS0xLTEtMS05NTU4_8dc93544-2123-452a-829f-d0d73c3b0bef" unitRef="shares">14850526</us-gaap:CommonStockSharesOutstanding> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i56aafc7718c145c8b150a8e54f33a5d2_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfNS0zLTEtMS05NTU4_909af3b1-353b-4168-8cfa-408168fb7c16" unitRef="usd">48612935</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="ib1da3f9dccc043f1b509c4e381803002_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfNS01LTEtMS05NTU4_41b7e1e7-83aa-4dbd-a223-934a3f5e6d50" unitRef="usd">-1790903</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="ied663adb59564577989ed6d27ea6493f_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfNS03LTEtMS05NTU4_b0d20a4f-9c66-44f0-8a11-94010dd8c102" unitRef="usd">-175767</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8yNS9mcmFnOjAyZWRiZDUwMGNiMTQ1YzBiNmRkNjQxZWJiZWQ3NDFiL3RhYmxlOjBjNDExMWRjOGQyZTQ0MzdhZTc0YmI5YzNjNjc5YmIwL3RhYmxlcmFuZ2U6MGM0MTExZGM4ZDJlNDQzN2FlNzRiYjljM2M2NzliYjBfNS05LTEtMS05NTU4_270319a0-ab49-4b31-8eaa-3c63149042c5" unitRef="usd">46646265</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zMS9mcmFnOjc4MTgyYzdiODkwMzRkOTdhYWUyNDJlZGY3MzU3NmU5L3RleHRyZWdpb246NzgxODJjN2I4OTAzNGQ5N2FhZTI0MmVkZjczNTc2ZTlfMTAwMzE_454135b1-1a94-46f8-8aba-ffa26ed95177">ORGANIZATION AND BASIS OF PRESENTATION<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland Pharmaceuticals Inc. (“Cumberland,” the “Company,” or as used in the context of “we,” “us,” or “our”) is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The Company's primary target markets are hospital acute care, gastroenterology and rheumatology. These medical specialties are characterized by relatively concentrated prescriber bases that the Company believes can be penetrated effectively by small, targeted sales forces. Cumberland is dedicated to providing innovative products that improve quality of care for patients and address unmet or poorly met medical needs. The Company promotes its approved products through its hospital and field sales forces in the United States and is establishing a network of international partners to bring its medicines to patients in their countries.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland focuses its resources on maximizing the commercial potential of its products, as well as developing new product candidates, and has both internal development and commercial capabilities. The Company’s products are manufactured by third parties, which are overseen by Cumberland’s quality control and manufacturing professionals. The Company works closely with its third-party distribution partners to make its products available in the United States.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited condensed consolidated financial statements of the Company have been prepared on a basis consistent with the December 31, 2020, audited consolidated financial statements and include all adjustments, consisting of only normal recurring adjustments, necessary to fairly present the information set forth herein. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited condensed consolidated financial statements have been prepared in accordance with the regulations of the Securities and Exchange Commission (the “SEC”), and certain information and disclosures have been condensed or omitted as permitted by the SEC for interim period presentation. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended December 31, 2020 (the “2020 Annual Report on Form 10-K”). The results of operations for the three and nine months ended September 30, 2021, are not necessarily indicative of the results to be expected for the entire fiscal year or any future period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Discontinued Operations</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed further in Note 9, during May 2019, Cumberland entered into a Dissolution Agreement ("Dissolution Agreement") with Clinigen Healthcare Limited ("Clinigen") in which the Company returned the exclusive rights to commercialize Ethyol</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Totect</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the United States to Clinigen. Under the terms of the Dissolution Agreement, Cumberland is no longer involved directly or indirectly with the distribution, marketing and promotion of either Ethyol or Totect or any competing products following December 31, 2019. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's exit from Ethyol and Totect meets the accounting criteria to be reported as discontinued operations and the discontinued operating results have been presented in the financial statements and footnotes to reflect the discontinued status of Ethyol and Totect. Refer to Note 9, for additional information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revision of prior period condensed consolidated statement of cash flows presentation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has made a revision to prior period amounts to conform to the current year presentation of the cash surrender value of life insurance policies over premiums paid on the condensed consolidated statement of cash flows. The revised amounts were previously included as net changes in assets affecting operating activities. These revisions have no net effect on the reported net cash provided by operating activities nor any impact on the reported operating results or balance sheet for the 2020 period presented. </span></div><div style="margin-bottom:8pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Pandemic </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the U.S. declared a health care emergency following the outbreak of the SARS-CoV-2, a novel strain of coronavirus that causes COVID-19, a respiratory illness. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland has remained open for business, as the Company is considered to be essential by the United States Department of Homeland Security. The Company has implemented measures to address the impact of the novel coronavirus on the business and taken appropriate action to protect its employees, secure the supply chain, and support the patients who can benefit from its medicines. All of the Company's employees have been given the opportunity to work remotely, and those that wish to work from Cumberland's office and laboratories are encouraged to practice the behaviors outlined by the Centers for Disease Control. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the pandemic, Cumberland has faced the same headwinds affecting other companies that rely on hospital admissions and patient visits to drive revenue. Our business and our clinical studies were impacted as less patients sought elective surgeries and our access to medical facilities was substantially limited. During 2020 and 2021, we carefully monitored our supply chain during the pandemic including the flow of raw materials into the plants that manufacture our products as well as the batches of finished product emerging from those facilities. Several of our brands were negatively impacted by the lockdowns and postponement of physician office visits and elective procedures. However, we are fortunate to have a diversified product portfolio, with other brands delivering a strong performance.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland relies on third-party organizations around the world to supply components, manufacture and distribute its products. The Company is aware that it may experience revenue loss, supply interruptions, time delays and incur unplanned expenses as a result of the impact of the ongoing COVID-19 pandemic. The Company continues to monitor the COVID-19 pandemic situation both in the U.S. and internationally in order to maintain its employees’ safety and well-being, while also keeping its business operating. Given the uncertainty, magnitude and impact of such changes, the Company is unable to quantify the impact on the future results as of the date of this filing.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Guidance</span></div><div style="margin-bottom:6pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements - Not Yet Adopted</span></div><div style="margin-bottom:6pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board ("FASB") issued ASU No. 2016-13, “Financial Instruments-Credit Losses,” which changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, companies will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, companies will measure credit losses in a manner similar to what they do today, except that the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. Companies will have to disclose additional information, including information they use to track credit quality by year of origination for most financing receivables. Companies will apply the ASU’s provisions as a cumulative-effect adjustment, if any, to retained earnings as of the beginning of the first reporting period in which the guidance is adopted.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related to ASU No. 2016-13 discussed above, in May 2019, the FASB issued ASU 2019-05, "Financial Instruments-Credit Losses (Topic 326): Targeted Transition Relief" which provides transition relief for ASU 2016-13 by providing entities with an alternative to irrevocably elect the fair value option for eligible financial assets measured at amortized cost upon adoption of the new credit losses standard. Certain eligibility requirements must be met and the election must be applied on an instrument-by-instrument basis. The election is not available for either available-for-sale or held-to-maturity debt securities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will adopt both ASU 2016-13 and ASU 2019-05 on January 1, 2023. The adoption of ASU 2016-13 and ASU 2019-05 are not expected to have a material impact on the Company’s consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Policies:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management of the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates under different assumptions and conditions. The Company's most significant estimates include: (1) its allowances for chargebacks and accruals for rebates and product returns, (2) the allowances for obsolescent or unmarketable inventory and (3) valuation of a contingent consideration liability associated with a business combination.</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Operating Segments</span></div>The Company has one operating segment which is specialty pharmaceutical products. Management has chosen to organize the Company based on the type of products sold. Operating segments are identified as components of an enterprise about which separate discrete financial information is evaluated by the chief operating decision maker, or decision-making group, in making decisions regarding resource allocation and assessing performance. The Company, which uses consolidated financial information in determining how to allocate resources and assess performance, has concluded that our specialty pharmaceutical products compete in similar economic markets and similar circumstances. Substantially all of the Company’s assets are located in the United States and total revenues are primarily attributable to U.S. customers.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock> <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zMS9mcmFnOjc4MTgyYzdiODkwMzRkOTdhYWUyNDJlZGY3MzU3NmU5L3RleHRyZWdpb246NzgxODJjN2I4OTAzNGQ5N2FhZTI0MmVkZjczNTc2ZTlfMTAwMzI_3a7841ca-7519-41ae-91eb-bbe84bc731f4"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Guidance</span></div><div style="margin-bottom:6pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements - Not Yet Adopted</span></div><div style="margin-bottom:6pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board ("FASB") issued ASU No. 2016-13, “Financial Instruments-Credit Losses,” which changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, companies will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, companies will measure credit losses in a manner similar to what they do today, except that the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. Companies will have to disclose additional information, including information they use to track credit quality by year of origination for most financing receivables. Companies will apply the ASU’s provisions as a cumulative-effect adjustment, if any, to retained earnings as of the beginning of the first reporting period in which the guidance is adopted.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related to ASU No. 2016-13 discussed above, in May 2019, the FASB issued ASU 2019-05, "Financial Instruments-Credit Losses (Topic 326): Targeted Transition Relief" which provides transition relief for ASU 2016-13 by providing entities with an alternative to irrevocably elect the fair value option for eligible financial assets measured at amortized cost upon adoption of the new credit losses standard. Certain eligibility requirements must be met and the election must be applied on an instrument-by-instrument basis. The election is not available for either available-for-sale or held-to-maturity debt securities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will adopt both ASU 2016-13 and ASU 2019-05 on January 1, 2023. The adoption of ASU 2016-13 and ASU 2019-05 are not expected to have a material impact on the Company’s consolidated financial statements.</span></div></us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock> <us-gaap:UseOfEstimates contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zMS9mcmFnOjc4MTgyYzdiODkwMzRkOTdhYWUyNDJlZGY3MzU3NmU5L3RleHRyZWdpb246NzgxODJjN2I4OTAzNGQ5N2FhZTI0MmVkZjczNTc2ZTlfMTAwMzU_2fff1938-59dd-444d-801f-b299631abdd1"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management of the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates under different assumptions and conditions. The Company's most significant estimates include: (1) its allowances for chargebacks and accruals for rebates and product returns, (2) the allowances for obsolescent or unmarketable inventory and (3) valuation of a contingent consideration liability associated with a business combination.</span></div></us-gaap:UseOfEstimates> <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zMS9mcmFnOjc4MTgyYzdiODkwMzRkOTdhYWUyNDJlZGY3MzU3NmU5L3RleHRyZWdpb246NzgxODJjN2I4OTAzNGQ5N2FhZTI0MmVkZjczNTc2ZTlfMTAwMzY_7ccfbc10-8b2c-455c-a58c-8d7144bc8c96">Operating SegmentsThe Company has one operating segment which is specialty pharmaceutical products. Management has chosen to organize the Company based on the type of products sold. Operating segments are identified as components of an enterprise about which separate discrete financial information is evaluated by the chief operating decision maker, or decision-making group, in making decisions regarding resource allocation and assessing performance. The Company, which uses consolidated financial information in determining how to allocate resources and assess performance, has concluded that our specialty pharmaceutical products compete in similar economic markets and similar circumstances. Substantially all of the Company’s assets are located in the United States and total revenues are primarily attributable to U.S. customers.</us-gaap:SegmentReportingPolicyPolicyTextBlock> <us-gaap:NumberOfOperatingSegments contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zMS9mcmFnOjc4MTgyYzdiODkwMzRkOTdhYWUyNDJlZGY3MzU3NmU5L3RleHRyZWdpb246NzgxODJjN2I4OTAzNGQ5N2FhZTI0MmVkZjczNTc2ZTlfOTIyNQ_1e7893e3-e3b9-4055-b4eb-4c6de5ad02f0" unitRef="segment">1</us-gaap:NumberOfOperatingSegments> <us-gaap:EarningsPerShareTextBlock contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RleHRyZWdpb246ZDJjZmQ4YzNmMGQzNDFlZjg1YzRkNGRjMzY5NDc2M2VfNDI1_26b21939-0832-4e2d-99c4-98d2376f2724">EARNINGS (LOSS) PER SHARE<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the numerator and denominator used to calculate diluted earnings (loss) per share for the three and nine months ended September 30, 2021 and 2020:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,583,480)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,275,620)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496,787 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777,916 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,086,693)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(497,704)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss at subsidiary attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,415 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,967 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to common shareholders</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,055,278)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(481,737)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding – basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,880,887 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,134,583 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of other securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding – diluted</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,880,887 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,134,583 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:58.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.518%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,209,545)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,838,249)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,491,004 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334,811 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281,459 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,503,438)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) at subsidiary attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,651 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,806 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to common shareholders</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340,110 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,455,632)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding – basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,939,919 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,206,179 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of other securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,985 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding – diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,139,904 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,206,179 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021 and 2020, restricted stock awards and options to purchase 158,900 and 197,210 shares of common stock, respectively, were outstanding but were not included in the computation of diluted earnings per share because the effect would be antidilutive.</span></div></us-gaap:EarningsPerShareTextBlock> <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RleHRyZWdpb246ZDJjZmQ4YzNmMGQzNDFlZjg1YzRkNGRjMzY5NDc2M2VfNDI3_45196b7b-e2ff-4caa-a182-02ca58cf409d">The following table reconciles the numerator and denominator used to calculate diluted earnings (loss) per share for the three and nine months ended September 30, 2021 and 2020:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,583,480)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,275,620)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496,787 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777,916 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,086,693)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(497,704)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss at subsidiary attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,415 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,967 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to common shareholders</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,055,278)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(481,737)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding – basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,880,887 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,134,583 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of other securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding – diluted</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,880,887 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,134,583 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:58.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.518%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,209,545)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,838,249)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,491,004 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334,811 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281,459 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,503,438)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) at subsidiary attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,651 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,806 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to common shareholders</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340,110 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,455,632)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding – basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,939,919 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,206,179 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of other securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,985 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding – diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,139,904 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,206,179 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock> <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfMy0xLTEtMS05NTU4_3656b68a-e37c-4633-8dd8-a003efd3e39e" unitRef="usd">-1583480</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfMy0zLTEtMS05NTU4_ec6850d2-e817-4b14-9487-ff3e910e4c91" unitRef="usd">-1275620</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ieb58760ea84940319b35492cd1910735_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfNC0xLTEtMS05NTU4_86849bd9-9c34-42dc-a4b6-2061e77af27b" unitRef="usd">496787</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ifca7f9fa06d14f85a52cbd81ac170d2c_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfNC0zLTEtMS05NTU4_0fe8db84-b272-4c9f-a304-4c34cd7b14a3" unitRef="usd">777916</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:ProfitLoss contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfNS0xLTEtMS05NTU4_06c37d4c-3b8e-4e9d-9a49-fdc7ea9995d1" unitRef="usd">-1086693</us-gaap:ProfitLoss> <us-gaap:ProfitLoss contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfNS0zLTEtMS05NTU4_1cc0f468-27ca-4623-bd4d-04fecde16f42" unitRef="usd">-497704</us-gaap:ProfitLoss> <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfNi0xLTEtMS05NTU4_95b61dfc-d977-4115-94c6-54e0d0af5a99" unitRef="usd">-31415</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest> <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfNi0zLTEtMS05NTU4_2141b745-6e38-4f81-959c-3756a18c45c0" unitRef="usd">-15967</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest> <us-gaap:NetIncomeLoss contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfNy0xLTEtMS05NTU4_8e25e5e8-98f3-44fe-bcfe-7cb6ae67a6e0" unitRef="usd">-1055278</us-gaap:NetIncomeLoss> <us-gaap:NetIncomeLoss contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfNy0zLTEtMS05NTU4_4df57ef8-bc72-4d47-97d5-a0535ac6e0d4" unitRef="usd">-481737</us-gaap:NetIncomeLoss> <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfOS0xLTEtMS05NTU4_b5e1a767-1b86-4012-89bc-7628a19420c8" unitRef="shares">14880887</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic> <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfOS0zLTEtMS05NTU4_7ddc136a-92bb-439a-a38a-0bfad779387e" unitRef="shares">15134583</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic> <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfMTAtMS0xLTEtOTU1OA_bf99d36d-91d8-4d26-9d88-a39c983f0874" unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment> <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfMTAtMy0xLTEtOTU1OA_2f272c37-da51-4356-beb0-a57c619788e9" unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment> <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfMTEtMS0xLTEtOTU1OA_206d45ec-0dfd-4dad-a09c-708e034903c8" unitRef="shares">14880887</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding> <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjYxZTdjZDNjMmM5ZTRkYzQ5MzI4MWE4ZjQ5MzgzMjA2L3RhYmxlcmFuZ2U6NjFlN2NkM2MyYzllNGRjNDkzMjgxYThmNDkzODMyMDZfMTEtMy0xLTEtOTU1OA_3069879d-a3f8-4c09-bc47-66a88a16ffee" unitRef="shares">15134583</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding> <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfNC0xLTEtMS05NTU4_4c64bffd-ba77-41a6-8d18-51bfc653c845" unitRef="usd">-1209545</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfNC0zLTEtMS05NTU4_85fb5be7-0aae-4020-9da3-9e25c9015f6a" unitRef="usd">-4838249</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i45bdfab35dd74d60ac86fc023b908b73_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfNS0xLTEtMS05NTU4_1acd7b61-10d3-4d57-a3bb-db27abac79f0" unitRef="usd">1491004</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ib8c8802e62b74a919450a1c6017bba7e_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfNS0zLTEtMS05NTU4_841b8fa5-722e-49de-805f-6e1ba99049bf" unitRef="usd">2334811</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:ProfitLoss contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfNi0xLTEtMS05NTU4_4dba1ef6-53d1-42f8-8c8d-2ffd0332f6c6" unitRef="usd">281459</us-gaap:ProfitLoss> <us-gaap:ProfitLoss contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfNi0zLTEtMS05NTU4_72f6cf1b-b278-4755-bba1-690b049afff5" unitRef="usd">-2503438</us-gaap:ProfitLoss> <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfNy0xLTEtMS05NTU4_ce0a12c3-7567-454b-93ce-355822e98dea" unitRef="usd">-58651</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest> <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfNy0zLTEtMS05NTU4_f17bcff7-0f96-4279-931e-32336eb1034d" unitRef="usd">-47806</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest> <us-gaap:NetIncomeLoss contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfOC0xLTEtMS05NTU4_5cb25c6b-5d1e-43e1-a9db-72676163fbcd" unitRef="usd">340110</us-gaap:NetIncomeLoss> <us-gaap:NetIncomeLoss contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfOC0zLTEtMS05NTU4_f7aef4bc-6f7d-491b-8a3f-1c613544acf4" unitRef="usd">-2455632</us-gaap:NetIncomeLoss> <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfMTAtMS0xLTEtOTU1OA_8cdb33ce-1515-4327-ae98-f1d30f78e45a" unitRef="shares">14939919</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic> <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfMTAtMy0xLTEtOTU1OA_3cebfc23-7264-4ddc-9953-b2de72843968" unitRef="shares">15206179</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic> <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfMTEtMS0xLTEtOTU1OA_605da32d-fcf5-4109-8a79-0d27864d7f97" unitRef="shares">199985</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment> <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfMTEtMy0xLTEtOTU1OA_b7b9a4ed-aabc-4e09-b4f1-13c2ea1d4302" unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment> <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfMTItMS0xLTEtOTU1OA_680872eb-8fa6-4a35-8e4b-96a35c60f7b4" unitRef="shares">15139904</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding> <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RhYmxlOjliMDI5ZWFiYjZiNDQ3MDhhMmJmMGYzZDEyNTk5ZGViL3RhYmxlcmFuZ2U6OWIwMjllYWJiNmI0NDcwOGEyYmYwZjNkMTI1OTlkZWJfMTItMy0xLTEtOTU1OA_74c47ba6-d296-4d83-a36d-d18b2064f105" unitRef="shares">15206179</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding> <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RleHRyZWdpb246ZDJjZmQ4YzNmMGQzNDFlZjg1YzRkNGRjMzY5NDc2M2VfMjQ4_c4b236a3-aad2-42f6-9b3f-a778532730c3" unitRef="shares">158900</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount> <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNC9mcmFnOmQyY2ZkOGMzZjBkMzQxZWY4NWM0ZDRkYzM2OTQ3NjNlL3RleHRyZWdpb246ZDJjZmQ4YzNmMGQzNDFlZjg1YzRkNGRjMzY5NDc2M2VfMjU1_c475d801-9266-4d56-8a11-b84fca1875bd" unitRef="shares">197210</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount> <us-gaap:SegmentReportingDisclosureTextBlock contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RleHRyZWdpb246ZmFiNDdlMmJmMGFlNDcxNzhiN2Q4ZmM2ZmYzMTEzNjBfMjU3NQ_1531aca6-8f7d-4f5a-92b9-225d8b4fdab2">REVENUES<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Revenues</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for revenues from contracts with customers under ASC 606, which became effective January 1, 2018. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s net revenues consisted of the following for the three and nine months ended September 30, 2021 and 2020:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kristalose</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,012,746 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,615,557 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,286,729 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,387,046 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vibativ</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,896,584 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813,249 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,799,891 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,551,125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Caldolor</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255,669 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,416,146 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,734,273 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,677,434 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vaprisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,774 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406,162 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861,130 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790,817 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acetadote</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,733 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,462 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638,704 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,527,173 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omeclamox-Pak</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,689 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,066 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(451,683)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640,435 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RediTrex</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,459 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,886 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,047 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,429 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605,570 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,072,540 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,250,689 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,665,182 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,179,600 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Omeclamox-Pak revenue for the first, second and third quarter of 2021 was the result of Cumberland currently being out of commercial inventory of this product. The packager for our Omeclamox-Pak product encountered financial difficulties due to the impact of COVID-19. They are under new management and are in the process of a reorganization. Discussions with the packager are ongoing. In the third quarter of 2021, the amounts noted were normal adjustments by channel partners. Net revenue was negatively impacted by product returns during the periods. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Revenues</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreements with international partners for commercialization of the Company's products with associated payments included in other revenues. Those agreements provide that each of the partners are responsible for seeking regulatory approvals for the product, and following approval, each partner will be responsible for the ongoing distribution and sales in the respective international territories. The Company provides a dossier for product registration and maintains responsibility for the relevant intellectual property. Cumberland is typically entitled to receive a non-refundable, up-front payment at the time each agreement is executed as consideration for the product dossier and for the rights to the distinct intellectual property rights in the respective international territory. These agreements also typically provide for additional payments upon a partner’s achievement of a defined regulatory approval and sales milestones. The Company may also be entitled to receive royalties on future sales of the products and a transfer price on supplies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual payments associated with the partner’s achievement of regulatory approvals, sales milestones and royalties on future sales are recognized as revenue upon occurrence, or at such time that the Company has a high degree of confidence that the revenue would not be reversed in a subsequent period.</span></div>Other revenues also include funding from federal grant programs including those secured by CET through the Small Business Administration as well as lease income generated by CET’s Life Sciences Center. The Life Sciences Center is a research center that provides scientists with access to flexible lab space and other resources to develop biomedical products. Grant revenue from these programs totaled approximately $0.02 million and $0.1 million for the three months ended September 30, 2021 and 2020</us-gaap:SegmentReportingDisclosureTextBlock> <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RleHRyZWdpb246ZmFiNDdlMmJmMGFlNDcxNzhiN2Q4ZmM2ZmYzMTEzNjBfMjU3OQ_6e8723dd-0e9c-4e15-94e7-da617c69baec"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s net revenues consisted of the following for the three and nine months ended September 30, 2021 and 2020:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kristalose</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,012,746 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,615,557 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,286,729 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,387,046 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vibativ</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,896,584 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813,249 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,799,891 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,551,125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Caldolor</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255,669 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,416,146 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,734,273 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,677,434 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vaprisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,774 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406,162 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861,130 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790,817 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acetadote</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,733 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,462 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638,704 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,527,173 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omeclamox-Pak</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,689 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,066 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(451,683)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640,435 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RediTrex</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,459 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,886 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,047 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,429 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605,570 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,072,540 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,250,689 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,665,182 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,179,600 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i2b064560ae764b05aee16232fc2b982f_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMy0xLTEtMS05NTU4_b715d0d9-0526-4ec0-b9c5-9d63854e4b5b" unitRef="usd">4012746</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="if9189ef3c405466780ff2b301ce69072_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMy0zLTEtMS05NTU4_40ba5e81-fcb0-4362-9f31-7b796c2c6e45" unitRef="usd">3615557</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ib543c8c5c4a0438eb3b83a9549c72767_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMy01LTEtMS05NTU4_c4cec850-b5cd-4b3e-a364-57a695a932fc" unitRef="usd">12286729</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i851181d1e03446adb4d2b6f666a489e7_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMy03LTEtMS05NTU4_c3aff0bd-99da-4696-a1fb-f112b43c42d9" unitRef="usd">10387046</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i343ad32279094a2585bfa47056ea0769_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNC0xLTEtMS05NTU4_d2a514f6-bc85-4d76-84a3-581ae3ca6690" unitRef="usd">1896584</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="idf76fee1053a41f897bb2b308eda43b7_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNC0zLTEtMS05NTU4_63f7b646-7f06-4718-81cf-677173d193cd" unitRef="usd">2813249</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i0a175b2126f3439e978ef755a5187703_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNC01LTEtMS05NTU4_797af799-1dd4-496c-b11b-64ff4c9660b0" unitRef="usd">8799891</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i1221e6e62b0d4437aa038a1593455cdb_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNC03LTEtMS05NTU4_18885835-bca3-4034-ae40-ec1503683622" unitRef="usd">8551125</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ide5a86375216464d9ebfdf112640aff3_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNS0xLTEtMS05NTU4_4ecd3416-3be0-4137-b77a-084667a1bde0" unitRef="usd">1255669</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i2d2eab230e924fb094455dfdb93d19f6_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNS0zLTEtMS05NTU4_96821b96-9f8c-4cda-8d66-222bf9410a62" unitRef="usd">1416146</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ib32ee538452d4d108fd0d0249f232e4e_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNS01LTEtMS05NTU4_63e26ee5-444b-420f-bbdf-8d62b3f3f1f9" unitRef="usd">3734273</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ie38185217cb649a98c782f849b956b81_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNS03LTEtMS05NTU4_f35bed30-7729-4eee-ae38-6037a38c4f22" unitRef="usd">3677434</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="icb5e5973ac81495ca434caa4250ad1e6_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNi0xLTEtMS05NTU4_bcdc676d-e769-47f8-9e93-4a6af5dae191" unitRef="usd">325774</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i6f2cff2563f6434383fad1a3433a95bf_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNi0zLTEtMS05NTU4_14b486ec-0bd1-4898-bb20-f5e8383adc00" unitRef="usd">406162</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i87b67bdb94e6413eab1ada4bb36a71b7_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNi01LTEtMS05NTU4_531a4f67-3812-4d7b-b851-f55ca5fa72ea" unitRef="usd">1861130</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i70e186cdc2a444de9d34c6b0a9840fa3_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNi03LTEtMS05NTU4_c31d8057-e712-41e2-9a8c-fb2cec4a248d" unitRef="usd">790817</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i0301ef84e6814fc1afd5bda0bb02be0c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNy0xLTEtMS05NTU4_be1eda32-358a-4637-973c-011b99e02535" unitRef="usd">368733</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i10d6fa0a80234f6fbdf7f486df4beed1_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNy0zLTEtMS05NTU4_8332fef3-e4a9-44d8-ad11-1ef54e387727" unitRef="usd">218462</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="iba2b0e3ce8dc46a892511cbd1f0b38cf_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNy01LTEtMS05NTU4_40b59073-22bc-4624-b110-4dcc10f7f41d" unitRef="usd">638704</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i2075e961d64a4c4184f2117135160c9e_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfNy03LTEtMS05NTU4_f267816f-c3dc-49ff-b1c1-3e8d6c459f9a" unitRef="usd">1527173</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i67bca755a168477fb7af6f54edd41311_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfOC0xLTEtMS05NTU4_45967abd-c12f-4676-9e2c-1e3bc25499eb" unitRef="usd">22689</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i369b52ac1f754a4a9275b8917dc3bb9d_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfOC0zLTEtMS05NTU4_a978c324-8dac-4cc2-adbe-bf474d3b5e4d" unitRef="usd">516066</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i2206c2c78e3347cf9fd2bb7625961847_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfOC01LTEtMS05NTU4_eed0fb91-555b-4171-94dc-a07afa3ca379" unitRef="usd">-451683</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i64299c3a88d84d888de7a4e8264da6a1_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfOC03LTEtMS05NTU4_dacbc3b7-5e42-48e1-b1ab-ebba0035bb20" unitRef="usd">640435</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ica59276837544b3e89921005c9db373f_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfOS0xLTEtMS05NTU4_2feb4625-fa02-4d92-9863-fbba89eb19a8" unitRef="usd">11459</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i8d8203f933864c8d869320c4b6ce16d2_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfOS0zLTEtMS05NTU4_90e04b12-42da-42f9-ad8f-f506afdf6003" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="if79d16ca01cf493f84c3a1bcbcf07c1d_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfOS01LTEtMS05NTU4_1a62f132-804a-4a37-8260-0b224d0637d8" unitRef="usd">-13291</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="id3900d92fcea4358838f65d608ad8088_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfOS03LTEtMS05NTU4_4a6e8da3-122d-455f-b241-eaff3c73e5ab" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i5d6efd6bd2c041769f9fbf0d1a3e5685_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMTAtMS0xLTEtOTU1OA_fc5c19a4-ab1e-4bd2-b9cf-4004082f324d" unitRef="usd">178886</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i1571108ca25f4e179a9d14073629ae96_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMTAtMy0xLTEtOTU1OA_79c09d38-4aa3-4992-8f2c-de5df9d3ffc3" unitRef="usd">265047</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i8cf12a139ea74881b685de000f63434e_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMTAtNS0xLTEtOTU1OA_558f692d-3089-4277-8ea5-29151151b7f3" unitRef="usd">809429</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="idbd3b5d4865547179a8bf7fbe50a430c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMTAtNy0xLTEtOTU1OA_fac5f00f-89f8-4736-a229-122f163e68dc" unitRef="usd">1605570</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMTEtMS0xLTEtOTU1OA_b6ac83bd-0458-4369-9a85-f470187e7f82" unitRef="usd">8072540</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ie2722c94900c4f68be9dd446637b8348_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMTEtMy0xLTEtOTU1OA_19f350b8-1c28-49a7-bf10-2f42e94db843" unitRef="usd">9250689</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMTEtNS0xLTEtOTU1OA_0094e52f-9c3c-4142-a794-86eaf014acc6" unitRef="usd">27665182</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RhYmxlOjc1ZWU0YjlmNmU1YjRhYTZhZWEwZTM1ZGQzZmE4NTUwL3RhYmxlcmFuZ2U6NzVlZTRiOWY2ZTViNGFhNmFlYTBlMzVkZDNmYTg1NTBfMTEtNy0xLTEtOTU1OA_bc779da5-b1ab-41b7-b6de-50878abe327d" unitRef="usd">27179600</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i7beb09efdc954e3387adf27b4cc99538_D20210701-20210930" decimals="-4" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RleHRyZWdpb246ZmFiNDdlMmJmMGFlNDcxNzhiN2Q4ZmM2ZmYzMTEzNjBfMjUxNQ_e38456b6-7808-436d-8cb6-1af633fc202d" unitRef="usd">20000.00</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i9c591eb458184e3baae21c9c26245264_D20200701-20200930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RleHRyZWdpb246ZmFiNDdlMmJmMGFlNDcxNzhiN2Q4ZmM2ZmYzMTEzNjBfMjUyMg_484f8b73-8f0c-41ba-ae46-dd3d1f82e948" unitRef="usd">100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i32601382eaeb463ba862531b12def23c_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RleHRyZWdpb246ZmFiNDdlMmJmMGFlNDcxNzhiN2Q4ZmM2ZmYzMTEzNjBfMTA5OTUxMTYzMDM3MQ_e3a1a333-4731-4893-82f3-be05efc8581a" unitRef="usd">300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i76c8b1e743d441a3ad6f81bc894366dd_D20200101-20200930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF8zNy9mcmFnOmZhYjQ3ZTJiZjBhZTQ3MTc4YjdkOGZjNmZmMzExMzYwL3RleHRyZWdpb246ZmFiNDdlMmJmMGFlNDcxNzhiN2Q4ZmM2ZmYzMTEzNjBfMTA5OTUxMTYzMDM4NA_1550654f-ba5a-4006-b699-93b2f67aeb94" unitRef="usd">700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:InventoryDisclosureTextBlock contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RleHRyZWdpb246NDg0YmI5ZDIyZGUzNDk5OGI0ZWJkOGQ5ZWY1OThjYTBfMjE2NQ_f9f5755f-ff5c-4d39-8f56-b7c16e52bfc6">INVENTORIES<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company works closely with third parties to manufacture and package finished goods for sale.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the arrangements with the manufacturer or packager, the Company will either take title to the finished goods at the time of shipment or at the time of arrival at the Company’s warehouses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company then holds such goods in inventory until distribution and sale. These finished goods inventories are stated at the lower of cost or net realizable value with cost determined using the first-in, first-out method.</span><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates inventory for potential losses due to excess, obsolete or slow-moving goods by comparing sales history and projections to the inventory on hand. When evidence indicates that the carrying value may not be recoverable, a charge is taken to reduce the inventory to its current net realizable value. At September 30, 2021 and December 31, 2020, the Company had recognized and maintained cumulative net realizable value charges for potential obsolescence and discontinuance losses of approximately $0.3 million and $0.2 million, respectively. </span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is responsible for the purchase of the active pharmaceutical ingredient (“API”) for Kristalose and maintains the inventory at third-party packagers. As that API is consumed in production, the value of the API is transferred from raw materials to finished goods. API for the Company's Vaprisol brand is also included in the raw materials inventory at September 30, 2021 and December 31, 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consigned inventory represents Authorized Generic inventory stored with Perrigo until shipment. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Vibativ acquisition, Cumberland acquired API and work in process inventories of $15.6 million that were all initially classified as non-current inventories at the date of acquisition. At September 30, 2021 and December 31, 2020, total non-current inventory, including Vibativ and ifetroban, was $9.5 million and $11.7 million, respectively. The Company had $0.2 million and $2.1 million of Vibativ finished goods included in non-current inventory at September 30, 2021 and December 31, 2020, respectively. The Company also has obtained $0.4 million of finished goods in non-current inventory for API related to its ifetroban clinical initiatives at September 30, 2021 and December 31, 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021 and December 31, 2020 the Company's net inventories consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:57.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.681%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and work in process</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,782,630 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,223,162 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consigned inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,583 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,005 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,812,293 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,943,732 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,739,506 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,294,899 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">less non-current inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,476,737)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,656,742)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories classified as current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,262,769 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,638,157 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></us-gaap:InventoryDisclosureTextBlock> <us-gaap:InventoryValuationReserves contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RleHRyZWdpb246NDg0YmI5ZDIyZGUzNDk5OGI0ZWJkOGQ5ZWY1OThjYTBfMTAzOA_fa408c45-20a7-4a34-a5ed-e06b546e3fa2" unitRef="usd">300000</us-gaap:InventoryValuationReserves> <us-gaap:InventoryValuationReserves contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RleHRyZWdpb246NDg0YmI5ZDIyZGUzNDk5OGI0ZWJkOGQ5ZWY1OThjYTBfMTA0NQ_127d42c6-8d00-406d-9c1e-194145fbe302" unitRef="usd">200000</us-gaap:InventoryValuationReserves> <us-gaap:InventoryNoncurrent contextRef="i890f0fecec4a4eb899b3171ad304df32_I20201231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RleHRyZWdpb246NDg0YmI5ZDIyZGUzNDk5OGI0ZWJkOGQ5ZWY1OThjYTBfMTYzNA_d3cebd19-55eb-470b-bfec-5b243c70155c" unitRef="usd">15600000</us-gaap:InventoryNoncurrent> <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="i5d7014c036534d1ab07ea1c7138ece74_I20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RleHRyZWdpb246NDg0YmI5ZDIyZGUzNDk5OGI0ZWJkOGQ5ZWY1OThjYTBfMTA5OTUxMTYyOTk0NQ_4ab0569c-c14e-4492-9b69-18f6d19f72c8" unitRef="usd">9500000</us-gaap:InventoryFinishedGoodsNetOfReserves> <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="i890f0fecec4a4eb899b3171ad304df32_I20201231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RleHRyZWdpb246NDg0YmI5ZDIyZGUzNDk5OGI0ZWJkOGQ5ZWY1OThjYTBfMTA5OTUxMTYyOTk1NA_874de2f0-2f47-4f8f-9188-998b4b02e087" unitRef="usd">11700000</us-gaap:InventoryFinishedGoodsNetOfReserves> <us-gaap:InventoryFinishedGoods contextRef="i5d7014c036534d1ab07ea1c7138ece74_I20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RleHRyZWdpb246NDg0YmI5ZDIyZGUzNDk5OGI0ZWJkOGQ5ZWY1OThjYTBfMTg0OQ_2ed9aba5-9edc-492b-8cdc-1e3a690c1101" unitRef="usd">200000</us-gaap:InventoryFinishedGoods> <us-gaap:InventoryFinishedGoods contextRef="i890f0fecec4a4eb899b3171ad304df32_I20201231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RleHRyZWdpb246NDg0YmI5ZDIyZGUzNDk5OGI0ZWJkOGQ5ZWY1OThjYTBfMTg1Ng_5eea83b7-3275-4299-b37f-fff4ff11c4fa" unitRef="usd">2100000</us-gaap:InventoryFinishedGoods> <us-gaap:InventoryNoncurrent contextRef="i2fb3c2ea35a146918884002eb0319cb9_I20201231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RleHRyZWdpb246NDg0YmI5ZDIyZGUzNDk5OGI0ZWJkOGQ5ZWY1OThjYTBfMTk3OA_b3d9ee24-5d32-4dfb-8196-00c2d48a3aba" unitRef="usd">400000</us-gaap:InventoryNoncurrent> <us-gaap:InventoryNoncurrent contextRef="i85407d87b0cc40608f88c792ee3187bc_I20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RleHRyZWdpb246NDg0YmI5ZDIyZGUzNDk5OGI0ZWJkOGQ5ZWY1OThjYTBfMTk3OA_f0bd8122-1a02-4f83-ac77-b4afdd80cd26" unitRef="usd">400000</us-gaap:InventoryNoncurrent> <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RleHRyZWdpb246NDg0YmI5ZDIyZGUzNDk5OGI0ZWJkOGQ5ZWY1OThjYTBfMjE2Ng_6d16846e-cb06-47a4-8900-fd09792f72f2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021 and December 31, 2020 the Company's net inventories consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:57.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.681%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and work in process</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,782,630 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,223,162 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consigned inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,583 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,005 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,812,293 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,943,732 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,739,506 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,294,899 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">less non-current inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,476,737)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,656,742)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories classified as current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,262,769 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,638,157 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></us-gaap:ScheduleOfInventoryCurrentTableTextBlock> <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfMi0yLTEtMS05NTU4_52255f9a-f9a5-44b9-a075-0b0113724cc3" unitRef="usd">13782630</us-gaap:InventoryRawMaterialsNetOfReserves> <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfMi00LTEtMS05NTU4_082938bd-a415-430e-947d-2f7f7b9e89ca" unitRef="usd">16223162</us-gaap:InventoryRawMaterialsNetOfReserves> <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfMi00LTEtMS05NTU4_906783ec-d2af-4d21-9732-091f7e7352c1" unitRef="usd">16223162</us-gaap:InventoryRawMaterialsNetOfReserves> <us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfMy0yLTEtMS05NTU4_0d78d7c6-ff7a-4083-890b-d2408268a4cc" unitRef="usd">144583</us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment> <us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfMy00LTEtMS05NTU4_51de1e87-e7ef-4372-b545-96bb85039d94" unitRef="usd">128005</us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment> <us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfMy00LTEtMS05NTU4_564a45e6-e8c7-4bb4-8024-c3d990ff3216" unitRef="usd">128005</us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment> <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfNC0yLTEtMS05NTU4_7fdd8ea8-8cfa-497a-9b82-c7679d7efe1f" unitRef="usd">5812293</us-gaap:InventoryFinishedGoodsNetOfReserves> <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfNC00LTEtMS05NTU4_2c8730e5-fba8-4578-a00b-a080bdb48a68" unitRef="usd">5943732</us-gaap:InventoryFinishedGoodsNetOfReserves> <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfNC00LTEtMS05NTU4_a80a1ef7-1394-4e54-a23b-aadacdab3e00" unitRef="usd">5943732</us-gaap:InventoryFinishedGoodsNetOfReserves> <us-gaap:InventoryGross contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfNS0yLTEtMS05NTU4_663fc4b7-39e2-46f6-8f84-d3070a4649d0" unitRef="usd">19739506</us-gaap:InventoryGross> <us-gaap:InventoryGross contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfNS00LTEtMS05NTU4_3adbed54-4d5e-4360-b3d0-2d5d89425076" unitRef="usd">22294899</us-gaap:InventoryGross> <us-gaap:InventoryNoncurrent contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfNi0yLTEtMS05NTU4_1b1b0259-48c4-487b-b5cf-3651f88ef0e4" unitRef="usd">9476737</us-gaap:InventoryNoncurrent> <us-gaap:InventoryNoncurrent contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfNi00LTEtMS05NTU4_e8de5d18-2729-4ad0-b514-412dd551c3b3" unitRef="usd">11656742</us-gaap:InventoryNoncurrent> <us-gaap:InventoryNet contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfNy0yLTEtMS05NTU4_ff6d04fc-6a3f-4dfd-bfc0-a29604136553" unitRef="usd">10262769</us-gaap:InventoryNet> <us-gaap:InventoryNet contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80MC9mcmFnOjQ4NGJiOWQyMmRlMzQ5OThiNGViZDhkOWVmNTk4Y2EwL3RhYmxlOjliYjQyZTEwYmNiNzRlNjU5OWM1MWRiOTZhNTIxMmQ0L3RhYmxlcmFuZ2U6OWJiNDJlMTBiY2I3NGU2NTk5YzUxZGI5NmE1MjEyZDRfNy00LTEtMS05NTU4_bf4ebc7e-94e4-46f3-badc-bae858aaf1d8" unitRef="usd">10638157</us-gaap:InventoryNet> <us-gaap:LesseeOperatingLeasesTextBlock contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RleHRyZWdpb246OThjNTVkMmNjZTEwNDcxZmJkMTkwMjYyODEzYmNmNGVfMTk3OA_fd0673d3-5ce2-4535-a5d9-f1aeac19171d">LEASES<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland’s significant operating leases include the lease of approximately 25,500 square feet of office space in Nashville, Tennessee for its corporate headquarters. This lease currently expires in October 2022. The Company's operating leases also include the lease of approximately 14,200 square feet of wet laboratory and office space in Nashville, Tennessee by CET, our majority-owned subsidiary, where it operates the CET Life Sciences Center. This lease currently expires in April 2023. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities are recorded as the present value of remaining lease payments not yet paid for the lease term discounted using the incremental borrowing rate associated with each lease. Operating lease right-of-use assets represent operating lease liabilities adjusted for lease incentives and initial direct costs. As Cumberland’s leases do not contain implicit borrowing rates, the incremental borrowing rates were calculated based on information available at January 1, 2019. Incremental borrowing rates reflect the Company’s estimated interest rates for collateralized borrowings over similar lease terms. The weighted-average incremental borrowing rate used to discount the present value of the remaining lease payments is 7.42%. The weighted-average remaining lease term at September 30, 2021 is 1.2 years.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lease Position</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021 and December 31, 2020 , the Company's lease assets and liabilities were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right-of-Use Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,282,275 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,028,148 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,094,187 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016,779 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease noncurrent liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,605 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,059,693 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323,792 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,076,472 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumulative future minimum sublease income under non-cancelable operating subleases totals approximately $0.1 million and will be paid through the leases ending in October 2022 and April 2023. Future minimum lease payments under non-cancelable operating leases (with initial or remaining lease terms in excess of one year) are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.554%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity of Lease Liabilities at September 30, 2021</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,038 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019,313 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,478 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,406,829 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,037 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323,792 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense is recognized over the expected term of the lease, including renewal option periods, if applicable, on a straight-line basis as a component of general and administrative expense. Rent expense and sublease income were as follows:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910,975 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871,441 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526,868 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491,391 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></us-gaap:LesseeOperatingLeasesTextBlock> <us-gaap:AreaOfRealEstateProperty contextRef="ifd0c03fd249e4e64a76675f06c950be1_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RleHRyZWdpb246OThjNTVkMmNjZTEwNDcxZmJkMTkwMjYyODEzYmNmNGVfOTQ_ce1e9220-ef32-45fc-b7cf-e49ef510d576" unitRef="sqft">25500</us-gaap:AreaOfRealEstateProperty> <us-gaap:AreaOfRealEstateProperty contextRef="i67e0bde90efc45a7a814f5c68fb0096f_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RleHRyZWdpb246OThjNTVkMmNjZTEwNDcxZmJkMTkwMjYyODEzYmNmNGVfMzAw_eb4a03e1-b8ae-40a3-85ec-d570c5113a29" unitRef="sqft">14200</us-gaap:AreaOfRealEstateProperty> <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RleHRyZWdpb246OThjNTVkMmNjZTEwNDcxZmJkMTkwMjYyODEzYmNmNGVfMTI0OA_2d76f378-da2f-4b82-a7c3-0b40798dc339" unitRef="number">0.0742</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent> <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RleHRyZWdpb246OThjNTVkMmNjZTEwNDcxZmJkMTkwMjYyODEzYmNmNGVfMTMwMw_cb651dca-3da6-49f5-a8c2-d4898c278cdc">P1Y2M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1> <cpix:AssetsAndLiabilitiesLesseeTableTextBlock contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RleHRyZWdpb246OThjNTVkMmNjZTEwNDcxZmJkMTkwMjYyODEzYmNmNGVfMTk3OQ_ead4bb19-3276-4229-a689-d63dbe2018b6"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021 and December 31, 2020 , the Company's lease assets and liabilities were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right-of-Use Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,282,275 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,028,148 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,094,187 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016,779 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease noncurrent liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,605 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,059,693 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323,792 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,076,472 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumulative future minimum sublease income under non-cancelable operating subleases totals approximately $0.1 million and will be paid through the leases ending in October 2022 and April 2023. Future minimum lease payments under non-cancelable operating leases (with initial or remaining lease terms in excess of one year) are as follows:</span></div></cpix:AssetsAndLiabilitiesLesseeTableTextBlock> <us-gaap:OperatingLeaseRightOfUseAsset contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjAxNTUzNDY5NGIyNjQwNWNiODgzODJlYmJmZTZlZGI3L3RhYmxlcmFuZ2U6MDE1NTM0Njk0YjI2NDA1Y2I4ODM4MmViYmZlNmVkYjdfMS0yLTEtMS05NTU4_03898100-deee-4659-8993-7d7a00a7e0cb" unitRef="usd">1282275</us-gaap:OperatingLeaseRightOfUseAsset> <us-gaap:OperatingLeaseRightOfUseAsset contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjAxNTUzNDY5NGIyNjQwNWNiODgzODJlYmJmZTZlZGI3L3RhYmxlcmFuZ2U6MDE1NTM0Njk0YjI2NDA1Y2I4ODM4MmViYmZlNmVkYjdfMS00LTEtMS05NTU4_37ee8221-5fb0-4021-9da4-00c47ee19b21" unitRef="usd">2028148</us-gaap:OperatingLeaseRightOfUseAsset> <us-gaap:OperatingLeaseLiabilityCurrent contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjU2YWY4M2IxZDI4ZTQ0YmJhNzYyMjhiYjFmYzhhNGQ2L3RhYmxlcmFuZ2U6NTZhZjgzYjFkMjhlNDRiYmE3NjIyOGJiMWZjOGE0ZDZfMS0yLTEtMS05NTU4_2e433f39-34c1-4921-a1eb-2c04de7596b4" unitRef="usd">1094187</us-gaap:OperatingLeaseLiabilityCurrent> <us-gaap:OperatingLeaseLiabilityCurrent contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjU2YWY4M2IxZDI4ZTQ0YmJhNzYyMjhiYjFmYzhhNGQ2L3RhYmxlcmFuZ2U6NTZhZjgzYjFkMjhlNDRiYmE3NjIyOGJiMWZjOGE0ZDZfMS00LTEtMS05NTU4_5444717e-03d4-4aae-b706-03fe5eee67e4" unitRef="usd">1016779</us-gaap:OperatingLeaseLiabilityCurrent> <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjU2YWY4M2IxZDI4ZTQ0YmJhNzYyMjhiYjFmYzhhNGQ2L3RhYmxlcmFuZ2U6NTZhZjgzYjFkMjhlNDRiYmE3NjIyOGJiMWZjOGE0ZDZfMy0yLTEtMS05NTU4_ac21f239-47a9-4048-b4e5-fb6a30904c23" unitRef="usd">229605</us-gaap:OperatingLeaseLiabilityNoncurrent> <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjU2YWY4M2IxZDI4ZTQ0YmJhNzYyMjhiYjFmYzhhNGQ2L3RhYmxlcmFuZ2U6NTZhZjgzYjFkMjhlNDRiYmE3NjIyOGJiMWZjOGE0ZDZfMy00LTEtMS05NTU4_33c77651-a926-495c-b2e7-10d92b256397" unitRef="usd">1059693</us-gaap:OperatingLeaseLiabilityNoncurrent> <cpix:LeaseLiability contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjU2YWY4M2IxZDI4ZTQ0YmJhNzYyMjhiYjFmYzhhNGQ2L3RhYmxlcmFuZ2U6NTZhZjgzYjFkMjhlNDRiYmE3NjIyOGJiMWZjOGE0ZDZfNC0yLTEtMS05NTU4_94ab13ee-3a95-4fd1-9cd5-7e087475d25a" unitRef="usd">1323792</cpix:LeaseLiability> <cpix:LeaseLiability contextRef="idb172cb6365440839665fd6ec022472c_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjU2YWY4M2IxZDI4ZTQ0YmJhNzYyMjhiYjFmYzhhNGQ2L3RhYmxlcmFuZ2U6NTZhZjgzYjFkMjhlNDRiYmE3NjIyOGJiMWZjOGE0ZDZfNC00LTEtMS05NTU4_44b00de6-b348-4030-8772-2419a4261b7f" unitRef="usd">2076472</cpix:LeaseLiability> <us-gaap:LessorOperatingLeasePaymentsToBeReceived contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RleHRyZWdpb246OThjNTVkMmNjZTEwNDcxZmJkMTkwMjYyODEzYmNmNGVfMTUxMA_061ec92c-9b5e-42ad-91fe-7b3b9071690b" unitRef="usd">100000</us-gaap:LessorOperatingLeasePaymentsToBeReceived> <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RleHRyZWdpb246OThjNTVkMmNjZTEwNDcxZmJkMTkwMjYyODEzYmNmNGVfMTk4MA_c7686295-6060-4904-bb25-afd463471d17"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.554%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity of Lease Liabilities at September 30, 2021</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,038 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019,313 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,478 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,406,829 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,037 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323,792 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock> <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjg1MDVmNWNhNDVjNDQ1ZjQ4NWMwZmRmYjdhNjZiOGNiL3RhYmxlcmFuZ2U6ODUwNWY1Y2E0NWM0NDVmNDg1YzBmZGZiN2E2NmI4Y2JfMS0yLTEtMS05NTU4_f3c41a5d-d2ee-41de-86f2-480ce6f9126d" unitRef="usd">295038</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths> <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjg1MDVmNWNhNDVjNDQ1ZjQ4NWMwZmRmYjdhNjZiOGNiL3RhYmxlcmFuZ2U6ODUwNWY1Y2E0NWM0NDVmNDg1YzBmZGZiN2E2NmI4Y2JfMi0yLTEtMS05NTU4_898b543d-e22f-4964-8f2e-6b6b708fff94" unitRef="usd">1019313</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo> <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjg1MDVmNWNhNDVjNDQ1ZjQ4NWMwZmRmYjdhNjZiOGNiL3RhYmxlcmFuZ2U6ODUwNWY1Y2E0NWM0NDVmNDg1YzBmZGZiN2E2NmI4Y2JfMy0yLTEtMS05NTU4_3235881e-2165-4f96-974f-908e882f6170" unitRef="usd">92478</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree> <cpix:LesseeOperatingLeaseLiabilityToBePaidAfterYearThree contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjg1MDVmNWNhNDVjNDQ1ZjQ4NWMwZmRmYjdhNjZiOGNiL3RhYmxlcmFuZ2U6ODUwNWY1Y2E0NWM0NDVmNDg1YzBmZGZiN2E2NmI4Y2JfNC0yLTEtMS05NTU4_0d2752e6-9c2a-4171-a5f4-d3080d1919c7" unitRef="usd">0</cpix:LesseeOperatingLeaseLiabilityToBePaidAfterYearThree> <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjg1MDVmNWNhNDVjNDQ1ZjQ4NWMwZmRmYjdhNjZiOGNiL3RhYmxlcmFuZ2U6ODUwNWY1Y2E0NWM0NDVmNDg1YzBmZGZiN2E2NmI4Y2JfNS0yLTEtMS05NTU4_720a3b83-65b9-4f98-a558-db21838b1bf5" unitRef="usd">1406829</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue> <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjg1MDVmNWNhNDVjNDQ1ZjQ4NWMwZmRmYjdhNjZiOGNiL3RhYmxlcmFuZ2U6ODUwNWY1Y2E0NWM0NDVmNDg1YzBmZGZiN2E2NmI4Y2JfNi0yLTEtMS05NTU4_5d86e601-a637-4f97-9354-bd1465bb2393" unitRef="usd">83037</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount> <us-gaap:OperatingLeaseLiability contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjg1MDVmNWNhNDVjNDQ1ZjQ4NWMwZmRmYjdhNjZiOGNiL3RhYmxlcmFuZ2U6ODUwNWY1Y2E0NWM0NDVmNDg1YzBmZGZiN2E2NmI4Y2JfNy0yLTEtMS05NTU4_a41f1f70-093b-4656-99e8-82c60f0845f6" unitRef="usd">1323792</us-gaap:OperatingLeaseLiability> <cpix:ScheduleofRentExpenseandSubleaseIncomeTableTextBlock contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RleHRyZWdpb246OThjNTVkMmNjZTEwNDcxZmJkMTkwMjYyODEzYmNmNGVfMTk4MQ_a07552b5-81b7-4736-b9cc-308851fc4066">Rent expense and sublease income were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910,975 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871,441 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526,868 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491,391 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></cpix:ScheduleofRentExpenseandSubleaseIncomeTableTextBlock> <us-gaap:OperatingLeaseExpense contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjg1MmFmZTE3YmM5YzQzMjFhZjFkNWUzYmIzOTg5YmVlL3RhYmxlcmFuZ2U6ODUyYWZlMTdiYzljNDMyMWFmMWQ1ZTNiYjM5ODliZWVfMi0yLTEtMS05NTU4_8485dfdd-3037-4ef3-bba8-bb574a0c3dfe" unitRef="usd">910975</us-gaap:OperatingLeaseExpense> <us-gaap:OperatingLeaseExpense contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjg1MmFmZTE3YmM5YzQzMjFhZjFkNWUzYmIzOTg5YmVlL3RhYmxlcmFuZ2U6ODUyYWZlMTdiYzljNDMyMWFmMWQ1ZTNiYjM5ODliZWVfMi00LTEtMS05NTU4_55241f73-83e6-4f7b-b9df-e0aabd4c2ecb" unitRef="usd">871441</us-gaap:OperatingLeaseExpense> <us-gaap:SubleaseIncome contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjg1MmFmZTE3YmM5YzQzMjFhZjFkNWUzYmIzOTg5YmVlL3RhYmxlcmFuZ2U6ODUyYWZlMTdiYzljNDMyMWFmMWQ1ZTNiYjM5ODliZWVfNC0yLTEtMS05NTU4_611e8fc1-afa2-4c67-8e71-090664bde8a9" unitRef="usd">526868</us-gaap:SubleaseIncome> <us-gaap:SubleaseIncome contextRef="iffc9469614ea454f887a8776d938bf3c_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80My9mcmFnOjk4YzU1ZDJjY2UxMDQ3MWZiZDE5MDI2MjgxM2JjZjRlL3RhYmxlOjg1MmFmZTE3YmM5YzQzMjFhZjFkNWUzYmIzOTg5YmVlL3RhYmxlcmFuZ2U6ODUyYWZlMTdiYzljNDMyMWFmMWQ1ZTNiYjM5ODliZWVfNC00LTEtMS05NTU4_6a8b050e-4a9d-4c02-86b9-097156bea41c" unitRef="usd">491391</us-gaap:SubleaseIncome> <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNzgyMQ_8c6372ab-cab9-431c-b845-9b651f6d39d6">SHAREHOLDERS’ EQUITY AND DEBT<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share repurchases</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland currently has a share repurchase program to repurchase up to $10 million of its common stock pursuant to Rule 10b-18 of the Securities Exchange Act of 1934. In January 2019, the Company's Board of Directors established the current $10 million repurchase program to replace the prior authorizations. During the nine months ended September 30, 2021 and September 30, 2020, the Company repurchased 326,537 shares and 407,683 shares, respectively, of common stock for approximately $1.0 million and $1.5 million, respectively. At September 30, 2021, approximately $5.2 million of common shares was left to repurchase under this program.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share purchases and sales</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the Company's March 2021 trading window, several members of Cumberland's Board of Directors entered into share purchase agreements of the Company's stock pursuant to Rule 10b-18 of the Securities Exchange Act of 1934. These purchases are designed to increase ownership in the Company by the members of the Board. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Sales</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2017, Cumberland filed a Shelf Registration on Form S-3 with the SEC associated with the sale of up to $100 million in corporate securities. The Shelf Registration was declared effective in January 2018. It also included an At the Market ("ATM") feature that allowed the Company to sell common shares at market prices, along with an agreement with B. Riley FBR Inc. to support such a placement of shares. The Company filed an updated Form S-3 with the SEC in December 2020, which was declared effective in January 2021. The Company does not currently have an ATM feature in place. Cumberland plans to continue to evaluate the market for its common shares, and if favorable, will further evaluate whether or not to enter into an ATM feature through B. Riley FBR, Inc. that would allow the Company to issue shares of its common stock. The Company did not issue any shares under an ATM during the nine months ended September 30, 2021 or September 30, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Share Grants and Incentive Stock Options</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2021 and September 30, 2020, the Company issued 36,850 shares and 230,491 shares of restricted stock to employees and directors, respectively. Restricted stock issued to employees generally cliff-vests on the fourth anniversary of the date of grant and for directors on the one-year anniversary of the date of grant. During the nine months ended September 30, 2021, the Company also issued 174,800 incentive stock options to employees that cliff-vest on the fourth anniversary of the date of grant, that are set to expire in March and May 2031. Stock compensation expense is presented as a component of general and administrative expense in the condensed consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Agreement</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2021, the Company and Pinnacle Bank entered into a Fourth Amendment to the Revolving Credit Note and Fifth Amendment ("Fifth Amendment") to the Revolving Credit Loan Agreement to renew the Revolving Credit Loan. </span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The original Pinnacle Agreement was dated July 2017. Beginning on August 14, 2018, and continuing until October 7, 2020, the Company and Pinnacle Bank entered into a series of amendments to extend and update the Revolving Credit Note and Revolving Credit Agreement. The most recent amendment dated October 28, 2021, extends the maturity date three years through October 1, 2024.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with prior Amendments, the Fifth Amendment provides for a principal balance available for borrowing of up to $15 million. The Company has the right to request an increase of up to an additional $5 million providing a maximum principal available of up to $20 million upon the satisfaction of certain conditions and with the approval of Pinnacle Bank. Also consistent with prior Amendments, the Company is required to maintain either a Funded Debt Ratio covenant or a Tangible Capital Ratio covenant. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate on the Pinnacle Agreement is based on LIBOR plus an interest rate spread. The pricing under the Fourth Amendment provides for an interest rate spread of 1.75% to 2.75% above LIBOR with a minimum LIBOR of 0.90%. The applicable interest rate under the Pinnacle Agreement was 3.65% at September 30, 2021. In addition, a fee of 0.25% per year is charged on the unused line of credit. Interest and the unused line fee are payable quarterly. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021 and December 31, 2020, the Company had $15.0 million in borrowings outstanding under its revolving credit facility. The Company was in compliance with the Tangible Capital Ratio financial covenant as of September 30, 2021. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the line of credit are collateralized by substantially all of our assets.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Paycheck Protection Program Loan</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 20, 2020, Cumberland received the funding of a loan from Pinnacle Bank in the amount of $2,187,140 pursuant to the Paycheck Protection Program (the “PPP”) under the Federal Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"), which was enacted March 27, 2020. The PPP is administered by the U.S. Small Business Administration ("SBA").</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the PPP requirements, loan funds were used to maintain payroll, continue group health care benefits, and pay for rent and utilities during the pandemic. We applied for this loan after carefully considering, with our bank, the eligibility criteria to participate in this program, and determining that Cumberland met those criteria. We evaluated and provided information on our payroll and other qualifying expenses to determine the amount of PPP funds to apply for. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the PPP, certain amounts of the loan may be forgiven if they are used for qualifying expenses as described in the CARES Act. Cumberland used the PPP loan funds for such qualifying expenses. Due to assistance from our PPP loan, the Company did not lay off or furlough any employees as a result of the COVID-19 pandemic.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland elected to account for the proceeds of the loan as a government grant under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Accounting Standard 20 ("IAS 20"), Accounting for Government Grants and Disclosure of Government Assistance. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The permitted analogous use of IAS 20 outlines a model for the accounting for government assistance, including forgivable loans. As a result, the Company recorded the $2,187,140 as a deferred income liability, which was included as a component of other current liabilities on the condensed consolidated balance sheet at December 31, 2020. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, Cumberland submitted a request for the loan’s forgiveness. On June 11, 2021, the Company received a formal notice from the SBA that the full amount of the loan was forgiven. The Company accounted for the forgiveness of the PPP loan under IAS 20 and recorded the $2,187,140 as other income.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Joint Venture Agreement</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, Cumberland entered into an agreement with WinHealth Investment (Singapore) Ltd creating </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">WHC Biopharmaceuticals, Pte. Ltd</span>. The joint venture, as a limited liability company, will focus on acquiring, developing, registering, and commercializing development stage and commercial stage biopharmaceuticals for China, Hong Kong and other Asian markets. The agreement provides for initial investment from WinHealth in the form of a $0.2 million equity contribution and an initial investment from Cumberland in the form of a $0.2 million convertible note, which was funded during the first quarter 2021. The joint venture will seek additional future capital from additional investors and has entered into exclusive option agreements to license intellectual property from both Cumberland Pharmaceuticals Inc. and Cumberland Emerging Technologies.</us-gaap:StockholdersEquityNoteDisclosureTextBlock> <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="i6b60adc716c54226bd1b0d9f82b62a4c_I20100513" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfMTMz_ba3f64fa-d60b-4ff9-b70f-3cf9b8753d17" unitRef="usd">10000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1> <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="i2d045c0da7504a3081ac01dc90d95aed_I20160131" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfMjk0_f678e4c8-a8f2-4356-884c-b1b9cb73b5be" unitRef="usd">10000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1> <us-gaap:StockRepurchasedDuringPeriodShares contextRef="i3eac19ab71204baa8b814cd80e8e55ab_D20210101-20210930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNDAw_73296c1c-97fa-4ffc-a460-0f989cbe74bc" unitRef="shares">326537</us-gaap:StockRepurchasedDuringPeriodShares> <us-gaap:StockRepurchasedDuringPeriodShares contextRef="i545187d4937e41ec99d80966b809dd78_D20200101-20200930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNDE0_15811f22-c3a0-4556-9429-51b724444c33" unitRef="shares">407683</us-gaap:StockRepurchasedDuringPeriodShares> <us-gaap:StockRepurchasedDuringPeriodValue contextRef="i3eac19ab71204baa8b814cd80e8e55ab_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNDcz_9cfa7502-61ab-47e0-b1ba-c818b27b3958" unitRef="usd">1000000</us-gaap:StockRepurchasedDuringPeriodValue> <us-gaap:StockRepurchasedDuringPeriodValue contextRef="i545187d4937e41ec99d80966b809dd78_D20200101-20200930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNDgw_aa52c0d5-afa4-473f-8330-856d30d985a8" unitRef="usd">1500000</us-gaap:StockRepurchasedDuringPeriodValue> <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="i56aafc7718c145c8b150a8e54f33a5d2_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfMTA5OTUxMTYzNTY0NA_9dedc84d-11d4-4922-988e-3accc0a508b2" unitRef="usd">5200000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1> <cpix:StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities contextRef="i4b890701c9304f309d867768f2a90a7b_D20171101-20171130" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfMTA2OA_4c7de529-a4f9-4d42-8a56-f199caf47357" unitRef="usd">100000000</cpix:StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities> <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="ib59b0ab18a9847a48768cc76def0c5ce_D20210101-20210930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfMTk1NA_8bcf9678-fe0e-4b49-8484-996291110dd8" unitRef="shares">36850</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod> <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="i7109429b4bb94262ab81694be586f875_D20200101-20200930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfMTk2OA_73466c05-659c-4db3-a7a7-b3179610f089" unitRef="shares">230491</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod> <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="i448fcba2bca740069897cf519754695f_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNzgxOQ_f7c65f96-fee8-4b79-8bad-5ee313476e7c">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1> <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="ie91a73f23b39413ca4897ecef5e9c6b9_D20210101-20210930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfMjI1Mw_87214b05-94bd-4f76-ad7b-47faea6bfb95" unitRef="shares">174800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod> <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="ie35d5d79a31d4a97ada4dc5eb118435d_I20211028" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfMTY0OTI2NzQ1NTc1OQ_c3038ab4-da2d-4b1c-ade8-9e3ba9509a53" unitRef="usd">15000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity> <cpix:LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount contextRef="ie35d5d79a31d4a97ada4dc5eb118435d_I20211028" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfMTY0OTI2NzQ1NTc0Nw_3185ae6b-bd95-4c31-b6d7-66ca9a182154" unitRef="usd">5000000</cpix:LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount> <cpix:LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity contextRef="ie35d5d79a31d4a97ada4dc5eb118435d_I20211028" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfMTY0OTI2NzQ1NTc3Mg_6a4b7f13-2028-469c-a8c0-781290ece41d" unitRef="usd">20000000</cpix:LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity> <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="i433310853533429eb0bd0de42c8cb8c0_D20200814-20200814" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNDU2MA_13cb7560-a435-4e9f-832d-f16665891a2a" unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1> <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="i7857ace04dd14acd90de8bfdfc44e2ad_D20200814-20200814" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNDU2Ng_51026c1a-824b-4d54-9b38-9a25058087c7" unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1> <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="ia066a8f68c2c4b2bb8d23f93616af446_D20200814-20200814" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNDYwNQ_d013790f-b4c3-4b49-bdec-497369f4088d" unitRef="number">0.009</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1> <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="i0c79a3c371c84f16b64c6d20ef3f26bd_I20210930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNDY3MQ_38ab6b8e-37e5-4857-b49c-d9fd0e5c894d" unitRef="number">0.0365</us-gaap:DebtInstrumentInterestRateStatedPercentage> <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage contextRef="i29e07103e7b54d69af01f448919f0979_D20210101-20210930" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNDcwNA_aba009bb-7351-49e8-bfa8-8c0659d42168" unitRef="number">0.0025</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage> <us-gaap:LongTermLineOfCredit contextRef="i5729693e898c46118beacc910390b13c_I20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfMTA5OTUxMTYzNzEwNQ_ef5585e4-2165-4512-834e-32005b7646ea" unitRef="usd">15000000</us-gaap:LongTermLineOfCredit> <cpix:TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived contextRef="i8f0ec15fc71f49aca22d17a26142e958_D20200420-20200420" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNTA0OA_1da139ea-f756-4e1a-8669-4516fdb4a578" unitRef="usd">2187140</cpix:TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived> <cpix:TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived contextRef="i8f0ec15fc71f49aca22d17a26142e958_D20200420-20200420" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNjQ5NQ_d6a212ef-2458-4366-8178-0386b71460d8" unitRef="usd">2187140</cpix:TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived> <cpix:TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived contextRef="i8f0ec15fc71f49aca22d17a26142e958_D20200420-20200420" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNjkzOQ_d6a212ef-2458-4366-8178-0386b71460d8" unitRef="usd">2187140</cpix:TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived> <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="i7f3eb3a61d724b16837687fe50bb6592_I20200831" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNzQyNQ_2a0d5b15-3e25-4b82-a442-1d8962f94a7e" unitRef="usd">200000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures> <us-gaap:DebtInstrumentFaceAmount contextRef="i10ede8aae6b6477eb6df1f13d1f8042a_I20200831" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80Ni9mcmFnOmJhNTMxMmRhZDAwNjQ3MmVhMDhkNmM5OTg4NDRkNWE5L3RleHRyZWdpb246YmE1MzEyZGFkMDA2NDcyZWEwOGQ2Yzk5ODg0NGQ1YTlfNzUwNw_027896fa-37c5-41ab-b0ed-802eeef9025a" unitRef="usd">200000</us-gaap:DebtInstrumentFaceAmount> <us-gaap:IncomeTaxDisclosureTextBlock contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80OS9mcmFnOjIwYTZlMDE2NzJiODRhMmJhZDBlYmZiMmE5NTk4Mzc4L3RleHRyZWdpb246MjBhNmUwMTY3MmI4NGEyYmFkMGViZmIyYTk1OTgzNzhfNjM3_aefd03d2-4c10-402c-92ed-1179f799f7f2">INCOME TAXESAs of September 30, 2021, the Company has approximately $56.5 million in federal net operating loss carryforwards including approximately $44.1 million of net operating loss carryforwards resulting from the exercise of nonqualified stock options. These have historically been used to significantly offset income tax obligations. The Company expects it will continue to pay minimal income taxes during 2021 and beyond, through the continued utilization of these net operating loss carryforwards, on any taxable income generated from our operations. The Company does not allocate any portion of its income tax expense (benefit) to discontinued operations.</us-gaap:IncomeTaxDisclosureTextBlock> <us-gaap:OperatingLossCarryforwards contextRef="ic25c3441c5a0477ebd8c769c3ea98555_I20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80OS9mcmFnOjIwYTZlMDE2NzJiODRhMmJhZDBlYmZiMmE5NTk4Mzc4L3RleHRyZWdpb246MjBhNmUwMTY3MmI4NGEyYmFkMGViZmIyYTk1OTgzNzhfNjI_3db0aa8b-d565-4727-8e06-406c0492c7df" unitRef="usd">56500000</us-gaap:OperatingLossCarryforwards> <us-gaap:OperatingLossCarryforwards contextRef="i5fc3bb3df16548c98cacace445d903da_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF80OS9mcmFnOjIwYTZlMDE2NzJiODRhMmJhZDBlYmZiMmE5NTk4Mzc4L3RleHRyZWdpb246MjBhNmUwMTY3MmI4NGEyYmFkMGViZmIyYTk1OTgzNzhfMTMz_063fd305-aa10-4eb0-be91-efc233c5669c" unitRef="usd">44100000</us-gaap:OperatingLossCarryforwards> <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81Mi9mcmFnOjkxYTMyNzA3NTQwODRlNzdiM2VmZjk4YWYwYTBhM2UxL3RleHRyZWdpb246OTFhMzI3MDc1NDA4NGU3N2IzZWZmOThhZjBhMGEzZTFfMTAyNg_6b27aa50-4a22-41f8-b835-f7fd88901262">COLLABORATIVE AGREEMENTS<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland is a party to several collaborative arrangements with research institutions to identify and pursue promising pharmaceutical product candidates. The funding for these programs is primarily provided through Federal Small Business Administration (SBIR/STTR) and other grant awards. The Company has determined that these collaborative agreements, with the exception of the collaborative payment received related to RediTrex, do not meet the criteria for accounting under ASC Topic 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The agreements do not specifically designate each party’s rights and obligations to each other under the collaborative arrangements. Except for patent defense costs, expenses incurred by one party are not required to be reimbursed by the other party. Expenses incurred under these collaborative agreements are included in research and development expenses and funding received from grants are recorded as net revenues in the condensed consolidated statements of operations.</span></us-gaap:CollaborativeArrangementDisclosureTextBlock> <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfNTg0MA_f24487e3-6f8c-4766-8223-21f98b90ef57">ADDITIONS AND RETURN OF PRODUCT RIGHTS<div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vibativ</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During November 2018, the Company closed on an agreement with Theravance Biopharma ("Theravance") to acquire the global responsibility for Vibativ including the marketing, distribution, manufacturing and regulatory activities associated with the brand. Vibativ is a patented, Food and Drug Administration ("FDA") approved injectable anti-infective for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia and complicated skin and skin structure infections. It addresses a range of Gram-positive bacterial pathogens, including those that are considered difficult-to-treat and multidrug-resistant. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland has accounted for the transaction as a business combination in accordance with ASC 805 and the product sales are included in the results of operations subsequent to the acquisition date. The Company made an upfront payment of $20.0 million at the closing of the transaction and a $5.0 million milestone payment in early April 2019. In addition, Cumberland has agreed to pay a royalty of up to 20% of on-going net sales of the product. The future royalty payments were required to be recognized at their acquisition-date fair value as a contingent consideration liability, as part of the contingent consideration transferred in the business combination. Cumberland prepared the valuations of the contingent consideration liability utilizing significant unobservable inputs. As a result, the valuation is classified as Level 3 fair value measurement. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the fair value of the contingent consideration liability that is remeasured on a recurring basis. The contingent consideration earned and accrued in operating expenses is paid to Theravance quarterly.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,200,552 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment of royalty during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,792,573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration included in operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(632,646)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration earned and accrued in operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134,333 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,909,666 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration liability of $6.9 million was classified as other current liabilities of $2.6 million and other long-term liabilities of $4.3 million on the condensed consolidated balance sheet as of September 30, 2021. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RediTrex</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2016, the Company announced an agreement with the Nordic Group B.V. ("Nordic") to acquire the exclusive U.S. rights to Nordic’s injectable methotrexate product line designed for the treatment of active rheumatoid arthritis, juvenile idiopathic arthritis, severe psoriatic arthritis, and severe disabling psoriasis. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As consideration for the license Cumberland paid a deposit of $100,000 at closing. The Company provided $0.9 million in consideration through a grant of 180,000 restricted shares of Cumberland common stock to be vested upon the FDA approval of the first Nordic product. Cumberland also agreed to provide Nordic a series of payments tied to the products’ FDA approval, launch and achievement of certain sales milestones. Under the terms of the agreement, Cumberland is responsible for the product registration and commercialization in the U.S. Nordic is responsible for product manufacturing and supply. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 27, 2019, Cumberland received FDA approval for the first Nordic injectable product and authorization to market them under the RediTrex brand name. The 180,000 shares of restricted Cumberland common stock previously provided to Nordic vested upon approval and were valued at $0.9 million on the vesting date. The FDA approval also resulted in a $1.0 million milestone payment due to Nordic. During December 2020, Cumberland introduced RediTrex and the launch that will take place in late 2021 will result in a $1.0 million milestone payment due to Nordic. This milestone payment will be paid during 2022 and is included as a current liability at September 30, 2021.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland has approximately $2.7 million in net intangible assets related to RediTrex at September 30, 2021. </span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ethyol and Totect </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2016, Cumberland entered into an agreement with Clinigen for the rights and responsibilities associated with the commercialization of Ethyol in the United States. In 2017, the Company entered into another agreement with Clinigen for the rights and responsibilities associated with the commercialization of Totect in the United States. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Early in 2019, Cumberland announced a strategic review of the Company's brands, capabilities, and international partners. This review followed an accelerated business development initiative, which resulted in a series of transactions. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During May 2019, Cumberland entered into the Dissolution Agreement with Clinigen in which the Company returned the exclusive rights to commercialize Ethyol and Totect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the United States to Clinigen. Under the final terms of the Dissolution Agreement, Cumberland was no longer responsible for the distribution, marketing and promotion of either Ethyol or Totect or any competing products after December 31, 2019.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In exchange for the return of these product license rights and the non-compete provisions of the Dissolution Agreement, Cumberland is receiving $5 million in financial consideration paid in quarterly installments over the two-years following the transition date. Cumberland recorded the first four quarterly installments totaling $3.0 million during 2020 and the next three installments totaling $1.5 million during the nine months ended September 30, 2021, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as discontinued operations. The Company will record the last remaining quarterly installment in the fourth quarter of 2021.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exit from Ethyol and Totect meets the accounting criteria to be reported as discontinued operations. December 31, 2019, as the transition date, was the final day Cumberland was responsible for the products. Cumberland was responsible for the products through December 31, 2019 and beginning on January 1, 2020, the products' rights transitioned back to Clinigen. As a result, January 1, 2020, was the first day of discontinued operations for the Ethyol and Totect products.</span></div><div style="margin-top:8pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dissolution payments from Clinigen are reflected as revenue from discontinued operations. The Company does not </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">incur expenses associated with these payments from Clinigen. </span></div><div style="margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496,787 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777,916 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,491,004 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334,811 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs of products sold</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, Marketing and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496,787 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777,916 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,491,004 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334,811 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></us-gaap:BusinessCombinationDisclosureTextBlock> <us-gaap:PaymentsToAcquireBusinessesGross contextRef="i57f795672a2a465e9209a65e0162f0b4_D20181101-20181130" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfOTcw_7e4f4541-973e-41c9-a96b-acda0c69e7b1" unitRef="usd">20000000</us-gaap:PaymentsToAcquireBusinessesGross> <us-gaap:OtherPaymentsToAcquireBusinesses contextRef="i57f795672a2a465e9209a65e0162f0b4_D20181101-20181130" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMTAxMw_c6c619d0-5a9a-4862-93bd-bac082c859aa" unitRef="usd">5000000</us-gaap:OtherPaymentsToAcquireBusinesses> <cpix:TieredRoyaltyPaymentsPercentage contextRef="i57f795672a2a465e9209a65e0162f0b4_D20181101-20181130" decimals="2" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMTExNg_5fd215db-2c05-4ad5-b957-dc4f3234dda8" unitRef="number">0.20</cpix:TieredRoyaltyPaymentsPercentage> <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfNTg0MQ_63cc83b6-0c84-430b-a0a8-ef4bdcc80d71"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the fair value of the contingent consideration liability that is remeasured on a recurring basis. The contingent consideration earned and accrued in operating expenses is paid to Theravance quarterly.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,200,552 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment of royalty during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,792,573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration included in operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(632,646)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration earned and accrued in operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134,333 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,909,666 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr></table></us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock> <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="i890f0fecec4a4eb899b3171ad304df32_I20201231" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjUyYWJlY2FiYzBlZDQ5NDRhNzg4YWIwNGI1NGUwMGFiL3RhYmxlcmFuZ2U6NTJhYmVjYWJjMGVkNDk0NGE3ODhhYjA0YjU0ZTAwYWJfOS0xLTEtMS05NTU4_c401baa2-4241-454e-a8e6-3422141524c2" unitRef="usd">8200552</us-gaap:BusinessCombinationContingentConsiderationLiability> <us-gaap:PaymentsForRoyalties contextRef="id08ba9ef8fce4ef0b1aebddae7a819be_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjUyYWJlY2FiYzBlZDQ5NDRhNzg4YWIwNGI1NGUwMGFiL3RhYmxlcmFuZ2U6NTJhYmVjYWJjMGVkNDk0NGE3ODhhYjA0YjU0ZTAwYWJfMTAtMS0xLTEtOTU1OA_71c82430-fe1a-4523-a9f5-0a188f0f9b04" unitRef="usd">1792573</us-gaap:PaymentsForRoyalties> <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="id08ba9ef8fce4ef0b1aebddae7a819be_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjUyYWJlY2FiYzBlZDQ5NDRhNzg4YWIwNGI1NGUwMGFiL3RhYmxlcmFuZ2U6NTJhYmVjYWJjMGVkNDk0NGE3ODhhYjA0YjU0ZTAwYWJfMTEtMS0xLTEtOTU1OA_8b843a3f-4aba-4599-b011-5eb43b1a13ae" unitRef="usd">-632646</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1> <cpix:BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses contextRef="id08ba9ef8fce4ef0b1aebddae7a819be_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjUyYWJlY2FiYzBlZDQ5NDRhNzg4YWIwNGI1NGUwMGFiL3RhYmxlcmFuZ2U6NTJhYmVjYWJjMGVkNDk0NGE3ODhhYjA0YjU0ZTAwYWJfMTItMS0xLTEtOTU1OA_65741f33-d908-4e37-a326-ec83e12aa2ec" unitRef="usd">1134333</cpix:BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses> <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="i5d7014c036534d1ab07ea1c7138ece74_I20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjUyYWJlY2FiYzBlZDQ5NDRhNzg4YWIwNGI1NGUwMGFiL3RhYmxlcmFuZ2U6NTJhYmVjYWJjMGVkNDk0NGE3ODhhYjA0YjU0ZTAwYWJfMTMtMS0xLTEtOTU1OA_ce52186d-c37c-470b-ba63-7b153ebc19ac" unitRef="usd">6909666</us-gaap:BusinessCombinationContingentConsiderationLiability> <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="i5d7014c036534d1ab07ea1c7138ece74_I20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMTg2Mw_58008847-255d-4a78-a316-fa566ad4af7d" unitRef="usd">6900000</us-gaap:BusinessCombinationContingentConsiderationLiability> <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="i0463cd68913447b0aec736a9a21b1701_I20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMTkxMw_e02dcf8f-caeb-4136-9ec8-9659b0b2055f" unitRef="usd">2600000</us-gaap:BusinessCombinationContingentConsiderationLiability> <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="icf562c30b2d9493a84db87baebada783_I20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMTk1MQ_c38a5770-195c-4619-a4be-92536441a70c" unitRef="usd">4300000</us-gaap:BusinessCombinationContingentConsiderationLiability> <us-gaap:PaymentsToAcquireBusinessesGross contextRef="if7d1c3dbcd4b4c6eabe94af067f29d41_D20161101-20161130" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMjQwOQ_8fb3a4e5-219e-441b-96b5-99345081c6ac" unitRef="usd">100000</us-gaap:PaymentsToAcquireBusinessesGross> <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="if7d1c3dbcd4b4c6eabe94af067f29d41_D20161101-20161130" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMjQ0Ng_6a25e1fb-d000-4426-9285-cd2deeea1d71" unitRef="usd">900000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred> <us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="ibb1ab73ec0354946b843823c167cac73_D20161101-20161130" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMjQ4NQ_376179ad-b353-4db2-a58c-98ba484c18c2" unitRef="shares">180000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions> <us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="ibb1ab73ec0354946b843823c167cac73_D20161101-20161130" decimals="INF" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMzA5Ng_170486f0-3188-4903-b50d-941bb79e6dd6" unitRef="shares">180000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions> <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="i9fbce1ec780d49a78a390da0ae5f4c6c_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMzIxNA_9bd7c5af-5bc2-4dd2-b7ba-9cb4a7cebe1a" unitRef="usd">900000</us-gaap:StockIssuedDuringPeriodValueAcquisitions> <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="i0a2ac195a36045adacdf507f9366ba39_I20200731" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMzI3NA_994c2cb0-774d-4e92-b009-1c78a3f5f6d5" unitRef="usd">1000000</us-gaap:BusinessCombinationContingentConsiderationLiability> <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="i0899d206bf0144cb8f97b035bbc59bdc_I20201231" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMzQzMA_3bf9017b-3a43-424d-b1de-5b5a7f6c6e64" unitRef="usd">1000000</us-gaap:BusinessCombinationContingentConsiderationLiability> <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="iab3199a2232b4c38950a9c717c8b9171_I20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfMzU5Ng_991683b6-233c-4928-af4f-17b9d058d786" unitRef="usd">2700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles> <us-gaap:ProceedsFromSaleOfIntangibleAssets contextRef="i3c783d360e1948c18a55f375b9840bca_D20191001-20210930" decimals="-6" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfNDgwOA_ebb4201e-3fc7-4588-94e9-1841362a7215" unitRef="usd">5000000</us-gaap:ProceedsFromSaleOfIntangibleAssets> <cpix:ProceedsFromSaleOfIntangibleAssetsInstallmentPayment contextRef="i54eac56082574a4c986a915dc06c3af5_D20210101-20210630" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfNDk4Ng_6c047bc2-19b9-467a-82a2-09a37b7365dd" unitRef="usd">3000000</cpix:ProceedsFromSaleOfIntangibleAssetsInstallmentPayment> <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="i45bdfab35dd74d60ac86fc023b908b73_D20210101-20210930" decimals="-5" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfNTA0MA_8a646cfd-70b9-46ad-a20c-f4a22a2f4631" unitRef="usd">1500000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax> <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock contextRef="i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RleHRyZWdpb246M2NjMTE0NzIwYTVhNDFkNDgwZDY5YjcyMjExYjBhMWJfNTg0Mg_3c327a04-eb39-4424-bbb1-9960eed76f96"><div style="margin-top:8pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dissolution payments from Clinigen are reflected as revenue from discontinued operations. The Company does not </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">incur expenses associated with these payments from Clinigen. </span></div><div style="margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496,787 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777,916 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,491,004 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334,811 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs of products sold</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, Marketing and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496,787 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777,916 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,491,004 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334,811 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ieb58760ea84940319b35492cd1910735_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfMy0yLTEtMS05NTU4_86849bd9-9c34-42dc-a4b6-2061e77af27b" unitRef="usd">496787</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ifca7f9fa06d14f85a52cbd81ac170d2c_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfMy00LTEtMS05NTU4_0fe8db84-b272-4c9f-a304-4c34cd7b14a3" unitRef="usd">777916</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="i45bdfab35dd74d60ac86fc023b908b73_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfMy01LTEtMS05NTU4_1acd7b61-10d3-4d57-a3bb-db27abac79f0" unitRef="usd">1491004</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="ib8c8802e62b74a919450a1c6017bba7e_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfMy03LTEtMS05NTU4_841b8fa5-722e-49de-805f-6e1ba99049bf" unitRef="usd">2334811</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:CostOfGoodsAndServicesSold contextRef="ieb58760ea84940319b35492cd1910735_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNC0yLTEtMS05NTU4_b370ba5e-0f89-4b8c-8e72-b4654071f9b9" unitRef="usd">0</us-gaap:CostOfGoodsAndServicesSold> <us-gaap:CostOfGoodsAndServicesSold contextRef="ifca7f9fa06d14f85a52cbd81ac170d2c_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNC00LTEtMS05NTU4_4f087064-ec6f-423b-b86f-0953ea7019c3" unitRef="usd">0</us-gaap:CostOfGoodsAndServicesSold> <us-gaap:CostOfGoodsAndServicesSold contextRef="i45bdfab35dd74d60ac86fc023b908b73_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNC01LTEtMS05NTU4_155b8afc-8ab1-457d-92e1-03a857618626" unitRef="usd">0</us-gaap:CostOfGoodsAndServicesSold> <us-gaap:CostOfGoodsAndServicesSold contextRef="ib8c8802e62b74a919450a1c6017bba7e_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNC03LTEtMS05NTU4_c03493ea-11f9-4d62-83fb-b13be2887ec5" unitRef="usd">0</us-gaap:CostOfGoodsAndServicesSold> <us-gaap:SellingAndMarketingExpense contextRef="ieb58760ea84940319b35492cd1910735_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNS0yLTEtMS05NTU4_7f78e0b8-872e-4890-b770-0a08422c7bcd" unitRef="usd">0</us-gaap:SellingAndMarketingExpense> <us-gaap:SellingAndMarketingExpense contextRef="ifca7f9fa06d14f85a52cbd81ac170d2c_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNS00LTEtMS05NTU4_11ac3d95-7e50-479f-ab22-21b3694b4b6a" unitRef="usd">0</us-gaap:SellingAndMarketingExpense> <us-gaap:SellingAndMarketingExpense contextRef="i45bdfab35dd74d60ac86fc023b908b73_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNS01LTEtMS05NTU4_34178999-de8e-4b4e-ac90-824fd32e5090" unitRef="usd">0</us-gaap:SellingAndMarketingExpense> <us-gaap:SellingAndMarketingExpense contextRef="ib8c8802e62b74a919450a1c6017bba7e_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNS03LTEtMS05NTU4_edecd593-95d2-431b-81e9-20a787b68ed8" unitRef="usd">0</us-gaap:SellingAndMarketingExpense> <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity contextRef="ieb58760ea84940319b35492cd1910735_D20210701-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNi0yLTEtMS05NTU4_bbd547b7-4377-470d-90d9-78decf2db53b" unitRef="usd">496787</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity> <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity contextRef="ifca7f9fa06d14f85a52cbd81ac170d2c_D20200701-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNi00LTEtMS05NTU4_3386f327-073b-4e39-8b3a-fea616e5490c" unitRef="usd">777916</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity> <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity contextRef="i45bdfab35dd74d60ac86fc023b908b73_D20210101-20210930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNi01LTEtMS05NTU4_b296a3be-7468-4125-abbc-ab4924871a99" unitRef="usd">1491004</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity> <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity contextRef="ib8c8802e62b74a919450a1c6017bba7e_D20200101-20200930" decimals="0" id="id3VybDovL2RvY3MudjEvZG9jOjhlOGJkYjkxZGM4OTQyMzRiOWQ4N2UxN2ExOGI1NGZkL3NlYzo4ZThiZGI5MWRjODk0MjM0YjlkODdlMTdhMThiNTRmZF81NS9mcmFnOjNjYzExNDcyMGE1YTQxZDQ4MGQ2OWI3MjIxMWIwYTFiL3RhYmxlOjI5OWQ0MTYwMGM5YTQ3MDlhNjZiNjg3MzFkMGNlNjQ0L3RhYmxlcmFuZ2U6Mjk5ZDQxNjAwYzlhNDcwOWE2NmI2ODczMWQwY2U2NDRfNi03LTEtMS05NTU4_4f55d8cf-b278-4038-beef-abe1a03978de" unitRef="usd">2334811</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity> </xbrl> </XML> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>24 <FILENAME>R1.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570218844312"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th> <th class="th" colspan="1">9 Months Ended</th> <th class="th" colspan="1"></th> </tr> <tr> <th class="th"><div>Sep. 30, 2021</div></th> <th class="th"><div>Nov. 08, 2021</div></th> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td> <td class="text">10-Q<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td> <td class="text">true<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td> <td class="text">Sep. 30, 2021<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td> <td class="text">false<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td> <td class="text">001-33637<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td> <td class="text">Cumberland Pharmaceuticals Inc.<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td> <td class="text">TN<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td> <td class="text">62-1765329<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td> <td class="text">2525 West End Avenue<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td> <td class="text">Suite 950<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td> <td class="text">Nashville<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td> <td class="text">TN<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td> <td class="text">37203<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td> <td class="text">615<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td> <td class="text">255-0068<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td> <td class="text">Common stock, no par value<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td> <td class="text">CPIX<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td> <td class="text">NASDAQ<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td> <td class="text">Yes<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td> <td class="text">Yes<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td> <td class="text">Non-accelerated Filer<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td> <td class="text">true<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td> <td class="text">false<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td> <td class="text">false<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td> <td class="text"> <span></span> </td> <td class="nump">14,809,628<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td> <td class="text">2021<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td> <td class="text">Q3<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td> <td class="text">false<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td> <td class="text">0001087294<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td> <td class="text">--12-31<span></span> </td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_AmendmentFlag</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:booleanItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_CityAreaCode</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:normalizedStringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_CoverAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:gMonthDayItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:fiscalPeriodItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:gYearItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:dateItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:booleanItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_DocumentTransitionReport</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:booleanItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_DocumentType</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:submissionTypeItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:normalizedStringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:normalizedStringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:normalizedStringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:normalizedStringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:stateOrProvinceItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityCentralIndexKey</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:centralIndexKeyItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:yesNoItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:booleanItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityFileNumber</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:fileNumberItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityFilerCategory</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:filerCategoryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:edgarStateCountryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:yesNoItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityRegistrantName</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:normalizedStringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityShellCompany</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:booleanItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntitySmallBusiness</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:booleanItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:employerIdItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_LocalPhoneNumber</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:normalizedStringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_Security12bTitle</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:securityTitleItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_SecurityExchangeName</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:edgarExchangeCodeItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_TradingSymbol</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:tradingSymbolItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>25 <FILENAME>R2.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570219965128"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br></strong></div></th> <th class="th"><div>Sep. 30, 2021</div></th> <th class="th"><div>Dec. 31, 2020</div></th> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td> <td class="nump">$ 25,843,231<span></span> </td> <td class="nump">$ 24,753,796<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td> <td class="nump">9,850,530<span></span> </td> <td class="nump">12,377,713<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td> <td class="nump">10,262,769<span></span> </td> <td class="nump">10,638,157<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Prepaid and other current assets</a></td> <td class="nump">1,259,098<span></span> </td> <td class="nump">2,199,926<span></span> </td> </tr> <tr class="rou"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td> <td class="nump">47,215,628<span></span> </td> <td class="nump">49,969,592<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNoncurrent', window );">Non-current inventories</a></td> <td class="nump">9,476,737<span></span> </td> <td class="nump">11,656,742<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td> <td class="nump">493,488<span></span> </td> <td class="nump">574,169<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td> <td class="nump">24,918,830<span></span> </td> <td class="nump">28,118,316<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td> <td class="nump">882,000<span></span> </td> <td class="nump">882,000<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td> <td class="nump">1,282,275<span></span> </td> <td class="nump">2,028,148<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td> <td class="nump">3,301,816<span></span> </td> <td class="nump">3,234,338<span></span> </td> </tr> <tr class="reu"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td> <td class="nump">87,570,774<span></span> </td> <td class="nump">96,463,305<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td> <td class="nump">9,233,383<span></span> </td> <td class="nump">13,396,286<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease current liabilities</a></td> <td class="nump">1,094,187<span></span> </td> <td class="nump">1,016,779<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td> <td class="nump">7,617,913<span></span> </td> <td class="nump">11,254,381<span></span> </td> </tr> <tr class="rou"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td> <td class="nump">17,945,483<span></span> </td> <td class="nump">25,667,446<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Revolving line of credit</a></td> <td class="nump">15,000,000<span></span> </td> <td class="nump">15,000,000<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease noncurrent liabilities</a></td> <td class="nump">229,605<span></span> </td> <td class="nump">1,059,693<span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_OtherLongTermObligationsExcludingCurrentPortion', window );">Other long-term liabilities</a></td> <td class="nump">7,749,421<span></span> </td> <td class="nump">7,862,772<span></span> </td> </tr> <tr class="rou"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td> <td class="nump">40,924,509<span></span> </td> <td class="nump">49,589,911<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders’ equity:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock—no par value; 100,000,000 shares authorized; 15,555,865 and 15,723,075 shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively</a></td> <td class="nump">48,612,935<span></span> </td> <td class="nump">49,121,523<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings (deficit)</a></td> <td class="num">(1,790,903)<span></span> </td> <td class="num">(2,131,013)<span></span> </td> </tr> <tr class="reu"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders’ equity</a></td> <td class="nump">46,822,032<span></span> </td> <td class="nump">46,990,510<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td> <td class="num">(175,767)<span></span> </td> <td class="num">(117,116)<span></span> </td> </tr> <tr class="reu"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td> <td class="nump">46,646,265<span></span> </td> <td class="nump">46,873,394<span></span> </td> </tr> <tr class="rou"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td> <td class="nump">$ 87,570,774<span></span> </td> <td class="nump">$ 96,463,305<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cpix_OtherLongTermObligationsExcludingCurrentPortion"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Long Term Obligations, Excluding Current Portion</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">cpix_OtherLongTermObligationsExcludingCurrentPortion</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>cpix_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_Assets</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AssetsCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CommonStockValue</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_Goodwill</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryNet</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNoncurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(d))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryNoncurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_Liabilities</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_MinorityInterest</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockholdersEquity</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>26 <FILENAME>R3.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570218595128"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th> <th class="th"><div>Sep. 30, 2021</div></th> <th class="th"><div>Dec. 31, 2020</div></th> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockNoParValue', window );">Common stock, par value (in dollars per share)</a></td> <td class="nump">$ 0<span></span> </td> <td class="nump">$ 0<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td> <td class="nump">100,000,000<span></span> </td> <td class="nump">100,000,000<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td> <td class="nump">14,850,526<span></span> </td> <td class="nump">14,988,429<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td> <td class="nump">14,850,526<span></span> </td> <td class="nump">14,988,429<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNoParValue"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value common stock.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CommonStockNoParValue</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>num:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>27 <FILENAME>R4.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570218937496"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br></strong></div></th> <th class="th" colspan="2">3 Months Ended</th> <th class="th" colspan="2">9 Months Ended</th> </tr> <tr> <th class="th"><div>Sep. 30, 2021</div></th> <th class="th"><div>Sep. 30, 2020</div></th> <th class="th"><div>Sep. 30, 2021</div></th> <th class="th"><div>Sep. 30, 2020</div></th> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td> <td class="nump">$ 8,072,540<span></span> </td> <td class="nump">$ 9,250,689<span></span> </td> <td class="nump">$ 27,665,182<span></span> </td> <td class="nump">$ 27,179,600<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td> <td class="nump">1,328,027<span></span> </td> <td class="nump">2,142,839<span></span> </td> <td class="nump">5,486,005<span></span> </td> <td class="nump">6,387,002<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td> <td class="nump">3,800,288<span></span> </td> <td class="nump">3,587,842<span></span> </td> <td class="nump">11,709,445<span></span> </td> <td class="nump">11,160,924<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td> <td class="nump">1,453,873<span></span> </td> <td class="nump">1,230,335<span></span> </td> <td class="nump">4,071,638<span></span> </td> <td class="nump">4,374,392<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td> <td class="nump">2,039,799<span></span> </td> <td class="nump">2,381,273<span></span> </td> <td class="nump">6,367,438<span></span> </td> <td class="nump">6,608,321<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization</a></td> <td class="nump">1,013,948<span></span> </td> <td class="nump">1,117,086<span></span> </td> <td class="nump">3,354,080<span></span> </td> <td class="nump">3,284,610<span></span> </td> </tr> <tr class="reu"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td> <td class="nump">9,635,935<span></span> </td> <td class="nump">10,459,375<span></span> </td> <td class="nump">30,988,606<span></span> </td> <td class="nump">31,815,249<span></span> </td> </tr> <tr class="rou"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td> <td class="num">(1,563,395)<span></span> </td> <td class="num">(1,208,686)<span></span> </td> <td class="num">(3,323,424)<span></span> </td> <td class="num">(4,635,649)<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td> <td class="nump">7,394<span></span> </td> <td class="nump">12,004<span></span> </td> <td class="nump">19,411<span></span> </td> <td class="nump">70,553<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other income</a></td> <td class="nump">0<span></span> </td> <td class="nump">0<span></span> </td> <td class="nump">2,187,140<span></span> </td> <td class="nump">0<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td> <td class="num">(20,021)<span></span> </td> <td class="num">(75,210)<span></span> </td> <td class="num">(70,297)<span></span> </td> <td class="num">(227,730)<span></span> </td> </tr> <tr class="rou"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) from continuing operations before income taxes</a></td> <td class="num">(1,576,022)<span></span> </td> <td class="num">(1,271,892)<span></span> </td> <td class="num">(1,187,170)<span></span> </td> <td class="num">(4,792,826)<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (expense) benefit</a></td> <td class="num">(7,458)<span></span> </td> <td class="num">(3,728)<span></span> </td> <td class="num">(22,375)<span></span> </td> <td class="num">(45,423)<span></span> </td> </tr> <tr class="rou"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest, Total</a></td> <td class="num">(1,583,480)<span></span> </td> <td class="num">(1,275,620)<span></span> </td> <td class="num">(1,209,545)<span></span> </td> <td class="num">(4,838,249)<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Discontinued operations</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">1,491,004<span></span> </td> <td class="nump">2,334,811<span></span> </td> </tr> <tr class="rou"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td> <td class="num">(1,086,693)<span></span> </td> <td class="num">(497,704)<span></span> </td> <td class="nump">281,459<span></span> </td> <td class="num">(2,503,438)<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net (income) loss at subsidiary attributable to noncontrolling interests</a></td> <td class="nump">31,415<span></span> </td> <td class="nump">15,967<span></span> </td> <td class="nump">58,651<span></span> </td> <td class="nump">47,806<span></span> </td> </tr> <tr class="rou"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to common shareholders</a></td> <td class="num">$ (1,055,278)<span></span> </td> <td class="num">$ (481,737)<span></span> </td> <td class="nump">$ 340,110<span></span> </td> <td class="num">$ (2,455,632)<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings (loss) per share attributable to common shareholders</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Earnings (loss) per share attributable to common shareholders - Continuing operations - basic (in dollars per share)</a></td> <td class="num">$ (0.10)<span></span> </td> <td class="num">$ (0.08)<span></span> </td> <td class="num">$ (0.08)<span></span> </td> <td class="num">$ (0.31)<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Earnings (loss) per share attributable to common shareholders - Discontinued operations - basic (in dollars per share)</a></td> <td class="nump">0.03<span></span> </td> <td class="nump">0.05<span></span> </td> <td class="nump">0.10<span></span> </td> <td class="nump">0.15<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings (loss) per share attributable to common shareholders - basic (in dollars per share)</a></td> <td class="num">(0.07)<span></span> </td> <td class="num">(0.03)<span></span> </td> <td class="nump">0.02<span></span> </td> <td class="num">(0.16)<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Earnings (loss) per share attributable to common shareholders - Continuing operations - diluted (in dollars per share)</a></td> <td class="num">(0.10)<span></span> </td> <td class="num">(0.08)<span></span> </td> <td class="num">(0.08)<span></span> </td> <td class="num">(0.31)<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Earnings (loss) per share attributable to common shareholders - Discontinued operations - diluted (in dollars per share)</a></td> <td class="nump">0.03<span></span> </td> <td class="nump">0.05<span></span> </td> <td class="nump">0.10<span></span> </td> <td class="nump">0.15<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings (loss) per share attributable to common shareholders - diluted (in dollars per share)</a></td> <td class="num">$ (0.07)<span></span> </td> <td class="num">$ (0.03)<span></span> </td> <td class="nump">$ 0.02<span></span> </td> <td class="num">$ (0.16)<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average shares outstanding</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">- basic (in shares)</a></td> <td class="nump">14,880,887<span></span> </td> <td class="nump">15,134,583<span></span> </td> <td class="nump">14,939,919<span></span> </td> <td class="nump">15,206,179<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">- diluted (in shares)</a></td> <td class="nump">14,880,887<span></span> </td> <td class="nump">15,134,583<span></span> </td> <td class="nump">15,139,904<span></span> </td> <td class="nump">15,206,179<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>num:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>num:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868656-224227<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>num:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868656-224227<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>num:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>num:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>num:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InterestExpense</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OtherIncome</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ProfitLoss</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>28 <FILENAME>R5.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570219777576"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th> <th class="th" colspan="2">9 Months Ended</th> </tr> <tr> <th class="th"><div>Sep. 30, 2021</div></th> <th class="th"><div>Sep. 30, 2020</div></th> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td> <td class="nump">$ 281,459<span></span> </td> <td class="num">$ (2,503,438)<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Discontinued operations</a></td> <td class="nump">1,491,004<span></span> </td> <td class="nump">2,334,811<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net income (loss) from continuing operations</a></td> <td class="num">(1,209,545)<span></span> </td> <td class="num">(4,838,249)<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) from continuing operations to net cash provided by operating activities:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td> <td class="nump">3,529,245<span></span> </td> <td class="nump">3,524,684<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td> <td class="nump">517,081<span></span> </td> <td class="nump">805,338<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities', window );">Decrease in non-cash contingent consideration</a></td> <td class="num">(632,646)<span></span> </td> <td class="num">(806,390)<span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy', window );">Increase (Decrease) In Cash Surrender Value Of Life Insurance Policy</a></td> <td class="num">(52,070)<span></span> </td> <td class="nump">169,406<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Noncash interest expense</a></td> <td class="nump">33,943<span></span> </td> <td class="nump">36,197<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Gain on forgiveness of debt</a></td> <td class="num">(2,187,140)<span></span> </td> <td class="nump">0<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Net changes in assets and liabilities affecting operating activities:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td> <td class="nump">2,527,183<span></span> </td> <td class="num">(1,817,490)<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td> <td class="nump">2,555,393<span></span> </td> <td class="nump">1,696,668<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other current assets and other assets</a></td> <td class="nump">1,627,350<span></span> </td> <td class="nump">1,962,024<span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_IncreaseDecreaseInCurrentOperatingLiabilities', window );">Accounts payable and other current liabilities</a></td> <td class="num">(2,873,596)<span></span> </td> <td class="nump">3,248,450<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td> <td class="num">(943,439)<span></span> </td> <td class="num">(1,585,584)<span></span> </td> </tr> <tr class="rou"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net cash provided by operating activities from continuing operations</a></td> <td class="nump">2,891,759<span></span> </td> <td class="nump">2,395,054<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations', window );">Discontinued operations</a></td> <td class="nump">1,491,004<span></span> </td> <td class="nump">2,166,086<span></span> </td> </tr> <tr class="rou"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td> <td class="nump">4,382,763<span></span> </td> <td class="nump">4,561,140<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions to property and equipment</a></td> <td class="num">(94,485)<span></span> </td> <td class="num">(95,189)<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from surrender of life insurance policies</a></td> <td class="nump">0<span></span> </td> <td class="nump">460,888<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Note receivable investment funding</a></td> <td class="num">(200,000)<span></span> </td> <td class="nump">0<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Additions to intangible assets</a></td> <td class="num">(180,613)<span></span> </td> <td class="num">(1,807,467)<span></span> </td> </tr> <tr class="rou"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td> <td class="num">(475,098)<span></span> </td> <td class="num">(1,441,768)<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit', window );">Borrowings on line of credit</a></td> <td class="nump">45,000,000<span></span> </td> <td class="nump">44,000,000<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments on line of credit</a></td> <td class="num">(45,000,000)<span></span> </td> <td class="num">(45,500,000)<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Cash payment of contingent consideration</a></td> <td class="num">(1,792,573)<span></span> </td> <td class="num">(834,014)<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Repurchase of subsidiary shares from noncontrolling interest</a></td> <td class="nump">0<span></span> </td> <td class="num">(800,000)<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common shares</a></td> <td class="num">(1,025,657)<span></span> </td> <td class="num">(1,551,463)<span></span> </td> </tr> <tr class="reu"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td> <td class="num">(2,818,230)<span></span> </td> <td class="num">(4,685,477)<span></span> </td> </tr> <tr class="rou"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td> <td class="nump">1,089,435<span></span> </td> <td class="num">(1,566,105)<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td> <td class="nump">24,753,796<span></span> </td> <td class="nump">28,212,635<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td> <td class="nump">$ 25,843,231<span></span> </td> <td class="nump">$ 26,646,530<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cpix_IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Cash Surrender Value Of Life Insurance Policy</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">cpix_IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>cpix_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cpix_IncreaseDecreaseInCurrentOperatingLiabilities"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">cpix_IncreaseDecreaseInCurrentOperatingLiabilities</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>cpix_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&oid=120383193&loc=d3e11374-113907<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period for redemption of redeemable noncontrolling interests.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfLinesOfCredit</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ProfitLoss</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>29 <FILENAME>R6.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570218648584"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statement of Equity - USD ($)<br></strong></div></th> <th class="th"><div>Total</div></th> <th class="th"><div>Common stock</div></th> <th class="th"><div>Retained earnings</div></th> <th class="th"><div>Noncontrolling interests</div></th> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, Beginning of Period at Dec. 31, 2019</a></td> <td class="nump">$ 51,085,253<span></span> </td> <td class="nump">$ 49,914,478<span></span> </td> <td class="nump">$ 1,208,395<span></span> </td> <td class="num">$ (37,620)<span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, Beginning of Period (in shares) at Dec. 31, 2019</a></td> <td class="text"> <span></span> </td> <td class="nump">15,263,555<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td> <td class="nump">264,574<span></span> </td> <td class="nump">$ 264,574<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td> <td class="text"> <span></span> </td> <td class="nump">219,850<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common shares</a></td> <td class="num">(441,624)<span></span> </td> <td class="num">$ (441,624)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of shares (in shares)</a></td> <td class="text"> <span></span> </td> <td class="num">(164,866)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td> <td class="num">(1,065,145)<span></span> </td> <td class="text"> <span></span> </td> <td class="num">(1,055,620)<span></span> </td> <td class="num">(9,525)<span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, End of Period at Mar. 31, 2020</a></td> <td class="nump">49,843,058<span></span> </td> <td class="nump">$ 49,737,428<span></span> </td> <td class="nump">152,775<span></span> </td> <td class="num">(47,145)<span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, End of Period (in shares) at Mar. 31, 2020</a></td> <td class="text"> <span></span> </td> <td class="nump">15,318,539<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, Beginning of Period at Dec. 31, 2019</a></td> <td class="nump">51,085,253<span></span> </td> <td class="nump">$ 49,914,478<span></span> </td> <td class="nump">1,208,395<span></span> </td> <td class="num">(37,620)<span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, Beginning of Period (in shares) at Dec. 31, 2019</a></td> <td class="text"> <span></span> </td> <td class="nump">15,263,555<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common shares</a></td> <td class="text"> <span></span> </td> <td class="num">$ (1,500,000)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of shares (in shares)</a></td> <td class="text"> <span></span> </td> <td class="num">(407,683)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td> <td class="num">(2,503,438)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, End of Period at Sep. 30, 2020</a></td> <td class="nump">47,843,377<span></span> </td> <td class="nump">$ 49,176,040<span></span> </td> <td class="num">(1,247,237)<span></span> </td> <td class="num">(85,426)<span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, End of Period (in shares) at Sep. 30, 2020</a></td> <td class="text"> <span></span> </td> <td class="nump">15,084,372<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, Beginning of Period at Mar. 31, 2020</a></td> <td class="nump">49,843,058<span></span> </td> <td class="nump">$ 49,737,428<span></span> </td> <td class="nump">152,775<span></span> </td> <td class="num">(47,145)<span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, Beginning of Period (in shares) at Mar. 31, 2020</a></td> <td class="text"> <span></span> </td> <td class="nump">15,318,539<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td> <td class="nump">278,349<span></span> </td> <td class="nump">$ 278,349<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td> <td class="text"> <span></span> </td> <td class="nump">4,200<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common shares</a></td> <td class="num">(769,648)<span></span> </td> <td class="num">$ (769,648)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of shares (in shares)</a></td> <td class="text"> <span></span> </td> <td class="num">(141,463)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td> <td class="num">(940,589)<span></span> </td> <td class="text"> <span></span> </td> <td class="num">(918,275)<span></span> </td> <td class="num">(22,314)<span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, End of Period at Jun. 30, 2020</a></td> <td class="nump">48,411,170<span></span> </td> <td class="nump">$ 49,246,129<span></span> </td> <td class="num">(765,500)<span></span> </td> <td class="num">(69,459)<span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, End of Period (in shares) at Jun. 30, 2020</a></td> <td class="text"> <span></span> </td> <td class="nump">15,181,276<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td> <td class="nump">262,415<span></span> </td> <td class="nump">$ 262,415<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td> <td class="text"> <span></span> </td> <td class="nump">4,450<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common shares</a></td> <td class="num">(332,504)<span></span> </td> <td class="num">$ (332,504)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of shares (in shares)</a></td> <td class="text"> <span></span> </td> <td class="num">(101,354)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td> <td class="num">(497,704)<span></span> </td> <td class="text"> <span></span> </td> <td class="num">(481,737)<span></span> </td> <td class="num">(15,967)<span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, End of Period at Sep. 30, 2020</a></td> <td class="nump">47,843,377<span></span> </td> <td class="nump">$ 49,176,040<span></span> </td> <td class="num">(1,247,237)<span></span> </td> <td class="num">(85,426)<span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, End of Period (in shares) at Sep. 30, 2020</a></td> <td class="text"> <span></span> </td> <td class="nump">15,084,372<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, Beginning of Period at Dec. 31, 2020</a></td> <td class="nump">$ 46,873,394<span></span> </td> <td class="nump">$ 49,121,523<span></span> </td> <td class="num">(2,131,013)<span></span> </td> <td class="num">(117,116)<span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, Beginning of Period (in shares) at Dec. 31, 2020</a></td> <td class="nump">14,988,429<span></span> </td> <td class="nump">14,988,429<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td> <td class="nump">$ 162,960<span></span> </td> <td class="nump">$ 162,960<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td> <td class="text"> <span></span> </td> <td class="nump">187,759<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common shares</a></td> <td class="num">(303,088)<span></span> </td> <td class="num">$ (303,088)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of shares (in shares)</a></td> <td class="text"> <span></span> </td> <td class="num">(91,724)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td> <td class="nump">144,661<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">166,828<span></span> </td> <td class="num">(22,167)<span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, End of Period at Mar. 31, 2021</a></td> <td class="nump">46,877,927<span></span> </td> <td class="nump">$ 48,981,395<span></span> </td> <td class="num">(1,964,185)<span></span> </td> <td class="num">(139,283)<span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, End of Period (in shares) at Mar. 31, 2021</a></td> <td class="text"> <span></span> </td> <td class="nump">15,084,464<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, Beginning of Period at Dec. 31, 2020</a></td> <td class="nump">$ 46,873,394<span></span> </td> <td class="nump">$ 49,121,523<span></span> </td> <td class="num">(2,131,013)<span></span> </td> <td class="num">(117,116)<span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, Beginning of Period (in shares) at Dec. 31, 2020</a></td> <td class="nump">14,988,429<span></span> </td> <td class="nump">14,988,429<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common shares</a></td> <td class="text"> <span></span> </td> <td class="num">$ (1,000,000)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of shares (in shares)</a></td> <td class="text"> <span></span> </td> <td class="num">(326,537)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td> <td class="nump">$ 281,459<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, End of Period at Sep. 30, 2021</a></td> <td class="nump">$ 46,646,265<span></span> </td> <td class="nump">$ 48,612,935<span></span> </td> <td class="num">(1,790,903)<span></span> </td> <td class="num">(175,767)<span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, End of Period (in shares) at Sep. 30, 2021</a></td> <td class="nump">14,850,526<span></span> </td> <td class="nump">14,850,526<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, Beginning of Period at Mar. 31, 2021</a></td> <td class="nump">$ 46,877,927<span></span> </td> <td class="nump">$ 48,981,395<span></span> </td> <td class="num">(1,964,185)<span></span> </td> <td class="num">(139,283)<span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, Beginning of Period (in shares) at Mar. 31, 2021</a></td> <td class="text"> <span></span> </td> <td class="nump">15,084,464<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td> <td class="nump">191,954<span></span> </td> <td class="nump">$ 191,954<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common shares</a></td> <td class="num">(484,965)<span></span> </td> <td class="num">$ (484,965)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of shares (in shares)</a></td> <td class="text"> <span></span> </td> <td class="num">(158,405)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td> <td class="nump">1,223,491<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">1,228,560<span></span> </td> <td class="num">(5,069)<span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, End of Period at Jun. 30, 2021</a></td> <td class="nump">47,808,407<span></span> </td> <td class="nump">$ 48,688,384<span></span> </td> <td class="num">(735,625)<span></span> </td> <td class="num">(144,352)<span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, End of Period (in shares) at Jun. 30, 2021</a></td> <td class="text"> <span></span> </td> <td class="nump">14,926,059<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td> <td class="nump">162,167<span></span> </td> <td class="nump">$ 162,167<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td> <td class="text"> <span></span> </td> <td class="nump">875<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common shares</a></td> <td class="num">(237,616)<span></span> </td> <td class="num">$ (237,616)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of shares (in shares)</a></td> <td class="text"> <span></span> </td> <td class="num">(76,408)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td> <td class="num">(1,086,693)<span></span> </td> <td class="text"> <span></span> </td> <td class="num">(1,055,278)<span></span> </td> <td class="num">(31,415)<span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, End of Period at Sep. 30, 2021</a></td> <td class="nump">$ 46,646,265<span></span> </td> <td class="nump">$ 48,612,935<span></span> </td> <td class="num">$ (1,790,903)<span></span> </td> <td class="num">$ (175,767)<span></span> </td> </tr> <tr class="rc"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, End of Period (in shares) at Sep. 30, 2021</a></td> <td class="nump">14,850,526<span></span> </td> <td class="nump">14,850,526<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ProfitLoss</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>30 <FILENAME>R7.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570212692696"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Basis of Presentation<br></strong></div></th> <th class="th" colspan="1">9 Months Ended</th> </tr> <tr><th class="th"><div>Sep. 30, 2021</div></th></tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">ORGANIZATION AND BASIS OF PRESENTATION</a></td> <td class="text">ORGANIZATION AND BASIS OF PRESENTATION<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland Pharmaceuticals Inc. (“Cumberland,” the “Company,” or as used in the context of “we,” “us,” or “our”) is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The Company's primary target markets are hospital acute care, gastroenterology and rheumatology. These medical specialties are characterized by relatively concentrated prescriber bases that the Company believes can be penetrated effectively by small, targeted sales forces. Cumberland is dedicated to providing innovative products that improve quality of care for patients and address unmet or poorly met medical needs. The Company promotes its approved products through its hospital and field sales forces in the United States and is establishing a network of international partners to bring its medicines to patients in their countries.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland focuses its resources on maximizing the commercial potential of its products, as well as developing new product candidates, and has both internal development and commercial capabilities. The Company’s products are manufactured by third parties, which are overseen by Cumberland’s quality control and manufacturing professionals. The Company works closely with its third-party distribution partners to make its products available in the United States.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited condensed consolidated financial statements of the Company have been prepared on a basis consistent with the December 31, 2020, audited consolidated financial statements and include all adjustments, consisting of only normal recurring adjustments, necessary to fairly present the information set forth herein. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited condensed consolidated financial statements have been prepared in accordance with the regulations of the Securities and Exchange Commission (the “SEC”), and certain information and disclosures have been condensed or omitted as permitted by the SEC for interim period presentation. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended December 31, 2020 (the “2020 Annual Report on Form 10-K”). The results of operations for the three and nine months ended September 30, 2021, are not necessarily indicative of the results to be expected for the entire fiscal year or any future period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Discontinued Operations</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed further in Note 9, during May 2019, Cumberland entered into a Dissolution Agreement ("Dissolution Agreement") with Clinigen Healthcare Limited ("Clinigen") in which the Company returned the exclusive rights to commercialize Ethyol</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Totect</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the United States to Clinigen. Under the terms of the Dissolution Agreement, Cumberland is no longer involved directly or indirectly with the distribution, marketing and promotion of either Ethyol or Totect or any competing products following December 31, 2019. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's exit from Ethyol and Totect meets the accounting criteria to be reported as discontinued operations and the discontinued operating results have been presented in the financial statements and footnotes to reflect the discontinued status of Ethyol and Totect. Refer to Note 9, for additional information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revision of prior period condensed consolidated statement of cash flows presentation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has made a revision to prior period amounts to conform to the current year presentation of the cash surrender value of life insurance policies over premiums paid on the condensed consolidated statement of cash flows. The revised amounts were previously included as net changes in assets affecting operating activities. These revisions have no net effect on the reported net cash provided by operating activities nor any impact on the reported operating results or balance sheet for the 2020 period presented. </span></div><div style="margin-bottom:8pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Pandemic </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the U.S. declared a health care emergency following the outbreak of the SARS-CoV-2, a novel strain of coronavirus that causes COVID-19, a respiratory illness. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland has remained open for business, as the Company is considered to be essential by the United States Department of Homeland Security. The Company has implemented measures to address the impact of the novel coronavirus on the business and taken appropriate action to protect its employees, secure the supply chain, and support the patients who can benefit from its medicines. All of the Company's employees have been given the opportunity to work remotely, and those that wish to work from Cumberland's office and laboratories are encouraged to practice the behaviors outlined by the Centers for Disease Control. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the pandemic, Cumberland has faced the same headwinds affecting other companies that rely on hospital admissions and patient visits to drive revenue. Our business and our clinical studies were impacted as less patients sought elective surgeries and our access to medical facilities was substantially limited. During 2020 and 2021, we carefully monitored our supply chain during the pandemic including the flow of raw materials into the plants that manufacture our products as well as the batches of finished product emerging from those facilities. Several of our brands were negatively impacted by the lockdowns and postponement of physician office visits and elective procedures. However, we are fortunate to have a diversified product portfolio, with other brands delivering a strong performance.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland relies on third-party organizations around the world to supply components, manufacture and distribute its products. The Company is aware that it may experience revenue loss, supply interruptions, time delays and incur unplanned expenses as a result of the impact of the ongoing COVID-19 pandemic. The Company continues to monitor the COVID-19 pandemic situation both in the U.S. and internationally in order to maintain its employees’ safety and well-being, while also keeping its business operating. Given the uncertainty, magnitude and impact of such changes, the Company is unable to quantify the impact on the future results as of the date of this filing.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Guidance</span></div><div style="margin-bottom:6pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements - Not Yet Adopted</span></div><div style="margin-bottom:6pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board ("FASB") issued ASU No. 2016-13, “Financial Instruments-Credit Losses,” which changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, companies will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, companies will measure credit losses in a manner similar to what they do today, except that the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. Companies will have to disclose additional information, including information they use to track credit quality by year of origination for most financing receivables. Companies will apply the ASU’s provisions as a cumulative-effect adjustment, if any, to retained earnings as of the beginning of the first reporting period in which the guidance is adopted.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related to ASU No. 2016-13 discussed above, in May 2019, the FASB issued ASU 2019-05, "Financial Instruments-Credit Losses (Topic 326): Targeted Transition Relief" which provides transition relief for ASU 2016-13 by providing entities with an alternative to irrevocably elect the fair value option for eligible financial assets measured at amortized cost upon adoption of the new credit losses standard. Certain eligibility requirements must be met and the election must be applied on an instrument-by-instrument basis. The election is not available for either available-for-sale or held-to-maturity debt securities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will adopt both ASU 2016-13 and ASU 2019-05 on January 1, 2023. The adoption of ASU 2016-13 and ASU 2019-05 are not expected to have a material impact on the Company’s consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Policies:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management of the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates under different assumptions and conditions. The Company's most significant estimates include: (1) its allowances for chargebacks and accruals for rebates and product returns, (2) the allowances for obsolescent or unmarketable inventory and (3) valuation of a contingent consideration liability associated with a business combination.</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Operating Segments</span></div>The Company has one operating segment which is specialty pharmaceutical products. Management has chosen to organize the Company based on the type of products sold. Operating segments are identified as components of an enterprise about which separate discrete financial information is evaluated by the chief operating decision maker, or decision-making group, in making decisions regarding resource allocation and assessing performance. The Company, which uses consolidated financial information in determining how to allocate resources and assess performance, has concluded that our specialty pharmaceutical products compete in similar economic markets and similar circumstances. Substantially all of the Company’s assets are located in the United States and total revenues are primarily attributable to U.S. customers.<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&trid=2197479<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>nonnum:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>31 <FILENAME>R8.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570212758808"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Share<br></strong></div></th> <th class="th" colspan="1">9 Months Ended</th> </tr> <tr><th class="th"><div>Sep. 30, 2021</div></th></tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS (LOSS) PER SHARE</a></td> <td class="text">EARNINGS (LOSS) PER SHARE<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the numerator and denominator used to calculate diluted earnings (loss) per share for the three and nine months ended September 30, 2021 and 2020:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,583,480)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,275,620)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496,787 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777,916 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,086,693)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(497,704)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss at subsidiary attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,415 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,967 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to common shareholders</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,055,278)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(481,737)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding – basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,880,887 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,134,583 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of other securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding – diluted</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,880,887 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,134,583 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:58.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.518%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,209,545)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,838,249)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,491,004 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334,811 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281,459 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,503,438)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) at subsidiary attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,651 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,806 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to common shareholders</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340,110 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,455,632)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding – basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,939,919 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,206,179 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of other securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,985 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding – diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,139,904 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,206,179 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021 and 2020, restricted stock awards and options to purchase 158,900 and 197,210 shares of common stock, respectively, were outstanding but were not included in the computation of diluted earnings per share because the effect would be antidilutive.</span></div><span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>nonnum:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>32 <FILENAME>R9.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570212698200"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues<br></strong></div></th> <th class="th" colspan="1">9 Months Ended</th> </tr> <tr><th class="th"><div>Sep. 30, 2021</div></th></tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">REVENUES</a></td> <td class="text">REVENUES<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Revenues</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for revenues from contracts with customers under ASC 606, which became effective January 1, 2018. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s net revenues consisted of the following for the three and nine months ended September 30, 2021 and 2020:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kristalose</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,012,746 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,615,557 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,286,729 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,387,046 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vibativ</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,896,584 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813,249 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,799,891 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,551,125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Caldolor</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255,669 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,416,146 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,734,273 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,677,434 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vaprisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,774 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406,162 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861,130 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790,817 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acetadote</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,733 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,462 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638,704 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,527,173 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omeclamox-Pak</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,689 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,066 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(451,683)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640,435 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RediTrex</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,459 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,886 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,047 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,429 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605,570 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,072,540 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,250,689 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,665,182 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,179,600 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Omeclamox-Pak revenue for the first, second and third quarter of 2021 was the result of Cumberland currently being out of commercial inventory of this product. The packager for our Omeclamox-Pak product encountered financial difficulties due to the impact of COVID-19. They are under new management and are in the process of a reorganization. Discussions with the packager are ongoing. In the third quarter of 2021, the amounts noted were normal adjustments by channel partners. Net revenue was negatively impacted by product returns during the periods. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Revenues</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreements with international partners for commercialization of the Company's products with associated payments included in other revenues. Those agreements provide that each of the partners are responsible for seeking regulatory approvals for the product, and following approval, each partner will be responsible for the ongoing distribution and sales in the respective international territories. The Company provides a dossier for product registration and maintains responsibility for the relevant intellectual property. Cumberland is typically entitled to receive a non-refundable, up-front payment at the time each agreement is executed as consideration for the product dossier and for the rights to the distinct intellectual property rights in the respective international territory. These agreements also typically provide for additional payments upon a partner’s achievement of a defined regulatory approval and sales milestones. The Company may also be entitled to receive royalties on future sales of the products and a transfer price on supplies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual payments associated with the partner’s achievement of regulatory approvals, sales milestones and royalties on future sales are recognized as revenue upon occurrence, or at such time that the Company has a high degree of confidence that the revenue would not be reversed in a subsequent period.</span></div>Other revenues also include funding from federal grant programs including those secured by CET through the Small Business Administration as well as lease income generated by CET’s Life Sciences Center. The Life Sciences Center is a research center that provides scientists with access to flexible lab space and other resources to develop biomedical products. Grant revenue from these programs totaled approximately $0.02 million and $0.1 million for the three months ended September 30, 2021 and 2020<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&trid=2134510<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>nonnum:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>33 <FILENAME>R10.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570212871272"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th> <th class="th" colspan="1">9 Months Ended</th> </tr> <tr><th class="th"><div>Sep. 30, 2021</div></th></tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td> <td class="text">INVENTORIES<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company works closely with third parties to manufacture and package finished goods for sale.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the arrangements with the manufacturer or packager, the Company will either take title to the finished goods at the time of shipment or at the time of arrival at the Company’s warehouses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company then holds such goods in inventory until distribution and sale. These finished goods inventories are stated at the lower of cost or net realizable value with cost determined using the first-in, first-out method.</span><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates inventory for potential losses due to excess, obsolete or slow-moving goods by comparing sales history and projections to the inventory on hand. When evidence indicates that the carrying value may not be recoverable, a charge is taken to reduce the inventory to its current net realizable value. At September 30, 2021 and December 31, 2020, the Company had recognized and maintained cumulative net realizable value charges for potential obsolescence and discontinuance losses of approximately $0.3 million and $0.2 million, respectively. </span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is responsible for the purchase of the active pharmaceutical ingredient (“API”) for Kristalose and maintains the inventory at third-party packagers. As that API is consumed in production, the value of the API is transferred from raw materials to finished goods. API for the Company's Vaprisol brand is also included in the raw materials inventory at September 30, 2021 and December 31, 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consigned inventory represents Authorized Generic inventory stored with Perrigo until shipment. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Vibativ acquisition, Cumberland acquired API and work in process inventories of $15.6 million that were all initially classified as non-current inventories at the date of acquisition. At September 30, 2021 and December 31, 2020, total non-current inventory, including Vibativ and ifetroban, was $9.5 million and $11.7 million, respectively. The Company had $0.2 million and $2.1 million of Vibativ finished goods included in non-current inventory at September 30, 2021 and December 31, 2020, respectively. The Company also has obtained $0.4 million of finished goods in non-current inventory for API related to its ifetroban clinical initiatives at September 30, 2021 and December 31, 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021 and December 31, 2020 the Company's net inventories consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:57.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.681%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and work in process</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,782,630 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,223,162 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consigned inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,583 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,005 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,812,293 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,943,732 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,739,506 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,294,899 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">less non-current inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,476,737)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,656,742)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories classified as current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,262,769 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,638,157 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&trid=2126998<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>nonnum:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>34 <FILENAME>R11.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570214167688"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th> <th class="th" colspan="1">9 Months Ended</th> </tr> <tr><th class="th"><div>Sep. 30, 2021</div></th></tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td> <td class="text">LEASES<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland’s significant operating leases include the lease of approximately 25,500 square feet of office space in Nashville, Tennessee for its corporate headquarters. This lease currently expires in October 2022. The Company's operating leases also include the lease of approximately 14,200 square feet of wet laboratory and office space in Nashville, Tennessee by CET, our majority-owned subsidiary, where it operates the CET Life Sciences Center. This lease currently expires in April 2023. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities are recorded as the present value of remaining lease payments not yet paid for the lease term discounted using the incremental borrowing rate associated with each lease. Operating lease right-of-use assets represent operating lease liabilities adjusted for lease incentives and initial direct costs. As Cumberland’s leases do not contain implicit borrowing rates, the incremental borrowing rates were calculated based on information available at January 1, 2019. Incremental borrowing rates reflect the Company’s estimated interest rates for collateralized borrowings over similar lease terms. The weighted-average incremental borrowing rate used to discount the present value of the remaining lease payments is 7.42%. The weighted-average remaining lease term at September 30, 2021 is 1.2 years.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lease Position</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021 and December 31, 2020 , the Company's lease assets and liabilities were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right-of-Use Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,282,275 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,028,148 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,094,187 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016,779 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease noncurrent liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,605 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,059,693 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323,792 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,076,472 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumulative future minimum sublease income under non-cancelable operating subleases totals approximately $0.1 million and will be paid through the leases ending in October 2022 and April 2023. Future minimum lease payments under non-cancelable operating leases (with initial or remaining lease terms in excess of one year) are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.554%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity of Lease Liabilities at September 30, 2021</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,038 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019,313 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,478 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,406,829 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,037 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323,792 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense is recognized over the expected term of the lease, including renewal option periods, if applicable, on a straight-line basis as a component of general and administrative expense. Rent expense and sublease income were as follows:</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910,975 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871,441 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526,868 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491,391 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LeasesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&trid=77888251<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>nonnum:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>35 <FILENAME>R12.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570212872392"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity and Debt<br></strong></div></th> <th class="th" colspan="1">9 Months Ended</th> </tr> <tr><th class="th"><div>Sep. 30, 2021</div></th></tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_EquityAndDebtAbstract', window );"><strong>Equity and Debt [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">SHAREHOLDERS' EQUITY AND DEBT</a></td> <td class="text">SHAREHOLDERS’ EQUITY AND DEBT<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share repurchases</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland currently has a share repurchase program to repurchase up to $10 million of its common stock pursuant to Rule 10b-18 of the Securities Exchange Act of 1934. In January 2019, the Company's Board of Directors established the current $10 million repurchase program to replace the prior authorizations. During the nine months ended September 30, 2021 and September 30, 2020, the Company repurchased 326,537 shares and 407,683 shares, respectively, of common stock for approximately $1.0 million and $1.5 million, respectively. At September 30, 2021, approximately $5.2 million of common shares was left to repurchase under this program.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share purchases and sales</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the Company's March 2021 trading window, several members of Cumberland's Board of Directors entered into share purchase agreements of the Company's stock pursuant to Rule 10b-18 of the Securities Exchange Act of 1934. These purchases are designed to increase ownership in the Company by the members of the Board. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Sales</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2017, Cumberland filed a Shelf Registration on Form S-3 with the SEC associated with the sale of up to $100 million in corporate securities. The Shelf Registration was declared effective in January 2018. It also included an At the Market ("ATM") feature that allowed the Company to sell common shares at market prices, along with an agreement with B. Riley FBR Inc. to support such a placement of shares. The Company filed an updated Form S-3 with the SEC in December 2020, which was declared effective in January 2021. The Company does not currently have an ATM feature in place. Cumberland plans to continue to evaluate the market for its common shares, and if favorable, will further evaluate whether or not to enter into an ATM feature through B. Riley FBR, Inc. that would allow the Company to issue shares of its common stock. The Company did not issue any shares under an ATM during the nine months ended September 30, 2021 or September 30, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Share Grants and Incentive Stock Options</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2021 and September 30, 2020, the Company issued 36,850 shares and 230,491 shares of restricted stock to employees and directors, respectively. Restricted stock issued to employees generally cliff-vests on the fourth anniversary of the date of grant and for directors on the one-year anniversary of the date of grant. During the nine months ended September 30, 2021, the Company also issued 174,800 incentive stock options to employees that cliff-vest on the fourth anniversary of the date of grant, that are set to expire in March and May 2031. Stock compensation expense is presented as a component of general and administrative expense in the condensed consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Agreement</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2021, the Company and Pinnacle Bank entered into a Fourth Amendment to the Revolving Credit Note and Fifth Amendment ("Fifth Amendment") to the Revolving Credit Loan Agreement to renew the Revolving Credit Loan. </span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The original Pinnacle Agreement was dated July 2017. Beginning on August 14, 2018, and continuing until October 7, 2020, the Company and Pinnacle Bank entered into a series of amendments to extend and update the Revolving Credit Note and Revolving Credit Agreement. The most recent amendment dated October 28, 2021, extends the maturity date three years through October 1, 2024.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with prior Amendments, the Fifth Amendment provides for a principal balance available for borrowing of up to $15 million. The Company has the right to request an increase of up to an additional $5 million providing a maximum principal available of up to $20 million upon the satisfaction of certain conditions and with the approval of Pinnacle Bank. Also consistent with prior Amendments, the Company is required to maintain either a Funded Debt Ratio covenant or a Tangible Capital Ratio covenant. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate on the Pinnacle Agreement is based on LIBOR plus an interest rate spread. The pricing under the Fourth Amendment provides for an interest rate spread of 1.75% to 2.75% above LIBOR with a minimum LIBOR of 0.90%. The applicable interest rate under the Pinnacle Agreement was 3.65% at September 30, 2021. In addition, a fee of 0.25% per year is charged on the unused line of credit. Interest and the unused line fee are payable quarterly. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021 and December 31, 2020, the Company had $15.0 million in borrowings outstanding under its revolving credit facility. The Company was in compliance with the Tangible Capital Ratio financial covenant as of September 30, 2021. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the line of credit are collateralized by substantially all of our assets.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Paycheck Protection Program Loan</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 20, 2020, Cumberland received the funding of a loan from Pinnacle Bank in the amount of $2,187,140 pursuant to the Paycheck Protection Program (the “PPP”) under the Federal Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"), which was enacted March 27, 2020. The PPP is administered by the U.S. Small Business Administration ("SBA").</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the PPP requirements, loan funds were used to maintain payroll, continue group health care benefits, and pay for rent and utilities during the pandemic. We applied for this loan after carefully considering, with our bank, the eligibility criteria to participate in this program, and determining that Cumberland met those criteria. We evaluated and provided information on our payroll and other qualifying expenses to determine the amount of PPP funds to apply for. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the PPP, certain amounts of the loan may be forgiven if they are used for qualifying expenses as described in the CARES Act. Cumberland used the PPP loan funds for such qualifying expenses. Due to assistance from our PPP loan, the Company did not lay off or furlough any employees as a result of the COVID-19 pandemic.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland elected to account for the proceeds of the loan as a government grant under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Accounting Standard 20 ("IAS 20"), Accounting for Government Grants and Disclosure of Government Assistance. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The permitted analogous use of IAS 20 outlines a model for the accounting for government assistance, including forgivable loans. As a result, the Company recorded the $2,187,140 as a deferred income liability, which was included as a component of other current liabilities on the condensed consolidated balance sheet at December 31, 2020. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, Cumberland submitted a request for the loan’s forgiveness. On June 11, 2021, the Company received a formal notice from the SBA that the full amount of the loan was forgiven. The Company accounted for the forgiveness of the PPP loan under IAS 20 and recorded the $2,187,140 as other income.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Joint Venture Agreement</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, Cumberland entered into an agreement with WinHealth Investment (Singapore) Ltd creating </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">WHC Biopharmaceuticals, Pte. Ltd</span>. The joint venture, as a limited liability company, will focus on acquiring, developing, registering, and commercializing development stage and commercial stage biopharmaceuticals for China, Hong Kong and other Asian markets. The agreement provides for initial investment from WinHealth in the form of a $0.2 million equity contribution and an initial investment from Cumberland in the form of a $0.2 million convertible note, which was funded during the first quarter 2021. The joint venture will seek additional future capital from additional investors and has entered into exclusive option agreements to license intellectual property from both Cumberland Pharmaceuticals Inc. and Cumberland Emerging Technologies.<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cpix_EquityAndDebtAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity and Debt [Abstract]</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">cpix_EquityAndDebtAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>cpix_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&trid=2208762<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>nonnum:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>36 <FILENAME>R13.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570212824408"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th> <th class="th" colspan="1">9 Months Ended</th> </tr> <tr><th class="th"><div>Sep. 30, 2021</div></th></tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td> <td class="text">INCOME TAXESAs of September 30, 2021, the Company has approximately $56.5 million in federal net operating loss carryforwards including approximately $44.1 million of net operating loss carryforwards resulting from the exercise of nonqualified stock options. These have historically been used to significantly offset income tax obligations. The Company expects it will continue to pay minimal income taxes during 2021 and beyond, through the continued utilization of these net operating loss carryforwards, on any taxable income generated from our operations. The Company does not allocate any portion of its income tax expense (benefit) to discontinued operations.<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>nonnum:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>37 <FILENAME>R14.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570212652200"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaborative Agreements<br></strong></div></th> <th class="th" colspan="1">9 Months Ended</th> </tr> <tr><th class="th"><div>Sep. 30, 2021</div></th></tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">COLLABORATIVE AGREEMENTS</a></td> <td class="text">COLLABORATIVE AGREEMENTS<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland is a party to several collaborative arrangements with research institutions to identify and pursue promising pharmaceutical product candidates. The funding for these programs is primarily provided through Federal Small Business Administration (SBIR/STTR) and other grant awards. The Company has determined that these collaborative agreements, with the exception of the collaborative payment received related to RediTrex, do not meet the criteria for accounting under ASC Topic 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The agreements do not specifically designate each party’s rights and obligations to each other under the collaborative arrangements. Except for patent defense costs, expenses incurred by one party are not required to be reimbursed by the other party. Expenses incurred under these collaborative agreements are included in research and development expenses and funding received from grants are recorded as net revenues in the condensed consolidated statements of operations.</span><span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI http://asc.fasb.org/topic&trid=5833765<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>nonnum:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>38 <FILENAME>R15.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570214369000"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Additions and Returns of Product Rights<br></strong></div></th> <th class="th" colspan="1">9 Months Ended</th> </tr> <tr><th class="th"><div>Sep. 30, 2021</div></th></tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">ADDITIONS AND RETURN OF PRODUCT RIGHTS</a></td> <td class="text">ADDITIONS AND RETURN OF PRODUCT RIGHTS<div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vibativ</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During November 2018, the Company closed on an agreement with Theravance Biopharma ("Theravance") to acquire the global responsibility for Vibativ including the marketing, distribution, manufacturing and regulatory activities associated with the brand. Vibativ is a patented, Food and Drug Administration ("FDA") approved injectable anti-infective for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia and complicated skin and skin structure infections. It addresses a range of Gram-positive bacterial pathogens, including those that are considered difficult-to-treat and multidrug-resistant. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland has accounted for the transaction as a business combination in accordance with ASC 805 and the product sales are included in the results of operations subsequent to the acquisition date. The Company made an upfront payment of $20.0 million at the closing of the transaction and a $5.0 million milestone payment in early April 2019. In addition, Cumberland has agreed to pay a royalty of up to 20% of on-going net sales of the product. The future royalty payments were required to be recognized at their acquisition-date fair value as a contingent consideration liability, as part of the contingent consideration transferred in the business combination. Cumberland prepared the valuations of the contingent consideration liability utilizing significant unobservable inputs. As a result, the valuation is classified as Level 3 fair value measurement. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the fair value of the contingent consideration liability that is remeasured on a recurring basis. The contingent consideration earned and accrued in operating expenses is paid to Theravance quarterly.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,200,552 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment of royalty during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,792,573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration included in operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(632,646)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration earned and accrued in operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134,333 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,909,666 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration liability of $6.9 million was classified as other current liabilities of $2.6 million and other long-term liabilities of $4.3 million on the condensed consolidated balance sheet as of September 30, 2021. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RediTrex</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2016, the Company announced an agreement with the Nordic Group B.V. ("Nordic") to acquire the exclusive U.S. rights to Nordic’s injectable methotrexate product line designed for the treatment of active rheumatoid arthritis, juvenile idiopathic arthritis, severe psoriatic arthritis, and severe disabling psoriasis. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As consideration for the license Cumberland paid a deposit of $100,000 at closing. The Company provided $0.9 million in consideration through a grant of 180,000 restricted shares of Cumberland common stock to be vested upon the FDA approval of the first Nordic product. Cumberland also agreed to provide Nordic a series of payments tied to the products’ FDA approval, launch and achievement of certain sales milestones. Under the terms of the agreement, Cumberland is responsible for the product registration and commercialization in the U.S. Nordic is responsible for product manufacturing and supply. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 27, 2019, Cumberland received FDA approval for the first Nordic injectable product and authorization to market them under the RediTrex brand name. The 180,000 shares of restricted Cumberland common stock previously provided to Nordic vested upon approval and were valued at $0.9 million on the vesting date. The FDA approval also resulted in a $1.0 million milestone payment due to Nordic. During December 2020, Cumberland introduced RediTrex and the launch that will take place in late 2021 will result in a $1.0 million milestone payment due to Nordic. This milestone payment will be paid during 2022 and is included as a current liability at September 30, 2021.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland has approximately $2.7 million in net intangible assets related to RediTrex at September 30, 2021. </span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ethyol and Totect </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2016, Cumberland entered into an agreement with Clinigen for the rights and responsibilities associated with the commercialization of Ethyol in the United States. In 2017, the Company entered into another agreement with Clinigen for the rights and responsibilities associated with the commercialization of Totect in the United States. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Early in 2019, Cumberland announced a strategic review of the Company's brands, capabilities, and international partners. This review followed an accelerated business development initiative, which resulted in a series of transactions. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During May 2019, Cumberland entered into the Dissolution Agreement with Clinigen in which the Company returned the exclusive rights to commercialize Ethyol and Totect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the United States to Clinigen. Under the final terms of the Dissolution Agreement, Cumberland was no longer responsible for the distribution, marketing and promotion of either Ethyol or Totect or any competing products after December 31, 2019.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In exchange for the return of these product license rights and the non-compete provisions of the Dissolution Agreement, Cumberland is receiving $5 million in financial consideration paid in quarterly installments over the two-years following the transition date. Cumberland recorded the first four quarterly installments totaling $3.0 million during 2020 and the next three installments totaling $1.5 million during the nine months ended September 30, 2021, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as discontinued operations. The Company will record the last remaining quarterly installment in the fourth quarter of 2021.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exit from Ethyol and Totect meets the accounting criteria to be reported as discontinued operations. December 31, 2019, as the transition date, was the final day Cumberland was responsible for the products. Cumberland was responsible for the products through December 31, 2019 and beginning on January 1, 2020, the products' rights transitioned back to Clinigen. As a result, January 1, 2020, was the first day of discontinued operations for the Ethyol and Totect products.</span></div><div style="margin-top:8pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dissolution payments from Clinigen are reflected as revenue from discontinued operations. The Company does not </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">incur expenses associated with these payments from Clinigen. </span></div><div style="margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496,787 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777,916 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,491,004 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334,811 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs of products sold</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, Marketing and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496,787 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777,916 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,491,004 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334,811 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&trid=2303972<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>nonnum:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>39 <FILENAME>R16.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570212636280"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Basis of Presentation (Policies)<br></strong></div></th> <th class="th" colspan="1">9 Months Ended</th> </tr> <tr><th class="th"><div>Sep. 30, 2021</div></th></tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Guidance</a></td> <td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Guidance</span></div><div style="margin-bottom:6pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements - Not Yet Adopted</span></div><div style="margin-bottom:6pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board ("FASB") issued ASU No. 2016-13, “Financial Instruments-Credit Losses,” which changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, companies will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, companies will measure credit losses in a manner similar to what they do today, except that the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. Companies will have to disclose additional information, including information they use to track credit quality by year of origination for most financing receivables. Companies will apply the ASU’s provisions as a cumulative-effect adjustment, if any, to retained earnings as of the beginning of the first reporting period in which the guidance is adopted.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related to ASU No. 2016-13 discussed above, in May 2019, the FASB issued ASU 2019-05, "Financial Instruments-Credit Losses (Topic 326): Targeted Transition Relief" which provides transition relief for ASU 2016-13 by providing entities with an alternative to irrevocably elect the fair value option for eligible financial assets measured at amortized cost upon adoption of the new credit losses standard. Certain eligibility requirements must be met and the election must be applied on an instrument-by-instrument basis. The election is not available for either available-for-sale or held-to-maturity debt securities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will adopt both ASU 2016-13 and ASU 2019-05 on January 1, 2023. The adoption of ASU 2016-13 and ASU 2019-05 are not expected to have a material impact on the Company’s consolidated financial statements.</span></div><span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td> <td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management of the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates under different assumptions and conditions. The Company's most significant estimates include: (1) its allowances for chargebacks and accruals for rebates and product returns, (2) the allowances for obsolescent or unmarketable inventory and (3) valuation of a contingent consideration liability associated with a business combination.</span></div><span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Operating Segments</a></td> <td class="text">Operating SegmentsThe Company has one operating segment which is specialty pharmaceutical products. Management has chosen to organize the Company based on the type of products sold. Operating segments are identified as components of an enterprise about which separate discrete financial information is evaluated by the chief operating decision maker, or decision-making group, in making decisions regarding resource allocation and assessing performance. The Company, which uses consolidated financial information in determining how to allocate resources and assess performance, has concluded that our specialty pharmaceutical products compete in similar economic markets and similar circumstances. Substantially all of the Company’s assets are located in the United States and total revenues are primarily attributable to U.S. customers.<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>nonnum:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>nonnum:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_UseOfEstimates</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>nonnum:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>40 <FILENAME>R17.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570214122664"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Share (Tables)<br></strong></div></th> <th class="th" colspan="1">9 Months Ended</th> </tr> <tr><th class="th"><div>Sep. 30, 2021</div></th></tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of numerator and denominator</a></td> <td class="text">The following table reconciles the numerator and denominator used to calculate diluted earnings (loss) per share for the three and nine months ended September 30, 2021 and 2020:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,583,480)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,275,620)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496,787 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777,916 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,086,693)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(497,704)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss at subsidiary attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,415 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,967 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to common shareholders</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,055,278)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(481,737)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding – basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,880,887 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,134,583 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of other securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding – diluted</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,880,887 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,134,583 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:58.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.518%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,209,545)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,838,249)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,491,004 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334,811 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281,459 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,503,438)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) at subsidiary attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,651 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,806 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to common shareholders</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340,110 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,455,632)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding – basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,939,919 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,206,179 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of other securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,985 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding – diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,139,904 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,206,179 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table><span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>nonnum:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>41 <FILENAME>R18.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570301522264"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues (Tables)<br></strong></div></th> <th class="th" colspan="1">9 Months Ended</th> </tr> <tr><th class="th"><div>Sep. 30, 2021</div></th></tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Summary of net revenue</a></td> <td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s net revenues consisted of the following for the three and nine months ended September 30, 2021 and 2020:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kristalose</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,012,746 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,615,557 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,286,729 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,387,046 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vibativ</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,896,584 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813,249 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,799,891 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,551,125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Caldolor</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255,669 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,416,146 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,734,273 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,677,434 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vaprisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,774 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406,162 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861,130 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790,817 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acetadote</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,733 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,462 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638,704 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,527,173 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omeclamox-Pak</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,689 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,066 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(451,683)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640,435 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RediTrex</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,459 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,886 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,047 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,429 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605,570 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,072,540 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,250,689 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,665,182 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,179,600 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>nonnum:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>42 <FILENAME>R19.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570301442168"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th> <th class="th" colspan="1">9 Months Ended</th> </tr> <tr><th class="th"><div>Sep. 30, 2021</div></th></tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventory</a></td> <td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021 and December 31, 2020 the Company's net inventories consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:57.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.681%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and work in process</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,782,630 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,223,162 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consigned inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,583 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,005 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,812,293 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,943,732 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,739,506 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,294,899 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">less non-current inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,476,737)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,656,742)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories classified as current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,262,769 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,638,157 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>nonnum:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>43 <FILENAME>R20.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570212565464"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th> <th class="th" colspan="1">9 Months Ended</th> </tr> <tr><th class="th"><div>Sep. 30, 2021</div></th></tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Lease Position</a></td> <td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021 and December 31, 2020 , the Company's lease assets and liabilities were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right-of-Use Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,282,275 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,028,148 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,094,187 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016,779 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease noncurrent liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,605 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,059,693 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323,792 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,076,472 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumulative future minimum sublease income under non-cancelable operating subleases totals approximately $0.1 million and will be paid through the leases ending in October 2022 and April 2023. Future minimum lease payments under non-cancelable operating leases (with initial or remaining lease terms in excess of one year) are as follows:</span></div><span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturity of Lease Liabilities</a></td> <td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.554%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity of Lease Liabilities at September 30, 2021</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,038 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019,313 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,478 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,406,829 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,037 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323,792 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_ScheduleofRentExpenseandSubleaseIncomeTableTextBlock', window );">Schedule of Rent Expense and Sublease Income</a></td> <td class="text">Rent expense and sublease income were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910,975 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871,441 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526,868 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491,391 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cpix_AssetsAndLiabilitiesLesseeTableTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets and Liabilities, Lessee</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">cpix_AssetsAndLiabilitiesLesseeTableTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>cpix_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>nonnum:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cpix_ScheduleofRentExpenseandSubleaseIncomeTableTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Rent Expense and Sublease Income [Table Text Block]</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">cpix_ScheduleofRentExpenseandSubleaseIncomeTableTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>cpix_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>nonnum:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LeasesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>nonnum:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>44 <FILENAME>R21.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570214144696"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Additions and Returns of Product Rights (Tables)<br></strong></div></th> <th class="th" colspan="1">9 Months Ended</th> </tr> <tr><th class="th"><div>Sep. 30, 2021</div></th></tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock', window );">Schedule of Business Acquisitions by Acquisition, Contingent Consideration</a></td> <td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the fair value of the contingent consideration liability that is remeasured on a recurring basis. The contingent consideration earned and accrued in operating expenses is paid to Theravance quarterly.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,200,552 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment of royalty during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,792,573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration included in operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(632,646)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration earned and accrued in operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134,333 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,909,666 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr></table><span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Schedule of Dissolution Payments</a></td> <td class="text"><div style="margin-top:8pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dissolution payments from Clinigen are reflected as revenue from discontinued operations. The Company does not </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">incur expenses associated with these payments from Clinigen. </span></div><div style="margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496,787 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777,916 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,491,004 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334,811 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs of products sold</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, Marketing and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496,787 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777,916 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,491,004 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334,811 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>nonnum:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>nonnum:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>45 <FILENAME>R22.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570212763576"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Basis of Presentation Organization (Details)<br></strong></div></th> <th class="th" colspan="1">9 Months Ended</th> </tr> <tr><th class="th"> <div>Sep. 30, 2021 </div> <div>Segment</div> </th></tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td> <td class="nump">1<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:integerItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>46 <FILENAME>R23.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570215050584"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Share (Details) - USD ($)<br></strong></div></th> <th class="th" colspan="6">3 Months Ended</th> <th class="th" colspan="2">9 Months Ended</th> </tr> <tr> <th class="th"><div>Sep. 30, 2021</div></th> <th class="th"><div>Jun. 30, 2021</div></th> <th class="th"><div>Mar. 31, 2021</div></th> <th class="th"><div>Sep. 30, 2020</div></th> <th class="th"><div>Jun. 30, 2020</div></th> <th class="th"><div>Mar. 31, 2020</div></th> <th class="th"><div>Sep. 30, 2021</div></th> <th class="th"><div>Sep. 30, 2020</div></th> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_NumeratorAbstract', window );"><strong>Numerator:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net income (loss) from continuing operations</a></td> <td class="num">$ (1,583,480)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="num">$ (1,275,620)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="num">$ (1,209,545)<span></span> </td> <td class="num">$ (4,838,249)<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Discontinued operations</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">1,491,004<span></span> </td> <td class="nump">2,334,811<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td> <td class="num">(1,086,693)<span></span> </td> <td class="nump">$ 1,223,491<span></span> </td> <td class="nump">$ 144,661<span></span> </td> <td class="num">(497,704)<span></span> </td> <td class="num">$ (940,589)<span></span> </td> <td class="num">$ (1,065,145)<span></span> </td> <td class="nump">281,459<span></span> </td> <td class="num">(2,503,438)<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net (income) loss at subsidiary attributable to noncontrolling interests</a></td> <td class="nump">31,415<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">15,967<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">58,651<span></span> </td> <td class="nump">47,806<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to common shareholders</a></td> <td class="num">$ (1,055,278)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="num">$ (481,737)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 340,110<span></span> </td> <td class="num">$ (2,455,632)<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_DenominatorAbstract', window );"><strong>Denominator:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares outstanding – basic (in shares)</a></td> <td class="nump">14,880,887<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">15,134,583<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">14,939,919<span></span> </td> <td class="nump">15,206,179<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Dilutive effect of other securities (in shares)</a></td> <td class="nump">0<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">0<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">199,985<span></span> </td> <td class="nump">0<span></span> </td> </tr> <tr class="rou"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares outstanding – diluted (in shares)</a></td> <td class="nump">14,880,887<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">15,134,583<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">15,139,904<span></span> </td> <td class="nump">15,206,179<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cpix_DenominatorAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Denominator.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">cpix_DenominatorAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>cpix_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cpix_NumeratorAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Numerator.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">cpix_NumeratorAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>cpix_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ProfitLoss</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>47 <FILENAME>R24.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570214750072"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Share (Details Textual) - shares<br></strong></div></th> <th class="th" colspan="2">9 Months Ended</th> </tr> <tr> <th class="th"><div>Sep. 30, 2021</div></th> <th class="th"><div>Sep. 30, 2020</div></th> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Common stock available for purchase through restricted stock awards and options (in shares)</a></td> <td class="nump">158,900<span></span> </td> <td class="nump">197,210<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>48 <FILENAME>R25.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570218928328"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues (Details) - USD ($)<br></strong></div></th> <th class="th" colspan="2">3 Months Ended</th> <th class="th" colspan="2">9 Months Ended</th> </tr> <tr> <th class="th"><div>Sep. 30, 2021</div></th> <th class="th"><div>Sep. 30, 2020</div></th> <th class="th"><div>Sep. 30, 2021</div></th> <th class="th"><div>Sep. 30, 2020</div></th> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_ProductsAbstract', window );"><strong>Products:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td> <td class="nump">$ 8,072,540<span></span> </td> <td class="nump">$ 9,250,689<span></span> </td> <td class="nump">$ 27,665,182<span></span> </td> <td class="nump">$ 27,179,600<span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cpix_AcetadoteMember', window );">Kristalose</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_ProductsAbstract', window );"><strong>Products:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td> <td class="nump">4,012,746<span></span> </td> <td class="nump">3,615,557<span></span> </td> <td class="nump">638,704<span></span> </td> <td class="nump">1,527,173<span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cpix_OmeclamoxPakMember', window );">Vibativ</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_ProductsAbstract', window );"><strong>Products:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td> <td class="nump">1,896,584<span></span> </td> <td class="nump">2,813,249<span></span> </td> <td class="num">(451,683)<span></span> </td> <td class="nump">640,435<span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cpix_KristaloseMember', window );">Caldolor</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_ProductsAbstract', window );"><strong>Products:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td> <td class="nump">1,255,669<span></span> </td> <td class="nump">1,416,146<span></span> </td> <td class="nump">12,286,729<span></span> </td> <td class="nump">10,387,046<span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cpix_VaprisolMember', window );">Acetadote</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_ProductsAbstract', window );"><strong>Products:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td> <td class="nump">368,733<span></span> </td> <td class="nump">218,462<span></span> </td> <td class="nump">1,861,130<span></span> </td> <td class="nump">790,817<span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cpix_CaldolorMember', window );">Omeclamox-Pak</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_ProductsAbstract', window );"><strong>Products:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td> <td class="nump">22,689<span></span> </td> <td class="nump">516,066<span></span> </td> <td class="nump">3,734,273<span></span> </td> <td class="nump">3,677,434<span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cpix_VIBATIVMember', window );">Vaprisol</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_ProductsAbstract', window );"><strong>Products:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td> <td class="nump">325,774<span></span> </td> <td class="nump">406,162<span></span> </td> <td class="nump">8,799,891<span></span> </td> <td class="nump">8,551,125<span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cpix_RediTrexMember', window );">RediTrex</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_ProductsAbstract', window );"><strong>Products:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td> <td class="nump">11,459<span></span> </td> <td class="nump">0<span></span> </td> <td class="num">(13,291)<span></span> </td> <td class="nump">0<span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cpix_OtherProductsMember', window );">Other revenue</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_ProductsAbstract', window );"><strong>Products:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td> <td class="nump">178,886<span></span> </td> <td class="nump">265,047<span></span> </td> <td class="nump">809,429<span></span> </td> <td class="nump">1,605,570<span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_GrantMember', window );">Grant</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_ProductsAbstract', window );"><strong>Products:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td> <td class="nump">$ 20,000.00<span></span> </td> <td class="nump">$ 100,000<span></span> </td> <td class="nump">$ 300,000<span></span> </td> <td class="nump">$ 700,000<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cpix_ProductsAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Products.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">cpix_ProductsAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>cpix_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cpix_AcetadoteMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_ProductOrServiceAxis=cpix_AcetadoteMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cpix_OmeclamoxPakMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_ProductOrServiceAxis=cpix_OmeclamoxPakMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cpix_KristaloseMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_ProductOrServiceAxis=cpix_KristaloseMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cpix_VaprisolMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_ProductOrServiceAxis=cpix_VaprisolMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cpix_CaldolorMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_ProductOrServiceAxis=cpix_CaldolorMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cpix_VIBATIVMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_ProductOrServiceAxis=cpix_VIBATIVMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cpix_RediTrexMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_ProductOrServiceAxis=cpix_RediTrexMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cpix_OtherProductsMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_ProductOrServiceAxis=cpix_OtherProductsMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_GrantMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_GrantMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>49 <FILENAME>R26.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570295982632"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Narrative) (Details) - USD ($)<br></strong></div></th> <th class="th"><div>Sep. 30, 2021</div></th> <th class="th"><div>Dec. 31, 2020</div></th> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Obsolescence and discontinuance losses</a></td> <td class="nump">$ 300,000<span></span> </td> <td class="nump">$ 200,000<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNoncurrent', window );">Non-current inventories</a></td> <td class="nump">9,476,737<span></span> </td> <td class="nump">11,656,742<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Inventory, Finished Goods, Net of Reserves</a></td> <td class="nump">5,812,293<span></span> </td> <td class="nump">5,943,732<span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryAxis=cpix_IfetrobanClinicalMember', window );">Ifetroban Clinical</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNoncurrent', window );">Non-current inventories</a></td> <td class="nump">400,000<span></span> </td> <td class="nump">400,000<span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cpix_VIBATIVMember', window );">Vaprisol</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNoncurrent', window );">Non-current inventories</a></td> <td class="text"> <span></span> </td> <td class="nump">15,600,000<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td> <td class="nump">200,000<span></span> </td> <td class="nump">2,100,000<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Inventory, Finished Goods, Net of Reserves</a></td> <td class="nump">$ 9,500,000<span></span> </td> <td class="nump">$ 11,700,000<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNoncurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(d))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryNoncurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesInventoryAxis=cpix_IfetrobanClinicalMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PublicUtilitiesInventoryAxis=cpix_IfetrobanClinicalMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cpix_VIBATIVMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cpix_VIBATIVMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>50 <FILENAME>R27.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570213317816"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Schedule of Inventories) (Details) - USD ($)<br></strong></div></th> <th class="th"><div>Sep. 30, 2021</div></th> <th class="th"><div>Dec. 31, 2020</div></th> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract', window );"><strong>Inventory</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials and work in process</a></td> <td class="nump">$ 13,782,630<span></span> </td> <td class="nump">$ 16,223,162<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment', window );">Consigned inventory</a></td> <td class="nump">144,583<span></span> </td> <td class="nump">128,005<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td> <td class="nump">5,812,293<span></span> </td> <td class="nump">5,943,732<span></span> </td> </tr> <tr class="reu"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Total inventories</a></td> <td class="nump">19,739,506<span></span> </td> <td class="nump">22,294,899<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNoncurrent', window );">Inventory, Noncurrent</a></td> <td class="num">(9,476,737)<span></span> </td> <td class="num">(11,656,742)<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories classified as current</a></td> <td class="nump">$ 10,262,769<span></span> </td> <td class="nump">$ 10,638,157<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryGross"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryGross</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryNet</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNoncurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(d))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryNoncurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of inventory owned by the entity but in the hands of a customer, typically a reseller.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>51 <FILENAME>R28.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570214689048"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Narrative) (Details)<br> $ in Millions</strong></div></th> <th class="th"> <div>Sep. 30, 2021 </div> <div>USD ($) </div> <div>ft²</div> </th> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Present value of remaining lease payments, percent</a></td> <td class="nump">7.42%<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td> <td class="text">1 year 2 months 12 days<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived', window );">Future minimum sublease income under noncancelable operating subleases | $</a></td> <td class="nump">$ 0.1<span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Office Space</a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Square feet of office space</a></td> <td class="nump">25,500<span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=srt_OfficeBuildingMember', window );">Wet Laboratory and Office Space</a></td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Square feet of office space</a></td> <td class="nump">14,200<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>num:areaItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payments to be received by lessor for operating lease.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&oid=121576215&loc=SL77919396-209981<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceived</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>num:percentItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:durationItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=srt_OfficeBuildingMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=srt_OfficeBuildingMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>52 <FILENAME>R29.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570212548344"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Lease Position) (Details) - USD ($)<br></strong></div></th> <th class="th"><div>Sep. 30, 2021</div></th> <th class="th"><div>Dec. 31, 2020</div></th> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td> <td class="nump">$ 1,282,275<span></span> </td> <td class="nump">$ 2,028,148<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease current liabilities</a></td> <td class="nump">1,094,187<span></span> </td> <td class="nump">1,016,779<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease noncurrent liabilities</a></td> <td class="nump">229,605<span></span> </td> <td class="nump">1,059,693<span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_LeaseLiability', window );">Total</a></td> <td class="nump">$ 1,323,792<span></span> </td> <td class="nump">$ 2,076,472<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cpix_LeaseLiability"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">cpix_LeaseLiability</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>cpix_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LeasesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>53 <FILENAME>R30.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570214779832"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Schedule of Lease Liabilities Maturity and Future Minimum Lease Commitments) (Details)<br></strong></div></th> <th class="th"> <div>Sep. 30, 2021 </div> <div>USD ($)</div> </th> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Maturity of Lease Liabilities at September 30, 2021</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td> <td class="nump">$ 295,038<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td> <td class="nump">1,019,313<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td> <td class="nump">92,478<span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree', window );">After 2023</a></td> <td class="nump">0<span></span> </td> </tr> <tr class="rou"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td> <td class="nump">1,406,829<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Interest</a></td> <td class="nump">83,037<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td> <td class="nump">$ 1,323,792<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cpix_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, to be Paid, after Year Three</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">cpix_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>cpix_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>54 <FILENAME>R31.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570214252824"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Rent Expense (Details) - USD ($)<br></strong></div></th> <th class="th" colspan="2">9 Months Ended</th> </tr> <tr> <th class="th"><div>Sep. 30, 2021</div></th> <th class="th"><div>Sep. 30, 2020</div></th> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Rent expense</a></td> <td class="nump">$ 910,975<span></span> </td> <td class="nump">$ 871,441<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td> <td class="nump">$ 526,868<span></span> </td> <td class="nump">$ 491,391<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LeasesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SubleaseIncome</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>55 <FILENAME>R32.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570297780168"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity and Debt (Shareholders' Equity) (Details) - USD ($)<br></strong></div></th> <th class="th" colspan="1">1 Months Ended</th> <th class="th" colspan="6">3 Months Ended</th> <th class="th" colspan="2">9 Months Ended</th> <th class="th" colspan="1"></th> <th class="th" colspan="1"></th> </tr> <tr> <th class="th"><div>Nov. 30, 2017</div></th> <th class="th"><div>Sep. 30, 2021</div></th> <th class="th"><div>Jun. 30, 2021</div></th> <th class="th"><div>Mar. 31, 2021</div></th> <th class="th"><div>Sep. 30, 2020</div></th> <th class="th"><div>Jun. 30, 2020</div></th> <th class="th"><div>Mar. 31, 2020</div></th> <th class="th"><div>Sep. 30, 2021</div></th> <th class="th"><div>Sep. 30, 2020</div></th> <th class="th"><div>Jan. 31, 2016</div></th> <th class="th"><div>May 13, 2010</div></th> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders' Equity (Textual) [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of shares, value</a></td> <td class="text"> <span></span> </td> <td class="num">$ (237,616)<span></span> </td> <td class="num">$ (484,965)<span></span> </td> <td class="num">$ (303,088)<span></span> </td> <td class="num">$ (332,504)<span></span> </td> <td class="num">$ (769,648)<span></span> </td> <td class="num">$ (441,624)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities', window );">Shelf Registration, sale of corporate securities (up to)</a></td> <td class="nump">$ 100,000,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders' Equity (Textual) [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted in period, shares</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">36,850<span></span> </td> <td class="nump">230,491<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cpix_IncentiveStockOptionsMember', window );">Incentive Stock Options</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders' Equity (Textual) [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted in period, shares</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">174,800<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Director | Restricted Stock</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders' Equity (Textual) [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Restricted stock awards, vesting period</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text">1 year<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders' Equity (Textual) [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Repurchase outstanding common shares</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 10,000,000<span></span> </td> <td class="nump">$ 10,000,000<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of shares (in shares)</a></td> <td class="text"> <span></span> </td> <td class="nump">76,408<span></span> </td> <td class="nump">158,405<span></span> </td> <td class="nump">91,724<span></span> </td> <td class="nump">101,354<span></span> </td> <td class="nump">141,463<span></span> </td> <td class="nump">164,866<span></span> </td> <td class="nump">326,537<span></span> </td> <td class="nump">407,683<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of shares, value</a></td> <td class="text"> <span></span> </td> <td class="num">$ (237,616)<span></span> </td> <td class="num">$ (484,965)<span></span> </td> <td class="num">$ (303,088)<span></span> </td> <td class="num">$ (332,504)<span></span> </td> <td class="num">$ (769,648)<span></span> </td> <td class="num">$ (441,624)<span></span> </td> <td class="num">$ (1,000,000)<span></span> </td> <td class="num">$ (1,500,000)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Common shares left to repurchase</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 5,200,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 5,200,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cpix_ShareholdersEquityTextualAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shareholders Equity.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">cpix_ShareholdersEquityTextualAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>cpix_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cpix_StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">cpix_StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>cpix_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:durationItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cpix_IncentiveStockOptionsMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cpix_IncentiveStockOptionsMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>56 <FILENAME>R33.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570219960536"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity and Debt (Debt) (Details) - USD ($)<br></strong></div></th> <th class="th" colspan="1"></th> <th class="th" colspan="1"></th> <th class="th" colspan="1">9 Months Ended</th> <th class="th" colspan="1"></th> <th class="th" colspan="1"></th> <th class="th" colspan="1"></th> </tr> <tr> <th class="th"><div>Aug. 14, 2020</div></th> <th class="th"><div>Apr. 20, 2020</div></th> <th class="th"><div>Sep. 30, 2021</div></th> <th class="th"><div>Oct. 28, 2021</div></th> <th class="th"><div>Dec. 31, 2020</div></th> <th class="th"><div>Aug. 31, 2020</div></th> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Revolving line of credit</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 15,000,000<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 15,000,000<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=cpix_WinHealthInvestmentSingaporeLtdDomain', window );">WinHealth</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Initial investment in joint ventures</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 200,000<span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | WinHealth</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible note</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 200,000<span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">LIBOR</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Variable rate</a></td> <td class="nump">0.90%<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Revolving line of credit</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 15,000,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=cpix_PinnacleBankMember', window );">Pinnacle Bank</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived', window );">Aggregate amount</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 2,187,140<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=cpix_PinnacleBankMember', window );">Pinnacle Bank | Line of Credit | Revolving Credit Facility</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate spread</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">3.65%<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Line of credit, unused capacity, commitment fee percentage</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">0.25%<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=cpix_PinnacleBankMember', window );">Pinnacle Bank | Line of Credit | Revolving Credit Facility | Minimum | LIBOR</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Variable rate</a></td> <td class="nump">1.75%<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=cpix_PinnacleBankMember', window );">Pinnacle Bank | Line of Credit | Revolving Credit Facility | Maximum | LIBOR</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Variable rate</a></td> <td class="nump">2.75%<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=cpix_PinnacleBankMember', window );">Pinnacle Bank | Fifth Amendment | Revolving Credit Facility | Subsequent Event</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit, maximum borrowing capacity</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 15,000,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount', window );">Increase amount (up to)</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">5,000,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity', window );">Total capacity</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 20,000,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cpix_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Maximum Borrowing Capacity, Increase Amount</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">cpix_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>cpix_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cpix_LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Maximum Borrowing Capacity, Total Capacity</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">cpix_LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>cpix_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cpix_TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Coronavirus Aid, Relief, and Economic Security Act, Loan Proceeds Received</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">cpix_TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>cpix_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>num:percentItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>num:percentItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>num:percentItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cpix_WinHealthInvestmentSingaporeLtdDomain"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_CounterpartyNameAxis=cpix_WinHealthInvestmentSingaporeLtdDomain</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=cpix_PinnacleBankMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=cpix_PinnacleBankMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_LineOfCreditMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_LineOfCreditMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cpix_FifthAmendmentMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cpix_FifthAmendmentMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>57 <FILENAME>R34.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570298423000"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Details Textual)<br></strong></div></th> <th class="th"> <div>Sep. 30, 2021 </div> <div>USD ($)</div> </th> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td> <td class="nump">$ 44,100,000<span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td> <td class="nump">$ 56,500,000<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>58 <FILENAME>R35.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570296074664"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Additions and Returns of Product Rights - Narrative (Details) - USD ($)<br></strong></div></th> <th class="th" colspan="2">1 Months Ended</th> <th class="th" colspan="1">6 Months Ended</th> <th class="th" colspan="1">9 Months Ended</th> <th class="th" colspan="1">24 Months Ended</th> <th class="th" colspan="1"></th> <th class="th" colspan="1"></th> </tr> <tr> <th class="th"><div>Nov. 30, 2018</div></th> <th class="th"><div>Nov. 30, 2016</div></th> <th class="th"><div>Jun. 30, 2021</div></th> <th class="th"><div>Sep. 30, 2021</div></th> <th class="th"><div>Sep. 30, 2021</div></th> <th class="th"><div>Dec. 31, 2020</div></th> <th class="th"><div>Jul. 31, 2020</div></th> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_ProceedsFromSaleOfIntangibleAssetsInstallmentPayment', window );">Financial consideration received in exchange for product license rights, installment payments</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 3,000,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=cpix_ClinigenHealthcareLimitedMember', window );">Clinigen</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfIntangibleAssets', window );">Financial consideration received in exchange for product license rights</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 5,000,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Discontinued operations income</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 1,500,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cpix_VIBATIVMember', window );">Vaprisol</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payment to acquire business upon closing</a></td> <td class="nump">$ 20,000,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPaymentsToAcquireBusinesses', window );">Other Payments to Acquire Businesses</a></td> <td class="nump">$ 5,000,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_TieredRoyaltyPaymentsPercentage', window );">Percentage of tiered royalty payments (up to)</a></td> <td class="nump">20.00%<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Additional liability</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">6,909,666<span></span> </td> <td class="nump">6,909,666<span></span> </td> <td class="nump">$ 8,200,552<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cpix_VIBATIVMember', window );">Vaprisol | Other current liabilities</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Additional liability</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">2,600,000<span></span> </td> <td class="nump">2,600,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cpix_VIBATIVMember', window );">Vaprisol | Other long-term liabilities</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Additional liability</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">4,300,000<span></span> </td> <td class="nump">4,300,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cpix_MethotrexateMember', window );">Methotrexate</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payment to acquire business upon closing</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 100,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Additional liability</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 1,000,000<span></span> </td> <td class="nump">$ 1,000,000<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Liability recorded</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 900,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Vested common stock, value</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">900,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Net intangible assets</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 2,700,000<span></span> </td> <td class="nump">$ 2,700,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cpix_MethotrexateMember', window );">Methotrexate | Restricted Stock</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Unvested restricted shares (in shares)</a></td> <td class="text"> <span></span> </td> <td class="nump">180,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cpix_ProceedsFromSaleOfIntangibleAssetsInstallmentPayment"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Sale of Intangible Assets, Installment Payment</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">cpix_ProceedsFromSaleOfIntangibleAssetsInstallmentPayment</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>cpix_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cpix_TieredRoyaltyPaymentsPercentage"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tiered Royalty Payments, Percentage</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">cpix_TieredRoyaltyPaymentsPercentage</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>cpix_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>num:percentItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPaymentsToAcquireBusinesses"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OtherPaymentsToAcquireBusinesses</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfIntangibleAssets"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from disposal of asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfIntangibleAssets</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cpix_ClinigenHealthcareLimitedMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_CounterpartyNameAxis=cpix_ClinigenHealthcareLimitedMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cpix_VIBATIVMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cpix_VIBATIVMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cpix_MethotrexateMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cpix_MethotrexateMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>59 <FILENAME>R36.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570218889960"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Additions and Returns of Product Rights - Change in Consideration (Details) - Vaprisol<br></strong></div></th> <th class="th" colspan="1">9 Months Ended</th> </tr> <tr><th class="th"> <div>Sep. 30, 2021 </div> <div>USD ($)</div> </th></tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Loss Contingency Accrual [Roll Forward]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Beginning balance</a></td> <td class="nump">$ 8,200,552<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRoyalties', window );">Cash payment of royalty during the period</a></td> <td class="num">(1,792,573)<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration included in operating expenses</a></td> <td class="num">(632,646)<span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cpix_BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses', window );">Contingent consideration earned and accrued in operating expenses</a></td> <td class="nump">1,134,333<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Ending balance</a></td> <td class="nump">$ 6,909,666<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cpix_BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Earned and Accrued in Operating Expenses</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">cpix_BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>cpix_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualRollForward"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LossContingencyAccrualRollForward</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRoyalties"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for royalties during the current period.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PaymentsForRoyalties</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cpix_VIBATIVMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cpix_VIBATIVMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>60 <FILENAME>R37.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140570212935272"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Additions and Returns of Product Rights - Dissolution Payments (Details) - USD ($)<br></strong></div></th> <th class="th" colspan="2">3 Months Ended</th> <th class="th" colspan="2">9 Months Ended</th> </tr> <tr> <th class="th"><div>Sep. 30, 2021</div></th> <th class="th"><div>Sep. 30, 2020</div></th> <th class="th"><div>Sep. 30, 2021</div></th> <th class="th"><div>Sep. 30, 2020</div></th> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td> <td class="nump">$ 8,072,540<span></span> </td> <td class="nump">$ 9,250,689<span></span> </td> <td class="nump">$ 27,665,182<span></span> </td> <td class="nump">$ 27,179,600<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Costs of products sold</a></td> <td class="nump">1,328,027<span></span> </td> <td class="nump">2,142,839<span></span> </td> <td class="nump">5,486,005<span></span> </td> <td class="nump">6,387,002<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling, Marketing and other</a></td> <td class="nump">3,800,288<span></span> </td> <td class="nump">3,587,842<span></span> </td> <td class="nump">11,709,445<span></span> </td> <td class="nump">11,160,924<span></span> </td> </tr> <tr class="rh"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=cpix_ClinigenHealthcareLimitedMember', window );">Clinigen</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td> <td class="nump">496,787<span></span> </td> <td class="nump">777,916<span></span> </td> <td class="nump">1,491,004<span></span> </td> <td class="nump">2,334,811<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Costs of products sold</a></td> <td class="nump">0<span></span> </td> <td class="nump">0<span></span> </td> <td class="nump">0<span></span> </td> <td class="nump">0<span></span> </td> </tr> <tr class="re"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling, Marketing and other</a></td> <td class="nump">0<span></span> </td> <td class="nump">0<span></span> </td> <td class="nump">0<span></span> </td> <td class="nump">0<span></span> </td> </tr> <tr class="ro"> <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Income from discontinued operations</a></td> <td class="nump">$ 496,787<span></span> </td> <td class="nump">$ 777,916<span></span> </td> <td class="nump">$ 1,491,004<span></span> </td> <td class="nump">$ 2,334,811<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856<br></p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cpix_ClinigenHealthcareLimitedMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_CounterpartyNameAxis=cpix_ClinigenHealthcareLimitedMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EXCEL <SEQUENCE>61 <FILENAME>Financial_Report.xlsx <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> begin 644 Financial_Report.xlsx M4$L#!!0 ( J*;%,'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04 M " *BFQ3&'8OUNX K @ $0 &1O8U!R;W!S+V-O<F4N>&ULS9+! M:@,A$(9?I7C?G=5 "K+92TM/"10::.E-=))(UU5TRF[>OJY--I3V 0I>G/G] MYANPU4%J'_$Y^H"1+*:[R?5#DCILV(DH2("D3^A4JG-BR,V#CTY1OL8C!*4_ MU!%!-,T:')(RBA3,P"HL1-:U1DL=49&/%[S1"SY\QK[ C ;LT>% "7C-@77S MQ'">^A9N@!E&&%WZ+J!9B*7Z)[9T@%V24[)+:AS'>ER57-Z!P]MN^U+6K>R0 M2 T:\ZMD)9T#;MAU\NOJX7'_Q#K1"%[Q?,1>",G7LKE_GUU_^-V$G3?V8/^Q M\56P:^'7O^B^ %!+ P04 " *BFQ3F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U. M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6 M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3 M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO' MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+ M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8 M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31 M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_ M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0 M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2 MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7 M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@ M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M J*;%-<-U#>2 4 $6 8 >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL MI5C?<^(V$'Z^_A4:GMJ9$-LR/V\29@A)>DSO.!+27J^=/@A;@">V1"49DO^^ M*QMLDC%K3^\%+-O[^=-J]>VNKO92/>L-YX:\)+'0UZV-,=N/CJ.##4^8OI1; M+N#)2JJ$&1BJM:.WBK,P,TIBA[INSTE8)%JCJ^S>7(VN9&KB2/"Y(CI-$J9> M;W@L]]<MKW6\\1BM-\;><$976[;F"VY^W\X5C)P")8P2+G0D!5%\==T:>Q\G MOF\-LC?^B/A>GUP3.Y6EE,]V, VO6ZYEQ&,>& O!X&_')SR.+1+P^/< VBJ^ M:0U/KX_H]]GD83)+IOE$QM^BT&RN6X,6"?F*I;%YE/M/_#"AKL4+9*RS7[+/ MW^UT6B1(M9')P1@8))'(_]G+P1$G!CX]8T /!O2=@7?N"_[!(/.<DS/+IG7+ M#!M=*;DGRKX-:/8B\TUF#;.)A%W&A5'P- ([,YK('5=D#BM&VD1OF.+ZRC$ M;!\[P0'D)@>A9T"&Y(L49J/)G0AY^-;> 4(%*WID=4-1P 7?7A+?O2#4I5X% MGPEN/I.[2^(.JLS?T/$+)_D9GH\ZZ>_Q4AL%<?</ MDI(#L99.<,Y*T,4M@- MACR];GF5QW%SSVT_("RZ!8MN,Q8/*5.&J_B5//*M5*:*$0YE5,H11KV"4:\9 MHSE7D0QM1!$([$H7X4C'&/KIPX>:,.@7W/H-UTPQT+%,ALZ["\=:L5AC_AH4 MG 8HSITPD7DE]U',R2Q-EEQ5<<$Q7-=K^W[/[R-\A@6?81,^CWP=V<T"SIJQ MI'+U<)Q)-I>8P?+/0942%O#41 %XC4Q%<(DP]=Q2^MPF7 %/*EA%9A?T@BP, MA!N1BDQD*HQZA?^P<@(UZ$\SC.2)/GM-2#ZQ%S(-(?BB%7@A"[WSRUT#V:-M MK]_K^G2(,:0E0]J$X3@,(7GHB^,%^0SOD:^BVG<X).W2+OG&M<GV_WC'!2HN M7BGDGO__N3[M9257''*11A OPZZ+$2S3@H<+^WN"$SN"8'R2>U%)#H>;,;W9 M17&,>J_,%AZN\>_)%5MEKN0N$D'U4N.8^#8ITX:'J_U[:G.I#8O)7]'V_/[% M$?T^=7V,6YDV/%SKLS4<0Y%]G@H.T/.Z&)$R5WBXT'^6(*"@IU)@R:(&A':[ M;>@1!ABC,EMXN,P_1082EUP1C_Z\_(4L>) J\%8EK9J$(9,$1!$*YN#Y@@A) MMDR1'8M1X:!EKJ U:JY8&(DU6;PF2QE7\:L!F,RG?V),RH1 <?4^^HC<O00; M)J!P/Y=A:X!FX\7M&*LB:9D":*,4,$F5LO517A1E[@*%2"L[BAK$[^_[D+?, M2L&GC01_*J"ZS5M&6TZR(]5*9CAB#;-2Z6DCI;>5&]0:(*1KJ2H#OP9G)D6; M!0$TQE#!\# 'Q!B6<D\;R?TB87%,;E(-CW7U6OY0:T!+D:>-1/XNX6IMH^M7 M0# ;4-5DRT2U[W# NBJ<EAI/<8D^^FK#P5<8H1]K"VBI];118W"0Q44NBXNL MP2=?4P/945A!JVRN<^1NAFS/@78CKS-PAST*HK^K8E7J/<55NFBA[B-M<]%W M#BI]#S>KXPH'J^ON2W'W<6U^S^K0>Y[E50/W@)4-?BGT/J[/8Z 4YK1B5K50 M-S4 =<'DE_KN-]-W(*/ /U,1\A?R&Z^,\!HH%[I-=]"GPP[&[.1D!E?C8\HY MC2?LS* &KMWV:-NOC"KGY)#-"E!V]JA)8+O$_+RMN%N<;XZS4SVG?#T_'/W" MK'YI$O,5F+J7?=AJ*C]OS =&;K,CNZ4T1B;9Y8:SD"O[ CQ?26F. _N!XM1W M]!]02P,$% @ "HIL4]9&R34K!@ HQ< !@ !X;"]W;W)K<VAE971S M+W-H965T,BYX;6RMF&UOVS80Q[^*X U#!R2U2(JBF"8&V@3;.F!+D*S;:T:B M8Z&RZ(JTT^S3[R@YDBU2=%XL0!(]'(]_GH[\'7GYK)JO>B6EB;ZOJUI?S5;& M;"[F<YVOY%KH]VHC:WBS5,U:&+AMGN9ZTTA1M(W6U1S'<3I?B[*>+2[;9W?- MXE)M3576\JZ)]':]%LW+)UFIYZL9FKT^N"^?5L8^F"\N-^))/DCS97/7P-V\ M]U*4:UGK4M51(Y=7LX_HXIJT#5J+OTOYK ^N(SN41Z6^VIO/Q=4LMHID)7-C M70CXMY/7LJJL)]#Q;>]TUO=I&QY>OWK_I1T\#.91:'FMJG_*PJRN9MDL*N12 M;"MSKYY_D_L!4>LO5Y5N_T;/>]MX%N5;;=1ZWQ@4K,NZ^R^^[P-QT E$PWP MO@%^:P.R;T#:@7;*VF'="",6EXUZCAIK#=[L11N;MC6,IJSM9WPP#;PMH9U9 M7*NZ@(\BBPBNM*K*0ABX^20J4><R>K".=70>?7FXB=[]^//EW$"GMND\WW?P MJ>L 3W3P(#?O(Q*?13C&R-/\.MS\1N;0'+7-X^/F<QAJ/U[<CQ>W_LC4>+=- M(VL3":UA8!<!CZ3W2%J/R91'H5>1J(LHMQ?RV[;<B0JZT+Y8=:[2UI6=8;L% MIEE",('0[ ZCXC%,&"6,I[WAD=JD5YL$U7[,<[4%<3 %<PE*'RMY%M72^,1V MGNB!!I[1F))XI-6U0Y@PQA#Q:Z6]5AK4^KG>01Q54TIO+*G;;8Q3S%(^TN<S M3$F&*//K2WM]:5#?72,WHBS:CZ_,2C8P80^SRR<Z]<2*\IAG(\VN'4:<<SSQ M^5DOF04E_Z6,J-X@DSG=)PPCFN*Q3H\AYRFG'/N%9KW0+"CT3U6?O\HLPWF0 MN6F:L)01-I+JVB&4TI0E$U)Y+Y6?2 . :F->VCRP\W\#F#.3LXI[(D:2;!Q8 MUXRR!!WD]I%6% _K?7QB4AE1/Y4P[_>??U+HWM%1#B8<99FS /@L,X0R@B;2 M%1W@"07E_JI4\5Q6E5<@<KK-,JA?''DG[8[%#2Q!."CN%KZ[,&7]%%422HFH ML37#N5J>;[4,3*Z]U^-%(,.8T;%PUQ PF*$DFU ^, N%H77;+E<!B<3IF9 8 M90<?="_18XA)0LB4Q %4*$RJ;JD*2'2QDS'*8L:2L48/R-(DA0'1"9$#H1!] M4SE1E>*QK$H#2U2HID #6E"8+3VG-^+%0MH; 1<2'!,(/1D'P$,=0CBLYE/S M<^ )"@-E/ 5R-R!>Z2XW4,P3E(T7;:\A2AF;6@@'P* P86Z/B'U*KPL/EB+& MD1-J'V4P3:#<F! \8 :%.7/,[E."77Z W(0F;G*XEIBF@,5D(CGPP!H<9LV] MW*EJUR8'O(G4,LH;691>VF"7(8C&[<](\%LLCP4/M,%AVHRSN5;U&^.-7<9@ MS--XO*1[[%!,H6*:J)7QP<;F!(S:?*Y4_71N9+,^*=AE"ZR</,'CG8C/,(,R MFTV437B $ Y#J$OH4SI=P"0QQPF-QV6^SY+3C',T,?7PP"(<9M&U6J]+8\LZ MW6WU5&VS1-;YE.J@/WLV<Z$W(I=7LTTCM6QV<K:(?+OC_\'1\9@'M.$PVAY6 MHI$K516RT3_]D&'$/K35K7D)$0X/A,-APMF8JCK21N5?6__X0ZT =TT$^^>M M_!"A.#Z+N]](6S$0^ZU9P3[@7UG :WI&*3W+4MI^$KAEF)S%C+X:EUIOY7YW MMC4:RM["SFRA[4+T^Q86I.Y8 F6MS0ULB->/,(6ZTP;$SF"/K#>R/6>J7KQ? MV>5JDJ4(<^),>X\E1["CPE/S?B P#A/X7AH!CV#K(9H:!JBC=X5<EGEIO*<U MV 7J.9 AYO$8##Y+C C@=TKSP%X<9F\W\_5DAGF%NV1-4JB:8X+'PGV6G,<4 M30%B8# .,QBVI7;N-ZJJ;"Z5-2RU4OL+5.R"%2)-86LZUNLS1 Q-[9[( & 2 M!G 7Y^F8$A>E20JE,4['">RUS!A4D<F$R &Z) Q=!P/]1GI"-'+.QB8*?X_E M1.$_/SA!M<?7?XCFJ:PUE %+:!J_9S#PICL1[FZ,VK2'JH_*&+5N+U=20"9; M WB_5,J\WMASVOY<?O$?4$L#!!0 ( J*;%-).>:5@@( - & 8 M>&PO=V]R:W-H965T<R]S:&5E=#,N>&ULE57+;MLP$/R5A=!# J21+%N*$]@" M$@=!>RA@Q&A[*'J@I;5%A")5DK+;?GV7E"(XJ9R'#Q8?.[,S2VHUVRO]8$I$ M"[\K(<T\**VMK\+0Y"56S)RK&B7M;)2NF*6IWH:FUL@*#ZI$&$=1&E:,RR"; M^;6ESF:JL8)+7&HP354Q_><&A=K/@U'PN'#/MZ5U"V$VJ]D65VB_UDM-L[!G M*7B%TG E0>-F'ER/KA:IB_<!WSCNS<$8G).U4@]N\KF8!Y$3A )SZQ@8/7:X M0"$<$<GXU7$&?4H'/!P_LM]Y[^1ES0PNE/C."UO.@VD !6Y8(^R]VG_"SD_B M^'(EC/^'?1N;7@20-\:JJ@.3@HK+]LE^=W4X (PF1P!Q!XC?"AAW@+$WVBKS MMFZ99=E,JSUH%TUL;N!KX]'DADMWBBNK:9<3SF8+)0LZ$RR 1D8)7C!+DQLF MF,P15H[8P,F2:92V1,MS)D[A(WR $$Q)JV866M+AV,*\RWG3YHR/Y%QA?0[C MZ SB*!X-P!<OPV\Q)_C(PZ.G\)#<]R6(^Q+$GF]\3(XERW0Q+:@-W'%)QCD3 ML%2&^YOVXWIMK*;[]O.%9.,^V=@GFQRM=U41)YUK_G &-=.P8Z)!..$2"B4$ MTP9JU&UM3X=JV_*GGM^]H[N,BK [+-]+$4]$3WK1DW>(;H\=6&-+I?E?NBU. M?+LZJ+@E3P[TC*+N]TSY6R*?.$AZ!\G['7!CFM?5)_]KFDR3*(G39^*' B^G MTTE\.:P][;6G[]=.#=E8)@LNMZ\92-]J8"APT$!XT&]<K__"])9+ P(W!(W. M+XA#M_VSG5A5^Q:T5I8:FA^6],E![0)H?Z.4?9RXKM9_Q+)_4$L#!!0 ( M J*;%-7E9#+I0< .<B 8 >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL MM5I=;]LX%OTK@K$/+=#$_))(!4F Q/;N!IB/HIG9>5CL@VPQL5!9]$ITDME? MOY>28]GDE9HVF#XTEGUXR7-X+WDHZ?+9U%^;M=8V>MF457,U65N[O9A.F]5: M;[+FW&QU!;\\F'J36;BL'Z?-MM99WC;:E%-&2#+=9$4UN;YLO_M<7U^:G2V+ M2G^NHV:WV63UG[>Z-,]7$SIY_>)+\;BV[HOI]>4V>]3WVOZ^_5S#U?00)2\V MNFH*4T6U?KB:W-"+!6>N08OX5Z&?FZ//D:.R-.:KN[C+KR;$C4B7>F5=B S^ M/.F9+DL7"<;QWWW0R:%/U_#X\VOTO[?D@<PR:_3,E'\4N5U?3=0DRO5#MBOM M%_/\3[TG%+MX*U,V[?_1\QY+)M%JUUBSV3>&$6R*JON;O>R%.&H <? &;-^ M^0W$0 .^;\#?VH/8-Q!O[2'>-VBI3SONK7#SS&;7E[5YCFJ'AFCN0ZM^VQKT M*BJ7*/>VAE\+:&>O9Z;*8=IU'L&GQI1%GEFXN+?P!_+!-I%YB'[=ZCIS\]I$ M9]'O]_/HP]\^7DXM=.^"3%?[KFZ[KMA 5SSZV51VW40+Z#)'VL_'VZ<C[:= M^\"=O7*_9:,![_7V/.+D4\0(H\AX9F]O3C Z[^M]\<.]GXC!#XG VWA\(-Y= MM3(;W4]\].^;96-K*.3_C$07A^BBC2X&HO\"2UZMGW2UTPV6.5WKI&WMUK:G M:T4DBP4P>SJ>D1"7LI@D*CW%S4,<DTD24\5.@0L,2&6:D+[G$\+Q@7 \*N?, M-% [695'^F7K"JRY&)$Q.41-1F5T45U!;FN3[U;0 50L5DFW79CXB!;E3!$F M/3U#'*."*>[K&>)BH4"DV),SQ"5<24(8KJ8\\):CO.]A(RFJQU9/V,^^:@M7 M&&\9],\5]*Z4QQO!Q4HJX:7'/,11*DDJA$\< ]*$I$S@S-6!N1IE_D4W.JM7 MZY9Z#A54FJTK3XR\"L<@8I"?>^01'..$<X_3/,0)(BE,J,<=P7$I>#HPZ>F! M>CI*_1^Z@FVG;)EG.>Q]A5N/G*_ R*=A)A.>RM3+Y!F"XXHR7Z1YB$MX JQ\ M\@@N(8J[)1TC3TF_,9-1^C<;4]OB?^V^BVZV))Q&0GDJ_%S'@"Z+5>)11H"0 M%((H;Q5>8$"F1$('%DUZY$;H*.G?C(497P6+)RH #4:1)CQ._3R>(4!*! "E MG_$(DI-4P4J7^!(@2*IHS$0ZH 'K-6"C&NS=%BQW1;<G?RA-T^"&BP6C.*-Q MPGD::( A&>1 F 4(DG/&Q=%2MM< 00J8@610@]Z,4#ZJP5UE=:UAL^LD0+GS MH'<)V>_S#E% FPB?- )+!:4^8Z1/$L=\@&[OCNBX/?K5KG4]QE4$_?K.Z-N0 M.0)A5$GJNZS%:*Q3BKT?HO';9G1?TBC-.$PHF"Q&?:X(3L:,!H0Q'&&I]/EB M_3(I^1#KWJ_1<<-V=US!T4-M-K"X55#<.U??IC]7+34<^O5KQ=OL96#-"PT6 M%+Q,"&.^1A@2O*U*?8^#(EU>R" O$*20*5,L&1"J-WATW.'='8A''_89\A%$ MJ?1#@7H=&AJN,RGB8.]#8%PRY4N P!@+]H<%AA.Q8$,+0._RZ+C->\V3G_H\ MF?5YTI^_/T7N) 4G@-^RET\1M"IWN4-\=E[!5-&-M76QW-EL68*8)OK%5"[? M:M/YY]<B_!2U&RTJ;.CF(,,4%[X+F*%()N.$!76((DD:!S8:0PK%U?"VVKM) M.FXGYT6S+SV='U4>>A\B-'54I#38-A8(D'&0B@ZX/]:[/S;N_MPT?W/[9Z$/ M.Z.PIR>I;_DQI$BE##9"!,@4'",\&[W L))G!\;Y%/JO0=DXQ[04?_0<?\8 M.>Y19J-FMVR*O,CJ/^'J-,>KTQPO]CF.KI\,LVV"^FX)@=$X3:0O5@B+51+[ MK@&!":G(P)K)>J/(QHUBD".!-/#;!E:%9IW5>FW*7->X*BRX"P)Y%,=,^NLI MAH1TESR0)@1R0:B_12^P@$S$X&$'3H^L]Y!L_([6(JLK2(CF51PH^4Z)[Y?I M= 2]K6/CMNY=(XC.CK< <WP+=IDUQ<K52)1#TF> /43&UXENF/)89'+NNRH< M1?R]\FVP!0[C0PMC[R/9N(]\KZ8#V\"/J-H-5!V[Y',2K+PHRC]XHJA@'4%! M\8"BO4=EXQ[UO8I^MVY)0,,ED"0G_X+LQ%OYMVT0&*#\N[YX,#JT(O<NEHV[ MV+^JX/.BW+G',M\ALD09^J*BJ+#DWP1;X+#!DN_-,1LWQW]=R?^ KNI-18^B M@J+'4$'1HZ"AHN_=,!MWP^_5] >42]%]XUMEC[<*RCZ$866/!ALJ>]Z;=4Y& MG<8?[>-HG9]E3Y!<C[I3H8G,SC8VJ_+@8<5I/[TSYN/.^'BM[;I E>:(>Q5* M$:7\QS\8,J8<SM&^P&C,E*<I]4\&:$Q&$BH'CG"\-[Q\W/">IMV8 N&=R2$% M$.2 C@R38-3(8I$%9@>/;C?Z/JQ?6.B@9+;5;9[='OX]O!6QDW[+H+W_2V] MF%'D^SF]6'3O7/3ANU= ?L[JQP(6P5(_0%?D7,)PZ^ZMBN["FFW[VL#26&LV M[<>USJ#\'0!^?S#&OEZX#@[OMES_'U!+ P04 " *BFQ3W<O28D8' : M'0 & 'AL+W=O<FMS:&5E=',O<VAE970U+GAM;)5966_C.!+^*X0Q#SW MNBU>.AI)@"0]1P,[,T$',_LL2[3-'4GTB'32V5^_14F1;)%B)WF(=13)KP[6 M5R5>/:OV;WT0PJ!O==7HZ]7!F..GS487!U'G^J,ZB@;>[%1;YP9NV_U&'UN1 ME]V@NMJ0*(HW=2Z;U<U5]^RAO;E2)U/)1CRT2)_J.F]?[D2EGJ]7>/7ZX*O< M'XQ]L+FY.N9[\2C,G\>'%NXVXRREK$6CI6I0*W;7JUO\Z9ZF=D G\9<4S_KL M&EE5MDK];6^^E->KR"(2E2B,G2*'GR=Q+ZK*S@0X_ADF78UKVH'GUZ^S_]PI M#\IL<RWN5?4?69K#]2I=H5+L\E-EOJKG7\6@$+?S%:K2W7_T/,A&*U2<M%'U M,!@0U++I?_-O@R'.!L \_@%D&$#F ]C" #H,H)VB/;).K<^YR6^N6O6,6BL- ML]F+SC;=:-!&-M:-CZ:%MQ+&F9M[U93@%%$BN-*JDF5NX.;1P ]XRVBD=N@^ MUP?T,WA<HS7Z\_$S^O##CU<; \O;23;%L-1=OQ196"I#OZG&'#3Z"98L+\=O M /:(G;QBOR/!"1_%\2.BT;\0B0CVX+E_^_ H (>.IJ3=?'3)E-9*N\Y*NU;5 M"+9:FQO9[/M8E48*_2FP#AO78=TZ;&&=WV%SRZ90M4 ?*J6UUQ7]%'$WA=W* M3S<DQ8QG5YNG<PNY8FO"(\IH.@I>8.0C1A[$^%GJ IPMFQ,$TV (B"\?TGXB M?@8!LPQ'$9M!=>4(I2S%V(\T'I'&[[-F[[P!O?5>&'[LP%IC$F6<\1E^CR!+ M:4I8YE<@&15(@F%W6_X7TD2_5XV"U K0"UD)U+Q#,SO2RA<VAH^M>I*P1='V MY=U!G(ZHTW" "&"=0N9]+F]*E->J-?)__0/Q[6B3DL_>J6-&RDE&''-[Y5B< M,K^ULQ%W%L3]>,A;L;;$48(E:PNS@^R#FCD0.$ZB%,^0NF)IQ.G2#L31E-FC M[YBX &+7 H( -:I9=[[MO;^':+&7&MS<+N(?YK\(V9B2F,4S#7R":133+%K0 MX8R=<%"'+\V@PX=7;7Y$7YJ>D!Y/;2N 2EKT5UZ=!/ICA_XM=P+>ZU.;-X5 M#\!GQ8M7->PBYB1*HKEFKAR.,Q;%"XJ123$23CNP2:T2LC&B%=J$0GZ8ZB*6 M:<;H'*M'+,99L@!UHC5,@U!_@6(0P::$FG$/)5<C=%<4E&)KO&BI:UJ"TP0S MQ[BNY%+ 3-R(63 ;VG1>''*(<&WC/M=:0%ZT"::2^59670)#^6YGR\@I!;XY MO^&) 7&8 F^+0IUL4H8\)^13OJW\SO7P&B<)3AWWNH)KG.*$+>ZRB0)QF ._ M-.!6HUK0W0O1I2[".:>9 ]$5A-T2Q_%2+ILX#B=!A'^8 ^SSHMOQYMRKJGO1 M/_!B3SR02$*Y$XP>P2R&TG"!,/#$=#A,=6,@'/,7&P5GN%\5.HM-KQ(NF:U) M"DID3B;VT!YA*>-+,3+Q'@X37^^!2C7[-62L^KN0759;0\IB=%Z!^@0Q3SE? M8FHR$2 )$^#O;RUHWEGR$9?N2)KAQ*FN?8(TXQ%?4FWB11+FQ7?4U\1#8=X" MVR-(<!Q'Z0+9D8GLR'?([JV.\.)W:0W:$Y+$\^SC$^0Q/N>=2_P3 Y+W=782 M\J5^!VF0B;Y(N+>[+4LY%N1@+;"1>>D2AOCG)(^VRO?:B/EV&TOG1;%7CN-T MH04A$]F1,-D]M*H0HASLH\?*#.J$RM9D<JS)CK8F6W*U2W'S-.T181"BZ0+# MD(D#R7?Z0&7$&54//K8&1[M34X*SO8@]71V)[-\<MRNX%)83*9(P*5X$"Q22 M4/7(CE\6V9"X) <U1!1C9R_Y!1,6+Y239*)#$J;#,1F<; \%-9IO-WG!>UB0 M)3S*TCEXCR!F#"=+=0B96)!D[\H$.]E 5+\]$]")O&B8O.Y4"V-@9FUK;_O6 M;B;H@<#G/NM0EVN ]7VAZ)-D,\E+T!,MT3 M?150XPR?#=\$VM.&+:'VBO(0 M[(F?:)B?.J\.R#O [VB2J<LZ:YQDA"?S/>633"F+\$(U0,\^/(8[-##[J86N M1W?FUJ<M0)9Y^X*T_5HQA&H#'2?HU:JJLO'ZVGAZ=0HU9H,RGBXO#3ECHD : MIL!+90I5UQ!*O2)>K!Y*PQ'A,4_FD'V2G&-V5DE<8I[HCX;IS\EIOKS@1>]I MZDB*4T(=@WLD69QREBQD9#I1'WW3)]#A0TLY?F@!/3JE;/G17=@:Y"FO[/[V M*N-I_Z(4JOYY&>(1!$_$,8[X@BX3)](P)]XO 4:Y05NQETW3%?@[!*655*57 M#Y?\"! -39QVRR>9$DQBNJ3(1),T3)-!183M((,JI.[W?^BH**'SKX\^R3AF M,:?SG;PY.V6J1;OO#M\TZIK;_M!F?#H>\-UVQUJSYW?XTWU_3#=-TY\:_I:W MX"&-*K&#*:./"5BV[0_B^ANCCMU9UE89H^KN\B!RR,]6 -[O%)1QPXU=8#P. MO?D_4$L#!!0 ( J*;%,VH25Z[ @ %$W 8 >&PO=V]R:W-H965T M<R]S:&5E=#8N>&ULQ9M=;^,V%H;_BF LL#- /1;)PP\528#&2;$MT&*0;'<O M%GNAL958&%M*)672_OM2MF)*Y"$MNY[,7$S\\9(Z.B+?1X>B+U[*ZG.]RK(F M^F.S+NK+R:IIGKZ?S>K%*MND]8?R*2OT-P]EM4D;_;9ZG-5/598NMXTVZQF- M8S';I'DQN;K8?O:QNKHHGYMU7F0?JZA^WFS2ZL_K;%V^7$[(Y/6#N_QQU;0? MS*XNGM+'[#YK?GOZ6.EWLWTORWR3%75>%E&5/5Q.?B#?WTK:-M@J_I-G+W7O M==2>RJ>R_-R^^6EY.8G;B+)UMFC:+E+]YTLVS];KMB<=Q^]=IY/],=N&_=>O MO?^X/7E],I_2.IN7Z__FRV9U.5&3:)D]I,_KYJY\^5?6G1!O^UN4ZWK[?_2R MT_)D$BV>ZZ;<=(UU!)N\V/U-_^@2T6M F*<![1K0L0U8UX#9#92G 70-P&I MN:<![QIL3WVV._=MXF[2)KVZJ,J7J&K5NK?VQ3;[V]8Z7WG1#I3[IM+?YKI= M<S4OBZ6^[-DRTJ_J<ITOTT:_N6_T'ST>FJA\B&Y_?\Z;/Z-I]-O]3?3N'^\O M9HT^<MM^MNB.<KT["O4<Y=]EDZZ19O-PLWFYV>C!I).P^(RTO@FWOLL:/5'T MR61I5>3%8XUT<1ONXM>R6)1%4Y5K_<UCE!=-5F5U8_4TTSG?)Y[N$T^W78.G MZ^MTG1:+[+OH.GO,BS:^-M4?LRHOEU':1#?9XD/$R'<1C4F"97S7O=AVW]K! MERM.8L4I9Q>S+_T<NT)($@(@U5!XXPH)C15+^%!WZ^JF3 H:[V6#A+!]0MCI M"7F7ZV&P2G7RWX])SGQW*-X_%4X%XYSC0<(^2-BV9)X@?RH6VH[K+'JG0]B^ M>J]'A9XN>H2NRO4RJ^I_OLZ7_]WI81-I.WM)J^7_ T.&[P_.@QFZ;Q,P;6UQ M&2W*C69%G;9NBXT.[B2 "N 2K+'!G4MIR0:!BGV@XJ1 ^Y<1NVK"#9HDBGL& MEMQ'(X/1W&5/S]5BU5XU/: 6G:=LH\ R)YT@I@!$4#MUTIT%EFX0K=I'JXZ( M=A?FH;PI-V0B0 F!AY+L0TF"H?RJ[U-R;8 ;/=S798T>^SI!CAT+3L!RC1M4 MR'G?-W;V@@@3;6OXN9#8@"X>YR^WQ7)HM;^DU:N;M,$@<(N=D"!1P&)N6>B\ M4P[-5C()U#9;I$]M45+:9HOHIB#[Z1WFHP=^<DH^+*<]E)MY=Y3A>3"B.$L\ M$1I"DJ^,R*Y_?IB19#0DD3YQ2B+"$":)X21Y0U"28TE)#"K)-V E,; D85H> M9_MSXJ)P2GC<_O,DPM"0A'%XBJ43EX53B*50S!.-H2$)XW"4JQ.$@I3'#)CR M'-_PC80!Y_?A^^Q)#]8XX,,NZ/0$!<:DM.>S0N8SD2*&V)[/&#PI2,JD/:$1 MI>) /90E!K,DS-EQ3GPH.W/B@E,/8)T>2?$(J6$G'<E.CQ,?)"@=35 ZFJ!( MGRA!$5V(H-00E(XDZ @C/LA1>BQ'::_2I&]OQ-3PBH9Y=4S90ET<4:D8)/8H M86[A,M0-@S70HO!52I>NV\$ ISYT4 ,Q>DZ(75.W[)M*D>A:P,X?0CM+.(S8 MP(Z>'W84@1T! L(#.VI@1\\ .XK +@%M38GM.)B0*.I:#H9/RHBG-J0&GO14 M>/[\7(3A21%X*B"$R-@>'!@\*0A"G80@2)2"\]BNZ3"A2(#[YJMA)ST'.P\E M9TXQ=A)%J/30G1EVLOCMW9<92+$PI(YQ7^8RB H*Q!K>\TXG_+IAL(94+%SQ MG>J^S*VU 'SK1JRW(ADFUY'NRUQX31G3M\WVTA%SZ64+AQ$;?+$PODYQ7^:B M:TIBPK@O&D,O%J;7*/=E"+/T'9^TLW:#"A61SHTZ)B0\$=)S/H9M+,RVOU&Z M,!=QGM*E4XXH79 ^/:4+I@R4+LSPE87Y>J;2A;F\#)<NS!"3C23FX44DSY5# M:"B49"QQIC5:=%)=E##[RB$XI(2UL\Z^<EAY2B0AODMGR,E&DO.X921/DA!^ MZ@)/@7W+,!^C'#Z:,:2%;T!:,*2%\Y$67((201-AWXH=U@V#-:2%KT-:0)8_ ME:ZY?1?/L!;.REK 6!NS6-F5#F"L'0J'$?<>!9Z?M8"P5IN[[Z$1&-3"&5 + M+A@)@!#$LB=,)X2R5V!N$9TN<X@/M&! "Z>"MK^.0M!S1$"K[5HFU 8M(*!5 MB2+.4OX-TN>4Z&*9*+OP0Y4LH;YE6S"DA7.0]E!ZYN A+0C?$#2DA:],6AA- M6DR)DQ9&DQ93AD@+AK3PAJ2%T:0=HQSN0S"DY=^ M-R0EH=)>^2C'>Y"5!<X M@4<[W&"4AS%Z"@,X]F"0"LX\MLD-0WF8H:,@P)&E4T6\2S'<\)"'>3BN.D)- MN^MY./,%")T5>\,*HE3MRA2S39MC9:U,XB2V9SZNY-+',=[;L!.F\O'E$9X> MC-N*Q[Q7P'7I&:$<GHMA,A_)Y!'/@/"S0'B+DQE3XF3FH\F,*@-DYH;,?"29 MCWP,A/*9'\MG;OC,U3<P;4-!'J;@4;O7$'0E).'.]K7$+8^&NN'^-0,X$7[@ M>60U(K!'C H2Q[Z$^W33%@XC-DP4QS!Q'(F$N]X[)5Q![(O&<%&$N3B*1 +; M2D.9OI.S9CDN5-PNEV\1X93'PH,V8< J1FZY"3YV05U/N(4J2*5G=&R[GG#! MK-&F%%/V2BC2YU0R+JAM>IA05WR,>Y;5A(&]. GV@><NJ-T)%[WZ'I6*V'<[ M(@Q[!7][NQ.]+;"G[8%%QXC+)B(&=727+9>+EFX8K$&8""/LY V[+JV4])F' M 94X9@OL8?/%2CPF!;%OCH1;-=K"8<2&;2+,MI/,%]GG*@7$GG4I:=@EP^P: MY;T2(1:)E1")74'C2LZIO37R%E,RXGTL* W;Y$E;5<?<.DNW]O-4%I@2KRP0 MI:>RP)7^RD(:P,J1>V/_7F4A$;+BE<48Y>Y<9KU?([4_-M/WO/J^N([6V8-N M&G^0NH]J]_NMW9NF?-K^0.E3V33E9OMRE:7:H%N!_OZA+)O7-^UOGO:_HKOZ M"U!+ P04 " *BFQ3<)RXO$<0 !&*0 & 'AL+W=O<FMS:&5E=',O M<VAE970W+GAM;*U::7,;-Q+]*RBE*I&K2.IR#I]5M&PGSL9'27:V=K?V S@# MDHAF@#$P(XK^]?NZ&Y@94K+CI/:+1,X!]/GZ=8./-SY<Q;4QK;JI*Q>?'*S; MMGEX=!2+M:EUG/G&.-Q9^E#K%E_#ZB@VP>B27ZJKH]/CXQ^.:FW=P=/'?.U= M>/K8=VUEG7D75.SJ6H?M,U/YS9.#DX-\X<*NUBU=.'KZN-$K<VG:#\V[@&]' M_2JEK8V+UCL5S/+)P?SDX;/[]#P_\+LUFSCZK$B3A?=7].55^>3@F 0RE2E: M6D'CW[4Y-U5%"T&,CVG-@WY+>G'\.:_^DG6'+@L=S;FO_FG+=OWDX*<#59JE M[JKVPF]^,4F?[VF]PE>1_ZI->O;X0!5=;'V=7H8$M77R7]\D.WS-"Z?IA5.6 M6S9B*9_K5C]]'/Q&!7H:J]$'5I7?AG#6D5,NVX"[%N^U3]^&E7;VDQ83N5(] MT]%&Y9?J73#1N);O/#YJL1>]<52D=9_)NJ>?6?>!>NU=NX[JA2M-N?O^$63L M!3W-@CX[_>*"EZ:9J;/CB3H]/CWYPGIGO>)GO-[95R@^4>?>15_9<K##6'TR MQTOKM"NLKM0E+AK$91O5?^:+V 9$UG^_(-']7J+[+-']STET\?/\S:M_S]^_ M>OM&S=\\5\_FEZ\NU=N7ZMW%B\L7;][SG;M<\?]85YUW]<*$BG5?:P1\8;K6 M%KJ*ZI4K9NKPVV]^.CT]?C0\-^$K)X]4NS8JW_5UH]VVO^6#TE%UT93*.GZP M0%R8FY9LFM[9F/[Q=*6+XP721=^%=/&>0HAJ%1M##FFWJMD1&%NP$&KI"][9 MR\ZZ^-C9:,7CI;D&(C7D1_8WWJE-H/5R-D# 1= 4O@IX%XM@&[[>!%]V!:!0 MO<>B2>'O(JY;PC75ZK "FN+SE4&,ZVL?&MI!,%UT+$^#:1*TT8L=C?Q-\ MY5=;%B.L30>LX0N\032J-B6KE?6U1E8MH#5BSP3["3(NM@#)2A/(55NR<H&E M T*U%Q]N8P2+L(9NV21)>K4PE85!(D1S^** ^2:];)9+4Z15L4>L=55-DI*X M'76%UU ="@.+C(((+BI9<'JJ]62V:UM:MT(@.'_-@O:V%(EL30\9];&#%^!6 M>(!,1:NK!B]PSM':NBRA$N+*U; TW?4^0#[ZEJWEC"EW?42[U;Z%N);6:7BS M<BQ#\-UJS7<'CV&[I375KJ8YF#\X2^HQ)(AH4-O$5B\J&]>DK(8@+54FTL:2 MLQV'%Y9N=&B="9&LLPAL&>S,\B.%^7*OM>QG QS;P:UVS]@2Z:(8+(-4(2$1 MK"@5MK:?:'%)OASE,%F+E>D3"=;&W@X3RM@-ZB3]3VE"[SN4V/0,A4E):&GH M:>R_QJ,+WZZSAM47\@LO-WIAX6'68N0@2N^3'Q\-HG"8U]IU2\1Y%R3*V[4- M)1O/TO:;M2W6_""\&:(QCAX:;-,OFJ.* @9QU(-:Y.&V':)L&+O[(4.LR15 M5#Y2'FQL*V'"LDQ)EJTJ+?+9+CH!B9%O:WUE=BRL]+6V%6+$W!E',P N7R6[ M)R2"H.!(9,U)PK($<B1WYW17\@+0K01CDD^IHAD*X%R\XE"\L.H8 M8:F;<@ M\P$N(+[@IB;$0$S3<M"/O,G*TYO/36'(RNKLA,LRBO-(CC_9G7/%%5570AF* MM?(/L!V^-\F[D6Z0TCN8W!$'JQ#<11?863LO.(@2(Z.O5TMM"0P:J> LJG7" M7\F:$2"!;U!B;8*Q;J;FV#_:E;-+( ?>X"#.180LW66)@8DN:B:4<60QH">X M&2L+AQ9C,B%A]/<\=(=+K&.!0HFGS>"*8%9=I46LY-=+LI258@')7]R@7+@5 M^[NV'.3J<%2X+U^<Y^HJ*5V8T(+4[YB.KB/,*0V0C6,!![6 QKZV+2D%4&A, M2%\X<R'6BW/&<[:QK>D!Z\OLK,%D\>\:+:Y]![1>D%%T]L<?G9,NH+?87XM4 M)V5#XI47!<2JN7/ %'5A&H0390LU"NKD>/H/5I&VV1H=E&$2<2M==NS/%SZ_ M8/:-A!.,A:Z#78WV+"3'YSU1QXP1L5%'5"U$7(0 C6Z3%(E+3Q@[H6"?1!;) M8QV7;JK1*9[RGE2LC#(W("-LLK0IU1(JU8@.:,!J$_<C%M81="='S]1S/ &) MK.OP]MM!^GGDT.HBN7G9(3\-18EZ ].K!R!L@M&O]19BG^#"J/PQB6*_0#I- M6\"G L3S%8S!5>CPX,[K!_<D*,[!F^T*H?R+ <=:,_'X#6E-2AX>Y+MX&C)) MS1FC9S!0TA'3(5O<($XBV2Y04\@V&_-+HUZTZRU*T+??G/QX_Q&[ZCW41&%- M5^ZD%U@EBS'#K=(D=R/%^JR_4\7)'B]S7E4>6$#VO?85D: 2SBM:.)Y3L__6 MI\NXN$T2MV44=F6B5:E0&<N.2PIBM:18"@9"57FS+X9+7U5^0Y?V,N3DP3[% M-C<6V(WM\OHCR]7&<$$V&;%I1;!>@AF=HC9P8@DRE>,X'&41P[QH?.L^5LQI ML(/-!%U#A_-9%%EZWPJ20)Q@EC2:N+T7O=2Q0V\I.0,T+,GMOD\+RC_089LX MY0BMZ>%K&Y-?T)T03Q:T_0R>]N(*\XYKM81GX@XX[[ BHGVUI@H.==)>3/5' M>^E:RB?G $M''YF,HI+39@P6S5Z_S0^0")&?HF"_UE7'<%39)95TW.$JV$"! M@NH<$4!:J+8=,J+1MF_]_IK"&62AD1D4V!A",;KJN\@0F:H!C ".KZ2^,E77 M #'RN;1.Q&+Z^.$QU$!]H^DMEV(*R4FK2=N5Y>\#ES<B0:6=DKIZU^I$F#CC MT%3I.Q:Z'=&>NL.*+2KSP SM7)IVZ[0!D)^__?W5\^G) _6.FN3:%D1;7^L M9!0RR @VNYRA%R@J9B\:E(O 5=HZ6!Y-I"NV(PA@VMNU"]3NJY[)S"\NI^?^ M]^GIA-HI>)DR*Q Y(;?Y@,B_MJ%+762AN17*XDTX.-'-05T/@FBK"LW5;OM$ M<8RPP8IB&<>Z+X#A]"@W1&.PSWRXY**3"F*,J9U*1&<7NY\3?VMSJ/WB:\,; M)Y*VG=U**[BMXM#$&K71PK>HNJ76EUEM<JV820PS-D?R>=9#H W-B)/F%VD* MV930V=2B,Y12KV*PO]\:ZK B"6EXJ=@U#4T7UC"5T$2Z0F2%[O;=ZF;MTR3! MF66&[)WF5DCW;@ORW6C7$;ZN4$AS/T1;=8ZZ.(C+737<!J&K[20!-QHT"8,- M&O#^*19@</AW!*\@^\*2T(EY#HX\6$%,@MZAWTJ#"[)0(098& @&=(LJ3;A[ M8GO.)$18&*HP7$:*<:M)WN71 MY)AI*,F>P'(7K1Q"&BK@UE2XFT*'>@A.NK M="<VSW("=:5PXC"V*!/)%Z\GSRA"&L'B,C _09>.HC-3;[NP&R?$;PMB&SQY M:L&638) B3K!O8H>[]T>24= 5R4#(X)ND(S<@="**,T<O+X?TT#C- I0&RP8 MNP5 F1,)&E7"OT :A?PQ$M%:0EPW,DI;=O0L:*Z%#XUL- [43!W'ED_HG2\3 M[%,T!KU!06/*4$6AD_P6')2'5*-Q!.\T-/7#U(0C1;?%VG =!R% , ZC)D$^ MVIOC4H)V,,0,L(!*)I,9VH+'D,GZSJSRC*]W1(K RA=7I=]DE_O8-M[UY:U9 M;R-R3[L<^BD6F#]GCT% !"!AS0P@M2$QV,QI"H?<(\2 53@]-8@+S5S0-X^4 MHQP%H%L_$?HH 9MT*-$JXQ69C-'\DYB@"4Q:4'EV4#G04#*AV#!F\:/!/:4K MBK-D#!*]XH3-OD>*0'^>#XR=EII8H;.[@YE=&*8A\T:'A">67+_EQ@<A354R M)0_L3C4B[<I];>AX5(RKK44:0VF][4<><&CG**((/&@Y1^5*1ZE3*,49%G?A M'9;R9+:^[.90WA4Z\TA),LD)P:?]]Q3<WPG?2J.[H6*+J*-A)6L&VY?"/JE4 MRG1@7"K2J W8M32MS+,I(Z8+ \%Y4E?1L"=Z=65,DP>>/>STE&2F?NXQ'XV[ M#"+:+;EQ!85X9$0"]O:)'4A'XE^3_5*-F*5)&Z3^V!&R++<[UDV<79K4S(5T MWU 1493/6&J)#"7Q+@P-U]5\:#1^[JR,9&[?>H<@]Z2&- )3HN[J7^!7\](W ME+Z@3;]VCGC6R0\B_7#8-%H'3,*5.B")GGG\0U/Z<G[YC!K2&*EOF%]^P-(S M7F9Z<C;)DX5AL5<.4=^Q&--S("5"^C?$KAE.6Z2QS4PVF\D&!I':(Y"YOM7 MEE&;D^GN:&KD4_O>;SBC60;-SY+SY &TF<9>DW_@M[6IRFGKIP!@)D7(FT4K M[,/*K+?R.J';K?4GHY*X <>3=N]C9Q-% R?D6?R&%$!6E]/*^RNR:S)3/]&@ M=,[V$)4Y_\%4"9.Y*:ZJG*HI:=#! *M8'T\AFIH83;26PD)H0<7&%DOT(^ I M[DSI;&%?74'/SH$*5WS"(Z_?4C2Q0_2Z[%%YBKL0@CT(C42OL1<G[B:=_,"X M*&V^U,@J<U.8IAT.A=(*@Q59IT]2\4<J(5G7/(/0U/'@.<)01N5D%71.H>47 M"PJ8E%&#AK.4IKTJ7%6(G,B,T7RFLYV,JO=X/,EZD:.I;(.U766;Y-$_"J5, MIE!7@UU90;=;(<U-41^8MZ34#/2D"E)N?&:1^SC&\J*K.SF.FZ9>;IA80X$E M-6<3&02TTGA ,H>]Q^BS,!#2I3FXS!9";%,79Z5V4ENV,Y-:92RB B880Y!5 MY9.X/: 8C=U A*\-67<T9F,\ M",88;N3(^_GZB#KP 7=?C>-R@W9Z<_W'NH MWN>#P_<T2I=,N:!"OSQ(*J3.-LJP79Y@*K!D1Z7]6?+%=G2L2.W7D#<4DU4J M8!)4-J!@^P(^W0KA$8,"W?)DH>FC =NM+%6-6R"7L@VV:O?CNVMH1%ZF97)7 M!L39S<R8<!QQE<!2=K,<H@FSI%;4B!=*03K7S'.I_@<M^2:%HTVG-6X$B=/% M=CI\DW,<X0K]$CP+;$?'4:R[3/#N "C<_#.,WCLUXW0ABPC%&/N.]!G%$HG_ M*U@:G>'(?/Q,UAH;]$OOYREVC^,#2\V,?J_F[Y\Z_NE1P&RGK*>ITT/U(3)# M>!%!]KC9)['EQ&9WG/473C'DV(*@C8S,$<W$;*A"U$HQ?1B-.]'18Z6&SJE3 M',71R>'^B5\^FC2]X'RVCC2OA;Y*29#6<W=ZE&=B5..&XE_9_EQW[ZA(!C4L M) FR\V"[Q[/,5Y[)?$Z@1,M39Y/Y];@'3"<1<_0#NNHY7\'G1J5=TH1UU)@- MYNEX#"E/\+GVR%1RQNVD7-WZ;0A7E_$1X[!H&B,^5(<G]^2'";ND@7[EL3(+ M5+/DGZ(('76G=#/@1G9<[K_D* (\X?#TGI3AW07] L8UD6FJIUY$IOGI.!JV MXS$9K7AX=H^AL8]B/79B'H')W>S2+5G%%Y9])T@\,'PPET4JNK-\]D/,UJS8 MK7?]B.IH]-LVGA?2+_BB_ Q"?N;67^U_)#B7W\8-C\LO#%]K:KII:+'$J\>S M'[\_D .:_*7U#?]2#EC5^IH_T@3&!'H ]VE^G[_0!OU/)Y_^#U!+ P04 M" *BFQ3&=;9<E,$ "Y"@ & 'AL+W=O<FMS:&5E=',O<VAE970X+GAM M;*U6VV[;1A#]E8%:%#; 6KR*I",+L!.W"="XAM4V#T4?5N1*7)CD,KO+*/G[ MGEU*M-+*CIOTP>9>9LY<SNQHYENI[G7%N:&/3=WJBTEE3'<^G>JBX@W39[+C M+6[64C7,8*LV4]TISDJGU-33T/=GTX:)=K*8N[-;M9C+WM2BY;>*=-\T3'VZ MXK7<7DR"R?[@3FPJ8P^FBWG'-GS)S>_=K<)N.J*4HN&M%K(EQ=<7D\O@_"JV M\D[@#\&W^F!--I*5E/=V\Z:\F/C6(5[SPE@$AL\'_I+7M06"&^]WF)/1I%4\ M7._1?W*Q(Y85T_REK-^)TE07DVQ")5^SOC9W<ON:[^))+%XA:^W^TW:0C?P) M%;TVLMDIPX-&M,.7?=SEX4 A>TPAW"F$SN_!D//R%3-L,5=R2\I* \TN7*A. M&\Z)UI*R- JW GIF<<U4*]J-II-?I-:G=,L5+2NF^'QJ &^%IL4.ZFJ "A^! MRNFM;$VEZ;HM>?FY_A1NC;Z%>]^NPB<!E[P[H\CW*/3#X F\:(PU<GC1EV(= M@Z0_+U?:*)3&7T_@QR-^[/#CQ_ O[V[>W/R\1"Y_72Z1R^L[6KZ^O+L^ELNO MA*+?*DYK6>,Q(10R;%5S/(Y"MH6HN2:#Z[9ON&)&*F)MB1)M)0K'[7O-2S*2 M"E87?<T,IU+4O<$A'^N@=G70(47:I0@/WZ&:2G'N$"'(J1FXYI9K E.&-ROH M[.ER@ECXY_#8*GY)WLK2S=[S<[I!0Q)M(1N^=VFM9$,(U(BVM[&C,4$63UO3 M]W02>$D6>7'FGPZ[,$V\68C=*Z%W2C!\H!/G,R_-4DK3U,N#V1�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end </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>62 <FILENAME>Show.js <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>63 <FILENAME>report.css <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>64 <FILENAME>FilingSummary.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <XML> <?xml version='1.0' encoding='utf-8'?> <FilingSummary> <Version>3.21.2</Version> <ProcessingTime/> <ReportFormat>html</ReportFormat> <ContextCount>137</ContextCount> <ElementCount>257</ElementCount> <EntityCount>1</EntityCount> <FootnotesReported>false</FootnotesReported> <SegmentCount>34</SegmentCount> <ScenarioCount>0</ScenarioCount> <TuplesReported>false</TuplesReported> <UnitCount>6</UnitCount> <MyReports> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R1.htm</HtmlFileName> <LongName>0001001 - Document - Cover Page</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/CoverPage</Role> <ShortName>Cover Page</ShortName> <MenuCategory>Cover</MenuCategory> <Position>1</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R2.htm</HtmlFileName> <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets</Role> <ShortName>Condensed Consolidated Balance Sheets</ShortName> <MenuCategory>Statements</MenuCategory> <Position>2</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R3.htm</HtmlFileName> <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role> <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName> <MenuCategory>Statements</MenuCategory> <Position>3</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R4.htm</HtmlFileName> <LongName>1003004 - Statement - Condensed Consolidated Statements of Operations</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations</Role> <ShortName>Condensed Consolidated Statements of Operations</ShortName> <MenuCategory>Statements</MenuCategory> <Position>4</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R5.htm</HtmlFileName> <LongName>1004005 - Statement - Condensed Consolidated Statements of Cash Flows</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows</Role> <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName> <MenuCategory>Statements</MenuCategory> <Position>5</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R6.htm</HtmlFileName> <LongName>1005006 - Statement - Condensed Consolidated Statement of Equity</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementofEquity</Role> <ShortName>Condensed Consolidated Statement of Equity</ShortName> <MenuCategory>Statements</MenuCategory> <Position>6</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R7.htm</HtmlFileName> <LongName>2101101 - Disclosure - Organization and Basis of Presentation</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/OrganizationandBasisofPresentation</Role> <ShortName>Organization and Basis of Presentation</ShortName> <MenuCategory>Notes</MenuCategory> <Position>7</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R8.htm</HtmlFileName> <LongName>2104102 - Disclosure - Earnings (Loss) Per Share</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/EarningsLossPerShare</Role> <ShortName>Earnings (Loss) Per Share</ShortName> <MenuCategory>Notes</MenuCategory> <Position>8</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R9.htm</HtmlFileName> <LongName>2108103 - Disclosure - Revenues</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/Revenues</Role> <ShortName>Revenues</ShortName> <MenuCategory>Notes</MenuCategory> <Position>9</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R10.htm</HtmlFileName> <LongName>2111104 - Disclosure - Inventories</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/Inventories</Role> <ShortName>Inventories</ShortName> <MenuCategory>Notes</MenuCategory> <Position>10</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R11.htm</HtmlFileName> <LongName>2115105 - Disclosure - Leases</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/Leases</Role> <ShortName>Leases</ShortName> <MenuCategory>Notes</MenuCategory> <Position>11</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R12.htm</HtmlFileName> <LongName>2121106 - Disclosure - Shareholders' Equity and Debt</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/ShareholdersEquityandDebt</Role> <ShortName>Shareholders' Equity and Debt</ShortName> <MenuCategory>Notes</MenuCategory> <Position>12</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R13.htm</HtmlFileName> <LongName>2124107 - Disclosure - Income Taxes</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/IncomeTaxes</Role> <ShortName>Income Taxes</ShortName> <MenuCategory>Notes</MenuCategory> <Position>13</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R14.htm</HtmlFileName> <LongName>2126108 - Disclosure - Collaborative Agreements</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/CollaborativeAgreements</Role> <ShortName>Collaborative Agreements</ShortName> <MenuCategory>Notes</MenuCategory> <Position>14</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R15.htm</HtmlFileName> <LongName>2127109 - Disclosure - Additions and Returns of Product Rights</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRights</Role> <ShortName>Additions and Returns of Product Rights</ShortName> <MenuCategory>Notes</MenuCategory> <Position>15</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R16.htm</HtmlFileName> <LongName>2202201 - Disclosure - Organization and Basis of Presentation (Policies)</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/OrganizationandBasisofPresentationPolicies</Role> <ShortName>Organization and Basis of Presentation (Policies)</ShortName> <MenuCategory>Policies</MenuCategory> <Position>16</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R17.htm</HtmlFileName> <LongName>2305301 - Disclosure - Earnings (Loss) Per Share (Tables)</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/EarningsLossPerShareTables</Role> <ShortName>Earnings (Loss) Per Share (Tables)</ShortName> <MenuCategory>Tables</MenuCategory> <ParentRole>http://www.cumberlandpharma.com/role/EarningsLossPerShare</ParentRole> <Position>17</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R18.htm</HtmlFileName> <LongName>2309302 - Disclosure - Revenues (Tables)</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/RevenuesTables</Role> <ShortName>Revenues (Tables)</ShortName> <MenuCategory>Tables</MenuCategory> <ParentRole>http://www.cumberlandpharma.com/role/Revenues</ParentRole> <Position>18</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R19.htm</HtmlFileName> <LongName>2312303 - Disclosure - Inventories (Tables)</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/InventoriesTables</Role> <ShortName>Inventories (Tables)</ShortName> <MenuCategory>Tables</MenuCategory> <ParentRole>http://www.cumberlandpharma.com/role/Inventories</ParentRole> <Position>19</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R20.htm</HtmlFileName> <LongName>2316304 - Disclosure - Leases (Tables)</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/LeasesTables</Role> <ShortName>Leases (Tables)</ShortName> <MenuCategory>Tables</MenuCategory> <ParentRole>http://www.cumberlandpharma.com/role/Leases</ParentRole> <Position>20</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R21.htm</HtmlFileName> <LongName>2328305 - Disclosure - Additions and Returns of Product Rights (Tables)</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsTables</Role> <ShortName>Additions and Returns of Product Rights (Tables)</ShortName> <MenuCategory>Tables</MenuCategory> <ParentRole>http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRights</ParentRole> <Position>21</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R22.htm</HtmlFileName> <LongName>2403401 - Disclosure - Organization and Basis of Presentation Organization (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/OrganizationandBasisofPresentationOrganizationDetails</Role> <ShortName>Organization and Basis of Presentation Organization (Details)</ShortName> <MenuCategory>Details</MenuCategory> <Position>22</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R23.htm</HtmlFileName> <LongName>2406402 - Disclosure - Earnings (Loss) Per Share (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/EarningsLossPerShareDetails</Role> <ShortName>Earnings (Loss) Per Share (Details)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://www.cumberlandpharma.com/role/EarningsLossPerShareTables</ParentRole> <Position>23</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R24.htm</HtmlFileName> <LongName>2407403 - Disclosure - Earnings (Loss) Per Share (Details Textual)</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/EarningsLossPerShareDetailsTextual</Role> <ShortName>Earnings (Loss) Per Share (Details Textual)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://www.cumberlandpharma.com/role/EarningsLossPerShareTables</ParentRole> <Position>24</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R25.htm</HtmlFileName> <LongName>2410404 - Disclosure - Revenues (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/RevenuesDetails</Role> <ShortName>Revenues (Details)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://www.cumberlandpharma.com/role/RevenuesTables</ParentRole> <Position>25</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R26.htm</HtmlFileName> <LongName>2413405 - Disclosure - Inventories (Narrative) (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/InventoriesNarrativeDetails</Role> <ShortName>Inventories (Narrative) (Details)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://www.cumberlandpharma.com/role/InventoriesTables</ParentRole> <Position>26</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R27.htm</HtmlFileName> <LongName>2414406 - Disclosure - Inventories (Schedule of Inventories) (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/InventoriesScheduleofInventoriesDetails</Role> <ShortName>Inventories (Schedule of Inventories) (Details)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://www.cumberlandpharma.com/role/InventoriesTables</ParentRole> <Position>27</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R28.htm</HtmlFileName> <LongName>2417407 - Disclosure - Leases (Narrative) (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/LeasesNarrativeDetails</Role> <ShortName>Leases (Narrative) (Details)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://www.cumberlandpharma.com/role/LeasesTables</ParentRole> <Position>28</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R29.htm</HtmlFileName> <LongName>2418408 - Disclosure - Leases (Lease Position) (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/LeasesLeasePositionDetails</Role> <ShortName>Leases (Lease Position) (Details)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://www.cumberlandpharma.com/role/LeasesTables</ParentRole> <Position>29</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R30.htm</HtmlFileName> <LongName>2419409 - Disclosure - Leases (Schedule of Lease Liabilities Maturity and Future Minimum Lease Commitments) (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails</Role> <ShortName>Leases (Schedule of Lease Liabilities Maturity and Future Minimum Lease Commitments) (Details)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://www.cumberlandpharma.com/role/LeasesTables</ParentRole> <Position>30</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R31.htm</HtmlFileName> <LongName>2420410 - Disclosure - Leases - Rent Expense (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/LeasesRentExpenseDetails</Role> <ShortName>Leases - Rent Expense (Details)</ShortName> <MenuCategory>Details</MenuCategory> <Position>31</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R32.htm</HtmlFileName> <LongName>2422411 - Disclosure - Shareholders' Equity and Debt (Shareholders' Equity) (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails</Role> <ShortName>Shareholders' Equity and Debt (Shareholders' Equity) (Details)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://www.cumberlandpharma.com/role/ShareholdersEquityandDebt</ParentRole> <Position>32</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R33.htm</HtmlFileName> <LongName>2423412 - Disclosure - Shareholders' Equity and Debt (Debt) (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails</Role> <ShortName>Shareholders' Equity and Debt (Debt) (Details)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://www.cumberlandpharma.com/role/ShareholdersEquityandDebt</ParentRole> <Position>33</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R34.htm</HtmlFileName> <LongName>2425413 - Disclosure - Income Taxes (Details Textual)</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/IncomeTaxesDetailsTextual</Role> <ShortName>Income Taxes (Details Textual)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://www.cumberlandpharma.com/role/IncomeTaxes</ParentRole> <Position>34</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R35.htm</HtmlFileName> <LongName>2429414 - Disclosure - Additions and Returns of Product Rights - Narrative (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails</Role> <ShortName>Additions and Returns of Product Rights - Narrative (Details)</ShortName> <MenuCategory>Details</MenuCategory> <Position>35</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R36.htm</HtmlFileName> <LongName>2430415 - Disclosure - Additions and Returns of Product Rights - Change in Consideration (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsChangeinConsiderationDetails</Role> <ShortName>Additions and Returns of Product Rights - Change in Consideration (Details)</ShortName> <MenuCategory>Details</MenuCategory> <Position>36</Position> </Report> <Report instance="cpix-20210930.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R37.htm</HtmlFileName> <LongName>2431416 - Disclosure - Additions and Returns of Product Rights - Dissolution Payments (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsDissolutionPaymentsDetails</Role> <ShortName>Additions and Returns of Product Rights - Dissolution Payments (Details)</ShortName> <MenuCategory>Details</MenuCategory> <Position>37</Position> </Report> <Report> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <LongName>All Reports</LongName> <ReportType>Book</ReportType> <ShortName>All Reports</ShortName> </Report> </MyReports> <InputFiles> <File doctype="10-Q" original="cpix-20210930.htm">cpix-20210930.htm</File> <File>a2021q3-exhibit311.htm</File> <File>a2021q3-exhibit312.htm</File> <File>a2021q3-exhibit321.htm</File> <File>cpix-20210930.xsd</File> <File>cpix-20210930_cal.xml</File> <File>cpix-20210930_def.xml</File> <File>cpix-20210930_lab.xml</File> <File>cpix-20210930_pre.xml</File> <File>pinnaclelocrenewal4thloa.htm</File> </InputFiles> <SupplementalFiles/> <BaseTaxonomies> <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy> <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy> <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy> </BaseTaxonomies> <HasPresentationLinkbase>true</HasPresentationLinkbase> <HasCalculationLinkbase>true</HasCalculationLinkbase> </FilingSummary> </XML> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>JSON <SEQUENCE>66 <FILENAME>MetaLinks.json <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> { "instance": { "cpix-20210930.htm": { "axisCustom": 0, "axisStandard": 17, "contextCount": 137, "dts": { "calculationLink": { "local": [ "cpix-20210930_cal.xml" ] }, "definitionLink": { "local": [ "cpix-20210930_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "cpix-20210930.htm" ] }, "labelLink": { "local": [ "cpix-20210930_lab.xml" ] }, "presentationLink": { "local": [ "cpix-20210930_pre.xml" ] }, "schema": { "local": [ "cpix-20210930.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 309, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 5, "total": 5 }, "keyCustom": 14, "keyStandard": 243, "memberCustom": 15, "memberStandard": 18, "nsprefix": "cpix", "nsuri": "http://www.cumberlandpharma.com/20210930", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page", "role": "http://www.cumberlandpharma.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2111104 - Disclosure - Inventories", "role": "http://www.cumberlandpharma.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2115105 - Disclosure - Leases", "role": "http://www.cumberlandpharma.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2121106 - Disclosure - Shareholders' Equity and Debt", "role": "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebt", "shortName": "Shareholders' Equity and Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2124107 - Disclosure - Income Taxes", "role": "http://www.cumberlandpharma.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2126108 - Disclosure - Collaborative Agreements", "role": "http://www.cumberlandpharma.com/role/CollaborativeAgreements", "shortName": "Collaborative Agreements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2127109 - Disclosure - Additions and Returns of Product Rights", "role": "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRights", "shortName": "Additions and Returns of Product Rights", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2202201 - Disclosure - Organization and Basis of Presentation (Policies)", "role": "http://www.cumberlandpharma.com/role/OrganizationandBasisofPresentationPolicies", "shortName": "Organization and Basis of Presentation (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2305301 - Disclosure - Earnings (Loss) Per Share (Tables)", "role": "http://www.cumberlandpharma.com/role/EarningsLossPerShareTables", "shortName": "Earnings (Loss) Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2309302 - Disclosure - Revenues (Tables)", "role": "http://www.cumberlandpharma.com/role/RevenuesTables", "shortName": "Revenues (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2312303 - Disclosure - Inventories (Tables)", "role": "http://www.cumberlandpharma.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5fc3bb3df16548c98cacace445d903da_I20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets", "role": "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5fc3bb3df16548c98cacace445d903da_I20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "cpix:AssetsAndLiabilitiesLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2316304 - Disclosure - Leases (Tables)", "role": "http://www.cumberlandpharma.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "cpix:AssetsAndLiabilitiesLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2328305 - Disclosure - Additions and Returns of Product Rights (Tables)", "role": "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsTables", "shortName": "Additions and Returns of Product Rights (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2403401 - Disclosure - Organization and Basis of Presentation Organization (Details)", "role": "http://www.cumberlandpharma.com/role/OrganizationandBasisofPresentationOrganizationDetails", "shortName": "Organization and Basis of Presentation Organization (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406402 - Disclosure - Earnings (Loss) Per Share (Details)", "role": "http://www.cumberlandpharma.com/role/EarningsLossPerShareDetails", "shortName": "Earnings (Loss) Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930", "decimals": "0", "lang": "en-US", "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407403 - Disclosure - Earnings (Loss) Per Share (Details Textual)", "role": "http://www.cumberlandpharma.com/role/EarningsLossPerShareDetailsTextual", "shortName": "Earnings (Loss) Per Share (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410404 - Disclosure - Revenues (Details)", "role": "http://www.cumberlandpharma.com/role/RevenuesDetails", "shortName": "Revenues (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i2b064560ae764b05aee16232fc2b982f_D20210701-20210930", "decimals": "0", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5fc3bb3df16548c98cacace445d903da_I20210930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InventoryValuationReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413405 - Disclosure - Inventories (Narrative) (Details)", "role": "http://www.cumberlandpharma.com/role/InventoriesNarrativeDetails", "shortName": "Inventories (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5fc3bb3df16548c98cacace445d903da_I20210930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InventoryValuationReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5fc3bb3df16548c98cacace445d903da_I20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414406 - Disclosure - Inventories (Schedule of Inventories) (Details)", "role": "http://www.cumberlandpharma.com/role/InventoriesScheduleofInventoriesDetails", "shortName": "Inventories (Schedule of Inventories) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5fc3bb3df16548c98cacace445d903da_I20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5fc3bb3df16548c98cacace445d903da_I20210930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417407 - Disclosure - Leases (Narrative) (Details)", "role": "http://www.cumberlandpharma.com/role/LeasesNarrativeDetails", "shortName": "Leases (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5fc3bb3df16548c98cacace445d903da_I20210930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cpix:AssetsAndLiabilitiesLesseeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5fc3bb3df16548c98cacace445d903da_I20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2418408 - Disclosure - Leases (Lease Position) (Details)", "role": "http://www.cumberlandpharma.com/role/LeasesLeasePositionDetails", "shortName": "Leases (Lease Position) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cpix:AssetsAndLiabilitiesLesseeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5fc3bb3df16548c98cacace445d903da_I20210930", "decimals": "0", "lang": "en-US", "name": "cpix:LeaseLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockNoParValue", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5fc3bb3df16548c98cacace445d903da_I20210930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockNoParValue", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "role": "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:CommonStockNoParValue", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5fc3bb3df16548c98cacace445d903da_I20210930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockNoParValue", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5fc3bb3df16548c98cacace445d903da_I20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2419409 - Disclosure - Leases (Schedule of Lease Liabilities Maturity and Future Minimum Lease Commitments) (Details)", "role": "http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails", "shortName": "Leases (Schedule of Lease Liabilities Maturity and Future Minimum Lease Commitments) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5fc3bb3df16548c98cacace445d903da_I20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420410 - Disclosure - Leases - Rent Expense (Details)", "role": "http://www.cumberlandpharma.com/role/LeasesRentExpenseDetails", "shortName": "Leases - Rent Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:StockRepurchasedDuringPeriodValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2422411 - Disclosure - Shareholders' Equity and Debt (Shareholders' Equity) (Details)", "role": "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails", "shortName": "Shareholders' Equity and Debt (Shareholders' Equity) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i4b890701c9304f309d867768f2a90a7b_D20171101-20171130", "decimals": "-6", "lang": "en-US", "name": "cpix:StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5fc3bb3df16548c98cacace445d903da_I20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:LongTermLineOfCredit", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2423412 - Disclosure - Shareholders' Equity and Debt (Debt) (Details)", "role": "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails", "shortName": "Shareholders' Equity and Debt (Debt) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i7f3eb3a61d724b16837687fe50bb6592_I20200831", "decimals": "-5", "lang": "en-US", "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5fc3bb3df16548c98cacace445d903da_I20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2425413 - Disclosure - Income Taxes (Details Textual)", "role": "http://www.cumberlandpharma.com/role/IncomeTaxesDetailsTextual", "shortName": "Income Taxes (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5fc3bb3df16548c98cacace445d903da_I20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i54eac56082574a4c986a915dc06c3af5_D20210101-20210630", "decimals": "-5", "first": true, "lang": "en-US", "name": "cpix:ProceedsFromSaleOfIntangibleAssetsInstallmentPayment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2429414 - Disclosure - Additions and Returns of Product Rights - Narrative (Details)", "role": "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails", "shortName": "Additions and Returns of Product Rights - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i54eac56082574a4c986a915dc06c3af5_D20210101-20210630", "decimals": "-5", "first": true, "lang": "en-US", "name": "cpix:ProceedsFromSaleOfIntangibleAssetsInstallmentPayment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i890f0fecec4a4eb899b3171ad304df32_I20201231", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2430415 - Disclosure - Additions and Returns of Product Rights - Change in Consideration (Details)", "role": "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsChangeinConsiderationDetails", "shortName": "Additions and Returns of Product Rights - Change in Consideration (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "id08ba9ef8fce4ef0b1aebddae7a819be_D20210101-20210930", "decimals": "0", "lang": "en-US", "name": "us-gaap:PaymentsForRoyalties", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2431416 - Disclosure - Additions and Returns of Product Rights - Dissolution Payments (Details)", "role": "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsDissolutionPaymentsDetails", "shortName": "Additions and Returns of Product Rights - Dissolution Payments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "ieb58760ea84940319b35492cd1910735_D20210701-20210930", "decimals": "0", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003004 - Statement - Condensed Consolidated Statements of Operations", "role": "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations", "shortName": "Condensed Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i5cfdffb6c8a4411a95e4596b0bd91b7c_D20210701-20210930", "decimals": "0", "lang": "en-US", "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004005 - Statement - Condensed Consolidated Statements of Cash Flows", "role": "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": "0", "lang": "en-US", "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fa410e0219e41c3b8a23d8140a1ca8c_I20191231", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005006 - Statement - Condensed Consolidated Statement of Equity", "role": "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementofEquity", "shortName": "Condensed Consolidated Statement of Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i4167fc9dfbd441ed853e3173c4f077bf_D20200101-20200331", "decimals": "0", "lang": "en-US", "name": "us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101101 - Disclosure - Organization and Basis of Presentation", "role": "http://www.cumberlandpharma.com/role/OrganizationandBasisofPresentation", "shortName": "Organization and Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2104102 - Disclosure - Earnings (Loss) Per Share", "role": "http://www.cumberlandpharma.com/role/EarningsLossPerShare", "shortName": "Earnings (Loss) Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2108103 - Disclosure - Revenues", "role": "http://www.cumberlandpharma.com/role/Revenues", "shortName": "Revenues", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cpix-20210930.htm", "contextRef": "i6fe1f45e467a44adb0adbb9c65a6f6f2_D20210101-20210930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 34, "tag": { "cpix_AcetadoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acetadote", "label": "Acetadote [Member]", "terseLabel": "Kristalose" } } }, "localname": "AcetadoteMember", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/RevenuesDetails" ], "xbrltype": "domainItemType" }, "cpix_AssetsAndLiabilitiesLesseeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets and Liabilities, Lessee", "label": "Assets and Liabilities, Lessee [Table Text Block]", "terseLabel": "Lease Position" } } }, "localname": "AssetsAndLiabilitiesLesseeTableTextBlock", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "cpix_BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Contingent Consideration, Earned and Accrued in Operating Expenses", "label": "Business Combination, Contingent Consideration, Earned and Accrued in Operating Expenses", "terseLabel": "Contingent consideration earned and accrued in operating expenses" } } }, "localname": "BusinessCombinationContingentConsiderationEarnedAndAccruedInOperatingExpenses", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsChangeinConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "cpix_CaldolorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Caldolor", "label": "Caldolor [Member]", "terseLabel": "Omeclamox-Pak" } } }, "localname": "CaldolorMember", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/RevenuesDetails" ], "xbrltype": "domainItemType" }, "cpix_ClinigenHealthcareLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Clinigen Healthcare Limited", "label": "Clinigen Healthcare Limited [Member]", "terseLabel": "Clinigen" } } }, "localname": "ClinigenHealthcareLimitedMember", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsDissolutionPaymentsDetails", "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails" ], "xbrltype": "domainItemType" }, "cpix_DenominatorAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Denominator.", "label": "Denominator [Abstract]", "verboseLabel": "Denominator:" } } }, "localname": "DenominatorAbstract", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/EarningsLossPerShareDetails" ], "xbrltype": "stringItemType" }, "cpix_EquityAndDebtAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity and Debt [Abstract]", "label": "Equity and Debt [Abstract]" } } }, "localname": "EquityAndDebtAbstract", "nsuri": "http://www.cumberlandpharma.com/20210930", "xbrltype": "stringItemType" }, "cpix_FifthAmendmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fifth Amendment", "label": "Fifth Amendment [Member]", "terseLabel": "Fifth Amendment" } } }, "localname": "FifthAmendmentMember", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "domainItemType" }, "cpix_IfetrobanClinicalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ifetroban Clinical", "label": "Ifetroban Clinical [Member]", "terseLabel": "Ifetroban Clinical" } } }, "localname": "IfetrobanClinicalMember", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/InventoriesNarrativeDetails" ], "xbrltype": "domainItemType" }, "cpix_IncentiveStockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Incentive Stock Options", "label": "Incentive Stock Options [Member]", "terseLabel": "Incentive Stock Options" } } }, "localname": "IncentiveStockOptionsMember", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "cpix_IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy": { "auth_ref": [], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) In Cash Surrender Value Of Life Insurance Policy", "label": "Increase (Decrease) In Cash Surrender Value Of Life Insurance Policy", "negatedTerseLabel": "Increase (Decrease) In Cash Surrender Value Of Life Insurance Policy" } } }, "localname": "IncreaseDecreaseInCashSurrenderValueOfLifeInsurancePolicy", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "cpix_IncreaseDecreaseInCurrentOperatingLiabilities": { "auth_ref": [], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "IncreaseDecreaseInCurrentOperatingLiabilities", "verboseLabel": "Accounts payable and other current liabilities" } } }, "localname": "IncreaseDecreaseInCurrentOperatingLiabilities", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "cpix_KristaloseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kristalose", "label": "Kristalose [Member]", "terseLabel": "Caldolor" } } }, "localname": "KristaloseMember", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/RevenuesDetails" ], "xbrltype": "domainItemType" }, "cpix_LeaseLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lease, Liability", "label": "Lease, Liability", "terseLabel": "Total" } } }, "localname": "LeaseLiability", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesLeasePositionDetails" ], "xbrltype": "monetaryItemType" }, "cpix_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree": { "auth_ref": [], "calculation": { "http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lessee, Operating Lease, Liability, to be Paid, after Year Three", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Three", "terseLabel": "After 2023" } } }, "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearThree", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "cpix_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit Facility, Maximum Borrowing Capacity, Increase Amount", "label": "Line of Credit Facility, Maximum Borrowing Capacity, Increase Amount", "terseLabel": "Increase amount (up to)" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacityIncreaseAmount", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "monetaryItemType" }, "cpix_LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit Facility, Maximum Borrowing Capacity, Total Capacity", "label": "Line of Credit Facility, Maximum Borrowing Capacity, Total Capacity", "terseLabel": "Total capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacityTotalCapacity", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "monetaryItemType" }, "cpix_MethotrexateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Methotrexate [Member]", "label": "Methotrexate [Member]", "terseLabel": "Methotrexate" } } }, "localname": "MethotrexateMember", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails" ], "xbrltype": "domainItemType" }, "cpix_NumeratorAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Numerator.", "label": "Numerator [Abstract]", "verboseLabel": "Numerator:" } } }, "localname": "NumeratorAbstract", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/EarningsLossPerShareDetails" ], "xbrltype": "stringItemType" }, "cpix_OmeclamoxPakMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Omeclamox-Pak", "label": "Omeclamox-Pak [Member]", "terseLabel": "Vibativ" } } }, "localname": "OmeclamoxPakMember", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/RevenuesDetails" ], "xbrltype": "domainItemType" }, "cpix_OtherLongTermObligationsExcludingCurrentPortion": { "auth_ref": [], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other Long Term Obligations, Excluding Current Portion", "label": "Other Long Term Obligations, Excluding Current Portion", "verboseLabel": "Other long-term liabilities" } } }, "localname": "OtherLongTermObligationsExcludingCurrentPortion", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "cpix_OtherProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Products", "label": "Other Products [Member]", "terseLabel": "Other revenue" } } }, "localname": "OtherProductsMember", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/RevenuesDetails" ], "xbrltype": "domainItemType" }, "cpix_PinnacleBankMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pinnacle Bank", "label": "Pinnacle Bank [Member]", "terseLabel": "Pinnacle Bank" } } }, "localname": "PinnacleBankMember", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails", "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "cpix_ProceedsFromSaleOfIntangibleAssetsInstallmentPayment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Proceeds from Sale of Intangible Assets, Installment Payment", "label": "Proceeds from Sale of Intangible Assets, Installment Payment", "terseLabel": "Financial consideration received in exchange for product license rights, installment payments" } } }, "localname": "ProceedsFromSaleOfIntangibleAssetsInstallmentPayment", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cpix_ProductsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Products.", "label": "Products [Abstract]", "verboseLabel": "Products:" } } }, "localname": "ProductsAbstract", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/RevenuesDetails" ], "xbrltype": "stringItemType" }, "cpix_RediTrexMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RediTrex", "label": "RediTrex [Member]", "terseLabel": "RediTrex" } } }, "localname": "RediTrexMember", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/RevenuesDetails" ], "xbrltype": "domainItemType" }, "cpix_ScheduleofRentExpenseandSubleaseIncomeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Rent Expense and Sublease Income [Table Text Block]", "label": "Schedule of Rent Expense and Sublease Income [Table Text Block]", "terseLabel": "Schedule of Rent Expense and Sublease Income" } } }, "localname": "ScheduleofRentExpenseandSubleaseIncomeTableTextBlock", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "cpix_ShareholdersEquityTextualAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shareholders Equity.", "label": "Shareholders Equity (Textual) [Abstract]", "verboseLabel": "Shareholders' Equity (Textual) [Abstract]" } } }, "localname": "ShareholdersEquityTextualAbstract", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "cpix_StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities", "terseLabel": "Shelf Registration, sale of corporate securities (up to)" } } }, "localname": "StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "cpix_TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The Coronavirus Aid, Relief, and Economic Security Act, Loan Proceeds Received", "label": "The Coronavirus Aid, Relief, and Economic Security Act, Loan Proceeds Received", "terseLabel": "Aggregate amount" } } }, "localname": "TheCoronavirusAidReliefAndEconomicSecurityActLoanProceedsReceived", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "monetaryItemType" }, "cpix_TieredRoyaltyPaymentsPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tiered Royalty Payments, Percentage", "label": "Tiered Royalty Payments, Percentage", "terseLabel": "Percentage of tiered royalty payments (up to)" } } }, "localname": "TieredRoyaltyPaymentsPercentage", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails" ], "xbrltype": "percentItemType" }, "cpix_VIBATIVMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "VIBATIV", "label": "VIBATIV [Member]", "terseLabel": "Vaprisol" } } }, "localname": "VIBATIVMember", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsChangeinConsiderationDetails", "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails", "http://www.cumberlandpharma.com/role/InventoriesNarrativeDetails", "http://www.cumberlandpharma.com/role/RevenuesDetails" ], "xbrltype": "domainItemType" }, "cpix_VaprisolMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vaprisol", "label": "Vaprisol [Member]", "terseLabel": "Acetadote" } } }, "localname": "VaprisolMember", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/RevenuesDetails" ], "xbrltype": "domainItemType" }, "cpix_WinHealthInvestmentSingaporeLtdDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "WinHealth Investment (Singapore) Ltd", "label": "WinHealth Investment (Singapore) Ltd [Domain]", "terseLabel": "WinHealth" } } }, "localname": "WinHealthInvestmentSingaporeLtdDomain", "nsuri": "http://www.cumberlandpharma.com/20210930", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r353" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r356" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r64", "r98" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsDissolutionPaymentsDetails", "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails", "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "stringItemType" }, "srt_DirectorMember": { "auth_ref": [ "r172" ], "lang": { "en-us": { "role": { "label": "Director [Member]", "terseLabel": "Director" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r203", "r205", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r340", "r342" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r203", "r205", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r340", "r342" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "domainItemType" }, "srt_OfficeBuildingMember": { "auth_ref": [ "r348", "r349" ], "lang": { "en-us": { "role": { "label": "Office Building [Member]", "terseLabel": "Wet Laboratory and Office Space" } } }, "localname": "OfficeBuildingMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r167", "r199", "r200", "r307", "r339", "r341" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/RevenuesDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r167", "r199", "r200", "r307", "r339", "r341" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/RevenuesDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r201", "r203", "r205", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r340", "r342" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r201", "r203", "r205", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r340", "r342" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsDissolutionPaymentsDetails", "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails", "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r172", "r298" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]", "terseLabel": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]", "terseLabel": "Relationship to Entity [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r49" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "verboseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r22", "r35", "r173", "r174" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "verboseLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Adjustments to reconcile net income (loss) from continuing operations to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r73", "r90", "r285" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "verboseLabel": "Noncash interest expense" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r90", "r183", "r185" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations": { "order": 5.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "verboseLabel": "Amortization" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "verboseLabel": "Common stock available for purchase through restricted stock awards and options (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/EarningsLossPerShareDetailsTextual" ], "xbrltype": "sharesItemType" }, "us-gaap_AreaOfRealEstateProperty": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area of a real estate property.", "label": "Area of Real Estate Property", "terseLabel": "Square feet of office space" } } }, "localname": "AreaOfRealEstateProperty", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesNarrativeDetails" ], "xbrltype": "areaItemType" }, "us-gaap_Assets": { "auth_ref": [ "r96", "r147", "r157", "r163", "r176", "r260", "r265", "r274", "r311", "r325" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "verboseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r23", "r24", "r63", "r96", "r176", "r260", "r265", "r274" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "verboseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r208", "r213" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails", "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r272", "r273" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r186" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Office Space" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r202", "r204" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsChangeinConsiderationDetails", "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails", "http://www.cumberlandpharma.com/role/InventoriesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r202", "r204", "r240", "r241" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsChangeinConsiderationDetails", "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails", "http://www.cumberlandpharma.com/role/InventoriesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]", "verboseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsChangeinConsiderationDetails", "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsDissolutionPaymentsDetails", "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": { "auth_ref": [ "r244", "r246", "r247", "r250" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.", "label": "Business Combination, Consideration Transferred, Liabilities Incurred", "terseLabel": "Liability recorded" } } }, "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "auth_ref": [ "r89", "r252" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.", "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability", "terseLabel": "Change in fair value of contingent consideration included in operating expenses" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsChangeinConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [ "r245", "r248", "r251" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.", "label": "Business Combination, Contingent Consideration, Liability", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Additional liability" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsChangeinConsiderationDetails", "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r253" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "ADDITIONS AND RETURN OF PRODUCT RIGHTS" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRights" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "auth_ref": [ "r242", "r243" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles", "verboseLabel": "Net intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r20", "r45", "r92" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r86", "r92", "r93" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r86", "r275" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": { "auth_ref": [ "r13", "r86" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Cash Provided by (Used in) Operating Activities, Discontinued Operations", "terseLabel": "Discontinued operations" } } }, "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CollaborativeArrangementDisclosureTextBlock": { "auth_ref": [ "r254", "r255", "r256" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.", "label": "Collaborative Arrangement Disclosure [Text Block]", "terseLabel": "COLLABORATIVE AGREEMENTS" } } }, "localname": "CollaborativeArrangementDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CollaborativeAgreements" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r56", "r190", "r316", "r330" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r102", "r103" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "verboseLabel": "Common stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementofEquity", "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockNoParValue": { "auth_ref": [ "r34" ], "lang": { "en-us": { "role": { "documentation": "Face amount per share of no-par value common stock.", "label": "Common Stock, No Par Value", "verboseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockNoParValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r34" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "verboseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r34" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "verboseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r34", "r195" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Balance, End of Period (in shares)", "periodStartLabel": "Balance, Beginning of Period (in shares)", "verboseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementofEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r34" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "verboseLabel": "Common stock\u2014no par value; 100,000,000 shares authorized; 15,555,865 and 15,723,075 shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r194" ], "lang": { "en-us": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]", "terseLabel": "Convertible Debt" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r75", "r307" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Costs of products sold", "verboseLabel": "Cost of products sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsDissolutionPaymentsDetails", "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r74" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total costs and expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Costs and Expenses [Abstract]", "verboseLabel": "Costs and expenses:" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r30", "r31", "r32", "r312", "r313", "r324" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Variable rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r284", "r286" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Convertible note" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r54" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate spread" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r55" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r90", "r145" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "verboseLabel": "Depreciation and amortization expense" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": { "auth_ref": [ "r1", "r2", "r3", "r4", "r5", "r12", "r70", "r332" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax", "terseLabel": "Discontinued operations income" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Tax Authority [Member]", "terseLabel": "Federal" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/IncomeTaxesDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "verboseLabel": "Earnings (loss) per share attributable to common shareholders" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r72", "r107", "r108", "r109", "r110", "r111", "r115", "r117", "r120", "r121", "r122", "r126", "r127", "r321", "r335" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "verboseLabel": "Earnings (loss) per share attributable to common shareholders - basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r72", "r107", "r108", "r109", "r110", "r111", "r117", "r120", "r121", "r122", "r126", "r127", "r321", "r335" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "verboseLabel": "Earnings (loss) per share attributable to common shareholders - diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r123", "r124", "r125", "r128" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "EARNINGS (LOSS) PER SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/EarningsLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue from External Customer [Line Items]", "terseLabel": "Revenue from External Customer [Line Items]" } } }, "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/RevenuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r102", "r103", "r104", "r106", "r112", "r114", "r129", "r177", "r195", "r196", "r214", "r215", "r216", "r230", "r231", "r276", "r277", "r278", "r279", "r280", "r281", "r343", "r344", "r345" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementofEquity", "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities": { "auth_ref": [ "r218" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.", "label": "Excess Tax Benefit from Share-based Compensation, Operating Activities", "negatedLabel": "Decrease in non-cash contingent consideration" } } }, "localname": "ExcessTaxBenefitFromShareBasedCompensationOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r184", "r308" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "verboseLabel": "Intangible assets, net" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r76" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations": { "order": 4.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "verboseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r181", "r182", "r310" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrantMember": { "auth_ref": [ "r200" ], "lang": { "en-us": { "role": { "documentation": "Award of money not required to be repaid.", "label": "Grant [Member]", "terseLabel": "Grant" } } }, "localname": "GrantMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/RevenuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r69", "r147", "r156", "r159", "r162", "r165", "r309", "r318", "r323", "r336" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income (loss) from continuing operations before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r96", "r105", "r147", "r156", "r159", "r162", "r165", "r176", "r259", "r274" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 }, "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income (loss) from continuing operations", "totalLabel": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest, Total" } } }, "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations", "http://www.cumberlandpharma.com/role/EarningsLossPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "auth_ref": [ "r67", "r72", "r105", "r107", "r108", "r109", "r110", "r117", "r120", "r121", "r317", "r319", "r321", "r331" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Basic Share", "terseLabel": "Earnings (loss) per share attributable to common shareholders - Continuing operations - basic (in dollars per share)" } } }, "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "auth_ref": [ "r67", "r72", "r105", "r107", "r108", "r109", "r110", "r117", "r120", "r121", "r122", "r321", "r331", "r334", "r335" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Diluted Share", "terseLabel": "Earnings (loss) per share attributable to common shareholders - Continuing operations - diluted (in dollars per share)" } } }, "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": { "auth_ref": [ "r1", "r2", "r3", "r4", "r5", "r15", "r18", "r236", "r332" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Discontinued operations" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations", "http://www.cumberlandpharma.com/role/EarningsLossPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": { "auth_ref": [ "r1", "r2", "r3", "r4", "r5", "r12", "r15", "r259" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent", "terseLabel": "Income from discontinued operations" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsDissolutionPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": { "auth_ref": [ "r70", "r72", "r118", "r120", "r121", "r321", "r332", "r334", "r335" ], "lang": { "en-us": { "role": { "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.", "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share", "terseLabel": "Earnings (loss) per share attributable to common shareholders - Discontinued operations - basic (in dollars per share)" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": { "auth_ref": [ "r118", "r120", "r121", "r270" ], "lang": { "en-us": { "role": { "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.", "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share", "terseLabel": "Earnings (loss) per share attributable to common shareholders - Discontinued operations - diluted (in dollars per share)" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r222" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/IncomeTaxesDetailsTextual" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/IncomeTaxesDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxContingencyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Tax Contingency [Line Items]", "terseLabel": "Income Tax Contingency [Line Items]" } } }, "localname": "IncomeTaxContingencyLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/IncomeTaxesDetailsTextual" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxContingencyTable": { "auth_ref": [ "r223", "r224", "r226", "r229" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.", "label": "Income Tax Contingency [Table]", "terseLabel": "Income Tax Contingency [Table]" } } }, "localname": "IncomeTaxContingencyTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/IncomeTaxesDetailsTextual" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r221", "r225", "r227", "r232", "r234", "r237", "r238", "r239" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r97", "r113", "r114", "r146", "r220", "r233", "r235", "r337" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income tax (expense) benefit" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r89" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r89" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "verboseLabel": "Net changes in assets and liabilities affecting operating activities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": { "auth_ref": [], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.", "label": "Increase (Decrease) in Other Noncurrent Liabilities", "terseLabel": "Other long-term liabilities" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r89" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other current assets and other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementofEquity" ], "xbrltype": "stringItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r68", "r144", "r283", "r285", "r322" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryCurrentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.", "label": "Inventory, Current [Table]", "terseLabel": "Inventory, Current [Table]" } } }, "localname": "InventoryCurrentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/InventoriesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r180" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "INVENTORIES" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r59" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Inventory, Finished Goods, Gross", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/InventoriesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r40", "r179" ], "calculation": { "http://www.cumberlandpharma.com/role/InventoriesScheduleofInventoriesDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Inventory, Finished Goods, Net of Reserves", "verboseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/InventoriesNarrativeDetails", "http://www.cumberlandpharma.com/role/InventoriesScheduleofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryGross": { "auth_ref": [ "r60" ], "calculation": { "http://www.cumberlandpharma.com/role/InventoriesScheduleofInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Inventory, Gross", "totalLabel": "Total inventories" } } }, "localname": "InventoryGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/InventoriesScheduleofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Inventory [Line Items]", "terseLabel": "Inventory [Line Items]" } } }, "localname": "InventoryLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/InventoriesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r21", "r60" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Total inventories classified as current", "verboseLabel": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets", "http://www.cumberlandpharma.com/role/InventoriesScheduleofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory, Net, Items Net of Reserve Alternative [Abstract]", "verboseLabel": "Inventory" } } }, "localname": "InventoryNetItemsNetOfReserveAlternativeAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/InventoriesScheduleofInventoriesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryNoncurrent": { "auth_ref": [ "r61" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.", "label": "Inventory, Noncurrent", "negatedLabel": "Inventory, Noncurrent", "terseLabel": "Non-current inventories" } } }, "localname": "InventoryNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets", "http://www.cumberlandpharma.com/role/InventoriesNarrativeDetails", "http://www.cumberlandpharma.com/role/InventoriesScheduleofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "auth_ref": [ "r41", "r179" ], "calculation": { "http://www.cumberlandpharma.com/role/InventoriesScheduleofInventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.", "label": "Inventory, Raw Materials, Net of Reserves", "verboseLabel": "Raw materials and work in process" } } }, "localname": "InventoryRawMaterialsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/InventoriesScheduleofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r60", "r101", "r178" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventory Valuation Reserves", "terseLabel": "Obsolescence and discontinuance losses" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/InventoriesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r77", "r143" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "verboseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": { "auth_ref": [ "r46" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.", "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures", "terseLabel": "Initial investment in joint ventures" } } }, "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r290" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Schedule of Maturity of Lease Liabilities" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r294" ], "calculation": { "http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r294" ], "calculation": { "http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r294" ], "calculation": { "http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r294" ], "calculation": { "http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r294" ], "calculation": { "http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails_1": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "verboseLabel": "Less: Interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "LEASES" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceived": { "auth_ref": [ "r297" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payments to be received by lessor for operating lease.", "label": "Lessor, Operating Lease, Payments to be Received", "terseLabel": "Future minimum sublease income under noncancelable operating subleases" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceived", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r51", "r96", "r158", "r176", "r261", "r265", "r266", "r274" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r39", "r96", "r176", "r274", "r315", "r328" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "verboseLabel": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r53", "r96", "r176", "r261", "r265", "r266", "r274" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "verboseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityAxis": { "auth_ref": [ "r50", "r99" ], "lang": { "en-us": { "role": { "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.", "label": "Lender Name [Axis]", "terseLabel": "Lender Name [Axis]" } } }, "localname": "LineOfCreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails", "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityLenderDomain": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.", "label": "Line of Credit Facility, Lender [Domain]", "terseLabel": "Line of Credit Facility, Lender [Domain]" } } }, "localname": "LineOfCreditFacilityLenderDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails", "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]", "terseLabel": "Line of Credit Facility [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r50" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Line of credit, maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r50", "r99" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]", "terseLabel": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.", "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage", "terseLabel": "Line of credit, unused capacity, commitment fee percentage" } } }, "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Line of Credit" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]", "terseLabel": "LIBOR" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermLineOfCredit": { "auth_ref": [ "r55", "r191", "r192" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit, Noncurrent", "verboseLabel": "Revolving line of credit" } } }, "localname": "LongTermLineOfCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets", "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r55" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r55", "r193" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingencyAccrualRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Loss Contingency Accrual [Roll Forward]", "terseLabel": "Loss Contingency Accrual [Roll Forward]" } } }, "localname": "LossContingencyAccrualRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsChangeinConsiderationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r58", "r96", "r176", "r274", "r314", "r327" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling interests" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r86" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "verboseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r86" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "verboseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r86", "r88", "r91" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations": { "auth_ref": [ "r86", "r88", "r91" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations", "totalLabel": "Net cash provided by operating activities from continuing operations" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r18", "r65", "r66", "r71", "r91", "r96", "r105", "r107", "r108", "r109", "r110", "r113", "r114", "r119", "r147", "r156", "r159", "r162", "r165", "r176", "r274", "r320", "r333" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income (loss) attributable to common shareholders", "totalLabel": "Net income (loss) attributable to common shareholders" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations", "http://www.cumberlandpharma.com/role/EarningsLossPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r65", "r66", "r113", "r114", "r263", "r268" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "negatedLabel": "Net (income) loss at subsidiary attributable to noncontrolling interests" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations", "http://www.cumberlandpharma.com/role/EarningsLossPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Guidance" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/OrganizationandBasisofPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r102", "r103", "r104", "r196", "r257" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "verboseLabel": "Noncontrolling interests" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementofEquity" ], "xbrltype": "domainItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/OrganizationandBasisofPresentationOrganizationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r147", "r156", "r159", "r162", "r165" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating income (loss)" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r289" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "terseLabel": "Rent expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesRentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]", "terseLabel": "Maturity of Lease Liabilities at September 30, 2021" } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r288" ], "calculation": { "http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails_1": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Present value of lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilitiesMaturityandFutureMinimumLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r288" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease current liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets", "http://www.cumberlandpharma.com/role/LeasesLeasePositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r288" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease noncurrent liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets", "http://www.cumberlandpharma.com/role/LeasesLeasePositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r287" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets", "http://www.cumberlandpharma.com/role/LeasesLeasePositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r293", "r295" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Present value of remaining lease payments, percent" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r292", "r295" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r228" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/IncomeTaxesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r19", "r271" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "ORGANIZATION AND BASIS OF PRESENTATION" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/OrganizationandBasisofPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r62" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "verboseLabel": "Prepaid and other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r48" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "verboseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current liabilities.", "label": "Other Current Liabilities [Member]", "terseLabel": "Other current liabilities" } } }, "localname": "OtherCurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherIncome": { "auth_ref": [ "r338" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue and income classified as other.", "label": "Other Income", "terseLabel": "Other income" } } }, "localname": "OtherIncome", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment": { "auth_ref": [ "r42" ], "calculation": { "http://www.cumberlandpharma.com/role/InventoriesScheduleofInventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of inventory owned by the entity but in the hands of a customer, typically a reseller.", "label": "Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross", "terseLabel": "Consigned inventory" } } }, "localname": "OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/InventoriesScheduleofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r25", "r26", "r52" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "verboseLabel": "Other current liabilities" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Member]", "terseLabel": "Other long-term liabilities" } } }, "localname": "OtherNoncurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherPaymentsToAcquireBusinesses": { "auth_ref": [ "r79" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs.", "label": "Other Payments to Acquire Businesses", "terseLabel": "Other Payments to Acquire Businesses" } } }, "localname": "OtherPaymentsToAcquireBusinesses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": { "auth_ref": [ "r84" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.", "label": "Payment for Contingent Consideration Liability, Financing Activities", "negatedLabel": "Cash payment of contingent consideration" } } }, "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r82" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchase of common shares" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest": { "auth_ref": [ "r82" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period for redemption of redeemable noncontrolling interests.", "label": "Payments for Repurchase of Redeemable Noncontrolling Interest", "negatedLabel": "Repurchase of subsidiary shares from noncontrolling interest" } } }, "localname": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRoyalties": { "auth_ref": [ "r87" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid for royalties during the current period.", "label": "Payments for Royalties", "negatedLabel": "Cash payment of royalty during the period" } } }, "localname": "PaymentsForRoyalties", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsChangeinConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r79", "r249" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Payment to acquire business upon closing" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r80" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Additions to intangible assets" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r81" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "negatedTerseLabel": "Note receivable investment funding" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r80" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Additions to property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": { "auth_ref": [ "r100" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).", "label": "Proceeds from (Repayments of) Lines of Credit", "terseLabel": "Borrowings on line of credit" } } }, "localname": "ProceedsFromRepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "auth_ref": [], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.", "label": "Proceeds from Sale and Maturity of Marketable Securities", "terseLabel": "Proceeds from surrender of life insurance policies" } } }, "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfIntangibleAssets": { "auth_ref": [ "r78" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from disposal of asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Proceeds from Sale of Intangible Assets", "terseLabel": "Financial consideration received in exchange for product license rights" } } }, "localname": "ProceedsFromSaleOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r18", "r65", "r66", "r85", "r96", "r105", "r113", "r114", "r147", "r156", "r159", "r162", "r165", "r176", "r259", "r262", "r264", "r268", "r269", "r274", "r323" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income (loss)", "totalLabel": "Net income (loss)", "verboseLabel": "Net income (loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementofEquity", "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations", "http://www.cumberlandpharma.com/role/EarningsLossPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r47", "r187" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r28", "r29", "r187", "r329" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "verboseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r28", "r186" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PublicUtilitiesInventoryAxis": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "Information by type of inventory held.", "label": "Inventory [Axis]", "terseLabel": "Inventory [Axis]" } } }, "localname": "PublicUtilitiesInventoryAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/InventoriesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PublicUtilitiesInventoryTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property that is held for sale in the ordinary course of business, in process of production for such sale or is to be currently consumed in the production of goods or services to be available for sale.", "label": "Inventory [Domain]", "terseLabel": "Inventory [Domain]" } } }, "localname": "PublicUtilitiesInventoryTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/InventoriesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r83" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayments of Notes Payable", "negatedTerseLabel": "Repayments on line of credit" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r219", "r350" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "verboseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Restricted Stock" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails", "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r36", "r196", "r217", "r326", "r346", "r347" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "verboseLabel": "Retained earnings (deficit)" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r102", "r103", "r104", "r106", "r112", "r114", "r177", "r214", "r215", "r216", "r230", "r231", "r343", "r345" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "verboseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementofEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r141", "r142", "r155", "r160", "r161", "r167", "r168", "r170", "r198", "r199", "r307" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Revenues", "verboseLabel": "Net revenues" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsDissolutionPaymentsDetails", "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations", "http://www.cumberlandpharma.com/role/RevenuesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "verboseLabel": "Net Revenues" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/RevenuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.", "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]", "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r240", "r241" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsChangeinConsiderationDetails", "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsDissolutionPaymentsDetails", "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": { "auth_ref": [ "r0", "r6", "r7", "r8", "r9", "r10", "r11", "r14", "r16", "r17", "r18", "r188", "r189" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]", "terseLabel": "Schedule of Dissolution Payments" } } }, "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r122" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Reconciliation of numerator and denominator" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/EarningsLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": { "auth_ref": [ "r167" ], "lang": { "en-us": { "role": { "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.", "label": "Revenue from External Customers by Products and Services [Table]", "terseLabel": "Revenue from External Customers by Products and Services [Table]" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/RevenuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": { "auth_ref": [ "r167" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.", "label": "Revenue from External Customers by Products and Services [Table Text Block]", "terseLabel": "Summary of net revenue" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/RevenuesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r27", "r42", "r43", "r44" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r208", "r213" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r137", "r139", "r140", "r147", "r148", "r159", "r163", "r164", "r165", "r166", "r167", "r169", "r170", "r171" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "REVENUES" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/Revenues" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r94", "r149", "r150", "r151", "r152", "r153", "r154", "r168" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting, Policy [Policy Text Block]", "verboseLabel": "Operating Segments" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/OrganizationandBasisofPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "terseLabel": "Selling, Marketing and other", "verboseLabel": "Selling and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsDissolutionPaymentsDetails", "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r89" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "verboseLabel": "Share-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r209" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Restricted stock awards, vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r211" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Restricted stock granted in period, shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r206", "r210" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Equity Award [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails", "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r57", "r102", "r103", "r104", "r106", "r112", "r114", "r129", "r177", "r195", "r196", "r214", "r215", "r216", "r230", "r231", "r276", "r277", "r278", "r279", "r280", "r281", "r343", "r344", "r345" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementofEquity", "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementofEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r102", "r103", "r104", "r129", "r307" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementofEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r33", "r34", "r196" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Unvested restricted shares (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r33", "r34", "r195", "r196" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Share-based compensation (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementofEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r57", "r195", "r196" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions", "terseLabel": "Vested common stock, value" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/AdditionsandReturnsofProductRightsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r33", "r34", "r196", "r207", "r212" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Share-based compensation" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementofEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "verboseLabel": "Repurchase outstanding common shares" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount remaining of a stock repurchase plan authorized.", "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount", "terseLabel": "Common shares left to repurchase" } } }, "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r33", "r34", "r195", "r196" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "negatedLabel": "Repurchase of shares (in shares)", "terseLabel": "Repurchase of shares (in shares)" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementofEquity", "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r33", "r34", "r195", "r196" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedLabel": "Repurchase of common shares", "negatedTerseLabel": "Repurchase of shares, value" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementofEquity", "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r34", "r37", "r38", "r96", "r175", "r176", "r274" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total shareholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "verboseLabel": "Shareholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r96", "r102", "r103", "r104", "r106", "r112", "r176", "r177", "r196", "r214", "r215", "r216", "r230", "r231", "r257", "r258", "r267", "r274", "r276", "r277", "r281", "r344", "r345" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance, End of Period", "periodStartLabel": "Balance, Beginning of Period", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets", "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementofEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "verboseLabel": "Equity:" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r95", "r196", "r197" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "SHAREHOLDERS' EQUITY AND DEBT" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubleaseIncome": { "auth_ref": [ "r291", "r295" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of sublease income excluding finance and operating lease expense.", "label": "Sublease Income", "terseLabel": "Sublease income" } } }, "localname": "SubleaseIncome", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/LeasesRentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r282", "r299" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r282", "r299" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r282", "r299" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrealizedGainLossOnInvestments": { "auth_ref": [ "r90" ], "calculation": { "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment.", "label": "Unrealized Gain (Loss) on Investments", "negatedTerseLabel": "Gain on forgiveness of debt" } } }, "localname": "UnrealizedGainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r130", "r131", "r132", "r133", "r134", "r135", "r136" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "verboseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/OrganizationandBasisofPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "auth_ref": [ "r122" ], "calculation": { "http://www.cumberlandpharma.com/role/EarningsLossPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.", "label": "Weighted Average Number Diluted Shares Outstanding Adjustment", "terseLabel": "Dilutive effect of other securities (in shares)" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/EarningsLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r116", "r122" ], "calculation": { "http://www.cumberlandpharma.com/role/EarningsLossPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "totalLabel": "Weighted-average shares outstanding \u2013 diluted (in shares)", "verboseLabel": "- diluted (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations", "http://www.cumberlandpharma.com/role/EarningsLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "verboseLabel": "Weighted-average shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r115", "r122" ], "calculation": { "http://www.cumberlandpharma.com/role/EarningsLossPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted-average shares outstanding \u2013 basic (in shares)", "verboseLabel": "- basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperations", "http://www.cumberlandpharma.com/role/EarningsLossPerShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258" }, "r128": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r171": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r180": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230" }, "r19": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4852-112606" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r197": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11374-113907" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r239": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479" }, "r253": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r256": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "808", "URI": "http://asc.fasb.org/topic&trid=5833765" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.E)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828" }, "r271": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971" }, "r296": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919396-209981" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "3B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(20))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.4)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r351": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r352": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r353": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r354": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r355": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r356": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(d))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(13))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868656-224227" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(14))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" } }, "version": "2.1" } </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>ZIP <SEQUENCE>67 <FILENAME>0001628280-21-023213-xbrl.zip <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> begin 644 0001628280-21-023213-xbrl.zip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̻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end </TEXT> </DOCUMENT> </SEC-DOCUMENT>